data_1clh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1clh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.298 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 88.8 Cg_exo . . . . . 0 C--O 1.235 0.373 0 N-CA-C 113.483 0.532 . . . . 0.0 113.483 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.466 ' CD2' ' HG2' ' A' ' 19' ' ' GLU . 37.3 m170 -147.8 114.23 5.95 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.093 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.557 HG23 HG11 ' A' ' 164' ' ' VAL . 14.8 t -71.46 96.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.543 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.491 ' CD1' ' HG2' ' A' ' 17' ' ' GLU . 15.8 tp -79.09 131.14 36.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.772 1.295 . . . . 0.0 109.52 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 1.255 HD21 ' O ' ' A' ' 161' ' ' SER . 8.8 mt -141.43 131.41 24.56 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.507 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.951 HG23 HD11 ' A' ' 160' ' ' LEU . 99.5 m -116.39 94.95 4.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 111.633 -2.531 . . . . 0.0 108.206 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.996 HG21 HG12 ' A' ' 159' ' ' ILE . 22.4 p -81.12 165.25 21.76 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 125.116 1.51 . . . . 0.0 110.715 170.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -39.09 -42.34 0.91 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.802 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.62 -63.09 1.26 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.431 1.082 . . . . 0.0 110.427 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.37 172.24 44.66 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.285 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 1.2 t-20 -76.97 108.21 9.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.428 -1.386 . . . . 0.0 110.006 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.787 HG22 HG12 ' A' ' 134' ' ' VAL . 13.5 pt -103.35 -169.74 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 124.826 1.329 . . . . 0.0 110.959 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 1.491 ' HG2' ' CD1' ' A' ' 8' ' ' LEU . 37.7 mt-10 -161.87 102.45 1.16 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.817 -173.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.062 HD22 HD12 ' A' ' 105' ' ' ILE . 2.7 mm? -73.41 160.74 31.32 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.344 1.027 . . . . 0.0 110.651 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.466 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -138.37 127.55 24.29 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.167 173.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 1.011 HD12 ' HE2' ' A' ' 125' ' ' PHE . 80.3 mt -122.01 143.57 49.41 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.805 1.316 . . . . 0.0 111.975 -168.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.668 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 73.2 m-20 -55.48 -126.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.977 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.962 ' HA ' HG13 ' A' ' 29' ' ' VAL . 38.2 ttmt 145.64 -59.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.029 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 32.4 tt0 -55.1 -57.12 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.096 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.866 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 20.3 tptm -69.09 -4.97 19.27 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.593 1.183 . . . . 0.0 113.465 -172.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.746 ' HB1' ' ND2' ' A' ' 79' ' ' ASN . . . -161.18 70.62 2.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.67 0.606 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 1.198 ' O ' HG21 ' A' ' 29' ' ' VAL . 63.6 Cg_exo -52.7 -54.17 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 111.504 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.13 -65.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 124.704 1.253 . . . . 0.0 110.21 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.4 p -47.2 -52.79 14.81 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.713 1.258 . . . . 0.0 110.886 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.577 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 32.7 m -47.44 -50.2 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.322 1.014 . . . . 0.0 110.653 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 1.039 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 58.2 tp60 -51.23 -52.48 44.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.336 1.023 . . . . 0.0 109.844 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.945 ' OD1' HG23 ' A' ' 73' ' ' ILE . 18.4 m120 -49.96 -66.05 0.46 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.579 1.175 . . . . 0.0 110.322 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 1.577 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 46.8 p90 -57.1 -46.18 82.78 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.448 1.092 . . . . 0.0 110.441 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 1.024 HG11 ' O ' ' A' ' 30' ' ' GLN . 12.0 p -49.33 -40.17 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.976 0.797 . . . . 0.0 110.406 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 1.039 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 2.1 m-20 -45.84 -61.51 1.7 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.097 0.873 . . . . 0.0 108.84 171.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.827 ' HH ' ' HG3' ' A' ' 71' ' ' PRO . 28.3 m-85 -58.35 -60.12 4.28 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.892 1.37 . . . . 0.0 109.302 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.747 HG13 HG13 ' A' ' 164' ' ' VAL . 58.4 t -39.27 -52.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 124.589 1.18 . . . . 0.0 110.683 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.734 ' O ' ' HB3' ' A' ' 38' ' ' SER . 23.1 m120 -38.77 -33.55 0.11 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.765 1.291 . . . . 0.0 111.858 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.734 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.9 p 158.02 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.155 0.909 . . . . 0.0 112.672 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 69.01 79.37 0.28 Allowed Glycine 0 N--CA 1.471 0.984 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.737 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.95 ' O ' HG22 ' A' ' 44' ' ' THR . 15.3 t80 168.76 -75.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.711 0.889 . . . . 0.0 109.514 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.438 ' N ' ' HD1' ' A' ' 40' ' ' PHE . 77.7 m-85 -66.69 -31.73 72.58 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.5 1.125 . . . . 0.0 112.411 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -38.72 -36.16 0.24 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.053 0.845 . . . . 0.0 112.977 -170.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 9.5 t30 -156.5 47.31 0.45 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.064 0.853 . . . . 0.0 110.748 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 40' ' ' PHE . 52.7 p -83.61 -140.56 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.266 161.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 1.074 HG21 ' HA ' ' A' ' 158' ' ' VAL . 46.4 p -163.1 -141.05 0.06 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.988 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.878 ' CE1' HD12 ' A' ' 159' ' ' ILE . 15.6 m-30 -146.11 92.28 2.17 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.25 -1.795 . . . . 0.0 106.384 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 1.261 ' HB2' ' OE1' ' A' ' 56' ' ' GLN . 21.3 m80 -23.31 -67.61 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.351 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.036 ' HB2' ' HA ' ' A' ' 152' ' ' VAL . 1.8 tpm_? -172.32 -142.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.764 1.29 . . . . 0.0 111.217 169.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.981 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 6.2 p -172.08 135.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.274 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.961 HG23 ' HD2' ' A' ' 53' ' ' PHE . 10.9 tt -62.49 129.74 92.84 Favored Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.483 159.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' PHE . 20.5 Cg_endo -45.2 153.04 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.014 2.476 . . . . 0.0 112.079 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 7.26 60.18 0.01 OUTLIER Glycine 0 N--CA 1.474 1.206 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.729 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.961 ' HD2' HG23 ' A' ' 50' ' ' ILE . 65.2 t80 -152.66 -54.63 0.12 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.817 0.951 . . . . 0.0 110.737 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.916 ' O ' HG21 ' A' ' 49' ' ' VAL . 43.5 ttp -171.94 113.68 0.33 Allowed 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.088 0.867 . . . . 0.0 112.124 -169.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.974 HG13 ' HB ' ' A' ' 105' ' ' ILE . 26.7 pt -90.86 155.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.755 164.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.332 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 78.9 mt-30 -68.61 -121.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.382 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 1.115 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -152.67 -119.96 0.81 Allowed Glycine 0 N--CA 1.47 0.932 0 O-C-N 118.624 -2.548 . . . . 0.0 110.549 3.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 61.28 106.86 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 47' ' ' HIS . . . -179.44 -122.8 0.79 Allowed Glycine 0 N--CA 1.475 1.296 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 1.108 ' HB3' ' CA ' ' A' ' 64' ' ' MET . 42.4 m-85 -45.57 113.75 0.65 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.58 0.812 . . . . 0.0 110.264 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.586 ' O ' HG22 ' A' ' 61' ' ' THR . 9.4 t -59.52 116.75 4.2 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.484 1.115 . . . . 0.0 110.565 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.78 ' HB3' ' OE1' ' A' ' 63' ' ' GLN . 44.9 mt-10 65.02 -118.87 0.4 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.748 1.28 . . . . 0.0 110.786 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.78 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 8.0 mp0 -41.67 -58.15 2.06 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.679 1.237 . . . . 0.0 109.363 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 1.108 ' CA ' ' HB3' ' A' ' 60' ' ' PHE . 16.9 ptm 138.63 94.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.704 1.253 . . . . 0.0 107.762 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.702 ' N ' ' HB3' ' A' ' 60' ' ' PHE . 8.8 mm-40 -159.19 105.83 1.74 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.901 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.737 ' HA ' HE21 ' A' ' 66' ' ' GLN . 1.2 mm-40 -29.28 133.39 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.807 -174.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 1.115 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -57.35 -97.73 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.684 168.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.65 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 4.3 ttmp? -167.85 66.92 0.79 Allowed Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.582 165.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 1.244 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 37.0 Cg_exo -69.18 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.58 2.853 . . . . 0.0 113.333 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.244 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 2.1 p-10 102.44 38.04 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 113.377 -1.738 . . . . 0.0 115.607 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 1.526 ' HD2' ' CB ' ' A' ' 100' ' ' THR . 17.7 Cg_endo -95.3 80.25 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.831 3.021 . . . . 0.0 107.541 171.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 1.207 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 75.5 Cg_exo -66.97 110.63 1.99 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.544 2.163 . . . . 0.0 112.08 -163.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.945 HG23 ' OD1' ' A' ' 31' ' ' ASN . 18.9 pt -79.3 -123.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 124.638 1.211 . . . . 0.0 109.207 175.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HD2' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -156.73 -151.72 0.34 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.964 0.79 . . . . 0.0 112.258 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.822 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . 51.7 p30 -39.74 145.41 0.14 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.624 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 1.031 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 1.8 mp0 -131.29 -92.68 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.768 1.292 . . . . 0.0 109.82 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.886 ' HB2' ' CE1' ' A' ' 120' ' ' PHE . . . -38.13 -37.06 0.25 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.674 1.234 . . . . 0.0 112.384 -172.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.822 ' OD2' ' HB2' ' A' ' 75' ' ' ASN . 4.3 p30 -68.8 33.89 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.087 0.867 . . . . 0.0 112.44 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 1.031 ' OD1' ' O ' ' A' ' 76' ' ' GLU . 2.1 p-10 -172.74 82.86 0.05 Allowed 'General case' 0 N--CA 1.469 0.491 0 O-C-N 124.24 0.962 . . . . 0.0 108.766 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.8 ' C ' HD21 ' A' ' 81' ' ' LEU . . . -168.95 0.34 0.04 OUTLIER Glycine 0 N--CA 1.477 1.389 0 CA-C-N 114.711 -1.132 . . . . 0.0 113.48 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 1.464 HD11 ' NH1' ' A' ' 82' ' ' ARG . 1.5 pt? 31.12 172.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 1.464 ' NH1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -60.0 158.1 11.58 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.032 -172.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.814 ' OD1' ' CG2' ' A' ' 87' ' ' THR . 1.0 OUTLIER 175.2 -146.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.464 170.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 1.494 HG22 ' NH1' ' A' ' 85' ' ' ARG . 15.8 m -170.34 162.95 8.66 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.51 0.506 . . . . 0.0 112.012 -167.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 1.494 ' NH1' HG22 ' A' ' 84' ' ' THR . 0.0 OUTLIER -34.15 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.956 1.36 . . . . 0.0 111.004 176.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 127' ' ' LYS . . . 156.6 -29.87 0.56 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-N 110.894 -2.867 . . . . 0.0 109.471 -169.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 1.014 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 50.1 p -81.68 144.73 30.97 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.204 0.591 . . . . 0.0 112.071 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 1.021 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -95.09 159.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.296 165.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.155 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -161.55 144.34 12.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.52 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 1.041 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 41.7 mtp -75.46 144.06 42.29 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.246 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.7 -118.21 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.543 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.256 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.54 -132.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.714 0.634 . . . . 0.0 111.011 176.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 1.256 HG22 ' O ' ' A' ' 92' ' ' ARG . 19.8 p 171.46 152.2 0.06 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.461 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.72 0.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.545 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 1.412 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 56.7 m-20 -40.01 -71.71 0.08 Allowed 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.654 1.221 . . . . 0.0 110.765 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.412 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 8.5 mtpm? 149.1 -94.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.91 1.381 . . . . 0.0 108.341 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.56 104.87 0.56 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.827 1.329 . . . . 0.0 109.197 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.874 ' O ' HG12 ' A' ' 73' ' ' ILE . 31.0 t -169.52 -102.19 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.664 1.228 . . . . 0.0 109.793 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 43.8 76.42 0.08 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.364 1.04 . . . . 0.0 108.6 -173.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 1.526 ' CB ' ' HD2' ' A' ' 71' ' ' PRO . 81.1 p -78.26 -43.47 28.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.105 -171.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 80.0 p -170.76 98.34 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.2 0.937 . . . . 0.0 109.54 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.9 tt0 169.48 123.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.777 1.298 . . . . 0.0 109.887 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 1.021 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.09 175.18 9.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.455 177.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.332 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 29.1 p90 -154.23 136.43 14.81 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.96 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.155 ' N ' ' O ' ' A' ' 56' ' ' GLN . 60.6 mt -95.46 115.06 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.663 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 52.5 m-20 -74.11 -172.61 1.41 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.514 1.134 . . . . 0.0 111.149 173.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 1.195 HG11 ' CE ' ' A' ' 132' ' ' MET . 32.7 m -157.84 -44.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.456 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.944 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -91.87 152.42 20.09 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.255 0.972 . . . . 0.0 112.038 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.851 ' OD1' ' HD2' ' A' ' 85' ' ' ARG . 39.1 m-20 -49.59 106.81 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.12 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 1.034 HD22 HD11 ' A' ' 113' ' ' LEU . 2.8 t-20 -99.3 -100.59 0.23 Allowed 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.832 1.333 . . . . 0.0 109.87 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.717 ' O ' ' CG ' ' A' ' 114' ' ' ASP . . . 75.29 -43.93 0.52 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.931 0.77 . . . . 0.0 110.935 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' HD2' HD21 ' A' ' 110' ' ' ASN . 39.8 m-85 -39.31 -50.69 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.285 0.991 . . . . 0.0 110.79 -176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 1.034 HD11 HD22 ' A' ' 110' ' ' ASN . 7.8 mp -58.41 -24.26 59.59 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.768 1.292 . . . . 0.0 111.492 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.717 ' CG ' ' O ' ' A' ' 111' ' ' ALA . 36.1 m-20 -39.17 101.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.757 0.661 . . . . 0.0 111.037 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -38.7 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.413 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.619 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.886 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.624 ' N ' ' HD1' ' A' ' 120' ' ' PHE . . . -156.24 -77.24 0.02 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 124.371 1.044 . . . . 0.0 112.032 -174.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.562 ' CD2' HD21 ' A' ' 113' ' ' LEU . 43.7 m-85 -77.24 120.51 22.39 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.245 0.615 . . . . 0.0 110.755 -167.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.155 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -70.62 -161.31 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.304 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.041 HG22 ' O ' ' A' ' 123' ' ' ALA . 76.1 t 177.57 141.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.173 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 1.011 ' HE2' HD12 ' A' ' 20' ' ' LEU . 20.2 p90 -174.34 25.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 1.191 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -156.53 -149.19 5.3 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 122.866 1.259 . . . . 0.0 113.823 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.191 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 7.2 mtpm? -179.37 -154.98 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.635 -2.283 . . . . 0.0 110.586 -170.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.78 HG23 HD12 ' A' ' 18' ' ' LEU . 94.3 t -160.04 117.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.722 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.719 HG22 ' CE1' ' A' ' 6' ' ' HIS . 82.6 t -84.5 -75.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 114.042 -1.436 . . . . 0.0 110.448 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 132' ' ' MET . 59.6 tttp -96.18 -94.65 0.2 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.474 1.109 . . . . 0.0 112.338 -167.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.575 ' O ' HG21 ' A' ' 16' ' ' ILE . . . -60.58 51.81 0.03 OUTLIER Glycine 0 N--CA 1.475 1.238 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.442 -165.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.195 ' CE ' HG11 ' A' ' 107' ' ' VAL . 12.1 tpt -60.7 -48.68 80.69 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.666 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.4 t0 -43.58 -57.99 2.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.425 1.078 . . . . 0.0 110.223 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.787 HG12 HG22 ' A' ' 16' ' ' ILE . 54.5 t -39.57 -59.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.458 1.099 . . . . 0.0 109.501 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.751 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -46.13 -52.22 12.56 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.795 1.31 . . . . 0.0 109.658 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.666 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 37.0 m-20 -50.78 -69.25 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.612 1.195 . . . . 0.0 109.553 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.749 ' CA ' ' HG2' ' A' ' 140' ' ' GLN . 8.2 ttpm? -41.29 -45.94 3.09 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.634 1.208 . . . . 0.0 110.395 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.898 ' O ' HG23 ' A' ' 141' ' ' VAL . 15.6 mt -53.8 -59.2 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.873 ' HA ' HH12 ' A' ' 48' ' ' ARG . 79.0 p -64.59 9.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.71 1.256 . . . . 0.0 113.838 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.749 ' HG2' ' CA ' ' A' ' 137' ' ' LYS . 39.6 mm-40 -96.06 -52.71 3.93 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.164 0.915 . . . . 0.0 109.432 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.9 m -49.59 123.69 14.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 124.505 1.128 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 82.6 Cg_exo -41.34 178.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.462 2.775 . . . . 0.0 113.553 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.154 HG21 ' CA ' ' A' ' 153' ' ' PRO . 4.2 p -161.31 -142.22 0.08 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 123.101 1.429 . . . . 0.0 112.137 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.82 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 179.33 145.37 0.17 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 110.691 -2.959 . . . . 0.0 111.941 173.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -63.38 121.67 14.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.102 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.889 HG21 ' HB ' ' A' ' 152' ' ' VAL . 1.5 t -78.09 -65.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.949 -168.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.64 -81.78 0.06 OUTLIER Glycine 0 N--CA 1.47 0.94 0 CA-C-N 111.736 -2.484 . . . . 0.0 107.998 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.771 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 73.6 Cg_endo -66.44 -73.48 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.523 2.816 . . . . 0.0 108.671 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.771 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 43.9 m-85 -76.98 102.73 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.616 1.197 . . . . 0.0 110.107 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 34.2 mt-30 -67.74 135.62 52.97 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.671 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 10.3 m120 83.04 96.51 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 1.036 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 63.0 t -154.07 127.03 4.11 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.876 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.154 ' CA ' HG21 ' A' ' 143' ' ' THR . 55.7 Cg_endo -61.45 102.73 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.554 2.836 . . . . 0.0 109.324 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.293 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 49.2 m -42.33 -58.62 2.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.027 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -82.31 88.46 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 O-C-N 124.832 1.332 . . . . 0.0 108.077 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.293 ' HD3' ' O ' ' A' ' 154' ' ' SER . 86.2 Cg_exo -61.65 141.36 90.76 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.531 2.821 . . . . 0.0 114.967 -166.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 158' ' ' VAL . 97.3 t -69.53 161.57 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.374 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 1.074 ' HA ' HG21 ' A' ' 45' ' ' THR . 99.1 t -147.45 118.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.144 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.996 HG12 HG21 ' A' ' 11' ' ' THR . 50.2 mt -69.35 143.5 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 113.602 -1.636 . . . . 0.0 111.705 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.951 HD11 HG23 ' A' ' 10' ' ' THR . 83.5 mt -95.44 -45.09 7.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 1.255 ' O ' HD21 ' A' ' 9' ' ' LEU . 25.7 t -169.08 165.78 11.11 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 1.049 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -149.95 109.25 3.96 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.524 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -131.18 111.51 12.0 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.438 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.747 HG13 HG13 ' A' ' 36' ' ' VAL . 34.0 m -76.53 135.02 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.78 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 78.5 mt -97.41 134.36 22.72 Favored Pre-proline 0 N--CA 1.479 1.015 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.025 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 165' ' ' LEU . 84.0 Cg_exo . . . . . 0 C--O 1.251 1.129 0 C-N-CA 123.539 2.826 . . . . 0.0 112.139 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.126 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 52.8 Cg_exo . . . . . 0 C--O 1.234 0.323 0 CA-C-O 120.679 0.2 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.7 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 12.9 m170 -160.04 74.62 0.58 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.492 1.12 . . . . 0.0 108.685 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.911 HG12 HD11 ' A' ' 20' ' ' LEU . 18.7 m -61.07 100.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.185 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.193 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 37.5 mt -78.34 145.3 35.35 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.64 1.212 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 1.107 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.8 mt -149.15 162.49 39.88 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.027 -2.352 . . . . 0.0 110.41 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 1.272 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.2 m -160.59 78.1 0.62 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.123 -2.308 . . . . 0.0 108.523 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 1.012 HG21 HG12 ' A' ' 159' ' ' ILE . 35.7 p -70.78 168.63 16.28 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 125.182 1.551 . . . . 0.0 111.44 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.422 ' OG ' HG12 ' A' ' 157' ' ' VAL . 80.5 p -39.57 -44.02 1.39 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.578 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.847 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -57.75 -60.8 3.14 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.443 1.089 . . . . 0.0 110.365 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 134' ' ' VAL . . . 172.03 -179.75 43.47 Favored Glycine 0 N--CA 1.478 1.456 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.222 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 1.107 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 9.7 t-20 -61.23 160.56 10.25 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.6 -1.3 . . . . 0.0 111.761 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.907 HG22 ' O ' ' A' ' 15' ' ' ASN . 10.4 pt -167.39 174.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.914 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 1.123 ' HG2' ' CD2' ' A' ' 8' ' ' LEU . 35.9 mt-10 -160.78 106.07 1.42 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.107 -169.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.159 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.7 mm? -87.35 105.88 17.56 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.64 1.212 . . . . 0.0 108.438 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.413 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -69.45 118.74 12.71 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.169 0.918 . . . . 0.0 108.77 174.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 1.159 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 6.4 mp -108.37 137.45 46.31 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.918 1.386 . . . . 0.0 110.905 -172.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.813 ' OD1' ' HG2' ' A' ' 23' ' ' GLN . 52.6 t0 -56.61 -116.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.787 174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.871 ' HA ' HG13 ' A' ' 29' ' ' VAL . 60.7 tttm 135.5 -57.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.594 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 1.013 ' OE1' ' NZ ' ' A' ' 24' ' ' LYS . 3.8 pt20 -55.75 -49.07 74.09 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.736 1.272 . . . . 0.0 110.573 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 1.013 ' NZ ' ' OE1' ' A' ' 23' ' ' GLN . 47.0 mmtm -69.11 -16.18 63.6 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.338 1.024 . . . . 0.0 113.219 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.499 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.42 71.72 2.94 Favored Pre-proline 0 N--CA 1.475 0.814 0 O-C-N 123.836 0.71 . . . . 0.0 109.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 1.095 ' O ' HG23 ' A' ' 29' ' ' VAL . 78.0 Cg_exo -51.42 -55.65 3.79 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.735 2.957 . . . . 0.0 111.538 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.6 t -46.68 -62.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 124.678 1.236 . . . . 0.0 110.125 -177.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.9 p -44.06 -54.2 5.7 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.725 1.266 . . . . 0.0 110.441 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.095 HG23 ' O ' ' A' ' 26' ' ' PRO . 29.0 m -56.8 -47.02 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 124.317 1.011 . . . . 0.0 110.617 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 1.008 HE21 ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -44.92 -69.48 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.196 0.935 . . . . 0.0 109.632 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.935 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.6 m-80 -46.03 -50.43 15.05 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.594 1.184 . . . . 0.0 109.488 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.86 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 45.4 t80 -40.61 -66.01 0.36 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.685 1.241 . . . . 0.0 110.231 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.806 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.3 t -45.81 -39.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.583 1.177 . . . . 0.0 111.099 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.935 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 88.1 m-20 -44.07 -62.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.089 0.868 . . . . 0.0 109.504 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.743 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 34.1 m-85 -64.33 -55.84 18.53 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.159 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' O ' ' A' ' 32' ' ' PHE . 58.8 t -39.33 -48.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 124.735 1.272 . . . . 0.0 111.015 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.824 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.1 t-20 -38.43 -33.5 0.1 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.754 1.284 . . . . 0.0 111.844 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.824 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 93.6 p 145.75 176.96 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.225 0.953 . . . . 0.0 113.061 175.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.64 -43.03 3.1 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.908 ' O ' HG21 ' A' ' 44' ' ' THR . 1.4 t80 -71.12 -74.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.586 0.815 . . . . 0.0 109.513 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.712 ' CB ' ' HB1' ' A' ' 162' ' ' ALA . 16.5 m-30 -62.5 -28.23 69.7 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.552 1.158 . . . . 0.0 112.678 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.595 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 53.0 p-10 -38.76 -36.68 0.28 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.932 0.77 . . . . 0.0 112.569 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.595 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 2.1 t-20 -161.25 47.58 0.2 Allowed 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.055 0.847 . . . . 0.0 110.753 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.908 HG21 ' O ' ' A' ' 40' ' ' PHE . 42.9 p -79.46 -136.57 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 160.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 1.05 HG21 ' HA ' ' A' ' 158' ' ' VAL . 47.7 p -163.36 -142.45 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.998 0.904 . . . . 0.0 112.024 174.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.762 ' HZ ' HD12 ' A' ' 9' ' ' LEU . 52.7 m-85 -158.85 74.16 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.242 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.809 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 2.4 p-80 -42.7 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.76 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.198 ' NH2' ' CA ' ' A' ' 51' ' ' PRO . 46.9 tpt85 -173.26 -150.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.433 1.111 . . . . 0.0 113.122 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 1.189 HG22 ' O ' ' A' ' 48' ' ' ARG . 48.1 t -175.83 -70.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.475 -2.148 . . . . 0.0 106.684 169.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.885 ' C ' ' NH2' ' A' ' 48' ' ' ARG . 59.2 mt -171.27 134.22 0.92 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.502 -1.681 . . . . 0.0 108.585 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.198 ' CA ' ' NH2' ' A' ' 48' ' ' ARG . 80.1 Cg_exo -35.54 155.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.068 2.512 . . . . 0.0 112.706 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -1.35 66.51 0.0 OUTLIER Glycine 0 N--CA 1.476 1.332 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.706 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.053 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.9 t80 -156.33 -50.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.856 0.974 . . . . 0.0 109.95 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.053 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 64.2 mtm -176.62 159.75 1.9 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.352 1.032 . . . . 0.0 111.409 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.02 HG12 ' O ' ' A' ' 105' ' ' ILE . 42.6 pt -153.68 165.31 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.815 -1.538 . . . . 0.0 110.108 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.201 ' CG ' ' HA ' ' A' ' 104' ' ' PHE . 33.5 mt-30 -164.49 136.55 4.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.146 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -120.93 -158.06 10.31 Favored Glycine 0 N--CA 1.479 1.537 0 O-C-N 124.828 1.33 . . . . 0.0 112.378 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 56.71 82.64 0.05 OUTLIER Glycine 0 N--CA 1.47 0.917 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.253 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.61 -118.47 0.63 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.651 0.853 . . . . 0.0 111.12 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -45.91 120.66 2.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.167 -1.017 . . . . 0.0 111.292 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 1.274 ' CG2' ' CD ' ' A' ' 67' ' ' LYS . 76.8 p -59.69 124.48 20.24 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.577 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 1.003 ' HG2' ' N ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 19.99 -108.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.827 -178.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 1.193 ' O ' ' CG ' ' A' ' 64' ' ' MET . 88.3 mt-30 -43.23 -58.17 2.64 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.671 1.232 . . . . 0.0 110.363 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 1.193 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 47.3 mtt 141.44 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.639 1.212 . . . . 0.0 107.893 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 64' ' ' MET . 32.6 mt-30 -159.59 78.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.513 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 65' ' ' GLN . 33.9 mt-30 -19.88 130.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.265 -173.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 1.274 ' CD ' ' CG2' ' A' ' 61' ' ' THR . 14.3 mmmm -62.17 -116.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.938 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 1.02 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -142.62 -62.7 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 112.567 -2.106 . . . . 0.0 109.734 -174.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 1.02 ' HD3' ' HB3' ' A' ' 68' ' ' LYS . 60.7 Cg_exo -28.34 136.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.066 2.511 . . . . 0.0 112.807 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.245 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 49.4 p-10 -168.69 -41.19 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 116.881 -1.533 . . . . 0.0 114.416 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 1.236 ' HD3' ' OD1' ' A' ' 70' ' ' ASN . 59.7 Cg_endo -68.28 89.78 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.961 2.44 . . . . 0.0 108.406 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 1.271 ' CB ' ' HA ' ' A' ' 98' ' ' SER . 84.6 Cg_exo -57.52 -155.69 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.637 2.892 . . . . 0.0 113.63 -172.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.846 ' CD1' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -160.06 151.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.776 176.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.684 ' O ' ' O ' ' A' ' 75' ' ' ASN . 74.6 mmtt -19.73 136.79 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.563 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 1.398 HD21 ' NZ ' ' A' ' 96' ' ' LYS . 45.9 p-10 -39.92 -120.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.536 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 1.164 ' CG ' HD22 ' A' ' 79' ' ' ASN . 0.8 OUTLIER 102.58 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.101 0.876 . . . . 0.0 111.305 -178.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.895 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 172.8 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.667 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 1.257 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 42.5 p-10 -68.03 -48.13 66.52 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.574 1.171 . . . . 0.0 109.676 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 1.164 HD22 ' CG ' ' A' ' 76' ' ' GLU . 50.1 p-10 -58.28 77.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.229 0.956 . . . . 0.0 108.699 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . -174.22 40.73 0.13 Allowed Glycine 0 N--CA 1.474 1.222 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.105 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.563 HD22 ' HG3' ' A' ' 24' ' ' LYS . 2.8 mm? 39.4 -132.29 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.333 0.666 . . . . 0.0 110.602 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 32.2 ptt-85 -174.04 131.56 0.4 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.021 0.826 . . . . 0.0 109.451 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.507 ' CG ' ' H ' ' A' ' 84' ' ' THR . 1.2 t-20 -150.79 -122.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.585 1.178 . . . . 0.0 109.804 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.567 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 23.0 m -160.79 159.58 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.032 0.833 . . . . 0.0 111.79 -167.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.736 ' CB ' ' N ' ' A' ' 108' ' ' ALA . 39.1 ptt180 -36.06 103.42 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.669 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.816 ' O ' HG21 ' A' ' 128' ' ' VAL . . . 153.89 -29.6 0.74 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 111.446 -2.615 . . . . 0.0 109.718 -170.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.84 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 35.8 p -76.46 131.45 39.05 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.685 0.755 . . . . 0.0 111.514 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 1.498 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -80.05 159.0 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.857 164.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.276 ' O ' ' HD1' ' A' ' 104' ' ' PHE . . . -164.11 128.01 2.64 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.63 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 1.152 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 96.5 mmm -51.27 123.13 8.91 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.783 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.683 ' HB1' ' NE2' ' A' ' 56' ' ' GLN . . . -66.52 -147.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.544 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.073 ' HG2' ' H ' ' A' ' 93' ' ' THR . 56.7 ttp180 179.5 -129.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 1.073 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 9.0 t 136.31 87.09 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.541 1.151 . . . . 0.0 109.963 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.1 -70.7 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.821 1.325 . . . . 0.0 109.732 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.58 ' HB3' ' HG ' ' A' ' 98' ' ' SER . 35.1 m-20 -40.13 110.95 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.527 1.142 . . . . 0.0 110.624 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.398 ' NZ ' HD21 ' A' ' 75' ' ' ASN . 27.8 tptp -46.13 -112.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.735 1.272 . . . . 0.0 110.52 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.579 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 36.0 m-20 -58.78 110.14 0.95 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.633 1.208 . . . . 0.0 109.258 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 1.271 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 70.6 m -166.53 -124.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 O-C-N 124.564 1.165 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.846 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 71.71 87.76 0.11 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.799 1.312 . . . . 0.0 108.162 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.86 HG22 ' HA ' ' A' ' 70' ' ' ASN . 81.6 p -78.88 -34.82 44.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.801 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.559 ' HB2' ' HE2' ' A' ' 40' ' ' PHE . 78.9 p -169.87 -47.9 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.132 0.895 . . . . 0.0 110.363 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.47 ' HG2' ' CB ' ' A' ' 91' ' ' ALA . 14.2 tt0 -38.93 144.02 0.14 Allowed 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.19 0.931 . . . . 0.0 111.184 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 1.063 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -160.31 159.68 31.58 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.58 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.276 ' HD1' ' O ' ' A' ' 89' ' ' ALA . 24.5 m-85 -81.94 155.52 25.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.774 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.02 ' O ' HG12 ' A' ' 55' ' ' ILE . 37.8 mt -146.23 91.85 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.325 158.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 1.27 ' O ' ' HE2' ' A' ' 132' ' ' MET . 1.8 m-20 -71.24 171.73 10.56 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 112.545 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 1.654 HG11 ' CE ' ' A' ' 132' ' ' MET . 35.6 m -160.68 48.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.243 -1.798 . . . . 0.0 108.377 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.795 ' HB2' ' HD1' ' A' ' 53' ' ' PHE . . . 176.82 147.48 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.233 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.705 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.5 m-20 -36.13 77.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.724 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.713 ' HB2' HD21 ' A' ' 106' ' ' ASN . 3.2 t30 -69.65 134.51 48.81 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.861 1.35 . . . . 0.0 110.364 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.628 ' H ' ' CD1' ' A' ' 113' ' ' LEU . . . 164.16 -53.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.82 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE2' ' O ' ' A' ' 109' ' ' ASP . 34.5 p90 -67.64 47.89 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.581 1.176 . . . . 0.0 110.374 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER 177.59 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.229 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.824 ' H ' HD12 ' A' ' 113' ' ' LEU . 64.6 t0 -43.45 -56.42 3.62 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.015 0.822 . . . . 0.0 110.738 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 1.257 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 0.2 OUTLIER 179.74 111.96 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.697 1.248 . . . . 0.0 109.61 -176.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.564 178.754 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 115' ' ' HIS . 8.3 m-30 . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 120.447 0.165 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 120' ' ' PHE . . . -171.25 -136.01 2.03 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.873 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 81.7 m-85 -79.21 127.78 32.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.583 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.152 ' HB2' ' O ' ' A' ' 90' ' ' MET . . . -53.89 -166.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.324 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.023 HG22 ' O ' ' A' ' 123' ' ' ALA . 60.3 t -179.69 134.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.585 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.966 ' CD1' ' HG2' ' A' ' 90' ' ' MET . 13.9 p90 -168.82 28.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.132 0.895 . . . . 0.0 111.07 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 1.498 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -147.11 176.53 25.93 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 123.321 1.511 . . . . 0.0 113.11 -173.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.413 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 8.2 ttpm? 177.81 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 110.77 -2.715 . . . . 0.0 109.989 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.816 HG21 ' O ' ' A' ' 86' ' ' GLY . 66.9 t -60.39 128.38 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.879 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 1.085 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 34.5 m -95.33 -42.18 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.699 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.471 ' N ' HG21 ' A' ' 129' ' ' VAL . 8.2 ttpm? 179.98 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.154 0.909 . . . . 0.0 109.697 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 134' ' ' VAL . . . 174.52 12.45 0.02 OUTLIER Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.768 1.292 . . . . 0.0 112.993 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.654 ' CE ' HG11 ' A' ' 107' ' ' VAL . 11.5 tpt -54.99 -50.83 68.02 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.583 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.7 t0 -40.84 -55.62 2.41 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.449 1.093 . . . . 0.0 110.262 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 15' ' ' ASN . 54.8 t -41.7 -63.23 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 124.464 1.103 . . . . 0.0 109.438 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 138' ' ' ILE . . . -49.79 -50.19 45.76 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.729 1.268 . . . . 0.0 109.635 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.692 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 37.8 m-20 -51.43 -69.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.513 1.133 . . . . 0.0 109.228 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 1.132 ' HZ1' ' CG1' ' A' ' 141' ' ' VAL . 5.9 tmtt? -38.11 -48.91 1.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.744 1.278 . . . . 0.0 110.386 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.031 ' O ' HG23 ' A' ' 141' ' ' VAL . 32.6 mt -54.06 -59.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 124.606 1.192 . . . . 0.0 108.309 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.52 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.1 p -65.76 8.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.763 1.29 . . . . 0.0 113.86 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 41.2 mm-40 -97.12 -51.92 4.03 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.212 0.945 . . . . 0.0 109.096 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.132 ' CG1' ' HZ1' ' A' ' 137' ' ' LYS . 33.5 m -48.39 132.52 13.18 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.584 1.177 . . . . 0.0 110.258 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -39.13 -178.02 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.395 2.73 . . . . 0.0 113.534 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.298 HG21 ' CA ' ' A' ' 153' ' ' PRO . 7.4 p -161.15 -151.78 0.24 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 123.2 1.476 . . . . 0.0 112.532 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.703 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 178.12 146.32 0.14 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.21 170.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 39.0 m-20 -67.59 114.13 5.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.68 167.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.952 ' CB ' ' O ' ' A' ' 149' ' ' TYR . 1.5 t -77.32 -159.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 124.474 1.109 . . . . 0.0 110.916 -166.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.851 ' H ' HG11 ' A' ' 146' ' ' VAL . . . -60.6 -115.46 0.01 OUTLIER Glycine 0 N--CA 1.471 1.015 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 171.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.926 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 91.8 Cg_endo -74.51 33.9 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.603 2.868 . . . . 0.0 110.744 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.952 ' O ' ' CB ' ' A' ' 146' ' ' VAL . 27.6 m-85 -170.41 104.52 0.28 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.735 0.647 . . . . 0.0 109.686 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 1.131 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 32.1 mt-30 -71.09 -169.71 0.4 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.847 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 1.131 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 52.1 p-10 44.6 76.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.18 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.836 HG22 ' CE ' ' A' ' 64' ' ' MET . 70.8 t -157.28 102.39 1.88 Allowed Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.615 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.298 ' CA ' HG21 ' A' ' 143' ' ' THR . 81.5 Cg_exo -49.95 109.67 0.31 Allowed 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.434 2.756 . . . . 0.0 110.961 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.282 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.5 t -40.0 -57.57 1.61 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.459 1.099 . . . . 0.0 108.972 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 62.6 mttp -69.61 88.25 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 164.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.282 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.2 Cg_endo -70.1 -157.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.615 2.877 . . . . 0.0 112.772 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 158' ' ' VAL . 99.4 t -153.78 153.87 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.326 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 1.05 ' HA ' HG21 ' A' ' 45' ' ' THR . 83.2 t -146.96 123.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.597 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.049 HG13 ' HA ' ' A' ' 45' ' ' THR . 36.9 mt -68.62 134.36 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.27 -175.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 1.272 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.9 mt -82.13 -48.61 11.12 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.822 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 32.2 t -167.1 166.42 15.09 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.521 1.138 . . . . 0.0 111.955 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 1.097 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -163.32 125.38 2.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.556 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 1.193 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 14.3 ptmm? -170.28 120.8 0.61 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.702 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.846 HG11 ' HA ' ' A' ' 7' ' ' VAL . 33.7 m -68.14 131.66 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 124.762 1.289 . . . . 0.0 110.57 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 1.116 HD11 ' HD2' ' A' ' 166' ' ' PRO . 49.3 tp -78.0 118.33 71.51 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.801 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 1.116 ' HD2' HD11 ' A' ' 165' ' ' LEU . 87.0 Cg_exo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 123.523 2.815 . . . . 0.0 112.026 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo . . . . . 0 C--O 1.235 0.371 0 CA-C-O 120.946 0.311 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 18.4 m170 -160.72 117.11 2.32 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.792 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.937 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 10.4 p -59.8 137.58 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.262 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.214 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 8.4 mp -125.55 130.65 52.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.531 1.144 . . . . 0.0 109.415 166.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.93 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 7.5 mp -123.93 -171.99 2.44 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.936 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 1.209 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 98.7 m -160.82 84.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.827 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.971 HG23 HG12 ' A' ' 159' ' ' ILE . 36.9 p -76.6 172.48 12.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 125.426 1.704 . . . . 0.0 111.18 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -39.28 -44.13 1.23 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.351 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.88 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.26 -64.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.558 1.161 . . . . 0.0 110.369 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.37 41.58 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 113.248 -1.796 . . . . 0.0 113.654 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.796 ' O ' HG22 ' A' ' 16' ' ' ILE . 58.7 t-20 -66.29 153.33 42.88 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.12 -1.54 . . . . 0.0 111.419 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.796 HG22 ' O ' ' A' ' 15' ' ' ASN . 13.9 pt -163.56 174.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.15 -1.387 . . . . 0.0 111.3 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 1.475 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . 36.7 mt-10 -161.34 122.07 2.76 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.947 -170.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 105' ' ' ILE . 2.5 mm? -95.64 162.96 13.4 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.817 1.323 . . . . 0.0 109.999 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.485 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -113.87 124.69 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.454 170.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.872 HD21 ' HE2' ' A' ' 125' ' ' PHE . 6.6 mp -106.01 120.05 40.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.931 1.395 . . . . 0.0 109.705 -172.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.607 ' OD2' ' HG ' ' A' ' 81' ' ' LEU . 32.2 m-20 -72.55 96.97 2.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.771 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.011 ' HA ' HG13 ' A' ' 29' ' ' VAL . 58.8 tttm -71.6 -56.15 6.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.658 1.224 . . . . 0.0 110.97 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.664 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 6.4 tp60 -46.17 -60.82 2.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.687 -171.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 51.8 tptt -68.17 -2.83 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.738 1.274 . . . . 0.0 113.138 -173.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.533 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -161.3 70.79 2.58 Favored Pre-proline 0 N--CA 1.476 0.831 0 O-C-N 123.705 0.628 . . . . 0.0 109.647 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 1.062 ' O ' HG21 ' A' ' 29' ' ' VAL . 62.9 Cg_exo -54.86 -56.18 2.62 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.635 2.89 . . . . 0.0 111.571 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.45 -64.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 124.726 1.266 . . . . 0.0 110.116 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -44.15 -58.32 2.92 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.734 1.272 . . . . 0.0 110.544 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.686 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 28.7 m -48.81 -50.14 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 124.752 1.282 . . . . 0.0 110.574 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 1.178 ' O ' HG11 ' A' ' 33' ' ' VAL . 1.6 tm0? -52.0 -54.18 32.96 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.358 1.036 . . . . 0.0 109.357 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.919 ' OD1' HG23 ' A' ' 73' ' ' ILE . 10.6 m120 -50.89 -64.69 0.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.549 1.156 . . . . 0.0 110.391 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 1.686 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 33.6 p90 -54.18 -43.57 70.8 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.439 1.087 . . . . 0.0 110.709 -172.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 1.178 HG11 ' O ' ' A' ' 30' ' ' GLN . 10.7 p -51.33 -40.29 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 124.044 0.84 . . . . 0.0 110.171 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.829 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 71.0 m-20 -46.61 -61.34 1.87 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.112 0.882 . . . . 0.0 109.285 173.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -54.61 -56.15 22.01 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.994 1.434 . . . . 0.0 109.124 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.846 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 97.6 t -46.42 -66.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 124.639 1.212 . . . . 0.0 109.344 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.549 ' OD1' HG23 ' A' ' 33' ' ' VAL . 1.9 m-20 -50.57 -48.74 57.43 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.814 1.321 . . . . 0.0 109.989 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.579 ' OG ' ' O ' ' A' ' 34' ' ' ASP . 67.5 m -53.97 -93.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.539 1.149 . . . . 0.0 110.284 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 38' ' ' SER . . . 174.42 87.41 0.07 OUTLIER Glycine 0 N--CA 1.472 1.073 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.098 ' O ' ' CD1' ' A' ' 41' ' ' TYR . 88.0 t80 -157.39 57.02 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.911 1.007 . . . . 0.0 108.561 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 1.098 ' CD1' ' O ' ' A' ' 40' ' ' PHE . 25.6 m-85 -171.68 -37.07 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -38.69 -37.21 0.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.149 0.905 . . . . 0.0 112.688 -171.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 13.9 t30 -155.04 44.89 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.061 0.851 . . . . 0.0 110.902 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.991 ' HG1' HD13 ' A' ' 159' ' ' ILE . 58.4 p -79.4 -141.97 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.387 162.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 1.068 ' HA ' HG13 ' A' ' 159' ' ' ILE . 48.7 p -163.89 -141.35 0.05 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.608 0.718 . . . . 0.0 111.644 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.82 ' CD1' ' O ' ' A' ' 45' ' ' THR . 17.2 m-30 -143.07 62.73 1.39 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.417 -1.72 . . . . 0.0 107.246 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 1.006 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 7.1 p-80 -51.58 -60.49 3.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.72 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.224 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 26.5 mmm180 -69.14 118.7 12.37 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.626 1.203 . . . . 0.0 110.059 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.614 HG21 HG21 ' A' ' 55' ' ' ILE . 8.7 p -163.64 149.6 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 124.713 1.258 . . . . 0.0 111.023 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.854 HD11 ' HD2' ' A' ' 53' ' ' PHE . 10.1 tt -165.54 126.61 1.35 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.242 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 53' ' ' PHE . 87.4 Cg_exo -35.55 160.96 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.618 2.879 . . . . 0.0 113.729 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -7.71 70.06 0.0 OUTLIER Glycine 0 N--CA 1.474 1.225 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.684 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.094 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -160.78 -53.24 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.828 0.958 . . . . 0.0 109.712 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.094 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 61.3 mtm -177.98 161.77 1.58 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.25 0.969 . . . . 0.0 112.249 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 105' ' ' ILE . 36.7 pt -150.61 174.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.798 170.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.224 ' NE2' ' HB3' ' A' ' 48' ' ' ARG . 31.8 mt-30 -158.98 167.01 30.47 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.201 -169.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.19 -178.08 31.89 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.578 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.09 84.57 0.08 OUTLIER Glycine 0 N--CA 1.47 0.912 0 CA-C-N 113.746 -1.227 . . . . 0.0 110.217 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.823 ' C ' ' HD2' ' A' ' 67' ' ' LYS . . . 178.98 -132.58 1.91 Allowed Glycine 0 N--CA 1.475 1.274 0 O-C-N 124.656 0.856 . . . . 0.0 111.305 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.527 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 56.6 m-85 -50.96 110.71 0.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.245 -0.978 . . . . 0.0 109.554 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 1.201 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 9.4 t -70.33 105.11 2.89 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.398 1.061 . . . . 0.0 110.082 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 1.201 ' HG2' ' O ' ' A' ' 61' ' ' THR . 12.6 pt-20 70.84 -127.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.801 1.313 . . . . 0.0 110.922 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 1.218 ' O ' ' CG ' ' A' ' 64' ' ' MET . 59.8 mt-30 -47.22 -55.45 8.56 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.808 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 1.218 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 50.7 mtt 145.72 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.637 1.208 . . . . 0.0 108.269 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 66' ' ' GLN . 18.4 tt0 -144.03 84.51 1.78 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.981 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.554 ' O ' ' O ' ' A' ' 67' ' ' LYS . 42.4 mt-30 -24.45 135.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.067 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 1.073 ' CD ' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -47.91 -120.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.427 -178.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 69' ' ' PRO . 4.2 ttmp? -170.84 73.05 0.56 Allowed Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.32 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.82 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 87.9 Cg_exo -51.17 -140.11 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.573 2.848 . . . . 0.0 113.127 -172.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.926 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 7.7 m120 164.83 168.72 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.579 -172.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.926 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 33.1 Cg_endo -44.66 98.39 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.549 2.166 . . . . 0.0 108.893 169.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.633 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.4 Cg_exo -44.11 -136.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.853 3.035 . . . . 0.0 113.336 -175.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.919 HG23 ' OD1' ' A' ' 31' ' ' ASN . 24.8 pt -152.34 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.438 1.086 . . . . 0.0 109.083 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 75' ' ' ASN . 21.6 ptmt -154.82 -148.37 0.24 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.03 0.831 . . . . 0.0 111.918 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.566 ' O ' ' O ' ' A' ' 74' ' ' LYS . 37.7 m-20 -44.93 -171.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.258 -1.792 . . . . 0.0 112.408 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 1.058 ' HG3' ' HB1' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 171.42 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.421 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.93 ' H ' ' CG ' ' A' ' 76' ' ' GLU . . . -44.72 -35.27 2.59 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.534 1.146 . . . . 0.0 111.887 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -68.89 25.81 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.058 0.848 . . . . 0.0 113.25 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.677 HD22 ' HB ' ' A' ' 124' ' ' VAL . 44.8 p-10 -63.63 -123.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.941 0.776 . . . . 0.0 109.017 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.6 -80.28 0.08 OUTLIER Glycine 0 N--CA 1.473 1.12 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 1.433 ' O ' ' CD ' ' A' ' 82' ' ' ARG . 2.8 mm? 40.17 -151.01 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.848 0.97 . . . . 0.0 111.185 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 1.433 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER 179.95 111.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.987 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 1.174 ' OD1' ' HD3' ' A' ' 127' ' ' LYS . 26.0 m120 -159.76 -156.77 0.52 Allowed 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.591 1.182 . . . . 0.0 111.267 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 1.097 HG23 ' HG2' ' A' ' 85' ' ' ARG . 12.0 m -169.46 166.03 10.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.283 -166.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 1.097 ' HG2' HG23 ' A' ' 84' ' ' THR . 16.4 ptm180 -18.63 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.108 1.432 . . . . 0.0 112.146 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.858 ' O ' HG21 ' A' ' 128' ' ' VAL . . . 148.18 -26.83 1.41 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-N 110.442 -3.072 . . . . 0.0 109.676 -168.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.799 HG21 ' HG2' ' A' ' 127' ' ' LYS . 26.8 p -73.86 134.31 43.27 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.689 0.757 . . . . 0.0 112.107 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 1.536 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -91.32 160.05 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.062 164.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.231 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -163.41 138.89 6.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.043 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.892 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 95.7 mmm -55.82 125.62 22.11 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.769 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 1.225 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . . . -74.74 -173.12 1.75 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.545 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.039 ' NH1' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.28 -120.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.407 175.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 1.039 ' HB ' ' NH1' ' A' ' 92' ' ' ARG . 20.7 m 173.79 -69.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.821 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 172.46 111.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.801 1.313 . . . . 0.0 108.89 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.821 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 88.4 m-20 161.84 145.3 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.152 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.654 ' O ' ' O ' ' A' ' 95' ' ' ASP . 53.4 mtmt -45.19 -122.5 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.043 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.33 118.16 5.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.713 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.6 m -163.87 -144.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.599 1.187 . . . . 0.0 110.938 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.722 ' O ' HD12 ' A' ' 73' ' ' ILE . . . 50.96 87.36 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.557 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.408 ' C ' ' HG ' ' A' ' 101' ' ' SER . 78.4 p -78.52 -41.35 32.54 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.246 -174.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.513 ' O ' ' HE3' ' A' ' 90' ' ' MET . 69.3 m -167.88 -53.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 124.231 0.957 . . . . 0.0 109.286 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 1.225 ' OE1' ' HB2' ' A' ' 91' ' ' ALA . 2.0 pp0? -34.44 142.86 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.519 1.137 . . . . 0.0 111.823 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.809 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.91 -171.8 4.03 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.526 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.971 ' CZ ' ' HB2' ' A' ' 89' ' ' ALA . 20.0 p90 -154.87 135.58 13.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.758 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.057 HD13 HD22 ' A' ' 18' ' ' LEU . 53.0 mt -102.19 101.2 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.822 -1.99 . . . . 0.0 108.923 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.642 ' OD1' ' CD1' ' A' ' 104' ' ' PHE . 18.9 m-20 -62.78 167.37 4.64 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.814 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 1.33 HG11 ' CE ' ' A' ' 132' ' ' MET . 33.0 m -157.93 51.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.273 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 53' ' ' PHE . . . -177.4 133.16 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.831 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.94 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 31.9 m-20 -31.68 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.458 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.84 ' ND2' ' HB3' ' A' ' 113' ' ' LEU . 1.1 t-20 -68.83 -119.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.858 1.349 . . . . 0.0 109.519 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 113' ' ' LEU . . . 61.21 -72.21 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.743 0.652 . . . . 0.0 110.24 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.94 ' CE1' ' O ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -67.63 56.07 0.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.377 1.048 . . . . 0.0 109.612 178.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.84 ' HB3' ' ND2' ' A' ' 110' ' ' ASN . 6.3 tt 177.44 -39.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.079 -173.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 115' ' ' HIS . 65.7 t0 -39.5 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.06 0.85 . . . . 0.0 110.644 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.657 ' CE1' ' H ' ' A' ' 120' ' ' PHE . 0.4 OUTLIER 179.27 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.739 1.274 . . . . 0.0 108.678 179.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.234 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.768 -178.438 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.657 ' H ' ' CE1' ' A' ' 115' ' ' HIS . 47.6 m-85 . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.93 0.871 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.69 -129.13 1.09 Allowed Glycine 0 N--CA 1.474 1.209 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.954 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.818 ' HD2' HD22 ' A' ' 113' ' ' LEU . 21.0 m-85 -79.72 116.72 20.06 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.486 0.757 . . . . 0.0 109.62 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.058 ' HB1' ' HG3' ' A' ' 76' ' ' GLU . . . -49.01 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.569 1.168 . . . . 0.0 111.051 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.231 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 70.2 t 179.86 133.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.806 -176.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.872 ' HE2' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -166.13 21.99 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.033 170.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 1.536 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -118.07 168.54 13.1 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 123.123 1.402 . . . . 0.0 112.753 -169.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.485 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 10.2 mtmp? 179.56 104.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 110.962 -2.619 . . . . 0.0 109.564 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.858 HG21 ' O ' ' A' ' 86' ' ' GLY . 66.8 t -43.56 119.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.083 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 1.475 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -63.91 -48.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.235 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.931 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 2.9 tmtm? 163.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.255 0.972 . . . . 0.0 109.612 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.65 32.61 0.09 OUTLIER Glycine 0 N--CA 1.476 1.33 0 O-C-N 124.817 1.323 . . . . 0.0 111.469 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.33 ' CE ' HG11 ' A' ' 107' ' ' VAL . 8.4 tpt -59.75 -40.91 89.71 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.162 0.566 . . . . 0.0 110.281 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 22.9 m-20 -44.05 -63.77 0.8 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.273 0.983 . . . . 0.0 109.937 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.688 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.2 t -43.89 -60.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 124.615 1.197 . . . . 0.0 109.219 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -46.18 -52.08 13.01 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.59 1.181 . . . . 0.0 109.772 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.606 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 39.9 m-20 -53.64 -65.43 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.562 1.164 . . . . 0.0 109.133 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -36.57 -49.24 0.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.711 1.257 . . . . 0.0 110.588 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.193 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.5 mt -57.1 -57.39 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 124.578 1.173 . . . . 0.0 108.642 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.3 p -61.7 3.26 0.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 41.0 mm-40 -96.25 -49.53 5.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.27 0.981 . . . . 0.0 109.313 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.193 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -47.28 123.85 8.68 Favored Pre-proline 0 N--CA 1.472 0.638 0 O-C-N 124.518 1.136 . . . . 0.0 110.055 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 141' ' ' VAL . 84.0 Cg_exo -41.17 179.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.517 2.811 . . . . 0.0 113.799 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.402 HG21 ' CA ' ' A' ' 153' ' ' PRO . 2.5 p -160.92 -151.48 0.24 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 123.589 1.662 . . . . 0.0 112.32 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.713 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.8 OUTLIER 178.24 165.06 0.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.148 174.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.691 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 77.7 m-20 -51.57 -144.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.752 166.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.824 HG23 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -162.19 -63.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.903 1.335 . . . . 0.0 107.914 170.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.01 -95.52 0.1 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-N 111.119 -2.764 . . . . 0.0 107.531 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.795 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 90.5 Cg_endo -70.54 -63.19 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.639 2.893 . . . . 0.0 108.928 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 59.6 m-85 -70.12 109.42 4.59 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.703 1.252 . . . . 0.0 110.702 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.596 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 22.4 mm-40 -75.9 151.21 37.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.75 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.738 ' O ' HG22 ' A' ' 152' ' ' VAL . 21.7 m-20 77.63 96.95 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.606 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.824 ' HB ' HG23 ' A' ' 146' ' ' VAL . 84.9 t -164.66 116.1 0.93 Allowed Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.409 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.402 ' CA ' HG21 ' A' ' 143' ' ' THR . 59.7 Cg_endo -65.02 108.53 1.13 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.534 2.822 . . . . 0.0 109.623 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.265 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 62.2 p -43.96 -58.83 2.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.928 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 88.3 tttt -74.3 88.53 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.265 ' HD3' ' O ' ' A' ' 154' ' ' SER . 59.1 Cg_endo -77.31 131.74 11.95 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.684 2.923 . . . . 0.0 112.486 -167.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.705 HG22 HG22 ' A' ' 138' ' ' ILE . 74.1 t -68.94 157.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.765 -1.562 . . . . 0.0 110.44 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 1.016 ' HA ' HG21 ' A' ' 45' ' ' THR . 98.9 t -143.75 120.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.517 174.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.068 HG13 ' HA ' ' A' ' 45' ' ' THR . 32.3 mt -68.21 133.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.091 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 1.209 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.7 mt -77.99 -50.51 11.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 112.383 -2.19 . . . . 0.0 109.744 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.415 ' HB3' ' H ' ' A' ' 162' ' ' ALA . 61.4 m -162.6 -165.46 1.17 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.655 1.222 . . . . 0.0 112.027 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.93 ' HB1' ' HG ' ' A' ' 9' ' ' LEU . . . 179.41 135.55 0.1 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.3 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -171.61 136.45 0.96 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.693 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.453 HG11 HG13 ' A' ' 36' ' ' VAL . 34.8 m -77.85 133.06 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.938 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 1.043 HD11 ' HD2' ' A' ' 166' ' ' PRO . 47.2 tp -91.98 117.24 67.62 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.29 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 1.043 ' HD2' HD11 ' A' ' 165' ' ' LEU . 88.4 Cg_exo . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.547 2.831 . . . . 0.0 111.828 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.225 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 84.8 Cg_exo . . . . . 0 C--O 1.235 0.338 0 CA-C-O 121.107 0.378 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.556 ' CD2' ' HG2' ' A' ' 19' ' ' GLU . 37.9 m170 -147.47 112.82 5.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.043 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 1.055 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 9.1 p -67.64 143.85 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.311 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.249 HD13 ' OE1' ' A' ' 17' ' ' GLU . 6.6 mp -129.76 115.01 16.66 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.625 1.202 . . . . 0.0 110.023 166.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 1.084 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 7.5 mp -107.69 -177.8 3.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 111.174 -2.739 . . . . 0.0 108.743 160.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.664 HG21 ' N ' ' A' ' 15' ' ' ASN . 96.0 m -160.84 100.99 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.103 174.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.97 HG21 HG12 ' A' ' 159' ' ' ILE . 41.7 p -78.8 172.65 13.44 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.527 1.767 . . . . 0.0 111.446 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -41.08 -43.33 2.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.417 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.847 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.64 -59.26 4.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.497 1.123 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' C ' HG21 ' A' ' 10' ' ' THR . . . 169.67 -176.03 43.67 Favored Glycine 0 N--CA 1.479 1.546 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.647 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 1.299 ' O ' HG22 ' A' ' 134' ' ' VAL . 10.2 t-20 -53.28 161.2 0.96 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 113.49 -1.355 . . . . 0.0 111.26 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.632 HG21 ' O ' ' A' ' 9' ' ' LEU . 11.8 tt -171.51 157.13 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.889 -174.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 1.249 ' OE1' HD13 ' A' ' 8' ' ' LEU . 39.7 tt0 -163.96 125.17 2.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.084 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.038 HD22 HD12 ' A' ' 105' ' ' ILE . 2.9 mm? -93.54 -177.43 4.4 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.934 1.396 . . . . 0.0 110.542 164.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.556 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -148.3 118.5 7.29 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.646 175.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.761 ' O ' ' OE2' ' A' ' 19' ' ' GLU . 6.0 mp -90.57 -162.22 0.88 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.031 -1.441 . . . . 0.0 111.523 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 20' ' ' LEU . 61.7 t0 -159.04 96.88 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.35 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.873 ' HA ' HG13 ' A' ' 29' ' ' VAL . 39.8 ttmt -62.28 -46.61 88.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.912 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -45.39 -67.34 0.29 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.483 1.114 . . . . 0.0 110.48 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.726 ' HZ3' HD22 ' A' ' 81' ' ' LEU . 31.0 mmtp -70.05 -0.54 7.79 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.826 1.329 . . . . 0.0 114.17 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.645 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -160.21 70.14 2.98 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 123.827 0.704 . . . . 0.0 110.06 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 1.004 ' O ' HG23 ' A' ' 29' ' ' VAL . 50.1 Cg_exo -56.18 -58.16 1.16 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.6 2.867 . . . . 0.0 111.043 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.9 t -50.71 -65.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 124.84 1.338 . . . . 0.0 110.173 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.1 m -43.99 -57.63 3.24 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.699 1.25 . . . . 0.0 110.675 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 26' ' ' PRO . 33.1 m -49.12 -49.08 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.642 1.214 . . . . 0.0 110.987 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.775 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 tm0? -50.85 -67.15 0.28 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.222 0.951 . . . . 0.0 109.086 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.92 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 t-20 -43.31 -53.11 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.581 1.176 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 36' ' ' VAL . 48.8 t80 -43.21 -62.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.523 1.14 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 37' ' ' ASN . 62.7 t -44.22 -39.32 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.624 1.202 . . . . 0.0 111.071 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.92 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 5.1 m-20 -44.49 -62.06 1.32 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.121 0.888 . . . . 0.0 109.583 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.848 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 94.2 m-85 -60.26 -63.77 1.18 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.9 1.375 . . . . 0.0 109.202 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 32' ' ' PHE . 57.4 t -39.52 -49.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 124.648 1.218 . . . . 0.0 110.869 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.754 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.7 t-20 -38.9 -31.34 0.06 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.738 1.274 . . . . 0.0 112.239 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.754 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.6 p 157.67 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.112 0.883 . . . . 0.0 112.425 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 68.69 81.62 0.2 Allowed Glycine 0 N--CA 1.47 0.928 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.401 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.848 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 1.7 t80 173.74 -81.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.819 0.953 . . . . 0.0 109.739 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -68.35 -12.41 61.06 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.344 1.027 . . . . 0.0 113.259 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 1.172 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 17.4 m-20 -38.97 -50.04 1.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.661 0.6 . . . . 0.0 111.714 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 1.172 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 20.6 m-20 -156.68 52.53 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.393 1.058 . . . . 0.0 109.782 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.882 ' O ' HG22 ' A' ' 45' ' ' THR . 27.8 m -78.62 -125.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 166.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 1.024 HG21 ' HA ' ' A' ' 158' ' ' VAL . 40.6 p -165.35 -140.05 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.222 1.011 . . . . 0.0 111.966 170.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.921 ' CD1' ' O ' ' A' ' 45' ' ' THR . 11.2 m-30 -152.98 81.31 1.21 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.49 -2.141 . . . . 0.0 105.962 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.886 ' HE2' ' H ' ' A' ' 60' ' ' PHE . 19.8 m80 -11.43 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.123 ' NH2' ' O ' ' A' ' 141' ' ' VAL . 28.0 tpt85 -172.4 -133.19 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.634 1.209 . . . . 0.0 110.098 166.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 50' ' ' ILE . 7.4 p -173.41 147.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.953 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 1.012 ' O ' HG23 ' A' ' 49' ' ' VAL . 57.0 mt -72.24 131.8 84.77 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.106 156.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' ILE . 19.2 Cg_endo -40.76 -139.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.386 0 C-N-CA 123.213 2.608 . . . . 0.0 111.582 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.63 76.49 0.01 OUTLIER Glycine 0 N--CA 1.471 0.998 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.732 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.1 t80 -162.11 -68.79 0.05 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.604 0.826 . . . . 0.0 109.833 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.929 ' O ' HG21 ' A' ' 49' ' ' VAL . 26.4 ptt? 177.16 130.77 0.05 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.212 0.945 . . . . 0.0 111.906 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.852 HG21 ' CB ' ' A' ' 49' ' ' VAL . 32.4 pt -90.2 176.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.047 169.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.285 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 20.6 mm-40 -69.28 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.499 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 1.035 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -157.47 -133.66 1.63 Allowed Glycine 0 N--CA 1.473 1.103 0 O-C-N 118.845 -2.409 . . . . 0.0 112.046 4.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.59 105.27 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.567 ' HA2' ' HD3' ' A' ' 67' ' ' LYS . . . -175.5 -121.38 0.64 Allowed Glycine 0 N--CA 1.475 1.278 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.913 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 21.0 m-85 -42.58 114.09 0.54 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.577 -0.812 . . . . 0.0 110.455 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.777 ' HA ' HG21 ' A' ' 44' ' ' THR . 97.7 m -59.94 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.613 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 64' ' ' MET . 44.7 mt-10 65.14 -106.11 0.13 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.817 1.323 . . . . 0.0 110.287 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.591 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 44.6 tp60 -71.41 50.3 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.67 1.232 . . . . 0.0 110.505 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.913 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 53.4 mtt 41.75 35.77 0.54 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.937 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' GLN . 10.7 tp-100 -77.67 87.67 3.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 172.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 67' ' ' LYS . 62.5 mt-30 -27.42 137.41 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.084 -171.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 66' ' ' GLN . 35.3 mtmm -43.85 -122.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.273 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -174.01 75.94 0.36 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 112.704 -2.044 . . . . 0.0 106.617 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 1.232 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 58.3 Cg_endo -78.21 -178.05 4.33 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.638 2.892 . . . . 0.0 113.593 -167.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.232 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 41.5 m-20 -166.0 168.98 7.18 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.887 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.892 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 99.3 Cg_exo -36.1 83.29 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.347 2.698 . . . . 0.0 111.295 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 1.081 ' HB3' HG23 ' A' ' 100' ' ' THR . 80.6 Cg_exo -49.82 154.17 5.2 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.846 3.031 . . . . 0.0 113.735 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.101 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 30.4 pt -78.98 162.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.923 -1.49 . . . . 0.0 112.03 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.927 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 95.7 mttt -59.84 -177.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.86 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 25.9 p30 -52.55 -169.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.31 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 1.202 ' OE1' ' HB3' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 157.39 122.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.924 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.626 ' HB1' ' CD2' ' A' ' 120' ' ' PHE . . . 167.12 -47.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.322 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.696 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 49.8 p-10 -69.03 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.485 1.116 . . . . 0.0 112.86 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 77' ' ' ALA . 43.6 p-10 -44.43 -46.94 9.81 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.996 0.81 . . . . 0.0 109.865 174.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.731 ' C ' HD11 ' A' ' 81' ' ' LEU . . . 73.53 68.24 1.62 Allowed Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.412 1.07 . . . . 0.0 111.166 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.731 HD11 ' C ' ' A' ' 80' ' ' GLY . 2.7 mp -151.36 174.32 13.47 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.854 0.973 . . . . 0.0 110.531 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.832 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 14.2 ptp180 -79.56 144.19 34.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.687 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.832 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.3 m120 -164.53 153.43 13.05 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.502 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 109' ' ' ASP . 17.8 m -165.26 159.49 17.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.421 -169.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 107' ' ' VAL . 67.1 ttt180 -21.21 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.792 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.86 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 146.06 -13.76 1.69 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.835 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 1.169 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 24.3 p -109.48 163.61 13.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.026 1.394 . . . . 0.0 112.584 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.912 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -131.37 158.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 111.28 -2.691 . . . . 0.0 108.719 -177.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -156.05 150.67 25.95 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.89 -1.504 . . . . 0.0 112.364 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 1.122 ' SD ' ' O ' ' A' ' 102' ' ' GLN . 15.6 tpt -61.77 127.3 30.77 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.676 -1.602 . . . . 0.0 110.739 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.875 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . . . -57.34 -119.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.526 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.979 ' HA ' ' H ' ' A' ' 99' ' ' ALA . 39.2 ptt180 179.21 -153.1 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.77 0.669 . . . . 0.0 111.353 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.77 ' HB ' ' HG ' ' A' ' 98' ' ' SER . 53.7 m -176.8 -90.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.17 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 164.52 117.85 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.695 1.247 . . . . 0.0 109.098 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.685 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 50.3 t0 159.64 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.303 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.142 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 64.3 mttm 153.98 22.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.072 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 1.142 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 89.4 m-20 178.96 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 1.365 ' CA ' ' O ' ' A' ' 99' ' ' ALA . 31.2 t 178.54 108.22 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.599 1.187 . . . . 0.0 109.137 -169.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 1.365 ' O ' ' CA ' ' A' ' 98' ' ' SER . . . 34.16 135.87 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.389 -1.444 . . . . 0.0 114.025 -2.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 1.081 HG23 ' HB3' ' A' ' 72' ' ' PRO . 38.6 p -160.92 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.774 -2.012 . . . . 0.0 108.682 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.603 ' H ' HE22 ' A' ' 102' ' ' GLN . 78.0 p -170.36 80.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.402 1.063 . . . . 0.0 108.398 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 1.122 ' O ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER 176.46 158.64 0.3 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.73 1.269 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.947 ' HD2' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -158.45 -173.7 4.43 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.89 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.285 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 22.2 p90 -156.64 139.65 15.39 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.655 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.038 HD12 HD22 ' A' ' 18' ' ' LEU . 60.4 mt -100.68 113.47 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.31 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 1.169 ' OD1' ' O ' ' A' ' 87' ' ' THR . 37.5 p-10 -72.42 -167.82 0.37 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.624 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 1.262 HG11 ' CE ' ' A' ' 132' ' ' MET . 34.5 m -160.7 -43.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.961 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' N ' HG21 ' A' ' 107' ' ' VAL . . . -86.5 133.7 33.73 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.258 0.974 . . . . 0.0 111.129 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.657 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 19.7 m-20 -51.04 112.14 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.422 174.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.748 ' O ' HD11 ' A' ' 113' ' ' LEU . 31.9 m120 -163.32 75.15 0.37 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.485 1.115 . . . . 0.0 109.547 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.38 -29.42 64.05 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.215 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -38.71 -40.24 0.58 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.074 0.858 . . . . 0.0 111.533 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.748 HD11 ' O ' ' A' ' 110' ' ' ASN . 6.4 mp -57.91 -24.82 59.46 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.436 1.085 . . . . 0.0 111.773 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.4 t0 -39.18 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.752 0.658 . . . . 0.0 111.072 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 1.419 ' ND1' ' HB3' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 178.59 120.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.696 1.247 . . . . 0.0 109.626 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.409 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.717 179.588 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.419 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 26.1 p90 . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.196 0.046 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 120' ' ' PHE . . . -171.29 -82.94 0.05 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 123.667 0.605 . . . . 0.0 111.65 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -77.26 123.69 26.81 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.488 0.757 . . . . 0.0 110.817 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.202 ' HB3' ' OE1' ' A' ' 76' ' ' GLU . . . -68.24 -156.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.242 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.14 HG22 ' O ' ' A' ' 123' ' ' ALA . 46.2 t 176.4 136.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.947 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 35.7 p90 -170.32 23.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 118.44 -0.791 . . . . 0.0 113.064 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.859 ' HA3' HG22 ' A' ' 88' ' ' ILE . . . -155.93 -166.4 15.85 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.093 1.385 . . . . 0.0 113.725 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.86 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 27.7 ttpp 176.99 132.05 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 110.996 -2.602 . . . . 0.0 110.131 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.884 HG13 ' HB2' ' A' ' 132' ' ' MET . 60.1 t -46.88 149.36 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 124.399 1.062 . . . . 0.0 110.882 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 1.128 HG13 ' CG ' ' A' ' 17' ' ' GLU . 6.5 p -129.72 -45.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.453 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 1.109 ' HE3' ' HA ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER 178.44 76.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.161 0.913 . . . . 0.0 108.688 -177.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.65 -16.02 0.02 OUTLIER Glycine 0 N--CA 1.476 1.364 0 O-C-N 124.819 1.325 . . . . 0.0 112.511 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.262 ' CE ' HG11 ' A' ' 107' ' ' VAL . 9.6 tpt -39.54 -43.3 1.27 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.815 0.362 . . . . 0.0 110.538 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' NZ ' ' A' ' 137' ' ' LYS . 65.2 t0 -44.09 -60.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.366 1.041 . . . . 0.0 109.967 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 1.299 HG22 ' O ' ' A' ' 15' ' ' ASN . 95.5 t -43.71 -56.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 124.491 1.12 . . . . 0.0 109.377 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 132' ' ' MET . . . -45.46 -51.73 11.14 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.786 1.304 . . . . 0.0 110.457 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.904 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 5.6 m-20 -49.01 -70.06 0.1 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.468 1.105 . . . . 0.0 109.417 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 38.0 mtmm -44.77 -46.53 10.59 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.758 1.286 . . . . 0.0 110.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.129 ' O ' HG23 ' A' ' 141' ' ' VAL . 18.5 mt -55.78 -62.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.269 0.981 . . . . 0.0 108.435 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.79 ' HA ' HH12 ' A' ' 48' ' ' ARG . 78.0 p -58.53 0.29 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.904 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 39.9 mm-40 -94.99 -48.97 5.76 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.25 0.969 . . . . 0.0 109.727 177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.129 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.8 m -49.98 124.98 17.59 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.508 1.13 . . . . 0.0 110.208 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.9 Cg_exo -43.79 -177.06 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.629 2.886 . . . . 0.0 113.903 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.325 HG21 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.08 -141.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.628 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.648 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 179.73 143.41 0.16 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 110.698 -2.956 . . . . 0.0 111.865 170.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -67.74 111.91 4.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.113 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.765 HG23 ' CG2' ' A' ' 152' ' ' VAL . 1.3 t -77.24 -144.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 124.642 1.214 . . . . 0.0 109.355 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 148' ' ' PRO . . . -63.44 -113.09 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 171.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.525 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 97.1 Cg_endo -68.97 -46.15 1.7 Allowed 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 123.596 2.864 . . . . 0.0 110.029 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 72.8 m-85 -68.67 97.82 0.84 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.454 1.096 . . . . 0.0 110.329 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -71.68 139.22 49.11 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.217 173.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 150' ' ' GLN . 17.6 m-20 81.2 82.4 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.873 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.765 ' CG2' HG23 ' A' ' 146' ' ' VAL . 72.9 t -140.27 121.05 9.17 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 114.167 -1.379 . . . . 0.0 107.714 168.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.325 ' CA ' HG21 ' A' ' 143' ' ' THR . 44.5 Cg_endo -62.05 102.88 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.565 2.843 . . . . 0.0 109.77 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.086 ' H ' ' HA ' ' A' ' 143' ' ' THR . 66.5 p -44.23 -54.02 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.731 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 155' ' ' LYS . 39.3 tptt -75.27 105.48 2.04 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.741 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.8 Cg_endo -78.7 122.71 5.56 Favored 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.032 -164.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.542 ' O ' HG21 ' A' ' 158' ' ' VAL . 93.1 t -69.44 157.79 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.054 166.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 1.024 ' HA ' HG21 ' A' ' 45' ' ' THR . 89.0 t -158.21 119.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.153 174.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.012 HG13 ' HA ' ' A' ' 45' ' ' THR . 39.5 mt -68.64 137.7 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.26 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -90.78 -47.11 7.83 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.778 -2.01 . . . . 0.0 110.471 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 28.5 t -166.83 170.12 12.6 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.424 1.077 . . . . 0.0 111.906 -175.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 1.084 ' HB1' ' HG ' ' A' ' 9' ' ' LEU . . . -168.88 134.72 1.7 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.739 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.638 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -170.83 151.22 3.36 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.085 174.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 36' ' ' VAL . 33.8 m -72.35 136.62 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.046 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 1.0 HD23 ' HD2' ' A' ' 166' ' ' PRO . 3.3 tm? -68.93 121.33 81.15 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.042 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 1.0 ' HD2' HD23 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 123.536 2.824 . . . . 0.0 112.015 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.417 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 74.5 Cg_endo . . . . . 0 C--O 1.235 0.325 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.417 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 28.4 m170 -153.03 79.14 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.775 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.628 HG21 HD11 ' A' ' 20' ' ' LEU . 43.1 t -60.08 75.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.091 ' HG ' ' HB3' ' A' ' 17' ' ' GLU . 7.9 tt -79.84 105.55 11.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 113.656 -1.611 . . . . 0.0 109.557 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 1.202 HD21 ' O ' ' A' ' 161' ' ' SER . 10.7 mt -92.88 177.08 6.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.935 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 1.129 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 99.2 m -160.47 84.61 0.7 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.678 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 1.031 HG23 HG12 ' A' ' 159' ' ' ILE . 24.2 p -78.4 162.72 26.22 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 125.054 1.471 . . . . 0.0 111.662 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 158' ' ' VAL . 65.0 m -41.1 -50.41 3.44 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.263 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.738 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -47.67 -58.38 4.36 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.594 1.184 . . . . 0.0 110.531 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.67 47.02 Favored Glycine 0 N--CA 1.476 1.352 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.965 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.891 ' O ' HG22 ' A' ' 16' ' ' ILE . 9.4 t-20 -65.6 151.56 46.19 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.416 -1.392 . . . . 0.0 111.799 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.891 HG22 ' O ' ' A' ' 15' ' ' ASN . 25.3 pt -168.81 166.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.822 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 1.091 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . 12.5 pt-20 -163.11 117.09 1.64 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.314 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 105' ' ' ILE . 3.0 mm? -76.87 165.52 24.58 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.738 1.274 . . . . 0.0 110.465 164.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.019 ' HG3' ' O ' ' A' ' 5' ' ' PRO . 39.8 tt0 -131.24 119.49 21.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.944 173.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.962 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.4 mp -99.88 115.12 28.89 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.118 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.72 98.24 0.51 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.579 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.105 ' HA ' HG13 ' A' ' 29' ' ' VAL . 10.0 mtmp? -69.67 -49.59 52.14 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.614 1.196 . . . . 0.0 111.763 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.551 ' NE2' ' HE2' ' A' ' 24' ' ' LYS . 47.4 tt0 -44.33 -62.87 1.01 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.333 1.021 . . . . 0.0 110.556 -171.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.551 ' HE2' ' NE2' ' A' ' 23' ' ' GLN . 4.2 mptp? -69.22 9.57 0.42 Allowed 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.724 1.265 . . . . 0.0 113.543 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -161.05 68.57 2.51 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 123.855 0.722 . . . . 0.0 109.452 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.818 ' O ' HG23 ' A' ' 29' ' ' VAL . 52.0 Cg_exo -56.21 -63.14 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.493 2.796 . . . . 0.0 110.94 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.0 t -54.0 -61.47 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 124.832 1.333 . . . . 0.0 109.944 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.535 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 37.1 t -43.99 -58.84 2.58 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.753 1.283 . . . . 0.0 110.624 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.105 HG13 ' HA ' ' A' ' 22' ' ' LYS . 28.1 m -51.76 -49.48 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 124.629 1.206 . . . . 0.0 110.69 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.848 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.6 tm0? -47.36 -57.77 4.9 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.314 1.009 . . . . 0.0 109.313 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 1.168 ' OD1' HG23 ' A' ' 73' ' ' ILE . 10.8 m120 -42.7 -55.26 3.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.636 1.21 . . . . 0.0 110.282 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.953 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 57.9 m-85 -44.1 -62.14 1.24 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.576 1.172 . . . . 0.0 110.022 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 62.0 t -40.64 -46.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.541 1.15 . . . . 0.0 110.758 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.848 ' OD1' ' NE2' ' A' ' 30' ' ' GLN . 7.0 m-20 -45.0 -60.51 2.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.37 1.044 . . . . 0.0 109.576 174.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 38' ' ' SER . 74.0 m-85 -57.29 -55.97 27.85 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.945 1.403 . . . . 0.0 109.149 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.569 HG13 HG12 ' A' ' 164' ' ' VAL . 69.4 t -44.4 -64.87 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.61 1.194 . . . . 0.0 109.589 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.4 t30 -45.8 -49.35 15.17 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.828 1.33 . . . . 0.0 110.133 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 58.2 m -53.93 -109.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.591 1.182 . . . . 0.0 110.215 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.848 ' HA2' ' OD1' ' A' ' 42' ' ' ASN . . . -174.88 48.07 0.13 Allowed Glycine 0 N--CA 1.474 1.213 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.215 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.81 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 22.9 t80 -73.84 -64.08 1.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.629 0.84 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.788 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . 39.9 m-85 -67.74 -23.18 65.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.118 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.848 ' OD1' ' HA2' ' A' ' 39' ' ' GLY . 35.2 m120 -38.74 -39.8 0.54 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.817 0.698 . . . . 0.0 112.592 -170.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -152.79 50.56 0.74 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.243 0.964 . . . . 0.0 110.133 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 1.061 ' HG1' HD13 ' A' ' 159' ' ' ILE . 49.4 p -79.06 -144.36 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.21 161.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.977 HG21 ' HA ' ' A' ' 158' ' ' VAL . 42.9 p -163.85 -139.21 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.746 0.784 . . . . 0.0 112.168 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 159' ' ' ILE . 51.7 m-85 -157.42 64.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.195 -1.821 . . . . 0.0 107.442 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.732 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 2.2 p-80 -61.61 -60.56 3.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.189 -1.368 . . . . 0.0 109.417 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.732 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.4 mtt180 -69.2 116.78 10.03 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.558 1.161 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 55' ' ' ILE . 68.3 t -152.21 150.74 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 124.87 1.357 . . . . 0.0 110.95 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 1.002 HD11 ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -158.75 122.34 2.09 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.457 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 53' ' ' PHE . 88.0 Cg_exo -37.54 160.61 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.637 2.891 . . . . 0.0 113.941 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.03 68.45 0.0 OUTLIER Glycine 0 N--CA 1.474 1.207 0 CA-C-N 114.022 -1.445 . . . . 0.0 113.831 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.28 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.6 t80 -161.15 -59.12 0.05 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.782 0.931 . . . . 0.0 109.495 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.28 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 57.5 mtm -163.29 157.21 19.92 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.54 1.15 . . . . 0.0 112.29 -171.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.909 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 42.4 pt -161.56 145.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.932 174.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.743 ' HG2' ' CB ' ' A' ' 104' ' ' PHE . 18.2 mt-30 -146.1 168.75 20.2 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.147 0.904 . . . . 0.0 112.079 -166.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.36 -158.95 9.91 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.672 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.81 ' HA2' ' CE1' ' A' ' 40' ' ' PHE . . . 65.97 78.23 0.24 Allowed Glycine 0 N--CA 1.47 0.93 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.159 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 1.54 ' CA ' ' HE3' ' A' ' 67' ' ' LYS . . . 177.89 -133.79 2.27 Favored Glycine 0 N--CA 1.475 1.267 0 O-C-N 124.669 0.864 . . . . 0.0 111.231 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 64.0 m-85 -42.54 128.02 3.9 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.282 -0.959 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.691 ' OG1' ' OE2' ' A' ' 62' ' ' GLU . 78.3 p -59.01 -149.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.344 1.027 . . . . 0.0 110.733 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 1.243 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -59.91 -89.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.282 178.083 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 1.243 ' H ' ' CG ' ' A' ' 62' ' ' GLU . 32.9 mt-30 -72.28 52.52 0.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.77 1.294 . . . . 0.0 110.018 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.663 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 50.4 mtt 40.84 35.74 0.36 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.071 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.579 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 58.0 tp60 -77.72 99.97 6.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' LYS . 88.7 mt-30 -27.03 140.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.446 -172.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 1.54 ' HE3' ' CA ' ' A' ' 59' ' ' GLY . 52.7 mttp -51.44 -127.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.84 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 1.198 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 98.1 mttt 179.57 84.79 0.18 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 112.683 -2.053 . . . . 0.0 106.897 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 1.048 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 52.9 Cg_endo -71.73 -167.93 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.639 2.893 . . . . 0.0 113.297 -171.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.048 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 79.1 m-20 -165.09 170.41 6.39 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 113.327 -1.761 . . . . 0.0 109.984 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.996 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 34.7 Cg_endo -45.77 103.78 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.631 2.221 . . . . 0.0 108.977 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 71' ' ' PRO . 97.7 Cg_exo -45.45 -147.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.859 3.04 . . . . 0.0 113.711 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.205 ' CG1' ' O ' ' A' ' 98' ' ' SER . 26.4 pt -156.33 -126.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.044 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.51 ' N ' HG13 ' A' ' 73' ' ' ILE . 57.0 mtpt -146.71 133.36 19.91 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.045 0.841 . . . . 0.0 110.789 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.702 ' H ' ' HA ' ' A' ' 97' ' ' ASP . 7.4 t-20 -59.36 170.16 1.05 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.886 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.574 ' H ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -178.02 165.78 1.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.412 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 175.65 -34.11 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.255 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 1.005 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 48.7 p-10 -67.17 -44.97 78.39 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.025 0.828 . . . . 0.0 110.319 -176.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 1.005 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 33.6 p-10 41.9 -101.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.221 0.951 . . . . 0.0 110.337 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.605 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 170.46 -69.97 0.13 Allowed Glycine 0 N--CA 1.473 1.116 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.735 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -38.47 159.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.693 0.878 . . . . 0.0 112.285 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 38.3 ptt180 -58.93 -139.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.569 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.8 t-20 171.14 130.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.133 -174.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -167.55 152.64 7.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.202 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.658 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 39.8 ptt180 -40.69 125.51 2.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.585 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 1.018 ' O ' HG21 ' A' ' 128' ' ' VAL . . . 113.33 -28.98 8.25 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.776 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 1.164 HG21 ' NZ ' ' A' ' 127' ' ' LYS . 17.8 p -79.97 131.0 35.72 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.824 0.821 . . . . 0.0 111.484 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 1.611 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -87.42 160.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.005 167.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.05 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -162.1 141.46 9.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.473 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 1.244 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -66.86 122.03 16.79 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.67 -176.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 1.14 ' O ' ' SD ' ' A' ' 90' ' ' MET . . . -81.0 -166.38 1.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.278 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.086 ' CD ' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.71 -149.7 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.83 175.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 1.086 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 55.3 m -167.2 -108.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.765 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.472 ' N ' HG23 ' A' ' 93' ' ' THR . . . -70.69 -93.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.467 1.104 . . . . 0.0 110.538 -171.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 97' ' ' ASP . 32.7 m-20 -43.9 117.06 1.1 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.133 0.896 . . . . 0.0 110.954 -175.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.127 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 53.6 mtmt -71.35 42.18 0.07 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.696 1.247 . . . . 0.0 111.087 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 1.127 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 90.7 m-20 179.27 86.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 1.205 ' O ' ' CG1' ' A' ' 73' ' ' ILE . 67.1 m -168.12 -96.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.679 1.237 . . . . 0.0 109.759 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 1.061 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 58.99 94.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.794 1.309 . . . . 0.0 107.947 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.7 p -77.88 -42.77 32.23 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.552 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -170.93 -44.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.247 0.967 . . . . 0.0 110.479 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.717 ' O ' ' HE3' ' A' ' 90' ' ' MET . 3.9 pt20 -36.15 146.05 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.295 0.997 . . . . 0.0 112.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.992 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -157.22 -179.52 8.27 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.881 -1.508 . . . . 0.0 110.405 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.806 ' CZ ' ' HB2' ' A' ' 89' ' ' ALA . 35.7 p90 -151.03 122.44 7.87 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.271 -169.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.029 HD12 HD22 ' A' ' 18' ' ' LEU . 58.1 mt -94.2 101.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.365 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.578 ' OD1' ' HD1' ' A' ' 104' ' ' PHE . 7.3 m-20 -67.14 -175.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.778 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 1.645 HG11 ' CE ' ' A' ' 132' ' ' MET . 35.1 m -155.6 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.68 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -83.95 145.59 28.47 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.421 1.076 . . . . 0.0 110.874 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.1 m-20 -45.9 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.847 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 1.067 ' OD1' HD13 ' A' ' 113' ' ' LEU . 7.1 t-20 -68.81 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.864 1.353 . . . . 0.0 109.936 -170.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 113' ' ' LEU . . . 70.52 -19.26 0.22 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.857 0.723 . . . . 0.0 112.251 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.546 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.5 m-85 -69.38 36.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.68 0.612 . . . . 0.0 111.414 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 1.067 HD13 ' OD1' ' A' ' 110' ' ' ASN . 0.0 OUTLIER 179.22 -17.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.783 0.677 . . . . 0.0 111.815 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.742 ' N ' HD23 ' A' ' 113' ' ' LEU . 57.4 p-10 -47.85 138.83 8.25 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.683 0.614 . . . . 0.0 111.139 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 1.245 ' CB ' ' O ' ' A' ' 120' ' ' PHE . 1.7 t60 -31.61 131.9 0.11 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.862 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.418 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . . . . . . 0 N--CA 1.477 1.392 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.062 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.245 ' O ' ' CB ' ' A' ' 115' ' ' HIS . 1.7 t80 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.68 -0.119 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' N ' ' A' ' 115' ' ' HIS . . . 89.97 176.68 45.18 Favored Glycine 0 N--CA 1.477 1.42 0 O-C-N 124.475 1.109 . . . . 0.0 113.108 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.82 ' CD1' HD21 ' A' ' 113' ' ' LEU . 68.1 m-85 -78.65 143.24 36.51 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.229 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.244 ' HB2' ' O ' ' A' ' 90' ' ' MET . . . -54.68 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.59 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.05 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 72.2 t -175.85 128.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.92 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.962 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.3 p90 -161.77 21.62 0.11 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.608 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 1.611 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -113.26 155.89 15.99 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 122.939 1.3 . . . . 0.0 112.507 -169.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.164 ' NZ ' HG21 ' A' ' 87' ' ' THR . 0.4 OUTLIER -171.07 110.99 0.34 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 110.985 -2.608 . . . . 0.0 110.261 173.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.018 HG21 ' O ' ' A' ' 86' ' ' GLY . 58.3 t -58.11 157.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.223 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 1.067 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 33.1 m -154.44 32.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.231 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 1.067 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 74.5 mmtt 120.92 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.773 0.671 . . . . 0.0 109.508 174.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.868 ' CA ' HG21 ' A' ' 16' ' ' ILE . . . 171.78 -26.12 0.09 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.04 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.645 ' CE ' HG11 ' A' ' 107' ' ' VAL . 12.1 tpt -39.52 -51.17 2.2 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.975 0.456 . . . . 0.0 110.921 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 36.6 m-20 -43.88 -61.6 1.39 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.37 1.044 . . . . 0.0 109.541 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 15' ' ' ASN . 54.4 t -41.45 -60.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 124.739 1.274 . . . . 0.0 109.551 173.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.909 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . . . -44.41 -53.09 7.2 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.654 1.221 . . . . 0.0 109.709 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.922 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 38.2 m-20 -50.69 -66.97 0.3 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.771 1.294 . . . . 0.0 109.03 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.558 ' O ' HG12 ' A' ' 141' ' ' VAL . 56.4 mtpt -40.2 -49.38 2.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.789 1.306 . . . . 0.0 110.539 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.281 ' O ' HG23 ' A' ' 141' ' ' VAL . 16.2 mt -57.84 -58.29 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.444 1.09 . . . . 0.0 108.837 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.705 ' HB3' HG23 ' A' ' 55' ' ' ILE . 84.9 p -65.51 3.42 0.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.922 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.5 mp0 -99.07 -49.39 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.168 0.917 . . . . 0.0 108.741 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.281 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.4 m -41.29 123.25 2.15 Favored Pre-proline 0 N--CA 1.473 0.711 0 O-C-N 124.349 1.031 . . . . 0.0 110.306 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.8 Cg_exo -38.83 -178.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.35 2.7 . . . . 0.0 113.575 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.424 HG21 ' CA ' ' A' ' 153' ' ' PRO . 6.0 p -160.96 -150.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.735 1.731 . . . . 0.0 112.688 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.77 ' CD2' ' O ' ' A' ' 145' ' ' ASP . 0.8 OUTLIER 178.02 167.34 0.75 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 109.726 -3.397 . . . . 0.0 111.312 174.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.77 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 36.8 m-20 -52.37 -149.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.819 165.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -161.99 -61.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.673 1.225 . . . . 0.0 108.347 171.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.59 -92.18 0.08 OUTLIER Glycine 0 N--CA 1.471 1.001 0 CA-C-N 111.335 -2.666 . . . . 0.0 107.687 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.805 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 80.2 Cg_endo -68.4 -67.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.479 2.786 . . . . 0.0 108.761 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.805 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 96.0 m-85 -72.0 117.05 13.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.583 1.177 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.753 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 4.3 pm0 -95.03 83.77 4.0 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.75 1.281 . . . . 0.0 107.945 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.767 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 27.6 p30 169.3 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.548 -177.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.698 ' CG2' HG22 ' A' ' 146' ' ' VAL . 95.9 t -160.31 116.25 1.45 Allowed Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.739 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.424 ' CA ' HG21 ' A' ' 143' ' ' THR . 58.1 Cg_endo -63.08 106.92 0.58 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 109.304 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.053 ' H ' ' HA ' ' A' ' 143' ' ' THR . 77.5 p -40.59 -51.64 2.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.289 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 1.245 ' HB3' ' CD ' ' A' ' 156' ' ' PRO . 10.8 mptt -61.45 -166.71 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.459 1.099 . . . . 0.0 111.933 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.245 ' CD ' ' HB3' ' A' ' 155' ' ' LYS . 78.3 Cg_endo -85.12 145.85 9.89 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.789 2.993 . . . . 0.0 112.733 -170.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.979 HG21 ' O ' ' A' ' 156' ' ' PRO . 38.3 t -170.55 115.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.794 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.977 ' HA ' HG21 ' A' ' 45' ' ' THR . 92.1 t -153.57 120.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.24 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.061 HD13 ' HG1' ' A' ' 44' ' ' THR . 43.3 mt -68.58 134.3 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.274 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 1.129 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.2 mt -79.67 -51.62 9.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 112.39 -2.186 . . . . 0.0 109.284 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 1.202 ' O ' HD21 ' A' ' 9' ' ' LEU . 68.0 m -165.27 174.95 9.65 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.57 1.169 . . . . 0.0 112.697 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.906 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -157.73 100.77 1.78 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.104 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.951 ' O ' ' CD1' ' A' ' 165' ' ' LEU . 32.4 mmmt -125.32 125.81 44.09 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.15 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.843 ' C ' HD11 ' A' ' 165' ' ' LEU . 34.4 m -67.93 131.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.597 1.186 . . . . 0.0 109.824 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 1.016 HD12 ' HB3' ' A' ' 8' ' ' LEU . 6.8 mp -133.65 135.63 25.3 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.925 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 165' ' ' LEU . 87.8 Cg_exo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.638 2.892 . . . . 0.0 112.027 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.257 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 71.1 Cg_exo . . . . . 0 C--O 1.235 0.361 0 N-CA-C 113.353 0.482 . . . . 0.0 113.353 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.257 ' HD2' ' O ' ' A' ' 5' ' ' PRO . 51.9 m170 -150.48 118.11 6.15 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.847 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.2 p -73.98 138.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.208 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.101 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 6.4 mp -127.78 116.12 19.71 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.471 1.107 . . . . 0.0 109.619 166.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.836 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 7.1 mp -110.73 -175.96 2.85 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.049 -2.341 . . . . 0.0 108.726 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.758 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 52.6 m -161.48 99.9 1.17 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.359 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 1.074 ' HG1' HD12 ' A' ' 138' ' ' ILE . 40.7 p -76.29 169.01 19.03 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 125.307 1.629 . . . . 0.0 111.407 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -40.71 -42.17 1.69 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.338 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.862 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.48 -60.54 3.21 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.483 1.115 . . . . 0.0 110.759 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 179.65 44.29 Favored Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.345 -1.752 . . . . 0.0 114.012 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 1.176 ' O ' HG22 ' A' ' 134' ' ' VAL . 58.6 t-20 -55.55 159.3 2.95 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.948 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' OD1' ' A' ' 15' ' ' ASN . 10.1 tt -171.36 160.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.289 -172.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 1.101 ' HG2' ' CG ' ' A' ' 8' ' ' LEU . 35.4 mt-10 -162.92 121.48 2.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.109 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.001 HD22 HD12 ' A' ' 105' ' ' ILE . 2.8 mm? -92.01 173.86 7.62 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.403 1.064 . . . . 0.0 110.322 161.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.432 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -134.57 124.12 24.94 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.047 175.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 20' ' ' LEU . 6.5 mp -109.39 141.8 41.26 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.814 1.321 . . . . 0.0 111.735 -168.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.738 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 63.0 m-20 -55.86 -118.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.892 170.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.015 ' HD3' ' O ' ' A' ' 22' ' ' LYS . 5.8 tmtt? 124.66 -48.62 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.131 -1.85 . . . . 0.0 109.517 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -45.81 -65.3 0.56 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.625 1.203 . . . . 0.0 109.727 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.926 ' HD3' HD22 ' A' ' 81' ' ' LEU . 53.3 mtpt -90.61 21.92 3.75 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.704 1.253 . . . . 0.0 113.87 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.593 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.85 65.18 2.16 Favored Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 124.205 0.941 . . . . 0.0 110.57 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.972 ' O ' HG23 ' A' ' 29' ' ' VAL . 52.4 Cg_exo -59.66 -59.76 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.533 2.822 . . . . 0.0 110.965 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.1 t -50.4 -63.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.151 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -42.67 -57.55 2.67 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.7 1.25 . . . . 0.0 110.51 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 26' ' ' PRO . 26.8 m -52.75 -47.14 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.666 1.229 . . . . 0.0 110.871 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.489 ' N ' HG21 ' A' ' 29' ' ' VAL . 42.6 tp60 -46.93 -70.36 0.1 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.179 0.924 . . . . 0.0 109.931 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 1.225 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 12.3 m-80 -42.07 -48.39 4.67 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.454 1.096 . . . . 0.0 110.312 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.739 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 69.7 t80 -42.98 -63.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.504 1.128 . . . . 0.0 109.759 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.733 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.0 t -45.51 -37.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.602 1.189 . . . . 0.0 111.021 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 1.225 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 84.2 m-20 -43.02 -63.44 0.8 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.063 0.852 . . . . 0.0 109.705 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 40' ' ' PHE . 96.2 m-85 -61.13 -59.27 5.6 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.796 1.31 . . . . 0.0 109.095 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.733 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 59.9 t -39.41 -48.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 124.69 1.243 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.77 ' O ' ' HB3' ' A' ' 38' ' ' SER . 50.4 t30 -38.56 -31.23 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.725 1.266 . . . . 0.0 112.401 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.77 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.0 p 154.89 159.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.103 0.877 . . . . 0.0 113.151 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.44 -39.64 3.1 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.117 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 35' ' ' TYR . 2.1 t80 -67.78 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.361 0.683 . . . . 0.0 110.92 -173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.508 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 81.6 m-85 -60.87 -36.74 79.97 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.336 1.022 . . . . 0.0 112.669 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 52.2 p-10 -38.95 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.089 0.868 . . . . 0.0 110.767 -171.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.978 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 10.7 m-20 76.59 39.47 0.25 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 113.49 -1.687 . . . . 0.0 111.633 175.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 1.004 ' HG1' HD13 ' A' ' 159' ' ' ILE . 48.9 p -78.66 -129.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 166.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.988 ' HA ' HG13 ' A' ' 159' ' ' ILE . 61.7 p -163.44 -147.42 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.824 1.297 . . . . 0.0 113.59 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 159' ' ' ILE . 16.7 m-85 -161.54 59.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 111.579 -2.555 . . . . 0.0 105.222 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 1.208 ' CE1' ' OE1' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -38.68 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.489 -173.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.156 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.0 mmm180 -173.35 -155.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 123.081 1.42 . . . . 0.0 113.33 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 1.078 HG11 ' HA ' ' A' ' 55' ' ' ILE . 7.6 p -179.7 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 111.682 -2.508 . . . . 0.0 107.539 159.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.93 HG21 ' HB2' ' A' ' 54' ' ' MET . 9.3 tt -171.75 131.3 0.74 Allowed Pre-proline 0 N--CA 1.476 0.873 0 O-C-N 124.451 1.094 . . . . 0.0 109.983 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.731 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 81.9 Cg_exo -48.85 157.7 1.5 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.893 3.062 . . . . 0.0 114.398 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.24 53.38 0.01 OUTLIER Glycine 0 N--CA 1.475 1.284 0 CA-C-N 114.02 -1.445 . . . . 0.0 114.192 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.322 ' CE2' ' HE2' ' A' ' 54' ' ' MET . 1.5 t80 -162.14 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.665 0.862 . . . . 0.0 110.037 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.322 ' HE2' ' CE2' ' A' ' 53' ' ' PHE . 45.0 mtt -160.18 147.57 16.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.231 0.957 . . . . 0.0 111.611 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.078 ' HA ' HG11 ' A' ' 49' ' ' VAL . 38.4 pt -148.62 141.66 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.276 -1.783 . . . . 0.0 108.19 167.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.465 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 62.5 mt-30 -64.75 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.146 -163.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 1.056 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -129.3 -121.17 2.32 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 118.667 -2.521 . . . . 0.0 109.928 0.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . 52.97 109.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.063 0 CA-C-N 114.271 -0.965 . . . . 0.0 111.22 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.86 -126.01 1.11 Allowed Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.525 0.779 . . . . 0.0 111.717 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.88 ' CE2' ' HG2' ' A' ' 66' ' ' GLN . 29.8 m-85 -43.08 134.02 3.65 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.788 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.968 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 61.7 p -59.36 124.67 20.8 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.265 0.978 . . . . 0.0 109.837 169.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 1.228 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 13.11 -104.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.757 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 1.24 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.5 mm100 -38.11 -59.99 0.8 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.778 1.299 . . . . 0.0 111.445 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 1.24 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 14.6 mmt 145.11 98.43 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.925 ' OE1' ' O ' ' A' ' 64' ' ' MET . 29.4 mm100 -160.65 71.04 0.42 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 112.621 -2.081 . . . . 0.0 106.966 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.88 ' HG2' ' CE2' ' A' ' 60' ' ' PHE . 39.6 mt-30 -28.52 130.73 0.06 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.24 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.968 ' HE3' ' CG2' ' A' ' 61' ' ' THR . 18.6 mmtp -72.57 153.7 41.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.396 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 7.5 mmpt? -48.03 95.33 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.799 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.86 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 71.4 Cg_exo -59.12 -69.79 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.593 2.862 . . . . 0.0 113.192 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.947 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 34.8 m120 89.75 163.28 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 O-C-N 124.402 1.064 . . . . 0.0 111.132 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 58.6 Cg_endo -67.71 112.04 2.54 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.875 3.05 . . . . 0.0 110.88 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 1.217 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 88.5 Cg_exo -52.1 -150.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.798 2.998 . . . . 0.0 112.957 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.52 156.79 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.974 ' HD2' ' H ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -33.3 135.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.192 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' LYS . 56.6 p30 -45.7 -164.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.44 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.745 ' HB3' HD22 ' A' ' 79' ' ' ASN . 8.4 mm-40 161.67 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.589 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 120' ' ' PHE . . . -71.29 -43.26 67.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.251 0.969 . . . . 0.0 109.791 171.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 1.069 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 20.9 p-10 -67.41 -53.5 28.61 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.424 1.077 . . . . 0.0 109.907 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.745 HD22 ' HB3' ' A' ' 76' ' ' GLU . 38.5 p-10 -63.51 99.26 0.2 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.237 1.018 . . . . 0.0 108.876 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 1.222 ' O ' HD12 ' A' ' 81' ' ' LEU . . . 172.22 46.87 0.04 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.359 -1.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 1.222 HD12 ' O ' ' A' ' 80' ' ' GLY . 1.7 mm? -146.14 -149.29 0.28 Allowed 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.626 0.839 . . . . 0.0 109.499 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 3.8 mpt_? -179.74 150.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' A' ' 84' ' ' THR . 60.3 t-20 -169.49 -124.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.519 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 1.11 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 16.2 m -168.6 163.46 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.025 0.828 . . . . 0.0 112.004 -162.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 1.11 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 8.3 ptm85 -19.92 108.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.19 164.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.743 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 137.2 -27.03 2.92 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 111.575 -2.557 . . . . 0.0 110.233 -168.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 1.083 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.2 p -92.66 142.82 26.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.91 0.862 . . . . 0.0 112.191 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.934 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.74 162.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.094 166.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.154 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -156.01 140.97 17.26 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 113.943 -1.48 . . . . 0.0 111.829 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.928 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.1 tpt -56.88 140.3 48.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.507 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.515 ' O ' ' HE2' ' A' ' 90' ' ' MET . . . -109.38 129.3 55.54 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.457 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.306 ' HG2' ' N ' ' A' ' 99' ' ' ALA . 29.9 tpt180 179.15 175.98 0.62 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.765 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.716 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 89.6 m -168.3 115.86 0.7 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.563 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.796 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 165.01 -50.69 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.025 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.796 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 16.0 p30 74.37 -177.39 0.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.541 1.151 . . . . 0.0 112.323 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.174 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 0.4 OUTLIER 79.94 -49.29 0.36 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.763 -172.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 1.174 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 73.7 m-20 -162.45 61.32 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.622 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 21.6 t -74.22 173.75 9.72 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.773 1.296 . . . . 0.0 113.333 -170.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 1.306 ' N ' ' HG2' ' A' ' 92' ' ' ARG . . . 65.01 170.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.76 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.947 HG21 ' HG3' ' A' ' 72' ' ' PRO . 72.8 p -150.93 -48.41 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.297 -174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.575 ' C ' ' HE3' ' A' ' 90' ' ' MET . 73.0 p -171.07 -52.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.257 0.973 . . . . 0.0 110.179 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.694 ' O ' ' SD ' ' A' ' 90' ' ' MET . 19.3 pt20 -42.83 154.22 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.353 1.033 . . . . 0.0 112.183 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.934 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -159.28 168.73 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.456 175.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.465 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 17.1 p90 -144.49 137.68 27.07 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.326 -170.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.069 ' N ' ' O ' ' A' ' 56' ' ' GLN . 63.1 mt -93.95 116.65 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 112.057 -2.338 . . . . 0.0 110.612 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.86 116.51 6.41 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.5 1.125 . . . . 0.0 109.572 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.888 ' HB ' ' C ' ' A' ' 53' ' ' PHE . 51.9 t -90.44 22.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 124.488 1.118 . . . . 0.0 112.133 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.868 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . 169.21 172.53 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.609 0.719 . . . . 0.0 112.108 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.571 ' N ' ' HB3' ' A' ' 85' ' ' ARG . 71.7 m-20 -38.62 144.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.596 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 113' ' ' LEU . 26.6 t-20 -170.57 155.95 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.435 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 176.13 -50.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.465 -1.698 . . . . 0.0 108.296 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.954 ' O ' ' HD1' ' A' ' 112' ' ' PHE . 3.2 p90 -61.26 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 167.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.8 HD13 ' CE1' ' A' ' 122' ' ' TYR . 36.9 tp 177.92 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.103 -171.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 122' ' ' TYR . 34.0 m-20 -38.47 -60.91 0.75 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.282 0.989 . . . . 0.0 111.182 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.601 ' ND1' ' HA ' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 179.05 84.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.587 1.179 . . . . 0.0 108.547 -175.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.157 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.584 179.686 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 1.3 t80 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.36 -130.44 0.09 OUTLIER Glycine 0 N--CA 1.473 1.156 0 CA-C-N 113.829 -1.532 . . . . 0.0 114.137 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.8 ' CE1' HD13 ' A' ' 113' ' ' LEU . 76.3 m-85 -78.93 150.41 32.1 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.499 -1.351 . . . . 0.0 112.674 -167.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.154 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -81.11 -163.15 0.56 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.6 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.999 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 73.9 t 179.39 140.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.111 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.676 ' HZ ' ' CD2' ' A' ' 103' ' ' PHE . 9.8 p90 -164.76 22.56 0.06 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 1.222 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -171.73 -136.3 2.1 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 122.976 1.32 . . . . 0.0 113.745 173.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.432 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 8.7 mtpm? 179.6 -133.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 111.275 -2.463 . . . . 0.0 109.162 -172.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.922 HG23 ' CD1' ' A' ' 18' ' ' LEU . 80.4 t -153.36 120.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.573 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.933 ' CG1' ' CB ' ' A' ' 17' ' ' GLU . 7.7 p -69.85 -46.49 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.104 172.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.81 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 58.5 mtpt -166.66 -135.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.449 1.093 . . . . 0.0 108.87 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . 62.36 -17.36 0.07 OUTLIER Glycine 0 N--CA 1.474 1.212 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.01 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.602 ' H ' ' C ' ' A' ' 130' ' ' LYS . 8.3 tpt -39.57 -42.88 1.23 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.009 0.404 . . . . 0.0 110.355 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 12.1 m-20 -45.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.438 1.087 . . . . 0.0 109.72 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 1.176 HG22 ' O ' ' A' ' 15' ' ' ASN . 59.5 t -46.5 -57.17 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.474 1.109 . . . . 0.0 109.167 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 132' ' ' MET . . . -44.4 -53.69 6.6 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.618 1.199 . . . . 0.0 109.672 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.837 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 42.0 m-20 -51.96 -64.37 0.84 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.623 1.202 . . . . 0.0 108.854 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 56.0 tptt -39.83 -54.07 2.18 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.86 1.35 . . . . 0.0 110.552 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.216 ' O ' HG11 ' A' ' 141' ' ' VAL . 21.0 mt -59.74 -58.68 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.561 1.163 . . . . 0.0 109.363 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.3 p -55.13 -8.73 0.32 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.837 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mm-40 -96.2 -44.69 7.16 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.356 1.035 . . . . 0.0 110.082 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.216 HG11 ' O ' ' A' ' 138' ' ' ILE . 8.0 p -48.96 131.48 15.02 Favored Pre-proline 0 N--CA 1.474 0.741 0 O-C-N 124.417 1.073 . . . . 0.0 110.444 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 86.3 Cg_exo -46.9 172.02 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.649 2.9 . . . . 0.0 113.795 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.381 HG21 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.06 -140.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.225 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.665 ' HD2' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 179.0 158.43 0.56 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 110.942 -2.844 . . . . 0.0 112.696 169.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 45.1 t0 -50.38 -179.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.734 165.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.947 HG23 ' CG2' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -158.03 -143.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.59 -110.33 0.01 OUTLIER Glycine 0 N--CA 1.472 1.059 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.975 ' HG2' ' HD1' ' A' ' 149' ' ' TYR . 94.6 Cg_endo -71.81 -46.7 0.54 Allowed 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 123.8 3.0 . . . . 0.0 110.259 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.975 ' HD1' ' HG2' ' A' ' 148' ' ' PRO . 34.9 m-85 -68.56 109.43 3.74 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.429 1.081 . . . . 0.0 110.933 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.575 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 7.6 mm-40 -84.94 64.47 8.68 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.213 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.845 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 54.7 p30 178.74 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.284 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.947 ' CG2' HG23 ' A' ' 146' ' ' VAL . 94.1 t -154.84 118.26 2.51 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.803 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.381 ' CA ' HG21 ' A' ' 143' ' ' THR . 61.0 Cg_endo -67.18 110.37 1.98 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.656 2.904 . . . . 0.0 109.736 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.919 ' H ' ' HA ' ' A' ' 143' ' ' THR . 40.0 t -44.95 -62.46 1.22 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.383 175.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 153' ' ' PRO . 67.3 mttm -66.99 140.65 96.18 Favored Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.633 1.208 . . . . 0.0 109.513 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 73.4 Cg_endo -88.11 114.82 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.107 2.538 . . . . 0.0 113.346 -161.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.692 ' O ' HG21 ' A' ' 158' ' ' VAL . 44.7 t -76.97 148.72 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.7 157.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.91 ' HA ' HG21 ' A' ' 45' ' ' THR . 95.8 t -163.67 122.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.88 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.004 HD13 ' HG1' ' A' ' 44' ' ' THR . 20.6 mt -68.01 130.49 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.361 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.758 ' HB2' ' O ' ' A' ' 10' ' ' THR . 84.7 mt -79.83 -48.05 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 112.535 -2.12 . . . . 0.0 110.171 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.7 m -162.84 -167.78 1.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.564 1.165 . . . . 0.0 112.484 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.836 ' HB1' ' HG ' ' A' ' 9' ' ' LEU . . . -178.99 139.66 0.16 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.283 -1.781 . . . . 0.0 109.703 -175.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 8' ' ' LEU . 22.0 ptmt -170.85 126.27 0.71 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.743 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.39 145.48 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.989 -1.46 . . . . 0.0 110.617 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 1.008 ' HB3' ' HD3' ' A' ' 166' ' ' PRO . 55.2 tp -58.52 -59.87 12.14 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.974 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 1.008 ' HD3' ' HB3' ' A' ' 165' ' ' LEU . 82.1 Cg_exo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 123.242 2.628 . . . . 0.0 111.985 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.453 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 71.9 Cg_endo . . . . . 0 C--O 1.234 0.3 0 N-CA-C 109.653 -0.941 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.453 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.1 m170 -158.23 97.99 1.54 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.621 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.97 ' HA ' HG11 ' A' ' 164' ' ' VAL . 87.1 t -61.02 79.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 165.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.116 ' HB3' ' O ' ' A' ' 163' ' ' LYS . 7.3 tt -79.86 106.91 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.356 -169.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 1.153 HD21 ' O ' ' A' ' 161' ' ' SER . 12.3 mt -103.64 171.88 7.12 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 113.163 -1.835 . . . . 0.0 112.331 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 1.294 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 94.6 m -160.52 79.08 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.9 -2.409 . . . . 0.0 107.084 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.985 HG21 HG12 ' A' ' 159' ' ' ILE . 32.4 p -74.73 167.1 22.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 125.132 1.52 . . . . 0.0 111.952 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.563 ' OG ' HG12 ' A' ' 157' ' ' VAL . 78.3 p -41.41 -49.52 3.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.459 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.734 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.47 -55.88 24.44 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.424 1.078 . . . . 0.0 110.289 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.598 ' O ' HG12 ' A' ' 134' ' ' VAL . . . 171.48 -179.95 42.92 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.911 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.887 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 10.4 t-20 -57.82 159.14 5.65 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.545 -1.328 . . . . 0.0 111.97 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.827 HG13 ' HB2' ' A' ' 9' ' ' LEU . 19.3 pt -162.59 -173.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.903 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.891 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 7.2 mm-40 -161.27 126.81 3.7 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.284 -170.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.975 HD22 HD13 ' A' ' 105' ' ' ILE . 2.9 mm? -112.0 114.04 26.69 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.547 1.154 . . . . 0.0 108.925 164.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.968 ' CG ' ' HB2' ' A' ' 127' ' ' LYS . 11.9 pt-20 -79.53 111.13 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.503 1.127 . . . . 0.0 108.53 169.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.809 ' O ' ' HB2' ' A' ' 5' ' ' PRO . 7.2 mp -108.56 131.58 54.71 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.881 1.363 . . . . 0.0 110.775 -174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.954 ' OD1' ' NZ ' ' A' ' 127' ' ' LYS . 40.1 m-20 -57.33 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.037 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.763 ' HG3' ' N ' ' A' ' 23' ' ' GLN . 22.2 ptmt 142.65 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.372 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.763 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 3.9 pt20 -49.74 -44.31 48.47 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.72 1.262 . . . . 0.0 110.473 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 1.103 ' HE3' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -68.55 -15.07 63.41 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.305 1.003 . . . . 0.0 112.906 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 1.001 ' O ' HG21 ' A' ' 29' ' ' VAL . . . -160.73 72.36 2.81 Favored Pre-proline 0 N--CA 1.475 0.81 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 75.6 Cg_exo -55.91 -64.44 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.633 2.889 . . . . 0.0 111.73 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.673 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 66.4 t -53.18 -67.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.68 1.237 . . . . 0.0 109.911 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.772 ' HA ' HG13 ' A' ' 73' ' ' ILE . 58.8 m -44.67 -61.71 1.47 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.579 1.174 . . . . 0.0 109.853 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.001 HG21 ' O ' ' A' ' 25' ' ' ALA . 47.3 t -49.25 -52.56 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 124.786 1.304 . . . . 0.0 109.92 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 38.6 tp60 -41.81 -61.47 1.1 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.475 1.109 . . . . 0.0 110.049 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.732 ' CG ' HG23 ' A' ' 73' ' ' ILE . 13.2 m-80 -42.91 -51.91 5.35 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.564 1.165 . . . . 0.0 109.765 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.969 ' O ' HG21 ' A' ' 36' ' ' VAL . 78.9 t80 -40.64 -57.76 1.79 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.629 1.206 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.821 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 57.6 t -51.18 -38.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.754 1.283 . . . . 0.0 111.316 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.789 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 8.4 p-10 -44.9 -55.51 5.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.951 0.782 . . . . 0.0 109.362 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.861 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 54.5 m-85 -69.64 -53.73 17.3 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.09 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.969 HG21 ' O ' ' A' ' 32' ' ' PHE . 61.9 t -39.39 -50.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.164 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.789 ' CG ' ' O ' ' A' ' 34' ' ' ASP . 51.0 p30 -37.92 -33.4 0.08 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.703 1.252 . . . . 0.0 112.098 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.762 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.3 p 146.4 136.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.239 0.962 . . . . 0.0 112.028 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 1.064 ' N ' ' OD1' ' A' ' 42' ' ' ASN . . . 131.14 -59.25 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.51 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.932 ' O ' HG22 ' A' ' 44' ' ' THR . 61.1 t80 -62.99 -74.35 0.1 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.291 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' CG ' ' HD1' ' A' ' 40' ' ' PHE . 68.5 m-85 -66.75 -25.08 66.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.485 1.115 . . . . 0.0 112.913 -173.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 1.064 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 14.0 m120 -38.75 -36.59 0.27 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.902 0.751 . . . . 0.0 112.467 -173.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.598 HD22 HG12 ' A' ' 158' ' ' VAL . 2.0 t-20 -157.97 47.46 0.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.124 0.89 . . . . 0.0 110.325 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 1.04 ' HG1' HD13 ' A' ' 159' ' ' ILE . 46.2 p -79.71 -133.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.314 164.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.965 ' HA ' HG13 ' A' ' 159' ' ' ILE . 77.8 p -162.96 -153.03 0.23 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.87 0.843 . . . . 0.0 111.817 173.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.082 ' HZ ' HD12 ' A' ' 9' ' ' LEU . 14.4 m-30 -141.85 63.42 1.42 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.174 -1.83 . . . . 0.0 106.585 174.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 1.094 ' CE1' ' HA2' ' A' ' 59' ' ' GLY . 1.1 p-80 -51.94 -72.67 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.684 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.888 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 84.2 mtm180 -71.49 130.48 41.37 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.42 1.075 . . . . 0.0 111.075 -173.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.97 HG21 ' HB ' ' A' ' 55' ' ' ILE . 10.9 p -159.96 157.36 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.844 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 1.054 HD11 ' HD2' ' A' ' 53' ' ' PHE . 9.9 tt -155.7 127.04 3.66 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.484 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 94.2 Cg_exo -38.7 155.14 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.577 2.851 . . . . 0.0 113.486 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -3.23 66.59 0.0 OUTLIER Glycine 0 N--CA 1.475 1.266 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.888 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.054 ' HD2' HD11 ' A' ' 50' ' ' ILE . 10.9 t80 -161.02 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.808 0.946 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.867 ' HG2' ' N ' ' A' ' 55' ' ' ILE . 54.2 ttp -167.62 177.45 5.87 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.484 1.115 . . . . 0.0 111.958 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.97 ' HB ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 171.39 113.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.12 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.951 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 66.6 mt-30 -98.62 -170.65 1.98 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.232 -166.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.22 28.79 Favored Glycine 0 N--CA 1.477 1.377 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.533 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.762 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 93.27 -59.69 2.28 Favored Glycine 0 N--CA 1.474 1.206 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 -165.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 1.094 ' HA2' ' CE1' ' A' ' 47' ' ' HIS . . . 41.34 143.65 0.0 OUTLIER Glycine 0 N--CA 1.472 1.074 0 CA-C-N 114.212 -0.994 . . . . 0.0 114.014 168.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.903 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 14.1 m-30 -46.89 150.7 0.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.406 -1.397 . . . . 0.0 110.673 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 1.252 HG22 ' OE1' ' A' ' 65' ' ' GLN . 94.8 m -59.08 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.316 -174.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 1.149 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 1.5 mp0 48.51 116.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.758 1.286 . . . . 0.0 110.745 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 1.31 ' O ' ' CG ' ' A' ' 64' ' ' MET . 8.5 pt20 69.02 -48.83 0.59 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.558 1.161 . . . . 0.0 111.0 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 1.31 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 25.0 mmt 158.38 98.22 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.981 1.372 . . . . 0.0 108.715 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 1.252 ' OE1' HG22 ' A' ' 61' ' ' THR . 48.4 tt0 -150.46 79.71 1.34 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.014 -2.812 . . . . 0.0 105.187 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.792 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -27.04 176.81 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.404 -1.725 . . . . 0.0 115.627 -166.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 1.109 ' H ' ' CD ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -48.07 -140.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 111.412 -2.631 . . . . 0.0 112.271 -174.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 1.067 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 40.2 ttpt 178.31 -70.94 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.076 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 1.067 ' CD ' ' HB3' ' A' ' 68' ' ' LYS . 59.8 Cg_endo -62.56 133.09 40.85 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.589 2.859 . . . . 0.0 111.011 173.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.538 ' HA ' ' CG2' ' A' ' 100' ' ' THR . 92.2 m-20 -168.61 72.14 0.8 Allowed Pre-proline 0 N--CA 1.474 0.725 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 1.024 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 80.0 Cg_exo -48.29 -64.06 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.391 2.728 . . . . 0.0 110.937 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 1.155 ' CB ' ' HA ' ' A' ' 98' ' ' SER . 50.3 Cg_exo -87.71 -140.63 0.16 OUTLIER 'Cis proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.798 -1.751 . . . . 0.0 110.835 -2.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.302 HD13 ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -158.6 150.95 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.642 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 74.4 mmtt -30.14 145.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.877 -1.51 . . . . 0.0 113.049 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 1.206 ' OD1' ' HB3' ' A' ' 96' ' ' LYS . 40.4 m-80 -42.77 -167.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.272 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 1.231 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 161.19 118.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.231 -177.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.861 ' HB3' HH11 ' A' ' 92' ' ' ARG . . . 174.06 -51.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.897 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 1.021 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 59.8 p30 -70.35 39.07 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.501 1.126 . . . . 0.0 111.693 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 77' ' ' ALA . 4.6 p30 -40.6 -41.43 1.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.281 0.988 . . . . 0.0 110.976 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.788 ' O ' HD21 ' A' ' 81' ' ' LEU . . . 64.02 71.06 0.91 Allowed Glycine 0 N--CA 1.47 0.916 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.788 HD21 ' O ' ' A' ' 80' ' ' GLY . 79.9 mt -163.94 -179.54 6.33 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.871 0.983 . . . . 0.0 111.022 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.716 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 35.4 mmt180 -72.72 138.63 46.69 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.321 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.0 m120 -155.12 132.8 11.31 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.827 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 m -166.75 154.82 9.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.967 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.87 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 78.2 ttt180 -34.12 110.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 113.932 -1.486 . . . . 0.0 110.687 169.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 1.422 ' HA2' ' ND2' ' A' ' 106' ' ' ASN . . . -137.53 79.22 0.31 Allowed Glycine 0 N--CA 1.469 0.844 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.564 3.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 1.053 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 48.1 p -60.55 139.47 57.76 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.823 0.954 . . . . 0.0 111.107 172.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 1.409 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -79.82 158.16 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.474 162.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.988 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -160.41 129.95 5.08 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.633 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 1.269 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -60.67 122.05 13.76 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.422 -177.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 1.208 ' O ' ' HG3' ' A' ' 92' ' ' ARG . . . -51.41 -173.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.441 1.088 . . . . 0.0 111.795 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.208 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 81.9 mtp180 179.43 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.738 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.3 m -52.67 -86.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.763 1.289 . . . . 0.0 110.14 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.9 -71.54 0.41 Allowed 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.946 1.404 . . . . 0.0 108.525 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.8 m-20 -46.14 128.35 9.39 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.41 1.069 . . . . 0.0 110.433 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.206 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 8.3 mtpm? -42.15 -103.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.531 1.145 . . . . 0.0 110.582 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.9 ' OD1' ' ND2' ' A' ' 75' ' ' ASN . 33.0 m-20 -53.06 114.22 1.38 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.64 1.212 . . . . 0.0 109.21 175.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 1.155 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 40.3 t -175.28 -44.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.562 1.164 . . . . 0.0 111.093 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 1.302 ' O ' HD13 ' A' ' 73' ' ' ILE . . . -34.81 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.096 0.873 . . . . 0.0 110.411 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 1.538 ' CG2' ' HA ' ' A' ' 70' ' ' ASN . 74.3 p -78.85 -37.04 41.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.608 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.553 ' C ' ' HE3' ' A' ' 90' ' ' MET . 78.7 p -170.07 -48.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.092 0.87 . . . . 0.0 110.634 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.907 ' HG3' ' HB2' ' A' ' 91' ' ' ALA . 3.9 pt20 -36.9 151.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.215 0.947 . . . . 0.0 112.114 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.953 ' HB2' HD13 ' A' ' 88' ' ' ILE . 11.6 p90 -157.18 -167.71 2.41 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.415 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.957 ' CZ ' ' HB2' ' A' ' 89' ' ' ALA . 27.7 p90 -158.15 121.1 3.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.927 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.975 HD13 HD22 ' A' ' 18' ' ' LEU . 65.1 mt -90.0 104.87 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.74 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 1.422 ' ND2' ' HA2' ' A' ' 86' ' ' GLY . 5.0 p-10 -63.87 153.21 37.5 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.259 0.974 . . . . 0.0 110.408 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.979 HG11 ' SD ' ' A' ' 132' ' ' MET . 32.6 m -141.53 47.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.026 176.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.618 ' O ' ' OD1' ' A' ' 110' ' ' ASN . . . 170.15 140.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.528 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 1.123 ' O ' ' OD1' ' A' ' 110' ' ' ASN . 32.3 m-20 -30.93 138.72 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 1.123 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 15.9 m-20 -158.18 157.3 32.42 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.049 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 1.155 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . 172.31 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.722 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CE1' ' HA ' ' A' ' 110' ' ' ASN . 32.6 p90 -39.64 -42.65 1.23 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.58 1.175 . . . . 0.0 110.238 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.955 HD13 ' CD2' ' A' ' 122' ' ' TYR . 68.1 tp -58.98 -52.33 66.23 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 0.0 109.619 175.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 1.155 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 57.4 p-10 -40.08 138.4 0.84 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.523 1.139 . . . . 0.0 111.815 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 1.021 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 4.0 t60 -36.62 113.52 0.24 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.809 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.743 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.925 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 78.7 m-85 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.38 0.61 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.35 -110.34 0.26 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.328 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.955 ' CD2' HD13 ' A' ' 113' ' ' LEU . 89.1 m-85 -78.77 116.3 19.02 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.808 0.946 . . . . 0.0 109.937 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.269 ' HB2' ' O ' ' A' ' 90' ' ' MET . . . -49.94 -158.41 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.247 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.1 HG22 ' O ' ' A' ' 123' ' ' ALA . 45.7 t 179.28 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.805 ' CE2' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.11 27.74 0.07 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.251 0.97 . . . . 0.0 111.135 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 1.409 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -150.92 -173.07 20.59 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 122.983 1.324 . . . . 0.0 112.223 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.217 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 36.2 mtmm 177.8 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 111.47 -2.365 . . . . 0.0 108.864 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.146 HG22 ' CE ' ' A' ' 132' ' ' MET . 62.8 t -40.03 116.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.59 1.181 . . . . 0.0 110.311 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.743 HG22 ' ND1' ' A' ' 6' ' ' HIS . 85.0 t -58.35 -51.43 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.392 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.637 ' HG3' HG11 ' A' ' 129' ' ' VAL . 0.0 OUTLIER 162.26 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.609 1.193 . . . . 0.0 108.798 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -166.38 22.46 0.12 Allowed Glycine 0 N--CA 1.475 1.237 0 O-C-N 124.826 1.329 . . . . 0.0 112.713 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.146 ' CE ' HG22 ' A' ' 128' ' ' VAL . 20.9 mmt -53.51 -22.22 7.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.439 171.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 63.2 t0 -47.88 -60.58 2.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 15' ' ' ASN . 87.2 t -62.31 -73.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.735 1.272 . . . . 0.0 109.423 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.705 ' O ' ' OG ' ' A' ' 139' ' ' SER . . . -39.95 -52.47 2.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.473 1.108 . . . . 0.0 110.373 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 1.017 ' OD2' ' HB3' ' A' ' 132' ' ' MET . 49.1 m-20 -60.8 -66.64 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.821 1.325 . . . . 0.0 108.382 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.992 ' O ' HG12 ' A' ' 141' ' ' VAL . 24.8 ttmm -34.49 -49.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.607 1.192 . . . . 0.0 110.363 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.264 ' O ' HG23 ' A' ' 141' ' ' VAL . 49.6 mt -60.31 -55.47 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 124.755 1.285 . . . . 0.0 107.909 168.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.919 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . 39.0 m -64.42 0.68 0.96 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.774 -1.557 . . . . 0.0 114.828 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.805 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 3.7 mp0 -107.03 -44.87 4.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.345 1.028 . . . . 0.0 109.017 173.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.264 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.3 m -40.07 127.97 1.64 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.287 0.992 . . . . 0.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.9 Cg_exo -37.57 177.13 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.355 2.703 . . . . 0.0 113.418 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.35 HG21 ' CA ' ' A' ' 153' ' ' PRO . 10.1 p -160.83 -151.18 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.56 1.648 . . . . 0.0 112.74 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.727 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 178.38 165.26 0.78 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 110.03 -3.259 . . . . 0.0 111.488 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.658 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 46.4 t0 -52.14 -150.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.501 166.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.873 HG23 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -161.16 -142.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -67.05 -102.97 0.02 OUTLIER Glycine 0 N--CA 1.471 0.991 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 166.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.709 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 86.4 Cg_endo -77.5 -53.91 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.919 3.079 . . . . 0.0 109.917 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.77 ' O ' HG21 ' A' ' 146' ' ' VAL . 61.7 m-85 -69.25 122.44 18.86 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.587 1.179 . . . . 0.0 111.604 -172.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 29.5 mm-40 -74.48 -176.66 2.81 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.063 170.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.615 ' O ' HG22 ' A' ' 152' ' ' VAL . 10.6 m120 48.73 86.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.716 175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.873 ' HB ' HG23 ' A' ' 146' ' ' VAL . 88.1 t -161.94 105.28 1.15 Allowed Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.337 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.35 ' CA ' HG21 ' A' ' 143' ' ' THR . 85.9 Cg_exo -45.12 139.83 8.12 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.409 2.739 . . . . 0.0 112.119 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.11 ' N ' ' HA ' ' A' ' 143' ' ' THR . 80.2 p -73.74 44.64 0.17 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.604 174.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.64 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 17.2 tppt? -178.51 72.71 0.21 Allowed Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 155' ' ' LYS . 80.9 Cg_exo -46.37 108.38 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.73 2.953 . . . . 0.0 112.362 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.563 HG12 ' OG ' ' A' ' 12' ' ' SER . 89.3 t -68.98 154.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.505 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.877 ' HA ' HG21 ' A' ' 45' ' ' THR . 76.7 t -141.45 118.03 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.997 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.04 HD13 ' HG1' ' A' ' 44' ' ' THR . 35.3 mt -69.06 135.38 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.035 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 1.294 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.8 mt -85.22 -49.16 8.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.701 -2.045 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 1.153 ' O ' HD21 ' A' ' 9' ' ' LEU . 34.7 t -170.46 161.04 7.75 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.434 1.084 . . . . 0.0 112.245 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 1.006 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -137.53 61.08 1.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.534 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 1.116 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 47.9 mmtm -69.92 93.15 0.75 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.49 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.99 ' HA ' ' O ' ' A' ' 6' ' ' HIS . 34.6 m -71.54 132.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.42 1.075 . . . . 0.0 110.383 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 1.039 HD21 ' HB2' ' A' ' 6' ' ' HIS . 3.3 mm? -78.23 121.97 84.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.359 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' A' ' 165' ' ' LEU . 66.9 Cg_endo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 123.583 2.855 . . . . 0.0 109.752 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.439 ' C ' ' HD2' ' A' ' 6' ' ' HIS . 80.8 Cg_exo . . . . . 0 C--O 1.235 0.369 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.439 ' HD2' ' C ' ' A' ' 5' ' ' PRO . 8.0 m170 -153.16 121.97 6.45 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.732 -176.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 1.036 HG11 ' HB2' ' A' ' 18' ' ' LEU . 7.9 p -73.79 116.74 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.427 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.795 ' HG ' ' CD ' ' A' ' 17' ' ' GLU . 6.5 mp -79.81 151.09 30.48 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.359 1.076 . . . . 0.0 110.748 169.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 1.157 ' O ' HG12 ' A' ' 16' ' ' ILE . 6.9 mt -160.59 96.54 1.16 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.559 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 1.218 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.0 m -88.14 79.98 7.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.637 -2.528 . . . . 0.0 107.969 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 1.038 HG21 HG12 ' A' ' 159' ' ' ILE . 37.0 p -73.24 169.72 16.48 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 125.018 1.449 . . . . 0.0 111.516 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.997 ' HG ' ' HA ' ' A' ' 157' ' ' VAL . 80.0 p -39.71 -46.24 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.746 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -60.37 -54.83 40.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.462 1.101 . . . . 0.0 110.623 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.01 173.76 39.65 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 113.767 -1.561 . . . . 0.0 113.597 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.888 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 5.5 t-20 -61.82 143.54 56.16 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.451 -1.374 . . . . 0.0 110.868 175.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 1.157 HG12 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -144.2 -178.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.982 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.915 ' HG2' ' O ' ' A' ' 130' ' ' LYS . 6.9 mm-40 -160.13 101.88 1.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.92 -165.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.036 ' HB2' HG11 ' A' ' 7' ' ' VAL . 2.4 mm? -85.0 161.03 19.91 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.297 0.998 . . . . 0.0 110.409 164.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.206 ' OE1' ' CD ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -127.27 110.84 13.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.529 173.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.86 HD11 ' CD2' ' A' ' 125' ' ' PHE . 3.0 mm? -79.37 -170.9 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.826 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -164.69 87.05 0.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.011 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.039 ' HA ' HG13 ' A' ' 29' ' ' VAL . 19.8 ptpt -59.16 -34.62 72.32 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.842 1.339 . . . . 0.0 112.303 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 11.3 tp-100 -41.07 -64.36 0.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.206 0.941 . . . . 0.0 110.69 -172.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 73.1 mmtt -69.97 -5.43 26.2 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.792 1.308 . . . . 0.0 113.896 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.837 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -160.18 71.59 3.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 O-C-N 123.818 0.699 . . . . 0.0 109.449 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 1.275 ' O ' HG23 ' A' ' 29' ' ' VAL . 57.5 Cg_exo -54.2 -64.69 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.667 2.912 . . . . 0.0 111.109 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 28' ' ' SER . 15.6 m -50.1 -62.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 124.734 1.271 . . . . 0.0 110.368 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.809 ' H ' HG22 ' A' ' 27' ' ' VAL . 42.1 t -41.82 -56.39 2.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.445 1.09 . . . . 0.0 110.466 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.275 HG23 ' O ' ' A' ' 26' ' ' PRO . 34.6 m -48.82 -45.07 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 124.734 1.272 . . . . 0.0 110.554 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 23.3 tp60 -45.7 -62.26 1.37 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.241 0.963 . . . . 0.0 109.551 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 1.021 ' OD1' HG23 ' A' ' 73' ' ' ILE . 11.0 m120 -47.35 -60.85 2.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.701 1.251 . . . . 0.0 109.497 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.531 ' HE1' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 t80 -43.24 -62.75 0.96 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.353 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 29' ' ' VAL . 61.3 t -49.26 -33.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 124.78 1.3 . . . . 0.0 111.452 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.935 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 55.2 m-20 -45.86 -63.68 0.92 Allowed 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.916 0.76 . . . . 0.0 109.771 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.738 ' CB ' ' HD1' ' A' ' 40' ' ' PHE . 19.7 m-85 -58.76 -61.89 2.28 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.826 1.329 . . . . 0.0 108.577 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.012 ' HA ' ' HB2' ' A' ' 40' ' ' PHE . 62.6 t -42.53 -53.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.308 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.0 t-20 -39.99 -33.58 0.23 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.713 1.258 . . . . 0.0 111.867 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 35' ' ' TYR . 83.0 p -173.44 136.54 0.6 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.273 0.983 . . . . 0.0 110.578 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.41 43.91 35.6 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.297 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 57.1 t80 -61.38 -96.06 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.838 ' HH ' ' HB3' ' A' ' 101' ' ' SER . 22.3 m-30 -133.12 58.32 1.77 Allowed 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.149 0.905 . . . . 0.0 109.04 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 49.1 p-10 -77.92 108.8 11.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 174.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 1.25 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 1.8 t-20 67.46 58.75 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.538 1.148 . . . . 0.0 109.742 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.826 ' HG1' HD13 ' A' ' 159' ' ' ILE . 32.6 p -104.2 -128.85 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.635 169.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.833 ' CA ' HG13 ' A' ' 159' ' ' ILE . 67.2 p -162.35 -176.93 5.36 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.906 0.86 . . . . 0.0 113.077 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.916 ' CE2' HG23 ' A' ' 11' ' ' THR . 7.4 m-30 -126.74 72.41 1.34 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.99 -1.914 . . . . 0.0 106.953 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.9 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 5.5 p-80 -58.27 -71.45 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.015 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.024 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 22.9 mmt85 -69.19 123.85 22.24 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.386 1.054 . . . . 0.0 110.833 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.79 HG23 HG12 ' A' ' 55' ' ' ILE . 90.8 t -162.0 140.05 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.976 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 1.066 HG23 ' HE1' ' A' ' 54' ' ' MET . 10.5 tt -155.17 126.76 3.71 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.101 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' PHE . 97.9 Cg_exo -39.45 168.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 123.555 2.836 . . . . 0.0 113.79 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -4.02 66.86 0.0 OUTLIER Glycine 0 N--CA 1.474 1.196 0 CA-C-N 114.102 -1.408 . . . . 0.0 114.051 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.4 t80 -161.16 -61.15 0.05 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.761 0.918 . . . . 0.0 108.847 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.066 ' HE1' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -170.7 -175.61 1.87 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.494 1.121 . . . . 0.0 111.717 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 174.65 113.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.549 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.024 ' OE1' ' O ' ' A' ' 48' ' ' ARG . 3.5 mp0 -96.8 -174.51 3.02 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.047 -169.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -166.91 178.83 41.02 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.934 165.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 1.012 ' O ' ' HB3' ' A' ' 102' ' ' GLN . . . 61.44 103.99 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 CA-C-N 113.728 -1.236 . . . . 0.0 110.712 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.81 -129.95 1.42 Allowed Glycine 0 N--CA 1.475 1.259 0 O-C-N 124.649 0.852 . . . . 0.0 111.701 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.946 ' CD1' ' HG2' ' A' ' 66' ' ' GLN . 12.6 m-30 -51.23 139.79 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.818 -1.191 . . . . 0.0 111.822 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.993 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 92.4 m -61.09 141.87 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.132 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.712 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.6 pt-20 -28.6 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.981 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 29.7 mt-30 90.58 43.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.804 1.315 . . . . 0.0 110.981 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.593 ' SD ' ' HD2' ' A' ' 60' ' ' PHE . 21.4 mmt 58.1 12.67 1.94 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.029 0.831 . . . . 0.0 113.148 174.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.993 ' O ' ' HB ' ' A' ' 61' ' ' THR . 88.0 mt-30 -79.41 65.22 4.51 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.946 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 30.2 mt-30 -39.45 132.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.181 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 61' ' ' THR . 54.9 mtpt -58.62 -109.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.124 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.644 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 61.5 pttt -154.55 66.53 5.22 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.294 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 1.061 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 31.5 Cg_exo -70.51 -151.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.424 2.749 . . . . 0.0 112.588 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.061 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 40.2 p30 67.34 78.65 0.24 Allowed Pre-proline 0 N--CA 1.472 0.627 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.642 169.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.893 ' HB2' ' C ' ' A' ' 72' ' ' PRO . 52.6 Cg_exo -49.53 -60.39 0.87 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.316 2.677 . . . . 0.0 109.438 173.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.893 ' C ' ' HB2' ' A' ' 71' ' ' PRO . 45.2 Cg_exo -89.7 -160.27 1.33 Allowed 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.556 -2.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.131 HD12 ' O ' ' A' ' 99' ' ' ALA . 2.1 pp -161.7 145.1 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.902 0.858 . . . . 0.0 111.822 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -45.32 161.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.225 -1.807 . . . . 0.0 113.809 -172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.759 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 52.5 p-10 -74.68 -160.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.248 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.759 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 10.1 tp10 145.25 130.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.011 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.946 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -162.6 -36.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.291 0.994 . . . . 0.0 112.002 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.764 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 58.6 p30 -67.24 -37.66 83.9 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.104 0.877 . . . . 0.0 111.975 -169.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.764 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 16.7 p-10 45.13 -119.41 0.77 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.112 0.883 . . . . 0.0 109.736 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . 164.6 -55.56 0.27 Allowed Glycine 0 N--CA 1.474 1.173 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 80' ' ' GLY . 46.3 mt -39.64 177.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.692 0.877 . . . . 0.0 112.807 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.731 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 36.9 mmt180 -68.84 149.18 49.24 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.055 168.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.731 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.7 m120 -156.12 129.09 7.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.921 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' ARG . 15.8 m -169.33 157.98 7.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.843 -173.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' THR . 63.0 ttt180 -23.13 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.953 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' A' ' 127' ' ' LYS . . . 143.24 -17.35 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 111.433 -2.621 . . . . 0.0 110.855 -171.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.95 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 34.9 p -106.25 146.08 30.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.286 1.041 . . . . 0.0 112.755 -174.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 1.074 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.27 164.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.075 171.105 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.936 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -161.76 141.23 9.99 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.594 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.906 ' HB3' ' HB2' ' A' ' 123' ' ' ALA . 6.7 ttm -57.27 137.67 55.71 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.061 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 1.062 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . . . -75.6 -59.43 2.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.598 ' HB3' ' CB ' ' A' ' 99' ' ' ALA . 5.3 tpm_? -32.75 169.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.39 1.056 . . . . 0.0 113.844 -172.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.675 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 9.7 t 161.94 162.44 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.634 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.738 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 83.26 130.51 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.491 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 1.365 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 42.3 m-20 101.37 -57.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.454 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 1.365 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 10.1 mtmp? 139.31 -94.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.821 1.326 . . . . 0.0 108.147 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 96' ' ' LYS . 64.1 t0 -64.24 104.43 0.75 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.817 1.323 . . . . 0.0 109.013 173.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.942 ' OG ' ' HD3' ' A' ' 92' ' ' ARG . 18.2 t -174.13 -179.72 1.72 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.632 1.208 . . . . 0.0 111.814 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 1.598 ' CB ' ' HB3' ' A' ' 92' ' ' ARG . . . 80.33 85.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.844 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 62.9 p -79.72 -40.25 29.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.649 -168.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.838 ' HB3' ' HH ' ' A' ' 41' ' ' TYR . 50.3 m -159.27 -73.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.288 0.993 . . . . 0.0 109.338 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 1.062 ' OE1' ' HB2' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -38.91 163.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.168 -175.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 1.074 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -155.3 -165.28 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.1 -172.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.973 ' CZ ' ' HB3' ' A' ' 122' ' ' TYR . 49.3 p90 -154.85 119.16 4.73 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.757 0.789 . . . . 0.0 111.019 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.027 HD13 HD22 ' A' ' 18' ' ' LEU . 67.1 mt -84.14 110.89 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.453 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.789 ' O ' ' HE3' ' A' ' 132' ' ' MET . 10.7 m120 -61.11 166.79 3.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.372 1.045 . . . . 0.0 111.41 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.686 HG11 ' CE ' ' A' ' 132' ' ' MET . 28.1 m -155.45 42.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.667 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.731 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . 173.6 137.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.379 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -39.55 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.887 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.875 ' OD1' HD13 ' A' ' 113' ' ' LEU . 11.9 t-20 -70.52 -119.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.876 1.36 . . . . 0.0 110.699 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 76.5 -33.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.782 0.677 . . . . 0.0 111.774 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 110' ' ' ASN . 16.4 m-30 -38.35 -50.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.071 0.857 . . . . 0.0 110.113 -176.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.914 HD12 ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.98 40.62 0.87 Allowed 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.752 1.282 . . . . 0.0 110.729 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' ' O ' ' A' ' 113' ' ' LEU . 39.9 p30 -39.21 -117.38 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.733 0.646 . . . . 0.0 111.602 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.9 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 12.1 m-70 179.34 109.65 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.963 0.789 . . . . 0.0 109.946 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.204 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.423 179.523 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.86 -130.48 0.01 OUTLIER Glycine 0 N--CA 1.471 1.013 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.97 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.973 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 71.1 m-85 -79.5 135.37 36.62 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.958 -1.121 . . . . 0.0 111.344 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.194 ' O ' HG21 ' A' ' 124' ' ' VAL . . . -67.17 -148.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.309 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.194 HG21 ' O ' ' A' ' 123' ' ' ALA . 37.1 t 177.39 133.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.906 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 24.2 p90 -171.32 26.13 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.809 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -166.68 -149.98 6.19 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-O 122.8 1.222 . . . . 0.0 114.084 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.206 ' CD ' ' OE1' ' A' ' 19' ' ' GLU . 29.7 mtpp -169.42 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 111.597 -2.301 . . . . 0.0 110.373 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.557 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 63.3 t -156.13 159.16 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.094 -175.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.766 ' O ' ' CD ' ' A' ' 130' ' ' LYS . 62.4 t -152.54 -43.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.992 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.915 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 32.4 mmmt -167.02 101.46 0.54 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.204 1.002 . . . . 0.0 109.032 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.428 ' O ' ' OD1' ' A' ' 133' ' ' ASP . . . -179.77 141.07 4.53 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.726 0.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.824 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 22.7 mmt -47.86 -26.11 1.55 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.963 -1.118 . . . . 0.0 111.805 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 37.8 p-10 -47.93 -55.09 10.73 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 16' ' ' ILE . 51.4 t -62.68 -68.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 124.378 1.049 . . . . 0.0 108.999 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 132' ' ' MET . . . -42.65 -47.15 5.24 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.667 1.229 . . . . 0.0 110.905 -177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 1.033 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 41.4 m-20 -50.47 -71.0 0.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.473 1.108 . . . . 0.0 109.424 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.686 ' O ' HG12 ' A' ' 141' ' ' VAL . 56.8 mtmt -42.97 -43.57 4.23 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.712 1.258 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.01 ' O ' HG23 ' A' ' 141' ' ' VAL . 14.5 mt -58.57 -61.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.707 ' HA ' HG13 ' A' ' 49' ' ' VAL . 84.5 p -68.54 16.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.426 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 1.033 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 60.6 mm-40 -115.36 -47.05 2.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.295 0.997 . . . . 0.0 109.368 176.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.01 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.7 m -47.65 127.92 10.78 Favored Pre-proline 0 N--CA 1.472 0.662 0 O-C-N 124.443 1.089 . . . . 0.0 110.1 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 141' ' ' VAL . 86.2 Cg_exo -38.09 176.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.338 2.692 . . . . 0.0 113.374 175.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.459 HG21 ' CA ' ' A' ' 153' ' ' PRO . 8.5 p -160.83 -150.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.727 1.727 . . . . 0.0 112.932 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.7 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 178.52 165.26 0.81 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 109.725 -3.398 . . . . 0.0 111.035 173.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.72 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 36.7 m-20 -50.86 -148.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.962 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.878 HG21 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -161.28 -148.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.729 0.643 . . . . 0.0 109.282 170.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.408 ' H ' HG11 ' A' ' 146' ' ' VAL . . . -65.31 -100.15 0.02 OUTLIER Glycine 0 N--CA 1.471 0.97 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 168.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.786 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 98.5 Cg_endo -73.49 -61.5 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.788 2.992 . . . . 0.0 109.321 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.878 ' O ' HG21 ' A' ' 146' ' ' VAL . 80.2 m-85 -69.78 120.77 16.04 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.606 1.191 . . . . 0.0 111.373 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.72 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 9.8 mm100 -68.89 -157.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.861 167.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.765 ' O ' HG22 ' A' ' 152' ' ' VAL . 10.7 m120 36.25 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.061 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.833 ' HB ' HG23 ' A' ' 146' ' ' VAL . 70.1 t -164.56 118.89 1.01 Allowed Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.238 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.459 ' CA ' HG21 ' A' ' 143' ' ' THR . 57.2 Cg_endo -66.21 111.97 2.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.646 2.897 . . . . 0.0 109.842 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.029 ' H ' ' HA ' ' A' ' 143' ' ' THR . 69.6 p -42.66 -52.85 4.73 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.743 1.277 . . . . 0.0 109.143 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.24 132.33 93.4 Favored Pre-proline 0 N--CA 1.474 0.742 0 O-C-N 124.572 1.17 . . . . 0.0 109.503 170.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.38 161.04 43.55 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 C-N-CA 123.658 2.905 . . . . 0.0 113.436 -172.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.997 ' HA ' ' HG ' ' A' ' 12' ' ' SER . 55.5 t -151.18 95.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.571 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.589 ' HA ' HG21 ' A' ' 45' ' ' THR . 91.8 t -88.58 121.24 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.711 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.25 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 11.0 mt -68.93 125.36 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.906 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 1.218 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -79.82 -51.26 9.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.212 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.798 ' O ' HD21 ' A' ' 9' ' ' LEU . 56.0 m -158.58 177.35 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.694 1.246 . . . . 0.0 112.206 -176.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.885 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -170.63 119.8 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.098 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.414 ' O ' HD12 ' A' ' 8' ' ' LEU . 21.4 ptmt -170.75 131.37 0.86 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.302 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 36' ' ' VAL . 35.9 m -69.01 142.33 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.9 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.979 HD11 ' HD2' ' A' ' 166' ' ' PRO . 58.6 tp -58.35 123.4 65.86 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.979 ' HD2' HD11 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.583 2.856 . . . . 0.0 112.12 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.4 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 86.7 Cg_exo . . . . . 0 C--O 1.235 0.325 0 N-CA-C 113.942 0.708 . . . . 0.0 113.942 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.4 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 22.1 m170 -154.55 117.75 4.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.148 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 1.089 HG23 ' HB2' ' A' ' 18' ' ' LEU . 30.2 m -71.76 109.19 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 124.387 1.054 . . . . 0.0 109.184 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.245 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 7.3 mp -79.26 131.08 36.05 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.383 1.052 . . . . 0.0 110.285 177.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 1.054 ' O ' HG12 ' A' ' 16' ' ' ILE . 8.6 mp -138.45 96.76 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.333 173.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 1.184 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 95.3 m -86.2 81.98 8.21 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.768 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 1.008 HG21 HG12 ' A' ' 159' ' ' ILE . 33.5 p -72.91 167.6 20.66 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.931 1.394 . . . . 0.0 111.41 174.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -39.49 -43.78 1.31 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.358 -1.747 . . . . 0.0 110.61 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.819 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -53.9 -61.94 1.98 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.471 1.107 . . . . 0.0 110.228 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.34 177.64 46.38 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 113.151 -1.84 . . . . 0.0 113.365 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.787 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 1.2 t-20 -77.82 89.46 4.05 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.684 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 1.054 HG12 ' O ' ' A' ' 9' ' ' LEU . 7.0 pt -77.9 175.01 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.308 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.928 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 6.2 mm-40 -159.73 100.08 1.43 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.4 -168.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.089 ' HB2' HG23 ' A' ' 7' ' ' VAL . 2.6 mm? -80.97 164.3 22.66 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.398 1.061 . . . . 0.0 110.712 166.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.964 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 40.0 tt0 -130.19 129.83 43.92 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.475 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 1.079 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.6 mp -117.53 116.56 27.37 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.964 1.415 . . . . 0.0 109.726 -169.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.37 104.9 2.84 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.314 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.698 ' HA ' HG13 ' A' ' 29' ' ' VAL . 3.9 ttmp? -69.0 -45.79 69.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.663 1.227 . . . . 0.0 111.542 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 25' ' ' ALA . 49.0 tt0 -47.77 -70.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.333 1.02 . . . . 0.0 110.256 -171.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 1.278 ' NZ ' HD22 ' A' ' 81' ' ' LEU . 61.6 mttp -71.94 13.1 0.32 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.77 1.294 . . . . 0.0 114.016 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.674 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -160.63 68.7 2.69 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 124.034 0.834 . . . . 0.0 109.486 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.879 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.6 Cg_exo -60.73 -63.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.475 2.784 . . . . 0.0 111.061 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.0 t -54.96 -62.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.137 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 t -42.2 -58.49 2.13 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.643 1.214 . . . . 0.0 110.472 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 26' ' ' PRO . 32.2 m -51.75 -46.97 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 124.735 1.272 . . . . 0.0 110.622 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.493 ' N ' HG21 ' A' ' 29' ' ' VAL . 1.2 tm0? -48.58 -69.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.239 0.962 . . . . 0.0 108.949 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 1.325 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 12.7 m-80 -45.08 -51.71 9.88 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.557 1.161 . . . . 0.0 109.75 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.67 ' O ' HG21 ' A' ' 36' ' ' VAL . 77.4 t80 -42.54 -59.65 1.81 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.598 1.186 . . . . 0.0 109.646 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.704 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.9 t -47.44 -37.3 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.707 1.254 . . . . 0.0 111.101 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 1.325 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 15.3 m-20 -43.84 -62.6 1.06 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.012 0.82 . . . . 0.0 109.381 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -61.27 -59.37 5.41 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.152 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.942 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 59.5 t -39.4 -48.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.976 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.811 ' O ' ' HB3' ' A' ' 38' ' ' SER . 1.9 t-20 -38.42 -32.38 0.07 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.779 1.299 . . . . 0.0 112.015 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.811 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.2 p 149.32 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.138 0.899 . . . . 0.0 113.005 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.6 -42.46 3.12 Favored Glycine 0 N--CA 1.474 1.198 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.356 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.643 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 28.4 t80 -67.11 -74.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.527 0.78 . . . . 0.0 109.888 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.942 ' CE2' ' HA ' ' A' ' 36' ' ' VAL . 79.9 m-85 -61.69 -29.49 70.12 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.513 1.133 . . . . 0.0 112.628 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -38.6 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.011 0.819 . . . . 0.0 111.312 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 1.15 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.5 m-20 44.24 47.81 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.265 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.82 ' O ' HG22 ' A' ' 45' ' ' THR . 28.6 m -78.59 -123.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 1.022 ' HA ' HG13 ' A' ' 159' ' ' ILE . 46.1 p -165.02 -143.8 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.254 1.026 . . . . 0.0 112.493 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.691 ' CD2' HG23 ' A' ' 11' ' ' THR . 65.4 m-85 -159.63 66.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.5 -2.137 . . . . 0.0 106.834 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.898 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 1.4 p-80 -51.72 -68.98 0.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.191 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.898 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.2 mtt180 -69.68 124.07 23.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.51 1.131 . . . . 0.0 110.296 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.658 ' O ' HG21 ' A' ' 49' ' ' VAL . 34.4 m -158.21 94.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 124.74 1.275 . . . . 0.0 109.374 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.908 HG23 ' HD2' ' A' ' 53' ' ' PHE . 57.2 mt -77.27 123.75 87.04 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.334 175.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 53' ' ' PHE . 82.4 Cg_exo -37.65 144.02 0.16 Allowed 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.271 2.647 . . . . 0.0 112.525 174.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.23 55.53 0.01 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.651 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.908 ' HD2' HG23 ' A' ' 50' ' ' ILE . 1.6 t80 -144.33 -63.1 0.37 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.778 0.929 . . . . 0.0 109.05 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.721 ' HE3' ' CE2' ' A' ' 53' ' ' PHE . 27.2 ptt? -179.56 114.91 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.386 1.054 . . . . 0.0 111.102 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.85 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 30.7 pt -84.73 160.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.791 165.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.784 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 20.0 mt-30 -156.58 162.35 39.9 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.804 0.69 . . . . 0.0 111.781 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.79 -154.07 7.05 Favored Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.272 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.666 ' O ' ' HG2' ' A' ' 102' ' ' GLN . . . 65.85 73.88 0.57 Allowed Glycine 0 N--CA 1.47 0.952 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 1.241 ' HA2' ' CD ' ' A' ' 67' ' ' LYS . . . -179.83 -122.83 0.8 Allowed Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 68.5 m-85 -45.18 132.91 7.12 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.622 0.836 . . . . 0.0 110.499 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.798 ' HA ' HG21 ' A' ' 44' ' ' THR . 88.6 m -59.2 -57.91 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.214 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.753 ' HG2' HG23 ' A' ' 45' ' ' THR . 0.1 OUTLIER -168.46 -75.7 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.614 1.196 . . . . 0.0 108.064 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -72.93 46.81 0.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.5 1.125 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.977 ' HE1' HG22 ' A' ' 152' ' ' VAL . 53.9 mtt 39.44 36.69 0.23 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.121 0.888 . . . . 0.0 111.961 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -78.14 87.46 4.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -30.69 147.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.69 -1.595 . . . . 0.0 113.418 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 1.241 ' CD ' ' HA2' ' A' ' 59' ' ' GLY . 47.4 mtmt -56.53 -131.12 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 112.849 -1.978 . . . . 0.0 112.393 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 1.134 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 46.6 mmtm 179.27 79.66 0.17 Allowed Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 112.641 -2.072 . . . . 0.0 106.363 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.812 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 47.8 Cg_endo -71.89 -165.88 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.606 2.871 . . . . 0.0 113.345 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.011 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 91.4 m-20 -166.54 170.76 5.19 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 113.237 -1.801 . . . . 0.0 109.923 -172.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 1.011 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 32.9 Cg_endo -45.44 104.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.606 2.204 . . . . 0.0 109.184 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.5 Cg_exo -44.58 -146.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.818 3.012 . . . . 0.0 113.603 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 99' ' ' ALA . 27.4 pt -160.18 141.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 124.387 1.054 . . . . 0.0 110.476 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -36.44 159.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.749 -1.569 . . . . 0.0 113.322 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 1.338 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 8.2 t-20 -43.12 169.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.285 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 1.338 ' HG2' ' O ' ' A' ' 75' ' ' ASN . 11.4 mm-40 172.98 128.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.478 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 1.426 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . . . 174.12 -40.28 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.976 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 52.9 p-10 -67.22 -43.71 81.36 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.299 0.999 . . . . 0.0 110.649 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 22.2 p30 -51.86 132.35 31.73 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.114 0.884 . . . . 0.0 110.325 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.606 ' H ' HD13 ' A' ' 81' ' ' LEU . . . -171.78 -62.11 0.04 OUTLIER Glycine 0 N--CA 1.474 1.199 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 1.278 HD22 ' NZ ' ' A' ' 24' ' ' LYS . 6.2 mp 81.6 -32.25 0.1 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.632 0.843 . . . . 0.0 112.444 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.624 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 16.4 ptp180 178.89 73.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.645 1.216 . . . . 0.0 110.211 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.615 HD21 ' HB3' ' A' ' 110' ' ' ASN . 1.2 p-10 -72.68 142.88 48.25 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.869 1.356 . . . . 0.0 111.204 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 m -169.28 148.04 3.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.419 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.729 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 51.6 ptt85 -42.03 101.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.05 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.782 ' O ' HG21 ' A' ' 128' ' ' VAL . . . 144.19 -29.04 1.94 Allowed Glycine 0 N--CA 1.473 1.107 0 CA-C-N 111.934 -2.393 . . . . 0.0 109.899 -169.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 20.5 p -83.56 129.85 34.98 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.716 0.77 . . . . 0.0 111.225 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 1.476 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -84.26 156.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.793 166.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.092 ' O ' ' CD2' ' A' ' 104' ' ' PHE . . . -165.31 128.69 2.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.659 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.801 ' HG3' ' H ' ' A' ' 91' ' ' ALA . 32.7 ttm -59.38 173.9 0.47 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.196 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.801 ' H ' ' HG3' ' A' ' 90' ' ' MET . . . -167.57 164.14 14.68 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.507 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.887 ' CG ' ' HA ' ' A' ' 99' ' ' ALA . 2.4 mmm-85 179.65 119.08 0.05 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.486 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 93.4 m -40.47 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.532 1.145 . . . . 0.0 110.438 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 93' ' ' THR . . . 71.39 -67.9 0.24 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.858 1.349 . . . . 0.0 109.175 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.787 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 59.3 m-20 66.13 -84.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.705 1.253 . . . . 0.0 110.109 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 95' ' ' ASP . 87.4 tttt 95.02 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.865 1.353 . . . . 0.0 109.213 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -165.88 81.16 0.3 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.625 ' HA ' ' HB3' ' A' ' 72' ' ' PRO . 66.3 m -163.06 -116.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.781 1.301 . . . . 0.0 110.565 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.887 ' HA ' ' CG ' ' A' ' 92' ' ' ARG . . . 54.27 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.644 1.215 . . . . 0.0 107.751 -169.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -77.71 -35.02 52.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.01 -170.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.453 ' C ' ' HE3' ' A' ' 90' ' ' MET . 80.7 p -170.31 -40.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.273 0.983 . . . . 0.0 110.14 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.747 ' CD ' ' HZ1' ' A' ' 67' ' ' LYS . 29.4 mt-30 -35.62 130.46 0.55 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.275 0.984 . . . . 0.0 111.308 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 1.046 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.32 178.87 7.44 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.793 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.092 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 49.1 p90 -153.2 122.63 6.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.052 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.965 HD13 HD22 ' A' ' 18' ' ' LEU . 59.4 mt -91.01 101.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.218 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.547 ' O ' HG12 ' A' ' 107' ' ' VAL . 18.1 p-10 -68.62 -173.04 0.41 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.354 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.741 HG23 ' C ' ' A' ' 53' ' ' PHE . 34.2 m -160.04 -42.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.623 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.729 ' CA ' ' HB3' ' A' ' 85' ' ' ARG . . . -74.25 139.71 44.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 124.373 1.046 . . . . 0.0 111.167 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -42.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.954 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.683 ' OD1' HD21 ' A' ' 113' ' ' LEU . 2.7 t30 -68.29 142.93 55.41 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.864 1.352 . . . . 0.0 111.026 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 110' ' ' ASN . . . 168.42 -51.21 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.922 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.762 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 47.5 p90 -66.44 60.65 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.611 1.195 . . . . 0.0 108.109 168.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.995 HD13 ' CD2' ' A' ' 122' ' ' TYR . 59.3 tp 178.31 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.807 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -38.08 125.7 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.821 0.701 . . . . 0.0 111.137 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 1.426 ' CD2' ' HB3' ' A' ' 77' ' ' ALA . 2.0 m-70 -42.92 108.67 0.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.379 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.026 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.288 -175.265 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.127 ' HZ ' ' OD1' ' A' ' 75' ' ' ASN . 21.4 p90 . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.51 -80.78 0.44 Allowed Glycine 0 N--CA 1.471 0.994 0 CA-C-N 113.638 -1.619 . . . . 0.0 113.734 -167.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 1.328 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 59.6 m-85 -76.98 130.45 37.5 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.46 0.741 . . . . 0.0 111.837 -161.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.031 ' O ' HG22 ' A' ' 124' ' ' VAL . . . -67.37 -158.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.995 174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.032 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 62.7 t 179.48 131.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.312 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 1.079 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.1 p90 -170.79 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.007 0.817 . . . . 0.0 111.605 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 1.476 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -138.35 173.85 22.28 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.194 1.441 . . . . 0.0 113.206 -171.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' H ' ' CG2' ' A' ' 88' ' ' ILE . 59.3 tttp 179.7 121.33 0.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 110.888 -2.656 . . . . 0.0 110.207 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.782 HG21 ' O ' ' A' ' 86' ' ' GLY . 59.2 t -58.94 156.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.302 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 1.117 HG22 ' ND1' ' A' ' 6' ' ' HIS . 57.3 t -130.7 -46.99 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.277 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.673 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER 172.59 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.118 0.886 . . . . 0.0 109.648 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' A' ' 128' ' ' VAL . . . 144.99 -147.46 18.64 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 119.778 -1.201 . . . . 0.0 112.426 -4.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.99 ' HG3' ' OD1' ' A' ' 136' ' ' ASP . 6.0 tpt -60.24 -31.15 69.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.939 -1.63 . . . . 0.0 111.878 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 63.7 t0 -47.49 -68.65 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.995 0.809 . . . . 0.0 109.531 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.825 ' HB ' HG21 ' A' ' 16' ' ' ILE . 78.3 t -49.78 -60.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.757 1.286 . . . . 0.0 109.296 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.85 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . . . -44.6 -51.81 8.69 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.567 1.167 . . . . 0.0 110.05 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.99 ' OD1' ' HG3' ' A' ' 132' ' ' MET . 36.4 m-20 -51.86 -70.34 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.683 1.239 . . . . 0.0 109.255 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.536 ' N ' ' OE1' ' A' ' 140' ' ' GLN . 30.5 mtpp -38.6 -44.6 0.99 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.658 1.224 . . . . 0.0 110.708 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.332 ' O ' HG23 ' A' ' 141' ' ' VAL . 30.8 mt -55.61 -58.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 124.374 1.046 . . . . 0.0 108.367 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 136' ' ' ASP . 82.2 p -62.6 2.75 0.25 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.709 1.256 . . . . 0.0 114.129 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.872 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.0 mp0 -96.99 -50.09 4.76 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.289 0.993 . . . . 0.0 108.587 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.332 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.2 m -39.93 124.83 1.6 Allowed Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 124.435 1.084 . . . . 0.0 110.652 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 141' ' ' VAL . 83.6 Cg_exo -40.84 178.81 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.469 2.779 . . . . 0.0 113.748 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.214 HG21 ' CA ' ' A' ' 153' ' ' PRO . 6.7 p -161.02 -145.26 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.87 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.92 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER 179.13 142.45 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.672 -2.967 . . . . 0.0 111.789 170.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 1.15 ' OD1' ' HG2' ' A' ' 150' ' ' GLN . 61.0 t0 -69.74 111.09 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.801 168.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.819 HG23 ' CG2' ' A' ' 152' ' ' VAL . 2.3 t -78.97 -147.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.115 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.78 ' H ' HG11 ' A' ' 146' ' ' VAL . . . -61.64 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.47 0.911 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 171.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.822 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 95.8 Cg_endo -71.32 -55.78 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.697 2.931 . . . . 0.0 109.508 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.822 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 84.0 m-85 -69.2 102.94 1.8 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.632 1.207 . . . . 0.0 110.103 -176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 1.171 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 31.9 mt-30 -86.43 55.41 3.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.065 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 1.171 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 75.1 m-20 -172.8 82.74 0.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.977 HG22 ' HE1' ' A' ' 64' ' ' MET . 62.9 t -156.04 102.04 2.11 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 124.405 1.065 . . . . 0.0 108.773 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.214 ' CA ' HG21 ' A' ' 143' ' ' THR . 75.7 Cg_exo -46.93 99.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 123.436 2.757 . . . . 0.0 110.268 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.194 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.6 t -34.87 -52.93 0.55 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.467 1.104 . . . . 0.0 109.861 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 32.3 mmmt -84.64 85.98 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 164.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.194 ' HD3' ' O ' ' A' ' 154' ' ' SER . 63.1 Cg_endo -79.0 140.78 16.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.606 2.871 . . . . 0.0 112.399 -168.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 138' ' ' ILE . 92.2 t -68.72 155.07 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.534 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 1.014 ' HA ' HG21 ' A' ' 45' ' ' THR . 98.1 t -142.98 119.44 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.374 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.15 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 32.3 mt -68.36 133.63 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.345 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 1.184 ' HB2' ' O ' ' A' ' 10' ' ' THR . 86.1 mt -76.36 -52.45 9.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.511 -2.131 . . . . 0.0 108.995 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 65.7 m -163.39 -166.11 1.18 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.671 1.232 . . . . 0.0 111.848 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 1.245 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . 179.07 119.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.347 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.71 ' O ' HD12 ' A' ' 8' ' ' LEU . 65.6 mttm -163.64 126.24 2.55 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.013 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.889 HG12 HG13 ' A' ' 36' ' ' VAL . 33.9 m -67.83 140.27 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.358 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 1.027 HD11 ' HD2' ' A' ' 166' ' ' PRO . 56.5 tp -157.98 121.03 2.1 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.991 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 1.027 ' HD2' HD11 ' A' ' 165' ' ' LEU . 88.3 Cg_exo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.646 2.897 . . . . 0.0 112.062 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.332 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 88.3 Cg_exo . . . . . 0 C--O 1.234 0.306 0 N-CA-C 114.298 0.845 . . . . 0.0 114.298 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.332 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 28.4 m170 -152.37 118.07 5.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.385 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.924 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.3 p -66.93 141.8 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.518 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.876 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 6.9 mp -121.11 132.53 54.92 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.424 1.078 . . . . 0.0 110.314 164.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.774 HD11 ' C ' ' A' ' 8' ' ' LEU . 8.2 mp -126.93 -177.38 4.01 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 111.929 -2.396 . . . . 0.0 109.16 164.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.865 HG23 HD11 ' A' ' 160' ' ' LEU . 99.9 m -160.61 90.29 0.86 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.844 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 1.015 HG23 HG12 ' A' ' 159' ' ' ILE . 34.8 p -78.05 169.6 18.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.398 1.686 . . . . 0.0 111.216 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -39.77 -42.98 1.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.536 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.81 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -58.22 -59.83 4.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.526 1.141 . . . . 0.0 110.572 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.59 178.51 41.36 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 113.529 -1.669 . . . . 0.0 114.201 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.796 ' O ' HG22 ' A' ' 16' ' ' ILE . 63.0 t-20 -61.67 153.83 27.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.08 -1.56 . . . . 0.0 111.063 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 1.113 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 16.0 pt -164.34 168.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.455 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 1.113 ' OE1' ' O ' ' A' ' 16' ' ' ILE . 4.3 mm-40 -145.61 113.56 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.473 -1.694 . . . . 0.0 112.059 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.057 HD22 HD12 ' A' ' 105' ' ' ILE . 2.7 mm? -94.71 147.03 23.74 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 124.481 1.113 . . . . 0.0 110.075 165.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.389 ' OE2' ' CB ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -109.56 112.01 23.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.203 171.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.912 HD21 ' HE2' ' A' ' 125' ' ' PHE . 6.4 mp -84.33 -158.97 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.541 -170.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.818 ' OD1' ' HG3' ' A' ' 23' ' ' GLN . 61.6 t0 -175.39 110.03 0.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.118 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.694 ' HA ' HG23 ' A' ' 29' ' ' VAL . 28.5 ttpp -96.98 -35.8 10.74 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.928 1.393 . . . . 0.0 111.954 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.868 ' OE1' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -42.46 -33.68 0.71 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.179 0.925 . . . . 0.0 112.306 -171.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.868 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 17.9 tppt? -108.01 10.68 28.23 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.283 0.989 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 1.0 ' O ' HG22 ' A' ' 29' ' ' VAL . . . -161.04 68.84 2.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 O-C-N 123.69 0.619 . . . . 0.0 110.162 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.6 Cg_exo -58.48 -58.46 0.73 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.57 2.847 . . . . 0.0 111.264 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 71.0 t -54.32 -69.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.835 1.334 . . . . 0.0 110.165 -175.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.526 ' OG ' ' HB3' ' A' ' 25' ' ' ALA . 72.7 p -47.5 -54.92 10.24 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.727 1.267 . . . . 0.0 110.95 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.019 ' O ' ' HB3' ' A' ' 32' ' ' PHE . 11.6 t -55.81 -45.27 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.375 1.047 . . . . 0.0 110.283 -175.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 66.5 tp60 -45.02 -63.27 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.236 0.96 . . . . 0.0 109.646 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 1.037 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 m-80 -42.98 -48.13 5.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.61 1.194 . . . . 0.0 110.058 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 1.019 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 15.6 t80 -39.75 -69.46 0.13 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.527 1.142 . . . . 0.0 109.967 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.707 HG11 ' ND2' ' A' ' 37' ' ' ASN . 48.9 t -43.96 -39.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.722 1.264 . . . . 0.0 111.201 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 1.037 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 16.6 m-20 -44.04 -62.26 1.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.148 0.905 . . . . 0.0 109.914 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 38' ' ' SER . 98.1 m-85 -57.48 -56.23 24.6 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.877 1.361 . . . . 0.0 109.364 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.846 ' HA ' ' HE2' ' A' ' 41' ' ' TYR . 96.0 t -42.97 -63.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 124.555 1.159 . . . . 0.0 109.279 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.707 ' ND2' HG11 ' A' ' 33' ' ' VAL . 22.0 m-20 -48.23 -49.75 32.04 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.796 1.31 . . . . 0.0 110.069 176.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 56.4 m -56.08 -117.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.543 1.152 . . . . 0.0 111.03 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.53 76.28 0.1 Allowed Glycine 0 N--CA 1.473 1.151 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.662 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 17.5 t80 -110.67 -56.54 2.34 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.914 -173.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.846 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 58.3 m-85 -59.59 -40.23 86.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.063 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.7 p-10 -39.23 113.64 0.34 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.919 . . . . 0.0 111.449 -173.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 10.7 t30 58.03 35.76 25.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.313 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.707 ' O ' HG22 ' A' ' 45' ' ' THR . 72.8 p -79.45 -146.01 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.194 0.934 . . . . 0.0 108.684 163.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 1.051 HG21 ' HA ' ' A' ' 158' ' ' VAL . 72.7 p -163.6 -154.1 0.26 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.742 0.782 . . . . 0.0 112.268 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.876 ' CE1' HD12 ' A' ' 159' ' ' ILE . 6.0 m-30 -134.75 62.08 1.65 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.201 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.875 ' CE1' ' HG2' ' A' ' 48' ' ' ARG . 21.4 p-80 -53.62 -49.53 67.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.407 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.875 ' HG2' ' CE1' ' A' ' 47' ' ' HIS . 24.8 mmm180 -68.28 107.38 2.79 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.53 1.144 . . . . 0.0 109.325 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.662 HG21 ' O ' ' A' ' 46' ' ' PHE . 90.9 t -152.01 135.03 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 124.663 1.227 . . . . 0.0 110.308 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 1.119 HD11 ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -146.91 120.28 4.99 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.076 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' PHE . 85.5 Cg_exo -35.13 152.17 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.589 2.86 . . . . 0.0 113.439 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 1.67 63.91 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 CA-C-N 114.219 -1.355 . . . . 0.0 113.801 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.119 ' HB3' HD11 ' A' ' 50' ' ' ILE . 8.4 t80 -155.32 -42.93 0.08 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.783 0.931 . . . . 0.0 110.897 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.883 ' CG ' ' CG2' ' A' ' 50' ' ' ILE . 22.3 ptt? 176.65 163.28 0.43 Allowed 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.897 0.748 . . . . 0.0 112.026 -176.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.061 HD13 ' HB3' ' A' ' 135' ' ' ALA . 46.5 pt -165.89 129.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.912 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.547 ' CB ' ' HA ' ' A' ' 104' ' ' PHE . 2.6 mm-40 -173.73 -166.09 0.29 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.721 164.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 56' ' ' GLN . . . -177.45 -146.82 6.41 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.306 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.662 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 130.62 -58.83 0.7 Allowed Glycine 0 N--CA 1.475 1.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -45.17 -117.01 0.0 OUTLIER Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.635 0.844 . . . . 0.0 112.194 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.698 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 18.7 m-30 -39.88 128.44 2.11 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.724 0.897 . . . . 0.0 111.062 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 1.042 ' HB ' ' CE ' ' A' ' 67' ' ' LYS . 13.1 t -59.41 -39.4 83.32 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.686 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 1.085 ' OE2' ' HG2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 174.27 121.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.201 0.938 . . . . 0.0 109.427 -174.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 1.329 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.3 mm100 77.45 -61.36 0.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.665 1.228 . . . . 0.0 108.507 -173.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 1.329 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 146.63 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.595 1.184 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.459 ' HG3' ' C ' ' A' ' 64' ' ' MET . 43.7 mt-30 -156.69 79.83 0.94 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 112.087 -2.324 . . . . 0.0 106.561 176.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' GLN . 65.1 mt-30 -25.16 133.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.095 -172.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 1.122 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 6.5 mmpt? -63.71 -117.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.369 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 33.7 mmtp -156.77 74.02 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 CA-C-N 112.92 -1.946 . . . . 0.0 107.997 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 1.149 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 83.8 Cg_exo -48.4 -166.19 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.604 2.869 . . . . 0.0 113.654 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.149 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 80.9 m-20 -171.23 165.57 4.59 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.411 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.822 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 84.8 Cg_exo -39.09 91.31 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.543 2.829 . . . . 0.0 111.422 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.902 ' HG3' ' CG2' ' A' ' 100' ' ' THR . 82.4 Cg_exo -44.38 -150.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.655 2.903 . . . . 0.0 113.043 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.33 168.3 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 124.281 0.988 . . . . 0.0 111.606 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 75' ' ' ASN . 26.8 mtpp -48.44 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 113.336 -1.756 . . . . 0.0 113.157 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.936 ' OD1' ' OD1' ' A' ' 78' ' ' ASP . 10.1 p30 -54.93 -149.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.864 -1.516 . . . . 0.0 111.245 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 1.294 ' OE1' ' HB3' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 173.11 -62.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.853 0.721 . . . . 0.0 109.696 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -36.8 -37.94 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.386 1.053 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.936 ' OD1' ' OD1' ' A' ' 75' ' ' ASN . 9.6 p-10 -68.8 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.13 0.894 . . . . 0.0 113.096 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.59 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 29.5 p30 -52.67 -101.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 161.06 -71.76 0.22 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 81' ' ' LEU . 2.4 pt? -40.66 132.75 2.13 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.878 0.987 . . . . 0.0 111.984 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.858 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 98.3 mtt180 -66.55 168.33 9.37 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.805 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.914 ' HB3' HG23 ' A' ' 87' ' ' THR . 21.9 m120 -167.07 -170.47 1.53 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.581 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.808 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 15.5 m -168.26 159.39 10.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.343 -171.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.808 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 16.6 ptm180 -25.33 99.72 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.776 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 1.042 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 149.27 -24.59 1.24 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 111.346 -2.661 . . . . 0.0 110.261 -171.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 1.035 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.7 p -96.12 136.32 36.73 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.485 0.66 . . . . 0.0 112.049 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 1.185 HD11 ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -90.48 163.16 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.348 168.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.141 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -163.43 144.75 9.37 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.114 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.91 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 17.8 ttm -69.16 137.4 53.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.905 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HA ' ' HE2' ' A' ' 104' ' ' PHE . . . -71.31 -100.71 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.531 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.231 ' O ' HG22 ' A' ' 93' ' ' THR . 17.1 ptm180 179.25 -139.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.902 0.751 . . . . 0.0 110.952 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 1.231 HG22 ' O ' ' A' ' 92' ' ' ARG . 22.5 p 145.82 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.678 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 44.05 -94.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.779 1.3 . . . . 0.0 110.462 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 96' ' ' LYS . 36.0 m-20 -49.53 127.46 15.54 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.196 0.935 . . . . 0.0 110.836 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.888 ' CD ' ' H ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -41.83 -103.85 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.645 175.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.888 ' H ' ' CD ' ' A' ' 96' ' ' LYS . 63.0 m-20 -43.49 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.403 1.064 . . . . 0.0 109.764 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.611 ' HA ' ' HB3' ' A' ' 72' ' ' PRO . 17.2 t -171.74 -113.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.588 1.18 . . . . 0.0 110.407 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.814 ' HB3' ' SD ' ' A' ' 90' ' ' MET . . . 43.74 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.226 0.954 . . . . 0.0 108.797 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.902 ' CG2' ' HG3' ' A' ' 72' ' ' PRO . 66.7 p -78.84 -44.85 22.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.342 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.9 p -170.19 92.29 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.344 1.027 . . . . 0.0 108.709 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.7 tt0 175.17 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 125.018 1.448 . . . . 0.0 109.575 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.895 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -146.74 -179.12 6.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.966 -177.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.547 ' HA ' ' CB ' ' A' ' 56' ' ' GLN . 11.7 p90 -157.32 170.54 22.24 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.346 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.057 HD12 HD22 ' A' ' 18' ' ' LEU . 85.2 mt -127.18 112.67 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 112.915 -1.948 . . . . 0.0 108.95 -170.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.817 ' OD1' ' O ' ' A' ' 87' ' ' THR . 36.0 p-10 -63.42 149.91 44.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.403 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 53' ' ' PHE . 31.4 m -136.3 23.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.801 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -163.91 136.24 5.0 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.763 0.664 . . . . 0.0 110.714 175.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -36.99 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.192 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 1.052 ' OD1' ' HB3' ' A' ' 113' ' ' LEU . 40.1 t30 -69.61 -95.51 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.93 1.394 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 65.08 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.176 0.922 . . . . 0.0 110.419 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.787 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 47.6 p90 -42.25 -39.87 2.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.296 0.998 . . . . 0.0 110.861 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 1.052 ' HB3' ' OD1' ' A' ' 110' ' ' ASN . 64.1 tp -58.68 -38.78 78.98 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.268 0.98 . . . . 0.0 110.504 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 111' ' ' ALA . 65.4 t0 -39.49 130.28 1.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.12 0.887 . . . . 0.0 111.681 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 1.025 ' ND1' ' O ' ' A' ' 120' ' ' PHE . 4.1 t60 -40.72 137.39 1.18 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.151 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.373 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.869 179.369 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.025 ' O ' ' ND1' ' A' ' 115' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.837 ' HA3' ' HB2' ' A' ' 115' ' ' HIS . . . 165.56 161.57 14.86 Favored Glycine 0 N--CA 1.479 1.536 0 O-C-N 123.862 0.726 . . . . 0.0 112.606 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 1.013 ' CE1' HD13 ' A' ' 113' ' ' LEU . 89.9 m-85 -78.83 137.11 37.54 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.043 -1.079 . . . . 0.0 110.599 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.294 ' HB3' ' OE1' ' A' ' 76' ' ' GLU . . . -56.1 -170.34 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.132 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.987 HG22 ' O ' ' A' ' 123' ' ' ALA . 70.3 t 178.51 144.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.352 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.912 ' HE2' HD21 ' A' ' 20' ' ' LEU . 2.5 p90 -170.42 25.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.625 ' C ' ' OE2' ' A' ' 19' ' ' GLU . . . -167.9 -139.85 2.78 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.652 1.14 . . . . 0.0 113.822 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.389 ' CB ' ' OE2' ' A' ' 19' ' ' GLU . 39.4 ttpt 179.62 -136.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 111.808 -2.196 . . . . 0.0 109.956 -172.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.088 ' N ' ' HG2' ' A' ' 127' ' ' LYS . 60.5 t -151.43 160.97 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.864 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 31.2 m -146.71 9.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.82 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 132' ' ' MET . 40.8 ttmt 173.1 -89.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.345 0.403 . . . . 0.0 111.86 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.573 ' HA3' HG21 ' A' ' 16' ' ' ILE . . . -51.93 59.87 0.0 OUTLIER Glycine 0 N--CA 1.473 1.127 0 O-C-N 124.572 1.17 . . . . 0.0 114.75 -165.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.707 ' N ' ' O ' ' A' ' 130' ' ' LYS . 4.3 mmt -74.48 -49.73 21.06 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' LYS . 23.3 m-20 -39.72 -54.55 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.181 0.926 . . . . 0.0 109.986 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.631 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 75.0 t -52.24 -64.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.583 1.177 . . . . 0.0 109.249 175.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 1.061 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -43.78 -53.81 5.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.516 1.135 . . . . 0.0 110.258 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.868 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -58.71 -65.36 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.758 1.286 . . . . 0.0 108.636 179.155 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 1.012 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 2.9 tmtm? -36.86 -48.96 0.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.6 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.233 ' O ' HG23 ' A' ' 141' ' ' VAL . 12.8 mt -58.21 -56.97 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.612 1.195 . . . . 0.0 108.744 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.563 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.7 p -61.79 3.14 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.868 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.1 mp0 -94.78 -51.94 4.49 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.233 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -45.64 126.24 6.42 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.462 1.101 . . . . 0.0 110.283 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.7 Cg_exo -49.92 -178.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.679 2.919 . . . . 0.0 114.673 -176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.204 HG21 ' CA ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -161.07 -139.69 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.69 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.668 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER -178.02 140.66 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.5 -2.136 . . . . 0.0 112.336 168.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 1.07 ' OD1' ' HG3' ' A' ' 150' ' ' GLN . 56.1 t0 -68.74 110.92 4.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 112.383 -2.19 . . . . 0.0 107.791 168.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.903 HG23 ' CG2' ' A' ' 152' ' ' VAL . 2.0 t -78.98 -142.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.737 -169.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.597 ' H ' HG11 ' A' ' 146' ' ' VAL . . . -63.57 -108.79 0.01 OUTLIER Glycine 0 N--CA 1.471 1.02 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 171.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 1.047 ' O ' ' OE1' ' A' ' 150' ' ' GLN . 97.1 Cg_endo -68.5 -50.17 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.593 2.862 . . . . 0.0 109.649 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.606 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 78.0 m-85 -68.68 84.45 0.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.612 1.195 . . . . 0.0 109.688 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 1.07 ' HG3' ' OD1' ' A' ' 145' ' ' ASP . 3.7 mp0 -70.97 66.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.756 175.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.567 ' O ' HG21 ' A' ' 152' ' ' VAL . 50.7 p30 170.51 89.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.61 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.903 ' CG2' HG23 ' A' ' 146' ' ' VAL . 75.0 t -156.24 115.87 2.15 Favored Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 124.392 1.057 . . . . 0.0 109.646 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.204 ' CA ' HG21 ' A' ' 143' ' ' THR . 83.6 Cg_exo -43.97 114.7 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.643 2.895 . . . . 0.0 111.44 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.11 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 88.0 p -41.69 -36.88 1.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.438 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 1.178 ' HB2' ' CD ' ' A' ' 156' ' ' PRO . 30.3 mtpp -175.55 -71.31 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 124.134 0.896 . . . . 0.0 110.115 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.178 ' CD ' ' HB2' ' A' ' 155' ' ' LYS . 98.8 Cg_exo -51.25 72.28 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.702 2.934 . . . . 0.0 113.6 -171.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 1.126 HG21 ' O ' ' A' ' 156' ' ' PRO . 43.3 t -172.07 126.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.9 169.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 1.051 ' HA ' HG21 ' A' ' 45' ' ' THR . 76.7 t -168.87 118.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.015 HG12 HG23 ' A' ' 11' ' ' THR . 25.8 mt -68.1 132.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.766 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.865 HD11 HG23 ' A' ' 10' ' ' THR . 86.2 mt -81.2 -49.18 11.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.158 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 27.7 t -167.6 169.98 11.48 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.553 1.158 . . . . 0.0 111.992 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.852 ' O ' ' HG3' ' A' ' 163' ' ' LYS . . . -152.07 137.18 17.36 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 37.9 mtmm -170.3 136.23 1.35 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.084 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.607 ' CG1' HG13 ' A' ' 36' ' ' VAL . 33.1 m -69.49 175.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.783 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.613 HD22 ' C ' ' A' ' 165' ' ' LEU . 5.4 tt -143.63 119.94 6.51 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.707 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.592 ' N ' HD22 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 123.684 2.923 . . . . 0.0 112.135 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.323 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 61.4 Cg_endo . . . . . 0 C--O 1.236 0.376 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.323 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 22.1 m170 -150.55 101.96 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.342 -175.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.949 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 7.7 p -59.85 107.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 171.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.998 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 5.2 tt -118.73 113.48 21.23 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.764 1.29 . . . . 0.0 109.79 -170.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.89 ' HG ' ' HA ' ' A' ' 162' ' ' ALA . 5.1 mp -127.67 -166.31 1.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.684 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 86.4 m -162.05 102.67 1.13 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.117 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 1.134 HG21 HG12 ' A' ' 159' ' ' ILE . 28.4 p -74.37 166.08 24.09 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.834 1.334 . . . . 0.0 111.693 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.564 ' OG ' HG11 ' A' ' 157' ' ' VAL . 80.1 p -40.93 -46.07 2.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.512 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.725 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -51.97 -59.15 4.67 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.451 1.094 . . . . 0.0 110.274 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.22 45.99 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 112.931 -1.94 . . . . 0.0 113.149 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 1.197 ' O ' HG22 ' A' ' 134' ' ' VAL . 9.0 t-20 -52.31 162.28 0.54 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.69 -1.255 . . . . 0.0 111.448 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.887 HG13 ' O ' ' A' ' 15' ' ' ASN . 9.3 mt -170.16 153.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.116 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.998 ' OE1' ' CD1' ' A' ' 8' ' ' LEU . 33.5 mt-10 -163.22 110.15 1.18 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.833 -173.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.949 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 2.2 mm? -82.42 150.42 27.1 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.294 0.996 . . . . 0.0 109.804 164.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.478 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -111.43 123.63 50.6 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.298 0.999 . . . . 0.0 109.578 174.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 1.256 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 75.8 mt -104.59 -171.33 1.9 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.751 1.282 . . . . 0.0 112.74 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 1.256 ' OD1' ' O ' ' A' ' 20' ' ' LEU . 47.8 m-20 -164.08 68.04 0.17 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.204 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 1.435 ' HD2' ' N ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -47.33 -27.28 1.53 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.821 1.326 . . . . 0.0 113.036 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 1.435 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 36.0 tt0 -41.93 -63.99 0.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.941 0.776 . . . . 0.0 110.09 -174.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.983 ' HD3' ' HA ' ' A' ' 79' ' ' ASN . 25.3 ttmm -78.9 18.41 0.62 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.815 1.322 . . . . 0.0 112.742 -178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 1.089 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -161.98 69.98 2.29 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 1.029 ' O ' HG23 ' A' ' 29' ' ' VAL . 69.0 Cg_endo -71.39 -61.41 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.731 2.954 . . . . 0.0 110.124 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.811 HG22 ' H ' ' A' ' 28' ' ' SER . 16.0 m -48.12 -63.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 124.609 1.193 . . . . 0.0 110.152 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.811 ' H ' HG22 ' A' ' 27' ' ' VAL . 42.9 t -48.43 -59.54 3.39 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.508 1.13 . . . . 0.0 110.346 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.615 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 35.2 m -45.3 -49.13 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 124.579 1.175 . . . . 0.0 110.898 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 1.218 ' O ' HG11 ' A' ' 33' ' ' VAL . 61.7 tp60 -50.11 -56.81 9.4 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.31 1.006 . . . . 0.0 109.745 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.895 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 3.4 t30 -50.2 -62.19 1.72 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.567 1.167 . . . . 0.0 110.587 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 1.615 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 29.1 p90 -56.08 -43.92 78.49 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.266 0.979 . . . . 0.0 110.64 -172.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 1.218 HG11 ' O ' ' A' ' 30' ' ' GLN . 11.5 p -51.05 -40.06 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 124.046 0.841 . . . . 0.0 110.094 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.895 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 45.4 m-20 -45.39 -61.07 1.82 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.045 0.84 . . . . 0.0 109.252 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.819 ' HE2' HD22 ' A' ' 31' ' ' ASN . 68.9 m-85 -54.52 -55.85 24.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.908 1.38 . . . . 0.0 109.491 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.725 HG23 ' CE1' ' A' ' 41' ' ' TYR . 77.1 t -46.06 -66.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 124.436 1.085 . . . . 0.0 109.537 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.6 t30 -43.89 -49.82 8.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.84 1.338 . . . . 0.0 110.695 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 35' ' ' TYR . 29.7 p -58.64 -107.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.53 1.144 . . . . 0.0 110.161 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.64 59.64 0.28 Allowed Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 44' ' ' THR . 17.7 t80 -89.27 -63.58 1.27 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.958 1.034 . . . . 0.0 109.726 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.725 ' CE1' HG23 ' A' ' 36' ' ' VAL . 35.1 m-85 -75.53 -14.24 60.4 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.524 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 1.126 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 52.7 p-10 -39.08 -41.62 0.82 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.642 0.589 . . . . 0.0 112.517 -170.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 1.126 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 19.5 m-20 -154.78 46.8 0.55 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.161 0.913 . . . . 0.0 110.296 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.681 ' O ' HG22 ' A' ' 45' ' ' THR . 74.3 p -78.92 -139.64 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 166.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.929 ' HA ' HG13 ' A' ' 159' ' ' ILE . 76.5 p -163.46 -153.95 0.26 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.934 0.873 . . . . 0.0 112.595 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.898 ' CE1' HD12 ' A' ' 159' ' ' ILE . 17.0 m-30 -129.65 84.39 2.21 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.845 -1.979 . . . . 0.0 106.279 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.824 ' CE1' ' O ' ' A' ' 56' ' ' GLN . 36.8 p-80 -56.42 -65.57 0.58 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.3 -169.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.326 ' HD3' ' N ' ' A' ' 49' ' ' VAL . 1.2 tmt_? -164.67 160.71 20.24 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -162.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 1.557 ' CG1' ' HG3' ' A' ' 54' ' ' MET . 45.8 t -175.73 -77.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.045 -2.343 . . . . 0.0 106.914 164.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.943 HG21 HG13 ' A' ' 49' ' ' VAL . 11.2 tt 171.3 138.8 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.688 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.853 ' HD2' HG13 ' A' ' 50' ' ' ILE . 83.4 Cg_exo -35.04 164.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.333 -0.289 0 C-N-CA 123.507 2.805 . . . . 0.0 113.846 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.98 69.46 0.0 OUTLIER Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.876 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.176 ' CE1' ' OD1' ' A' ' 110' ' ' ASN . 9.8 t80 -160.99 -53.46 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.787 0.934 . . . . 0.0 109.843 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.557 ' HG3' ' CG1' ' A' ' 49' ' ' VAL . 24.1 ptt? -164.36 154.06 14.03 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.457 1.098 . . . . 0.0 111.912 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.815 HG13 ' HB ' ' A' ' 105' ' ' ILE . 48.4 pt -160.21 124.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.73 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.116 ' HG2' ' CA ' ' A' ' 104' ' ' PHE . 33.2 mt-30 -120.36 128.72 53.5 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.385 1.053 . . . . 0.0 110.334 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.0 -162.6 32.11 Favored Glycine 0 N--CA 1.477 1.404 0 O-C-N 124.631 1.207 . . . . 0.0 112.803 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.997 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 44.45 96.65 0.01 OUTLIER Glycine 0 N--CA 1.47 0.915 0 CA-C-N 113.725 -1.238 . . . . 0.0 111.38 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.76 ' HA2' ' OE1' ' A' ' 102' ' ' GLN . . . 174.46 -121.79 0.86 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.705 0.885 . . . . 0.0 110.925 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -46.08 146.04 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.047 -1.077 . . . . 0.0 111.636 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.6 m -58.12 -43.06 87.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.908 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 1.104 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 12.6 pt-20 -172.48 -100.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.248 0.968 . . . . 0.0 109.166 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 1.172 ' O ' ' CG ' ' A' ' 64' ' ' MET . 9.7 tp-100 -46.3 -57.55 4.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.673 1.233 . . . . 0.0 109.623 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 1.172 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 20.0 mmt 165.4 27.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.614 1.196 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -78.64 84.94 4.71 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.14 133.43 1.22 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 31.2 mmmt -64.13 -119.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.283 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' PRO . 24.8 ttmm -171.14 83.4 0.51 Allowed Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.73 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 1.025 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 89.2 Cg_exo -45.55 -155.59 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.631 2.887 . . . . 0.0 113.279 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.16 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.2 m120 -166.86 167.63 7.67 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.313 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.941 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 39.4 Cg_endo -49.07 87.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.845 2.363 . . . . 0.0 108.55 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 1.16 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 89.7 Cg_exo -48.29 -151.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.79 2.993 . . . . 0.0 113.789 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -155.27 149.1 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.369 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -32.39 133.6 0.11 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.394 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.61 167.63 5.54 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.832 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.951 ' OE2' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -168.16 155.35 7.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.032 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 177.59 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.191 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.844 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 42.0 p-10 -67.02 -48.28 68.83 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.983 0.802 . . . . 0.0 109.809 -176.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.983 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 19.0 p-10 40.21 -73.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.078 0.861 . . . . 0.0 111.541 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . 87.76 88.43 1.11 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.729 HD21 ' O ' ' A' ' 80' ' ' GLY . 85.9 mt -161.46 -158.3 0.56 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.113 -1.043 . . . . 0.0 109.893 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.79 ' N ' ' HD2' ' A' ' 82' ' ' ARG . 1.3 mpt_? -59.1 -165.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.253 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.779 ' OD1' ' HB3' ' A' ' 111' ' ' ALA . 1.7 t-20 168.3 100.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.151 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' GLY . 22.8 m -170.31 134.57 1.19 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.63 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 1.383 ' HB2' ' C ' ' A' ' 107' ' ' VAL . 4.0 ppt_? -38.51 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.672 1.225 . . . . 0.0 110.299 176.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 160.59 -22.9 0.25 Allowed Glycine 0 CA--C 1.534 1.226 0 CA-C-N 111.395 -2.639 . . . . 0.0 110.478 -170.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 1.095 ' CA ' ' HA ' ' A' ' 127' ' ' LYS . 40.5 p -98.94 148.74 23.66 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.63 0.729 . . . . 0.0 111.793 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 1.104 ' CD1' ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -96.54 159.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.342 168.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.064 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -142.89 176.96 8.67 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.08 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.909 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.3 tpt -101.95 129.92 48.33 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.766 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.88 -144.51 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.857 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.229 ' HG2' ' N ' ' A' ' 93' ' ' THR . 37.8 ttm180 -177.65 -165.52 0.11 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.84 0.828 . . . . 0.0 111.852 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 1.229 ' N ' ' HG2' ' A' ' 92' ' ' ARG . 25.3 p 176.07 116.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 108.239 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.812 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -17.48 120.28 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.514 1.134 . . . . 0.0 112.906 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.817 ' OD2' ' O ' ' A' ' 97' ' ' ASP . 39.0 t70 142.18 139.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.42 ' HB3' ' H ' ' A' ' 97' ' ' ASP . 53.0 tptt -42.89 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.431 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.817 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 38.2 m-20 -67.3 117.7 9.67 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.688 1.243 . . . . 0.0 108.5 168.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 24.8 t -151.48 170.65 19.1 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.57 1.169 . . . . 0.0 111.973 -173.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.577 ' HB3' ' CE ' ' A' ' 90' ' ' MET . . . 84.76 136.24 0.05 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.729 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 100' ' ' THR . 35.5 m -155.74 2.3 0.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.453 1.095 . . . . 0.0 113.205 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.408 ' C ' ' HE3' ' A' ' 90' ' ' MET . 34.3 p -171.73 -76.34 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.562 0.539 . . . . 0.0 110.852 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.997 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 3.5 mp0 -38.25 154.57 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.006 0.816 . . . . 0.0 111.9 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 1.05 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -160.86 167.03 27.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.545 177.038 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.116 ' CA ' ' HG2' ' A' ' 56' ' ' GLN . 72.4 m-85 -84.23 151.24 24.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.638 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.887 HD12 HD22 ' A' ' 18' ' ' LEU . 22.9 mt -139.58 94.24 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.617 159.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.959 ' O ' ' HE3' ' A' ' 132' ' ' MET . 48.9 m-20 -69.22 -173.29 0.51 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.309 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 1.383 ' C ' ' HB2' ' A' ' 85' ' ' ARG . 35.9 m -158.27 -46.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.571 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 1.217 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -101.49 150.46 23.04 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 124.518 1.136 . . . . 0.0 110.915 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' N ' ' CG ' ' A' ' 85' ' ' ARG . 3.1 m-20 -37.59 138.18 0.37 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.174 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 1.176 ' OD1' ' CE1' ' A' ' 53' ' ' PHE . 64.9 m-80 -157.45 170.46 22.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.765 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.779 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . . . 153.38 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.361 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -39.67 -55.51 1.87 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.152 0.907 . . . . 0.0 110.334 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.889 HD23 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -63.49 -8.86 10.43 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.837 1.336 . . . . 0.0 112.662 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.737 ' N ' HD11 ' A' ' 113' ' ' LEU . 57.6 p-10 -43.74 127.34 5.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.667 0.604 . . . . 0.0 111.657 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.768 ' CD2' ' HD1' ' A' ' 120' ' ' PHE . 0.1 OUTLIER -34.27 126.92 0.45 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.309 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.549 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . . . . . . 0 N--CA 1.474 1.168 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.485 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.768 ' HD1' ' CD2' ' A' ' 115' ' ' HIS . 25.1 m-85 . . . . . 0 N--CA 1.476 0.833 0 CA-C-O 121.219 0.533 . . . . 0.0 112.065 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.33 -134.18 1.73 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.042 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.889 ' CD2' HD23 ' A' ' 113' ' ' LEU . 58.9 m-85 -79.55 118.17 21.15 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.443 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.064 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -57.36 -162.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.784 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.054 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 75.5 t 179.95 146.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.582 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.813 ' CE2' HD23 ' A' ' 20' ' ' LEU . 21.6 p90 -171.18 25.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 1.069 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -167.13 -139.55 2.69 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 122.645 1.136 . . . . 0.0 113.436 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.478 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 94.0 mttt 179.35 -135.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.822 -2.189 . . . . 0.0 109.727 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.802 HG23 ' CD1' ' A' ' 18' ' ' LEU . 91.7 t -160.29 152.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.5 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 19' ' ' GLU . 33.1 m -137.11 -27.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.69 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -170.83 86.95 0.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . -166.92 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 124.763 1.289 . . . . 0.0 110.883 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.959 ' HE3' ' O ' ' A' ' 106' ' ' ASN . 22.9 mmt -39.32 -38.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.216 0.597 . . . . 0.0 111.3 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -47.75 -59.21 3.46 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 1.197 HG22 ' O ' ' A' ' 15' ' ' ASN . 46.6 t -58.74 -63.01 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 124.75 1.281 . . . . 0.0 108.949 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 132' ' ' MET . . . -41.28 -51.03 3.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.955 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.96 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 37.1 m-20 -50.79 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.6 1.187 . . . . 0.0 109.04 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -43.34 -45.7 6.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.463 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.214 ' O ' HG11 ' A' ' 141' ' ' VAL . 42.4 mt -57.01 -61.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.422 1.076 . . . . 0.0 108.871 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.9 p -65.31 2.44 0.85 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.96 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.1 mp0 -93.01 -49.52 5.98 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 124.232 0.958 . . . . 0.0 109.124 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.214 HG11 ' O ' ' A' ' 138' ' ' ILE . 8.6 p -39.7 135.36 1.25 Allowed Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 124.272 0.982 . . . . 0.0 111.043 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.642 ' HD2' HG21 ' A' ' 141' ' ' VAL . 79.9 Cg_exo -42.54 168.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.332 -0.328 0 C-N-CA 123.573 2.848 . . . . 0.0 113.658 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.561 HG21 ' CA ' ' A' ' 153' ' ' PRO . 5.9 p -160.84 -149.92 0.19 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 123.415 1.579 . . . . 0.0 112.313 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.741 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.8 OUTLIER 178.6 161.38 0.66 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 110.28 -3.145 . . . . 0.0 111.441 172.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.719 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 35.3 m-20 -50.33 -157.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.059 164.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.869 ' CG2' ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -160.85 -143.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.11 -110.3 0.02 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 167.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.767 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 84.8 Cg_endo -70.69 -48.78 0.48 Allowed 'Trans proline' 0 C--N 1.333 -0.286 0 C-N-CA 123.662 2.908 . . . . 0.0 109.781 169.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.869 ' O ' ' CG2' ' A' ' 146' ' ' VAL . 93.7 m-85 -68.95 88.48 0.39 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.584 1.177 . . . . 0.0 110.722 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 16.0 pt20 -71.73 143.1 49.73 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.855 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 1.112 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 10.0 m120 84.33 90.12 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.548 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.812 HG23 HG22 ' A' ' 146' ' ' VAL . 91.2 t -160.62 97.86 1.4 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.208 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.561 ' CA ' HG21 ' A' ' 143' ' ' THR . 88.6 Cg_exo -46.15 106.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 123.52 2.813 . . . . 0.0 110.891 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 1.143 ' H ' ' HA ' ' A' ' 143' ' ' THR . 65.8 p -41.35 -56.3 2.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.655 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 65.4 mttm -79.62 95.62 0.21 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.582 1.176 . . . . 0.0 108.308 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.091 ' HD3' ' O ' ' A' ' 154' ' ' SER . 61.6 Cg_endo -77.01 132.3 12.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.771 2.981 . . . . 0.0 112.246 -171.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.564 HG11 ' OG ' ' A' ' 12' ' ' SER . 47.7 t -69.32 162.72 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.723 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.893 ' HA ' HG21 ' A' ' 45' ' ' THR . 86.5 t -147.28 120.12 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.108 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.134 HG12 HG21 ' A' ' 11' ' ' THR . 34.9 mt -68.84 134.61 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.258 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 10' ' ' THR . 87.5 mt -85.72 -49.76 7.71 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 110.182 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 9' ' ' LEU . 69.2 m -146.82 178.82 8.03 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.67 1.231 . . . . 0.0 111.974 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.89 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . . . -178.7 122.94 0.09 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.364 -175.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.62 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -171.09 152.9 3.58 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.254 173.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.02 141.67 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.732 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.696 HD22 ' N ' ' A' ' 166' ' ' PRO . 5.5 tt -57.82 126.07 75.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.16 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.696 ' N ' HD22 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.607 2.872 . . . . 0.0 112.179 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 1.483 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 83.4 Cg_endo . . . . . 0 CA--C 1.531 0.374 0 N-CA-C 110.096 -0.771 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 1.483 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.4 m170 -154.5 88.49 1.21 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.21 0.944 . . . . 0.0 110.066 -176.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 7' ' ' VAL . 25.5 t -67.78 81.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 167.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.054 ' HG ' ' HG2' ' A' ' 17' ' ' GLU . 7.5 tt -80.38 108.92 14.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.356 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 1.358 HD21 ' O ' ' A' ' 161' ' ' SER . 7.3 mt -109.51 174.44 5.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 112.737 -2.029 . . . . 0.0 112.532 -173.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.927 HG23 HD11 ' A' ' 160' ' ' LEU . 94.9 m -159.91 95.11 1.16 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.078 -2.328 . . . . 0.0 108.447 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 1.049 HG21 HG12 ' A' ' 159' ' ' ILE . 19.8 p -84.53 161.2 20.31 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.997 1.436 . . . . 0.0 111.217 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.757 ' HG ' ' HA ' ' A' ' 157' ' ' VAL . 81.7 p -39.09 -43.59 1.05 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.861 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.825 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -52.84 -63.84 1.01 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.42 1.075 . . . . 0.0 110.105 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.49 171.18 43.87 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.089 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.853 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 2.1 t-20 -68.32 133.31 48.55 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.309 -1.445 . . . . 0.0 110.719 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.679 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 16.5 pt -143.73 -179.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.922 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 1.054 ' HG2' ' HG ' ' A' ' 8' ' ' LEU . 35.9 mt-10 -161.62 110.89 1.55 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.799 -169.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.109 HD22 HD12 ' A' ' 105' ' ' ILE . 3.1 mm? -77.36 150.65 35.11 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 124.541 1.15 . . . . 0.0 110.106 165.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.825 ' HG3' ' HB3' ' A' ' 127' ' ' LYS . 12.6 pt-20 -122.84 121.49 36.37 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.909 174.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 1.005 HD12 ' HE2' ' A' ' 125' ' ' PHE . 61.3 mt -104.19 173.55 6.25 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.803 1.315 . . . . 0.0 112.66 -169.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 125' ' ' PHE . 73.2 m-20 -128.83 104.5 7.65 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.569 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -76.26 -39.54 54.11 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.831 1.332 . . . . 0.0 112.055 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.916 ' HG3' ' HD2' ' A' ' 24' ' ' LYS . 8.1 tp-100 -45.08 -66.85 0.34 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.211 0.945 . . . . 0.0 110.275 -171.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.916 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -83.55 19.48 1.59 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.817 1.323 . . . . 0.0 113.804 -175.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 1.039 ' O ' HG22 ' A' ' 29' ' ' VAL . . . -160.59 64.97 2.21 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 123.904 0.752 . . . . 0.0 111.134 173.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.8 Cg_exo -59.91 -58.72 0.51 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.517 2.811 . . . . 0.0 111.071 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.551 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 80.7 t -53.9 -69.86 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.157 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 25' ' ' ALA . 75.2 p -48.05 -53.92 14.77 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.704 1.252 . . . . 0.0 111.023 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 1.039 HG22 ' O ' ' A' ' 25' ' ' ALA . 3.5 t -60.45 -41.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.318 1.012 . . . . 0.0 110.625 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 1.319 ' O ' HG11 ' A' ' 33' ' ' VAL . 7.3 tm0? -49.87 -62.43 1.57 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.111 0.882 . . . . 0.0 108.923 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 1.043 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 m-80 -44.25 -52.48 7.45 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.585 1.178 . . . . 0.0 110.274 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.892 ' CD2' ' HA ' ' A' ' 29' ' ' VAL . 20.8 m-30 -41.51 -67.3 0.26 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.456 1.098 . . . . 0.0 109.806 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 1.319 HG11 ' O ' ' A' ' 30' ' ' GLN . 7.2 p -40.5 -40.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 124.782 1.301 . . . . 0.0 111.118 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 1.043 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 8.0 m-20 -44.96 -61.94 1.42 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.028 0.83 . . . . 0.0 109.445 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 38' ' ' SER . 78.1 m-85 -55.53 -53.36 57.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.813 1.321 . . . . 0.0 109.317 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.686 HG13 HG12 ' A' ' 164' ' ' VAL . 76.3 t -45.15 -65.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.556 1.16 . . . . 0.0 109.464 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' SER . 22.1 m-20 -48.32 -48.63 36.01 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.803 1.314 . . . . 0.0 110.227 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 37' ' ' ASN . 54.5 m -52.98 -113.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.463 1.102 . . . . 0.0 110.913 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.1 78.05 0.08 OUTLIER Glycine 0 N--CA 1.473 1.141 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 74.4 t80 -116.22 -63.86 1.39 Allowed 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.196 1.174 . . . . 0.0 109.358 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.986 ' O ' HG22 ' A' ' 44' ' ' THR . 51.6 m-85 -59.73 -41.77 91.63 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.715 1.259 . . . . 0.0 111.605 -172.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.584 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.0 p30 -39.32 117.18 0.68 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.19 0.931 . . . . 0.0 111.333 -173.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.7 t30 60.02 35.22 21.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.011 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.986 HG22 ' O ' ' A' ' 41' ' ' TYR . 69.9 p -79.2 -143.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.159 0.912 . . . . 0.0 108.848 165.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.944 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 55.3 p -163.21 -144.0 0.08 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.822 0.82 . . . . 0.0 112.725 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.944 ' CD1' ' O ' ' A' ' 45' ' ' THR . 8.2 m-30 -154.68 67.1 0.69 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.016 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.837 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 6.3 p-80 -59.06 -65.04 0.73 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.855 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.917 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 25.3 tpt180 -69.29 119.02 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.583 1.177 . . . . 0.0 110.656 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 55' ' ' ILE . 84.6 t -154.93 147.55 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 124.805 1.316 . . . . 0.0 110.834 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.617 HG21 ' HG3' ' A' ' 54' ' ' MET . 11.0 tt -157.95 125.58 2.74 Favored Pre-proline 0 N--CA 1.476 0.857 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.955 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 76.0 Cg_exo -34.22 161.78 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.67 2.913 . . . . 0.0 113.958 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -8.85 71.07 0.0 OUTLIER Glycine 0 N--CA 1.475 1.252 0 CA-C-N 114.049 -1.432 . . . . 0.0 113.548 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.113 ' HD1' ' HG2' ' A' ' 54' ' ' MET . 56.5 t80 -160.61 -58.97 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.856 0.974 . . . . 0.0 109.552 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.113 ' HG2' ' HD1' ' A' ' 53' ' ' PHE . 26.3 ptt? -169.22 159.64 9.08 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.299 0.999 . . . . 0.0 112.371 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 105' ' ' ILE . 41.7 pt -154.7 156.58 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 113.171 -1.831 . . . . 0.0 109.203 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.008 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 11.5 mt-30 -150.57 164.83 35.05 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.876 0.735 . . . . 0.0 112.142 -166.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.67 ' O ' ' CD1' ' A' ' 103' ' ' PHE . . . -162.11 155.98 27.43 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 124.06 0.85 . . . . 0.0 112.959 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.513 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 136.63 -57.29 0.67 Allowed Glycine 0 N--CA 1.475 1.271 0 CA-C-N 113.426 -1.387 . . . . 0.0 110.331 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -51.62 -125.16 0.01 OUTLIER Glycine 0 N--CA 1.471 1.033 0 O-C-N 124.593 0.819 . . . . 0.0 113.21 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -39.5 148.01 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.441 -172.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 62' ' ' GLU . 94.0 m -59.94 -92.47 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.463 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.688 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.3 pt-20 -138.85 117.04 11.81 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 124.895 1.372 . . . . 0.0 108.882 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 1.291 ' O ' ' CG ' ' A' ' 64' ' ' MET . 67.2 tt0 76.91 -56.75 0.54 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.629 1.206 . . . . 0.0 108.8 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 1.291 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 155.82 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.046 1.403 . . . . 0.0 109.163 175.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.775 ' O ' ' O ' ' A' ' 66' ' ' GLN . 29.1 mm100 -142.87 82.21 1.76 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 110.908 -2.86 . . . . 0.0 104.965 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.825 ' C ' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -27.54 174.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -165.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 68' ' ' LYS . 7.0 mtpm? -68.62 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 111.0 -2.818 . . . . 0.0 113.617 -169.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 67' ' ' LYS . 28.0 tptp 179.11 73.75 0.14 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 112.325 -2.216 . . . . 0.0 105.758 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.606 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 62.5 Cg_endo -83.37 -165.02 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 123.351 2.701 . . . . 0.0 113.746 -162.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.989 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 8.6 m120 -163.34 169.89 8.06 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 113.126 -1.852 . . . . 0.0 110.029 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.989 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 35.1 Cg_endo -50.74 95.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.12 2.547 . . . . 0.0 109.818 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.961 ' HG3' HG21 ' A' ' 100' ' ' THR . 82.4 Cg_exo -51.86 -146.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.908 3.072 . . . . 0.0 113.46 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.05 152.83 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 124.296 0.997 . . . . 0.0 110.981 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 61.3 mttp -37.66 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.181 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 76' ' ' GLU . 56.0 p30 -64.02 -168.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.19 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.889 ' HB2' HD22 ' A' ' 79' ' ' ASN . 0.0 OUTLIER 160.43 141.17 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.383 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 1.015 ' HB2' ' CD2' ' A' ' 115' ' ' HIS . . . -157.6 -51.24 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.242 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -68.28 -49.43 60.55 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.473 1.108 . . . . 0.0 110.372 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.889 HD22 ' HB2' ' A' ' 76' ' ' GLU . 45.1 p30 -43.02 -43.38 4.23 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.22 0.95 . . . . 0.0 110.103 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.672 ' N ' ' OD1' ' A' ' 79' ' ' ASN . . . -42.85 -33.32 1.61 Allowed Glycine 0 N--CA 1.471 1.029 0 O-C-N 124.411 1.069 . . . . 0.0 112.131 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 66.1 mt 98.39 -131.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 1.018 ' O ' ' NE ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -169.0 110.12 0.49 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.977 0.798 . . . . 0.0 109.673 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.775 ' HB2' HG23 ' A' ' 87' ' ' THR . 2.0 m-20 -132.74 -134.16 0.18 Allowed 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.963 1.414 . . . . 0.0 109.865 -176.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' OD1' ' A' ' 109' ' ' ASP . 10.2 m -169.6 163.77 10.21 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.822 0.82 . . . . 0.0 111.734 -167.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.932 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 58.2 ttt180 -18.67 103.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.199 165.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.989 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 140.35 -23.19 2.7 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.256 -2.702 . . . . 0.0 110.581 -169.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 1.086 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.7 p -98.28 146.98 25.11 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.023 0.916 . . . . 0.0 112.94 -175.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.966 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.67 161.94 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.972 164.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.06 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -159.78 156.66 27.95 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.558 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 1.242 ' CE ' ' HB3' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -74.4 123.74 25.23 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.752 -176.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.588 ' N ' ' SD ' ' A' ' 90' ' ' MET . . . -57.75 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.089 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.824 ' NH1' ' O ' ' A' ' 93' ' ' THR . 68.0 ttp85 179.71 -104.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.743 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.824 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 97.3 m 100.71 -98.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.638 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 93' ' ' THR . . . -61.95 -132.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.58 1.175 . . . . 0.0 110.93 -174.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 35.2 m-20 -58.24 172.12 0.49 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -56.16 -111.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.723 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.642 ' OD1' ' CG ' ' A' ' 75' ' ' ASN . 35.2 m-20 -52.4 103.57 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.776 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.852 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 68.4 m -165.76 -34.75 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.467 1.104 . . . . 0.0 111.619 -175.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 1.242 ' HB3' ' CE ' ' A' ' 90' ' ' MET . . . -33.58 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.846 0.716 . . . . 0.0 110.701 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.961 HG21 ' HG3' ' A' ' 72' ' ' PRO . 48.8 p -78.87 -60.4 2.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.182 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.7 p -171.57 97.57 0.18 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.251 0.97 . . . . 0.0 109.274 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.914 ' OE1' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER 171.23 134.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.727 1.267 . . . . 0.0 109.109 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.966 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -140.24 -171.29 3.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.458 -177.041 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 1.008 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 43.6 p90 -155.93 129.06 8.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.47 -172.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.109 HD12 HD22 ' A' ' 18' ' ' LEU . 57.8 mt -93.27 111.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.515 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 104' ' ' PHE . 50.9 m-20 -65.38 155.26 35.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.398 1.061 . . . . 0.0 110.766 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 54' ' ' MET . 22.4 m -146.92 38.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.11 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 178.95 122.93 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.142 0.901 . . . . 0.0 110.067 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.932 ' OD1' ' HB3' ' A' ' 85' ' ' ARG . 34.0 m-20 -37.17 137.11 0.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.14 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -150.8 108.79 3.71 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.65 1.218 . . . . 0.0 110.097 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . -90.92 -49.96 6.14 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.893 170.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 1.263 ' O ' HD11 ' A' ' 113' ' ' LEU . 30.6 p90 -49.35 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.469 1.106 . . . . 0.0 109.235 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 1.263 HD11 ' O ' ' A' ' 112' ' ' PHE . 3.1 mp 179.28 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.641 -2.072 . . . . 0.0 108.519 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.67 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 6.6 m-20 -38.92 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.856 0.723 . . . . 0.0 110.657 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 1.054 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 44.5 m-70 -46.92 122.27 4.23 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.901 1.375 . . . . 0.0 110.182 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.455 0 O-C-N 124.524 1.14 . . . . 0.0 112.182 -177.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.11 -131.34 1.31 Allowed Glycine 0 N--CA 1.476 1.318 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 1.054 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 89.9 m-85 -79.45 133.86 36.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.422 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.071 ' O ' HG22 ' A' ' 124' ' ' VAL . . . -69.55 -161.65 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.519 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.071 HG22 ' O ' ' A' ' 123' ' ' ALA . 54.9 t 178.8 144.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.753 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 1.005 ' HE2' HD12 ' A' ' 20' ' ' LEU . 30.3 p90 -168.74 26.16 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.806 ' HA3' HD21 ' A' ' 20' ' ' LEU . . . -167.17 -143.98 3.96 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 122.87 1.261 . . . . 0.0 113.906 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 1.086 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 40.4 ttmt 179.76 -139.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 111.51 -2.345 . . . . 0.0 109.656 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.084 ' H ' ' CG ' ' A' ' 127' ' ' LYS . 95.8 t -159.78 117.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.952 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.841 ' O ' ' HG3' ' A' ' 130' ' ' LYS . 35.2 m -73.75 -40.99 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.739 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.841 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 8.4 mtpm? -166.19 -156.2 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.261 0.976 . . . . 0.0 111.379 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 134' ' ' VAL . . . 49.75 18.36 1.77 Allowed Glycine 0 N--CA 1.473 1.154 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.539 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.529 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 10.4 tpt -55.03 -48.04 73.95 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.727 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 2.2 m-20 -43.29 -56.07 3.7 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.437 1.085 . . . . 0.0 110.018 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.64 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.1 t -39.7 -59.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.49 1.118 . . . . 0.0 109.671 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 132' ' ' MET . . . -45.5 -52.22 10.63 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.655 1.222 . . . . 0.0 109.529 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.929 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 1.8 m-20 -50.51 -65.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.553 1.158 . . . . 0.0 109.042 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 14.5 mmmm -35.46 -55.02 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.498 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.18 ' O ' HG23 ' A' ' 141' ' ' VAL . 13.8 mt -56.95 -56.81 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.868 1.355 . . . . 0.0 109.169 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.405 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 82.0 p -64.23 3.25 0.46 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.929 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.9 mp0 -97.24 -51.47 4.18 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.213 0.946 . . . . 0.0 108.717 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.18 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -45.78 125.83 6.6 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.436 1.085 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -44.6 177.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 123.637 2.891 . . . . 0.0 114.022 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.424 HG21 ' CA ' ' A' ' 153' ' ' PRO . 1.5 p -161.23 -140.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.127 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' ASP . 0.7 OUTLIER 179.65 164.49 1.06 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 110.485 -3.052 . . . . 0.0 111.017 169.591 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.82 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 34.7 m-20 -50.42 -143.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.652 168.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.936 HG21 ' O ' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -161.68 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 168.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.55 -94.65 0.05 OUTLIER Glycine 0 N--CA 1.47 0.964 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 168.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.803 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 97.5 Cg_endo -76.83 -65.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.917 3.078 . . . . 0.0 109.603 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.936 ' O ' HG21 ' A' ' 146' ' ' VAL . 39.3 m-85 -69.83 124.73 24.75 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.564 1.165 . . . . 0.0 111.695 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.82 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 49.5 mm-40 -75.75 -171.84 1.71 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.744 169.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.542 ' O ' HG22 ' A' ' 152' ' ' VAL . 20.6 m-20 44.89 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.615 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.861 ' HB ' HG23 ' A' ' 146' ' ' VAL . 83.7 t -159.16 128.74 3.26 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 113.164 -1.835 . . . . 0.0 107.726 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 1.424 ' CA ' HG21 ' A' ' 143' ' ' THR . 96.5 Cg_exo -39.25 -145.71 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.308 2.672 . . . . 0.0 112.508 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 45.7 t -163.86 -8.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.373 1.046 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 1.084 ' HB3' ' HD3' ' A' ' 156' ' ' PRO . 87.8 tttt 178.91 -67.36 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.534 0.521 . . . . 0.0 111.667 175.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.156 ' O ' HG21 ' A' ' 157' ' ' VAL . 56.7 Cg_endo -75.04 76.84 3.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 111.672 -168.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 1.156 HG21 ' O ' ' A' ' 156' ' ' PRO . 42.8 t -172.52 127.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.679 168.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.799 ' HA ' HG21 ' A' ' 45' ' ' THR . 81.2 t -167.29 118.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.068 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.049 HG12 HG21 ' A' ' 11' ' ' THR . 34.2 mt -68.29 133.89 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.881 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.927 HD11 HG23 ' A' ' 10' ' ' THR . 84.4 mt -87.23 -48.32 8.12 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.375 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 1.358 ' O ' HD21 ' A' ' 9' ' ' LEU . 32.4 t -167.89 162.68 13.68 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.395 1.059 . . . . 0.0 113.128 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 1.028 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -152.75 118.08 5.24 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.835 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.7 ptpt -151.13 135.2 16.68 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.686 HG12 HG13 ' A' ' 36' ' ' VAL . 33.8 m -68.71 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.98 HD11 ' HD2' ' A' ' 166' ' ' PRO . 48.7 tp -62.12 121.5 66.34 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.795 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.98 ' HD2' HD11 ' A' ' 165' ' ' LEU . 86.1 Cg_exo . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.573 2.848 . . . . 0.0 112.074 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 55.36 -96.08 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 124.8 1.312 . . . . 0.0 109.59 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.547 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . 173.13 99.07 0.12 Allowed Glycine 0 N--CA 1.473 1.142 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.547 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 67.8 m-20 -170.13 103.83 0.44 Allowed Pre-proline 0 N--CA 1.474 0.758 0 O-C-N 124.635 0.844 . . . . 0.0 109.335 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.298 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 88.8 Cg_exo -48.61 136.75 26.83 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.837 3.025 . . . . 0.0 113.483 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.466 ' CD2' ' HG2' ' A' ' 19' ' ' GLU . 37.3 m170 -147.8 114.23 5.95 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.093 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.557 HG23 HG11 ' A' ' 164' ' ' VAL . 14.8 t -71.46 96.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.543 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.491 ' CD1' ' HG2' ' A' ' 17' ' ' GLU . 15.8 tp -79.09 131.14 36.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.772 1.295 . . . . 0.0 109.52 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.255 HD21 ' O ' ' A' ' 161' ' ' SER . 8.8 mt -141.43 131.41 24.56 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.507 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.951 HG23 HD11 ' A' ' 160' ' ' LEU . 99.5 m -116.39 94.95 4.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 111.633 -2.531 . . . . 0.0 108.206 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.996 HG21 HG12 ' A' ' 159' ' ' ILE . 22.4 p -81.12 165.25 21.76 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 125.116 1.51 . . . . 0.0 110.715 170.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -39.09 -42.34 0.91 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.802 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.62 -63.09 1.26 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.431 1.082 . . . . 0.0 110.427 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.37 172.24 44.66 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.285 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 1.2 t-20 -76.97 108.21 9.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.428 -1.386 . . . . 0.0 110.006 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.787 HG22 HG12 ' A' ' 134' ' ' VAL . 13.5 pt -103.35 -169.74 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 124.826 1.329 . . . . 0.0 110.959 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.491 ' HG2' ' CD1' ' A' ' 8' ' ' LEU . 37.7 mt-10 -161.87 102.45 1.16 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.817 -173.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.062 HD22 HD12 ' A' ' 105' ' ' ILE . 2.7 mm? -73.41 160.74 31.32 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.344 1.027 . . . . 0.0 110.651 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.466 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -138.37 127.55 24.29 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.167 173.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 1.011 HD12 ' HE2' ' A' ' 125' ' ' PHE . 80.3 mt -122.01 143.57 49.41 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.805 1.316 . . . . 0.0 111.975 -168.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.668 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 73.2 m-20 -55.48 -126.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.977 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.962 ' HA ' HG13 ' A' ' 29' ' ' VAL . 38.2 ttmt 145.64 -59.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.029 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.404 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 32.4 tt0 -55.1 -57.12 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.096 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.866 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 20.3 tptm -69.09 -4.97 19.27 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.593 1.183 . . . . 0.0 113.465 -172.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.746 ' HB1' ' ND2' ' A' ' 79' ' ' ASN . . . -161.18 70.62 2.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.67 0.606 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 1.198 ' O ' HG21 ' A' ' 29' ' ' VAL . 63.6 Cg_exo -52.7 -54.17 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 111.504 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.13 -65.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 124.704 1.253 . . . . 0.0 110.21 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.4 p -47.2 -52.79 14.81 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.713 1.258 . . . . 0.0 110.886 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.577 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 32.7 m -47.44 -50.2 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.322 1.014 . . . . 0.0 110.653 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 1.039 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 58.2 tp60 -51.23 -52.48 44.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.336 1.023 . . . . 0.0 109.844 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.945 ' OD1' HG23 ' A' ' 73' ' ' ILE . 18.4 m120 -49.96 -66.05 0.46 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.579 1.175 . . . . 0.0 110.322 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 1.577 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 46.8 p90 -57.1 -46.18 82.78 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.448 1.092 . . . . 0.0 110.441 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 1.024 HG11 ' O ' ' A' ' 30' ' ' GLN . 12.0 p -49.33 -40.17 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.976 0.797 . . . . 0.0 110.406 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 1.039 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 2.1 m-20 -45.84 -61.51 1.7 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.097 0.873 . . . . 0.0 108.84 171.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.827 ' HH ' ' HG3' ' A' ' 71' ' ' PRO . 28.3 m-85 -58.35 -60.12 4.28 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.892 1.37 . . . . 0.0 109.302 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.747 HG13 HG13 ' A' ' 164' ' ' VAL . 58.4 t -39.27 -52.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 124.589 1.18 . . . . 0.0 110.683 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.734 ' O ' ' HB3' ' A' ' 38' ' ' SER . 23.1 m120 -38.77 -33.55 0.11 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.765 1.291 . . . . 0.0 111.858 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.734 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.9 p 158.02 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.155 0.909 . . . . 0.0 112.672 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 69.01 79.37 0.28 Allowed Glycine 0 N--CA 1.471 0.984 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.737 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.95 ' O ' HG22 ' A' ' 44' ' ' THR . 15.3 t80 168.76 -75.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.711 0.889 . . . . 0.0 109.514 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.438 ' N ' ' HD1' ' A' ' 40' ' ' PHE . 77.7 m-85 -66.69 -31.73 72.58 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.5 1.125 . . . . 0.0 112.411 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -38.72 -36.16 0.24 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.053 0.845 . . . . 0.0 112.977 -170.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 9.5 t30 -156.5 47.31 0.45 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.064 0.853 . . . . 0.0 110.748 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 40' ' ' PHE . 52.7 p -83.61 -140.56 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.266 161.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 1.074 HG21 ' HA ' ' A' ' 158' ' ' VAL . 46.4 p -163.1 -141.05 0.06 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.988 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.878 ' CE1' HD12 ' A' ' 159' ' ' ILE . 15.6 m-30 -146.11 92.28 2.17 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.25 -1.795 . . . . 0.0 106.384 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 1.261 ' HB2' ' OE1' ' A' ' 56' ' ' GLN . 21.3 m80 -23.31 -67.61 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.351 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.036 ' HB2' ' HA ' ' A' ' 152' ' ' VAL . 1.8 tpm_? -172.32 -142.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.764 1.29 . . . . 0.0 111.217 169.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.981 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 6.2 p -172.08 135.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.274 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.961 HG23 ' HD2' ' A' ' 53' ' ' PHE . 10.9 tt -62.49 129.74 92.84 Favored Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.483 159.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' PHE . 20.5 Cg_endo -45.2 153.04 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.014 2.476 . . . . 0.0 112.079 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 7.26 60.18 0.01 OUTLIER Glycine 0 N--CA 1.474 1.206 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.729 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.961 ' HD2' HG23 ' A' ' 50' ' ' ILE . 65.2 t80 -152.66 -54.63 0.12 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.817 0.951 . . . . 0.0 110.737 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.916 ' O ' HG21 ' A' ' 49' ' ' VAL . 43.5 ttp -171.94 113.68 0.33 Allowed 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.088 0.867 . . . . 0.0 112.124 -169.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.974 HG13 ' HB ' ' A' ' 105' ' ' ILE . 26.7 pt -90.86 155.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.755 164.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.332 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 78.9 mt-30 -68.61 -121.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.382 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 1.115 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -152.67 -119.96 0.81 Allowed Glycine 0 N--CA 1.47 0.932 0 O-C-N 118.624 -2.548 . . . . 0.0 110.549 3.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 61.28 106.86 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 47' ' ' HIS . . . -179.44 -122.8 0.79 Allowed Glycine 0 N--CA 1.475 1.296 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 1.108 ' HB3' ' CA ' ' A' ' 64' ' ' MET . 42.4 m-85 -45.57 113.75 0.65 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.58 0.812 . . . . 0.0 110.264 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.586 ' O ' HG22 ' A' ' 61' ' ' THR . 9.4 t -59.52 116.75 4.2 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.484 1.115 . . . . 0.0 110.565 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.78 ' HB3' ' OE1' ' A' ' 63' ' ' GLN . 44.9 mt-10 65.02 -118.87 0.4 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.748 1.28 . . . . 0.0 110.786 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.78 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 8.0 mp0 -41.67 -58.15 2.06 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.679 1.237 . . . . 0.0 109.363 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 1.108 ' CA ' ' HB3' ' A' ' 60' ' ' PHE . 16.9 ptm 138.63 94.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.704 1.253 . . . . 0.0 107.762 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.702 ' N ' ' HB3' ' A' ' 60' ' ' PHE . 8.8 mm-40 -159.19 105.83 1.74 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.901 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.737 ' HA ' HE21 ' A' ' 66' ' ' GLN . 1.2 mm-40 -29.28 133.39 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.807 -174.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 1.115 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -57.35 -97.73 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.684 168.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.65 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 4.3 ttmp? -167.85 66.92 0.79 Allowed Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.582 165.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 1.244 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 37.0 Cg_exo -69.18 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.58 2.853 . . . . 0.0 113.333 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.244 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 2.1 p-10 102.44 38.04 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 113.377 -1.738 . . . . 0.0 115.607 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 1.526 ' HD2' ' CB ' ' A' ' 100' ' ' THR . 17.7 Cg_endo -95.3 80.25 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.831 3.021 . . . . 0.0 107.541 171.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 1.207 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 75.5 Cg_exo -66.97 110.63 1.99 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.544 2.163 . . . . 0.0 112.08 -163.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.945 HG23 ' OD1' ' A' ' 31' ' ' ASN . 18.9 pt -79.3 -123.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 124.638 1.211 . . . . 0.0 109.207 175.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HD2' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -156.73 -151.72 0.34 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.964 0.79 . . . . 0.0 112.258 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.822 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . 51.7 p30 -39.74 145.41 0.14 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.624 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 1.031 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 1.8 mp0 -131.29 -92.68 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.768 1.292 . . . . 0.0 109.82 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.886 ' HB2' ' CE1' ' A' ' 120' ' ' PHE . . . -38.13 -37.06 0.25 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.674 1.234 . . . . 0.0 112.384 -172.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.822 ' OD2' ' HB2' ' A' ' 75' ' ' ASN . 4.3 p30 -68.8 33.89 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.087 0.867 . . . . 0.0 112.44 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 1.031 ' OD1' ' O ' ' A' ' 76' ' ' GLU . 2.1 p-10 -172.74 82.86 0.05 Allowed 'General case' 0 N--CA 1.469 0.491 0 O-C-N 124.24 0.962 . . . . 0.0 108.766 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.8 ' C ' HD21 ' A' ' 81' ' ' LEU . . . -168.95 0.34 0.04 OUTLIER Glycine 0 N--CA 1.477 1.389 0 CA-C-N 114.711 -1.132 . . . . 0.0 113.48 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 1.464 HD11 ' NH1' ' A' ' 82' ' ' ARG . 1.5 pt? 31.12 172.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 1.464 ' NH1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -60.0 158.1 11.58 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.032 -172.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.814 ' OD1' ' CG2' ' A' ' 87' ' ' THR . 1.0 OUTLIER 175.2 -146.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.464 170.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 1.494 HG22 ' NH1' ' A' ' 85' ' ' ARG . 15.8 m -170.34 162.95 8.66 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.51 0.506 . . . . 0.0 112.012 -167.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 1.494 ' NH1' HG22 ' A' ' 84' ' ' THR . 0.0 OUTLIER -34.15 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.956 1.36 . . . . 0.0 111.004 176.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 127' ' ' LYS . . . 156.6 -29.87 0.56 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-N 110.894 -2.867 . . . . 0.0 109.471 -169.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 1.014 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 50.1 p -81.68 144.73 30.97 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.204 0.591 . . . . 0.0 112.071 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 1.021 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -95.09 159.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.296 165.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.155 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -161.55 144.34 12.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.52 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 1.041 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 41.7 mtp -75.46 144.06 42.29 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.246 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.7 -118.21 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.543 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.256 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.54 -132.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.714 0.634 . . . . 0.0 111.011 176.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 1.256 HG22 ' O ' ' A' ' 92' ' ' ARG . 19.8 p 171.46 152.2 0.06 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.461 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.72 0.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.545 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 1.412 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 56.7 m-20 -40.01 -71.71 0.08 Allowed 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.654 1.221 . . . . 0.0 110.765 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.412 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 8.5 mtpm? 149.1 -94.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.91 1.381 . . . . 0.0 108.341 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.56 104.87 0.56 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.827 1.329 . . . . 0.0 109.197 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.874 ' O ' HG12 ' A' ' 73' ' ' ILE . 31.0 t -169.52 -102.19 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.664 1.228 . . . . 0.0 109.793 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 43.8 76.42 0.08 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.364 1.04 . . . . 0.0 108.6 -173.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 1.526 ' CB ' ' HD2' ' A' ' 71' ' ' PRO . 81.1 p -78.26 -43.47 28.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.105 -171.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 80.0 p -170.76 98.34 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.2 0.937 . . . . 0.0 109.54 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.9 tt0 169.48 123.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.777 1.298 . . . . 0.0 109.887 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 1.021 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.09 175.18 9.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.455 177.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.332 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 29.1 p90 -154.23 136.43 14.81 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.96 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.155 ' N ' ' O ' ' A' ' 56' ' ' GLN . 60.6 mt -95.46 115.06 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.663 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 52.5 m-20 -74.11 -172.61 1.41 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.514 1.134 . . . . 0.0 111.149 173.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 1.195 HG11 ' CE ' ' A' ' 132' ' ' MET . 32.7 m -157.84 -44.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.456 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.944 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -91.87 152.42 20.09 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.255 0.972 . . . . 0.0 112.038 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.851 ' OD1' ' HD2' ' A' ' 85' ' ' ARG . 39.1 m-20 -49.59 106.81 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.12 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 1.034 HD22 HD11 ' A' ' 113' ' ' LEU . 2.8 t-20 -99.3 -100.59 0.23 Allowed 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.832 1.333 . . . . 0.0 109.87 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.717 ' O ' ' CG ' ' A' ' 114' ' ' ASP . . . 75.29 -43.93 0.52 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.931 0.77 . . . . 0.0 110.935 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' HD2' HD21 ' A' ' 110' ' ' ASN . 39.8 m-85 -39.31 -50.69 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.285 0.991 . . . . 0.0 110.79 -176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 1.034 HD11 HD22 ' A' ' 110' ' ' ASN . 7.8 mp -58.41 -24.26 59.59 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.768 1.292 . . . . 0.0 111.492 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.717 ' CG ' ' O ' ' A' ' 111' ' ' ALA . 36.1 m-20 -39.17 101.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.757 0.661 . . . . 0.0 111.037 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -38.7 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.413 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 1.264 ' O ' ' HG2' ' A' ' 117' ' ' GLN . . . -179.5 66.16 0.07 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 1.264 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 90.5 mm-40 163.53 178.23 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.616 -0.792 . . . . 0.0 110.052 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -62.72 69.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.755 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 117' ' ' GLN . 17.9 p-10 179.0 164.07 0.85 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.72 1.263 . . . . 0.0 111.485 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.886 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 0.8 OUTLIER 170.77 119.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.175 -175.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.624 ' N ' ' HD1' ' A' ' 120' ' ' PHE . . . -156.24 -77.24 0.02 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 124.371 1.044 . . . . 0.0 112.032 -174.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.562 ' CD2' HD21 ' A' ' 113' ' ' LEU . 43.7 m-85 -77.24 120.51 22.39 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.245 0.615 . . . . 0.0 110.755 -167.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.155 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -70.62 -161.31 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.304 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.041 HG22 ' O ' ' A' ' 123' ' ' ALA . 76.1 t 177.57 141.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.173 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 1.011 ' HE2' HD12 ' A' ' 20' ' ' LEU . 20.2 p90 -174.34 25.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 1.191 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -156.53 -149.19 5.3 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 122.866 1.259 . . . . 0.0 113.823 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.191 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 7.2 mtpm? -179.37 -154.98 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.635 -2.283 . . . . 0.0 110.586 -170.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.78 HG23 HD12 ' A' ' 18' ' ' LEU . 94.3 t -160.04 117.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.722 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.719 HG22 ' CE1' ' A' ' 6' ' ' HIS . 82.6 t -84.5 -75.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 114.042 -1.436 . . . . 0.0 110.448 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 132' ' ' MET . 59.6 tttp -96.18 -94.65 0.2 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.474 1.109 . . . . 0.0 112.338 -167.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.575 ' O ' HG21 ' A' ' 16' ' ' ILE . . . -60.58 51.81 0.03 OUTLIER Glycine 0 N--CA 1.475 1.238 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.442 -165.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.195 ' CE ' HG11 ' A' ' 107' ' ' VAL . 12.1 tpt -60.7 -48.68 80.69 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.666 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.4 t0 -43.58 -57.99 2.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.425 1.078 . . . . 0.0 110.223 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.787 HG12 HG22 ' A' ' 16' ' ' ILE . 54.5 t -39.57 -59.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.458 1.099 . . . . 0.0 109.501 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.751 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -46.13 -52.22 12.56 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.795 1.31 . . . . 0.0 109.658 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.666 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 37.0 m-20 -50.78 -69.25 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.612 1.195 . . . . 0.0 109.553 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.749 ' CA ' ' HG2' ' A' ' 140' ' ' GLN . 8.2 ttpm? -41.29 -45.94 3.09 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.634 1.208 . . . . 0.0 110.395 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.898 ' O ' HG23 ' A' ' 141' ' ' VAL . 15.6 mt -53.8 -59.2 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.873 ' HA ' HH12 ' A' ' 48' ' ' ARG . 79.0 p -64.59 9.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.71 1.256 . . . . 0.0 113.838 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.749 ' HG2' ' CA ' ' A' ' 137' ' ' LYS . 39.6 mm-40 -96.06 -52.71 3.93 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.164 0.915 . . . . 0.0 109.432 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.9 m -49.59 123.69 14.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 124.505 1.128 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 82.6 Cg_exo -41.34 178.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.462 2.775 . . . . 0.0 113.553 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.154 HG21 ' CA ' ' A' ' 153' ' ' PRO . 4.2 p -161.31 -142.22 0.08 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 123.101 1.429 . . . . 0.0 112.137 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.82 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 179.33 145.37 0.17 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 110.691 -2.959 . . . . 0.0 111.941 173.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -63.38 121.67 14.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.102 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.889 HG21 ' HB ' ' A' ' 152' ' ' VAL . 1.5 t -78.09 -65.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.949 -168.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.64 -81.78 0.06 OUTLIER Glycine 0 N--CA 1.47 0.94 0 CA-C-N 111.736 -2.484 . . . . 0.0 107.998 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.771 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 73.6 Cg_endo -66.44 -73.48 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.523 2.816 . . . . 0.0 108.671 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.771 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 43.9 m-85 -76.98 102.73 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.616 1.197 . . . . 0.0 110.107 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 34.2 mt-30 -67.74 135.62 52.97 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.671 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 10.3 m120 83.04 96.51 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 1.036 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 63.0 t -154.07 127.03 4.11 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.876 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.154 ' CA ' HG21 ' A' ' 143' ' ' THR . 55.7 Cg_endo -61.45 102.73 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.554 2.836 . . . . 0.0 109.324 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.293 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 49.2 m -42.33 -58.62 2.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.027 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -82.31 88.46 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 O-C-N 124.832 1.332 . . . . 0.0 108.077 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.293 ' HD3' ' O ' ' A' ' 154' ' ' SER . 86.2 Cg_exo -61.65 141.36 90.76 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.531 2.821 . . . . 0.0 114.967 -166.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 158' ' ' VAL . 97.3 t -69.53 161.57 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.374 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 1.074 ' HA ' HG21 ' A' ' 45' ' ' THR . 99.1 t -147.45 118.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.144 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.996 HG12 HG21 ' A' ' 11' ' ' THR . 50.2 mt -69.35 143.5 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 113.602 -1.636 . . . . 0.0 111.705 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.951 HD11 HG23 ' A' ' 10' ' ' THR . 83.5 mt -95.44 -45.09 7.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 1.255 ' O ' HD21 ' A' ' 9' ' ' LEU . 25.7 t -169.08 165.78 11.11 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 1.049 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -149.95 109.25 3.96 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.524 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -131.18 111.51 12.0 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.438 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.747 HG13 HG13 ' A' ' 36' ' ' VAL . 34.0 m -76.53 135.02 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.78 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 78.5 mt -97.41 134.36 22.72 Favored Pre-proline 0 N--CA 1.479 1.015 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.025 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 165' ' ' LEU . 84.0 Cg_exo . . . . . 0 C--O 1.251 1.129 0 C-N-CA 123.539 2.826 . . . . 0.0 112.139 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -47.62 114.48 0.9 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.401 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 1.191 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 179.97 96.42 0.1 Allowed Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.505 1.128 . . . . 0.0 110.694 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.191 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 85.3 m-20 -174.05 67.75 0.31 Allowed Pre-proline 0 N--CA 1.474 0.771 0 O-C-N 124.602 0.824 . . . . 0.0 109.208 173.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.126 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 52.8 Cg_exo -58.78 107.94 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.477 2.784 . . . . 0.0 111.658 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.7 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 12.9 m170 -160.04 74.62 0.58 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.492 1.12 . . . . 0.0 108.685 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.911 HG12 HD11 ' A' ' 20' ' ' LEU . 18.7 m -61.07 100.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.185 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.193 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 37.5 mt -78.34 145.3 35.35 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.64 1.212 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.107 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.8 mt -149.15 162.49 39.88 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.027 -2.352 . . . . 0.0 110.41 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 1.272 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.2 m -160.59 78.1 0.62 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.123 -2.308 . . . . 0.0 108.523 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 1.012 HG21 HG12 ' A' ' 159' ' ' ILE . 35.7 p -70.78 168.63 16.28 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 125.182 1.551 . . . . 0.0 111.44 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.422 ' OG ' HG12 ' A' ' 157' ' ' VAL . 80.5 p -39.57 -44.02 1.39 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.578 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.847 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -57.75 -60.8 3.14 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.443 1.089 . . . . 0.0 110.365 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 134' ' ' VAL . . . 172.03 -179.75 43.47 Favored Glycine 0 N--CA 1.478 1.456 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.222 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 1.107 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 9.7 t-20 -61.23 160.56 10.25 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.6 -1.3 . . . . 0.0 111.761 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.907 HG22 ' O ' ' A' ' 15' ' ' ASN . 10.4 pt -167.39 174.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.914 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.123 ' HG2' ' CD2' ' A' ' 8' ' ' LEU . 35.9 mt-10 -160.78 106.07 1.42 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.107 -169.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.159 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.7 mm? -87.35 105.88 17.56 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.64 1.212 . . . . 0.0 108.438 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.413 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -69.45 118.74 12.71 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.169 0.918 . . . . 0.0 108.77 174.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 1.159 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 6.4 mp -108.37 137.45 46.31 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.918 1.386 . . . . 0.0 110.905 -172.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.813 ' OD1' ' HG2' ' A' ' 23' ' ' GLN . 52.6 t0 -56.61 -116.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.787 174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.871 ' HA ' HG13 ' A' ' 29' ' ' VAL . 60.7 tttm 135.5 -57.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.594 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 1.013 ' OE1' ' NZ ' ' A' ' 24' ' ' LYS . 3.8 pt20 -55.75 -49.07 74.09 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.736 1.272 . . . . 0.0 110.573 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 1.013 ' NZ ' ' OE1' ' A' ' 23' ' ' GLN . 47.0 mmtm -69.11 -16.18 63.6 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.338 1.024 . . . . 0.0 113.219 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.499 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.42 71.72 2.94 Favored Pre-proline 0 N--CA 1.475 0.814 0 O-C-N 123.836 0.71 . . . . 0.0 109.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 1.095 ' O ' HG23 ' A' ' 29' ' ' VAL . 78.0 Cg_exo -51.42 -55.65 3.79 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.735 2.957 . . . . 0.0 111.538 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.6 t -46.68 -62.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 124.678 1.236 . . . . 0.0 110.125 -177.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.9 p -44.06 -54.2 5.7 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.725 1.266 . . . . 0.0 110.441 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.095 HG23 ' O ' ' A' ' 26' ' ' PRO . 29.0 m -56.8 -47.02 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 124.317 1.011 . . . . 0.0 110.617 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 1.008 HE21 ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -44.92 -69.48 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.196 0.935 . . . . 0.0 109.632 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.935 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.6 m-80 -46.03 -50.43 15.05 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.594 1.184 . . . . 0.0 109.488 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.86 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 45.4 t80 -40.61 -66.01 0.36 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.685 1.241 . . . . 0.0 110.231 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.806 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.3 t -45.81 -39.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.583 1.177 . . . . 0.0 111.099 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.935 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 88.1 m-20 -44.07 -62.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.089 0.868 . . . . 0.0 109.504 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.743 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 34.1 m-85 -64.33 -55.84 18.53 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.159 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' O ' ' A' ' 32' ' ' PHE . 58.8 t -39.33 -48.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 124.735 1.272 . . . . 0.0 111.015 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.824 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.1 t-20 -38.43 -33.5 0.1 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.754 1.284 . . . . 0.0 111.844 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.824 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 93.6 p 145.75 176.96 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.225 0.953 . . . . 0.0 113.061 175.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.64 -43.03 3.1 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.908 ' O ' HG21 ' A' ' 44' ' ' THR . 1.4 t80 -71.12 -74.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.586 0.815 . . . . 0.0 109.513 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.712 ' CB ' ' HB1' ' A' ' 162' ' ' ALA . 16.5 m-30 -62.5 -28.23 69.7 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.552 1.158 . . . . 0.0 112.678 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.595 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 53.0 p-10 -38.76 -36.68 0.28 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.932 0.77 . . . . 0.0 112.569 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.595 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 2.1 t-20 -161.25 47.58 0.2 Allowed 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.055 0.847 . . . . 0.0 110.753 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.908 HG21 ' O ' ' A' ' 40' ' ' PHE . 42.9 p -79.46 -136.57 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 160.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 1.05 HG21 ' HA ' ' A' ' 158' ' ' VAL . 47.7 p -163.36 -142.45 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.998 0.904 . . . . 0.0 112.024 174.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.762 ' HZ ' HD12 ' A' ' 9' ' ' LEU . 52.7 m-85 -158.85 74.16 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.242 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.809 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 2.4 p-80 -42.7 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.76 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.198 ' NH2' ' CA ' ' A' ' 51' ' ' PRO . 46.9 tpt85 -173.26 -150.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.433 1.111 . . . . 0.0 113.122 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 1.189 HG22 ' O ' ' A' ' 48' ' ' ARG . 48.1 t -175.83 -70.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.475 -2.148 . . . . 0.0 106.684 169.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.885 ' C ' ' NH2' ' A' ' 48' ' ' ARG . 59.2 mt -171.27 134.22 0.92 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.502 -1.681 . . . . 0.0 108.585 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.198 ' CA ' ' NH2' ' A' ' 48' ' ' ARG . 80.1 Cg_exo -35.54 155.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.068 2.512 . . . . 0.0 112.706 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -1.35 66.51 0.0 OUTLIER Glycine 0 N--CA 1.476 1.332 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.706 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.053 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.9 t80 -156.33 -50.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.856 0.974 . . . . 0.0 109.95 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.053 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 64.2 mtm -176.62 159.75 1.9 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.352 1.032 . . . . 0.0 111.409 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.02 HG12 ' O ' ' A' ' 105' ' ' ILE . 42.6 pt -153.68 165.31 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.815 -1.538 . . . . 0.0 110.108 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.201 ' CG ' ' HA ' ' A' ' 104' ' ' PHE . 33.5 mt-30 -164.49 136.55 4.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.146 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -120.93 -158.06 10.31 Favored Glycine 0 N--CA 1.479 1.537 0 O-C-N 124.828 1.33 . . . . 0.0 112.378 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 56.71 82.64 0.05 OUTLIER Glycine 0 N--CA 1.47 0.917 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.253 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.61 -118.47 0.63 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.651 0.853 . . . . 0.0 111.12 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -45.91 120.66 2.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.167 -1.017 . . . . 0.0 111.292 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 1.274 ' CG2' ' CD ' ' A' ' 67' ' ' LYS . 76.8 p -59.69 124.48 20.24 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.577 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 1.003 ' HG2' ' N ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 19.99 -108.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.827 -178.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 1.193 ' O ' ' CG ' ' A' ' 64' ' ' MET . 88.3 mt-30 -43.23 -58.17 2.64 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.671 1.232 . . . . 0.0 110.363 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 1.193 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 47.3 mtt 141.44 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.639 1.212 . . . . 0.0 107.893 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 64' ' ' MET . 32.6 mt-30 -159.59 78.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.513 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 65' ' ' GLN . 33.9 mt-30 -19.88 130.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.265 -173.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 1.274 ' CD ' ' CG2' ' A' ' 61' ' ' THR . 14.3 mmmm -62.17 -116.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.938 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 1.02 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -142.62 -62.7 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 112.567 -2.106 . . . . 0.0 109.734 -174.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 1.02 ' HD3' ' HB3' ' A' ' 68' ' ' LYS . 60.7 Cg_exo -28.34 136.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.066 2.511 . . . . 0.0 112.807 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.245 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 49.4 p-10 -168.69 -41.19 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 116.881 -1.533 . . . . 0.0 114.416 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 1.236 ' HD3' ' OD1' ' A' ' 70' ' ' ASN . 59.7 Cg_endo -68.28 89.78 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.961 2.44 . . . . 0.0 108.406 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 1.271 ' CB ' ' HA ' ' A' ' 98' ' ' SER . 84.6 Cg_exo -57.52 -155.69 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.637 2.892 . . . . 0.0 113.63 -172.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.846 ' CD1' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -160.06 151.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.776 176.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.684 ' O ' ' O ' ' A' ' 75' ' ' ASN . 74.6 mmtt -19.73 136.79 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.563 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 1.398 HD21 ' NZ ' ' A' ' 96' ' ' LYS . 45.9 p-10 -39.92 -120.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.536 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 1.164 ' CG ' HD22 ' A' ' 79' ' ' ASN . 0.8 OUTLIER 102.58 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.101 0.876 . . . . 0.0 111.305 -178.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.895 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 172.8 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.667 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 1.257 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 42.5 p-10 -68.03 -48.13 66.52 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.574 1.171 . . . . 0.0 109.676 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 1.164 HD22 ' CG ' ' A' ' 76' ' ' GLU . 50.1 p-10 -58.28 77.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.229 0.956 . . . . 0.0 108.699 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . -174.22 40.73 0.13 Allowed Glycine 0 N--CA 1.474 1.222 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.105 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.563 HD22 ' HG3' ' A' ' 24' ' ' LYS . 2.8 mm? 39.4 -132.29 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.333 0.666 . . . . 0.0 110.602 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 32.2 ptt-85 -174.04 131.56 0.4 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.021 0.826 . . . . 0.0 109.451 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.507 ' CG ' ' H ' ' A' ' 84' ' ' THR . 1.2 t-20 -150.79 -122.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.585 1.178 . . . . 0.0 109.804 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.567 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 23.0 m -160.79 159.58 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.032 0.833 . . . . 0.0 111.79 -167.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.736 ' CB ' ' N ' ' A' ' 108' ' ' ALA . 39.1 ptt180 -36.06 103.42 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.669 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.816 ' O ' HG21 ' A' ' 128' ' ' VAL . . . 153.89 -29.6 0.74 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 111.446 -2.615 . . . . 0.0 109.718 -170.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.84 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 35.8 p -76.46 131.45 39.05 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.685 0.755 . . . . 0.0 111.514 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 1.498 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -80.05 159.0 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.857 164.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.276 ' O ' ' HD1' ' A' ' 104' ' ' PHE . . . -164.11 128.01 2.64 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.63 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 1.152 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 96.5 mmm -51.27 123.13 8.91 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.783 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.683 ' HB1' ' NE2' ' A' ' 56' ' ' GLN . . . -66.52 -147.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.544 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.073 ' HG2' ' H ' ' A' ' 93' ' ' THR . 56.7 ttp180 179.5 -129.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 1.073 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 9.0 t 136.31 87.09 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.541 1.151 . . . . 0.0 109.963 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.1 -70.7 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.821 1.325 . . . . 0.0 109.732 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.58 ' HB3' ' HG ' ' A' ' 98' ' ' SER . 35.1 m-20 -40.13 110.95 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.527 1.142 . . . . 0.0 110.624 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.398 ' NZ ' HD21 ' A' ' 75' ' ' ASN . 27.8 tptp -46.13 -112.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.735 1.272 . . . . 0.0 110.52 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.579 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 36.0 m-20 -58.78 110.14 0.95 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.633 1.208 . . . . 0.0 109.258 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 1.271 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 70.6 m -166.53 -124.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 O-C-N 124.564 1.165 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.846 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 71.71 87.76 0.11 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.799 1.312 . . . . 0.0 108.162 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.86 HG22 ' HA ' ' A' ' 70' ' ' ASN . 81.6 p -78.88 -34.82 44.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.801 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.559 ' HB2' ' HE2' ' A' ' 40' ' ' PHE . 78.9 p -169.87 -47.9 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.132 0.895 . . . . 0.0 110.363 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.47 ' HG2' ' CB ' ' A' ' 91' ' ' ALA . 14.2 tt0 -38.93 144.02 0.14 Allowed 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.19 0.931 . . . . 0.0 111.184 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 1.063 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -160.31 159.68 31.58 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.58 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.276 ' HD1' ' O ' ' A' ' 89' ' ' ALA . 24.5 m-85 -81.94 155.52 25.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.774 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.02 ' O ' HG12 ' A' ' 55' ' ' ILE . 37.8 mt -146.23 91.85 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.325 158.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 1.27 ' O ' ' HE2' ' A' ' 132' ' ' MET . 1.8 m-20 -71.24 171.73 10.56 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 112.545 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 1.654 HG11 ' CE ' ' A' ' 132' ' ' MET . 35.6 m -160.68 48.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.243 -1.798 . . . . 0.0 108.377 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.795 ' HB2' ' HD1' ' A' ' 53' ' ' PHE . . . 176.82 147.48 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.233 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.705 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.5 m-20 -36.13 77.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.724 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.713 ' HB2' HD21 ' A' ' 106' ' ' ASN . 3.2 t30 -69.65 134.51 48.81 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.861 1.35 . . . . 0.0 110.364 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.628 ' H ' ' CD1' ' A' ' 113' ' ' LEU . . . 164.16 -53.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.82 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE2' ' O ' ' A' ' 109' ' ' ASP . 34.5 p90 -67.64 47.89 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.581 1.176 . . . . 0.0 110.374 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER 177.59 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.229 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.824 ' H ' HD12 ' A' ' 113' ' ' LEU . 64.6 t0 -43.45 -56.42 3.62 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.015 0.822 . . . . 0.0 110.738 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 1.257 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 0.2 OUTLIER 179.74 111.96 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.697 1.248 . . . . 0.0 109.61 -176.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.757 ' O ' ' N ' ' A' ' 118' ' ' ARG . . . -177.44 -118.7 0.56 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.564 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.603 ' C ' ' HG3' ' A' ' 118' ' ' ARG . 29.6 mm100 38.95 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.495 0.762 . . . . 0.0 111.327 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.757 ' N ' ' O ' ' A' ' 116' ' ' GLY . 99.1 mtt180 -161.75 -106.71 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.553 1.158 . . . . 0.0 109.091 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -59.63 72.41 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.679 1.237 . . . . 0.0 109.759 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 115' ' ' HIS . 8.3 m-30 42.27 -150.77 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.627 1.204 . . . . 0.0 110.838 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 120' ' ' PHE . . . -171.25 -136.01 2.03 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.873 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 81.7 m-85 -79.21 127.78 32.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.583 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.152 ' HB2' ' O ' ' A' ' 90' ' ' MET . . . -53.89 -166.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.324 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.023 HG22 ' O ' ' A' ' 123' ' ' ALA . 60.3 t -179.69 134.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.585 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.966 ' CD1' ' HG2' ' A' ' 90' ' ' MET . 13.9 p90 -168.82 28.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.132 0.895 . . . . 0.0 111.07 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 1.498 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -147.11 176.53 25.93 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 123.321 1.511 . . . . 0.0 113.11 -173.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.413 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 8.2 ttpm? 177.81 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 110.77 -2.715 . . . . 0.0 109.989 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.816 HG21 ' O ' ' A' ' 86' ' ' GLY . 66.9 t -60.39 128.38 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.879 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 1.085 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 34.5 m -95.33 -42.18 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.699 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.471 ' N ' HG21 ' A' ' 129' ' ' VAL . 8.2 ttpm? 179.98 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.154 0.909 . . . . 0.0 109.697 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 134' ' ' VAL . . . 174.52 12.45 0.02 OUTLIER Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.768 1.292 . . . . 0.0 112.993 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.654 ' CE ' HG11 ' A' ' 107' ' ' VAL . 11.5 tpt -54.99 -50.83 68.02 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.583 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.7 t0 -40.84 -55.62 2.41 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.449 1.093 . . . . 0.0 110.262 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 15' ' ' ASN . 54.8 t -41.7 -63.23 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 124.464 1.103 . . . . 0.0 109.438 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 138' ' ' ILE . . . -49.79 -50.19 45.76 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.729 1.268 . . . . 0.0 109.635 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.692 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 37.8 m-20 -51.43 -69.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.513 1.133 . . . . 0.0 109.228 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 1.132 ' HZ1' ' CG1' ' A' ' 141' ' ' VAL . 5.9 tmtt? -38.11 -48.91 1.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.744 1.278 . . . . 0.0 110.386 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.031 ' O ' HG23 ' A' ' 141' ' ' VAL . 32.6 mt -54.06 -59.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 124.606 1.192 . . . . 0.0 108.309 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.52 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.1 p -65.76 8.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.763 1.29 . . . . 0.0 113.86 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 41.2 mm-40 -97.12 -51.92 4.03 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.212 0.945 . . . . 0.0 109.096 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.132 ' CG1' ' HZ1' ' A' ' 137' ' ' LYS . 33.5 m -48.39 132.52 13.18 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.584 1.177 . . . . 0.0 110.258 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -39.13 -178.02 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.395 2.73 . . . . 0.0 113.534 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.298 HG21 ' CA ' ' A' ' 153' ' ' PRO . 7.4 p -161.15 -151.78 0.24 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 123.2 1.476 . . . . 0.0 112.532 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.703 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 178.12 146.32 0.14 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.21 170.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.621 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 39.0 m-20 -67.59 114.13 5.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.68 167.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.952 ' CB ' ' O ' ' A' ' 149' ' ' TYR . 1.5 t -77.32 -159.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 124.474 1.109 . . . . 0.0 110.916 -166.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.851 ' H ' HG11 ' A' ' 146' ' ' VAL . . . -60.6 -115.46 0.01 OUTLIER Glycine 0 N--CA 1.471 1.015 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 171.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.926 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 91.8 Cg_endo -74.51 33.9 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.603 2.868 . . . . 0.0 110.744 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.952 ' O ' ' CB ' ' A' ' 146' ' ' VAL . 27.6 m-85 -170.41 104.52 0.28 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.735 0.647 . . . . 0.0 109.686 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 1.131 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 32.1 mt-30 -71.09 -169.71 0.4 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.847 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 1.131 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 52.1 p-10 44.6 76.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.18 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.836 HG22 ' CE ' ' A' ' 64' ' ' MET . 70.8 t -157.28 102.39 1.88 Allowed Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.615 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.298 ' CA ' HG21 ' A' ' 143' ' ' THR . 81.5 Cg_exo -49.95 109.67 0.31 Allowed 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.434 2.756 . . . . 0.0 110.961 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.282 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.5 t -40.0 -57.57 1.61 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.459 1.099 . . . . 0.0 108.972 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 62.6 mttp -69.61 88.25 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 164.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.282 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.2 Cg_endo -70.1 -157.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.615 2.877 . . . . 0.0 112.772 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 158' ' ' VAL . 99.4 t -153.78 153.87 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.326 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 1.05 ' HA ' HG21 ' A' ' 45' ' ' THR . 83.2 t -146.96 123.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.597 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.049 HG13 ' HA ' ' A' ' 45' ' ' THR . 36.9 mt -68.62 134.36 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.27 -175.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 1.272 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.9 mt -82.13 -48.61 11.12 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.822 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 32.2 t -167.1 166.42 15.09 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.521 1.138 . . . . 0.0 111.955 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 1.097 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -163.32 125.38 2.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.556 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 1.193 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 14.3 ptmm? -170.28 120.8 0.61 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.702 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.846 HG11 ' HA ' ' A' ' 7' ' ' VAL . 33.7 m -68.14 131.66 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 124.762 1.289 . . . . 0.0 110.57 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 1.116 HD11 ' HD2' ' A' ' 166' ' ' PRO . 49.3 tp -78.0 118.33 71.51 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.801 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 1.116 ' HD2' HD11 ' A' ' 165' ' ' LEU . 87.0 Cg_exo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 123.523 2.815 . . . . 0.0 112.026 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.752 ' O ' ' CB ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.752 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 40.2 ttpt 130.36 95.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.296 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 1.261 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 54.65 95.84 0.01 OUTLIER Glycine 0 N--CA 1.471 0.976 0 O-C-N 124.795 1.309 . . . . 0.0 110.119 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.261 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 63.4 m-20 -167.63 135.52 1.95 Allowed Pre-proline 0 N--CA 1.476 0.85 0 O-C-N 124.736 0.903 . . . . 0.0 110.043 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 4' ' ' ASP . 80.6 Cg_exo -40.1 124.82 1.62 Allowed 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.595 2.863 . . . . 0.0 112.489 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 4' ' ' ASP . 18.4 m170 -160.72 117.11 2.32 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.792 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.937 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 10.4 p -59.8 137.58 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.262 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.214 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 8.4 mp -125.55 130.65 52.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.531 1.144 . . . . 0.0 109.415 166.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.93 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 7.5 mp -123.93 -171.99 2.44 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.936 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 1.209 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 98.7 m -160.82 84.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.827 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.971 HG23 HG12 ' A' ' 159' ' ' ILE . 36.9 p -76.6 172.48 12.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 125.426 1.704 . . . . 0.0 111.18 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -39.28 -44.13 1.23 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.351 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.88 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.26 -64.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.558 1.161 . . . . 0.0 110.369 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.37 41.58 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 113.248 -1.796 . . . . 0.0 113.654 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.796 ' O ' HG22 ' A' ' 16' ' ' ILE . 58.7 t-20 -66.29 153.33 42.88 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.12 -1.54 . . . . 0.0 111.419 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.796 HG22 ' O ' ' A' ' 15' ' ' ASN . 13.9 pt -163.56 174.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.15 -1.387 . . . . 0.0 111.3 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.475 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . 36.7 mt-10 -161.34 122.07 2.76 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.947 -170.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 105' ' ' ILE . 2.5 mm? -95.64 162.96 13.4 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.817 1.323 . . . . 0.0 109.999 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.485 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -113.87 124.69 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.454 170.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.872 HD21 ' HE2' ' A' ' 125' ' ' PHE . 6.6 mp -106.01 120.05 40.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.931 1.395 . . . . 0.0 109.705 -172.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.607 ' OD2' ' HG ' ' A' ' 81' ' ' LEU . 32.2 m-20 -72.55 96.97 2.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.771 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.011 ' HA ' HG13 ' A' ' 29' ' ' VAL . 58.8 tttm -71.6 -56.15 6.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.658 1.224 . . . . 0.0 110.97 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.664 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 6.4 tp60 -46.17 -60.82 2.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.687 -171.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 51.8 tptt -68.17 -2.83 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.738 1.274 . . . . 0.0 113.138 -173.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.533 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -161.3 70.79 2.58 Favored Pre-proline 0 N--CA 1.476 0.831 0 O-C-N 123.705 0.628 . . . . 0.0 109.647 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 1.062 ' O ' HG21 ' A' ' 29' ' ' VAL . 62.9 Cg_exo -54.86 -56.18 2.62 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.635 2.89 . . . . 0.0 111.571 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.45 -64.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 124.726 1.266 . . . . 0.0 110.116 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -44.15 -58.32 2.92 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.734 1.272 . . . . 0.0 110.544 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.686 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 28.7 m -48.81 -50.14 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 124.752 1.282 . . . . 0.0 110.574 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 1.178 ' O ' HG11 ' A' ' 33' ' ' VAL . 1.6 tm0? -52.0 -54.18 32.96 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.358 1.036 . . . . 0.0 109.357 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.919 ' OD1' HG23 ' A' ' 73' ' ' ILE . 10.6 m120 -50.89 -64.69 0.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.549 1.156 . . . . 0.0 110.391 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 1.686 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 33.6 p90 -54.18 -43.57 70.8 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.439 1.087 . . . . 0.0 110.709 -172.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 1.178 HG11 ' O ' ' A' ' 30' ' ' GLN . 10.7 p -51.33 -40.29 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 124.044 0.84 . . . . 0.0 110.171 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.829 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 71.0 m-20 -46.61 -61.34 1.87 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.112 0.882 . . . . 0.0 109.285 173.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -54.61 -56.15 22.01 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.994 1.434 . . . . 0.0 109.124 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.846 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 97.6 t -46.42 -66.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 124.639 1.212 . . . . 0.0 109.344 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.549 ' OD1' HG23 ' A' ' 33' ' ' VAL . 1.9 m-20 -50.57 -48.74 57.43 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.814 1.321 . . . . 0.0 109.989 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.579 ' OG ' ' O ' ' A' ' 34' ' ' ASP . 67.5 m -53.97 -93.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.539 1.149 . . . . 0.0 110.284 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 38' ' ' SER . . . 174.42 87.41 0.07 OUTLIER Glycine 0 N--CA 1.472 1.073 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.098 ' O ' ' CD1' ' A' ' 41' ' ' TYR . 88.0 t80 -157.39 57.02 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.911 1.007 . . . . 0.0 108.561 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 1.098 ' CD1' ' O ' ' A' ' 40' ' ' PHE . 25.6 m-85 -171.68 -37.07 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -38.69 -37.21 0.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.149 0.905 . . . . 0.0 112.688 -171.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 13.9 t30 -155.04 44.89 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.061 0.851 . . . . 0.0 110.902 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.991 ' HG1' HD13 ' A' ' 159' ' ' ILE . 58.4 p -79.4 -141.97 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.387 162.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 1.068 ' HA ' HG13 ' A' ' 159' ' ' ILE . 48.7 p -163.89 -141.35 0.05 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.608 0.718 . . . . 0.0 111.644 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.82 ' CD1' ' O ' ' A' ' 45' ' ' THR . 17.2 m-30 -143.07 62.73 1.39 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.417 -1.72 . . . . 0.0 107.246 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 1.006 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 7.1 p-80 -51.58 -60.49 3.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.72 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.224 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 26.5 mmm180 -69.14 118.7 12.37 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.626 1.203 . . . . 0.0 110.059 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.614 HG21 HG21 ' A' ' 55' ' ' ILE . 8.7 p -163.64 149.6 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 124.713 1.258 . . . . 0.0 111.023 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.854 HD11 ' HD2' ' A' ' 53' ' ' PHE . 10.1 tt -165.54 126.61 1.35 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.242 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 53' ' ' PHE . 87.4 Cg_exo -35.55 160.96 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.618 2.879 . . . . 0.0 113.729 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -7.71 70.06 0.0 OUTLIER Glycine 0 N--CA 1.474 1.225 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.684 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.094 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -160.78 -53.24 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.828 0.958 . . . . 0.0 109.712 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.094 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 61.3 mtm -177.98 161.77 1.58 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.25 0.969 . . . . 0.0 112.249 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 105' ' ' ILE . 36.7 pt -150.61 174.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.798 170.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.224 ' NE2' ' HB3' ' A' ' 48' ' ' ARG . 31.8 mt-30 -158.98 167.01 30.47 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.201 -169.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.19 -178.08 31.89 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.578 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.09 84.57 0.08 OUTLIER Glycine 0 N--CA 1.47 0.912 0 CA-C-N 113.746 -1.227 . . . . 0.0 110.217 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.823 ' C ' ' HD2' ' A' ' 67' ' ' LYS . . . 178.98 -132.58 1.91 Allowed Glycine 0 N--CA 1.475 1.274 0 O-C-N 124.656 0.856 . . . . 0.0 111.305 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.527 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 56.6 m-85 -50.96 110.71 0.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.245 -0.978 . . . . 0.0 109.554 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 1.201 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 9.4 t -70.33 105.11 2.89 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.398 1.061 . . . . 0.0 110.082 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 1.201 ' HG2' ' O ' ' A' ' 61' ' ' THR . 12.6 pt-20 70.84 -127.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.801 1.313 . . . . 0.0 110.922 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 1.218 ' O ' ' CG ' ' A' ' 64' ' ' MET . 59.8 mt-30 -47.22 -55.45 8.56 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.808 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 1.218 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 50.7 mtt 145.72 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.637 1.208 . . . . 0.0 108.269 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 66' ' ' GLN . 18.4 tt0 -144.03 84.51 1.78 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.981 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.554 ' O ' ' O ' ' A' ' 67' ' ' LYS . 42.4 mt-30 -24.45 135.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.067 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 1.073 ' CD ' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -47.91 -120.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.427 -178.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 69' ' ' PRO . 4.2 ttmp? -170.84 73.05 0.56 Allowed Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.32 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.82 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 87.9 Cg_exo -51.17 -140.11 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.573 2.848 . . . . 0.0 113.127 -172.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.926 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 7.7 m120 164.83 168.72 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.579 -172.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.926 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 33.1 Cg_endo -44.66 98.39 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.549 2.166 . . . . 0.0 108.893 169.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.633 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.4 Cg_exo -44.11 -136.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.853 3.035 . . . . 0.0 113.336 -175.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.919 HG23 ' OD1' ' A' ' 31' ' ' ASN . 24.8 pt -152.34 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.438 1.086 . . . . 0.0 109.083 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 75' ' ' ASN . 21.6 ptmt -154.82 -148.37 0.24 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.03 0.831 . . . . 0.0 111.918 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.566 ' O ' ' O ' ' A' ' 74' ' ' LYS . 37.7 m-20 -44.93 -171.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.258 -1.792 . . . . 0.0 112.408 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 1.058 ' HG3' ' HB1' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 171.42 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.421 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.93 ' H ' ' CG ' ' A' ' 76' ' ' GLU . . . -44.72 -35.27 2.59 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.534 1.146 . . . . 0.0 111.887 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -68.89 25.81 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.058 0.848 . . . . 0.0 113.25 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.677 HD22 ' HB ' ' A' ' 124' ' ' VAL . 44.8 p-10 -63.63 -123.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.941 0.776 . . . . 0.0 109.017 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.6 -80.28 0.08 OUTLIER Glycine 0 N--CA 1.473 1.12 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 1.433 ' O ' ' CD ' ' A' ' 82' ' ' ARG . 2.8 mm? 40.17 -151.01 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.848 0.97 . . . . 0.0 111.185 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 1.433 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER 179.95 111.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.987 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 1.174 ' OD1' ' HD3' ' A' ' 127' ' ' LYS . 26.0 m120 -159.76 -156.77 0.52 Allowed 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.591 1.182 . . . . 0.0 111.267 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 1.097 HG23 ' HG2' ' A' ' 85' ' ' ARG . 12.0 m -169.46 166.03 10.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.283 -166.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 1.097 ' HG2' HG23 ' A' ' 84' ' ' THR . 16.4 ptm180 -18.63 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.108 1.432 . . . . 0.0 112.146 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.858 ' O ' HG21 ' A' ' 128' ' ' VAL . . . 148.18 -26.83 1.41 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-N 110.442 -3.072 . . . . 0.0 109.676 -168.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.799 HG21 ' HG2' ' A' ' 127' ' ' LYS . 26.8 p -73.86 134.31 43.27 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.689 0.757 . . . . 0.0 112.107 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 1.536 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -91.32 160.05 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.062 164.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.231 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -163.41 138.89 6.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.043 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.892 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 95.7 mmm -55.82 125.62 22.11 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.769 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 1.225 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . . . -74.74 -173.12 1.75 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.545 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.039 ' NH1' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.28 -120.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.407 175.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 1.039 ' HB ' ' NH1' ' A' ' 92' ' ' ARG . 20.7 m 173.79 -69.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.821 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 172.46 111.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.801 1.313 . . . . 0.0 108.89 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.821 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 88.4 m-20 161.84 145.3 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.152 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.654 ' O ' ' O ' ' A' ' 95' ' ' ASP . 53.4 mtmt -45.19 -122.5 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.043 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.33 118.16 5.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.713 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.6 m -163.87 -144.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.599 1.187 . . . . 0.0 110.938 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.722 ' O ' HD12 ' A' ' 73' ' ' ILE . . . 50.96 87.36 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.557 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.408 ' C ' ' HG ' ' A' ' 101' ' ' SER . 78.4 p -78.52 -41.35 32.54 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.246 -174.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.513 ' O ' ' HE3' ' A' ' 90' ' ' MET . 69.3 m -167.88 -53.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 124.231 0.957 . . . . 0.0 109.286 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 1.225 ' OE1' ' HB2' ' A' ' 91' ' ' ALA . 2.0 pp0? -34.44 142.86 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.519 1.137 . . . . 0.0 111.823 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.809 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.91 -171.8 4.03 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.526 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.971 ' CZ ' ' HB2' ' A' ' 89' ' ' ALA . 20.0 p90 -154.87 135.58 13.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.758 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.057 HD13 HD22 ' A' ' 18' ' ' LEU . 53.0 mt -102.19 101.2 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.822 -1.99 . . . . 0.0 108.923 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.642 ' OD1' ' CD1' ' A' ' 104' ' ' PHE . 18.9 m-20 -62.78 167.37 4.64 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.814 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 1.33 HG11 ' CE ' ' A' ' 132' ' ' MET . 33.0 m -157.93 51.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.273 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 53' ' ' PHE . . . -177.4 133.16 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.831 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.94 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 31.9 m-20 -31.68 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.458 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.84 ' ND2' ' HB3' ' A' ' 113' ' ' LEU . 1.1 t-20 -68.83 -119.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.858 1.349 . . . . 0.0 109.519 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 113' ' ' LEU . . . 61.21 -72.21 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.743 0.652 . . . . 0.0 110.24 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.94 ' CE1' ' O ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -67.63 56.07 0.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.377 1.048 . . . . 0.0 109.612 178.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.84 ' HB3' ' ND2' ' A' ' 110' ' ' ASN . 6.3 tt 177.44 -39.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.079 -173.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 115' ' ' HIS . 65.7 t0 -39.5 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.06 0.85 . . . . 0.0 110.644 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.657 ' CE1' ' H ' ' A' ' 120' ' ' PHE . 0.4 OUTLIER 179.27 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.739 1.274 . . . . 0.0 108.678 179.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -177.63 118.4 0.63 Allowed Glycine 0 N--CA 1.475 1.234 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.768 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.761 ' O ' ' CB ' ' A' ' 118' ' ' ARG . 26.4 tt0 77.97 73.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.761 ' CB ' ' O ' ' A' ' 117' ' ' GLN . 59.0 ttt85 126.92 102.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.205 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -34.96 110.0 0.09 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.771 1.294 . . . . 0.0 111.662 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.657 ' H ' ' CE1' ' A' ' 115' ' ' HIS . 47.6 m-85 54.38 171.22 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.893 1.37 . . . . 0.0 112.521 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.69 -129.13 1.09 Allowed Glycine 0 N--CA 1.474 1.209 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.954 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.818 ' HD2' HD22 ' A' ' 113' ' ' LEU . 21.0 m-85 -79.72 116.72 20.06 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.486 0.757 . . . . 0.0 109.62 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.058 ' HB1' ' HG3' ' A' ' 76' ' ' GLU . . . -49.01 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.569 1.168 . . . . 0.0 111.051 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.231 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 70.2 t 179.86 133.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.806 -176.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.872 ' HE2' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -166.13 21.99 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.033 170.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 1.536 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -118.07 168.54 13.1 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 123.123 1.402 . . . . 0.0 112.753 -169.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.485 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 10.2 mtmp? 179.56 104.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 110.962 -2.619 . . . . 0.0 109.564 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.858 HG21 ' O ' ' A' ' 86' ' ' GLY . 66.8 t -43.56 119.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.083 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 1.475 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -63.91 -48.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.235 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.931 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 2.9 tmtm? 163.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.255 0.972 . . . . 0.0 109.612 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.65 32.61 0.09 OUTLIER Glycine 0 N--CA 1.476 1.33 0 O-C-N 124.817 1.323 . . . . 0.0 111.469 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.33 ' CE ' HG11 ' A' ' 107' ' ' VAL . 8.4 tpt -59.75 -40.91 89.71 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.162 0.566 . . . . 0.0 110.281 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 22.9 m-20 -44.05 -63.77 0.8 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.273 0.983 . . . . 0.0 109.937 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.688 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.2 t -43.89 -60.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 124.615 1.197 . . . . 0.0 109.219 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -46.18 -52.08 13.01 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.59 1.181 . . . . 0.0 109.772 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.606 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 39.9 m-20 -53.64 -65.43 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.562 1.164 . . . . 0.0 109.133 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -36.57 -49.24 0.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.711 1.257 . . . . 0.0 110.588 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.193 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.5 mt -57.1 -57.39 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 124.578 1.173 . . . . 0.0 108.642 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.3 p -61.7 3.26 0.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 41.0 mm-40 -96.25 -49.53 5.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.27 0.981 . . . . 0.0 109.313 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.193 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -47.28 123.85 8.68 Favored Pre-proline 0 N--CA 1.472 0.638 0 O-C-N 124.518 1.136 . . . . 0.0 110.055 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 141' ' ' VAL . 84.0 Cg_exo -41.17 179.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.517 2.811 . . . . 0.0 113.799 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.402 HG21 ' CA ' ' A' ' 153' ' ' PRO . 2.5 p -160.92 -151.48 0.24 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 123.589 1.662 . . . . 0.0 112.32 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.713 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.8 OUTLIER 178.24 165.06 0.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.148 174.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.691 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 77.7 m-20 -51.57 -144.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.752 166.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.824 HG23 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -162.19 -63.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.903 1.335 . . . . 0.0 107.914 170.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.01 -95.52 0.1 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-N 111.119 -2.764 . . . . 0.0 107.531 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.795 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 90.5 Cg_endo -70.54 -63.19 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.639 2.893 . . . . 0.0 108.928 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 59.6 m-85 -70.12 109.42 4.59 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.703 1.252 . . . . 0.0 110.702 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.596 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 22.4 mm-40 -75.9 151.21 37.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.75 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.738 ' O ' HG22 ' A' ' 152' ' ' VAL . 21.7 m-20 77.63 96.95 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.606 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.824 ' HB ' HG23 ' A' ' 146' ' ' VAL . 84.9 t -164.66 116.1 0.93 Allowed Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.409 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.402 ' CA ' HG21 ' A' ' 143' ' ' THR . 59.7 Cg_endo -65.02 108.53 1.13 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.534 2.822 . . . . 0.0 109.623 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.265 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 62.2 p -43.96 -58.83 2.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.928 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 88.3 tttt -74.3 88.53 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.265 ' HD3' ' O ' ' A' ' 154' ' ' SER . 59.1 Cg_endo -77.31 131.74 11.95 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.684 2.923 . . . . 0.0 112.486 -167.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.705 HG22 HG22 ' A' ' 138' ' ' ILE . 74.1 t -68.94 157.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.765 -1.562 . . . . 0.0 110.44 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 1.016 ' HA ' HG21 ' A' ' 45' ' ' THR . 98.9 t -143.75 120.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.517 174.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.068 HG13 ' HA ' ' A' ' 45' ' ' THR . 32.3 mt -68.21 133.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.091 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 1.209 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.7 mt -77.99 -50.51 11.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 112.383 -2.19 . . . . 0.0 109.744 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.415 ' HB3' ' H ' ' A' ' 162' ' ' ALA . 61.4 m -162.6 -165.46 1.17 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.655 1.222 . . . . 0.0 112.027 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.93 ' HB1' ' HG ' ' A' ' 9' ' ' LEU . . . 179.41 135.55 0.1 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.3 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -171.61 136.45 0.96 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.693 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.453 HG11 HG13 ' A' ' 36' ' ' VAL . 34.8 m -77.85 133.06 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.938 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 1.043 HD11 ' HD2' ' A' ' 166' ' ' PRO . 47.2 tp -91.98 117.24 67.62 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.29 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 1.043 ' HD2' HD11 ' A' ' 165' ' ' LEU . 88.4 Cg_exo . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.547 2.831 . . . . 0.0 111.828 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.652 ' O ' ' O ' ' A' ' 3' ' ' GLY . 55.9 tptt -50.74 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.26 -1.337 . . . . 0.0 109.587 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.686 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . -47.12 -141.34 0.0 OUTLIER Glycine 0 N--CA 1.473 1.146 0 O-C-N 124.689 1.243 . . . . 0.0 112.404 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.151 ' HB2' ' CD ' ' A' ' 5' ' ' PRO . 63.2 m-20 -179.08 -75.9 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 114.5 -0.85 . . . . 0.0 108.896 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.225 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 84.8 Cg_exo -45.76 78.76 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.776 2.984 . . . . 0.0 112.012 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.556 ' CD2' ' HG2' ' A' ' 19' ' ' GLU . 37.9 m170 -147.47 112.82 5.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.043 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.055 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 9.1 p -67.64 143.85 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.311 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.249 HD13 ' OE1' ' A' ' 17' ' ' GLU . 6.6 mp -129.76 115.01 16.66 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.625 1.202 . . . . 0.0 110.023 166.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.084 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 7.5 mp -107.69 -177.8 3.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 111.174 -2.739 . . . . 0.0 108.743 160.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.664 HG21 ' N ' ' A' ' 15' ' ' ASN . 96.0 m -160.84 100.99 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.103 174.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.97 HG21 HG12 ' A' ' 159' ' ' ILE . 41.7 p -78.8 172.65 13.44 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.527 1.767 . . . . 0.0 111.446 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -41.08 -43.33 2.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.417 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.847 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.64 -59.26 4.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.497 1.123 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' C ' HG21 ' A' ' 10' ' ' THR . . . 169.67 -176.03 43.67 Favored Glycine 0 N--CA 1.479 1.546 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.647 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 1.299 ' O ' HG22 ' A' ' 134' ' ' VAL . 10.2 t-20 -53.28 161.2 0.96 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 113.49 -1.355 . . . . 0.0 111.26 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.632 HG21 ' O ' ' A' ' 9' ' ' LEU . 11.8 tt -171.51 157.13 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.889 -174.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.249 ' OE1' HD13 ' A' ' 8' ' ' LEU . 39.7 tt0 -163.96 125.17 2.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.084 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.038 HD22 HD12 ' A' ' 105' ' ' ILE . 2.9 mm? -93.54 -177.43 4.4 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.934 1.396 . . . . 0.0 110.542 164.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.556 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -148.3 118.5 7.29 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.646 175.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.761 ' O ' ' OE2' ' A' ' 19' ' ' GLU . 6.0 mp -90.57 -162.22 0.88 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.031 -1.441 . . . . 0.0 111.523 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 20' ' ' LEU . 61.7 t0 -159.04 96.88 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.35 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.873 ' HA ' HG13 ' A' ' 29' ' ' VAL . 39.8 ttmt -62.28 -46.61 88.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.912 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -45.39 -67.34 0.29 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.483 1.114 . . . . 0.0 110.48 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.726 ' HZ3' HD22 ' A' ' 81' ' ' LEU . 31.0 mmtp -70.05 -0.54 7.79 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.826 1.329 . . . . 0.0 114.17 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.645 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -160.21 70.14 2.98 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 123.827 0.704 . . . . 0.0 110.06 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 1.004 ' O ' HG23 ' A' ' 29' ' ' VAL . 50.1 Cg_exo -56.18 -58.16 1.16 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.6 2.867 . . . . 0.0 111.043 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.9 t -50.71 -65.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 124.84 1.338 . . . . 0.0 110.173 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.1 m -43.99 -57.63 3.24 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.699 1.25 . . . . 0.0 110.675 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 26' ' ' PRO . 33.1 m -49.12 -49.08 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.642 1.214 . . . . 0.0 110.987 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.775 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 tm0? -50.85 -67.15 0.28 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.222 0.951 . . . . 0.0 109.086 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.92 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 t-20 -43.31 -53.11 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.581 1.176 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 36' ' ' VAL . 48.8 t80 -43.21 -62.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.523 1.14 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 37' ' ' ASN . 62.7 t -44.22 -39.32 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.624 1.202 . . . . 0.0 111.071 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.92 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 5.1 m-20 -44.49 -62.06 1.32 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.121 0.888 . . . . 0.0 109.583 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.848 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 94.2 m-85 -60.26 -63.77 1.18 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.9 1.375 . . . . 0.0 109.202 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 32' ' ' PHE . 57.4 t -39.52 -49.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 124.648 1.218 . . . . 0.0 110.869 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.754 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.7 t-20 -38.9 -31.34 0.06 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.738 1.274 . . . . 0.0 112.239 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.754 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.6 p 157.67 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.112 0.883 . . . . 0.0 112.425 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 68.69 81.62 0.2 Allowed Glycine 0 N--CA 1.47 0.928 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.401 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.848 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 1.7 t80 173.74 -81.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.819 0.953 . . . . 0.0 109.739 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -68.35 -12.41 61.06 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.344 1.027 . . . . 0.0 113.259 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 1.172 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 17.4 m-20 -38.97 -50.04 1.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.661 0.6 . . . . 0.0 111.714 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 1.172 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 20.6 m-20 -156.68 52.53 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.393 1.058 . . . . 0.0 109.782 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.882 ' O ' HG22 ' A' ' 45' ' ' THR . 27.8 m -78.62 -125.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 166.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 1.024 HG21 ' HA ' ' A' ' 158' ' ' VAL . 40.6 p -165.35 -140.05 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.222 1.011 . . . . 0.0 111.966 170.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.921 ' CD1' ' O ' ' A' ' 45' ' ' THR . 11.2 m-30 -152.98 81.31 1.21 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.49 -2.141 . . . . 0.0 105.962 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.886 ' HE2' ' H ' ' A' ' 60' ' ' PHE . 19.8 m80 -11.43 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.123 ' NH2' ' O ' ' A' ' 141' ' ' VAL . 28.0 tpt85 -172.4 -133.19 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.634 1.209 . . . . 0.0 110.098 166.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 50' ' ' ILE . 7.4 p -173.41 147.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.953 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 1.012 ' O ' HG23 ' A' ' 49' ' ' VAL . 57.0 mt -72.24 131.8 84.77 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.106 156.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' ILE . 19.2 Cg_endo -40.76 -139.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.386 0 C-N-CA 123.213 2.608 . . . . 0.0 111.582 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.63 76.49 0.01 OUTLIER Glycine 0 N--CA 1.471 0.998 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.732 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.1 t80 -162.11 -68.79 0.05 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.604 0.826 . . . . 0.0 109.833 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.929 ' O ' HG21 ' A' ' 49' ' ' VAL . 26.4 ptt? 177.16 130.77 0.05 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.212 0.945 . . . . 0.0 111.906 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.852 HG21 ' CB ' ' A' ' 49' ' ' VAL . 32.4 pt -90.2 176.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.047 169.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.285 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 20.6 mm-40 -69.28 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.499 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 1.035 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -157.47 -133.66 1.63 Allowed Glycine 0 N--CA 1.473 1.103 0 O-C-N 118.845 -2.409 . . . . 0.0 112.046 4.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.59 105.27 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.567 ' HA2' ' HD3' ' A' ' 67' ' ' LYS . . . -175.5 -121.38 0.64 Allowed Glycine 0 N--CA 1.475 1.278 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.913 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 21.0 m-85 -42.58 114.09 0.54 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.577 -0.812 . . . . 0.0 110.455 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.777 ' HA ' HG21 ' A' ' 44' ' ' THR . 97.7 m -59.94 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.613 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 64' ' ' MET . 44.7 mt-10 65.14 -106.11 0.13 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.817 1.323 . . . . 0.0 110.287 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.591 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 44.6 tp60 -71.41 50.3 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.67 1.232 . . . . 0.0 110.505 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.913 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 53.4 mtt 41.75 35.77 0.54 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.937 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' GLN . 10.7 tp-100 -77.67 87.67 3.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 172.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 67' ' ' LYS . 62.5 mt-30 -27.42 137.41 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.084 -171.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 66' ' ' GLN . 35.3 mtmm -43.85 -122.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.273 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -174.01 75.94 0.36 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 112.704 -2.044 . . . . 0.0 106.617 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 1.232 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 58.3 Cg_endo -78.21 -178.05 4.33 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.638 2.892 . . . . 0.0 113.593 -167.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.232 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 41.5 m-20 -166.0 168.98 7.18 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.887 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.892 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 99.3 Cg_exo -36.1 83.29 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.347 2.698 . . . . 0.0 111.295 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 1.081 ' HB3' HG23 ' A' ' 100' ' ' THR . 80.6 Cg_exo -49.82 154.17 5.2 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.846 3.031 . . . . 0.0 113.735 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.101 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 30.4 pt -78.98 162.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.923 -1.49 . . . . 0.0 112.03 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.927 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 95.7 mttt -59.84 -177.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.86 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 25.9 p30 -52.55 -169.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.31 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 1.202 ' OE1' ' HB3' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 157.39 122.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.924 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.626 ' HB1' ' CD2' ' A' ' 120' ' ' PHE . . . 167.12 -47.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.322 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.696 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 49.8 p-10 -69.03 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.485 1.116 . . . . 0.0 112.86 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 77' ' ' ALA . 43.6 p-10 -44.43 -46.94 9.81 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.996 0.81 . . . . 0.0 109.865 174.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.731 ' C ' HD11 ' A' ' 81' ' ' LEU . . . 73.53 68.24 1.62 Allowed Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.412 1.07 . . . . 0.0 111.166 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.731 HD11 ' C ' ' A' ' 80' ' ' GLY . 2.7 mp -151.36 174.32 13.47 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.854 0.973 . . . . 0.0 110.531 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.832 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 14.2 ptp180 -79.56 144.19 34.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.687 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.832 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.3 m120 -164.53 153.43 13.05 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.502 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 109' ' ' ASP . 17.8 m -165.26 159.49 17.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.421 -169.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 107' ' ' VAL . 67.1 ttt180 -21.21 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.792 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.86 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 146.06 -13.76 1.69 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.835 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 1.169 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 24.3 p -109.48 163.61 13.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.026 1.394 . . . . 0.0 112.584 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.912 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -131.37 158.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 111.28 -2.691 . . . . 0.0 108.719 -177.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -156.05 150.67 25.95 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.89 -1.504 . . . . 0.0 112.364 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 1.122 ' SD ' ' O ' ' A' ' 102' ' ' GLN . 15.6 tpt -61.77 127.3 30.77 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.676 -1.602 . . . . 0.0 110.739 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.875 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . . . -57.34 -119.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.526 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.979 ' HA ' ' H ' ' A' ' 99' ' ' ALA . 39.2 ptt180 179.21 -153.1 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.77 0.669 . . . . 0.0 111.353 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.77 ' HB ' ' HG ' ' A' ' 98' ' ' SER . 53.7 m -176.8 -90.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.17 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 164.52 117.85 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.695 1.247 . . . . 0.0 109.098 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.685 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 50.3 t0 159.64 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.303 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.142 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 64.3 mttm 153.98 22.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.072 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 1.142 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 89.4 m-20 178.96 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 1.365 ' CA ' ' O ' ' A' ' 99' ' ' ALA . 31.2 t 178.54 108.22 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.599 1.187 . . . . 0.0 109.137 -169.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 1.365 ' O ' ' CA ' ' A' ' 98' ' ' SER . . . 34.16 135.87 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.389 -1.444 . . . . 0.0 114.025 -2.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 1.081 HG23 ' HB3' ' A' ' 72' ' ' PRO . 38.6 p -160.92 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.774 -2.012 . . . . 0.0 108.682 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.603 ' H ' HE22 ' A' ' 102' ' ' GLN . 78.0 p -170.36 80.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.402 1.063 . . . . 0.0 108.398 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 1.122 ' O ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER 176.46 158.64 0.3 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.73 1.269 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.947 ' HD2' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -158.45 -173.7 4.43 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.89 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.285 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 22.2 p90 -156.64 139.65 15.39 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.655 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.038 HD12 HD22 ' A' ' 18' ' ' LEU . 60.4 mt -100.68 113.47 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.31 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 1.169 ' OD1' ' O ' ' A' ' 87' ' ' THR . 37.5 p-10 -72.42 -167.82 0.37 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.624 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 1.262 HG11 ' CE ' ' A' ' 132' ' ' MET . 34.5 m -160.7 -43.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.961 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' N ' HG21 ' A' ' 107' ' ' VAL . . . -86.5 133.7 33.73 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.258 0.974 . . . . 0.0 111.129 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.657 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 19.7 m-20 -51.04 112.14 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.422 174.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.748 ' O ' HD11 ' A' ' 113' ' ' LEU . 31.9 m120 -163.32 75.15 0.37 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.485 1.115 . . . . 0.0 109.547 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.38 -29.42 64.05 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.215 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -38.71 -40.24 0.58 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.074 0.858 . . . . 0.0 111.533 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.748 HD11 ' O ' ' A' ' 110' ' ' ASN . 6.4 mp -57.91 -24.82 59.46 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.436 1.085 . . . . 0.0 111.773 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.4 t0 -39.18 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.752 0.658 . . . . 0.0 111.072 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 1.419 ' ND1' ' HB3' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 178.59 120.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.696 1.247 . . . . 0.0 109.626 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -168.81 -169.74 32.59 Favored Glycine 0 N--CA 1.477 1.409 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.717 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.508 ' HB3' ' O ' ' A' ' 116' ' ' GLY . 65.8 tt0 72.39 -56.34 0.65 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.488 -0.856 . . . . 0.0 109.402 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.437 ' O ' ' HE1' ' A' ' 115' ' ' HIS . 27.7 tpt180 178.29 -97.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.61 1.194 . . . . 0.0 108.958 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 120' ' ' PHE . 55.6 p-10 -73.23 89.55 1.55 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.7 1.25 . . . . 0.0 110.138 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.419 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 26.1 p90 -50.45 -154.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.562 1.164 . . . . 0.0 110.944 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 120' ' ' PHE . . . -171.29 -82.94 0.05 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 123.667 0.605 . . . . 0.0 111.65 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -77.26 123.69 26.81 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.488 0.757 . . . . 0.0 110.817 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.202 ' HB3' ' OE1' ' A' ' 76' ' ' GLU . . . -68.24 -156.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.242 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.14 HG22 ' O ' ' A' ' 123' ' ' ALA . 46.2 t 176.4 136.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.947 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 35.7 p90 -170.32 23.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 118.44 -0.791 . . . . 0.0 113.064 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.859 ' HA3' HG22 ' A' ' 88' ' ' ILE . . . -155.93 -166.4 15.85 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.093 1.385 . . . . 0.0 113.725 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.86 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 27.7 ttpp 176.99 132.05 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 110.996 -2.602 . . . . 0.0 110.131 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.884 HG13 ' HB2' ' A' ' 132' ' ' MET . 60.1 t -46.88 149.36 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 124.399 1.062 . . . . 0.0 110.882 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 1.128 HG13 ' CG ' ' A' ' 17' ' ' GLU . 6.5 p -129.72 -45.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.453 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 1.109 ' HE3' ' HA ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER 178.44 76.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.161 0.913 . . . . 0.0 108.688 -177.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.65 -16.02 0.02 OUTLIER Glycine 0 N--CA 1.476 1.364 0 O-C-N 124.819 1.325 . . . . 0.0 112.511 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.262 ' CE ' HG11 ' A' ' 107' ' ' VAL . 9.6 tpt -39.54 -43.3 1.27 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.815 0.362 . . . . 0.0 110.538 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' NZ ' ' A' ' 137' ' ' LYS . 65.2 t0 -44.09 -60.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.366 1.041 . . . . 0.0 109.967 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 1.299 HG22 ' O ' ' A' ' 15' ' ' ASN . 95.5 t -43.71 -56.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 124.491 1.12 . . . . 0.0 109.377 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 132' ' ' MET . . . -45.46 -51.73 11.14 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.786 1.304 . . . . 0.0 110.457 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.904 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 5.6 m-20 -49.01 -70.06 0.1 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.468 1.105 . . . . 0.0 109.417 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 38.0 mtmm -44.77 -46.53 10.59 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.758 1.286 . . . . 0.0 110.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.129 ' O ' HG23 ' A' ' 141' ' ' VAL . 18.5 mt -55.78 -62.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.269 0.981 . . . . 0.0 108.435 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.79 ' HA ' HH12 ' A' ' 48' ' ' ARG . 78.0 p -58.53 0.29 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.904 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 39.9 mm-40 -94.99 -48.97 5.76 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.25 0.969 . . . . 0.0 109.727 177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.129 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.8 m -49.98 124.98 17.59 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.508 1.13 . . . . 0.0 110.208 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.9 Cg_exo -43.79 -177.06 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.629 2.886 . . . . 0.0 113.903 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.325 HG21 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.08 -141.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.628 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.648 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 179.73 143.41 0.16 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 110.698 -2.956 . . . . 0.0 111.865 170.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -67.74 111.91 4.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.113 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.765 HG23 ' CG2' ' A' ' 152' ' ' VAL . 1.3 t -77.24 -144.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 124.642 1.214 . . . . 0.0 109.355 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 148' ' ' PRO . . . -63.44 -113.09 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 171.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.525 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 97.1 Cg_endo -68.97 -46.15 1.7 Allowed 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 123.596 2.864 . . . . 0.0 110.029 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 72.8 m-85 -68.67 97.82 0.84 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.454 1.096 . . . . 0.0 110.329 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -71.68 139.22 49.11 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.217 173.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 150' ' ' GLN . 17.6 m-20 81.2 82.4 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.873 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.765 ' CG2' HG23 ' A' ' 146' ' ' VAL . 72.9 t -140.27 121.05 9.17 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 114.167 -1.379 . . . . 0.0 107.714 168.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.325 ' CA ' HG21 ' A' ' 143' ' ' THR . 44.5 Cg_endo -62.05 102.88 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.565 2.843 . . . . 0.0 109.77 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.086 ' H ' ' HA ' ' A' ' 143' ' ' THR . 66.5 p -44.23 -54.02 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.731 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 155' ' ' LYS . 39.3 tptt -75.27 105.48 2.04 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.741 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.8 Cg_endo -78.7 122.71 5.56 Favored 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.032 -164.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.542 ' O ' HG21 ' A' ' 158' ' ' VAL . 93.1 t -69.44 157.79 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.054 166.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 1.024 ' HA ' HG21 ' A' ' 45' ' ' THR . 89.0 t -158.21 119.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.153 174.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.012 HG13 ' HA ' ' A' ' 45' ' ' THR . 39.5 mt -68.64 137.7 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.26 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -90.78 -47.11 7.83 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.778 -2.01 . . . . 0.0 110.471 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 28.5 t -166.83 170.12 12.6 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.424 1.077 . . . . 0.0 111.906 -175.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 1.084 ' HB1' ' HG ' ' A' ' 9' ' ' LEU . . . -168.88 134.72 1.7 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.739 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.638 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -170.83 151.22 3.36 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.085 174.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 36' ' ' VAL . 33.8 m -72.35 136.62 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.046 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 1.0 HD23 ' HD2' ' A' ' 166' ' ' PRO . 3.3 tm? -68.93 121.33 81.15 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.042 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 1.0 ' HD2' HD23 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 123.536 2.824 . . . . 0.0 112.015 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.932 ' O ' ' HG2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.932 ' HG2' ' O ' ' A' ' 1' ' ' ALA . 33.5 mmtp 112.72 -117.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.544 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 1.27 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . -47.92 164.75 0.22 Allowed Glycine 0 N--CA 1.474 1.189 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.243 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.27 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 72.3 m-20 -171.97 82.44 0.47 Allowed Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.417 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 74.5 Cg_endo -73.91 63.35 4.95 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.834 3.023 . . . . 0.0 110.169 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.417 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 28.4 m170 -153.03 79.14 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.775 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.628 HG21 HD11 ' A' ' 20' ' ' LEU . 43.1 t -60.08 75.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.091 ' HG ' ' HB3' ' A' ' 17' ' ' GLU . 7.9 tt -79.84 105.55 11.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 113.656 -1.611 . . . . 0.0 109.557 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.202 HD21 ' O ' ' A' ' 161' ' ' SER . 10.7 mt -92.88 177.08 6.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.935 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 1.129 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 99.2 m -160.47 84.61 0.7 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.678 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 1.031 HG23 HG12 ' A' ' 159' ' ' ILE . 24.2 p -78.4 162.72 26.22 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 125.054 1.471 . . . . 0.0 111.662 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 158' ' ' VAL . 65.0 m -41.1 -50.41 3.44 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.263 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.738 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -47.67 -58.38 4.36 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.594 1.184 . . . . 0.0 110.531 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.67 47.02 Favored Glycine 0 N--CA 1.476 1.352 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.965 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.891 ' O ' HG22 ' A' ' 16' ' ' ILE . 9.4 t-20 -65.6 151.56 46.19 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.416 -1.392 . . . . 0.0 111.799 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.891 HG22 ' O ' ' A' ' 15' ' ' ASN . 25.3 pt -168.81 166.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.822 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.091 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . 12.5 pt-20 -163.11 117.09 1.64 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.314 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.029 HD22 HD12 ' A' ' 105' ' ' ILE . 3.0 mm? -76.87 165.52 24.58 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.738 1.274 . . . . 0.0 110.465 164.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.019 ' HG3' ' O ' ' A' ' 5' ' ' PRO . 39.8 tt0 -131.24 119.49 21.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.944 173.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.962 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.4 mp -99.88 115.12 28.89 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.118 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.72 98.24 0.51 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.579 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.105 ' HA ' HG13 ' A' ' 29' ' ' VAL . 10.0 mtmp? -69.67 -49.59 52.14 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.614 1.196 . . . . 0.0 111.763 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.551 ' NE2' ' HE2' ' A' ' 24' ' ' LYS . 47.4 tt0 -44.33 -62.87 1.01 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.333 1.021 . . . . 0.0 110.556 -171.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.551 ' HE2' ' NE2' ' A' ' 23' ' ' GLN . 4.2 mptp? -69.22 9.57 0.42 Allowed 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.724 1.265 . . . . 0.0 113.543 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -161.05 68.57 2.51 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 123.855 0.722 . . . . 0.0 109.452 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.818 ' O ' HG23 ' A' ' 29' ' ' VAL . 52.0 Cg_exo -56.21 -63.14 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.493 2.796 . . . . 0.0 110.94 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.0 t -54.0 -61.47 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 124.832 1.333 . . . . 0.0 109.944 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.535 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 37.1 t -43.99 -58.84 2.58 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.753 1.283 . . . . 0.0 110.624 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.105 HG13 ' HA ' ' A' ' 22' ' ' LYS . 28.1 m -51.76 -49.48 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 124.629 1.206 . . . . 0.0 110.69 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.848 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.6 tm0? -47.36 -57.77 4.9 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.314 1.009 . . . . 0.0 109.313 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 1.168 ' OD1' HG23 ' A' ' 73' ' ' ILE . 10.8 m120 -42.7 -55.26 3.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.636 1.21 . . . . 0.0 110.282 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.953 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 57.9 m-85 -44.1 -62.14 1.24 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.576 1.172 . . . . 0.0 110.022 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 62.0 t -40.64 -46.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.541 1.15 . . . . 0.0 110.758 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.848 ' OD1' ' NE2' ' A' ' 30' ' ' GLN . 7.0 m-20 -45.0 -60.51 2.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.37 1.044 . . . . 0.0 109.576 174.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 38' ' ' SER . 74.0 m-85 -57.29 -55.97 27.85 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.945 1.403 . . . . 0.0 109.149 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.569 HG13 HG12 ' A' ' 164' ' ' VAL . 69.4 t -44.4 -64.87 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.61 1.194 . . . . 0.0 109.589 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.4 t30 -45.8 -49.35 15.17 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.828 1.33 . . . . 0.0 110.133 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 58.2 m -53.93 -109.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.591 1.182 . . . . 0.0 110.215 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.848 ' HA2' ' OD1' ' A' ' 42' ' ' ASN . . . -174.88 48.07 0.13 Allowed Glycine 0 N--CA 1.474 1.213 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.215 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.81 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 22.9 t80 -73.84 -64.08 1.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.629 0.84 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.788 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . 39.9 m-85 -67.74 -23.18 65.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.118 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.848 ' OD1' ' HA2' ' A' ' 39' ' ' GLY . 35.2 m120 -38.74 -39.8 0.54 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.817 0.698 . . . . 0.0 112.592 -170.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -152.79 50.56 0.74 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.243 0.964 . . . . 0.0 110.133 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 1.061 ' HG1' HD13 ' A' ' 159' ' ' ILE . 49.4 p -79.06 -144.36 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.21 161.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.977 HG21 ' HA ' ' A' ' 158' ' ' VAL . 42.9 p -163.85 -139.21 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.746 0.784 . . . . 0.0 112.168 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 159' ' ' ILE . 51.7 m-85 -157.42 64.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.195 -1.821 . . . . 0.0 107.442 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.732 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 2.2 p-80 -61.61 -60.56 3.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.189 -1.368 . . . . 0.0 109.417 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.732 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.4 mtt180 -69.2 116.78 10.03 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.558 1.161 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 55' ' ' ILE . 68.3 t -152.21 150.74 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 124.87 1.357 . . . . 0.0 110.95 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 1.002 HD11 ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -158.75 122.34 2.09 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.457 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 53' ' ' PHE . 88.0 Cg_exo -37.54 160.61 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.637 2.891 . . . . 0.0 113.941 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.03 68.45 0.0 OUTLIER Glycine 0 N--CA 1.474 1.207 0 CA-C-N 114.022 -1.445 . . . . 0.0 113.831 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.28 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.6 t80 -161.15 -59.12 0.05 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.782 0.931 . . . . 0.0 109.495 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.28 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 57.5 mtm -163.29 157.21 19.92 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.54 1.15 . . . . 0.0 112.29 -171.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.909 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 42.4 pt -161.56 145.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.932 174.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.743 ' HG2' ' CB ' ' A' ' 104' ' ' PHE . 18.2 mt-30 -146.1 168.75 20.2 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.147 0.904 . . . . 0.0 112.079 -166.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.36 -158.95 9.91 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.672 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.81 ' HA2' ' CE1' ' A' ' 40' ' ' PHE . . . 65.97 78.23 0.24 Allowed Glycine 0 N--CA 1.47 0.93 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.159 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 1.54 ' CA ' ' HE3' ' A' ' 67' ' ' LYS . . . 177.89 -133.79 2.27 Favored Glycine 0 N--CA 1.475 1.267 0 O-C-N 124.669 0.864 . . . . 0.0 111.231 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.663 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 64.0 m-85 -42.54 128.02 3.9 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.282 -0.959 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.691 ' OG1' ' OE2' ' A' ' 62' ' ' GLU . 78.3 p -59.01 -149.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.344 1.027 . . . . 0.0 110.733 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 1.243 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -59.91 -89.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.282 178.083 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 1.243 ' H ' ' CG ' ' A' ' 62' ' ' GLU . 32.9 mt-30 -72.28 52.52 0.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.77 1.294 . . . . 0.0 110.018 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.663 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 50.4 mtt 40.84 35.74 0.36 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.071 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.579 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 58.0 tp60 -77.72 99.97 6.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' LYS . 88.7 mt-30 -27.03 140.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.446 -172.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 1.54 ' HE3' ' CA ' ' A' ' 59' ' ' GLY . 52.7 mttp -51.44 -127.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.84 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 1.198 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 98.1 mttt 179.57 84.79 0.18 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 112.683 -2.053 . . . . 0.0 106.897 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 1.048 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 52.9 Cg_endo -71.73 -167.93 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.639 2.893 . . . . 0.0 113.297 -171.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.048 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 79.1 m-20 -165.09 170.41 6.39 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 113.327 -1.761 . . . . 0.0 109.984 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.996 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 34.7 Cg_endo -45.77 103.78 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.631 2.221 . . . . 0.0 108.977 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 71' ' ' PRO . 97.7 Cg_exo -45.45 -147.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.859 3.04 . . . . 0.0 113.711 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.205 ' CG1' ' O ' ' A' ' 98' ' ' SER . 26.4 pt -156.33 -126.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.044 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.51 ' N ' HG13 ' A' ' 73' ' ' ILE . 57.0 mtpt -146.71 133.36 19.91 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.045 0.841 . . . . 0.0 110.789 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.702 ' H ' ' HA ' ' A' ' 97' ' ' ASP . 7.4 t-20 -59.36 170.16 1.05 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.886 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.574 ' H ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -178.02 165.78 1.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.412 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 175.65 -34.11 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.255 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 1.005 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 48.7 p-10 -67.17 -44.97 78.39 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.025 0.828 . . . . 0.0 110.319 -176.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 1.005 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 33.6 p-10 41.9 -101.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.221 0.951 . . . . 0.0 110.337 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.605 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 170.46 -69.97 0.13 Allowed Glycine 0 N--CA 1.473 1.116 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.735 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -38.47 159.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.693 0.878 . . . . 0.0 112.285 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 38.3 ptt180 -58.93 -139.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.569 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.8 t-20 171.14 130.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.133 -174.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -167.55 152.64 7.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.202 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.658 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 39.8 ptt180 -40.69 125.51 2.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.585 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 1.018 ' O ' HG21 ' A' ' 128' ' ' VAL . . . 113.33 -28.98 8.25 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.776 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 1.164 HG21 ' NZ ' ' A' ' 127' ' ' LYS . 17.8 p -79.97 131.0 35.72 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.824 0.821 . . . . 0.0 111.484 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 1.611 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -87.42 160.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.005 167.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.05 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -162.1 141.46 9.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.473 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 1.244 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -66.86 122.03 16.79 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.67 -176.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 1.14 ' O ' ' SD ' ' A' ' 90' ' ' MET . . . -81.0 -166.38 1.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.278 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.086 ' CD ' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.71 -149.7 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.83 175.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 1.086 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 55.3 m -167.2 -108.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.765 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.472 ' N ' HG23 ' A' ' 93' ' ' THR . . . -70.69 -93.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.467 1.104 . . . . 0.0 110.538 -171.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 97' ' ' ASP . 32.7 m-20 -43.9 117.06 1.1 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.133 0.896 . . . . 0.0 110.954 -175.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.127 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 53.6 mtmt -71.35 42.18 0.07 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.696 1.247 . . . . 0.0 111.087 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 1.127 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 90.7 m-20 179.27 86.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 1.205 ' O ' ' CG1' ' A' ' 73' ' ' ILE . 67.1 m -168.12 -96.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.679 1.237 . . . . 0.0 109.759 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 1.061 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 58.99 94.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.794 1.309 . . . . 0.0 107.947 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.7 p -77.88 -42.77 32.23 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.552 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -170.93 -44.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.247 0.967 . . . . 0.0 110.479 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.717 ' O ' ' HE3' ' A' ' 90' ' ' MET . 3.9 pt20 -36.15 146.05 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.295 0.997 . . . . 0.0 112.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.992 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -157.22 -179.52 8.27 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.881 -1.508 . . . . 0.0 110.405 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.806 ' CZ ' ' HB2' ' A' ' 89' ' ' ALA . 35.7 p90 -151.03 122.44 7.87 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.271 -169.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.029 HD12 HD22 ' A' ' 18' ' ' LEU . 58.1 mt -94.2 101.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.365 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.578 ' OD1' ' HD1' ' A' ' 104' ' ' PHE . 7.3 m-20 -67.14 -175.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.778 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 1.645 HG11 ' CE ' ' A' ' 132' ' ' MET . 35.1 m -155.6 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.68 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -83.95 145.59 28.47 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.421 1.076 . . . . 0.0 110.874 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.1 m-20 -45.9 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.847 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 1.067 ' OD1' HD13 ' A' ' 113' ' ' LEU . 7.1 t-20 -68.81 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.864 1.353 . . . . 0.0 109.936 -170.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 113' ' ' LEU . . . 70.52 -19.26 0.22 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.857 0.723 . . . . 0.0 112.251 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.546 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.5 m-85 -69.38 36.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.68 0.612 . . . . 0.0 111.414 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 1.067 HD13 ' OD1' ' A' ' 110' ' ' ASN . 0.0 OUTLIER 179.22 -17.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.783 0.677 . . . . 0.0 111.815 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.742 ' N ' HD23 ' A' ' 113' ' ' LEU . 57.4 p-10 -47.85 138.83 8.25 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.683 0.614 . . . . 0.0 111.139 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 1.245 ' CB ' ' O ' ' A' ' 120' ' ' PHE . 1.7 t60 -31.61 131.9 0.11 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.862 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.418 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . -171.4 163.97 36.81 Favored Glycine 0 N--CA 1.477 1.392 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.062 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 118' ' ' ARG . 10.3 pt20 -39.32 119.93 0.98 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.229 -0.986 . . . . 0.0 110.995 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.825 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 58.0 ttp180 71.58 27.15 3.04 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.279 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 65.4 t0 177.9 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.011 0.819 . . . . 0.0 109.409 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.245 ' O ' ' CB ' ' A' ' 115' ' ' HIS . 1.7 t80 -43.89 -45.61 7.64 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.643 1.215 . . . . 0.0 110.68 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' N ' ' A' ' 115' ' ' HIS . . . 89.97 176.68 45.18 Favored Glycine 0 N--CA 1.477 1.42 0 O-C-N 124.475 1.109 . . . . 0.0 113.108 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.82 ' CD1' HD21 ' A' ' 113' ' ' LEU . 68.1 m-85 -78.65 143.24 36.51 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.229 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.244 ' HB2' ' O ' ' A' ' 90' ' ' MET . . . -54.68 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.59 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.05 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 72.2 t -175.85 128.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.92 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.962 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.3 p90 -161.77 21.62 0.11 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.608 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 1.611 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -113.26 155.89 15.99 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 122.939 1.3 . . . . 0.0 112.507 -169.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.164 ' NZ ' HG21 ' A' ' 87' ' ' THR . 0.4 OUTLIER -171.07 110.99 0.34 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 110.985 -2.608 . . . . 0.0 110.261 173.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.018 HG21 ' O ' ' A' ' 86' ' ' GLY . 58.3 t -58.11 157.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.223 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 1.067 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 33.1 m -154.44 32.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.231 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 1.067 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 74.5 mmtt 120.92 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.773 0.671 . . . . 0.0 109.508 174.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.868 ' CA ' HG21 ' A' ' 16' ' ' ILE . . . 171.78 -26.12 0.09 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.04 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.645 ' CE ' HG11 ' A' ' 107' ' ' VAL . 12.1 tpt -39.52 -51.17 2.2 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.975 0.456 . . . . 0.0 110.921 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 36.6 m-20 -43.88 -61.6 1.39 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.37 1.044 . . . . 0.0 109.541 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 15' ' ' ASN . 54.4 t -41.45 -60.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 124.739 1.274 . . . . 0.0 109.551 173.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.909 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . . . -44.41 -53.09 7.2 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.654 1.221 . . . . 0.0 109.709 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.922 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 38.2 m-20 -50.69 -66.97 0.3 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.771 1.294 . . . . 0.0 109.03 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.558 ' O ' HG12 ' A' ' 141' ' ' VAL . 56.4 mtpt -40.2 -49.38 2.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.789 1.306 . . . . 0.0 110.539 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.281 ' O ' HG23 ' A' ' 141' ' ' VAL . 16.2 mt -57.84 -58.29 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.444 1.09 . . . . 0.0 108.837 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.705 ' HB3' HG23 ' A' ' 55' ' ' ILE . 84.9 p -65.51 3.42 0.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.922 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.5 mp0 -99.07 -49.39 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.168 0.917 . . . . 0.0 108.741 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.281 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.4 m -41.29 123.25 2.15 Favored Pre-proline 0 N--CA 1.473 0.711 0 O-C-N 124.349 1.031 . . . . 0.0 110.306 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.8 Cg_exo -38.83 -178.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.35 2.7 . . . . 0.0 113.575 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.424 HG21 ' CA ' ' A' ' 153' ' ' PRO . 6.0 p -160.96 -150.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.735 1.731 . . . . 0.0 112.688 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.77 ' CD2' ' O ' ' A' ' 145' ' ' ASP . 0.8 OUTLIER 178.02 167.34 0.75 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 109.726 -3.397 . . . . 0.0 111.312 174.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.77 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 36.8 m-20 -52.37 -149.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.819 165.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -161.99 -61.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.673 1.225 . . . . 0.0 108.347 171.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.59 -92.18 0.08 OUTLIER Glycine 0 N--CA 1.471 1.001 0 CA-C-N 111.335 -2.666 . . . . 0.0 107.687 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.805 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 80.2 Cg_endo -68.4 -67.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.479 2.786 . . . . 0.0 108.761 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.805 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 96.0 m-85 -72.0 117.05 13.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.583 1.177 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.753 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 4.3 pm0 -95.03 83.77 4.0 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.75 1.281 . . . . 0.0 107.945 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.767 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 27.6 p30 169.3 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.548 -177.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.698 ' CG2' HG22 ' A' ' 146' ' ' VAL . 95.9 t -160.31 116.25 1.45 Allowed Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.739 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.424 ' CA ' HG21 ' A' ' 143' ' ' THR . 58.1 Cg_endo -63.08 106.92 0.58 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 109.304 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.053 ' H ' ' HA ' ' A' ' 143' ' ' THR . 77.5 p -40.59 -51.64 2.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.289 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 1.245 ' HB3' ' CD ' ' A' ' 156' ' ' PRO . 10.8 mptt -61.45 -166.71 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.459 1.099 . . . . 0.0 111.933 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.245 ' CD ' ' HB3' ' A' ' 155' ' ' LYS . 78.3 Cg_endo -85.12 145.85 9.89 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.789 2.993 . . . . 0.0 112.733 -170.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.979 HG21 ' O ' ' A' ' 156' ' ' PRO . 38.3 t -170.55 115.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.794 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.977 ' HA ' HG21 ' A' ' 45' ' ' THR . 92.1 t -153.57 120.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.24 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.061 HD13 ' HG1' ' A' ' 44' ' ' THR . 43.3 mt -68.58 134.3 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.274 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 1.129 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.2 mt -79.67 -51.62 9.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 112.39 -2.186 . . . . 0.0 109.284 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 1.202 ' O ' HD21 ' A' ' 9' ' ' LEU . 68.0 m -165.27 174.95 9.65 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.57 1.169 . . . . 0.0 112.697 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.906 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -157.73 100.77 1.78 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.104 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.951 ' O ' ' CD1' ' A' ' 165' ' ' LEU . 32.4 mmmt -125.32 125.81 44.09 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.15 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.843 ' C ' HD11 ' A' ' 165' ' ' LEU . 34.4 m -67.93 131.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.597 1.186 . . . . 0.0 109.824 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 1.016 HD12 ' HB3' ' A' ' 8' ' ' LEU . 6.8 mp -133.65 135.63 25.3 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.925 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.725 ' HD3' ' OD2' ' A' ' 4' ' ' ASP . 87.8 Cg_exo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.638 2.892 . . . . 0.0 112.027 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.716 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 2.0 tmtp? -48.49 -44.27 35.76 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.703 1.252 . . . . 0.0 110.422 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 1.192 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 179.6 112.53 0.35 Allowed Glycine 0 N--CA 1.475 1.251 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.192 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 85.9 m-20 -171.36 89.64 0.45 Allowed Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.433 0.725 . . . . 0.0 109.303 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.257 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 71.1 Cg_exo -54.94 127.45 26.35 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.832 3.022 . . . . 0.0 113.353 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.257 ' HD2' ' O ' ' A' ' 5' ' ' PRO . 51.9 m170 -150.48 118.11 6.15 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.847 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.2 p -73.98 138.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.208 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.101 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 6.4 mp -127.78 116.12 19.71 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.471 1.107 . . . . 0.0 109.619 166.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.836 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 7.1 mp -110.73 -175.96 2.85 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.049 -2.341 . . . . 0.0 108.726 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.758 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 52.6 m -161.48 99.9 1.17 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.359 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 1.074 ' HG1' HD12 ' A' ' 138' ' ' ILE . 40.7 p -76.29 169.01 19.03 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 125.307 1.629 . . . . 0.0 111.407 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -40.71 -42.17 1.69 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.338 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.862 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.48 -60.54 3.21 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.483 1.115 . . . . 0.0 110.759 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 179.65 44.29 Favored Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.345 -1.752 . . . . 0.0 114.012 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 1.176 ' O ' HG22 ' A' ' 134' ' ' VAL . 58.6 t-20 -55.55 159.3 2.95 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.948 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' OD1' ' A' ' 15' ' ' ASN . 10.1 tt -171.36 160.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.289 -172.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.101 ' HG2' ' CG ' ' A' ' 8' ' ' LEU . 35.4 mt-10 -162.92 121.48 2.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.109 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.001 HD22 HD12 ' A' ' 105' ' ' ILE . 2.8 mm? -92.01 173.86 7.62 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.403 1.064 . . . . 0.0 110.322 161.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.432 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -134.57 124.12 24.94 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.047 175.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 20' ' ' LEU . 6.5 mp -109.39 141.8 41.26 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.814 1.321 . . . . 0.0 111.735 -168.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.738 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 63.0 m-20 -55.86 -118.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.892 170.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.015 ' HD3' ' O ' ' A' ' 22' ' ' LYS . 5.8 tmtt? 124.66 -48.62 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.131 -1.85 . . . . 0.0 109.517 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -45.81 -65.3 0.56 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.625 1.203 . . . . 0.0 109.727 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.926 ' HD3' HD22 ' A' ' 81' ' ' LEU . 53.3 mtpt -90.61 21.92 3.75 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.704 1.253 . . . . 0.0 113.87 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.593 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.85 65.18 2.16 Favored Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 124.205 0.941 . . . . 0.0 110.57 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.972 ' O ' HG23 ' A' ' 29' ' ' VAL . 52.4 Cg_exo -59.66 -59.76 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.533 2.822 . . . . 0.0 110.965 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.1 t -50.4 -63.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.151 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -42.67 -57.55 2.67 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.7 1.25 . . . . 0.0 110.51 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 26' ' ' PRO . 26.8 m -52.75 -47.14 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.666 1.229 . . . . 0.0 110.871 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.489 ' N ' HG21 ' A' ' 29' ' ' VAL . 42.6 tp60 -46.93 -70.36 0.1 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.179 0.924 . . . . 0.0 109.931 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 1.225 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 12.3 m-80 -42.07 -48.39 4.67 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.454 1.096 . . . . 0.0 110.312 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.739 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 69.7 t80 -42.98 -63.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.504 1.128 . . . . 0.0 109.759 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.733 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.0 t -45.51 -37.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.602 1.189 . . . . 0.0 111.021 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 1.225 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 84.2 m-20 -43.02 -63.44 0.8 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.063 0.852 . . . . 0.0 109.705 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 40' ' ' PHE . 96.2 m-85 -61.13 -59.27 5.6 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.796 1.31 . . . . 0.0 109.095 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.733 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 59.9 t -39.41 -48.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 124.69 1.243 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.77 ' O ' ' HB3' ' A' ' 38' ' ' SER . 50.4 t30 -38.56 -31.23 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.725 1.266 . . . . 0.0 112.401 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.77 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.0 p 154.89 159.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.103 0.877 . . . . 0.0 113.151 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.44 -39.64 3.1 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.117 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 35' ' ' TYR . 2.1 t80 -67.78 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.361 0.683 . . . . 0.0 110.92 -173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.508 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 81.6 m-85 -60.87 -36.74 79.97 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.336 1.022 . . . . 0.0 112.669 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 52.2 p-10 -38.95 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.089 0.868 . . . . 0.0 110.767 -171.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.978 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 10.7 m-20 76.59 39.47 0.25 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 113.49 -1.687 . . . . 0.0 111.633 175.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 1.004 ' HG1' HD13 ' A' ' 159' ' ' ILE . 48.9 p -78.66 -129.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 166.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.988 ' HA ' HG13 ' A' ' 159' ' ' ILE . 61.7 p -163.44 -147.42 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.824 1.297 . . . . 0.0 113.59 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 159' ' ' ILE . 16.7 m-85 -161.54 59.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 111.579 -2.555 . . . . 0.0 105.222 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 1.208 ' CE1' ' OE1' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -38.68 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.489 -173.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.156 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.0 mmm180 -173.35 -155.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 123.081 1.42 . . . . 0.0 113.33 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 1.078 HG11 ' HA ' ' A' ' 55' ' ' ILE . 7.6 p -179.7 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 111.682 -2.508 . . . . 0.0 107.539 159.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.93 HG21 ' HB2' ' A' ' 54' ' ' MET . 9.3 tt -171.75 131.3 0.74 Allowed Pre-proline 0 N--CA 1.476 0.873 0 O-C-N 124.451 1.094 . . . . 0.0 109.983 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.731 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 81.9 Cg_exo -48.85 157.7 1.5 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.893 3.062 . . . . 0.0 114.398 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.24 53.38 0.01 OUTLIER Glycine 0 N--CA 1.475 1.284 0 CA-C-N 114.02 -1.445 . . . . 0.0 114.192 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.322 ' CE2' ' HE2' ' A' ' 54' ' ' MET . 1.5 t80 -162.14 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.665 0.862 . . . . 0.0 110.037 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.322 ' HE2' ' CE2' ' A' ' 53' ' ' PHE . 45.0 mtt -160.18 147.57 16.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.231 0.957 . . . . 0.0 111.611 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.078 ' HA ' HG11 ' A' ' 49' ' ' VAL . 38.4 pt -148.62 141.66 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.276 -1.783 . . . . 0.0 108.19 167.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.465 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 62.5 mt-30 -64.75 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.146 -163.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 1.056 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -129.3 -121.17 2.32 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 118.667 -2.521 . . . . 0.0 109.928 0.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . 52.97 109.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.063 0 CA-C-N 114.271 -0.965 . . . . 0.0 111.22 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.86 -126.01 1.11 Allowed Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.525 0.779 . . . . 0.0 111.717 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.88 ' CE2' ' HG2' ' A' ' 66' ' ' GLN . 29.8 m-85 -43.08 134.02 3.65 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.788 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.968 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 61.7 p -59.36 124.67 20.8 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.265 0.978 . . . . 0.0 109.837 169.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 1.228 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 13.11 -104.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.757 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 1.24 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.5 mm100 -38.11 -59.99 0.8 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.778 1.299 . . . . 0.0 111.445 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 1.24 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 14.6 mmt 145.11 98.43 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.925 ' OE1' ' O ' ' A' ' 64' ' ' MET . 29.4 mm100 -160.65 71.04 0.42 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 112.621 -2.081 . . . . 0.0 106.966 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.88 ' HG2' ' CE2' ' A' ' 60' ' ' PHE . 39.6 mt-30 -28.52 130.73 0.06 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.24 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.968 ' HE3' ' CG2' ' A' ' 61' ' ' THR . 18.6 mmtp -72.57 153.7 41.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.396 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 7.5 mmpt? -48.03 95.33 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.799 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.86 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 71.4 Cg_exo -59.12 -69.79 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.593 2.862 . . . . 0.0 113.192 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.947 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 34.8 m120 89.75 163.28 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 O-C-N 124.402 1.064 . . . . 0.0 111.132 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 58.6 Cg_endo -67.71 112.04 2.54 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.875 3.05 . . . . 0.0 110.88 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 1.217 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 88.5 Cg_exo -52.1 -150.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.798 2.998 . . . . 0.0 112.957 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.544 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.52 156.79 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.974 ' HD2' ' H ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -33.3 135.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.192 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' LYS . 56.6 p30 -45.7 -164.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.44 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.745 ' HB3' HD22 ' A' ' 79' ' ' ASN . 8.4 mm-40 161.67 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.589 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 120' ' ' PHE . . . -71.29 -43.26 67.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.251 0.969 . . . . 0.0 109.791 171.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 1.069 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 20.9 p-10 -67.41 -53.5 28.61 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.424 1.077 . . . . 0.0 109.907 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.745 HD22 ' HB3' ' A' ' 76' ' ' GLU . 38.5 p-10 -63.51 99.26 0.2 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.237 1.018 . . . . 0.0 108.876 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 1.222 ' O ' HD12 ' A' ' 81' ' ' LEU . . . 172.22 46.87 0.04 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.359 -1.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 1.222 HD12 ' O ' ' A' ' 80' ' ' GLY . 1.7 mm? -146.14 -149.29 0.28 Allowed 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.626 0.839 . . . . 0.0 109.499 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.424 ' H ' ' HB3' ' A' ' 81' ' ' LEU . 3.8 mpt_? -179.74 150.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' A' ' 84' ' ' THR . 60.3 t-20 -169.49 -124.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.519 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 1.11 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 16.2 m -168.6 163.46 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.025 0.828 . . . . 0.0 112.004 -162.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 1.11 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 8.3 ptm85 -19.92 108.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.19 164.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.743 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 137.2 -27.03 2.92 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 111.575 -2.557 . . . . 0.0 110.233 -168.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 1.083 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.2 p -92.66 142.82 26.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.91 0.862 . . . . 0.0 112.191 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.934 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.74 162.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.094 166.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.154 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -156.01 140.97 17.26 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 113.943 -1.48 . . . . 0.0 111.829 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.928 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.1 tpt -56.88 140.3 48.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.507 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.515 ' O ' ' HE2' ' A' ' 90' ' ' MET . . . -109.38 129.3 55.54 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.457 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.306 ' HG2' ' N ' ' A' ' 99' ' ' ALA . 29.9 tpt180 179.15 175.98 0.62 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.765 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.716 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 89.6 m -168.3 115.86 0.7 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.563 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.796 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 165.01 -50.69 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.025 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.796 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 16.0 p30 74.37 -177.39 0.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.541 1.151 . . . . 0.0 112.323 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.174 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 0.4 OUTLIER 79.94 -49.29 0.36 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.763 -172.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 1.174 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 73.7 m-20 -162.45 61.32 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.622 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 21.6 t -74.22 173.75 9.72 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.773 1.296 . . . . 0.0 113.333 -170.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 1.306 ' N ' ' HG2' ' A' ' 92' ' ' ARG . . . 65.01 170.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.76 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.947 HG21 ' HG3' ' A' ' 72' ' ' PRO . 72.8 p -150.93 -48.41 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.297 -174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.575 ' C ' ' HE3' ' A' ' 90' ' ' MET . 73.0 p -171.07 -52.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.257 0.973 . . . . 0.0 110.179 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.694 ' O ' ' SD ' ' A' ' 90' ' ' MET . 19.3 pt20 -42.83 154.22 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.353 1.033 . . . . 0.0 112.183 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.934 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -159.28 168.73 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.456 175.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.465 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 17.1 p90 -144.49 137.68 27.07 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.326 -170.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.069 ' N ' ' O ' ' A' ' 56' ' ' GLN . 63.1 mt -93.95 116.65 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 112.057 -2.338 . . . . 0.0 110.612 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.86 116.51 6.41 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.5 1.125 . . . . 0.0 109.572 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.888 ' HB ' ' C ' ' A' ' 53' ' ' PHE . 51.9 t -90.44 22.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 124.488 1.118 . . . . 0.0 112.133 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.868 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . 169.21 172.53 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.609 0.719 . . . . 0.0 112.108 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.571 ' N ' ' HB3' ' A' ' 85' ' ' ARG . 71.7 m-20 -38.62 144.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.596 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 113' ' ' LEU . 26.6 t-20 -170.57 155.95 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.435 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 176.13 -50.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.465 -1.698 . . . . 0.0 108.296 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.954 ' O ' ' HD1' ' A' ' 112' ' ' PHE . 3.2 p90 -61.26 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 167.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.8 HD13 ' CE1' ' A' ' 122' ' ' TYR . 36.9 tp 177.92 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.103 -171.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 122' ' ' TYR . 34.0 m-20 -38.47 -60.91 0.75 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.282 0.989 . . . . 0.0 111.182 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.601 ' ND1' ' HA ' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 179.05 84.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.587 1.179 . . . . 0.0 108.547 -175.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 117' ' ' GLN . . . 171.22 100.96 0.14 Allowed Glycine 0 N--CA 1.473 1.157 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.584 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.591 HE21 ' HG2' ' A' ' 118' ' ' ARG . 35.1 tt0 176.14 -92.14 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.602 0.824 . . . . 0.0 109.292 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.591 ' HG2' HE21 ' A' ' 117' ' ' GLN . 26.4 mmm180 -69.57 -46.29 66.73 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.08 0.862 . . . . 0.0 111.023 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -173.29 -47.56 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.295 0.997 . . . . 0.0 111.092 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 1.3 t80 -178.03 83.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.36 -130.44 0.09 OUTLIER Glycine 0 N--CA 1.473 1.156 0 CA-C-N 113.829 -1.532 . . . . 0.0 114.137 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.8 ' CE1' HD13 ' A' ' 113' ' ' LEU . 76.3 m-85 -78.93 150.41 32.1 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.499 -1.351 . . . . 0.0 112.674 -167.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.154 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -81.11 -163.15 0.56 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.6 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.999 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 73.9 t 179.39 140.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.111 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.676 ' HZ ' ' CD2' ' A' ' 103' ' ' PHE . 9.8 p90 -164.76 22.56 0.06 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 1.222 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -171.73 -136.3 2.1 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 122.976 1.32 . . . . 0.0 113.745 173.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.432 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 8.7 mtpm? 179.6 -133.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 111.275 -2.463 . . . . 0.0 109.162 -172.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.922 HG23 ' CD1' ' A' ' 18' ' ' LEU . 80.4 t -153.36 120.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.573 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.933 ' CG1' ' CB ' ' A' ' 17' ' ' GLU . 7.7 p -69.85 -46.49 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.104 172.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.81 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 58.5 mtpt -166.66 -135.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.449 1.093 . . . . 0.0 108.87 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . 62.36 -17.36 0.07 OUTLIER Glycine 0 N--CA 1.474 1.212 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.01 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.602 ' H ' ' C ' ' A' ' 130' ' ' LYS . 8.3 tpt -39.57 -42.88 1.23 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.009 0.404 . . . . 0.0 110.355 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 12.1 m-20 -45.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.438 1.087 . . . . 0.0 109.72 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 1.176 HG22 ' O ' ' A' ' 15' ' ' ASN . 59.5 t -46.5 -57.17 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.474 1.109 . . . . 0.0 109.167 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 132' ' ' MET . . . -44.4 -53.69 6.6 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.618 1.199 . . . . 0.0 109.672 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.837 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 42.0 m-20 -51.96 -64.37 0.84 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.623 1.202 . . . . 0.0 108.854 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 56.0 tptt -39.83 -54.07 2.18 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.86 1.35 . . . . 0.0 110.552 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.216 ' O ' HG11 ' A' ' 141' ' ' VAL . 21.0 mt -59.74 -58.68 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.561 1.163 . . . . 0.0 109.363 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.3 p -55.13 -8.73 0.32 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.837 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mm-40 -96.2 -44.69 7.16 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.356 1.035 . . . . 0.0 110.082 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.216 HG11 ' O ' ' A' ' 138' ' ' ILE . 8.0 p -48.96 131.48 15.02 Favored Pre-proline 0 N--CA 1.474 0.741 0 O-C-N 124.417 1.073 . . . . 0.0 110.444 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 86.3 Cg_exo -46.9 172.02 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.649 2.9 . . . . 0.0 113.795 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.381 HG21 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.06 -140.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.225 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.665 ' HD2' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 179.0 158.43 0.56 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 110.942 -2.844 . . . . 0.0 112.696 169.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 45.1 t0 -50.38 -179.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.734 165.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.947 HG23 ' CG2' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -158.03 -143.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.59 -110.33 0.01 OUTLIER Glycine 0 N--CA 1.472 1.059 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.975 ' HG2' ' HD1' ' A' ' 149' ' ' TYR . 94.6 Cg_endo -71.81 -46.7 0.54 Allowed 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 123.8 3.0 . . . . 0.0 110.259 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.975 ' HD1' ' HG2' ' A' ' 148' ' ' PRO . 34.9 m-85 -68.56 109.43 3.74 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.429 1.081 . . . . 0.0 110.933 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.575 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 7.6 mm-40 -84.94 64.47 8.68 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.213 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.845 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 54.7 p30 178.74 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.284 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.947 ' CG2' HG23 ' A' ' 146' ' ' VAL . 94.1 t -154.84 118.26 2.51 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.803 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.381 ' CA ' HG21 ' A' ' 143' ' ' THR . 61.0 Cg_endo -67.18 110.37 1.98 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.656 2.904 . . . . 0.0 109.736 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.919 ' H ' ' HA ' ' A' ' 143' ' ' THR . 40.0 t -44.95 -62.46 1.22 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.383 175.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 153' ' ' PRO . 67.3 mttm -66.99 140.65 96.18 Favored Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.633 1.208 . . . . 0.0 109.513 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 73.4 Cg_endo -88.11 114.82 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.107 2.538 . . . . 0.0 113.346 -161.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.692 ' O ' HG21 ' A' ' 158' ' ' VAL . 44.7 t -76.97 148.72 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.7 157.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.91 ' HA ' HG21 ' A' ' 45' ' ' THR . 95.8 t -163.67 122.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.88 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.004 HD13 ' HG1' ' A' ' 44' ' ' THR . 20.6 mt -68.01 130.49 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.361 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.758 ' HB2' ' O ' ' A' ' 10' ' ' THR . 84.7 mt -79.83 -48.05 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 112.535 -2.12 . . . . 0.0 110.171 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.7 m -162.84 -167.78 1.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.564 1.165 . . . . 0.0 112.484 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.836 ' HB1' ' HG ' ' A' ' 9' ' ' LEU . . . -178.99 139.66 0.16 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.283 -1.781 . . . . 0.0 109.703 -175.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 8' ' ' LEU . 22.0 ptmt -170.85 126.27 0.71 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.743 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.39 145.48 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.989 -1.46 . . . . 0.0 110.617 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 1.008 ' HB3' ' HD3' ' A' ' 166' ' ' PRO . 55.2 tp -58.52 -59.87 12.14 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.974 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 1.008 ' HD3' ' HB3' ' A' ' 165' ' ' LEU . 82.1 Cg_exo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 123.242 2.628 . . . . 0.0 111.985 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.741 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.741 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 63.1 pttt 151.34 163.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.733 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 1.252 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . -168.69 -69.52 0.03 OUTLIER Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.252 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 73.1 m-20 -169.74 86.18 0.59 Allowed Pre-proline 0 N--CA 1.473 0.704 0 O-C-N 124.561 0.8 . . . . 0.0 108.989 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.453 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 71.9 Cg_endo -62.53 118.65 5.54 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.496 2.798 . . . . 0.0 109.653 173.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.453 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.1 m170 -158.23 97.99 1.54 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.621 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.97 ' HA ' HG11 ' A' ' 164' ' ' VAL . 87.1 t -61.02 79.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 165.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.116 ' HB3' ' O ' ' A' ' 163' ' ' LYS . 7.3 tt -79.86 106.91 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.356 -169.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.153 HD21 ' O ' ' A' ' 161' ' ' SER . 12.3 mt -103.64 171.88 7.12 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 113.163 -1.835 . . . . 0.0 112.331 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 1.294 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 94.6 m -160.52 79.08 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.9 -2.409 . . . . 0.0 107.084 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.985 HG21 HG12 ' A' ' 159' ' ' ILE . 32.4 p -74.73 167.1 22.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 125.132 1.52 . . . . 0.0 111.952 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.563 ' OG ' HG12 ' A' ' 157' ' ' VAL . 78.3 p -41.41 -49.52 3.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.459 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.734 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -54.47 -55.88 24.44 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.424 1.078 . . . . 0.0 110.289 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.598 ' O ' HG12 ' A' ' 134' ' ' VAL . . . 171.48 -179.95 42.92 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.911 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.887 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 10.4 t-20 -57.82 159.14 5.65 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.545 -1.328 . . . . 0.0 111.97 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.827 HG13 ' HB2' ' A' ' 9' ' ' LEU . 19.3 pt -162.59 -173.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.903 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.891 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 7.2 mm-40 -161.27 126.81 3.7 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.284 -170.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.975 HD22 HD13 ' A' ' 105' ' ' ILE . 2.9 mm? -112.0 114.04 26.69 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.547 1.154 . . . . 0.0 108.925 164.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.968 ' CG ' ' HB2' ' A' ' 127' ' ' LYS . 11.9 pt-20 -79.53 111.13 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.503 1.127 . . . . 0.0 108.53 169.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.809 ' O ' ' HB2' ' A' ' 5' ' ' PRO . 7.2 mp -108.56 131.58 54.71 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.881 1.363 . . . . 0.0 110.775 -174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.954 ' OD1' ' NZ ' ' A' ' 127' ' ' LYS . 40.1 m-20 -57.33 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.037 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.763 ' HG3' ' N ' ' A' ' 23' ' ' GLN . 22.2 ptmt 142.65 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.372 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.763 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 3.9 pt20 -49.74 -44.31 48.47 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.72 1.262 . . . . 0.0 110.473 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 1.103 ' HE3' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -68.55 -15.07 63.41 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.305 1.003 . . . . 0.0 112.906 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 1.001 ' O ' HG21 ' A' ' 29' ' ' VAL . . . -160.73 72.36 2.81 Favored Pre-proline 0 N--CA 1.475 0.81 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 75.6 Cg_exo -55.91 -64.44 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.633 2.889 . . . . 0.0 111.73 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.673 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 66.4 t -53.18 -67.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.68 1.237 . . . . 0.0 109.911 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.772 ' HA ' HG13 ' A' ' 73' ' ' ILE . 58.8 m -44.67 -61.71 1.47 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.579 1.174 . . . . 0.0 109.853 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.001 HG21 ' O ' ' A' ' 25' ' ' ALA . 47.3 t -49.25 -52.56 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 124.786 1.304 . . . . 0.0 109.92 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 38.6 tp60 -41.81 -61.47 1.1 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.475 1.109 . . . . 0.0 110.049 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.732 ' CG ' HG23 ' A' ' 73' ' ' ILE . 13.2 m-80 -42.91 -51.91 5.35 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.564 1.165 . . . . 0.0 109.765 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.969 ' O ' HG21 ' A' ' 36' ' ' VAL . 78.9 t80 -40.64 -57.76 1.79 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.629 1.206 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.821 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 57.6 t -51.18 -38.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.754 1.283 . . . . 0.0 111.316 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.789 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 8.4 p-10 -44.9 -55.51 5.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.951 0.782 . . . . 0.0 109.362 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.861 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 54.5 m-85 -69.64 -53.73 17.3 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.09 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.969 HG21 ' O ' ' A' ' 32' ' ' PHE . 61.9 t -39.39 -50.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.164 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.789 ' CG ' ' O ' ' A' ' 34' ' ' ASP . 51.0 p30 -37.92 -33.4 0.08 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.703 1.252 . . . . 0.0 112.098 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.762 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.3 p 146.4 136.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.239 0.962 . . . . 0.0 112.028 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 1.064 ' N ' ' OD1' ' A' ' 42' ' ' ASN . . . 131.14 -59.25 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.51 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.932 ' O ' HG22 ' A' ' 44' ' ' THR . 61.1 t80 -62.99 -74.35 0.1 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.291 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' CG ' ' HD1' ' A' ' 40' ' ' PHE . 68.5 m-85 -66.75 -25.08 66.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.485 1.115 . . . . 0.0 112.913 -173.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 1.064 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 14.0 m120 -38.75 -36.59 0.27 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.902 0.751 . . . . 0.0 112.467 -173.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.598 HD22 HG12 ' A' ' 158' ' ' VAL . 2.0 t-20 -157.97 47.46 0.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.124 0.89 . . . . 0.0 110.325 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 1.04 ' HG1' HD13 ' A' ' 159' ' ' ILE . 46.2 p -79.71 -133.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.314 164.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.965 ' HA ' HG13 ' A' ' 159' ' ' ILE . 77.8 p -162.96 -153.03 0.23 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.87 0.843 . . . . 0.0 111.817 173.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.082 ' HZ ' HD12 ' A' ' 9' ' ' LEU . 14.4 m-30 -141.85 63.42 1.42 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.174 -1.83 . . . . 0.0 106.585 174.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 1.094 ' CE1' ' HA2' ' A' ' 59' ' ' GLY . 1.1 p-80 -51.94 -72.67 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.684 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.888 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 84.2 mtm180 -71.49 130.48 41.37 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.42 1.075 . . . . 0.0 111.075 -173.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.97 HG21 ' HB ' ' A' ' 55' ' ' ILE . 10.9 p -159.96 157.36 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.844 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 1.054 HD11 ' HD2' ' A' ' 53' ' ' PHE . 9.9 tt -155.7 127.04 3.66 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.484 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 94.2 Cg_exo -38.7 155.14 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.577 2.851 . . . . 0.0 113.486 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -3.23 66.59 0.0 OUTLIER Glycine 0 N--CA 1.475 1.266 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.888 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.054 ' HD2' HD11 ' A' ' 50' ' ' ILE . 10.9 t80 -161.02 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.808 0.946 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.867 ' HG2' ' N ' ' A' ' 55' ' ' ILE . 54.2 ttp -167.62 177.45 5.87 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.484 1.115 . . . . 0.0 111.958 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.97 ' HB ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 171.39 113.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.12 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.951 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 66.6 mt-30 -98.62 -170.65 1.98 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.232 -166.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.22 28.79 Favored Glycine 0 N--CA 1.477 1.377 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.533 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.762 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 93.27 -59.69 2.28 Favored Glycine 0 N--CA 1.474 1.206 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 -165.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 1.094 ' HA2' ' CE1' ' A' ' 47' ' ' HIS . . . 41.34 143.65 0.0 OUTLIER Glycine 0 N--CA 1.472 1.074 0 CA-C-N 114.212 -0.994 . . . . 0.0 114.014 168.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.903 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 14.1 m-30 -46.89 150.7 0.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.406 -1.397 . . . . 0.0 110.673 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 1.252 HG22 ' OE1' ' A' ' 65' ' ' GLN . 94.8 m -59.08 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.316 -174.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 1.149 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 1.5 mp0 48.51 116.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.758 1.286 . . . . 0.0 110.745 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 1.31 ' O ' ' CG ' ' A' ' 64' ' ' MET . 8.5 pt20 69.02 -48.83 0.59 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.558 1.161 . . . . 0.0 111.0 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 1.31 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 25.0 mmt 158.38 98.22 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.981 1.372 . . . . 0.0 108.715 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 1.252 ' OE1' HG22 ' A' ' 61' ' ' THR . 48.4 tt0 -150.46 79.71 1.34 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.014 -2.812 . . . . 0.0 105.187 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.792 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -27.04 176.81 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.404 -1.725 . . . . 0.0 115.627 -166.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 1.109 ' H ' ' CD ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -48.07 -140.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 111.412 -2.631 . . . . 0.0 112.271 -174.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 1.067 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 40.2 ttpt 178.31 -70.94 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.076 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 1.067 ' CD ' ' HB3' ' A' ' 68' ' ' LYS . 59.8 Cg_endo -62.56 133.09 40.85 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.589 2.859 . . . . 0.0 111.011 173.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.538 ' HA ' ' CG2' ' A' ' 100' ' ' THR . 92.2 m-20 -168.61 72.14 0.8 Allowed Pre-proline 0 N--CA 1.474 0.725 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 1.024 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 80.0 Cg_exo -48.29 -64.06 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.391 2.728 . . . . 0.0 110.937 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 1.155 ' CB ' ' HA ' ' A' ' 98' ' ' SER . 50.3 Cg_exo -87.71 -140.63 0.16 OUTLIER 'Cis proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.798 -1.751 . . . . 0.0 110.835 -2.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.302 HD13 ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -158.6 150.95 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.642 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 74.4 mmtt -30.14 145.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.877 -1.51 . . . . 0.0 113.049 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 1.206 ' OD1' ' HB3' ' A' ' 96' ' ' LYS . 40.4 m-80 -42.77 -167.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.272 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 1.231 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 161.19 118.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.231 -177.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.861 ' HB3' HH11 ' A' ' 92' ' ' ARG . . . 174.06 -51.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.897 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 1.021 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 59.8 p30 -70.35 39.07 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.501 1.126 . . . . 0.0 111.693 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 77' ' ' ALA . 4.6 p30 -40.6 -41.43 1.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.281 0.988 . . . . 0.0 110.976 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.788 ' O ' HD21 ' A' ' 81' ' ' LEU . . . 64.02 71.06 0.91 Allowed Glycine 0 N--CA 1.47 0.916 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.788 HD21 ' O ' ' A' ' 80' ' ' GLY . 79.9 mt -163.94 -179.54 6.33 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.871 0.983 . . . . 0.0 111.022 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.716 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 35.4 mmt180 -72.72 138.63 46.69 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.321 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.0 m120 -155.12 132.8 11.31 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.827 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 m -166.75 154.82 9.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.967 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.87 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 78.2 ttt180 -34.12 110.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 113.932 -1.486 . . . . 0.0 110.687 169.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 1.422 ' HA2' ' ND2' ' A' ' 106' ' ' ASN . . . -137.53 79.22 0.31 Allowed Glycine 0 N--CA 1.469 0.844 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.564 3.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 1.053 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 48.1 p -60.55 139.47 57.76 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.823 0.954 . . . . 0.0 111.107 172.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 1.409 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -79.82 158.16 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.474 162.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.988 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -160.41 129.95 5.08 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.633 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 1.269 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -60.67 122.05 13.76 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.422 -177.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 1.208 ' O ' ' HG3' ' A' ' 92' ' ' ARG . . . -51.41 -173.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.441 1.088 . . . . 0.0 111.795 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.208 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 81.9 mtp180 179.43 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.738 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.3 m -52.67 -86.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.763 1.289 . . . . 0.0 110.14 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.9 -71.54 0.41 Allowed 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.946 1.404 . . . . 0.0 108.525 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.8 m-20 -46.14 128.35 9.39 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.41 1.069 . . . . 0.0 110.433 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.206 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 8.3 mtpm? -42.15 -103.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.531 1.145 . . . . 0.0 110.582 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.9 ' OD1' ' ND2' ' A' ' 75' ' ' ASN . 33.0 m-20 -53.06 114.22 1.38 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.64 1.212 . . . . 0.0 109.21 175.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 1.155 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 40.3 t -175.28 -44.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.562 1.164 . . . . 0.0 111.093 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 1.302 ' O ' HD13 ' A' ' 73' ' ' ILE . . . -34.81 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.096 0.873 . . . . 0.0 110.411 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 1.538 ' CG2' ' HA ' ' A' ' 70' ' ' ASN . 74.3 p -78.85 -37.04 41.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.608 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.553 ' C ' ' HE3' ' A' ' 90' ' ' MET . 78.7 p -170.07 -48.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.092 0.87 . . . . 0.0 110.634 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.907 ' HG3' ' HB2' ' A' ' 91' ' ' ALA . 3.9 pt20 -36.9 151.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.215 0.947 . . . . 0.0 112.114 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.953 ' HB2' HD13 ' A' ' 88' ' ' ILE . 11.6 p90 -157.18 -167.71 2.41 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.415 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.957 ' CZ ' ' HB2' ' A' ' 89' ' ' ALA . 27.7 p90 -158.15 121.1 3.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.927 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.975 HD13 HD22 ' A' ' 18' ' ' LEU . 65.1 mt -90.0 104.87 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.74 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 1.422 ' ND2' ' HA2' ' A' ' 86' ' ' GLY . 5.0 p-10 -63.87 153.21 37.5 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.259 0.974 . . . . 0.0 110.408 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.979 HG11 ' SD ' ' A' ' 132' ' ' MET . 32.6 m -141.53 47.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.026 176.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.618 ' O ' ' OD1' ' A' ' 110' ' ' ASN . . . 170.15 140.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.528 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 1.123 ' O ' ' OD1' ' A' ' 110' ' ' ASN . 32.3 m-20 -30.93 138.72 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 1.123 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 15.9 m-20 -158.18 157.3 32.42 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.049 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 1.155 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . 172.31 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.722 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CE1' ' HA ' ' A' ' 110' ' ' ASN . 32.6 p90 -39.64 -42.65 1.23 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.58 1.175 . . . . 0.0 110.238 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.955 HD13 ' CD2' ' A' ' 122' ' ' TYR . 68.1 tp -58.98 -52.33 66.23 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 0.0 109.619 175.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 1.155 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 57.4 p-10 -40.08 138.4 0.84 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.523 1.139 . . . . 0.0 111.815 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 1.021 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 4.0 t60 -36.62 113.52 0.24 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.809 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -176.56 -96.17 0.1 Allowed Glycine 0 N--CA 1.472 1.092 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 6.3 tp60 -47.79 110.77 0.35 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.673 0.867 . . . . 0.0 109.775 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' A' ' 117' ' ' GLN . 99.0 mtt180 91.76 -74.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.043 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 59.0 p30 179.04 -174.15 0.18 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.806 1.316 . . . . 0.0 111.794 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.925 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 78.7 m-85 -45.17 172.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.87 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.35 -110.34 0.26 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.328 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.955 ' CD2' HD13 ' A' ' 113' ' ' LEU . 89.1 m-85 -78.77 116.3 19.02 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.808 0.946 . . . . 0.0 109.937 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.269 ' HB2' ' O ' ' A' ' 90' ' ' MET . . . -49.94 -158.41 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.247 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.1 HG22 ' O ' ' A' ' 123' ' ' ALA . 45.7 t 179.28 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.805 ' CE2' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.11 27.74 0.07 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.251 0.97 . . . . 0.0 111.135 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 1.409 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -150.92 -173.07 20.59 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 122.983 1.324 . . . . 0.0 112.223 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.217 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 36.2 mtmm 177.8 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 111.47 -2.365 . . . . 0.0 108.864 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.146 HG22 ' CE ' ' A' ' 132' ' ' MET . 62.8 t -40.03 116.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.59 1.181 . . . . 0.0 110.311 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.743 HG22 ' ND1' ' A' ' 6' ' ' HIS . 85.0 t -58.35 -51.43 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.392 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.637 ' HG3' HG11 ' A' ' 129' ' ' VAL . 0.0 OUTLIER 162.26 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.609 1.193 . . . . 0.0 108.798 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -166.38 22.46 0.12 Allowed Glycine 0 N--CA 1.475 1.237 0 O-C-N 124.826 1.329 . . . . 0.0 112.713 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.146 ' CE ' HG22 ' A' ' 128' ' ' VAL . 20.9 mmt -53.51 -22.22 7.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.439 171.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 63.2 t0 -47.88 -60.58 2.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 15' ' ' ASN . 87.2 t -62.31 -73.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.735 1.272 . . . . 0.0 109.423 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.705 ' O ' ' OG ' ' A' ' 139' ' ' SER . . . -39.95 -52.47 2.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.473 1.108 . . . . 0.0 110.373 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 1.017 ' OD2' ' HB3' ' A' ' 132' ' ' MET . 49.1 m-20 -60.8 -66.64 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.821 1.325 . . . . 0.0 108.382 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.992 ' O ' HG12 ' A' ' 141' ' ' VAL . 24.8 ttmm -34.49 -49.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.607 1.192 . . . . 0.0 110.363 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.264 ' O ' HG23 ' A' ' 141' ' ' VAL . 49.6 mt -60.31 -55.47 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 124.755 1.285 . . . . 0.0 107.909 168.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.919 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . 39.0 m -64.42 0.68 0.96 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.774 -1.557 . . . . 0.0 114.828 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.805 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 3.7 mp0 -107.03 -44.87 4.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.345 1.028 . . . . 0.0 109.017 173.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.264 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.3 m -40.07 127.97 1.64 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.287 0.992 . . . . 0.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.9 Cg_exo -37.57 177.13 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.355 2.703 . . . . 0.0 113.418 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.35 HG21 ' CA ' ' A' ' 153' ' ' PRO . 10.1 p -160.83 -151.18 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.56 1.648 . . . . 0.0 112.74 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.727 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 178.38 165.26 0.78 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 110.03 -3.259 . . . . 0.0 111.488 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.658 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 46.4 t0 -52.14 -150.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.501 166.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.873 HG23 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -161.16 -142.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -67.05 -102.97 0.02 OUTLIER Glycine 0 N--CA 1.471 0.991 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 166.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.709 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 86.4 Cg_endo -77.5 -53.91 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.919 3.079 . . . . 0.0 109.917 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.77 ' O ' HG21 ' A' ' 146' ' ' VAL . 61.7 m-85 -69.25 122.44 18.86 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.587 1.179 . . . . 0.0 111.604 -172.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 29.5 mm-40 -74.48 -176.66 2.81 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.063 170.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.615 ' O ' HG22 ' A' ' 152' ' ' VAL . 10.6 m120 48.73 86.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.716 175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.873 ' HB ' HG23 ' A' ' 146' ' ' VAL . 88.1 t -161.94 105.28 1.15 Allowed Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.337 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.35 ' CA ' HG21 ' A' ' 143' ' ' THR . 85.9 Cg_exo -45.12 139.83 8.12 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.409 2.739 . . . . 0.0 112.119 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.11 ' N ' ' HA ' ' A' ' 143' ' ' THR . 80.2 p -73.74 44.64 0.17 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.604 174.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.64 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 17.2 tppt? -178.51 72.71 0.21 Allowed Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 155' ' ' LYS . 80.9 Cg_exo -46.37 108.38 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.73 2.953 . . . . 0.0 112.362 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.563 HG12 ' OG ' ' A' ' 12' ' ' SER . 89.3 t -68.98 154.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.505 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.877 ' HA ' HG21 ' A' ' 45' ' ' THR . 76.7 t -141.45 118.03 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.997 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.04 HD13 ' HG1' ' A' ' 44' ' ' THR . 35.3 mt -69.06 135.38 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.035 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 1.294 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.8 mt -85.22 -49.16 8.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.701 -2.045 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 1.153 ' O ' HD21 ' A' ' 9' ' ' LEU . 34.7 t -170.46 161.04 7.75 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.434 1.084 . . . . 0.0 112.245 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 1.006 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -137.53 61.08 1.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.534 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 1.116 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 47.9 mmtm -69.92 93.15 0.75 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.49 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.99 ' HA ' ' O ' ' A' ' 6' ' ' HIS . 34.6 m -71.54 132.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.42 1.075 . . . . 0.0 110.383 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 1.039 HD21 ' HB2' ' A' ' 6' ' ' HIS . 3.3 mm? -78.23 121.97 84.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.359 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' A' ' 165' ' ' LEU . 66.9 Cg_endo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 123.583 2.855 . . . . 0.0 109.752 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -46.51 153.97 0.33 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.819 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.76 -129.04 1.15 Allowed Glycine 0 N--CA 1.474 1.209 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.959 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.1 ' O ' ' NE2' ' A' ' 6' ' ' HIS . 2.3 m-20 -46.65 152.09 0.96 Allowed Pre-proline 0 N--CA 1.473 0.705 0 CA-C-N 114.425 -0.887 . . . . 0.0 111.873 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.439 ' C ' ' HD2' ' A' ' 6' ' ' HIS . 80.8 Cg_exo -41.38 173.49 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.631 2.887 . . . . 0.0 113.864 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.439 ' HD2' ' C ' ' A' ' 5' ' ' PRO . 8.0 m170 -153.16 121.97 6.45 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.732 -176.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.036 HG11 ' HB2' ' A' ' 18' ' ' LEU . 7.9 p -73.79 116.74 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.427 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.795 ' HG ' ' CD ' ' A' ' 17' ' ' GLU . 6.5 mp -79.81 151.09 30.48 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.359 1.076 . . . . 0.0 110.748 169.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.157 ' O ' HG12 ' A' ' 16' ' ' ILE . 6.9 mt -160.59 96.54 1.16 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.559 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 1.218 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.0 m -88.14 79.98 7.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.637 -2.528 . . . . 0.0 107.969 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 1.038 HG21 HG12 ' A' ' 159' ' ' ILE . 37.0 p -73.24 169.72 16.48 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 125.018 1.449 . . . . 0.0 111.516 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.997 ' HG ' ' HA ' ' A' ' 157' ' ' VAL . 80.0 p -39.71 -46.24 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.746 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -60.37 -54.83 40.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.462 1.101 . . . . 0.0 110.623 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.01 173.76 39.65 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 113.767 -1.561 . . . . 0.0 113.597 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.888 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 5.5 t-20 -61.82 143.54 56.16 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.451 -1.374 . . . . 0.0 110.868 175.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 1.157 HG12 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -144.2 -178.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.982 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.915 ' HG2' ' O ' ' A' ' 130' ' ' LYS . 6.9 mm-40 -160.13 101.88 1.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.92 -165.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.036 ' HB2' HG11 ' A' ' 7' ' ' VAL . 2.4 mm? -85.0 161.03 19.91 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.297 0.998 . . . . 0.0 110.409 164.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.206 ' OE1' ' CD ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -127.27 110.84 13.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.529 173.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.86 HD11 ' CD2' ' A' ' 125' ' ' PHE . 3.0 mm? -79.37 -170.9 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.826 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -164.69 87.05 0.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.011 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.039 ' HA ' HG13 ' A' ' 29' ' ' VAL . 19.8 ptpt -59.16 -34.62 72.32 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.842 1.339 . . . . 0.0 112.303 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 11.3 tp-100 -41.07 -64.36 0.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.206 0.941 . . . . 0.0 110.69 -172.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 73.1 mmtt -69.97 -5.43 26.2 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.792 1.308 . . . . 0.0 113.896 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.837 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -160.18 71.59 3.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 O-C-N 123.818 0.699 . . . . 0.0 109.449 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 1.275 ' O ' HG23 ' A' ' 29' ' ' VAL . 57.5 Cg_exo -54.2 -64.69 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.667 2.912 . . . . 0.0 111.109 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 28' ' ' SER . 15.6 m -50.1 -62.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 124.734 1.271 . . . . 0.0 110.368 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.809 ' H ' HG22 ' A' ' 27' ' ' VAL . 42.1 t -41.82 -56.39 2.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.445 1.09 . . . . 0.0 110.466 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.275 HG23 ' O ' ' A' ' 26' ' ' PRO . 34.6 m -48.82 -45.07 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 124.734 1.272 . . . . 0.0 110.554 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 23.3 tp60 -45.7 -62.26 1.37 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.241 0.963 . . . . 0.0 109.551 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 1.021 ' OD1' HG23 ' A' ' 73' ' ' ILE . 11.0 m120 -47.35 -60.85 2.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.701 1.251 . . . . 0.0 109.497 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.531 ' HE1' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 t80 -43.24 -62.75 0.96 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.353 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 29' ' ' VAL . 61.3 t -49.26 -33.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 124.78 1.3 . . . . 0.0 111.452 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.935 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 55.2 m-20 -45.86 -63.68 0.92 Allowed 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.916 0.76 . . . . 0.0 109.771 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.738 ' CB ' ' HD1' ' A' ' 40' ' ' PHE . 19.7 m-85 -58.76 -61.89 2.28 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.826 1.329 . . . . 0.0 108.577 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.012 ' HA ' ' HB2' ' A' ' 40' ' ' PHE . 62.6 t -42.53 -53.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.308 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.0 t-20 -39.99 -33.58 0.23 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.713 1.258 . . . . 0.0 111.867 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 35' ' ' TYR . 83.0 p -173.44 136.54 0.6 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.273 0.983 . . . . 0.0 110.578 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.41 43.91 35.6 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.297 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 57.1 t80 -61.38 -96.06 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.838 ' HH ' ' HB3' ' A' ' 101' ' ' SER . 22.3 m-30 -133.12 58.32 1.77 Allowed 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.149 0.905 . . . . 0.0 109.04 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 49.1 p-10 -77.92 108.8 11.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 174.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 1.25 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 1.8 t-20 67.46 58.75 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.538 1.148 . . . . 0.0 109.742 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.826 ' HG1' HD13 ' A' ' 159' ' ' ILE . 32.6 p -104.2 -128.85 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.635 169.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.833 ' CA ' HG13 ' A' ' 159' ' ' ILE . 67.2 p -162.35 -176.93 5.36 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.906 0.86 . . . . 0.0 113.077 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.916 ' CE2' HG23 ' A' ' 11' ' ' THR . 7.4 m-30 -126.74 72.41 1.34 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.99 -1.914 . . . . 0.0 106.953 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.9 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 5.5 p-80 -58.27 -71.45 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.015 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.024 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 22.9 mmt85 -69.19 123.85 22.24 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.386 1.054 . . . . 0.0 110.833 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.79 HG23 HG12 ' A' ' 55' ' ' ILE . 90.8 t -162.0 140.05 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.976 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 1.066 HG23 ' HE1' ' A' ' 54' ' ' MET . 10.5 tt -155.17 126.76 3.71 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.101 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' PHE . 97.9 Cg_exo -39.45 168.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 123.555 2.836 . . . . 0.0 113.79 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -4.02 66.86 0.0 OUTLIER Glycine 0 N--CA 1.474 1.196 0 CA-C-N 114.102 -1.408 . . . . 0.0 114.051 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.4 t80 -161.16 -61.15 0.05 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.761 0.918 . . . . 0.0 108.847 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.066 ' HE1' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -170.7 -175.61 1.87 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.494 1.121 . . . . 0.0 111.717 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 174.65 113.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.549 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.024 ' OE1' ' O ' ' A' ' 48' ' ' ARG . 3.5 mp0 -96.8 -174.51 3.02 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.047 -169.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -166.91 178.83 41.02 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.934 165.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 1.012 ' O ' ' HB3' ' A' ' 102' ' ' GLN . . . 61.44 103.99 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 CA-C-N 113.728 -1.236 . . . . 0.0 110.712 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.81 -129.95 1.42 Allowed Glycine 0 N--CA 1.475 1.259 0 O-C-N 124.649 0.852 . . . . 0.0 111.701 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.946 ' CD1' ' HG2' ' A' ' 66' ' ' GLN . 12.6 m-30 -51.23 139.79 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.818 -1.191 . . . . 0.0 111.822 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.993 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 92.4 m -61.09 141.87 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.132 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.712 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.6 pt-20 -28.6 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.981 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 29.7 mt-30 90.58 43.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.804 1.315 . . . . 0.0 110.981 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.593 ' SD ' ' HD2' ' A' ' 60' ' ' PHE . 21.4 mmt 58.1 12.67 1.94 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.029 0.831 . . . . 0.0 113.148 174.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.993 ' O ' ' HB ' ' A' ' 61' ' ' THR . 88.0 mt-30 -79.41 65.22 4.51 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.946 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 30.2 mt-30 -39.45 132.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.181 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 61' ' ' THR . 54.9 mtpt -58.62 -109.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.124 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.644 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 61.5 pttt -154.55 66.53 5.22 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.294 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 1.061 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 31.5 Cg_exo -70.51 -151.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.424 2.749 . . . . 0.0 112.588 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.061 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 40.2 p30 67.34 78.65 0.24 Allowed Pre-proline 0 N--CA 1.472 0.627 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.642 169.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.893 ' HB2' ' C ' ' A' ' 72' ' ' PRO . 52.6 Cg_exo -49.53 -60.39 0.87 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.316 2.677 . . . . 0.0 109.438 173.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.893 ' C ' ' HB2' ' A' ' 71' ' ' PRO . 45.2 Cg_exo -89.7 -160.27 1.33 Allowed 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.556 -2.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.131 HD12 ' O ' ' A' ' 99' ' ' ALA . 2.1 pp -161.7 145.1 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.902 0.858 . . . . 0.0 111.822 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -45.32 161.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.225 -1.807 . . . . 0.0 113.809 -172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.759 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 52.5 p-10 -74.68 -160.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.248 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.759 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 10.1 tp10 145.25 130.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.011 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.946 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -162.6 -36.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.291 0.994 . . . . 0.0 112.002 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.764 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 58.6 p30 -67.24 -37.66 83.9 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.104 0.877 . . . . 0.0 111.975 -169.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.764 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 16.7 p-10 45.13 -119.41 0.77 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.112 0.883 . . . . 0.0 109.736 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . 164.6 -55.56 0.27 Allowed Glycine 0 N--CA 1.474 1.173 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 80' ' ' GLY . 46.3 mt -39.64 177.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.692 0.877 . . . . 0.0 112.807 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.731 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 36.9 mmt180 -68.84 149.18 49.24 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.055 168.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.731 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.7 m120 -156.12 129.09 7.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.921 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' ARG . 15.8 m -169.33 157.98 7.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.843 -173.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' THR . 63.0 ttt180 -23.13 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.953 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' A' ' 127' ' ' LYS . . . 143.24 -17.35 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 111.433 -2.621 . . . . 0.0 110.855 -171.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.95 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 34.9 p -106.25 146.08 30.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.286 1.041 . . . . 0.0 112.755 -174.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 1.074 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.27 164.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.075 171.105 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.936 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -161.76 141.23 9.99 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.594 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.906 ' HB3' ' HB2' ' A' ' 123' ' ' ALA . 6.7 ttm -57.27 137.67 55.71 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.061 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 1.062 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . . . -75.6 -59.43 2.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.598 ' HB3' ' CB ' ' A' ' 99' ' ' ALA . 5.3 tpm_? -32.75 169.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.39 1.056 . . . . 0.0 113.844 -172.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.675 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 9.7 t 161.94 162.44 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.634 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.738 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 83.26 130.51 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.491 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 1.365 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 42.3 m-20 101.37 -57.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.454 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.365 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 10.1 mtmp? 139.31 -94.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.821 1.326 . . . . 0.0 108.147 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 96' ' ' LYS . 64.1 t0 -64.24 104.43 0.75 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.817 1.323 . . . . 0.0 109.013 173.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.942 ' OG ' ' HD3' ' A' ' 92' ' ' ARG . 18.2 t -174.13 -179.72 1.72 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.632 1.208 . . . . 0.0 111.814 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 1.598 ' CB ' ' HB3' ' A' ' 92' ' ' ARG . . . 80.33 85.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.844 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 62.9 p -79.72 -40.25 29.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.649 -168.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.838 ' HB3' ' HH ' ' A' ' 41' ' ' TYR . 50.3 m -159.27 -73.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.288 0.993 . . . . 0.0 109.338 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 1.062 ' OE1' ' HB2' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -38.91 163.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.168 -175.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 1.074 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -155.3 -165.28 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.1 -172.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.973 ' CZ ' ' HB3' ' A' ' 122' ' ' TYR . 49.3 p90 -154.85 119.16 4.73 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.757 0.789 . . . . 0.0 111.019 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.027 HD13 HD22 ' A' ' 18' ' ' LEU . 67.1 mt -84.14 110.89 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.453 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.789 ' O ' ' HE3' ' A' ' 132' ' ' MET . 10.7 m120 -61.11 166.79 3.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.372 1.045 . . . . 0.0 111.41 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.686 HG11 ' CE ' ' A' ' 132' ' ' MET . 28.1 m -155.45 42.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.667 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.731 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . 173.6 137.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.379 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -39.55 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.887 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.875 ' OD1' HD13 ' A' ' 113' ' ' LEU . 11.9 t-20 -70.52 -119.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.876 1.36 . . . . 0.0 110.699 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 76.5 -33.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.782 0.677 . . . . 0.0 111.774 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.502 ' H ' ' C ' ' A' ' 110' ' ' ASN . 16.4 m-30 -38.35 -50.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.071 0.857 . . . . 0.0 110.113 -176.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.914 HD12 ' H ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.98 40.62 0.87 Allowed 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.752 1.282 . . . . 0.0 110.729 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' ' O ' ' A' ' 113' ' ' LEU . 39.9 p30 -39.21 -117.38 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.733 0.646 . . . . 0.0 111.602 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.9 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 12.1 m-70 179.34 109.65 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.963 0.789 . . . . 0.0 109.946 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 117' ' ' GLN . . . 173.41 109.76 0.23 Allowed Glycine 0 N--CA 1.474 1.204 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.423 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 1.24 ' O ' ' CG ' ' A' ' 118' ' ' ARG . 71.1 tp60 167.32 -57.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.559 0.8 . . . . 0.0 109.533 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 1.24 ' CG ' ' O ' ' A' ' 117' ' ' GLN . 37.7 mmt180 159.41 61.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.574 1.171 . . . . 0.0 109.375 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 1.069 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 97.4 m-20 -179.99 -55.9 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.337 1.023 . . . . 0.0 110.301 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.642 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 7.0 m-85 81.36 102.23 0.06 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.43 1.081 . . . . 0.0 108.422 -170.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.86 -130.48 0.01 OUTLIER Glycine 0 N--CA 1.471 1.013 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.97 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.973 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 71.1 m-85 -79.5 135.37 36.62 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.958 -1.121 . . . . 0.0 111.344 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.194 ' O ' HG21 ' A' ' 124' ' ' VAL . . . -67.17 -148.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.309 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.194 HG21 ' O ' ' A' ' 123' ' ' ALA . 37.1 t 177.39 133.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.906 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 24.2 p90 -171.32 26.13 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.809 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -166.68 -149.98 6.19 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-O 122.8 1.222 . . . . 0.0 114.084 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.206 ' CD ' ' OE1' ' A' ' 19' ' ' GLU . 29.7 mtpp -169.42 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 111.597 -2.301 . . . . 0.0 110.373 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.557 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 63.3 t -156.13 159.16 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.094 -175.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.766 ' O ' ' CD ' ' A' ' 130' ' ' LYS . 62.4 t -152.54 -43.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.992 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.915 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 32.4 mmmt -167.02 101.46 0.54 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.204 1.002 . . . . 0.0 109.032 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.428 ' O ' ' OD1' ' A' ' 133' ' ' ASP . . . -179.77 141.07 4.53 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.726 0.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.824 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 22.7 mmt -47.86 -26.11 1.55 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.963 -1.118 . . . . 0.0 111.805 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 37.8 p-10 -47.93 -55.09 10.73 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.692 HG12 HG22 ' A' ' 16' ' ' ILE . 51.4 t -62.68 -68.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 124.378 1.049 . . . . 0.0 108.999 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 132' ' ' MET . . . -42.65 -47.15 5.24 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.667 1.229 . . . . 0.0 110.905 -177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 1.033 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 41.4 m-20 -50.47 -71.0 0.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.473 1.108 . . . . 0.0 109.424 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.686 ' O ' HG12 ' A' ' 141' ' ' VAL . 56.8 mtmt -42.97 -43.57 4.23 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.712 1.258 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.01 ' O ' HG23 ' A' ' 141' ' ' VAL . 14.5 mt -58.57 -61.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.707 ' HA ' HG13 ' A' ' 49' ' ' VAL . 84.5 p -68.54 16.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.426 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 1.033 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 60.6 mm-40 -115.36 -47.05 2.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.295 0.997 . . . . 0.0 109.368 176.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.01 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.7 m -47.65 127.92 10.78 Favored Pre-proline 0 N--CA 1.472 0.662 0 O-C-N 124.443 1.089 . . . . 0.0 110.1 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 141' ' ' VAL . 86.2 Cg_exo -38.09 176.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.338 2.692 . . . . 0.0 113.374 175.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.459 HG21 ' CA ' ' A' ' 153' ' ' PRO . 8.5 p -160.83 -150.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.727 1.727 . . . . 0.0 112.932 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.7 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 178.52 165.26 0.81 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 109.725 -3.398 . . . . 0.0 111.035 173.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.72 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 36.7 m-20 -50.86 -148.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.962 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.878 HG21 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -161.28 -148.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.729 0.643 . . . . 0.0 109.282 170.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.408 ' H ' HG11 ' A' ' 146' ' ' VAL . . . -65.31 -100.15 0.02 OUTLIER Glycine 0 N--CA 1.471 0.97 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 168.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.786 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 98.5 Cg_endo -73.49 -61.5 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.788 2.992 . . . . 0.0 109.321 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.878 ' O ' HG21 ' A' ' 146' ' ' VAL . 80.2 m-85 -69.78 120.77 16.04 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.606 1.191 . . . . 0.0 111.373 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.72 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 9.8 mm100 -68.89 -157.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.861 167.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.765 ' O ' HG22 ' A' ' 152' ' ' VAL . 10.7 m120 36.25 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.061 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.833 ' HB ' HG23 ' A' ' 146' ' ' VAL . 70.1 t -164.56 118.89 1.01 Allowed Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.238 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.459 ' CA ' HG21 ' A' ' 143' ' ' THR . 57.2 Cg_endo -66.21 111.97 2.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.646 2.897 . . . . 0.0 109.842 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.029 ' H ' ' HA ' ' A' ' 143' ' ' THR . 69.6 p -42.66 -52.85 4.73 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.743 1.277 . . . . 0.0 109.143 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.24 132.33 93.4 Favored Pre-proline 0 N--CA 1.474 0.742 0 O-C-N 124.572 1.17 . . . . 0.0 109.503 170.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.38 161.04 43.55 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 C-N-CA 123.658 2.905 . . . . 0.0 113.436 -172.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.997 ' HA ' ' HG ' ' A' ' 12' ' ' SER . 55.5 t -151.18 95.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.571 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.589 ' HA ' HG21 ' A' ' 45' ' ' THR . 91.8 t -88.58 121.24 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.711 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.25 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 11.0 mt -68.93 125.36 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.906 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 1.218 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -79.82 -51.26 9.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.212 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.798 ' O ' HD21 ' A' ' 9' ' ' LEU . 56.0 m -158.58 177.35 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.694 1.246 . . . . 0.0 112.206 -176.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.885 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -170.63 119.8 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.098 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.414 ' O ' HD12 ' A' ' 8' ' ' LEU . 21.4 ptmt -170.75 131.37 0.86 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.302 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 36' ' ' VAL . 35.9 m -69.01 142.33 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.9 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.979 HD11 ' HD2' ' A' ' 166' ' ' PRO . 58.6 tp -58.35 123.4 65.86 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.979 ' HD2' HD11 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.583 2.856 . . . . 0.0 112.12 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.88 ' O ' ' HB2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.88 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER 140.89 41.81 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.702 1.251 . . . . 0.0 110.566 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 1.273 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 157.5 127.86 1.0 Allowed Glycine 0 N--CA 1.476 1.334 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.273 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 52.4 m-20 -165.43 102.49 0.76 Allowed Pre-proline 0 N--CA 1.475 0.775 0 O-C-N 124.492 0.76 . . . . 0.0 109.301 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.4 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 86.7 Cg_exo -45.04 179.0 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.639 2.893 . . . . 0.0 113.942 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.4 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 22.1 m170 -154.55 117.75 4.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.148 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.089 HG23 ' HB2' ' A' ' 18' ' ' LEU . 30.2 m -71.76 109.19 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 124.387 1.054 . . . . 0.0 109.184 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.245 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 7.3 mp -79.26 131.08 36.05 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.383 1.052 . . . . 0.0 110.285 177.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.054 ' O ' HG12 ' A' ' 16' ' ' ILE . 8.6 mp -138.45 96.76 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.333 173.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 1.184 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 95.3 m -86.2 81.98 8.21 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.768 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 1.008 HG21 HG12 ' A' ' 159' ' ' ILE . 33.5 p -72.91 167.6 20.66 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.931 1.394 . . . . 0.0 111.41 174.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -39.49 -43.78 1.31 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.358 -1.747 . . . . 0.0 110.61 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.819 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -53.9 -61.94 1.98 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.471 1.107 . . . . 0.0 110.228 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.34 177.64 46.38 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 113.151 -1.84 . . . . 0.0 113.365 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.787 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 1.2 t-20 -77.82 89.46 4.05 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.684 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 1.054 HG12 ' O ' ' A' ' 9' ' ' LEU . 7.0 pt -77.9 175.01 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.308 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.928 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 6.2 mm-40 -159.73 100.08 1.43 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.4 -168.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.089 ' HB2' HG23 ' A' ' 7' ' ' VAL . 2.6 mm? -80.97 164.3 22.66 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.398 1.061 . . . . 0.0 110.712 166.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.964 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 40.0 tt0 -130.19 129.83 43.92 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.475 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 1.079 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.6 mp -117.53 116.56 27.37 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.964 1.415 . . . . 0.0 109.726 -169.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.37 104.9 2.84 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.314 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.698 ' HA ' HG13 ' A' ' 29' ' ' VAL . 3.9 ttmp? -69.0 -45.79 69.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.663 1.227 . . . . 0.0 111.542 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 25' ' ' ALA . 49.0 tt0 -47.77 -70.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.333 1.02 . . . . 0.0 110.256 -171.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 1.278 ' NZ ' HD22 ' A' ' 81' ' ' LEU . 61.6 mttp -71.94 13.1 0.32 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.77 1.294 . . . . 0.0 114.016 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.674 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -160.63 68.7 2.69 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 124.034 0.834 . . . . 0.0 109.486 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.879 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.6 Cg_exo -60.73 -63.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.475 2.784 . . . . 0.0 111.061 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.0 t -54.96 -62.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.137 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 t -42.2 -58.49 2.13 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.643 1.214 . . . . 0.0 110.472 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 26' ' ' PRO . 32.2 m -51.75 -46.97 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 124.735 1.272 . . . . 0.0 110.622 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.493 ' N ' HG21 ' A' ' 29' ' ' VAL . 1.2 tm0? -48.58 -69.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.239 0.962 . . . . 0.0 108.949 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 1.325 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 12.7 m-80 -45.08 -51.71 9.88 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.557 1.161 . . . . 0.0 109.75 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.67 ' O ' HG21 ' A' ' 36' ' ' VAL . 77.4 t80 -42.54 -59.65 1.81 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.598 1.186 . . . . 0.0 109.646 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.704 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.9 t -47.44 -37.3 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.707 1.254 . . . . 0.0 111.101 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 1.325 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 15.3 m-20 -43.84 -62.6 1.06 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.012 0.82 . . . . 0.0 109.381 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -61.27 -59.37 5.41 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.152 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.942 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 59.5 t -39.4 -48.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.976 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.811 ' O ' ' HB3' ' A' ' 38' ' ' SER . 1.9 t-20 -38.42 -32.38 0.07 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.779 1.299 . . . . 0.0 112.015 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.811 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.2 p 149.32 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.138 0.899 . . . . 0.0 113.005 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.6 -42.46 3.12 Favored Glycine 0 N--CA 1.474 1.198 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.356 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.643 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 28.4 t80 -67.11 -74.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.527 0.78 . . . . 0.0 109.888 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.942 ' CE2' ' HA ' ' A' ' 36' ' ' VAL . 79.9 m-85 -61.69 -29.49 70.12 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.513 1.133 . . . . 0.0 112.628 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -38.6 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.011 0.819 . . . . 0.0 111.312 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 1.15 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.5 m-20 44.24 47.81 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.265 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.82 ' O ' HG22 ' A' ' 45' ' ' THR . 28.6 m -78.59 -123.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 1.022 ' HA ' HG13 ' A' ' 159' ' ' ILE . 46.1 p -165.02 -143.8 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.254 1.026 . . . . 0.0 112.493 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.691 ' CD2' HG23 ' A' ' 11' ' ' THR . 65.4 m-85 -159.63 66.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.5 -2.137 . . . . 0.0 106.834 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.898 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 1.4 p-80 -51.72 -68.98 0.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.191 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.898 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.2 mtt180 -69.68 124.07 23.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.51 1.131 . . . . 0.0 110.296 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.658 ' O ' HG21 ' A' ' 49' ' ' VAL . 34.4 m -158.21 94.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 124.74 1.275 . . . . 0.0 109.374 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.908 HG23 ' HD2' ' A' ' 53' ' ' PHE . 57.2 mt -77.27 123.75 87.04 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.334 175.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 53' ' ' PHE . 82.4 Cg_exo -37.65 144.02 0.16 Allowed 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.271 2.647 . . . . 0.0 112.525 174.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.23 55.53 0.01 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.651 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.908 ' HD2' HG23 ' A' ' 50' ' ' ILE . 1.6 t80 -144.33 -63.1 0.37 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.778 0.929 . . . . 0.0 109.05 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.721 ' HE3' ' CE2' ' A' ' 53' ' ' PHE . 27.2 ptt? -179.56 114.91 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.386 1.054 . . . . 0.0 111.102 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.85 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 30.7 pt -84.73 160.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.791 165.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.784 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 20.0 mt-30 -156.58 162.35 39.9 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.804 0.69 . . . . 0.0 111.781 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.79 -154.07 7.05 Favored Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.272 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.666 ' O ' ' HG2' ' A' ' 102' ' ' GLN . . . 65.85 73.88 0.57 Allowed Glycine 0 N--CA 1.47 0.952 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 1.241 ' HA2' ' CD ' ' A' ' 67' ' ' LYS . . . -179.83 -122.83 0.8 Allowed Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.53 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 68.5 m-85 -45.18 132.91 7.12 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.622 0.836 . . . . 0.0 110.499 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.798 ' HA ' HG21 ' A' ' 44' ' ' THR . 88.6 m -59.2 -57.91 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.214 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.753 ' HG2' HG23 ' A' ' 45' ' ' THR . 0.1 OUTLIER -168.46 -75.7 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.614 1.196 . . . . 0.0 108.064 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -72.93 46.81 0.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.5 1.125 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.977 ' HE1' HG22 ' A' ' 152' ' ' VAL . 53.9 mtt 39.44 36.69 0.23 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.121 0.888 . . . . 0.0 111.961 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -78.14 87.46 4.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -30.69 147.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.69 -1.595 . . . . 0.0 113.418 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 1.241 ' CD ' ' HA2' ' A' ' 59' ' ' GLY . 47.4 mtmt -56.53 -131.12 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 112.849 -1.978 . . . . 0.0 112.393 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 1.134 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 46.6 mmtm 179.27 79.66 0.17 Allowed Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 112.641 -2.072 . . . . 0.0 106.363 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.812 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 47.8 Cg_endo -71.89 -165.88 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.606 2.871 . . . . 0.0 113.345 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.011 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 91.4 m-20 -166.54 170.76 5.19 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 113.237 -1.801 . . . . 0.0 109.923 -172.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 1.011 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 32.9 Cg_endo -45.44 104.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.606 2.204 . . . . 0.0 109.184 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.5 Cg_exo -44.58 -146.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.818 3.012 . . . . 0.0 113.603 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 99' ' ' ALA . 27.4 pt -160.18 141.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 124.387 1.054 . . . . 0.0 110.476 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -36.44 159.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.749 -1.569 . . . . 0.0 113.322 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 1.338 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 8.2 t-20 -43.12 169.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.285 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 1.338 ' HG2' ' O ' ' A' ' 75' ' ' ASN . 11.4 mm-40 172.98 128.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.478 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 1.426 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . . . 174.12 -40.28 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.976 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 52.9 p-10 -67.22 -43.71 81.36 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.299 0.999 . . . . 0.0 110.649 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 22.2 p30 -51.86 132.35 31.73 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.114 0.884 . . . . 0.0 110.325 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.606 ' H ' HD13 ' A' ' 81' ' ' LEU . . . -171.78 -62.11 0.04 OUTLIER Glycine 0 N--CA 1.474 1.199 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 1.278 HD22 ' NZ ' ' A' ' 24' ' ' LYS . 6.2 mp 81.6 -32.25 0.1 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.632 0.843 . . . . 0.0 112.444 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.624 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 16.4 ptp180 178.89 73.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.645 1.216 . . . . 0.0 110.211 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.615 HD21 ' HB3' ' A' ' 110' ' ' ASN . 1.2 p-10 -72.68 142.88 48.25 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.869 1.356 . . . . 0.0 111.204 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 m -169.28 148.04 3.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.419 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.729 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 51.6 ptt85 -42.03 101.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.05 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.782 ' O ' HG21 ' A' ' 128' ' ' VAL . . . 144.19 -29.04 1.94 Allowed Glycine 0 N--CA 1.473 1.107 0 CA-C-N 111.934 -2.393 . . . . 0.0 109.899 -169.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 20.5 p -83.56 129.85 34.98 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.716 0.77 . . . . 0.0 111.225 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 1.476 HG22 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -84.26 156.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.793 166.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.092 ' O ' ' CD2' ' A' ' 104' ' ' PHE . . . -165.31 128.69 2.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.659 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.801 ' HG3' ' H ' ' A' ' 91' ' ' ALA . 32.7 ttm -59.38 173.9 0.47 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.196 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.801 ' H ' ' HG3' ' A' ' 90' ' ' MET . . . -167.57 164.14 14.68 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.507 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.887 ' CG ' ' HA ' ' A' ' 99' ' ' ALA . 2.4 mmm-85 179.65 119.08 0.05 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.486 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 93.4 m -40.47 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.532 1.145 . . . . 0.0 110.438 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 93' ' ' THR . . . 71.39 -67.9 0.24 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.858 1.349 . . . . 0.0 109.175 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.787 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 59.3 m-20 66.13 -84.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.705 1.253 . . . . 0.0 110.109 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 95' ' ' ASP . 87.4 tttt 95.02 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.865 1.353 . . . . 0.0 109.213 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -165.88 81.16 0.3 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.625 ' HA ' ' HB3' ' A' ' 72' ' ' PRO . 66.3 m -163.06 -116.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.781 1.301 . . . . 0.0 110.565 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.887 ' HA ' ' CG ' ' A' ' 92' ' ' ARG . . . 54.27 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.644 1.215 . . . . 0.0 107.751 -169.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -77.71 -35.02 52.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.01 -170.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.453 ' C ' ' HE3' ' A' ' 90' ' ' MET . 80.7 p -170.31 -40.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.273 0.983 . . . . 0.0 110.14 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.747 ' CD ' ' HZ1' ' A' ' 67' ' ' LYS . 29.4 mt-30 -35.62 130.46 0.55 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.275 0.984 . . . . 0.0 111.308 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 1.046 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.32 178.87 7.44 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.793 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.092 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 49.1 p90 -153.2 122.63 6.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.052 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.965 HD13 HD22 ' A' ' 18' ' ' LEU . 59.4 mt -91.01 101.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.218 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.547 ' O ' HG12 ' A' ' 107' ' ' VAL . 18.1 p-10 -68.62 -173.04 0.41 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.354 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.741 HG23 ' C ' ' A' ' 53' ' ' PHE . 34.2 m -160.04 -42.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.623 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.729 ' CA ' ' HB3' ' A' ' 85' ' ' ARG . . . -74.25 139.71 44.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 124.373 1.046 . . . . 0.0 111.167 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -42.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.954 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.683 ' OD1' HD21 ' A' ' 113' ' ' LEU . 2.7 t30 -68.29 142.93 55.41 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.864 1.352 . . . . 0.0 111.026 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 110' ' ' ASN . . . 168.42 -51.21 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.922 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.762 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 47.5 p90 -66.44 60.65 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.611 1.195 . . . . 0.0 108.109 168.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.995 HD13 ' CD2' ' A' ' 122' ' ' TYR . 59.3 tp 178.31 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.807 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -38.08 125.7 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.821 0.701 . . . . 0.0 111.137 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 1.426 ' CD2' ' HB3' ' A' ' 77' ' ' ALA . 2.0 m-70 -42.92 108.67 0.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.379 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -34.23 -79.18 0.03 OUTLIER Glycine 0 N--CA 1.471 1.026 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.288 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.862 ' OE1' ' NH1' ' A' ' 118' ' ' ARG . 64.4 tt0 177.54 -64.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.677 0.869 . . . . 0.0 108.811 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.862 ' NH1' ' OE1' ' A' ' 117' ' ' GLN . 0.0 OUTLIER -52.2 -100.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.545 1.153 . . . . 0.0 108.75 178.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.76 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 64.0 t0 -64.73 -56.99 10.19 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.83 1.331 . . . . 0.0 110.082 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.127 ' HZ ' ' OD1' ' A' ' 75' ' ' ASN . 21.4 p90 57.28 108.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.763 1.29 . . . . 0.0 109.255 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.51 -80.78 0.44 Allowed Glycine 0 N--CA 1.471 0.994 0 CA-C-N 113.638 -1.619 . . . . 0.0 113.734 -167.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 1.328 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 59.6 m-85 -76.98 130.45 37.5 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.46 0.741 . . . . 0.0 111.837 -161.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.031 ' O ' HG22 ' A' ' 124' ' ' VAL . . . -67.37 -158.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.995 174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.032 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 62.7 t 179.48 131.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.312 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 1.079 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.1 p90 -170.79 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.007 0.817 . . . . 0.0 111.605 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 1.476 ' CA ' HG22 ' A' ' 88' ' ' ILE . . . -138.35 173.85 22.28 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.194 1.441 . . . . 0.0 113.206 -171.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' H ' ' CG2' ' A' ' 88' ' ' ILE . 59.3 tttp 179.7 121.33 0.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 110.888 -2.656 . . . . 0.0 110.207 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.782 HG21 ' O ' ' A' ' 86' ' ' GLY . 59.2 t -58.94 156.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.302 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 1.117 HG22 ' ND1' ' A' ' 6' ' ' HIS . 57.3 t -130.7 -46.99 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.277 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.673 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER 172.59 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.118 0.886 . . . . 0.0 109.648 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' A' ' 128' ' ' VAL . . . 144.99 -147.46 18.64 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 119.778 -1.201 . . . . 0.0 112.426 -4.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.99 ' HG3' ' OD1' ' A' ' 136' ' ' ASP . 6.0 tpt -60.24 -31.15 69.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.939 -1.63 . . . . 0.0 111.878 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 63.7 t0 -47.49 -68.65 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.995 0.809 . . . . 0.0 109.531 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.825 ' HB ' HG21 ' A' ' 16' ' ' ILE . 78.3 t -49.78 -60.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.757 1.286 . . . . 0.0 109.296 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.85 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . . . -44.6 -51.81 8.69 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.567 1.167 . . . . 0.0 110.05 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.99 ' OD1' ' HG3' ' A' ' 132' ' ' MET . 36.4 m-20 -51.86 -70.34 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.683 1.239 . . . . 0.0 109.255 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.536 ' N ' ' OE1' ' A' ' 140' ' ' GLN . 30.5 mtpp -38.6 -44.6 0.99 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.658 1.224 . . . . 0.0 110.708 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.332 ' O ' HG23 ' A' ' 141' ' ' VAL . 30.8 mt -55.61 -58.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 124.374 1.046 . . . . 0.0 108.367 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 136' ' ' ASP . 82.2 p -62.6 2.75 0.25 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.709 1.256 . . . . 0.0 114.129 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.872 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.0 mp0 -96.99 -50.09 4.76 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.289 0.993 . . . . 0.0 108.587 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.332 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.2 m -39.93 124.83 1.6 Allowed Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 124.435 1.084 . . . . 0.0 110.652 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 141' ' ' VAL . 83.6 Cg_exo -40.84 178.81 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.469 2.779 . . . . 0.0 113.748 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.214 HG21 ' CA ' ' A' ' 153' ' ' PRO . 6.7 p -161.02 -145.26 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.87 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.92 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER 179.13 142.45 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.672 -2.967 . . . . 0.0 111.789 170.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 1.15 ' OD1' ' HG2' ' A' ' 150' ' ' GLN . 61.0 t0 -69.74 111.09 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.801 168.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.819 HG23 ' CG2' ' A' ' 152' ' ' VAL . 2.3 t -78.97 -147.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.115 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.78 ' H ' HG11 ' A' ' 146' ' ' VAL . . . -61.64 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.47 0.911 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 171.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.822 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 95.8 Cg_endo -71.32 -55.78 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.697 2.931 . . . . 0.0 109.508 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.822 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 84.0 m-85 -69.2 102.94 1.8 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.632 1.207 . . . . 0.0 110.103 -176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 1.171 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 31.9 mt-30 -86.43 55.41 3.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.065 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 1.171 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 75.1 m-20 -172.8 82.74 0.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.977 HG22 ' HE1' ' A' ' 64' ' ' MET . 62.9 t -156.04 102.04 2.11 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 124.405 1.065 . . . . 0.0 108.773 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.214 ' CA ' HG21 ' A' ' 143' ' ' THR . 75.7 Cg_exo -46.93 99.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 123.436 2.757 . . . . 0.0 110.268 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.194 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.6 t -34.87 -52.93 0.55 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.467 1.104 . . . . 0.0 109.861 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 32.3 mmmt -84.64 85.98 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 164.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.194 ' HD3' ' O ' ' A' ' 154' ' ' SER . 63.1 Cg_endo -79.0 140.78 16.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.606 2.871 . . . . 0.0 112.399 -168.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 138' ' ' ILE . 92.2 t -68.72 155.07 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.534 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 1.014 ' HA ' HG21 ' A' ' 45' ' ' THR . 98.1 t -142.98 119.44 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.374 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.15 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 32.3 mt -68.36 133.63 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.345 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 1.184 ' HB2' ' O ' ' A' ' 10' ' ' THR . 86.1 mt -76.36 -52.45 9.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.511 -2.131 . . . . 0.0 108.995 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 65.7 m -163.39 -166.11 1.18 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.671 1.232 . . . . 0.0 111.848 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 1.245 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . 179.07 119.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.347 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.71 ' O ' HD12 ' A' ' 8' ' ' LEU . 65.6 mttm -163.64 126.24 2.55 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.013 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.889 HG12 HG13 ' A' ' 36' ' ' VAL . 33.9 m -67.83 140.27 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.358 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 1.027 HD11 ' HD2' ' A' ' 166' ' ' PRO . 56.5 tp -157.98 121.03 2.1 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.991 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 1.027 ' HD2' HD11 ' A' ' 165' ' ' LEU . 88.3 Cg_exo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.646 2.897 . . . . 0.0 112.062 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.751 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 24.9 ttmm 89.71 -111.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.709 1.256 . . . . 0.0 110.44 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 1.224 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . -174.8 -118.03 0.5 Allowed Glycine 0 N--CA 1.475 1.248 0 O-C-N 124.554 1.159 . . . . 0.0 110.986 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.224 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 71.4 m-20 -167.29 130.08 1.38 Allowed Pre-proline 0 N--CA 1.476 0.871 0 O-C-N 124.506 0.768 . . . . 0.0 110.274 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.332 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 88.3 Cg_exo -50.35 154.78 5.59 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.86 3.04 . . . . 0.0 114.298 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.332 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 28.4 m170 -152.37 118.07 5.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.385 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.924 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.3 p -66.93 141.8 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.518 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.876 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 6.9 mp -121.11 132.53 54.92 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.424 1.078 . . . . 0.0 110.314 164.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.774 HD11 ' C ' ' A' ' 8' ' ' LEU . 8.2 mp -126.93 -177.38 4.01 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 111.929 -2.396 . . . . 0.0 109.16 164.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.865 HG23 HD11 ' A' ' 160' ' ' LEU . 99.9 m -160.61 90.29 0.86 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.844 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 1.015 HG23 HG12 ' A' ' 159' ' ' ILE . 34.8 p -78.05 169.6 18.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.398 1.686 . . . . 0.0 111.216 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -39.77 -42.98 1.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.536 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.81 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -58.22 -59.83 4.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.526 1.141 . . . . 0.0 110.572 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.59 178.51 41.36 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 113.529 -1.669 . . . . 0.0 114.201 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.796 ' O ' HG22 ' A' ' 16' ' ' ILE . 63.0 t-20 -61.67 153.83 27.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.08 -1.56 . . . . 0.0 111.063 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 1.113 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 16.0 pt -164.34 168.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.455 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.113 ' OE1' ' O ' ' A' ' 16' ' ' ILE . 4.3 mm-40 -145.61 113.56 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.473 -1.694 . . . . 0.0 112.059 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.057 HD22 HD12 ' A' ' 105' ' ' ILE . 2.7 mm? -94.71 147.03 23.74 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 124.481 1.113 . . . . 0.0 110.075 165.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.389 ' OE2' ' CB ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -109.56 112.01 23.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.203 171.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.912 HD21 ' HE2' ' A' ' 125' ' ' PHE . 6.4 mp -84.33 -158.97 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.541 -170.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.818 ' OD1' ' HG3' ' A' ' 23' ' ' GLN . 61.6 t0 -175.39 110.03 0.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.118 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.694 ' HA ' HG23 ' A' ' 29' ' ' VAL . 28.5 ttpp -96.98 -35.8 10.74 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.928 1.393 . . . . 0.0 111.954 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.868 ' OE1' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -42.46 -33.68 0.71 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.179 0.925 . . . . 0.0 112.306 -171.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.868 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 17.9 tppt? -108.01 10.68 28.23 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.283 0.989 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 1.0 ' O ' HG22 ' A' ' 29' ' ' VAL . . . -161.04 68.84 2.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 O-C-N 123.69 0.619 . . . . 0.0 110.162 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.6 Cg_exo -58.48 -58.46 0.73 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.57 2.847 . . . . 0.0 111.264 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 71.0 t -54.32 -69.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.835 1.334 . . . . 0.0 110.165 -175.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.526 ' OG ' ' HB3' ' A' ' 25' ' ' ALA . 72.7 p -47.5 -54.92 10.24 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.727 1.267 . . . . 0.0 110.95 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.019 ' O ' ' HB3' ' A' ' 32' ' ' PHE . 11.6 t -55.81 -45.27 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.375 1.047 . . . . 0.0 110.283 -175.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 66.5 tp60 -45.02 -63.27 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.236 0.96 . . . . 0.0 109.646 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 1.037 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 m-80 -42.98 -48.13 5.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.61 1.194 . . . . 0.0 110.058 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 1.019 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 15.6 t80 -39.75 -69.46 0.13 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.527 1.142 . . . . 0.0 109.967 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.707 HG11 ' ND2' ' A' ' 37' ' ' ASN . 48.9 t -43.96 -39.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.722 1.264 . . . . 0.0 111.201 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 1.037 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 16.6 m-20 -44.04 -62.26 1.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.148 0.905 . . . . 0.0 109.914 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 38' ' ' SER . 98.1 m-85 -57.48 -56.23 24.6 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.877 1.361 . . . . 0.0 109.364 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.846 ' HA ' ' HE2' ' A' ' 41' ' ' TYR . 96.0 t -42.97 -63.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 124.555 1.159 . . . . 0.0 109.279 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.707 ' ND2' HG11 ' A' ' 33' ' ' VAL . 22.0 m-20 -48.23 -49.75 32.04 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.796 1.31 . . . . 0.0 110.069 176.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 56.4 m -56.08 -117.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.543 1.152 . . . . 0.0 111.03 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.53 76.28 0.1 Allowed Glycine 0 N--CA 1.473 1.151 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.662 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 17.5 t80 -110.67 -56.54 2.34 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.914 -173.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.846 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 58.3 m-85 -59.59 -40.23 86.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.063 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.7 p-10 -39.23 113.64 0.34 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.919 . . . . 0.0 111.449 -173.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 10.7 t30 58.03 35.76 25.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.313 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.707 ' O ' HG22 ' A' ' 45' ' ' THR . 72.8 p -79.45 -146.01 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.194 0.934 . . . . 0.0 108.684 163.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 1.051 HG21 ' HA ' ' A' ' 158' ' ' VAL . 72.7 p -163.6 -154.1 0.26 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.742 0.782 . . . . 0.0 112.268 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.876 ' CE1' HD12 ' A' ' 159' ' ' ILE . 6.0 m-30 -134.75 62.08 1.65 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.201 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.875 ' CE1' ' HG2' ' A' ' 48' ' ' ARG . 21.4 p-80 -53.62 -49.53 67.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.407 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.875 ' HG2' ' CE1' ' A' ' 47' ' ' HIS . 24.8 mmm180 -68.28 107.38 2.79 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.53 1.144 . . . . 0.0 109.325 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.662 HG21 ' O ' ' A' ' 46' ' ' PHE . 90.9 t -152.01 135.03 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 124.663 1.227 . . . . 0.0 110.308 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 1.119 HD11 ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -146.91 120.28 4.99 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.076 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' PHE . 85.5 Cg_exo -35.13 152.17 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.589 2.86 . . . . 0.0 113.439 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 1.67 63.91 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 CA-C-N 114.219 -1.355 . . . . 0.0 113.801 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.119 ' HB3' HD11 ' A' ' 50' ' ' ILE . 8.4 t80 -155.32 -42.93 0.08 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.783 0.931 . . . . 0.0 110.897 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.883 ' CG ' ' CG2' ' A' ' 50' ' ' ILE . 22.3 ptt? 176.65 163.28 0.43 Allowed 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.897 0.748 . . . . 0.0 112.026 -176.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.061 HD13 ' HB3' ' A' ' 135' ' ' ALA . 46.5 pt -165.89 129.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.912 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.547 ' CB ' ' HA ' ' A' ' 104' ' ' PHE . 2.6 mm-40 -173.73 -166.09 0.29 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.721 164.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 56' ' ' GLN . . . -177.45 -146.82 6.41 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.306 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.662 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 130.62 -58.83 0.7 Allowed Glycine 0 N--CA 1.475 1.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -45.17 -117.01 0.0 OUTLIER Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.635 0.844 . . . . 0.0 112.194 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.698 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 18.7 m-30 -39.88 128.44 2.11 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.724 0.897 . . . . 0.0 111.062 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 1.042 ' HB ' ' CE ' ' A' ' 67' ' ' LYS . 13.1 t -59.41 -39.4 83.32 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.686 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 1.085 ' OE2' ' HG2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 174.27 121.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.201 0.938 . . . . 0.0 109.427 -174.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 1.329 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.3 mm100 77.45 -61.36 0.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.665 1.228 . . . . 0.0 108.507 -173.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 1.329 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 146.63 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.595 1.184 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.459 ' HG3' ' C ' ' A' ' 64' ' ' MET . 43.7 mt-30 -156.69 79.83 0.94 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 112.087 -2.324 . . . . 0.0 106.561 176.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' GLN . 65.1 mt-30 -25.16 133.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.095 -172.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 1.122 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 6.5 mmpt? -63.71 -117.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.369 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 33.7 mmtp -156.77 74.02 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 CA-C-N 112.92 -1.946 . . . . 0.0 107.997 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 1.149 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 83.8 Cg_exo -48.4 -166.19 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.604 2.869 . . . . 0.0 113.654 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.149 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 80.9 m-20 -171.23 165.57 4.59 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.411 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.822 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 84.8 Cg_exo -39.09 91.31 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.543 2.829 . . . . 0.0 111.422 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.902 ' HG3' ' CG2' ' A' ' 100' ' ' THR . 82.4 Cg_exo -44.38 -150.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.655 2.903 . . . . 0.0 113.043 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.33 168.3 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 124.281 0.988 . . . . 0.0 111.606 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 75' ' ' ASN . 26.8 mtpp -48.44 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 113.336 -1.756 . . . . 0.0 113.157 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.936 ' OD1' ' OD1' ' A' ' 78' ' ' ASP . 10.1 p30 -54.93 -149.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.864 -1.516 . . . . 0.0 111.245 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 1.294 ' OE1' ' HB3' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 173.11 -62.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.853 0.721 . . . . 0.0 109.696 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -36.8 -37.94 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.386 1.053 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.936 ' OD1' ' OD1' ' A' ' 75' ' ' ASN . 9.6 p-10 -68.8 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.13 0.894 . . . . 0.0 113.096 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.59 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 29.5 p30 -52.67 -101.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 161.06 -71.76 0.22 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 81' ' ' LEU . 2.4 pt? -40.66 132.75 2.13 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.878 0.987 . . . . 0.0 111.984 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.858 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 98.3 mtt180 -66.55 168.33 9.37 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.805 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.914 ' HB3' HG23 ' A' ' 87' ' ' THR . 21.9 m120 -167.07 -170.47 1.53 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.581 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.808 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 15.5 m -168.26 159.39 10.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.343 -171.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.808 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 16.6 ptm180 -25.33 99.72 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.776 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 1.042 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 149.27 -24.59 1.24 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 111.346 -2.661 . . . . 0.0 110.261 -171.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 1.035 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.7 p -96.12 136.32 36.73 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.485 0.66 . . . . 0.0 112.049 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 1.185 HD11 ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -90.48 163.16 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.348 168.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.141 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -163.43 144.75 9.37 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.114 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.91 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 17.8 ttm -69.16 137.4 53.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.905 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HA ' ' HE2' ' A' ' 104' ' ' PHE . . . -71.31 -100.71 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.531 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.231 ' O ' HG22 ' A' ' 93' ' ' THR . 17.1 ptm180 179.25 -139.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.902 0.751 . . . . 0.0 110.952 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 1.231 HG22 ' O ' ' A' ' 92' ' ' ARG . 22.5 p 145.82 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.678 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 44.05 -94.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.779 1.3 . . . . 0.0 110.462 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 96' ' ' LYS . 36.0 m-20 -49.53 127.46 15.54 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.196 0.935 . . . . 0.0 110.836 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.888 ' CD ' ' H ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -41.83 -103.85 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.645 175.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.888 ' H ' ' CD ' ' A' ' 96' ' ' LYS . 63.0 m-20 -43.49 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.403 1.064 . . . . 0.0 109.764 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.611 ' HA ' ' HB3' ' A' ' 72' ' ' PRO . 17.2 t -171.74 -113.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.588 1.18 . . . . 0.0 110.407 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.814 ' HB3' ' SD ' ' A' ' 90' ' ' MET . . . 43.74 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.226 0.954 . . . . 0.0 108.797 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.902 ' CG2' ' HG3' ' A' ' 72' ' ' PRO . 66.7 p -78.84 -44.85 22.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.342 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.9 p -170.19 92.29 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.344 1.027 . . . . 0.0 108.709 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.7 tt0 175.17 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 125.018 1.448 . . . . 0.0 109.575 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.895 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -146.74 -179.12 6.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.966 -177.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.547 ' HA ' ' CB ' ' A' ' 56' ' ' GLN . 11.7 p90 -157.32 170.54 22.24 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.346 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.057 HD12 HD22 ' A' ' 18' ' ' LEU . 85.2 mt -127.18 112.67 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 112.915 -1.948 . . . . 0.0 108.95 -170.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.817 ' OD1' ' O ' ' A' ' 87' ' ' THR . 36.0 p-10 -63.42 149.91 44.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.403 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 53' ' ' PHE . 31.4 m -136.3 23.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.801 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -163.91 136.24 5.0 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.763 0.664 . . . . 0.0 110.714 175.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -36.99 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.192 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 1.052 ' OD1' ' HB3' ' A' ' 113' ' ' LEU . 40.1 t30 -69.61 -95.51 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.93 1.394 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 65.08 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.176 0.922 . . . . 0.0 110.419 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.787 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 47.6 p90 -42.25 -39.87 2.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.296 0.998 . . . . 0.0 110.861 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 1.052 ' HB3' ' OD1' ' A' ' 110' ' ' ASN . 64.1 tp -58.68 -38.78 78.98 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.268 0.98 . . . . 0.0 110.504 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 111' ' ' ALA . 65.4 t0 -39.49 130.28 1.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.12 0.887 . . . . 0.0 111.681 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 1.025 ' ND1' ' O ' ' A' ' 120' ' ' PHE . 4.1 t60 -40.72 137.39 1.18 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.151 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.02 -147.9 5.58 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.869 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.61 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 4.4 pt20 -49.23 124.22 8.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.267 -0.967 . . . . 0.0 110.854 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.61 ' HB2' ' O ' ' A' ' 117' ' ' GLN . 75.2 mtp180 82.63 -120.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.481 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 120' ' ' PHE . 75.0 m-20 -46.21 127.27 8.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.676 1.235 . . . . 0.0 110.547 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.025 ' O ' ' ND1' ' A' ' 115' ' ' HIS . 1.0 OUTLIER -45.49 -102.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.98 -176.334 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.837 ' HA3' ' HB2' ' A' ' 115' ' ' HIS . . . 165.56 161.57 14.86 Favored Glycine 0 N--CA 1.479 1.536 0 O-C-N 123.862 0.726 . . . . 0.0 112.606 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 1.013 ' CE1' HD13 ' A' ' 113' ' ' LEU . 89.9 m-85 -78.83 137.11 37.54 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.043 -1.079 . . . . 0.0 110.599 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.294 ' HB3' ' OE1' ' A' ' 76' ' ' GLU . . . -56.1 -170.34 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.132 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.987 HG22 ' O ' ' A' ' 123' ' ' ALA . 70.3 t 178.51 144.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.352 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.912 ' HE2' HD21 ' A' ' 20' ' ' LEU . 2.5 p90 -170.42 25.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.625 ' C ' ' OE2' ' A' ' 19' ' ' GLU . . . -167.9 -139.85 2.78 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.652 1.14 . . . . 0.0 113.822 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.389 ' CB ' ' OE2' ' A' ' 19' ' ' GLU . 39.4 ttpt 179.62 -136.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 111.808 -2.196 . . . . 0.0 109.956 -172.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.088 ' N ' ' HG2' ' A' ' 127' ' ' LYS . 60.5 t -151.43 160.97 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.864 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 31.2 m -146.71 9.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.82 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 132' ' ' MET . 40.8 ttmt 173.1 -89.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.345 0.403 . . . . 0.0 111.86 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.573 ' HA3' HG21 ' A' ' 16' ' ' ILE . . . -51.93 59.87 0.0 OUTLIER Glycine 0 N--CA 1.473 1.127 0 O-C-N 124.572 1.17 . . . . 0.0 114.75 -165.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.707 ' N ' ' O ' ' A' ' 130' ' ' LYS . 4.3 mmt -74.48 -49.73 21.06 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' LYS . 23.3 m-20 -39.72 -54.55 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.181 0.926 . . . . 0.0 109.986 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.631 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 75.0 t -52.24 -64.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.583 1.177 . . . . 0.0 109.249 175.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 1.061 ' HB3' HD13 ' A' ' 55' ' ' ILE . . . -43.78 -53.81 5.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.516 1.135 . . . . 0.0 110.258 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.868 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -58.71 -65.36 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.758 1.286 . . . . 0.0 108.636 179.155 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 1.012 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 2.9 tmtm? -36.86 -48.96 0.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.6 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.233 ' O ' HG23 ' A' ' 141' ' ' VAL . 12.8 mt -58.21 -56.97 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.612 1.195 . . . . 0.0 108.744 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.563 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.7 p -61.79 3.14 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.868 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.1 mp0 -94.78 -51.94 4.49 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.233 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -45.64 126.24 6.42 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.462 1.101 . . . . 0.0 110.283 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.7 Cg_exo -49.92 -178.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.679 2.919 . . . . 0.0 114.673 -176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.204 HG21 ' CA ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -161.07 -139.69 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.69 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.668 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER -178.02 140.66 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.5 -2.136 . . . . 0.0 112.336 168.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 1.07 ' OD1' ' HG3' ' A' ' 150' ' ' GLN . 56.1 t0 -68.74 110.92 4.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 112.383 -2.19 . . . . 0.0 107.791 168.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.903 HG23 ' CG2' ' A' ' 152' ' ' VAL . 2.0 t -78.98 -142.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.737 -169.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.597 ' H ' HG11 ' A' ' 146' ' ' VAL . . . -63.57 -108.79 0.01 OUTLIER Glycine 0 N--CA 1.471 1.02 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 171.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 1.047 ' O ' ' OE1' ' A' ' 150' ' ' GLN . 97.1 Cg_endo -68.5 -50.17 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.593 2.862 . . . . 0.0 109.649 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.606 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 78.0 m-85 -68.68 84.45 0.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.612 1.195 . . . . 0.0 109.688 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 1.07 ' HG3' ' OD1' ' A' ' 145' ' ' ASP . 3.7 mp0 -70.97 66.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.756 175.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.567 ' O ' HG21 ' A' ' 152' ' ' VAL . 50.7 p30 170.51 89.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.61 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.903 ' CG2' HG23 ' A' ' 146' ' ' VAL . 75.0 t -156.24 115.87 2.15 Favored Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 124.392 1.057 . . . . 0.0 109.646 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.204 ' CA ' HG21 ' A' ' 143' ' ' THR . 83.6 Cg_exo -43.97 114.7 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.643 2.895 . . . . 0.0 111.44 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.11 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 88.0 p -41.69 -36.88 1.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.438 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 1.178 ' HB2' ' CD ' ' A' ' 156' ' ' PRO . 30.3 mtpp -175.55 -71.31 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 124.134 0.896 . . . . 0.0 110.115 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.178 ' CD ' ' HB2' ' A' ' 155' ' ' LYS . 98.8 Cg_exo -51.25 72.28 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.702 2.934 . . . . 0.0 113.6 -171.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 1.126 HG21 ' O ' ' A' ' 156' ' ' PRO . 43.3 t -172.07 126.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.9 169.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 1.051 ' HA ' HG21 ' A' ' 45' ' ' THR . 76.7 t -168.87 118.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.015 HG12 HG23 ' A' ' 11' ' ' THR . 25.8 mt -68.1 132.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.766 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.865 HD11 HG23 ' A' ' 10' ' ' THR . 86.2 mt -81.2 -49.18 11.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.158 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 27.7 t -167.6 169.98 11.48 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.553 1.158 . . . . 0.0 111.992 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.852 ' O ' ' HG3' ' A' ' 163' ' ' LYS . . . -152.07 137.18 17.36 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 37.9 mtmm -170.3 136.23 1.35 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.084 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.607 ' CG1' HG13 ' A' ' 36' ' ' VAL . 33.1 m -69.49 175.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.783 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.613 HD22 ' C ' ' A' ' 165' ' ' LEU . 5.4 tt -143.63 119.94 6.51 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.707 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.592 ' N ' HD22 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 123.684 2.923 . . . . 0.0 112.135 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 120.902 0.382 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 3.4 tppp? 176.12 -94.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.676 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 1.135 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 179.48 146.15 6.65 Favored Glycine 0 N--CA 1.477 1.376 0 O-C-N 124.403 1.064 . . . . 0.0 111.901 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.135 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 89.7 m-20 -170.33 122.76 0.6 Allowed Pre-proline 0 N--CA 1.476 0.842 0 CA-C-N 114.459 -0.87 . . . . 0.0 109.714 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.323 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 61.4 Cg_endo -68.99 117.37 4.99 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.894 3.063 . . . . 0.0 110.929 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.323 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 22.1 m170 -150.55 101.96 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.342 -175.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.949 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 7.7 p -59.85 107.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 171.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.998 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 5.2 tt -118.73 113.48 21.23 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.764 1.29 . . . . 0.0 109.79 -170.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.89 ' HG ' ' HA ' ' A' ' 162' ' ' ALA . 5.1 mp -127.67 -166.31 1.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.684 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 86.4 m -162.05 102.67 1.13 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.117 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 1.134 HG21 HG12 ' A' ' 159' ' ' ILE . 28.4 p -74.37 166.08 24.09 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.834 1.334 . . . . 0.0 111.693 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.564 ' OG ' HG11 ' A' ' 157' ' ' VAL . 80.1 p -40.93 -46.07 2.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.512 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.725 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -51.97 -59.15 4.67 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.451 1.094 . . . . 0.0 110.274 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.22 45.99 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 112.931 -1.94 . . . . 0.0 113.149 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 1.197 ' O ' HG22 ' A' ' 134' ' ' VAL . 9.0 t-20 -52.31 162.28 0.54 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.69 -1.255 . . . . 0.0 111.448 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.887 HG13 ' O ' ' A' ' 15' ' ' ASN . 9.3 mt -170.16 153.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.116 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.998 ' OE1' ' CD1' ' A' ' 8' ' ' LEU . 33.5 mt-10 -163.22 110.15 1.18 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.833 -173.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.949 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 2.2 mm? -82.42 150.42 27.1 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.294 0.996 . . . . 0.0 109.804 164.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.478 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -111.43 123.63 50.6 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.298 0.999 . . . . 0.0 109.578 174.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 1.256 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 75.8 mt -104.59 -171.33 1.9 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.751 1.282 . . . . 0.0 112.74 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 1.256 ' OD1' ' O ' ' A' ' 20' ' ' LEU . 47.8 m-20 -164.08 68.04 0.17 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.204 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 1.435 ' HD2' ' N ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -47.33 -27.28 1.53 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.821 1.326 . . . . 0.0 113.036 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 1.435 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 36.0 tt0 -41.93 -63.99 0.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.941 0.776 . . . . 0.0 110.09 -174.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.983 ' HD3' ' HA ' ' A' ' 79' ' ' ASN . 25.3 ttmm -78.9 18.41 0.62 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.815 1.322 . . . . 0.0 112.742 -178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 1.089 ' O ' HG12 ' A' ' 29' ' ' VAL . . . -161.98 69.98 2.29 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 1.029 ' O ' HG23 ' A' ' 29' ' ' VAL . 69.0 Cg_endo -71.39 -61.41 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.731 2.954 . . . . 0.0 110.124 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.811 HG22 ' H ' ' A' ' 28' ' ' SER . 16.0 m -48.12 -63.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 124.609 1.193 . . . . 0.0 110.152 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.811 ' H ' HG22 ' A' ' 27' ' ' VAL . 42.9 t -48.43 -59.54 3.39 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.508 1.13 . . . . 0.0 110.346 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.615 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 35.2 m -45.3 -49.13 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 124.579 1.175 . . . . 0.0 110.898 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 1.218 ' O ' HG11 ' A' ' 33' ' ' VAL . 61.7 tp60 -50.11 -56.81 9.4 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.31 1.006 . . . . 0.0 109.745 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.895 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 3.4 t30 -50.2 -62.19 1.72 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.567 1.167 . . . . 0.0 110.587 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 1.615 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 29.1 p90 -56.08 -43.92 78.49 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.266 0.979 . . . . 0.0 110.64 -172.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 1.218 HG11 ' O ' ' A' ' 30' ' ' GLN . 11.5 p -51.05 -40.06 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 124.046 0.841 . . . . 0.0 110.094 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.895 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 45.4 m-20 -45.39 -61.07 1.82 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.045 0.84 . . . . 0.0 109.252 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.819 ' HE2' HD22 ' A' ' 31' ' ' ASN . 68.9 m-85 -54.52 -55.85 24.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.908 1.38 . . . . 0.0 109.491 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.725 HG23 ' CE1' ' A' ' 41' ' ' TYR . 77.1 t -46.06 -66.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 124.436 1.085 . . . . 0.0 109.537 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.6 t30 -43.89 -49.82 8.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.84 1.338 . . . . 0.0 110.695 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 35' ' ' TYR . 29.7 p -58.64 -107.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.53 1.144 . . . . 0.0 110.161 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.64 59.64 0.28 Allowed Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.592 ' O ' HG22 ' A' ' 44' ' ' THR . 17.7 t80 -89.27 -63.58 1.27 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.958 1.034 . . . . 0.0 109.726 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.725 ' CE1' HG23 ' A' ' 36' ' ' VAL . 35.1 m-85 -75.53 -14.24 60.4 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.524 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 1.126 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 52.7 p-10 -39.08 -41.62 0.82 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.642 0.589 . . . . 0.0 112.517 -170.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 1.126 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 19.5 m-20 -154.78 46.8 0.55 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.161 0.913 . . . . 0.0 110.296 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.681 ' O ' HG22 ' A' ' 45' ' ' THR . 74.3 p -78.92 -139.64 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 166.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.929 ' HA ' HG13 ' A' ' 159' ' ' ILE . 76.5 p -163.46 -153.95 0.26 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.934 0.873 . . . . 0.0 112.595 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.898 ' CE1' HD12 ' A' ' 159' ' ' ILE . 17.0 m-30 -129.65 84.39 2.21 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.845 -1.979 . . . . 0.0 106.279 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.824 ' CE1' ' O ' ' A' ' 56' ' ' GLN . 36.8 p-80 -56.42 -65.57 0.58 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.3 -169.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.326 ' HD3' ' N ' ' A' ' 49' ' ' VAL . 1.2 tmt_? -164.67 160.71 20.24 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -162.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 1.557 ' CG1' ' HG3' ' A' ' 54' ' ' MET . 45.8 t -175.73 -77.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.045 -2.343 . . . . 0.0 106.914 164.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.943 HG21 HG13 ' A' ' 49' ' ' VAL . 11.2 tt 171.3 138.8 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.688 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.853 ' HD2' HG13 ' A' ' 50' ' ' ILE . 83.4 Cg_exo -35.04 164.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.333 -0.289 0 C-N-CA 123.507 2.805 . . . . 0.0 113.846 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.98 69.46 0.0 OUTLIER Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.876 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.176 ' CE1' ' OD1' ' A' ' 110' ' ' ASN . 9.8 t80 -160.99 -53.46 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.787 0.934 . . . . 0.0 109.843 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.557 ' HG3' ' CG1' ' A' ' 49' ' ' VAL . 24.1 ptt? -164.36 154.06 14.03 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.457 1.098 . . . . 0.0 111.912 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.815 HG13 ' HB ' ' A' ' 105' ' ' ILE . 48.4 pt -160.21 124.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.73 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.116 ' HG2' ' CA ' ' A' ' 104' ' ' PHE . 33.2 mt-30 -120.36 128.72 53.5 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.385 1.053 . . . . 0.0 110.334 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.0 -162.6 32.11 Favored Glycine 0 N--CA 1.477 1.404 0 O-C-N 124.631 1.207 . . . . 0.0 112.803 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.997 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 44.45 96.65 0.01 OUTLIER Glycine 0 N--CA 1.47 0.915 0 CA-C-N 113.725 -1.238 . . . . 0.0 111.38 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.76 ' HA2' ' OE1' ' A' ' 102' ' ' GLN . . . 174.46 -121.79 0.86 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.705 0.885 . . . . 0.0 110.925 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -46.08 146.04 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.047 -1.077 . . . . 0.0 111.636 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.6 m -58.12 -43.06 87.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.908 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 1.104 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 12.6 pt-20 -172.48 -100.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.248 0.968 . . . . 0.0 109.166 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 1.172 ' O ' ' CG ' ' A' ' 64' ' ' MET . 9.7 tp-100 -46.3 -57.55 4.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.673 1.233 . . . . 0.0 109.623 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 1.172 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 20.0 mmt 165.4 27.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.614 1.196 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -78.64 84.94 4.71 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.14 133.43 1.22 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 31.2 mmmt -64.13 -119.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.283 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' PRO . 24.8 ttmm -171.14 83.4 0.51 Allowed Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.73 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 1.025 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 89.2 Cg_exo -45.55 -155.59 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.631 2.887 . . . . 0.0 113.279 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.16 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.2 m120 -166.86 167.63 7.67 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.313 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.941 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 39.4 Cg_endo -49.07 87.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.845 2.363 . . . . 0.0 108.55 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 1.16 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 89.7 Cg_exo -48.29 -151.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.79 2.993 . . . . 0.0 113.789 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -155.27 149.1 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.369 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -32.39 133.6 0.11 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.394 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.61 167.63 5.54 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.832 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.951 ' OE2' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -168.16 155.35 7.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.032 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.86 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 177.59 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.191 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.844 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 42.0 p-10 -67.02 -48.28 68.83 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.983 0.802 . . . . 0.0 109.809 -176.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.983 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 19.0 p-10 40.21 -73.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.078 0.861 . . . . 0.0 111.541 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . 87.76 88.43 1.11 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.729 HD21 ' O ' ' A' ' 80' ' ' GLY . 85.9 mt -161.46 -158.3 0.56 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.113 -1.043 . . . . 0.0 109.893 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.79 ' N ' ' HD2' ' A' ' 82' ' ' ARG . 1.3 mpt_? -59.1 -165.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.253 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.779 ' OD1' ' HB3' ' A' ' 111' ' ' ALA . 1.7 t-20 168.3 100.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.151 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' GLY . 22.8 m -170.31 134.57 1.19 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.63 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 1.383 ' HB2' ' C ' ' A' ' 107' ' ' VAL . 4.0 ppt_? -38.51 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.672 1.225 . . . . 0.0 110.299 176.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 160.59 -22.9 0.25 Allowed Glycine 0 CA--C 1.534 1.226 0 CA-C-N 111.395 -2.639 . . . . 0.0 110.478 -170.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 1.095 ' CA ' ' HA ' ' A' ' 127' ' ' LYS . 40.5 p -98.94 148.74 23.66 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.63 0.729 . . . . 0.0 111.793 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 1.104 ' CD1' ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -96.54 159.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.342 168.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.064 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -142.89 176.96 8.67 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.08 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.909 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.3 tpt -101.95 129.92 48.33 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.766 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.88 -144.51 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.857 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.229 ' HG2' ' N ' ' A' ' 93' ' ' THR . 37.8 ttm180 -177.65 -165.52 0.11 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.84 0.828 . . . . 0.0 111.852 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 1.229 ' N ' ' HG2' ' A' ' 92' ' ' ARG . 25.3 p 176.07 116.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 108.239 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.812 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -17.48 120.28 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.514 1.134 . . . . 0.0 112.906 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.817 ' OD2' ' O ' ' A' ' 97' ' ' ASP . 39.0 t70 142.18 139.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.42 ' HB3' ' H ' ' A' ' 97' ' ' ASP . 53.0 tptt -42.89 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.431 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.817 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 38.2 m-20 -67.3 117.7 9.67 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.688 1.243 . . . . 0.0 108.5 168.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 24.8 t -151.48 170.65 19.1 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.57 1.169 . . . . 0.0 111.973 -173.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.577 ' HB3' ' CE ' ' A' ' 90' ' ' MET . . . 84.76 136.24 0.05 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.729 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 100' ' ' THR . 35.5 m -155.74 2.3 0.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.453 1.095 . . . . 0.0 113.205 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.408 ' C ' ' HE3' ' A' ' 90' ' ' MET . 34.3 p -171.73 -76.34 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.562 0.539 . . . . 0.0 110.852 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.997 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 3.5 mp0 -38.25 154.57 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.006 0.816 . . . . 0.0 111.9 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 1.05 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -160.86 167.03 27.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.545 177.038 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.116 ' CA ' ' HG2' ' A' ' 56' ' ' GLN . 72.4 m-85 -84.23 151.24 24.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.638 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.887 HD12 HD22 ' A' ' 18' ' ' LEU . 22.9 mt -139.58 94.24 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.617 159.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.959 ' O ' ' HE3' ' A' ' 132' ' ' MET . 48.9 m-20 -69.22 -173.29 0.51 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.309 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 1.383 ' C ' ' HB2' ' A' ' 85' ' ' ARG . 35.9 m -158.27 -46.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.571 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 1.217 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -101.49 150.46 23.04 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 124.518 1.136 . . . . 0.0 110.915 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' N ' ' CG ' ' A' ' 85' ' ' ARG . 3.1 m-20 -37.59 138.18 0.37 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.174 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 1.176 ' OD1' ' CE1' ' A' ' 53' ' ' PHE . 64.9 m-80 -157.45 170.46 22.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.765 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.779 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . . . 153.38 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.361 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -39.67 -55.51 1.87 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.152 0.907 . . . . 0.0 110.334 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.889 HD23 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -63.49 -8.86 10.43 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.837 1.336 . . . . 0.0 112.662 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.737 ' N ' HD11 ' A' ' 113' ' ' LEU . 57.6 p-10 -43.74 127.34 5.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.667 0.604 . . . . 0.0 111.657 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.768 ' CD2' ' HD1' ' A' ' 120' ' ' PHE . 0.1 OUTLIER -34.27 126.92 0.45 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.309 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . -176.71 -114.87 0.4 Allowed Glycine 0 N--CA 1.474 1.168 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.485 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.687 ' O ' ' CB ' ' A' ' 118' ' ' ARG . 29.8 tt0 -50.7 123.64 9.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.48 -0.86 . . . . 0.0 111.013 -176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.875 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 73.7 ttt-85 106.14 -81.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.177 173.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.875 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 88.3 m-20 -176.54 101.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.445 1.09 . . . . 0.0 109.425 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.768 ' HD1' ' CD2' ' A' ' 115' ' ' HIS . 25.1 m-85 42.37 -166.39 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.671 1.232 . . . . 0.0 112.065 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.33 -134.18 1.73 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.042 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.889 ' CD2' HD23 ' A' ' 113' ' ' LEU . 58.9 m-85 -79.55 118.17 21.15 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.443 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.064 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -57.36 -162.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.784 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.054 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 75.5 t 179.95 146.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.582 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.813 ' CE2' HD23 ' A' ' 20' ' ' LEU . 21.6 p90 -171.18 25.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 1.069 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -167.13 -139.55 2.69 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 122.645 1.136 . . . . 0.0 113.436 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.478 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 94.0 mttt 179.35 -135.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.822 -2.189 . . . . 0.0 109.727 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.802 HG23 ' CD1' ' A' ' 18' ' ' LEU . 91.7 t -160.29 152.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.5 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 19' ' ' GLU . 33.1 m -137.11 -27.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.69 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -170.83 86.95 0.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . -166.92 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 124.763 1.289 . . . . 0.0 110.883 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.959 ' HE3' ' O ' ' A' ' 106' ' ' ASN . 22.9 mmt -39.32 -38.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.216 0.597 . . . . 0.0 111.3 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -47.75 -59.21 3.46 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 1.197 HG22 ' O ' ' A' ' 15' ' ' ASN . 46.6 t -58.74 -63.01 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 124.75 1.281 . . . . 0.0 108.949 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 132' ' ' MET . . . -41.28 -51.03 3.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.955 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.96 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 37.1 m-20 -50.79 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.6 1.187 . . . . 0.0 109.04 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -43.34 -45.7 6.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.463 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.214 ' O ' HG11 ' A' ' 141' ' ' VAL . 42.4 mt -57.01 -61.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.422 1.076 . . . . 0.0 108.871 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.9 p -65.31 2.44 0.85 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.96 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.1 mp0 -93.01 -49.52 5.98 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 124.232 0.958 . . . . 0.0 109.124 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.214 HG11 ' O ' ' A' ' 138' ' ' ILE . 8.6 p -39.7 135.36 1.25 Allowed Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 124.272 0.982 . . . . 0.0 111.043 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.642 ' HD2' HG21 ' A' ' 141' ' ' VAL . 79.9 Cg_exo -42.54 168.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.332 -0.328 0 C-N-CA 123.573 2.848 . . . . 0.0 113.658 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.561 HG21 ' CA ' ' A' ' 153' ' ' PRO . 5.9 p -160.84 -149.92 0.19 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 123.415 1.579 . . . . 0.0 112.313 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.741 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.8 OUTLIER 178.6 161.38 0.66 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 110.28 -3.145 . . . . 0.0 111.441 172.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.719 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 35.3 m-20 -50.33 -157.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.059 164.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.869 ' CG2' ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -160.85 -143.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.11 -110.3 0.02 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 167.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.767 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 84.8 Cg_endo -70.69 -48.78 0.48 Allowed 'Trans proline' 0 C--N 1.333 -0.286 0 C-N-CA 123.662 2.908 . . . . 0.0 109.781 169.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.869 ' O ' ' CG2' ' A' ' 146' ' ' VAL . 93.7 m-85 -68.95 88.48 0.39 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.584 1.177 . . . . 0.0 110.722 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 16.0 pt20 -71.73 143.1 49.73 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.855 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 1.112 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 10.0 m120 84.33 90.12 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.548 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.812 HG23 HG22 ' A' ' 146' ' ' VAL . 91.2 t -160.62 97.86 1.4 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.208 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.561 ' CA ' HG21 ' A' ' 143' ' ' THR . 88.6 Cg_exo -46.15 106.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 123.52 2.813 . . . . 0.0 110.891 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 1.143 ' H ' ' HA ' ' A' ' 143' ' ' THR . 65.8 p -41.35 -56.3 2.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.655 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 65.4 mttm -79.62 95.62 0.21 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.582 1.176 . . . . 0.0 108.308 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.091 ' HD3' ' O ' ' A' ' 154' ' ' SER . 61.6 Cg_endo -77.01 132.3 12.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.771 2.981 . . . . 0.0 112.246 -171.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.564 HG11 ' OG ' ' A' ' 12' ' ' SER . 47.7 t -69.32 162.72 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.723 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.893 ' HA ' HG21 ' A' ' 45' ' ' THR . 86.5 t -147.28 120.12 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.108 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.134 HG12 HG21 ' A' ' 11' ' ' THR . 34.9 mt -68.84 134.61 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.258 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 10' ' ' THR . 87.5 mt -85.72 -49.76 7.71 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 110.182 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 9' ' ' LEU . 69.2 m -146.82 178.82 8.03 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.67 1.231 . . . . 0.0 111.974 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.89 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . . . -178.7 122.94 0.09 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.364 -175.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.62 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -171.09 152.9 3.58 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.254 173.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.02 141.67 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.732 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.696 HD22 ' N ' ' A' ' 166' ' ' PRO . 5.5 tt -57.82 126.07 75.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.16 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.696 ' N ' HD22 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.607 2.872 . . . . 0.0 112.179 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 22.1 ptmt 169.02 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.633 1.208 . . . . 0.0 110.529 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 1.034 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 160.63 -133.96 3.43 Favored Glycine 0 N--CA 1.476 1.351 0 O-C-N 124.467 1.105 . . . . 0.0 111.025 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 1.034 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 97.9 m-20 -175.11 69.28 0.27 Allowed Pre-proline 0 N--CA 1.474 0.768 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 1.483 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 83.4 Cg_endo -89.8 60.94 1.99 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.657 2.905 . . . . 0.0 110.096 -171.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 1.483 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.4 m170 -154.5 88.49 1.21 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.21 0.944 . . . . 0.0 110.066 -176.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 7' ' ' VAL . 25.5 t -67.78 81.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 167.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.054 ' HG ' ' HG2' ' A' ' 17' ' ' GLU . 7.5 tt -80.38 108.92 14.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.356 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.358 HD21 ' O ' ' A' ' 161' ' ' SER . 7.3 mt -109.51 174.44 5.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 112.737 -2.029 . . . . 0.0 112.532 -173.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.927 HG23 HD11 ' A' ' 160' ' ' LEU . 94.9 m -159.91 95.11 1.16 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.078 -2.328 . . . . 0.0 108.447 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 1.049 HG21 HG12 ' A' ' 159' ' ' ILE . 19.8 p -84.53 161.2 20.31 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.997 1.436 . . . . 0.0 111.217 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.757 ' HG ' ' HA ' ' A' ' 157' ' ' VAL . 81.7 p -39.09 -43.59 1.05 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.861 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.825 ' HB1' HG12 ' A' ' 138' ' ' ILE . . . -52.84 -63.84 1.01 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.42 1.075 . . . . 0.0 110.105 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.49 171.18 43.87 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.089 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.853 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 2.1 t-20 -68.32 133.31 48.55 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.309 -1.445 . . . . 0.0 110.719 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.679 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 16.5 pt -143.73 -179.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.922 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 1.054 ' HG2' ' HG ' ' A' ' 8' ' ' LEU . 35.9 mt-10 -161.62 110.89 1.55 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.799 -169.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.109 HD22 HD12 ' A' ' 105' ' ' ILE . 3.1 mm? -77.36 150.65 35.11 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 124.541 1.15 . . . . 0.0 110.106 165.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.825 ' HG3' ' HB3' ' A' ' 127' ' ' LYS . 12.6 pt-20 -122.84 121.49 36.37 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.909 174.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 1.005 HD12 ' HE2' ' A' ' 125' ' ' PHE . 61.3 mt -104.19 173.55 6.25 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.803 1.315 . . . . 0.0 112.66 -169.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 125' ' ' PHE . 73.2 m-20 -128.83 104.5 7.65 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.569 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -76.26 -39.54 54.11 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.831 1.332 . . . . 0.0 112.055 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.916 ' HG3' ' HD2' ' A' ' 24' ' ' LYS . 8.1 tp-100 -45.08 -66.85 0.34 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.211 0.945 . . . . 0.0 110.275 -171.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.916 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -83.55 19.48 1.59 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.817 1.323 . . . . 0.0 113.804 -175.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 1.039 ' O ' HG22 ' A' ' 29' ' ' VAL . . . -160.59 64.97 2.21 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 123.904 0.752 . . . . 0.0 111.134 173.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.8 Cg_exo -59.91 -58.72 0.51 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.517 2.811 . . . . 0.0 111.071 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.551 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 80.7 t -53.9 -69.86 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.157 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 25' ' ' ALA . 75.2 p -48.05 -53.92 14.77 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.704 1.252 . . . . 0.0 111.023 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 1.039 HG22 ' O ' ' A' ' 25' ' ' ALA . 3.5 t -60.45 -41.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.318 1.012 . . . . 0.0 110.625 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 1.319 ' O ' HG11 ' A' ' 33' ' ' VAL . 7.3 tm0? -49.87 -62.43 1.57 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.111 0.882 . . . . 0.0 108.923 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 1.043 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 m-80 -44.25 -52.48 7.45 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.585 1.178 . . . . 0.0 110.274 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.892 ' CD2' ' HA ' ' A' ' 29' ' ' VAL . 20.8 m-30 -41.51 -67.3 0.26 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.456 1.098 . . . . 0.0 109.806 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 1.319 HG11 ' O ' ' A' ' 30' ' ' GLN . 7.2 p -40.5 -40.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 124.782 1.301 . . . . 0.0 111.118 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 1.043 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 8.0 m-20 -44.96 -61.94 1.42 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.028 0.83 . . . . 0.0 109.445 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 38' ' ' SER . 78.1 m-85 -55.53 -53.36 57.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.813 1.321 . . . . 0.0 109.317 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.686 HG13 HG12 ' A' ' 164' ' ' VAL . 76.3 t -45.15 -65.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.556 1.16 . . . . 0.0 109.464 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' SER . 22.1 m-20 -48.32 -48.63 36.01 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.803 1.314 . . . . 0.0 110.227 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 37' ' ' ASN . 54.5 m -52.98 -113.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.463 1.102 . . . . 0.0 110.913 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.1 78.05 0.08 OUTLIER Glycine 0 N--CA 1.473 1.141 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 74.4 t80 -116.22 -63.86 1.39 Allowed 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.196 1.174 . . . . 0.0 109.358 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.986 ' O ' HG22 ' A' ' 44' ' ' THR . 51.6 m-85 -59.73 -41.77 91.63 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.715 1.259 . . . . 0.0 111.605 -172.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.584 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.0 p30 -39.32 117.18 0.68 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.19 0.931 . . . . 0.0 111.333 -173.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.7 t30 60.02 35.22 21.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.011 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.986 HG22 ' O ' ' A' ' 41' ' ' TYR . 69.9 p -79.2 -143.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.159 0.912 . . . . 0.0 108.848 165.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.944 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 55.3 p -163.21 -144.0 0.08 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.822 0.82 . . . . 0.0 112.725 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.944 ' CD1' ' O ' ' A' ' 45' ' ' THR . 8.2 m-30 -154.68 67.1 0.69 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.016 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.837 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 6.3 p-80 -59.06 -65.04 0.73 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.855 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.917 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 25.3 tpt180 -69.29 119.02 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.583 1.177 . . . . 0.0 110.656 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 55' ' ' ILE . 84.6 t -154.93 147.55 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 124.805 1.316 . . . . 0.0 110.834 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.617 HG21 ' HG3' ' A' ' 54' ' ' MET . 11.0 tt -157.95 125.58 2.74 Favored Pre-proline 0 N--CA 1.476 0.857 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.955 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 76.0 Cg_exo -34.22 161.78 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.67 2.913 . . . . 0.0 113.958 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -8.85 71.07 0.0 OUTLIER Glycine 0 N--CA 1.475 1.252 0 CA-C-N 114.049 -1.432 . . . . 0.0 113.548 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.113 ' HD1' ' HG2' ' A' ' 54' ' ' MET . 56.5 t80 -160.61 -58.97 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.856 0.974 . . . . 0.0 109.552 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.113 ' HG2' ' HD1' ' A' ' 53' ' ' PHE . 26.3 ptt? -169.22 159.64 9.08 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.299 0.999 . . . . 0.0 112.371 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 105' ' ' ILE . 41.7 pt -154.7 156.58 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 113.171 -1.831 . . . . 0.0 109.203 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.008 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 11.5 mt-30 -150.57 164.83 35.05 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.876 0.735 . . . . 0.0 112.142 -166.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.67 ' O ' ' CD1' ' A' ' 103' ' ' PHE . . . -162.11 155.98 27.43 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 124.06 0.85 . . . . 0.0 112.959 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.513 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 136.63 -57.29 0.67 Allowed Glycine 0 N--CA 1.475 1.271 0 CA-C-N 113.426 -1.387 . . . . 0.0 110.331 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -51.62 -125.16 0.01 OUTLIER Glycine 0 N--CA 1.471 1.033 0 O-C-N 124.593 0.819 . . . . 0.0 113.21 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -39.5 148.01 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.441 -172.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 62' ' ' GLU . 94.0 m -59.94 -92.47 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.463 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.688 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.3 pt-20 -138.85 117.04 11.81 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 124.895 1.372 . . . . 0.0 108.882 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 1.291 ' O ' ' CG ' ' A' ' 64' ' ' MET . 67.2 tt0 76.91 -56.75 0.54 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.629 1.206 . . . . 0.0 108.8 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 1.291 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 155.82 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.046 1.403 . . . . 0.0 109.163 175.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.775 ' O ' ' O ' ' A' ' 66' ' ' GLN . 29.1 mm100 -142.87 82.21 1.76 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 110.908 -2.86 . . . . 0.0 104.965 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.825 ' C ' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -27.54 174.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -165.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 68' ' ' LYS . 7.0 mtpm? -68.62 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 111.0 -2.818 . . . . 0.0 113.617 -169.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 67' ' ' LYS . 28.0 tptp 179.11 73.75 0.14 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 112.325 -2.216 . . . . 0.0 105.758 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.606 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 62.5 Cg_endo -83.37 -165.02 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 123.351 2.701 . . . . 0.0 113.746 -162.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.989 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 8.6 m120 -163.34 169.89 8.06 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 113.126 -1.852 . . . . 0.0 110.029 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.989 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 35.1 Cg_endo -50.74 95.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.12 2.547 . . . . 0.0 109.818 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.961 ' HG3' HG21 ' A' ' 100' ' ' THR . 82.4 Cg_exo -51.86 -146.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.908 3.072 . . . . 0.0 113.46 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.05 152.83 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 124.296 0.997 . . . . 0.0 110.981 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 61.3 mttp -37.66 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.181 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 76' ' ' GLU . 56.0 p30 -64.02 -168.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.19 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.889 ' HB2' HD22 ' A' ' 79' ' ' ASN . 0.0 OUTLIER 160.43 141.17 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.383 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 1.015 ' HB2' ' CD2' ' A' ' 115' ' ' HIS . . . -157.6 -51.24 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.242 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -68.28 -49.43 60.55 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.473 1.108 . . . . 0.0 110.372 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.889 HD22 ' HB2' ' A' ' 76' ' ' GLU . 45.1 p30 -43.02 -43.38 4.23 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.22 0.95 . . . . 0.0 110.103 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.672 ' N ' ' OD1' ' A' ' 79' ' ' ASN . . . -42.85 -33.32 1.61 Allowed Glycine 0 N--CA 1.471 1.029 0 O-C-N 124.411 1.069 . . . . 0.0 112.131 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 66.1 mt 98.39 -131.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 1.018 ' O ' ' NE ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -169.0 110.12 0.49 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.977 0.798 . . . . 0.0 109.673 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.775 ' HB2' HG23 ' A' ' 87' ' ' THR . 2.0 m-20 -132.74 -134.16 0.18 Allowed 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.963 1.414 . . . . 0.0 109.865 -176.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' OD1' ' A' ' 109' ' ' ASP . 10.2 m -169.6 163.77 10.21 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.822 0.82 . . . . 0.0 111.734 -167.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.932 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 58.2 ttt180 -18.67 103.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.199 165.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.989 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 140.35 -23.19 2.7 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.256 -2.702 . . . . 0.0 110.581 -169.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 1.086 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.7 p -98.28 146.98 25.11 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.023 0.916 . . . . 0.0 112.94 -175.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.966 HD13 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.67 161.94 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.972 164.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.06 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -159.78 156.66 27.95 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.558 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 1.242 ' CE ' ' HB3' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -74.4 123.74 25.23 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.752 -176.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.588 ' N ' ' SD ' ' A' ' 90' ' ' MET . . . -57.75 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.089 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.824 ' NH1' ' O ' ' A' ' 93' ' ' THR . 68.0 ttp85 179.71 -104.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.743 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.824 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 97.3 m 100.71 -98.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.638 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 93' ' ' THR . . . -61.95 -132.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.58 1.175 . . . . 0.0 110.93 -174.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 35.2 m-20 -58.24 172.12 0.49 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -56.16 -111.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.723 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.642 ' OD1' ' CG ' ' A' ' 75' ' ' ASN . 35.2 m-20 -52.4 103.57 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.776 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.852 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 68.4 m -165.76 -34.75 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.467 1.104 . . . . 0.0 111.619 -175.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 1.242 ' HB3' ' CE ' ' A' ' 90' ' ' MET . . . -33.58 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.846 0.716 . . . . 0.0 110.701 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.961 HG21 ' HG3' ' A' ' 72' ' ' PRO . 48.8 p -78.87 -60.4 2.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.182 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.7 p -171.57 97.57 0.18 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.251 0.97 . . . . 0.0 109.274 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.914 ' OE1' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER 171.23 134.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.727 1.267 . . . . 0.0 109.109 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.966 ' HB2' HD13 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -140.24 -171.29 3.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.458 -177.041 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 1.008 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 43.6 p90 -155.93 129.06 8.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.47 -172.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.109 HD12 HD22 ' A' ' 18' ' ' LEU . 57.8 mt -93.27 111.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.515 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 104' ' ' PHE . 50.9 m-20 -65.38 155.26 35.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.398 1.061 . . . . 0.0 110.766 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 54' ' ' MET . 22.4 m -146.92 38.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.11 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 178.95 122.93 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.142 0.901 . . . . 0.0 110.067 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.932 ' OD1' ' HB3' ' A' ' 85' ' ' ARG . 34.0 m-20 -37.17 137.11 0.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.14 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -150.8 108.79 3.71 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.65 1.218 . . . . 0.0 110.097 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . -90.92 -49.96 6.14 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.893 170.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 1.263 ' O ' HD11 ' A' ' 113' ' ' LEU . 30.6 p90 -49.35 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.469 1.106 . . . . 0.0 109.235 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 1.263 HD11 ' O ' ' A' ' 112' ' ' PHE . 3.1 mp 179.28 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.641 -2.072 . . . . 0.0 108.519 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.67 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 6.6 m-20 -38.92 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.856 0.723 . . . . 0.0 110.657 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 1.054 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 44.5 m-70 -46.92 122.27 4.23 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.901 1.375 . . . . 0.0 110.182 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.78 172.41 40.48 Favored Glycine 0 N--CA 1.478 1.455 0 O-C-N 124.524 1.14 . . . . 0.0 112.182 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 118' ' ' ARG . 3.0 mp0 53.25 -148.76 0.43 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.08 -1.06 . . . . 0.0 109.847 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.486 ' O ' ' O ' ' A' ' 117' ' ' GLN . 83.8 mtm180 -51.1 -115.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.726 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 120' ' ' PHE . 37.0 m-20 -60.28 126.68 28.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.625 1.203 . . . . 0.0 111.943 -175.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' A' ' 119' ' ' ASP . 24.3 m-85 -54.02 -140.82 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.446 173.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.11 -131.34 1.31 Allowed Glycine 0 N--CA 1.476 1.318 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 1.054 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 89.9 m-85 -79.45 133.86 36.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.422 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.071 ' O ' HG22 ' A' ' 124' ' ' VAL . . . -69.55 -161.65 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.519 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.071 HG22 ' O ' ' A' ' 123' ' ' ALA . 54.9 t 178.8 144.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.753 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 1.005 ' HE2' HD12 ' A' ' 20' ' ' LEU . 30.3 p90 -168.74 26.16 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.806 ' HA3' HD21 ' A' ' 20' ' ' LEU . . . -167.17 -143.98 3.96 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 122.87 1.261 . . . . 0.0 113.906 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 1.086 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 40.4 ttmt 179.76 -139.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 111.51 -2.345 . . . . 0.0 109.656 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.084 ' H ' ' CG ' ' A' ' 127' ' ' LYS . 95.8 t -159.78 117.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.952 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.841 ' O ' ' HG3' ' A' ' 130' ' ' LYS . 35.2 m -73.75 -40.99 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.739 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.841 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 8.4 mtpm? -166.19 -156.2 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.261 0.976 . . . . 0.0 111.379 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 134' ' ' VAL . . . 49.75 18.36 1.77 Allowed Glycine 0 N--CA 1.473 1.154 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.539 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.529 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 10.4 tpt -55.03 -48.04 73.95 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.727 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 2.2 m-20 -43.29 -56.07 3.7 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.437 1.085 . . . . 0.0 110.018 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.64 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.1 t -39.7 -59.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.49 1.118 . . . . 0.0 109.671 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 132' ' ' MET . . . -45.5 -52.22 10.63 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.655 1.222 . . . . 0.0 109.529 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.929 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 1.8 m-20 -50.51 -65.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.553 1.158 . . . . 0.0 109.042 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 14.5 mmmm -35.46 -55.02 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.498 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.18 ' O ' HG23 ' A' ' 141' ' ' VAL . 13.8 mt -56.95 -56.81 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.868 1.355 . . . . 0.0 109.169 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.405 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 82.0 p -64.23 3.25 0.46 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.929 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.9 mp0 -97.24 -51.47 4.18 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.213 0.946 . . . . 0.0 108.717 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.18 HG23 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -45.78 125.83 6.6 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.436 1.085 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -44.6 177.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 123.637 2.891 . . . . 0.0 114.022 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.424 HG21 ' CA ' ' A' ' 153' ' ' PRO . 1.5 p -161.23 -140.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.127 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' ASP . 0.7 OUTLIER 179.65 164.49 1.06 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 110.485 -3.052 . . . . 0.0 111.017 169.591 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.82 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 34.7 m-20 -50.42 -143.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.652 168.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.936 HG21 ' O ' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -161.68 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 168.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.55 -94.65 0.05 OUTLIER Glycine 0 N--CA 1.47 0.964 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 168.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.803 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 97.5 Cg_endo -76.83 -65.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.917 3.078 . . . . 0.0 109.603 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.936 ' O ' HG21 ' A' ' 146' ' ' VAL . 39.3 m-85 -69.83 124.73 24.75 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.564 1.165 . . . . 0.0 111.695 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.82 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 49.5 mm-40 -75.75 -171.84 1.71 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.744 169.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.542 ' O ' HG22 ' A' ' 152' ' ' VAL . 20.6 m-20 44.89 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.615 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.861 ' HB ' HG23 ' A' ' 146' ' ' VAL . 83.7 t -159.16 128.74 3.26 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 113.164 -1.835 . . . . 0.0 107.726 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 1.424 ' CA ' HG21 ' A' ' 143' ' ' THR . 96.5 Cg_exo -39.25 -145.71 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.308 2.672 . . . . 0.0 112.508 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 45.7 t -163.86 -8.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.373 1.046 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 1.084 ' HB3' ' HD3' ' A' ' 156' ' ' PRO . 87.8 tttt 178.91 -67.36 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.534 0.521 . . . . 0.0 111.667 175.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.156 ' O ' HG21 ' A' ' 157' ' ' VAL . 56.7 Cg_endo -75.04 76.84 3.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 111.672 -168.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 1.156 HG21 ' O ' ' A' ' 156' ' ' PRO . 42.8 t -172.52 127.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.679 168.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.799 ' HA ' HG21 ' A' ' 45' ' ' THR . 81.2 t -167.29 118.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.068 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.049 HG12 HG21 ' A' ' 11' ' ' THR . 34.2 mt -68.29 133.89 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.881 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.927 HD11 HG23 ' A' ' 10' ' ' THR . 84.4 mt -87.23 -48.32 8.12 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.375 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 1.358 ' O ' HD21 ' A' ' 9' ' ' LEU . 32.4 t -167.89 162.68 13.68 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.395 1.059 . . . . 0.0 113.128 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 1.028 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -152.75 118.08 5.24 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.835 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.7 ptpt -151.13 135.2 16.68 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.686 HG12 HG13 ' A' ' 36' ' ' VAL . 33.8 m -68.71 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.98 HD11 ' HD2' ' A' ' 166' ' ' PRO . 48.7 tp -62.12 121.5 66.34 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.795 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.98 ' HD2' HD11 ' A' ' 165' ' ' LEU . 86.1 Cg_exo . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.573 2.848 . . . . 0.0 112.074 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.986 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 88.8 Cg_exo . . . . . 0 C--O 1.235 0.373 0 N-CA-C 113.483 0.532 . . . . 0.0 113.483 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.298 ' CE1' ' HG2' ' A' ' 19' ' ' GLU . 2.2 m-70 -147.8 114.23 5.95 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.093 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 164' ' ' VAL . 14.8 t -71.46 96.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.543 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.499 ' CD1' ' HG2' ' A' ' 17' ' ' GLU . 15.8 tp -79.09 131.14 36.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.772 1.295 . . . . 0.0 109.52 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.288 HD23 ' O ' ' A' ' 161' ' ' SER . 8.8 mt -141.43 131.41 24.56 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.507 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.935 HG22 HD12 ' A' ' 160' ' ' LEU . 99.5 m -116.39 94.95 4.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 111.633 -2.531 . . . . 0.0 108.206 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.958 HG22 HG12 ' A' ' 159' ' ' ILE . 22.4 p -81.12 165.25 21.76 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 125.116 1.51 . . . . 0.0 110.715 170.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -39.09 -42.34 0.91 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.62 -63.09 1.26 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.431 1.082 . . . . 0.0 110.427 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.37 172.24 44.66 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.285 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 39.3 t30 -76.97 108.21 9.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.428 -1.386 . . . . 0.0 110.006 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 134' ' ' VAL . 13.5 pt -103.35 -169.74 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 124.826 1.329 . . . . 0.0 110.959 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 1.499 ' HG2' ' CD1' ' A' ' 8' ' ' LEU . 37.7 mt-10 -161.87 102.45 1.16 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.817 -173.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.058 HD21 HD11 ' A' ' 105' ' ' ILE . 2.7 mm? -73.41 160.74 31.32 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.344 1.027 . . . . 0.0 110.651 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.298 ' HG2' ' CE1' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -138.37 127.55 24.29 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.167 173.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.979 HD13 ' HE2' ' A' ' 125' ' ' PHE . 80.3 mt -122.01 143.57 49.41 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.805 1.316 . . . . 0.0 111.975 -168.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 73.2 m-20 -55.48 -126.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.977 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.907 ' HA ' HG11 ' A' ' 29' ' ' VAL . 38.2 ttmt 145.64 -59.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.029 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -55.1 -57.12 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.096 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.854 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 20.3 tptm -69.09 -4.97 19.27 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.593 1.183 . . . . 0.0 113.465 -172.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.713 ' HB2' ' ND2' ' A' ' 79' ' ' ASN . . . -161.18 70.62 2.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.67 0.606 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 1.17 ' O ' HG22 ' A' ' 29' ' ' VAL . 63.6 Cg_exo -52.7 -54.17 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 111.504 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.13 -65.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 124.704 1.253 . . . . 0.0 110.21 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.4 p -47.2 -52.79 14.81 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.713 1.258 . . . . 0.0 110.886 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.608 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 32.7 m -47.44 -50.2 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.322 1.014 . . . . 0.0 110.653 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 1.039 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 58.2 tp60 -51.23 -52.48 44.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.336 1.023 . . . . 0.0 109.844 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.911 ' OD1' HG21 ' A' ' 73' ' ' ILE . 18.4 m120 -49.96 -66.05 0.46 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.579 1.175 . . . . 0.0 110.322 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 1.608 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 46.8 p90 -57.1 -46.18 82.78 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.448 1.092 . . . . 0.0 110.441 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.997 HG12 ' O ' ' A' ' 30' ' ' GLN . 12.0 p -49.33 -40.17 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.976 0.797 . . . . 0.0 110.406 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 1.039 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 2.1 m-20 -45.84 -61.51 1.7 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.097 0.873 . . . . 0.0 108.84 171.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.627 ' OH ' ' HG3' ' A' ' 71' ' ' PRO . 28.3 m-85 -58.35 -60.12 4.28 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.892 1.37 . . . . 0.0 109.302 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 32' ' ' PHE . 58.4 t -39.27 -52.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 124.589 1.18 . . . . 0.0 110.683 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 38' ' ' SER . 23.1 m120 -38.77 -33.55 0.11 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.765 1.291 . . . . 0.0 111.858 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.727 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.9 p 158.02 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.155 0.909 . . . . 0.0 112.672 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 69.01 79.37 0.28 Allowed Glycine 0 N--CA 1.471 0.984 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.737 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.92 ' O ' HG23 ' A' ' 44' ' ' THR . 15.3 t80 168.76 -75.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.711 0.889 . . . . 0.0 109.514 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' ' HD1' ' A' ' 40' ' ' PHE . 77.7 m-85 -66.69 -31.73 72.58 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.5 1.125 . . . . 0.0 112.411 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -38.72 -36.16 0.24 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.053 0.845 . . . . 0.0 112.977 -170.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.468 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 27.6 t-20 -156.5 47.31 0.45 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.064 0.853 . . . . 0.0 110.748 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.92 HG23 ' O ' ' A' ' 40' ' ' PHE . 52.7 p -83.61 -140.56 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.266 161.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 1.119 HG22 ' HA ' ' A' ' 158' ' ' VAL . 46.4 p -163.1 -141.05 0.06 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.988 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.856 ' CE1' HD11 ' A' ' 159' ' ' ILE . 15.6 m-30 -146.11 92.28 2.17 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.25 -1.795 . . . . 0.0 106.384 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 1.257 ' HB2' ' OE1' ' A' ' 56' ' ' GLN . 21.3 m80 -23.31 -67.61 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.351 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.995 ' HB2' ' HA ' ' A' ' 152' ' ' VAL . 1.8 tpm_? -172.32 -142.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.764 1.29 . . . . 0.0 111.217 169.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.991 ' H ' ' HG3' ' A' ' 48' ' ' ARG . 6.2 p -172.08 135.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.274 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.953 HG21 ' HD2' ' A' ' 53' ' ' PHE . 10.9 tt -62.49 129.74 92.84 Favored Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.483 159.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' PHE . 20.5 Cg_endo -45.2 153.04 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.014 2.476 . . . . 0.0 112.079 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 7.26 60.18 0.01 OUTLIER Glycine 0 N--CA 1.474 1.206 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.729 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.953 ' HD2' HG21 ' A' ' 50' ' ' ILE . 65.2 t80 -152.66 -54.63 0.12 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.817 0.951 . . . . 0.0 110.737 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.9 ' O ' HG23 ' A' ' 49' ' ' VAL . 43.5 ttp -171.94 113.68 0.33 Allowed 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.088 0.867 . . . . 0.0 112.124 -169.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.953 HG13 ' HB ' ' A' ' 105' ' ' ILE . 26.7 pt -90.86 155.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.755 164.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 1.319 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 78.9 mt-30 -68.61 -121.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.382 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 1.136 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -152.67 -119.96 0.81 Allowed Glycine 0 N--CA 1.47 0.932 0 O-C-N 118.624 -2.548 . . . . 0.0 110.549 3.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 61.28 106.86 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE1' ' A' ' 47' ' ' HIS . . . -179.44 -122.8 0.79 Allowed Glycine 0 N--CA 1.475 1.296 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.092 ' HB3' ' CA ' ' A' ' 64' ' ' MET . 42.4 m-85 -45.57 113.75 0.65 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.58 0.812 . . . . 0.0 110.264 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 61' ' ' THR . 9.4 t -59.52 116.75 4.2 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.484 1.115 . . . . 0.0 110.565 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.769 ' HB3' ' OE1' ' A' ' 63' ' ' GLN . 44.9 mt-10 65.02 -118.87 0.4 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.748 1.28 . . . . 0.0 110.786 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.769 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 8.0 mp0 -41.67 -58.15 2.06 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.679 1.237 . . . . 0.0 109.363 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 1.092 ' CA ' ' HB3' ' A' ' 60' ' ' PHE . 16.9 ptm 138.63 94.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.704 1.253 . . . . 0.0 107.762 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.695 ' N ' ' HB3' ' A' ' 60' ' ' PHE . 8.8 mm-40 -159.19 105.83 1.74 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.901 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.538 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 10.2 mm100 -29.28 133.39 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.807 -174.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 1.106 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -57.35 -97.73 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.684 168.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.639 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 4.3 ttmp? -167.85 66.92 0.79 Allowed Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.582 165.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 37.0 Cg_exo -69.18 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.58 2.853 . . . . 0.0 113.333 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.19 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 7.8 p30 102.44 38.04 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 113.377 -1.738 . . . . 0.0 115.607 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.511 ' HD2' ' CB ' ' A' ' 100' ' ' THR . 17.7 Cg_endo -95.3 80.25 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.831 3.021 . . . . 0.0 107.541 171.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.19 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 75.5 Cg_exo -66.97 110.63 1.99 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.544 2.163 . . . . 0.0 112.08 -163.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.911 HG21 ' OD1' ' A' ' 31' ' ' ASN . 18.9 pt -79.3 -123.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 124.638 1.211 . . . . 0.0 109.207 175.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.787 ' HD2' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -156.73 -151.72 0.34 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.964 0.79 . . . . 0.0 112.258 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.81 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . 51.7 p30 -39.74 145.41 0.14 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.624 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.031 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 1.8 mp0 -131.29 -92.68 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.768 1.292 . . . . 0.0 109.82 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 120' ' ' PHE . . . -38.13 -37.06 0.25 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.674 1.234 . . . . 0.0 112.384 -172.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.81 ' OD2' ' HB2' ' A' ' 75' ' ' ASN . 4.3 p30 -68.8 33.89 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.087 0.867 . . . . 0.0 112.44 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 1.031 ' OD1' ' O ' ' A' ' 76' ' ' GLU . 2.1 p-10 -172.74 82.86 0.05 Allowed 'General case' 0 N--CA 1.469 0.491 0 O-C-N 124.24 0.962 . . . . 0.0 108.766 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.812 ' C ' HD23 ' A' ' 81' ' ' LEU . . . -168.95 0.34 0.04 OUTLIER Glycine 0 N--CA 1.477 1.389 0 CA-C-N 114.711 -1.132 . . . . 0.0 113.48 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.495 HD12 ' NH1' ' A' ' 82' ' ' ARG . 1.5 pt? 31.12 172.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 1.495 ' NH1' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -60.0 158.1 11.58 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.032 -172.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.814 ' OD1' ' CG2' ' A' ' 87' ' ' THR . 1.0 OUTLIER 175.2 -146.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.464 170.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 1.456 HG21 ' NH1' ' A' ' 85' ' ' ARG . 15.8 m -170.34 162.95 8.66 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.51 0.506 . . . . 0.0 112.012 -167.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 1.456 ' NH1' HG21 ' A' ' 84' ' ' THR . 0.0 OUTLIER -34.15 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.956 1.36 . . . . 0.0 111.004 176.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 127' ' ' LYS . . . 156.6 -29.87 0.56 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-N 110.894 -2.867 . . . . 0.0 109.471 -169.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.034 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 50.1 p -81.68 144.73 30.97 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.204 0.591 . . . . 0.0 112.071 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.061 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -95.09 159.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.296 165.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.14 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -161.55 144.34 12.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.52 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 1.009 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 41.7 mtp -75.46 144.06 42.29 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.246 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.7 -118.21 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.543 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.242 ' O ' HG23 ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.54 -132.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.714 0.634 . . . . 0.0 111.011 176.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.242 HG23 ' O ' ' A' ' 92' ' ' ARG . 19.8 p 171.46 152.2 0.06 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.461 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.72 0.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.545 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 1.412 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 56.7 m-20 -40.01 -71.71 0.08 Allowed 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.654 1.221 . . . . 0.0 110.765 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.412 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 8.5 mtpm? 149.1 -94.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.91 1.381 . . . . 0.0 108.341 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.56 104.87 0.56 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.827 1.329 . . . . 0.0 109.197 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.862 ' O ' HG12 ' A' ' 73' ' ' ILE . 31.0 t -169.52 -102.19 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.664 1.228 . . . . 0.0 109.793 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 43.8 76.42 0.08 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.364 1.04 . . . . 0.0 108.6 -173.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 1.511 ' CB ' ' HD2' ' A' ' 71' ' ' PRO . 81.1 p -78.26 -43.47 28.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.105 -171.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 80.0 p -170.76 98.34 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.2 0.937 . . . . 0.0 109.54 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.9 tt0 169.48 123.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.777 1.298 . . . . 0.0 109.887 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 1.061 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.09 175.18 9.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.455 177.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 1.319 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 29.1 p90 -154.23 136.43 14.81 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.96 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.155 ' N ' ' O ' ' A' ' 56' ' ' GLN . 60.6 mt -95.46 115.06 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.663 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 52.5 m-20 -74.11 -172.61 1.41 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.514 1.134 . . . . 0.0 111.149 173.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.21 HG12 ' CE ' ' A' ' 132' ' ' MET . 32.7 m -157.84 -44.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.456 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.928 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -91.87 152.42 20.09 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.255 0.972 . . . . 0.0 112.038 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.835 ' OD1' ' HD2' ' A' ' 85' ' ' ARG . 39.1 m-20 -49.59 106.81 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.12 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.584 HD22 HD13 ' A' ' 113' ' ' LEU . 51.2 t30 -99.3 -100.59 0.23 Allowed 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.832 1.333 . . . . 0.0 109.87 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.717 ' O ' ' CG ' ' A' ' 114' ' ' ASP . . . 75.29 -43.93 0.52 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.931 0.77 . . . . 0.0 110.935 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 110' ' ' ASN . 39.8 m-85 -39.31 -50.69 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.285 0.991 . . . . 0.0 110.79 -176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.596 HD23 ' CD2' ' A' ' 122' ' ' TYR . 7.8 mp -58.41 -24.26 59.59 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.768 1.292 . . . . 0.0 111.492 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.717 ' CG ' ' O ' ' A' ' 111' ' ' ALA . 36.1 m-20 -39.17 101.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.757 0.661 . . . . 0.0 111.037 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -38.7 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.413 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.619 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.891 ' CE1' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.624 ' N ' ' HD1' ' A' ' 120' ' ' PHE . . . -156.24 -77.24 0.02 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 124.371 1.044 . . . . 0.0 112.032 -174.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.596 ' CD2' HD23 ' A' ' 113' ' ' LEU . 43.7 m-85 -77.24 120.51 22.39 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.245 0.615 . . . . 0.0 110.755 -167.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.14 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -70.62 -161.31 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.304 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.047 HG23 ' O ' ' A' ' 123' ' ' ALA . 76.1 t 177.57 141.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.173 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.979 ' HE2' HD13 ' A' ' 20' ' ' LEU . 20.2 p90 -174.34 25.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 1.199 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -156.53 -149.19 5.3 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 122.866 1.259 . . . . 0.0 113.823 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.199 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 7.2 mtpm? -179.37 -154.98 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.635 -2.283 . . . . 0.0 110.586 -170.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.716 HG22 HD13 ' A' ' 18' ' ' LEU . 94.3 t -160.04 117.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.722 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 6' ' ' HIS . 82.6 t -84.5 -75.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 114.042 -1.436 . . . . 0.0 110.448 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 132' ' ' MET . 59.6 tttp -96.18 -94.65 0.2 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.474 1.109 . . . . 0.0 112.338 -167.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -60.58 51.81 0.03 OUTLIER Glycine 0 N--CA 1.475 1.238 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.442 -165.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 1.21 ' CE ' HG12 ' A' ' 107' ' ' VAL . 12.1 tpt -60.7 -48.68 80.69 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.4 t0 -43.58 -57.99 2.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.425 1.078 . . . . 0.0 110.223 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 16' ' ' ILE . 54.5 t -39.57 -59.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.458 1.099 . . . . 0.0 109.501 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -46.13 -52.22 12.56 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.795 1.31 . . . . 0.0 109.658 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 37.0 m-20 -50.78 -69.25 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.612 1.195 . . . . 0.0 109.553 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.741 ' CA ' ' HG2' ' A' ' 140' ' ' GLN . 8.2 ttpm? -41.29 -45.94 3.09 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.634 1.208 . . . . 0.0 110.395 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.877 ' O ' HG22 ' A' ' 141' ' ' VAL . 15.6 mt -53.8 -59.2 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.629 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 79.0 p -64.59 9.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.71 1.256 . . . . 0.0 113.838 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.741 ' HG2' ' CA ' ' A' ' 137' ' ' LYS . 10.3 mm100 -96.06 -52.71 3.93 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.164 0.915 . . . . 0.0 109.432 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.9 m -49.59 123.69 14.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 124.505 1.128 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 82.6 Cg_exo -41.34 178.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.462 2.775 . . . . 0.0 113.553 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.139 HG22 ' CA ' ' A' ' 153' ' ' PRO . 4.2 p -161.31 -142.22 0.08 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 123.101 1.429 . . . . 0.0 112.137 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.496 ' H ' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER 179.33 145.37 0.17 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 110.691 -2.959 . . . . 0.0 111.941 173.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -63.38 121.67 14.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.102 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.842 HG22 ' HB ' ' A' ' 152' ' ' VAL . 1.5 t -78.09 -65.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.949 -168.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.64 -81.78 0.06 OUTLIER Glycine 0 N--CA 1.47 0.94 0 CA-C-N 111.736 -2.484 . . . . 0.0 107.998 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.692 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 73.6 Cg_endo -66.44 -73.48 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.523 2.816 . . . . 0.0 108.671 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.692 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 43.9 m-85 -76.98 102.73 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.616 1.197 . . . . 0.0 110.107 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 34.2 mt-30 -67.74 135.62 52.97 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.671 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.586 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 73.2 m-20 83.04 96.51 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.995 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 63.0 t -154.07 127.03 4.11 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.876 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.139 ' CA ' HG22 ' A' ' 143' ' ' THR . 55.7 Cg_endo -61.45 102.73 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.554 2.836 . . . . 0.0 109.324 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . 1.304 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 49.2 m -42.33 -58.62 2.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.027 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -82.31 88.46 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 O-C-N 124.832 1.332 . . . . 0.0 108.077 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.304 ' HD3' ' O ' ' A' ' 154' ' ' SER . 86.2 Cg_exo -61.65 141.36 90.76 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.531 2.821 . . . . 0.0 114.967 -166.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 158' ' ' VAL . 97.3 t -69.53 161.57 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.374 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 1.119 ' HA ' HG22 ' A' ' 45' ' ' THR . 99.1 t -147.45 118.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.144 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.958 HG12 HG22 ' A' ' 11' ' ' THR . 50.2 mt -69.35 143.5 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 113.602 -1.636 . . . . 0.0 111.705 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.935 HD12 HG22 ' A' ' 10' ' ' THR . 83.5 mt -95.44 -45.09 7.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . 1.288 ' O ' HD23 ' A' ' 9' ' ' LEU . 25.7 t -169.08 165.78 11.11 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 1.093 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -149.95 109.25 3.96 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.524 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -131.18 111.51 12.0 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.438 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.713 HG11 HG11 ' A' ' 36' ' ' VAL . 34.0 m -76.53 135.02 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.78 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 165' ' ' LEU . 78.5 mt -97.41 134.36 22.72 Favored Pre-proline 0 N--CA 1.479 1.015 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.025 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 165' ' ' LEU . 84.0 Cg_exo . . . . . 0 C--O 1.251 1.129 0 C-N-CA 123.539 2.826 . . . . 0.0 112.139 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.126 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 52.8 Cg_exo . . . . . 0 C--O 1.234 0.323 0 CA-C-O 120.679 0.2 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.69 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 0.3 OUTLIER -160.04 74.62 0.58 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.492 1.12 . . . . 0.0 108.685 -178.125 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.863 HG13 HD13 ' A' ' 20' ' ' LEU . 18.7 m -61.07 100.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.185 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.182 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 37.5 mt -78.34 145.3 35.35 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.64 1.212 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.104 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.8 mt -149.15 162.49 39.88 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.027 -2.352 . . . . 0.0 110.41 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 1.292 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.2 m -160.59 78.1 0.62 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.123 -2.308 . . . . 0.0 108.523 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.979 HG22 HG12 ' A' ' 159' ' ' ILE . 35.7 p -70.78 168.63 16.28 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 125.182 1.551 . . . . 0.0 111.44 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.419 ' OG ' HG13 ' A' ' 157' ' ' VAL . 80.5 p -39.57 -44.02 1.39 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.578 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.807 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -57.75 -60.8 3.14 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.443 1.089 . . . . 0.0 110.365 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.03 -179.75 43.47 Favored Glycine 0 N--CA 1.478 1.456 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.222 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 1.104 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 9.7 t-20 -61.23 160.56 10.25 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.6 -1.3 . . . . 0.0 111.761 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 15' ' ' ASN . 10.4 pt -167.39 174.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.914 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 1.113 ' HG2' ' CD2' ' A' ' 8' ' ' LEU . 35.9 mt-10 -160.78 106.07 1.42 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.107 -169.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.159 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.7 mm? -87.35 105.88 17.56 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.64 1.212 . . . . 0.0 108.438 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.428 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -69.45 118.74 12.71 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.169 0.918 . . . . 0.0 108.77 174.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.159 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 6.4 mp -108.37 137.45 46.31 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.918 1.386 . . . . 0.0 110.905 -172.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.797 ' OD1' ' HG2' ' A' ' 23' ' ' GLN . 52.6 t0 -56.61 -116.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.787 174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.844 ' HA ' HG11 ' A' ' 29' ' ' VAL . 60.7 tttm 135.5 -57.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.594 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 1.013 ' OE1' ' NZ ' ' A' ' 24' ' ' LYS . 3.8 pt20 -55.75 -49.07 74.09 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.736 1.272 . . . . 0.0 110.573 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 1.013 ' NZ ' ' OE1' ' A' ' 23' ' ' GLN . 47.0 mmtm -69.11 -16.18 63.6 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.338 1.024 . . . . 0.0 113.219 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.49 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.42 71.72 2.94 Favored Pre-proline 0 N--CA 1.475 0.814 0 O-C-N 123.836 0.71 . . . . 0.0 109.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 1.067 ' O ' HG22 ' A' ' 29' ' ' VAL . 78.0 Cg_exo -51.42 -55.65 3.79 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.735 2.957 . . . . 0.0 111.538 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.6 t -46.68 -62.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 124.678 1.236 . . . . 0.0 110.125 -177.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.9 p -44.06 -54.2 5.7 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.725 1.266 . . . . 0.0 110.441 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.067 HG22 ' O ' ' A' ' 26' ' ' PRO . 29.0 m -56.8 -47.02 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 124.317 1.011 . . . . 0.0 110.617 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.72 ' OE1' ' HA ' ' A' ' 30' ' ' GLN . 3.9 tp60 -44.92 -69.48 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.196 0.935 . . . . 0.0 109.632 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.928 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 12.0 m120 -46.03 -50.43 15.05 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.594 1.184 . . . . 0.0 109.488 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.845 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 45.4 t80 -40.61 -66.01 0.36 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.685 1.241 . . . . 0.0 110.231 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.81 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.3 t -45.81 -39.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.583 1.177 . . . . 0.0 111.099 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.928 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 88.1 m-20 -44.07 -62.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.089 0.868 . . . . 0.0 109.504 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.73 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 34.1 m-85 -64.33 -55.84 18.53 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.159 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 32' ' ' PHE . 58.8 t -39.33 -48.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 124.735 1.272 . . . . 0.0 111.015 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.822 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.1 t-20 -38.43 -33.5 0.1 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.754 1.284 . . . . 0.0 111.844 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.822 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 93.6 p 145.75 176.96 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.225 0.953 . . . . 0.0 113.061 175.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.64 -43.03 3.1 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.883 ' O ' HG23 ' A' ' 44' ' ' THR . 1.4 t80 -71.12 -74.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.586 0.815 . . . . 0.0 109.513 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.667 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 16.5 m-30 -62.5 -28.23 69.7 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.552 1.158 . . . . 0.0 112.678 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.6 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 53.0 p-10 -38.76 -36.68 0.28 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.932 0.77 . . . . 0.0 112.569 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 34.7 t30 -161.25 47.58 0.2 Allowed 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.055 0.847 . . . . 0.0 110.753 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 40' ' ' PHE . 42.9 p -79.46 -136.57 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 160.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 1.041 ' HA ' HG13 ' A' ' 159' ' ' ILE . 47.7 p -163.36 -142.45 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.998 0.904 . . . . 0.0 112.024 174.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.724 ' HZ ' HD13 ' A' ' 9' ' ' LEU . 52.7 m-85 -158.85 74.16 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.242 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.714 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -42.7 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.76 -177.109 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.198 ' NH2' ' CA ' ' A' ' 51' ' ' PRO . 46.9 tpt85 -173.26 -150.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.433 1.111 . . . . 0.0 113.122 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.191 HG23 ' O ' ' A' ' 48' ' ' ARG . 48.1 t -175.83 -70.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.475 -2.148 . . . . 0.0 106.684 169.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.885 ' C ' ' NH2' ' A' ' 48' ' ' ARG . 59.2 mt -171.27 134.22 0.92 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.502 -1.681 . . . . 0.0 108.585 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.198 ' CA ' ' NH2' ' A' ' 48' ' ' ARG . 80.1 Cg_exo -35.54 155.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.068 2.512 . . . . 0.0 112.706 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -1.35 66.51 0.0 OUTLIER Glycine 0 N--CA 1.476 1.332 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.706 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.0 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -156.33 -50.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.856 0.974 . . . . 0.0 109.95 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.0 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 64.2 mtm -176.62 159.75 1.9 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.352 1.032 . . . . 0.0 111.409 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.0 HG12 ' O ' ' A' ' 105' ' ' ILE . 42.6 pt -153.68 165.31 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.815 -1.538 . . . . 0.0 110.108 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 1.195 ' CG ' ' HA ' ' A' ' 104' ' ' PHE . 76.4 mt-30 -164.49 136.55 4.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.146 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -120.93 -158.06 10.31 Favored Glycine 0 N--CA 1.479 1.537 0 O-C-N 124.828 1.33 . . . . 0.0 112.378 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 56.71 82.64 0.05 OUTLIER Glycine 0 N--CA 1.47 0.917 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.253 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.61 -118.47 0.63 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.651 0.853 . . . . 0.0 111.12 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -45.91 120.66 2.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.167 -1.017 . . . . 0.0 111.292 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.274 ' CG2' ' CD ' ' A' ' 67' ' ' LYS . 76.8 p -59.69 124.48 20.24 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.577 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 1.012 ' HG2' ' N ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 19.99 -108.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.827 -178.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 1.193 ' O ' ' CG ' ' A' ' 64' ' ' MET . 88.3 mt-30 -43.23 -58.17 2.64 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.671 1.232 . . . . 0.0 110.363 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 1.193 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 47.3 mtt 141.44 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.639 1.212 . . . . 0.0 107.893 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 64' ' ' MET . 32.6 mt-30 -159.59 78.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.513 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 65' ' ' GLN . 33.9 mt-30 -19.88 130.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.265 -173.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 1.274 ' CD ' ' CG2' ' A' ' 61' ' ' THR . 14.3 mmmm -62.17 -116.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.938 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -142.62 -62.7 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 112.567 -2.106 . . . . 0.0 109.734 -174.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 68' ' ' LYS . 60.7 Cg_exo -28.34 136.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.066 2.511 . . . . 0.0 112.807 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.256 ' OD1' ' HD3' ' A' ' 71' ' ' PRO . 49.4 p-10 -168.69 -41.19 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 116.881 -1.533 . . . . 0.0 114.416 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.256 ' HD3' ' OD1' ' A' ' 70' ' ' ASN . 59.7 Cg_endo -68.28 89.78 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.961 2.44 . . . . 0.0 108.406 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.246 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 84.6 Cg_exo -57.52 -155.69 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.637 2.892 . . . . 0.0 113.63 -172.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.846 ' CD1' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -160.06 151.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.776 176.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.684 ' O ' ' O ' ' A' ' 75' ' ' ASN . 74.6 mmtt -19.73 136.79 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.563 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.941 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -39.92 -120.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.536 -178.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.172 ' CG ' HD21 ' A' ' 79' ' ' ASN . 0.8 OUTLIER 102.58 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.101 0.876 . . . . 0.0 111.305 -178.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.881 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 172.8 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.667 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 1.049 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 42.5 p-10 -68.03 -48.13 66.52 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.574 1.171 . . . . 0.0 109.676 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 1.172 HD21 ' CG ' ' A' ' 76' ' ' GLU . 50.1 p-10 -58.28 77.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.229 0.956 . . . . 0.0 108.699 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . -174.22 40.73 0.13 Allowed Glycine 0 N--CA 1.474 1.222 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.105 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.601 ' N ' HD22 ' A' ' 81' ' ' LEU . 2.8 mm? 39.4 -132.29 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.333 0.666 . . . . 0.0 110.602 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 32.2 ptt-85 -174.04 131.56 0.4 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.021 0.826 . . . . 0.0 109.451 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.464 ' HB3' HG21 ' A' ' 87' ' ' THR . 49.3 t30 -150.79 -122.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.585 1.178 . . . . 0.0 109.804 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.549 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 23.0 m -160.79 159.58 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.032 0.833 . . . . 0.0 111.79 -167.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.736 ' CB ' ' N ' ' A' ' 108' ' ' ALA . 39.1 ptt180 -36.06 103.42 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.669 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.821 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 153.89 -29.6 0.74 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 111.446 -2.615 . . . . 0.0 109.718 -170.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.869 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 35.8 p -76.46 131.45 39.05 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.685 0.755 . . . . 0.0 111.514 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.479 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -80.05 159.0 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.857 164.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.275 ' O ' ' HD1' ' A' ' 104' ' ' PHE . . . -164.11 128.01 2.64 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.63 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 1.186 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 96.5 mmm -51.27 123.13 8.91 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.783 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.642 ' HA ' ' HE1' ' A' ' 104' ' ' PHE . . . -66.52 -147.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.544 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.033 ' HG2' ' H ' ' A' ' 93' ' ' THR . 56.7 ttp180 179.5 -129.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.033 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 9.0 t 136.31 87.09 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.541 1.151 . . . . 0.0 109.963 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.1 -70.7 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.821 1.325 . . . . 0.0 109.732 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.1 m-20 -40.13 110.95 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.527 1.142 . . . . 0.0 110.624 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.857 ' NZ ' ' OD1' ' A' ' 75' ' ' ASN . 27.8 tptp -46.13 -112.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.735 1.272 . . . . 0.0 110.52 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 36.0 m-20 -58.78 110.14 0.95 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.633 1.208 . . . . 0.0 109.258 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 1.242 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 70.6 m -166.53 -124.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 O-C-N 124.564 1.165 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.846 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 71.71 87.76 0.11 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.799 1.312 . . . . 0.0 108.162 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.87 HG21 ' HA ' ' A' ' 70' ' ' ASN . 81.6 p -78.88 -34.82 44.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.801 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.544 ' HB2' ' HE2' ' A' ' 40' ' ' PHE . 78.9 p -169.87 -47.9 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.132 0.895 . . . . 0.0 110.363 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.473 ' HG2' ' CB ' ' A' ' 91' ' ' ALA . 14.2 tt0 -38.93 144.02 0.14 Allowed 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.19 0.931 . . . . 0.0 111.184 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 1.017 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -160.31 159.68 31.58 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.58 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 1.275 ' HD1' ' O ' ' A' ' 89' ' ' ALA . 24.5 m-85 -81.94 155.52 25.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.774 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.0 ' O ' HG12 ' A' ' 55' ' ' ILE . 37.8 mt -146.23 91.85 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.325 158.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.945 ' O ' ' HE1' ' A' ' 132' ' ' MET . 1.8 m-20 -71.24 171.73 10.56 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 112.545 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.627 HG12 ' CE ' ' A' ' 132' ' ' MET . 35.6 m -160.68 48.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.243 -1.798 . . . . 0.0 108.377 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.749 ' HB3' ' HD1' ' A' ' 53' ' ' PHE . . . 176.82 147.48 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.233 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.705 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.5 m-20 -36.13 77.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.724 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.718 ' HB2' HD22 ' A' ' 106' ' ' ASN . 3.2 t30 -69.65 134.51 48.81 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.861 1.35 . . . . 0.0 110.364 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.632 ' H ' ' CD1' ' A' ' 113' ' ' LEU . . . 164.16 -53.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.82 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE2' ' O ' ' A' ' 109' ' ' ASP . 34.5 p90 -67.64 47.89 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.581 1.176 . . . . 0.0 110.374 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER 177.59 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.229 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.81 ' H ' HD13 ' A' ' 113' ' ' LEU . 64.6 t0 -43.45 -56.42 3.62 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.015 0.822 . . . . 0.0 110.738 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 1.049 ' ND1' ' HB3' ' A' ' 78' ' ' ASP . 9.0 t-160 179.74 111.96 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.697 1.248 . . . . 0.0 109.61 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.594 ' N ' ' HD2' ' A' ' 115' ' ' HIS . . . . . . . . 0 N--CA 1.474 1.178 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.564 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.667 ' HA ' ' CD2' ' A' ' 115' ' ' HIS . 8.3 m-30 . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 120.447 0.165 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 120' ' ' PHE . . . -171.25 -136.01 2.03 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.86 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 81.7 m-85 -79.21 127.78 32.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.583 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.186 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -53.89 -166.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.324 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 123' ' ' ALA . 60.3 t -179.69 134.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.585 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.951 ' CD1' ' HG2' ' A' ' 90' ' ' MET . 13.9 p90 -168.82 28.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.132 0.895 . . . . 0.0 111.07 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 1.479 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -147.11 176.53 25.93 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 123.321 1.511 . . . . 0.0 113.11 -173.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.428 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 8.2 ttpm? 177.81 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 110.77 -2.715 . . . . 0.0 109.989 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 86' ' ' GLY . 66.9 t -60.39 128.38 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.879 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 34.5 m -95.33 -42.18 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.699 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.476 ' N ' HG23 ' A' ' 129' ' ' VAL . 8.2 ttpm? 179.98 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.154 0.909 . . . . 0.0 109.697 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 174.52 12.45 0.02 OUTLIER Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.768 1.292 . . . . 0.0 112.993 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 1.627 ' CE ' HG12 ' A' ' 107' ' ' VAL . 11.5 tpt -54.99 -50.83 68.02 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.7 t0 -40.84 -55.62 2.41 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.449 1.093 . . . . 0.0 110.262 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.888 HG21 ' O ' ' A' ' 15' ' ' ASN . 54.8 t -41.7 -63.23 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 124.464 1.103 . . . . 0.0 109.438 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.546 ' O ' ' HB ' ' A' ' 138' ' ' ILE . . . -49.79 -50.19 45.76 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.729 1.268 . . . . 0.0 109.635 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.675 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 37.8 m-20 -51.43 -69.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.513 1.133 . . . . 0.0 109.228 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.989 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 5.9 tmtt? -38.11 -48.91 1.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.744 1.278 . . . . 0.0 110.386 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.008 ' O ' HG22 ' A' ' 141' ' ' VAL . 32.6 mt -54.06 -59.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 124.606 1.192 . . . . 0.0 108.309 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.1 p -65.76 8.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.763 1.29 . . . . 0.0 113.86 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.675 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 10.8 mm100 -97.12 -51.92 4.03 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.212 0.945 . . . . 0.0 109.096 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.008 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -48.39 132.52 13.18 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.584 1.177 . . . . 0.0 110.258 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -39.13 -178.02 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.395 2.73 . . . . 0.0 113.534 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.285 HG22 ' CA ' ' A' ' 153' ' ' PRO . 7.4 p -161.15 -151.78 0.24 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 123.2 1.476 . . . . 0.0 112.532 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 178.12 146.32 0.14 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.21 170.202 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.599 ' HB3' ' HG2' ' A' ' 150' ' ' GLN . 39.0 m-20 -67.59 114.13 5.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.68 167.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.957 ' HB ' ' O ' ' A' ' 149' ' ' TYR . 1.5 t -77.32 -159.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 124.474 1.109 . . . . 0.0 110.916 -166.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.826 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -60.6 -115.46 0.01 OUTLIER Glycine 0 N--CA 1.471 1.015 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 171.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.926 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 91.8 Cg_endo -74.51 33.9 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.603 2.868 . . . . 0.0 110.744 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.957 ' O ' ' HB ' ' A' ' 146' ' ' VAL . 27.6 m-85 -170.41 104.52 0.28 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.735 0.647 . . . . 0.0 109.686 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 1.131 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 32.1 mt-30 -71.09 -169.71 0.4 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.847 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 1.131 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 52.1 p-10 44.6 76.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.18 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.805 HG21 ' CE ' ' A' ' 64' ' ' MET . 70.8 t -157.28 102.39 1.88 Allowed Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.615 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.285 ' CA ' HG22 ' A' ' 143' ' ' THR . 81.5 Cg_exo -49.95 109.67 0.31 Allowed 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.434 2.756 . . . . 0.0 110.961 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . 1.276 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.5 t -40.0 -57.57 1.61 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.459 1.099 . . . . 0.0 108.972 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 62.6 mttp -69.61 88.25 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 164.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.276 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.2 Cg_endo -70.1 -157.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.615 2.877 . . . . 0.0 112.772 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 158' ' ' VAL . 99.4 t -153.78 153.87 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.326 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 1.018 ' HA ' HG22 ' A' ' 45' ' ' THR . 83.2 t -146.96 123.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.597 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.041 HG13 ' HA ' ' A' ' 45' ' ' THR . 36.9 mt -68.62 134.36 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.27 -175.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.292 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.9 mt -82.13 -48.61 11.12 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.771 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 32.2 t -167.1 166.42 15.09 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.521 1.138 . . . . 0.0 111.955 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 1.078 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -163.32 125.38 2.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.556 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 1.182 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 14.3 ptmm? -170.28 120.8 0.61 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.702 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 7' ' ' VAL . 33.7 m -68.14 131.66 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 124.762 1.289 . . . . 0.0 110.57 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.127 HD12 ' HD2' ' A' ' 166' ' ' PRO . 49.3 tp -78.0 118.33 71.51 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.801 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 1.127 ' HD2' HD12 ' A' ' 165' ' ' LEU . 87.0 Cg_exo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 123.523 2.815 . . . . 0.0 112.026 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo . . . . . 0 C--O 1.235 0.371 0 CA-C-O 120.946 0.311 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -160.72 117.11 2.32 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.792 -177.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.9 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 10.4 p -59.8 137.58 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.262 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.197 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 8.4 mp -125.55 130.65 52.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.531 1.144 . . . . 0.0 109.415 166.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.923 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.5 mp -123.93 -171.99 2.44 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.936 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 1.218 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 98.7 m -160.82 84.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.827 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 1.006 HG22 HG12 ' A' ' 159' ' ' ILE . 36.9 p -76.6 172.48 12.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 125.426 1.704 . . . . 0.0 111.18 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -39.28 -44.13 1.23 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.351 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.838 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.26 -64.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.558 1.161 . . . . 0.0 110.369 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.37 41.58 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 113.248 -1.796 . . . . 0.0 113.654 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 16' ' ' ILE . 58.7 t-20 -66.29 153.33 42.88 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.12 -1.54 . . . . 0.0 111.419 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 15' ' ' ASN . 13.9 pt -163.56 174.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.15 -1.387 . . . . 0.0 111.3 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 1.47 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . 36.7 mt-10 -161.34 122.07 2.76 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.947 -170.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.025 HD21 HD11 ' A' ' 105' ' ' ILE . 2.5 mm? -95.64 162.96 13.4 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.817 1.323 . . . . 0.0 109.999 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.469 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -113.87 124.69 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.454 170.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.887 HD23 ' HE2' ' A' ' 125' ' ' PHE . 6.6 mp -106.01 120.05 40.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.931 1.395 . . . . 0.0 109.705 -172.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.591 ' OD2' ' HG ' ' A' ' 81' ' ' LEU . 32.2 m-20 -72.55 96.97 2.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.771 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.974 ' HA ' HG11 ' A' ' 29' ' ' VAL . 58.8 tttm -71.6 -56.15 6.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.658 1.224 . . . . 0.0 110.97 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.643 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 6.4 tp60 -46.17 -60.82 2.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.687 -171.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 51.8 tptt -68.17 -2.83 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.738 1.274 . . . . 0.0 113.138 -173.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.523 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -161.3 70.79 2.58 Favored Pre-proline 0 N--CA 1.476 0.831 0 O-C-N 123.705 0.628 . . . . 0.0 109.647 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 1.04 ' O ' HG22 ' A' ' 29' ' ' VAL . 62.9 Cg_exo -54.86 -56.18 2.62 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.635 2.89 . . . . 0.0 111.571 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.45 -64.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 124.726 1.266 . . . . 0.0 110.116 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -44.15 -58.32 2.92 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.734 1.272 . . . . 0.0 110.544 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.653 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 28.7 m -48.81 -50.14 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 124.752 1.282 . . . . 0.0 110.574 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 1.152 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -52.0 -54.18 32.96 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.358 1.036 . . . . 0.0 109.357 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.899 ' OD1' HG21 ' A' ' 73' ' ' ILE . 10.6 m120 -50.89 -64.69 0.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.549 1.156 . . . . 0.0 110.391 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 1.653 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 33.6 p90 -54.18 -43.57 70.8 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.439 1.087 . . . . 0.0 110.709 -172.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.152 HG12 ' O ' ' A' ' 30' ' ' GLN . 10.7 p -51.33 -40.29 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 124.044 0.84 . . . . 0.0 110.171 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.836 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 71.0 m-20 -46.61 -61.34 1.87 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.112 0.882 . . . . 0.0 109.285 173.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 33.5 m-85 -54.61 -56.15 22.01 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.994 1.434 . . . . 0.0 109.124 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.834 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 97.6 t -46.42 -66.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 124.639 1.212 . . . . 0.0 109.344 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 33' ' ' VAL . 1.9 m-20 -50.57 -48.74 57.43 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.814 1.321 . . . . 0.0 109.989 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.637 ' OG ' ' O ' ' A' ' 34' ' ' ASP . 67.5 m -53.97 -93.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.539 1.149 . . . . 0.0 110.284 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.42 87.41 0.07 OUTLIER Glycine 0 N--CA 1.472 1.073 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 1.098 ' O ' ' CD1' ' A' ' 41' ' ' TYR . 88.0 t80 -157.39 57.02 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.911 1.007 . . . . 0.0 108.561 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.098 ' CD1' ' O ' ' A' ' 40' ' ' PHE . 25.6 m-85 -171.68 -37.07 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -38.69 -37.21 0.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.149 0.905 . . . . 0.0 112.688 -171.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -155.04 44.89 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.061 0.851 . . . . 0.0 110.902 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 45' ' ' THR . 58.4 p -79.4 -141.97 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.387 162.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 1.062 ' HA ' HG13 ' A' ' 159' ' ' ILE . 48.7 p -163.89 -141.35 0.05 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.608 0.718 . . . . 0.0 111.644 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.82 ' CD1' ' O ' ' A' ' 45' ' ' THR . 17.2 m-30 -143.07 62.73 1.39 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.417 -1.72 . . . . 0.0 107.246 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.994 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 7.1 p-80 -51.58 -60.49 3.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.72 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.061 ' HB3' ' OE1' ' A' ' 56' ' ' GLN . 26.5 mmm180 -69.14 118.7 12.37 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.626 1.203 . . . . 0.0 110.059 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 55' ' ' ILE . 8.7 p -163.64 149.6 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 124.713 1.258 . . . . 0.0 111.023 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.84 HD13 ' HD2' ' A' ' 53' ' ' PHE . 10.1 tt -165.54 126.61 1.35 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.242 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 53' ' ' PHE . 87.4 Cg_exo -35.55 160.96 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.618 2.879 . . . . 0.0 113.729 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -7.71 70.06 0.0 OUTLIER Glycine 0 N--CA 1.474 1.225 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.684 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.082 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -160.78 -53.24 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.828 0.958 . . . . 0.0 109.712 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.082 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 61.3 mtm -177.98 161.77 1.58 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.25 0.969 . . . . 0.0 112.249 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.709 HG12 ' O ' ' A' ' 105' ' ' ILE . 36.7 pt -150.61 174.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.798 170.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 1.061 ' OE1' ' HB3' ' A' ' 48' ' ' ARG . 42.7 mt-30 -158.98 167.01 30.47 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.201 -169.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.19 -178.08 31.89 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.578 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.09 84.57 0.08 OUTLIER Glycine 0 N--CA 1.47 0.912 0 CA-C-N 113.746 -1.227 . . . . 0.0 110.217 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.801 ' C ' ' HD2' ' A' ' 67' ' ' LYS . . . 178.98 -132.58 1.91 Allowed Glycine 0 N--CA 1.475 1.274 0 O-C-N 124.656 0.856 . . . . 0.0 111.305 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 56.6 m-85 -50.96 110.71 0.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.245 -0.978 . . . . 0.0 109.554 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.213 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 9.4 t -70.33 105.11 2.89 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.398 1.061 . . . . 0.0 110.082 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 1.213 ' HG2' ' O ' ' A' ' 61' ' ' THR . 12.6 pt-20 70.84 -127.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.801 1.313 . . . . 0.0 110.922 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 1.218 ' O ' ' CG ' ' A' ' 64' ' ' MET . 59.8 mt-30 -47.22 -55.45 8.56 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.808 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 1.218 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 50.7 mtt 145.72 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.637 1.208 . . . . 0.0 108.269 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 66' ' ' GLN . 18.4 tt0 -144.03 84.51 1.78 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.981 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.554 ' O ' ' O ' ' A' ' 67' ' ' LYS . 42.4 mt-30 -24.45 135.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.067 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 1.166 ' CD ' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -47.91 -120.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.427 -178.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 69' ' ' PRO . 4.2 ttmp? -170.84 73.05 0.56 Allowed Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.32 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.82 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 87.9 Cg_exo -51.17 -140.11 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.573 2.848 . . . . 0.0 113.127 -172.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.917 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 93.6 m-20 164.83 168.72 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.579 -172.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.917 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 33.1 Cg_endo -44.66 98.39 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.549 2.166 . . . . 0.0 108.893 169.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.633 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.4 Cg_exo -44.11 -136.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.853 3.035 . . . . 0.0 113.336 -175.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.899 HG21 ' OD1' ' A' ' 31' ' ' ASN . 24.8 pt -152.34 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.438 1.086 . . . . 0.0 109.083 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 75' ' ' ASN . 21.6 ptmt -154.82 -148.37 0.24 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.03 0.831 . . . . 0.0 111.918 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.566 ' O ' ' O ' ' A' ' 74' ' ' LYS . 37.7 m-20 -44.93 -171.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.258 -1.792 . . . . 0.0 112.408 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.05 ' HG3' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 171.42 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.421 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.941 ' N ' ' HG2' ' A' ' 76' ' ' GLU . . . -44.72 -35.27 2.59 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.534 1.146 . . . . 0.0 111.887 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -68.89 25.81 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.058 0.848 . . . . 0.0 113.25 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.635 HD21 ' HB ' ' A' ' 124' ' ' VAL . 44.8 p-10 -63.63 -123.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.941 0.776 . . . . 0.0 109.017 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.6 -80.28 0.08 OUTLIER Glycine 0 N--CA 1.473 1.12 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.433 ' O ' ' CD ' ' A' ' 82' ' ' ARG . 2.8 mm? 40.17 -151.01 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.848 0.97 . . . . 0.0 111.185 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 1.433 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER 179.95 111.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.987 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 1.21 ' OD1' ' HD3' ' A' ' 127' ' ' LYS . 26.0 m120 -159.76 -156.77 0.52 Allowed 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.591 1.182 . . . . 0.0 111.267 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 1.126 HG22 ' HG2' ' A' ' 85' ' ' ARG . 12.0 m -169.46 166.03 10.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.283 -166.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 1.126 ' HG2' HG22 ' A' ' 84' ' ' THR . 16.4 ptm180 -18.63 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.108 1.432 . . . . 0.0 112.146 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.858 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 148.18 -26.83 1.41 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-N 110.442 -3.072 . . . . 0.0 109.676 -168.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.776 HG22 ' HG2' ' A' ' 127' ' ' LYS . 26.8 p -73.86 134.31 43.27 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.689 0.757 . . . . 0.0 112.107 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.53 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -91.32 160.05 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.062 164.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.263 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -163.41 138.89 6.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.043 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.922 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 95.7 mmm -55.82 125.62 22.11 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.769 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 1.226 ' HB3' ' OE1' ' A' ' 102' ' ' GLN . . . -74.74 -173.12 1.75 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.545 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.02 ' NH1' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.28 -120.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.407 175.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.02 ' HB ' ' NH1' ' A' ' 92' ' ' ARG . 20.7 m 173.79 -69.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.821 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 172.46 111.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.801 1.313 . . . . 0.0 108.89 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.821 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 88.4 m-20 161.84 145.3 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.152 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.654 ' O ' ' O ' ' A' ' 95' ' ' ASP . 53.4 mtmt -45.19 -122.5 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.043 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.33 118.16 5.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.713 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.6 m -163.87 -144.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.599 1.187 . . . . 0.0 110.938 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.726 ' O ' HD11 ' A' ' 73' ' ' ILE . . . 50.96 87.36 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.557 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 78.4 p -78.52 -41.35 32.54 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.246 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.3 m -167.88 -53.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 124.231 0.957 . . . . 0.0 109.286 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 1.226 ' OE1' ' HB3' ' A' ' 91' ' ' ALA . 2.0 pp0? -34.44 142.86 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.519 1.137 . . . . 0.0 111.823 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.761 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.91 -171.8 4.03 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.526 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.949 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 20.0 p90 -154.87 135.58 13.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.758 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.025 HD11 HD21 ' A' ' 18' ' ' LEU . 53.0 mt -102.19 101.2 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.822 -1.99 . . . . 0.0 108.923 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.642 ' OD1' ' CD1' ' A' ' 104' ' ' PHE . 18.9 m-20 -62.78 167.37 4.64 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.814 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.322 HG12 ' CE ' ' A' ' 132' ' ' MET . 33.0 m -157.93 51.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.273 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 53' ' ' PHE . . . -177.4 133.16 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.831 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.94 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 31.9 m-20 -31.68 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.458 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.697 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 46.9 t30 -68.83 -119.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.858 1.349 . . . . 0.0 109.519 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 61.21 -72.21 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.743 0.652 . . . . 0.0 110.24 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.94 ' CE1' ' O ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -67.63 56.07 0.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.377 1.048 . . . . 0.0 109.612 178.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.843 HD21 ' HD2' ' A' ' 122' ' ' TYR . 6.3 tt 177.44 -39.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.079 -173.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -39.5 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.06 0.85 . . . . 0.0 110.644 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.27 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.739 1.274 . . . . 0.0 108.678 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.234 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.768 -178.438 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.93 0.871 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.69 -129.13 1.09 Allowed Glycine 0 N--CA 1.474 1.209 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.954 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.843 ' HD2' HD21 ' A' ' 113' ' ' LEU . 21.0 m-85 -79.72 116.72 20.06 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.486 0.757 . . . . 0.0 109.62 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.05 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . . . -49.01 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.569 1.168 . . . . 0.0 111.051 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.263 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 70.2 t 179.86 133.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.806 -176.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.887 ' HE2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -166.13 21.99 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.033 170.366 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 1.53 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -118.07 168.54 13.1 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 123.123 1.402 . . . . 0.0 112.753 -169.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.469 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 10.2 mtmp? 179.56 104.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 110.962 -2.619 . . . . 0.0 109.564 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 86' ' ' GLY . 66.8 t -43.56 119.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.083 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.47 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -63.91 -48.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.235 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.908 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 2.9 tmtm? 163.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.255 0.972 . . . . 0.0 109.612 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.65 32.61 0.09 OUTLIER Glycine 0 N--CA 1.476 1.33 0 O-C-N 124.817 1.323 . . . . 0.0 111.469 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 1.322 ' CE ' HG12 ' A' ' 107' ' ' VAL . 8.4 tpt -59.75 -40.91 89.71 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.162 0.566 . . . . 0.0 110.281 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 22.9 m-20 -44.05 -63.77 0.8 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.273 0.983 . . . . 0.0 109.937 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.675 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.2 t -43.89 -60.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 124.615 1.197 . . . . 0.0 109.219 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.412 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -46.18 -52.08 13.01 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.59 1.181 . . . . 0.0 109.772 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.599 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 39.9 m-20 -53.64 -65.43 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.562 1.164 . . . . 0.0 109.133 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -36.57 -49.24 0.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.711 1.257 . . . . 0.0 110.588 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.163 ' O ' HG22 ' A' ' 141' ' ' VAL . 23.5 mt -57.1 -57.39 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 124.578 1.173 . . . . 0.0 108.642 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.599 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.3 p -61.7 3.26 0.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 10.9 mm100 -96.25 -49.53 5.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.27 0.981 . . . . 0.0 109.313 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.163 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -47.28 123.85 8.68 Favored Pre-proline 0 N--CA 1.472 0.638 0 O-C-N 124.518 1.136 . . . . 0.0 110.055 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 141' ' ' VAL . 84.0 Cg_exo -41.17 179.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.517 2.811 . . . . 0.0 113.799 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.389 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.5 p -160.92 -151.48 0.24 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 123.589 1.662 . . . . 0.0 112.32 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 154' ' ' SER . 0.0 OUTLIER 178.24 165.06 0.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.148 174.176 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 146' ' ' VAL . 77.7 m-20 -51.57 -144.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.752 166.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.771 HG22 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -162.19 -63.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.903 1.335 . . . . 0.0 107.914 170.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.01 -95.52 0.1 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-N 111.119 -2.764 . . . . 0.0 107.531 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 90.5 Cg_endo -70.54 -63.19 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.639 2.893 . . . . 0.0 108.928 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.68 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 59.6 m-85 -70.12 109.42 4.59 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.703 1.252 . . . . 0.0 110.702 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.566 ' O ' ' NH1' ' A' ' 48' ' ' ARG . 22.4 mm-40 -75.9 151.21 37.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.75 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.736 ' O ' HG23 ' A' ' 152' ' ' VAL . 21.7 m-20 77.63 96.95 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.606 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.771 ' HB ' HG22 ' A' ' 146' ' ' VAL . 84.9 t -164.66 116.1 0.93 Allowed Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.409 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.389 ' CA ' HG22 ' A' ' 143' ' ' THR . 59.7 Cg_endo -65.02 108.53 1.13 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.534 2.822 . . . . 0.0 109.623 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . 1.251 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 62.2 p -43.96 -58.83 2.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.928 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 88.3 tttt -74.3 88.53 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.251 ' HD3' ' O ' ' A' ' 154' ' ' SER . 59.1 Cg_endo -77.31 131.74 11.95 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.684 2.923 . . . . 0.0 112.486 -167.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.641 HG21 HG23 ' A' ' 138' ' ' ILE . 74.1 t -68.94 157.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.765 -1.562 . . . . 0.0 110.44 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 1.039 ' HA ' HG22 ' A' ' 45' ' ' THR . 98.9 t -143.75 120.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.517 174.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.062 HG13 ' HA ' ' A' ' 45' ' ' THR . 32.3 mt -68.21 133.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.091 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.218 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.7 mt -77.99 -50.51 11.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 112.383 -2.19 . . . . 0.0 109.744 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.4 m -162.6 -165.46 1.17 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.655 1.222 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.923 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . 179.41 135.55 0.1 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.3 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 8' ' ' LEU . 61.1 pttt -171.61 136.45 0.96 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.693 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 36' ' ' VAL . 34.8 m -77.85 133.06 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.938 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.103 HD12 ' HD2' ' A' ' 166' ' ' PRO . 47.2 tp -91.98 117.24 67.62 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.29 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 1.103 ' HD2' HD12 ' A' ' 165' ' ' LEU . 88.4 Cg_exo . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.547 2.831 . . . . 0.0 111.828 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.996 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 84.8 Cg_exo . . . . . 0 C--O 1.235 0.338 0 CA-C-O 121.107 0.378 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.546 ' CE1' ' CG ' ' A' ' 19' ' ' GLU . 2.1 m-70 -147.47 112.82 5.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.043 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.038 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 9.1 p -67.64 143.85 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.311 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.282 HD11 ' OE1' ' A' ' 17' ' ' GLU . 6.6 mp -129.76 115.01 16.66 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.625 1.202 . . . . 0.0 110.023 166.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.056 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.5 mp -107.69 -177.8 3.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 111.174 -2.739 . . . . 0.0 108.743 160.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.647 HG23 ' N ' ' A' ' 15' ' ' ASN . 96.0 m -160.84 100.99 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.103 174.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.942 HG22 HG12 ' A' ' 159' ' ' ILE . 41.7 p -78.8 172.65 13.44 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.527 1.767 . . . . 0.0 111.446 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -41.08 -43.33 2.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.417 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.803 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.64 -59.26 4.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.497 1.123 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 10' ' ' THR . . . 169.67 -176.03 43.67 Favored Glycine 0 N--CA 1.479 1.546 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.647 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 1.329 ' O ' HG21 ' A' ' 134' ' ' VAL . 50.4 t30 -53.28 161.2 0.96 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 113.49 -1.355 . . . . 0.0 111.26 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 9' ' ' LEU . 11.8 tt -171.51 157.13 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.889 -174.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 1.282 ' OE1' HD11 ' A' ' 8' ' ' LEU . 39.7 tt0 -163.96 125.17 2.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.084 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 105' ' ' ILE . 2.9 mm? -93.54 -177.43 4.4 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.934 1.396 . . . . 0.0 110.542 164.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.546 ' CG ' ' CE1' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -148.3 118.5 7.29 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.646 175.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.761 ' O ' ' OE2' ' A' ' 19' ' ' GLU . 6.0 mp -90.57 -162.22 0.88 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.031 -1.441 . . . . 0.0 111.523 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.04 96.88 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.35 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.847 ' HA ' HG11 ' A' ' 29' ' ' VAL . 39.8 ttmt -62.28 -46.61 88.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.912 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -45.39 -67.34 0.29 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.483 1.114 . . . . 0.0 110.48 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HZ2' HD21 ' A' ' 81' ' ' LEU . 31.0 mmtp -70.05 -0.54 7.79 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.826 1.329 . . . . 0.0 114.17 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.628 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.21 70.14 2.98 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 123.827 0.704 . . . . 0.0 110.06 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.975 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.1 Cg_exo -56.18 -58.16 1.16 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.6 2.867 . . . . 0.0 111.043 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.9 t -50.71 -65.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 124.84 1.338 . . . . 0.0 110.173 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.1 m -43.99 -57.63 3.24 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.699 1.25 . . . . 0.0 110.675 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 26' ' ' PRO . 33.1 m -49.12 -49.08 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.642 1.214 . . . . 0.0 110.987 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.775 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 tm0? -50.85 -67.15 0.28 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.222 0.951 . . . . 0.0 109.086 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.914 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 t-20 -43.31 -53.11 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.581 1.176 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.716 ' CE2' HG21 ' A' ' 36' ' ' VAL . 48.8 t80 -43.21 -62.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.523 1.14 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 37' ' ' ASN . 62.7 t -44.22 -39.32 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.624 1.202 . . . . 0.0 111.071 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.914 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 5.1 m-20 -44.49 -62.06 1.32 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.121 0.888 . . . . 0.0 109.583 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.83 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 94.2 m-85 -60.26 -63.77 1.18 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.9 1.375 . . . . 0.0 109.202 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.716 HG21 ' CE2' ' A' ' 32' ' ' PHE . 57.4 t -39.52 -49.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 124.648 1.218 . . . . 0.0 110.869 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.751 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.7 t-20 -38.9 -31.34 0.06 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.738 1.274 . . . . 0.0 112.239 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.751 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.6 p 157.67 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.112 0.883 . . . . 0.0 112.425 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 68.69 81.62 0.2 Allowed Glycine 0 N--CA 1.47 0.928 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.401 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.83 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 1.7 t80 173.74 -81.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.819 0.953 . . . . 0.0 109.739 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -68.35 -12.41 61.06 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.344 1.027 . . . . 0.0 113.259 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 1.172 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 17.4 m-20 -38.97 -50.04 1.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.661 0.6 . . . . 0.0 111.714 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 1.172 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 20.6 m-20 -156.68 52.53 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.393 1.058 . . . . 0.0 109.782 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.891 ' O ' HG23 ' A' ' 45' ' ' THR . 27.8 m -78.62 -125.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 166.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 1.012 HG22 ' HA ' ' A' ' 158' ' ' VAL . 40.6 p -165.35 -140.05 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.222 1.011 . . . . 0.0 111.966 170.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.921 ' CD1' ' O ' ' A' ' 45' ' ' THR . 11.2 m-30 -152.98 81.31 1.21 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.49 -2.141 . . . . 0.0 105.962 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.789 ' O ' ' CD ' ' A' ' 153' ' ' PRO . 19.8 m80 -11.43 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.123 ' NH2' ' O ' ' A' ' 141' ' ' VAL . 28.0 tpt85 -172.4 -133.19 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.634 1.209 . . . . 0.0 110.098 166.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 50' ' ' ILE . 7.4 p -173.41 147.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.953 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 49' ' ' VAL . 57.0 mt -72.24 131.8 84.77 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.106 156.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' ILE . 19.2 Cg_endo -40.76 -139.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.386 0 C-N-CA 123.213 2.608 . . . . 0.0 111.582 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.63 76.49 0.01 OUTLIER Glycine 0 N--CA 1.471 0.998 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.67 ' HD2' HG21 ' A' ' 50' ' ' ILE . 1.1 t80 -162.11 -68.79 0.05 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.604 0.826 . . . . 0.0 109.833 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.902 ' O ' HG23 ' A' ' 49' ' ' VAL . 26.4 ptt? 177.16 130.77 0.05 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.212 0.945 . . . . 0.0 111.906 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.849 HG22 ' CB ' ' A' ' 49' ' ' VAL . 32.4 pt -90.2 176.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.047 169.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 1.287 ' O ' ' HA ' ' A' ' 104' ' ' PHE . 20.6 mm-40 -69.28 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.499 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 1.042 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -157.47 -133.66 1.63 Allowed Glycine 0 N--CA 1.473 1.103 0 O-C-N 118.845 -2.409 . . . . 0.0 112.046 4.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.59 105.27 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA2' ' HD3' ' A' ' 67' ' ' LYS . . . -175.5 -121.38 0.64 Allowed Glycine 0 N--CA 1.475 1.278 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.93 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 21.0 m-85 -42.58 114.09 0.54 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.577 -0.812 . . . . 0.0 110.455 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.747 ' HA ' HG23 ' A' ' 44' ' ' THR . 97.7 m -59.94 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.613 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 65.14 -106.11 0.13 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.817 1.323 . . . . 0.0 110.287 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 44.6 tp60 -71.41 50.3 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.67 1.232 . . . . 0.0 110.505 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.93 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 53.4 mtt 41.75 35.77 0.54 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.937 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' GLN . 10.7 tp-100 -77.67 87.67 3.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 172.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 67' ' ' LYS . 62.5 mt-30 -27.42 137.41 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.084 -171.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 66' ' ' GLN . 35.3 mtmm -43.85 -122.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.273 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -174.01 75.94 0.36 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 112.704 -2.044 . . . . 0.0 106.617 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 1.232 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 58.3 Cg_endo -78.21 -178.05 4.33 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.638 2.892 . . . . 0.0 113.593 -167.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.232 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 41.5 m-20 -166.0 168.98 7.18 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.887 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.863 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 99.3 Cg_exo -36.1 83.29 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.347 2.698 . . . . 0.0 111.295 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.046 ' HB3' HG22 ' A' ' 100' ' ' THR . 80.6 Cg_exo -49.82 154.17 5.2 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.846 3.031 . . . . 0.0 113.735 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.094 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 30.4 pt -78.98 162.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.923 -1.49 . . . . 0.0 112.03 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.944 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 95.7 mttt -59.84 -177.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.846 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 25.9 p30 -52.55 -169.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.31 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.22 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 157.39 122.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.924 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 167.12 -47.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.322 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 49.8 p-10 -69.03 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.485 1.116 . . . . 0.0 112.86 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 80' ' ' GLY . 43.6 p-10 -44.43 -46.94 9.81 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.996 0.81 . . . . 0.0 109.865 174.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.752 ' C ' HD12 ' A' ' 81' ' ' LEU . . . 73.53 68.24 1.62 Allowed Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.412 1.07 . . . . 0.0 111.166 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.752 HD12 ' C ' ' A' ' 80' ' ' GLY . 2.7 mp -151.36 174.32 13.47 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.854 0.973 . . . . 0.0 110.531 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.682 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 14.2 ptp180 -79.56 144.19 34.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.687 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.682 ' OD1' ' O ' ' A' ' 82' ' ' ARG . 87.0 m-20 -164.53 153.43 13.05 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.502 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' ' 109' ' ' ASP . 17.8 m -165.26 159.49 17.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.421 -169.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' THR . 67.1 ttt180 -21.21 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.792 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.851 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 146.06 -13.76 1.69 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.835 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.169 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 24.3 p -109.48 163.61 13.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.026 1.394 . . . . 0.0 112.584 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.871 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -131.37 158.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 111.28 -2.691 . . . . 0.0 108.719 -177.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -156.05 150.67 25.95 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.89 -1.504 . . . . 0.0 112.364 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 1.122 ' SD ' ' O ' ' A' ' 102' ' ' GLN . 15.6 tpt -61.77 127.3 30.77 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.676 -1.602 . . . . 0.0 110.739 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.827 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . . . -57.34 -119.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.526 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.938 ' HA ' ' H ' ' A' ' 99' ' ' ALA . 39.2 ptt180 179.21 -153.1 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.77 0.669 . . . . 0.0 111.353 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 53.7 m -176.8 -90.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.17 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 164.52 117.85 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.695 1.247 . . . . 0.0 109.098 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 50.3 t0 159.64 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.303 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.142 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 64.3 mttm 153.98 22.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.072 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 1.142 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 89.4 m-20 178.96 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 1.365 ' CA ' ' O ' ' A' ' 99' ' ' ALA . 31.2 t 178.54 108.22 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.599 1.187 . . . . 0.0 109.137 -169.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 1.365 ' O ' ' CA ' ' A' ' 98' ' ' SER . . . 34.16 135.87 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.389 -1.444 . . . . 0.0 114.025 -2.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 1.046 HG22 ' HB3' ' A' ' 72' ' ' PRO . 38.6 p -160.92 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.774 -2.012 . . . . 0.0 108.682 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.612 ' H ' ' NE2' ' A' ' 102' ' ' GLN . 78.0 p -170.36 80.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.402 1.063 . . . . 0.0 108.398 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 1.122 ' O ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER 176.46 158.64 0.3 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.73 1.269 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.949 ' HD2' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -158.45 -173.7 4.43 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.89 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 1.287 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 22.2 p90 -156.64 139.65 15.39 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.655 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.042 HD11 HD21 ' A' ' 18' ' ' LEU . 60.4 mt -100.68 113.47 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.31 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 1.169 ' OD1' ' O ' ' A' ' 87' ' ' THR . 37.5 p-10 -72.42 -167.82 0.37 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.624 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.257 HG12 ' CE ' ' A' ' 132' ' ' MET . 34.5 m -160.7 -43.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.961 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 107' ' ' VAL . . . -86.5 133.7 33.73 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.258 0.974 . . . . 0.0 111.129 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.604 ' HA ' HG23 ' A' ' 84' ' ' THR . 19.7 m-20 -51.04 112.14 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.422 174.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 113' ' ' LEU . 81.3 m-20 -163.32 75.15 0.37 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.485 1.115 . . . . 0.0 109.547 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.38 -29.42 64.05 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.215 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -38.71 -40.24 0.58 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.074 0.858 . . . . 0.0 111.533 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.724 HD13 ' O ' ' A' ' 110' ' ' ASN . 6.4 mp -57.91 -24.82 59.46 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.436 1.085 . . . . 0.0 111.773 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.4 t0 -39.18 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.752 0.658 . . . . 0.0 111.072 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 1.617 ' CD2' ' HB3' ' A' ' 120' ' ' PHE . 4.0 t-160 178.59 120.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.696 1.247 . . . . 0.0 109.626 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.437 ' N ' ' CD2' ' A' ' 115' ' ' HIS . . . . . . . . 0 N--CA 1.477 1.409 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.717 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 1.617 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 26.1 p90 . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.196 0.046 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.29 -82.94 0.05 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 123.667 0.605 . . . . 0.0 111.65 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -77.26 123.69 26.81 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.488 0.757 . . . . 0.0 110.817 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.22 ' HB1' ' OE1' ' A' ' 76' ' ' GLU . . . -68.24 -156.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.242 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.158 HG23 ' O ' ' A' ' 123' ' ' ALA . 46.2 t 176.4 136.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.949 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 35.7 p90 -170.32 23.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 118.44 -0.791 . . . . 0.0 113.064 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.804 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -155.93 -166.4 15.85 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.093 1.385 . . . . 0.0 113.725 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.851 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 27.7 ttpp 176.99 132.05 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 110.996 -2.602 . . . . 0.0 110.131 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.843 HG11 ' HB2' ' A' ' 132' ' ' MET . 60.1 t -46.88 149.36 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 124.399 1.062 . . . . 0.0 110.882 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.093 HG11 ' CG ' ' A' ' 17' ' ' GLU . 6.5 p -129.72 -45.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.453 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 1.101 ' HE3' ' HA ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER 178.44 76.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.161 0.913 . . . . 0.0 108.688 -177.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.65 -16.02 0.02 OUTLIER Glycine 0 N--CA 1.476 1.364 0 O-C-N 124.819 1.325 . . . . 0.0 112.511 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 1.257 ' CE ' HG12 ' A' ' 107' ' ' VAL . 9.6 tpt -39.54 -43.3 1.27 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.815 0.362 . . . . 0.0 110.538 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' NZ ' ' A' ' 137' ' ' LYS . 65.2 t0 -44.09 -60.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.366 1.041 . . . . 0.0 109.967 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 1.329 HG21 ' O ' ' A' ' 15' ' ' ASN . 95.5 t -43.71 -56.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 124.491 1.12 . . . . 0.0 109.377 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -45.46 -51.73 11.14 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.786 1.304 . . . . 0.0 110.457 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.886 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 5.6 m-20 -49.01 -70.06 0.1 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.468 1.105 . . . . 0.0 109.417 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 38.0 mtmm -44.77 -46.53 10.59 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.758 1.286 . . . . 0.0 110.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.106 ' O ' HG22 ' A' ' 141' ' ' VAL . 18.5 mt -55.78 -62.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.269 0.981 . . . . 0.0 108.435 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.826 ' HA ' HH12 ' A' ' 48' ' ' ARG . 78.0 p -58.53 0.29 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.886 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 10.7 mm100 -94.99 -48.97 5.76 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.25 0.969 . . . . 0.0 109.727 177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.123 ' O ' ' NH2' ' A' ' 48' ' ' ARG . 33.8 m -49.98 124.98 17.59 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.508 1.13 . . . . 0.0 110.208 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.9 Cg_exo -43.79 -177.06 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.629 2.886 . . . . 0.0 113.903 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.307 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.08 -141.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.628 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.491 ' H ' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER 179.73 143.41 0.16 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 110.698 -2.956 . . . . 0.0 111.865 170.115 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -67.74 111.91 4.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.113 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.75 ' CG2' ' HB ' ' A' ' 152' ' ' VAL . 1.3 t -77.24 -144.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 124.642 1.214 . . . . 0.0 109.355 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -63.44 -113.09 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 171.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.527 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 97.1 Cg_endo -68.97 -46.15 1.7 Allowed 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 123.596 2.864 . . . . 0.0 110.029 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.527 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 72.8 m-85 -68.67 97.82 0.84 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.454 1.096 . . . . 0.0 110.329 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -71.68 139.22 49.11 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.217 173.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 150' ' ' GLN . 17.6 m-20 81.2 82.4 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.873 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.75 ' HB ' ' CG2' ' A' ' 146' ' ' VAL . 72.9 t -140.27 121.05 9.17 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 114.167 -1.379 . . . . 0.0 107.714 168.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.307 ' CA ' HG22 ' A' ' 143' ' ' THR . 44.5 Cg_endo -62.05 102.88 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.565 2.843 . . . . 0.0 109.77 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.908 ' H ' ' HA ' ' A' ' 143' ' ' THR . 66.5 p -44.23 -54.02 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.731 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 155' ' ' LYS . 39.3 tptt -75.27 105.48 2.04 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.71 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.8 Cg_endo -78.7 122.71 5.56 Favored 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.032 -164.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 158' ' ' VAL . 93.1 t -69.44 157.79 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.054 166.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 1.012 ' HA ' HG22 ' A' ' 45' ' ' THR . 89.0 t -158.21 119.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.153 174.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.993 HG13 ' HA ' ' A' ' 45' ' ' THR . 39.5 mt -68.64 137.7 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.26 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -90.78 -47.11 7.83 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.778 -2.01 . . . . 0.0 110.471 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 28.5 t -166.83 170.12 12.6 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.424 1.077 . . . . 0.0 111.906 -175.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 1.056 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . -168.88 134.72 1.7 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.739 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.622 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -170.83 151.22 3.36 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.085 174.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.35 136.62 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.046 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.043 HD22 ' HD2' ' A' ' 166' ' ' PRO . 3.3 tm? -68.93 121.33 81.15 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.042 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 1.043 ' HD2' HD22 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 123.536 2.824 . . . . 0.0 112.015 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.217 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 74.5 Cg_endo . . . . . 0 C--O 1.235 0.325 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.217 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 1.7 m-70 -153.03 79.14 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.775 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.639 HG23 HD13 ' A' ' 20' ' ' LEU . 43.1 t -60.08 75.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.129 ' HG ' ' HB3' ' A' ' 17' ' ' GLU . 7.9 tt -79.84 105.55 11.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 113.656 -1.611 . . . . 0.0 109.557 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.191 HD23 ' O ' ' A' ' 161' ' ' SER . 10.7 mt -92.88 177.08 6.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.935 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 1.143 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 99.2 m -160.47 84.61 0.7 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.678 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.997 HG22 HG12 ' A' ' 159' ' ' ILE . 24.2 p -78.4 162.72 26.22 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 125.054 1.471 . . . . 0.0 111.662 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 158' ' ' VAL . 65.0 m -41.1 -50.41 3.44 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.263 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.693 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -47.67 -58.38 4.36 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.594 1.184 . . . . 0.0 110.531 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.67 47.02 Favored Glycine 0 N--CA 1.476 1.352 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.965 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.897 ' O ' HG23 ' A' ' 16' ' ' ILE . 46.0 t30 -65.6 151.56 46.19 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.416 -1.392 . . . . 0.0 111.799 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 15' ' ' ASN . 25.3 pt -168.81 166.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.822 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 1.129 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . 12.5 pt-20 -163.11 117.09 1.64 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.314 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.988 HD21 HD11 ' A' ' 105' ' ' ILE . 3.0 mm? -76.87 165.52 24.58 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.738 1.274 . . . . 0.0 110.465 164.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.217 ' OE2' ' CE1' ' A' ' 6' ' ' HIS . 39.8 tt0 -131.24 119.49 21.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.944 173.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.939 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.4 mp -99.88 115.12 28.89 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.118 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.72 98.24 0.51 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.579 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.049 ' HA ' HG11 ' A' ' 29' ' ' VAL . 10.0 mtmp? -69.67 -49.59 52.14 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.614 1.196 . . . . 0.0 111.763 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.446 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 13.8 tt0 -44.33 -62.87 1.01 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.333 1.021 . . . . 0.0 110.556 -171.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.22 9.57 0.42 Allowed 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.724 1.265 . . . . 0.0 113.543 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.68 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -161.05 68.57 2.51 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 123.855 0.722 . . . . 0.0 109.452 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 29' ' ' VAL . 52.0 Cg_exo -56.21 -63.14 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.493 2.796 . . . . 0.0 110.94 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.0 t -54.0 -61.47 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 124.832 1.333 . . . . 0.0 109.944 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 37.1 t -43.99 -58.84 2.58 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.753 1.283 . . . . 0.0 110.624 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.049 HG11 ' HA ' ' A' ' 22' ' ' LYS . 28.1 m -51.76 -49.48 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 124.629 1.206 . . . . 0.0 110.69 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.848 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.6 tm0? -47.36 -57.77 4.9 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.314 1.009 . . . . 0.0 109.313 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 1.15 ' OD1' HG21 ' A' ' 73' ' ' ILE . 10.8 m120 -42.7 -55.26 3.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.636 1.21 . . . . 0.0 110.282 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.967 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 57.9 m-85 -44.1 -62.14 1.24 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.576 1.172 . . . . 0.0 110.022 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 62.0 t -40.64 -46.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.541 1.15 . . . . 0.0 110.758 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.848 ' OD1' ' NE2' ' A' ' 30' ' ' GLN . 7.0 m-20 -45.0 -60.51 2.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.37 1.044 . . . . 0.0 109.576 174.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.484 ' O ' ' HB2' ' A' ' 38' ' ' SER . 74.0 m-85 -57.29 -55.97 27.85 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.945 1.403 . . . . 0.0 109.149 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 HG13 ' A' ' 164' ' ' VAL . 69.4 t -44.4 -64.87 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.61 1.194 . . . . 0.0 109.589 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.2 t-20 -45.8 -49.35 15.17 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.828 1.33 . . . . 0.0 110.133 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 58.2 m -53.93 -109.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.591 1.182 . . . . 0.0 110.215 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.828 ' HA2' ' OD1' ' A' ' 42' ' ' ASN . . . -174.88 48.07 0.13 Allowed Glycine 0 N--CA 1.474 1.213 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.215 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.803 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 22.9 t80 -73.84 -64.08 1.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.629 0.84 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.747 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 39.9 m-85 -67.74 -23.18 65.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.118 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.828 ' OD1' ' HA2' ' A' ' 39' ' ' GLY . 35.2 m120 -38.74 -39.8 0.54 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.817 0.698 . . . . 0.0 112.592 -170.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -152.79 50.56 0.74 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.243 0.964 . . . . 0.0 110.133 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 45' ' ' THR . 49.4 p -79.06 -144.36 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.21 161.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.93 HG22 ' HA ' ' A' ' 158' ' ' VAL . 42.9 p -163.85 -139.21 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.746 0.784 . . . . 0.0 112.168 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 159' ' ' ILE . 51.7 m-85 -157.42 64.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.195 -1.821 . . . . 0.0 107.442 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.715 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 2.2 p-80 -61.61 -60.56 3.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.189 -1.368 . . . . 0.0 109.417 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.715 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.4 mtt180 -69.2 116.78 10.03 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.558 1.161 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 55' ' ' ILE . 68.3 t -152.21 150.74 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 124.87 1.357 . . . . 0.0 110.95 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.974 HD12 ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -158.75 122.34 2.09 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.457 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 53' ' ' PHE . 88.0 Cg_exo -37.54 160.61 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.637 2.891 . . . . 0.0 113.941 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.03 68.45 0.0 OUTLIER Glycine 0 N--CA 1.474 1.207 0 CA-C-N 114.022 -1.445 . . . . 0.0 113.831 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.018 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.6 t80 -161.15 -59.12 0.05 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.782 0.931 . . . . 0.0 109.495 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.018 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 57.5 mtm -163.29 157.21 19.92 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.54 1.15 . . . . 0.0 112.29 -171.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.894 ' CD1' ' HB1' ' A' ' 135' ' ' ALA . 42.4 pt -161.56 145.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.932 174.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.75 ' HG2' ' CB ' ' A' ' 104' ' ' PHE . 18.2 mt-30 -146.1 168.75 20.2 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.147 0.904 . . . . 0.0 112.079 -166.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.36 -158.95 9.91 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.672 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.803 ' HA2' ' CE1' ' A' ' 40' ' ' PHE . . . 65.97 78.23 0.24 Allowed Glycine 0 N--CA 1.47 0.93 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.159 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 1.569 ' CA ' ' HE3' ' A' ' 67' ' ' LYS . . . 177.89 -133.79 2.27 Favored Glycine 0 N--CA 1.475 1.267 0 O-C-N 124.669 0.864 . . . . 0.0 111.231 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 64.0 m-85 -42.54 128.02 3.9 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.282 -0.959 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.655 ' OG1' ' OE2' ' A' ' 62' ' ' GLU . 78.3 p -59.01 -149.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.344 1.027 . . . . 0.0 110.733 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 1.161 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -59.91 -89.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.282 178.083 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 1.161 ' H ' ' CG ' ' A' ' 62' ' ' GLU . 32.9 mt-30 -72.28 52.52 0.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.77 1.294 . . . . 0.0 110.018 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.635 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 50.4 mtt 40.84 35.74 0.36 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.071 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.574 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 58.0 tp60 -77.72 99.97 6.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' LYS . 88.7 mt-30 -27.03 140.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.446 -172.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 1.569 ' HE3' ' CA ' ' A' ' 59' ' ' GLY . 52.7 mttp -51.44 -127.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.84 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 1.178 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 98.1 mttt 179.57 84.79 0.18 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 112.683 -2.053 . . . . 0.0 106.897 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 1.048 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 52.9 Cg_endo -71.73 -167.93 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.639 2.893 . . . . 0.0 113.297 -171.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.048 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 79.1 m-20 -165.09 170.41 6.39 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 113.327 -1.761 . . . . 0.0 109.984 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.981 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 34.7 Cg_endo -45.77 103.78 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.631 2.221 . . . . 0.0 108.977 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 71' ' ' PRO . 97.7 Cg_exo -45.45 -147.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.859 3.04 . . . . 0.0 113.711 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.208 HG13 ' O ' ' A' ' 98' ' ' SER . 26.4 pt -156.33 -126.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.044 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.504 ' N ' HG13 ' A' ' 73' ' ' ILE . 57.0 mtpt -146.71 133.36 19.91 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.045 0.841 . . . . 0.0 110.789 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.748 ' H ' ' HA ' ' A' ' 97' ' ' ASP . 61.9 t30 -59.36 170.16 1.05 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.886 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.02 165.78 1.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.412 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.758 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 175.65 -34.11 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.255 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 1.005 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 48.7 p-10 -67.17 -44.97 78.39 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.025 0.828 . . . . 0.0 110.319 -176.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 1.005 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 33.6 p-10 41.9 -101.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.221 0.951 . . . . 0.0 110.337 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 170.46 -69.97 0.13 Allowed Glycine 0 N--CA 1.473 1.116 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.762 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -38.47 159.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.693 0.878 . . . . 0.0 112.285 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 38.3 ptt180 -58.93 -139.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.569 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 45.4 t30 171.14 130.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.133 -174.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -167.55 152.64 7.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.202 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.643 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 39.8 ptt180 -40.69 125.51 2.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.585 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 1.007 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 113.33 -28.98 8.25 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.776 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.136 HG22 ' NZ ' ' A' ' 127' ' ' LYS . 17.8 p -79.97 131.0 35.72 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.824 0.821 . . . . 0.0 111.484 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.569 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -87.42 160.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.005 167.033 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.07 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -162.1 141.46 9.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.473 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 1.265 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -66.86 122.03 16.79 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.67 -176.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 1.14 ' O ' ' SD ' ' A' ' 90' ' ' MET . . . -81.0 -166.38 1.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.278 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.086 ' CD ' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.71 -149.7 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.83 175.342 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.086 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 55.3 m -167.2 -108.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.765 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.495 ' N ' HG22 ' A' ' 93' ' ' THR . . . -70.69 -93.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.467 1.104 . . . . 0.0 110.538 -171.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 97' ' ' ASP . 32.7 m-20 -43.9 117.06 1.1 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.133 0.896 . . . . 0.0 110.954 -175.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.127 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 53.6 mtmt -71.35 42.18 0.07 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.696 1.247 . . . . 0.0 111.087 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 1.127 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 90.7 m-20 179.27 86.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 1.208 ' O ' HG13 ' A' ' 73' ' ' ILE . 67.1 m -168.12 -96.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.679 1.237 . . . . 0.0 109.759 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 1.061 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 58.99 94.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.794 1.309 . . . . 0.0 107.947 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.7 p -77.88 -42.77 32.23 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.552 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -170.93 -44.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.247 0.967 . . . . 0.0 110.479 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.791 ' O ' ' HE2' ' A' ' 90' ' ' MET . 3.9 pt20 -36.15 146.05 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.295 0.997 . . . . 0.0 112.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.945 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -157.22 -179.52 8.27 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.881 -1.508 . . . . 0.0 110.405 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.769 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 35.7 p90 -151.03 122.44 7.87 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.271 -169.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.988 HD11 HD21 ' A' ' 18' ' ' LEU . 58.1 mt -94.2 101.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.365 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.576 ' OD1' ' HD1' ' A' ' 104' ' ' PHE . 7.3 m-20 -67.14 -175.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.778 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.608 HG12 ' CE ' ' A' ' 132' ' ' MET . 35.1 m -155.6 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.68 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -83.95 145.59 28.47 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.421 1.076 . . . . 0.0 110.874 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.1 m-20 -45.9 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.847 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 1.103 ' OD1' HD11 ' A' ' 113' ' ' LEU . 7.1 t-20 -68.81 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.864 1.353 . . . . 0.0 109.936 -170.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 110' ' ' ASN . . . 70.52 -19.26 0.22 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.857 0.723 . . . . 0.0 112.251 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' HD13 ' A' ' 113' ' ' LEU . 35.5 m-85 -69.38 36.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.68 0.612 . . . . 0.0 111.414 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.103 HD11 ' OD1' ' A' ' 110' ' ' ASN . 0.0 OUTLIER 179.22 -17.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.783 0.677 . . . . 0.0 111.815 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.764 ' N ' HD22 ' A' ' 113' ' ' LEU . 57.4 p-10 -47.85 138.83 8.25 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.683 0.614 . . . . 0.0 111.139 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 1.245 ' CB ' ' O ' ' A' ' 120' ' ' PHE . 17.1 t-160 -31.61 131.9 0.11 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.862 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.617 ' N ' ' CD2' ' A' ' 115' ' ' HIS . . . . . . . . 0 N--CA 1.477 1.392 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.062 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 1.245 ' O ' ' CB ' ' A' ' 115' ' ' HIS . 1.7 t80 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.68 -0.119 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' N ' ' A' ' 115' ' ' HIS . . . 89.97 176.68 45.18 Favored Glycine 0 N--CA 1.477 1.42 0 O-C-N 124.475 1.109 . . . . 0.0 113.108 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.835 ' CD1' HD23 ' A' ' 113' ' ' LEU . 68.1 m-85 -78.65 143.24 36.51 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.229 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.265 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -54.68 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.59 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.07 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 72.2 t -175.85 128.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.92 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.939 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.3 p90 -161.77 21.62 0.11 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.608 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 1.569 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -113.26 155.89 15.99 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 122.939 1.3 . . . . 0.0 112.507 -169.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.136 ' NZ ' HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -171.07 110.99 0.34 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 110.985 -2.608 . . . . 0.0 110.261 173.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.007 HG23 ' O ' ' A' ' 86' ' ' GLY . 58.3 t -58.11 157.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.223 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.052 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 33.1 m -154.44 32.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.231 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 1.052 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 74.5 mmtt 120.92 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.773 0.671 . . . . 0.0 109.508 174.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.861 ' CA ' HG22 ' A' ' 16' ' ' ILE . . . 171.78 -26.12 0.09 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.04 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 1.608 ' CE ' HG12 ' A' ' 107' ' ' VAL . 12.1 tpt -39.52 -51.17 2.2 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.975 0.456 . . . . 0.0 110.921 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.653 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 36.6 m-20 -43.88 -61.6 1.39 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.37 1.044 . . . . 0.0 109.541 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 15' ' ' ASN . 54.4 t -41.45 -60.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 124.739 1.274 . . . . 0.0 109.551 173.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.894 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -44.41 -53.09 7.2 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.654 1.221 . . . . 0.0 109.709 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.922 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 38.2 m-20 -50.69 -66.97 0.3 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.771 1.294 . . . . 0.0 109.03 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.541 ' O ' HG13 ' A' ' 141' ' ' VAL . 56.4 mtpt -40.2 -49.38 2.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.789 1.306 . . . . 0.0 110.539 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.27 ' O ' HG22 ' A' ' 141' ' ' VAL . 16.2 mt -57.84 -58.29 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.444 1.09 . . . . 0.0 108.837 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.658 ' HB3' HG21 ' A' ' 55' ' ' ILE . 84.9 p -65.51 3.42 0.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.922 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.5 mp0 -99.07 -49.39 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.168 0.917 . . . . 0.0 108.741 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.27 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.4 m -41.29 123.25 2.15 Favored Pre-proline 0 N--CA 1.473 0.711 0 O-C-N 124.349 1.031 . . . . 0.0 110.306 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.8 Cg_exo -38.83 -178.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.35 2.7 . . . . 0.0 113.575 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.41 HG22 ' CA ' ' A' ' 153' ' ' PRO . 6.0 p -160.96 -150.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.735 1.731 . . . . 0.0 112.688 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.57 ' ND1' ' O ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER 178.02 167.34 0.75 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 109.726 -3.397 . . . . 0.0 111.312 174.053 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 146' ' ' VAL . 36.8 m-20 -52.37 -149.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.819 165.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -161.99 -61.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.673 1.225 . . . . 0.0 108.347 171.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.59 -92.18 0.08 OUTLIER Glycine 0 N--CA 1.471 1.001 0 CA-C-N 111.335 -2.666 . . . . 0.0 107.687 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.699 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 80.2 Cg_endo -68.4 -67.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.479 2.786 . . . . 0.0 108.761 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.699 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 96.0 m-85 -72.0 117.05 13.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.583 1.177 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.755 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 4.3 pm0 -95.03 83.77 4.0 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.75 1.281 . . . . 0.0 107.945 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.917 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 0.3 OUTLIER 169.3 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.548 -177.035 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.672 ' CG2' HG21 ' A' ' 146' ' ' VAL . 95.9 t -160.31 116.25 1.45 Allowed Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.739 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.41 ' CA ' HG22 ' A' ' 143' ' ' THR . 58.1 Cg_endo -63.08 106.92 0.58 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 109.304 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.996 ' H ' ' HA ' ' A' ' 143' ' ' THR . 77.5 p -40.59 -51.64 2.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.289 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 1.234 ' HB3' ' CD ' ' A' ' 156' ' ' PRO . 10.8 mptt -61.45 -166.71 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.459 1.099 . . . . 0.0 111.933 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.234 ' CD ' ' HB3' ' A' ' 155' ' ' LYS . 78.3 Cg_endo -85.12 145.85 9.89 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.789 2.993 . . . . 0.0 112.733 -170.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.98 HG23 ' O ' ' A' ' 156' ' ' PRO . 38.3 t -170.55 115.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.794 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.93 ' HA ' HG22 ' A' ' 45' ' ' THR . 92.1 t -153.57 120.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.24 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.997 HG12 HG22 ' A' ' 11' ' ' THR . 43.3 mt -68.58 134.3 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.274 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.143 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.2 mt -79.67 -51.62 9.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 112.39 -2.186 . . . . 0.0 109.284 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . 1.191 ' O ' HD23 ' A' ' 9' ' ' LEU . 68.0 m -165.27 174.95 9.65 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.57 1.169 . . . . 0.0 112.697 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.905 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -157.73 100.77 1.78 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.104 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.951 ' O ' ' CD1' ' A' ' 165' ' ' LEU . 32.4 mmmt -125.32 125.81 44.09 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.15 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.845 ' C ' HD12 ' A' ' 165' ' ' LEU . 34.4 m -67.93 131.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.597 1.186 . . . . 0.0 109.824 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.026 HD22 HD13 ' A' ' 8' ' ' LEU . 6.8 mp -133.65 135.63 25.3 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.925 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 165' ' ' LEU . 87.8 Cg_exo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.638 2.892 . . . . 0.0 112.027 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.039 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 71.1 Cg_exo . . . . . 0 C--O 1.235 0.361 0 N-CA-C 113.353 0.482 . . . . 0.0 113.353 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.039 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 3.1 m-70 -150.48 118.11 6.15 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.86 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.2 p -73.98 138.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.208 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.096 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 6.4 mp -127.78 116.12 19.71 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.471 1.107 . . . . 0.0 109.619 166.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.83 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.1 mp -110.73 -175.96 2.85 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.049 -2.341 . . . . 0.0 108.726 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.762 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 52.6 m -161.48 99.9 1.17 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.359 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.926 HG22 HG12 ' A' ' 159' ' ' ILE . 40.7 p -76.29 169.01 19.03 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 125.307 1.629 . . . . 0.0 111.407 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -40.71 -42.17 1.69 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.338 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.825 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.48 -60.54 3.21 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.483 1.115 . . . . 0.0 110.759 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 179.65 44.29 Favored Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.345 -1.752 . . . . 0.0 114.012 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 1.146 ' O ' HG21 ' A' ' 134' ' ' VAL . 58.6 t-20 -55.55 159.3 2.95 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.948 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' OD1' ' A' ' 15' ' ' ASN . 10.1 tt -171.36 160.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.289 -172.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 1.096 ' HG2' ' CG ' ' A' ' 8' ' ' LEU . 35.4 mt-10 -162.92 121.48 2.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.109 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.007 HD21 HD11 ' A' ' 105' ' ' ILE . 2.8 mm? -92.01 173.86 7.62 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.403 1.064 . . . . 0.0 110.322 161.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.429 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -134.57 124.12 24.94 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.047 175.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 20' ' ' LEU . 6.5 mp -109.39 141.8 41.26 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.814 1.321 . . . . 0.0 111.735 -168.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.738 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 63.0 m-20 -55.86 -118.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.892 170.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.995 ' HD3' ' O ' ' A' ' 22' ' ' LYS . 5.8 tmtt? 124.66 -48.62 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.131 -1.85 . . . . 0.0 109.517 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -45.81 -65.3 0.56 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.625 1.203 . . . . 0.0 109.727 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.906 ' HD3' HD21 ' A' ' 81' ' ' LEU . 53.3 mtpt -90.61 21.92 3.75 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.704 1.253 . . . . 0.0 113.87 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.584 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.85 65.18 2.16 Favored Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 124.205 0.941 . . . . 0.0 110.57 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.95 ' O ' HG22 ' A' ' 29' ' ' VAL . 52.4 Cg_exo -59.66 -59.76 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.533 2.822 . . . . 0.0 110.965 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.1 t -50.4 -63.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.151 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -42.67 -57.55 2.67 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.7 1.25 . . . . 0.0 110.51 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.95 HG22 ' O ' ' A' ' 26' ' ' PRO . 26.8 m -52.75 -47.14 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.666 1.229 . . . . 0.0 110.871 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 29' ' ' VAL . 42.6 tp60 -46.93 -70.36 0.1 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.179 0.924 . . . . 0.0 109.931 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 1.218 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.7 m120 -42.07 -48.39 4.67 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.454 1.096 . . . . 0.0 110.312 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.718 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 69.7 t80 -42.98 -63.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.504 1.128 . . . . 0.0 109.759 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.0 t -45.51 -37.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.602 1.189 . . . . 0.0 111.021 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 1.218 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 84.2 m-20 -43.02 -63.44 0.8 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.063 0.852 . . . . 0.0 109.705 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.671 ' HB3' ' CD2' ' A' ' 40' ' ' PHE . 96.2 m-85 -61.13 -59.27 5.6 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.796 1.31 . . . . 0.0 109.095 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.722 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 59.9 t -39.41 -48.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 124.69 1.243 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.771 ' O ' ' HB3' ' A' ' 38' ' ' SER . 50.4 t30 -38.56 -31.23 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.725 1.266 . . . . 0.0 112.401 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.771 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.0 p 154.89 159.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.103 0.877 . . . . 0.0 113.151 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.44 -39.64 3.1 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.117 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.671 ' CD2' ' HB3' ' A' ' 35' ' ' TYR . 2.1 t80 -67.78 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.361 0.683 . . . . 0.0 110.92 -173.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 81.6 m-85 -60.87 -36.74 79.97 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.336 1.022 . . . . 0.0 112.669 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 52.2 p-10 -38.95 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.089 0.868 . . . . 0.0 110.767 -171.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.956 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 10.7 m-20 76.59 39.47 0.25 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 113.49 -1.687 . . . . 0.0 111.633 175.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 45' ' ' THR . 48.9 p -78.66 -129.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 166.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.986 ' HA ' HG13 ' A' ' 159' ' ' ILE . 61.7 p -163.44 -147.42 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.824 1.297 . . . . 0.0 113.59 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.727 ' CD1' HD11 ' A' ' 159' ' ' ILE . 16.7 m-85 -161.54 59.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 111.579 -2.555 . . . . 0.0 105.222 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 1.208 ' CE1' ' OE1' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -38.68 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.489 -173.389 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.143 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.0 mmm180 -173.35 -155.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 123.081 1.42 . . . . 0.0 113.33 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.044 HG12 ' HA ' ' A' ' 55' ' ' ILE . 7.6 p -179.7 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 111.682 -2.508 . . . . 0.0 107.539 159.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.886 HG22 ' HB2' ' A' ' 54' ' ' MET . 9.3 tt -171.75 131.3 0.74 Allowed Pre-proline 0 N--CA 1.476 0.873 0 O-C-N 124.451 1.094 . . . . 0.0 109.983 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.682 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 81.9 Cg_exo -48.85 157.7 1.5 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.893 3.062 . . . . 0.0 114.398 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.24 53.38 0.01 OUTLIER Glycine 0 N--CA 1.475 1.284 0 CA-C-N 114.02 -1.445 . . . . 0.0 114.192 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.047 ' CE2' ' HE3' ' A' ' 54' ' ' MET . 1.5 t80 -162.14 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.665 0.862 . . . . 0.0 110.037 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.047 ' HE3' ' CE2' ' A' ' 53' ' ' PHE . 45.0 mtt -160.18 147.57 16.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.231 0.957 . . . . 0.0 111.611 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.044 ' HA ' HG12 ' A' ' 49' ' ' VAL . 38.4 pt -148.62 141.66 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.276 -1.783 . . . . 0.0 108.19 167.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 1.468 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 62.5 mt-30 -64.75 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.146 -163.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 1.11 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -129.3 -121.17 2.32 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 118.667 -2.521 . . . . 0.0 109.928 0.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . 52.97 109.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.063 0 CA-C-N 114.271 -0.965 . . . . 0.0 111.22 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.86 -126.01 1.11 Allowed Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.525 0.779 . . . . 0.0 111.717 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.862 ' CE2' ' HG2' ' A' ' 66' ' ' GLN . 29.8 m-85 -43.08 134.02 3.65 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.788 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.967 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 61.7 p -59.36 124.67 20.8 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.265 0.978 . . . . 0.0 109.837 169.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 1.129 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 13.11 -104.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.757 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 1.24 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.5 mm100 -38.11 -59.99 0.8 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.778 1.299 . . . . 0.0 111.445 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 1.24 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 14.6 mmt 145.11 98.43 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 1.071 ' NE2' ' O ' ' A' ' 64' ' ' MET . 90.0 mm-40 -160.65 71.04 0.42 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 112.621 -2.081 . . . . 0.0 106.966 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.862 ' HG2' ' CE2' ' A' ' 60' ' ' PHE . 39.6 mt-30 -28.52 130.73 0.06 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.24 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.967 ' HE3' ' CG2' ' A' ' 61' ' ' THR . 18.6 mmtp -72.57 153.7 41.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.396 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.775 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 7.5 mmpt? -48.03 95.33 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.799 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.865 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 71.4 Cg_exo -59.12 -69.79 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.593 2.862 . . . . 0.0 113.192 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.925 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 34.8 m120 89.75 163.28 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 O-C-N 124.402 1.064 . . . . 0.0 111.132 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.925 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 58.6 Cg_endo -67.71 112.04 2.54 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.875 3.05 . . . . 0.0 110.88 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.212 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 88.5 Cg_exo -52.1 -150.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.798 2.998 . . . . 0.0 112.957 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.569 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.52 156.79 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 1.043 ' HD2' ' H ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -33.3 135.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.192 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' LYS . 56.6 p30 -45.7 -164.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.44 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB3' HD21 ' A' ' 79' ' ' ASN . 8.4 mm-40 161.67 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.589 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.848 ' HB3' ' CE1' ' A' ' 120' ' ' PHE . . . -71.29 -43.26 67.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.251 0.969 . . . . 0.0 109.791 171.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 1.064 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 20.9 p-10 -67.41 -53.5 28.61 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.424 1.077 . . . . 0.0 109.907 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 76' ' ' GLU . 38.5 p-10 -63.51 99.26 0.2 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.237 1.018 . . . . 0.0 108.876 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 1.232 ' O ' HD13 ' A' ' 81' ' ' LEU . . . 172.22 46.87 0.04 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.359 -1.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.232 HD13 ' O ' ' A' ' 80' ' ' GLY . 1.7 mm? -146.14 -149.29 0.28 Allowed 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.626 0.839 . . . . 0.0 109.499 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -179.74 150.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -169.49 -124.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.519 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 1.114 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 16.2 m -168.6 163.46 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.025 0.828 . . . . 0.0 112.004 -162.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 1.114 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 8.3 ptm85 -19.92 108.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.19 164.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.743 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 137.2 -27.03 2.92 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 111.575 -2.557 . . . . 0.0 110.233 -168.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.153 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.2 p -92.66 142.82 26.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.91 0.862 . . . . 0.0 112.191 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.894 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.74 162.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.094 166.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.117 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -156.01 140.97 17.26 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 113.943 -1.48 . . . . 0.0 111.829 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.916 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.1 tpt -56.88 140.3 48.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.507 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . . . -109.38 129.3 55.54 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.457 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.28 ' HG2' ' N ' ' A' ' 99' ' ' ALA . 29.9 tpt180 179.15 175.98 0.62 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.765 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.707 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 89.6 m -168.3 115.86 0.7 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.563 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.796 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 165.01 -50.69 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.025 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.796 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 16.0 p30 74.37 -177.39 0.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.541 1.151 . . . . 0.0 112.323 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.174 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 0.4 OUTLIER 79.94 -49.29 0.36 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.763 -172.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 1.174 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 73.7 m-20 -162.45 61.32 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.617 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 21.6 t -74.22 173.75 9.72 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.773 1.296 . . . . 0.0 113.333 -170.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 1.28 ' N ' ' HG2' ' A' ' 92' ' ' ARG . . . 65.01 170.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.76 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.996 HG22 ' HG3' ' A' ' 72' ' ' PRO . 72.8 p -150.93 -48.41 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.297 -174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.0 p -171.07 -52.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.257 0.973 . . . . 0.0 110.179 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.694 ' O ' ' SD ' ' A' ' 90' ' ' MET . 14.1 pt20 -42.83 154.22 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.353 1.033 . . . . 0.0 112.183 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.894 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -159.28 168.73 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.456 175.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 1.468 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 17.1 p90 -144.49 137.68 27.07 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.326 -170.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.069 ' N ' ' O ' ' A' ' 56' ' ' GLN . 63.1 mt -93.95 116.65 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 112.057 -2.338 . . . . 0.0 110.612 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -64.86 116.51 6.41 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.5 1.125 . . . . 0.0 109.572 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.871 ' HB ' ' C ' ' A' ' 53' ' ' PHE . 51.9 t -90.44 22.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 124.488 1.118 . . . . 0.0 112.133 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.852 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . 169.21 172.53 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.609 0.719 . . . . 0.0 112.108 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.558 ' N ' ' HB3' ' A' ' 85' ' ' ARG . 71.7 m-20 -38.62 144.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.596 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.548 HD21 ' HB2' ' A' ' 113' ' ' LEU . 26.6 t-20 -170.57 155.95 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.435 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 176.13 -50.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.465 -1.698 . . . . 0.0 108.296 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.953 ' O ' ' HD1' ' A' ' 112' ' ' PHE . 3.2 p90 -61.26 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 167.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.76 HD11 ' CE1' ' A' ' 122' ' ' TYR . 36.9 tp 177.92 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.103 -171.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 122' ' ' TYR . 34.0 m-20 -38.47 -60.91 0.75 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.282 0.989 . . . . 0.0 111.182 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.601 ' ND1' ' HA ' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 179.05 84.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.587 1.179 . . . . 0.0 108.547 -175.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.157 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.584 179.686 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.848 ' CE1' ' HB3' ' A' ' 77' ' ' ALA . 1.3 t80 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.36 -130.44 0.09 OUTLIER Glycine 0 N--CA 1.473 1.156 0 CA-C-N 113.829 -1.532 . . . . 0.0 114.137 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.76 ' CE1' HD11 ' A' ' 113' ' ' LEU . 76.3 m-85 -78.93 150.41 32.1 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.499 -1.351 . . . . 0.0 112.674 -167.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.117 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -81.11 -163.15 0.56 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.6 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.993 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 73.9 t 179.39 140.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.111 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.681 ' CZ ' ' HD2' ' A' ' 103' ' ' PHE . 9.8 p90 -164.76 22.56 0.06 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 1.217 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -171.73 -136.3 2.1 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 122.976 1.32 . . . . 0.0 113.745 173.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.429 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 8.7 mtpm? 179.6 -133.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 111.275 -2.463 . . . . 0.0 109.162 -172.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.903 HG22 ' CD1' ' A' ' 18' ' ' LEU . 80.4 t -153.36 120.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.573 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.933 ' CG1' ' CB ' ' A' ' 17' ' ' GLU . 7.7 p -69.85 -46.49 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.104 172.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.809 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 58.5 mtpt -166.66 -135.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.449 1.093 . . . . 0.0 108.87 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . 62.36 -17.36 0.07 OUTLIER Glycine 0 N--CA 1.474 1.212 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.01 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.542 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 8.3 tpt -39.57 -42.88 1.23 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.009 0.404 . . . . 0.0 110.355 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 12.1 m-20 -45.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.438 1.087 . . . . 0.0 109.72 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 1.146 HG21 ' O ' ' A' ' 15' ' ' ASN . 59.5 t -46.5 -57.17 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.474 1.109 . . . . 0.0 109.167 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -44.4 -53.69 6.6 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.618 1.199 . . . . 0.0 109.672 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.819 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 42.0 m-20 -51.96 -64.37 0.84 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.623 1.202 . . . . 0.0 108.854 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 56.0 tptt -39.83 -54.07 2.18 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.86 1.35 . . . . 0.0 110.552 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.199 ' O ' HG12 ' A' ' 141' ' ' VAL . 21.0 mt -59.74 -58.68 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.561 1.163 . . . . 0.0 109.363 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.3 p -55.13 -8.73 0.32 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.819 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 11.5 mm100 -96.2 -44.69 7.16 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.356 1.035 . . . . 0.0 110.082 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.199 HG12 ' O ' ' A' ' 138' ' ' ILE . 8.0 p -48.96 131.48 15.02 Favored Pre-proline 0 N--CA 1.474 0.741 0 O-C-N 124.417 1.073 . . . . 0.0 110.444 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 86.3 Cg_exo -46.9 172.02 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.649 2.9 . . . . 0.0 113.795 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.366 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.06 -140.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.225 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.5 ' H ' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER 179.0 158.43 0.56 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 110.942 -2.844 . . . . 0.0 112.696 169.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 146' ' ' VAL . 45.1 t0 -50.38 -179.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.734 165.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.924 HG21 ' CG2' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -158.03 -143.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.59 -110.33 0.01 OUTLIER Glycine 0 N--CA 1.472 1.059 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.982 ' HG2' ' HD1' ' A' ' 149' ' ' TYR . 94.6 Cg_endo -71.81 -46.7 0.54 Allowed 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 123.8 3.0 . . . . 0.0 110.259 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.982 ' HD1' ' HG2' ' A' ' 148' ' ' PRO . 34.9 m-85 -68.56 109.43 3.74 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.429 1.081 . . . . 0.0 110.933 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.569 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 7.6 mm-40 -84.94 64.47 8.68 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.213 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.839 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 54.7 p30 178.74 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.284 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.924 ' CG2' HG21 ' A' ' 146' ' ' VAL . 94.1 t -154.84 118.26 2.51 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.803 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.366 ' CA ' HG22 ' A' ' 143' ' ' THR . 61.0 Cg_endo -67.18 110.37 1.98 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.656 2.904 . . . . 0.0 109.736 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.728 ' H ' ' HA ' ' A' ' 143' ' ' THR . 40.0 t -44.95 -62.46 1.22 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.383 175.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 153' ' ' PRO . 67.3 mttm -66.99 140.65 96.18 Favored Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.633 1.208 . . . . 0.0 109.513 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 73.4 Cg_endo -88.11 114.82 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.107 2.538 . . . . 0.0 113.346 -161.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 158' ' ' VAL . 44.7 t -76.97 148.72 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.7 157.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.883 ' HA ' HG22 ' A' ' 45' ' ' THR . 95.8 t -163.67 122.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.88 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.986 HG13 ' HA ' ' A' ' 45' ' ' THR . 20.6 mt -68.01 130.49 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.361 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.762 ' HB2' ' O ' ' A' ' 10' ' ' THR . 84.7 mt -79.83 -48.05 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 112.535 -2.12 . . . . 0.0 110.171 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.7 m -162.84 -167.78 1.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.564 1.165 . . . . 0.0 112.484 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.83 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . -178.99 139.66 0.16 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.283 -1.781 . . . . 0.0 109.703 -175.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 8' ' ' LEU . 22.0 ptmt -170.85 126.27 0.71 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.743 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.39 145.48 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.989 -1.46 . . . . 0.0 110.617 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.989 ' HB3' ' HD3' ' A' ' 166' ' ' PRO . 55.2 tp -58.52 -59.87 12.14 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.974 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.989 ' HD3' ' HB3' ' A' ' 165' ' ' LEU . 82.1 Cg_exo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 123.242 2.628 . . . . 0.0 111.985 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.253 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 71.9 Cg_endo . . . . . 0 C--O 1.234 0.3 0 N-CA-C 109.653 -0.941 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.253 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -158.23 97.99 1.54 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.621 -175.054 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.992 ' HA ' HG12 ' A' ' 164' ' ' VAL . 87.1 t -61.02 79.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 165.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.095 ' HB3' ' O ' ' A' ' 163' ' ' LYS . 7.3 tt -79.86 106.91 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.356 -169.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.155 HD23 ' O ' ' A' ' 161' ' ' SER . 12.3 mt -103.64 171.88 7.12 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 113.163 -1.835 . . . . 0.0 112.331 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 1.274 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 94.6 m -160.52 79.08 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.9 -2.409 . . . . 0.0 107.084 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.956 HG22 HG12 ' A' ' 159' ' ' ILE . 32.4 p -74.73 167.1 22.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 125.132 1.52 . . . . 0.0 111.952 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.558 ' OG ' HG13 ' A' ' 157' ' ' VAL . 78.3 p -41.41 -49.52 3.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.459 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.681 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.47 -55.88 24.44 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.424 1.078 . . . . 0.0 110.289 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' HG11 ' A' ' 134' ' ' VAL . . . 171.48 -179.95 42.92 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.911 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.883 ' O ' HG21 ' A' ' 134' ' ' VAL . 49.7 t30 -57.82 159.14 5.65 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.545 -1.328 . . . . 0.0 111.97 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.786 HG13 ' HB2' ' A' ' 9' ' ' LEU . 19.3 pt -162.59 -173.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.903 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.892 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 7.2 mm-40 -161.27 126.81 3.7 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.284 -170.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.953 HD21 HD11 ' A' ' 105' ' ' ILE . 2.9 mm? -112.0 114.04 26.69 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.547 1.154 . . . . 0.0 108.925 164.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.947 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 11.9 pt-20 -79.53 111.13 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.503 1.127 . . . . 0.0 108.53 169.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.811 HD23 ' CE2' ' A' ' 125' ' ' PHE . 7.2 mp -108.56 131.58 54.71 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.881 1.363 . . . . 0.0 110.775 -174.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.954 ' OD1' ' NZ ' ' A' ' 127' ' ' LYS . 40.1 m-20 -57.33 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.037 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.739 ' HG3' ' N ' ' A' ' 23' ' ' GLN . 22.2 ptmt 142.65 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.372 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.739 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 3.9 pt20 -49.74 -44.31 48.47 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.72 1.262 . . . . 0.0 110.473 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 1.078 ' HE3' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -68.55 -15.07 63.41 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.305 1.003 . . . . 0.0 112.906 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.008 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -160.73 72.36 2.81 Favored Pre-proline 0 N--CA 1.475 0.81 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 75.6 Cg_exo -55.91 -64.44 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.633 2.889 . . . . 0.0 111.73 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 66.4 t -53.18 -67.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.68 1.237 . . . . 0.0 109.911 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.742 ' HA ' HG13 ' A' ' 73' ' ' ILE . 58.8 m -44.67 -61.71 1.47 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.579 1.174 . . . . 0.0 109.853 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 25' ' ' ALA . 47.3 t -49.25 -52.56 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 124.786 1.304 . . . . 0.0 109.92 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.537 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 38.6 tp60 -41.81 -61.47 1.1 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.475 1.109 . . . . 0.0 110.049 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.698 ' CG ' HG21 ' A' ' 73' ' ' ILE . 11.9 m120 -42.91 -51.91 5.35 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.564 1.165 . . . . 0.0 109.765 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.958 ' O ' HG23 ' A' ' 36' ' ' VAL . 78.9 t80 -40.64 -57.76 1.79 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.629 1.206 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.823 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 57.6 t -51.18 -38.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.754 1.283 . . . . 0.0 111.316 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.789 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 8.4 p-10 -44.9 -55.51 5.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.951 0.782 . . . . 0.0 109.362 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.88 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 54.5 m-85 -69.64 -53.73 17.3 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.09 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 32' ' ' PHE . 61.9 t -39.39 -50.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.164 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.789 ' CG ' ' O ' ' A' ' 34' ' ' ASP . 51.0 p30 -37.92 -33.4 0.08 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.703 1.252 . . . . 0.0 112.098 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.766 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.3 p 146.4 136.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.239 0.962 . . . . 0.0 112.028 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 1.064 ' N ' ' OD1' ' A' ' 42' ' ' ASN . . . 131.14 -59.25 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.51 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.896 ' O ' HG23 ' A' ' 44' ' ' THR . 61.1 t80 -62.99 -74.35 0.1 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.291 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.446 ' CG ' ' HD1' ' A' ' 40' ' ' PHE . 68.5 m-85 -66.75 -25.08 66.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.485 1.115 . . . . 0.0 112.913 -173.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 1.064 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 14.0 m120 -38.75 -36.59 0.27 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.902 0.751 . . . . 0.0 112.467 -173.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -157.97 47.46 0.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.124 0.89 . . . . 0.0 110.325 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.896 HG23 ' O ' ' A' ' 40' ' ' PHE . 46.2 p -79.71 -133.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.314 164.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.959 ' HA ' HG13 ' A' ' 159' ' ' ILE . 77.8 p -162.96 -153.03 0.23 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.87 0.843 . . . . 0.0 111.817 173.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.072 ' HZ ' HD13 ' A' ' 9' ' ' LEU . 14.4 m-30 -141.85 63.42 1.42 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.174 -1.83 . . . . 0.0 106.585 174.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 1.085 ' CE1' ' HA2' ' A' ' 59' ' ' GLY . 1.1 p-80 -51.94 -72.67 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.684 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.896 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 84.2 mtm180 -71.49 130.48 41.37 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.42 1.075 . . . . 0.0 111.075 -173.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.926 HG23 ' HB ' ' A' ' 55' ' ' ILE . 10.9 p -159.96 157.36 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.844 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.078 HD13 ' HD2' ' A' ' 53' ' ' PHE . 9.9 tt -155.7 127.04 3.66 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.484 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 94.2 Cg_exo -38.7 155.14 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.577 2.851 . . . . 0.0 113.486 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -3.23 66.59 0.0 OUTLIER Glycine 0 N--CA 1.475 1.266 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.888 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.078 ' HD2' HD13 ' A' ' 50' ' ' ILE . 10.9 t80 -161.02 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.808 0.946 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.866 ' HG2' ' N ' ' A' ' 55' ' ' ILE . 54.2 ttp -167.62 177.45 5.87 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.484 1.115 . . . . 0.0 111.958 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.926 ' HB ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 171.39 113.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.12 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 18.6 mt-30 -98.62 -170.65 1.98 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.232 -166.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.22 28.79 Favored Glycine 0 N--CA 1.477 1.377 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.533 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.762 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 93.27 -59.69 2.28 Favored Glycine 0 N--CA 1.474 1.206 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 -165.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 1.085 ' HA2' ' CE1' ' A' ' 47' ' ' HIS . . . 41.34 143.65 0.0 OUTLIER Glycine 0 N--CA 1.472 1.074 0 CA-C-N 114.212 -0.994 . . . . 0.0 114.014 168.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.905 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 14.1 m-30 -46.89 150.7 0.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.406 -1.397 . . . . 0.0 110.673 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.273 HG21 ' OE1' ' A' ' 65' ' ' GLN . 94.8 m -59.08 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.316 -174.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 1.129 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 1.5 mp0 48.51 116.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.758 1.286 . . . . 0.0 110.745 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 1.31 ' O ' ' CG ' ' A' ' 64' ' ' MET . 8.5 pt20 69.02 -48.83 0.59 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.558 1.161 . . . . 0.0 111.0 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 1.31 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 25.0 mmt 158.38 98.22 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.981 1.372 . . . . 0.0 108.715 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 1.273 ' OE1' HG21 ' A' ' 61' ' ' THR . 48.4 tt0 -150.46 79.71 1.34 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.014 -2.812 . . . . 0.0 105.187 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.792 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -27.04 176.81 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.404 -1.725 . . . . 0.0 115.627 -166.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 1.199 ' H ' ' CD ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -48.07 -140.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 111.412 -2.631 . . . . 0.0 112.271 -174.143 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 1.06 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 40.2 ttpt 178.31 -70.94 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.076 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 1.06 ' CD ' ' HB3' ' A' ' 68' ' ' LYS . 59.8 Cg_endo -62.56 133.09 40.85 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.589 2.859 . . . . 0.0 111.011 173.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.518 ' HA ' ' CG2' ' A' ' 100' ' ' THR . 92.2 m-20 -168.61 72.14 0.8 Allowed Pre-proline 0 N--CA 1.474 0.725 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.033 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 80.0 Cg_exo -48.29 -64.06 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.391 2.728 . . . . 0.0 110.937 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.15 ' CB ' ' HA ' ' A' ' 98' ' ' SER . 50.3 Cg_exo -87.71 -140.63 0.16 OUTLIER 'Cis proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.798 -1.751 . . . . 0.0 110.835 -2.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.318 HD11 ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -158.6 150.95 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 74.4 mmtt -30.14 145.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.877 -1.51 . . . . 0.0 113.049 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 1.219 ' OD1' ' HB3' ' A' ' 96' ' ' LYS . 40.4 m-80 -42.77 -167.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.272 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.223 ' OE1' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 161.19 118.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.231 -177.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.882 ' HB2' HH11 ' A' ' 92' ' ' ARG . . . 174.06 -51.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.897 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 1.008 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 59.8 p30 -70.35 39.07 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.501 1.126 . . . . 0.0 111.693 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 77' ' ' ALA . 4.6 p30 -40.6 -41.43 1.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.281 0.988 . . . . 0.0 110.976 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.819 ' O ' HD23 ' A' ' 81' ' ' LEU . . . 64.02 71.06 0.91 Allowed Glycine 0 N--CA 1.47 0.916 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.819 HD23 ' O ' ' A' ' 80' ' ' GLY . 79.9 mt -163.94 -179.54 6.33 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.871 0.983 . . . . 0.0 111.022 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.566 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 35.4 mmt180 -72.72 138.63 46.69 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.321 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.566 ' OD1' ' O ' ' A' ' 82' ' ' ARG . 85.4 m-20 -155.12 132.8 11.31 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.827 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 m -166.75 154.82 9.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.967 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.872 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 78.2 ttt180 -34.12 110.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 113.932 -1.486 . . . . 0.0 110.687 169.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 1.372 ' HA2' ' ND2' ' A' ' 106' ' ' ASN . . . -137.53 79.22 0.31 Allowed Glycine 0 N--CA 1.469 0.844 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.564 3.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.098 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 48.1 p -60.55 139.47 57.76 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.823 0.954 . . . . 0.0 111.107 172.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.385 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -79.82 158.16 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.474 162.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.986 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -160.41 129.95 5.08 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.633 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 1.267 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -60.67 122.05 13.76 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.422 -177.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 1.194 ' O ' ' HG3' ' A' ' 92' ' ' ARG . . . -51.41 -173.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.441 1.088 . . . . 0.0 111.795 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.194 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 81.9 mtp180 179.43 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.738 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.3 m -52.67 -86.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.763 1.289 . . . . 0.0 110.14 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.9 -71.54 0.41 Allowed 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.946 1.404 . . . . 0.0 108.525 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.8 m-20 -46.14 128.35 9.39 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.41 1.069 . . . . 0.0 110.433 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.219 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 8.3 mtpm? -42.15 -103.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.531 1.145 . . . . 0.0 110.582 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.9 ' OD1' ' ND2' ' A' ' 75' ' ' ASN . 33.0 m-20 -53.06 114.22 1.38 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.64 1.212 . . . . 0.0 109.21 175.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 1.15 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 40.3 t -175.28 -44.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.562 1.164 . . . . 0.0 111.093 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 1.318 ' O ' HD11 ' A' ' 73' ' ' ILE . . . -34.81 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.096 0.873 . . . . 0.0 110.411 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 1.518 ' CG2' ' HA ' ' A' ' 70' ' ' ASN . 74.3 p -78.85 -37.04 41.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.608 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.417 ' C ' ' HE2' ' A' ' 90' ' ' MET . 78.7 p -170.07 -48.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.092 0.87 . . . . 0.0 110.634 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.899 ' HG3' ' HB3' ' A' ' 91' ' ' ALA . 3.9 pt20 -36.9 151.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.215 0.947 . . . . 0.0 112.114 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.904 ' HB2' HD11 ' A' ' 88' ' ' ILE . 11.6 p90 -157.18 -167.71 2.41 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.415 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.935 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.7 p90 -158.15 121.1 3.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.927 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.953 HD11 HD21 ' A' ' 18' ' ' LEU . 65.1 mt -90.0 104.87 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.74 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 1.372 ' ND2' ' HA2' ' A' ' 86' ' ' GLY . 5.0 p-10 -63.87 153.21 37.5 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.259 0.974 . . . . 0.0 110.408 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.969 HG12 ' SD ' ' A' ' 132' ' ' MET . 32.6 m -141.53 47.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.026 176.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.618 ' O ' ' OD1' ' A' ' 110' ' ' ASN . . . 170.15 140.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.528 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 1.123 ' O ' ' OD1' ' A' ' 110' ' ' ASN . 32.3 m-20 -30.93 138.72 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 1.123 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 15.9 m-20 -158.18 157.3 32.42 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.049 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.155 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . 172.31 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.722 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.515 ' CE1' ' HA ' ' A' ' 110' ' ' ASN . 32.6 p90 -39.64 -42.65 1.23 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.58 1.175 . . . . 0.0 110.238 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.958 HD11 ' CD2' ' A' ' 122' ' ' TYR . 68.1 tp -58.98 -52.33 66.23 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 0.0 109.619 175.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 1.155 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 57.4 p-10 -40.08 138.4 0.84 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.523 1.139 . . . . 0.0 111.815 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 1.008 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 4.0 t60 -36.62 113.52 0.24 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.809 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.743 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.918 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 78.7 m-85 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.38 0.61 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.35 -110.34 0.26 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.328 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.958 ' CD2' HD11 ' A' ' 113' ' ' LEU . 89.1 m-85 -78.77 116.3 19.02 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.808 0.946 . . . . 0.0 109.937 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.267 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -49.94 -158.41 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.247 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.085 HG23 ' O ' ' A' ' 123' ' ' ALA . 45.7 t 179.28 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.811 ' CE2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.11 27.74 0.07 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.251 0.97 . . . . 0.0 111.135 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 1.385 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -150.92 -173.07 20.59 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 122.983 1.324 . . . . 0.0 112.223 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.174 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 36.2 mtmm 177.8 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 111.47 -2.365 . . . . 0.0 108.864 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.128 HG21 ' CE ' ' A' ' 132' ' ' MET . 62.8 t -40.03 116.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.59 1.181 . . . . 0.0 110.311 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.923 HG21 ' CD2' ' A' ' 6' ' ' HIS . 85.0 t -58.35 -51.43 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.392 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER 162.26 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.609 1.193 . . . . 0.0 108.798 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -166.38 22.46 0.12 Allowed Glycine 0 N--CA 1.475 1.237 0 O-C-N 124.826 1.329 . . . . 0.0 112.713 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 1.128 ' CE ' HG21 ' A' ' 128' ' ' VAL . 20.9 mmt -53.51 -22.22 7.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.439 171.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 63.2 t0 -47.88 -60.58 2.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.883 HG21 ' O ' ' A' ' 15' ' ' ASN . 87.2 t -62.31 -73.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.735 1.272 . . . . 0.0 109.423 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.705 ' O ' ' OG ' ' A' ' 139' ' ' SER . . . -39.95 -52.47 2.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.473 1.108 . . . . 0.0 110.373 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 1.013 ' OD2' ' HB3' ' A' ' 132' ' ' MET . 49.1 m-20 -60.8 -66.64 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.821 1.325 . . . . 0.0 108.382 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.97 ' O ' HG13 ' A' ' 141' ' ' VAL . 24.8 ttmm -34.49 -49.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.607 1.192 . . . . 0.0 110.363 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.252 ' O ' HG22 ' A' ' 141' ' ' VAL . 49.6 mt -60.31 -55.47 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 124.755 1.285 . . . . 0.0 107.909 168.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.89 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . 39.0 m -64.42 0.68 0.96 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.774 -1.557 . . . . 0.0 114.828 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.805 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 3.7 mp0 -107.03 -44.87 4.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.345 1.028 . . . . 0.0 109.017 173.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.252 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.3 m -40.07 127.97 1.64 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.287 0.992 . . . . 0.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.9 Cg_exo -37.57 177.13 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.355 2.703 . . . . 0.0 113.418 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.345 HG22 ' CA ' ' A' ' 153' ' ' PRO . 10.1 p -160.83 -151.18 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.56 1.648 . . . . 0.0 112.74 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 178.38 165.26 0.78 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 110.03 -3.259 . . . . 0.0 111.488 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.668 ' O ' HG22 ' A' ' 146' ' ' VAL . 46.4 t0 -52.14 -150.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.501 166.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.841 HG22 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -161.16 -142.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -67.05 -102.97 0.02 OUTLIER Glycine 0 N--CA 1.471 0.991 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 166.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.55 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 86.4 Cg_endo -77.5 -53.91 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.919 3.079 . . . . 0.0 109.917 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 146' ' ' VAL . 61.7 m-85 -69.25 122.44 18.86 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.587 1.179 . . . . 0.0 111.604 -172.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 29.5 mm-40 -74.48 -176.66 2.81 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.063 170.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.61 ' O ' HG23 ' A' ' 152' ' ' VAL . 76.9 m-20 48.73 86.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.716 175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.841 ' HB ' HG22 ' A' ' 146' ' ' VAL . 88.1 t -161.94 105.28 1.15 Allowed Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.337 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.345 ' CA ' HG22 ' A' ' 143' ' ' THR . 85.9 Cg_exo -45.12 139.83 8.12 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.409 2.739 . . . . 0.0 112.119 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . 1.068 ' N ' ' HA ' ' A' ' 143' ' ' THR . 80.2 p -73.74 44.64 0.17 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.604 174.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.615 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 17.2 tppt? -178.51 72.71 0.21 Allowed Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 155' ' ' LYS . 80.9 Cg_exo -46.37 108.38 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.73 2.953 . . . . 0.0 112.362 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG13 ' OG ' ' A' ' 12' ' ' SER . 89.3 t -68.98 154.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.505 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.858 ' HA ' HG22 ' A' ' 45' ' ' THR . 76.7 t -141.45 118.03 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.997 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.959 HG13 ' HA ' ' A' ' 45' ' ' THR . 35.3 mt -69.06 135.38 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.035 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.274 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.8 mt -85.22 -49.16 8.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.701 -2.045 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . 1.155 ' O ' HD23 ' A' ' 9' ' ' LEU . 34.7 t -170.46 161.04 7.75 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.434 1.084 . . . . 0.0 112.245 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.979 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -137.53 61.08 1.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.534 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 1.095 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 47.9 mmtm -69.92 93.15 0.75 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.49 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.992 HG12 ' HA ' ' A' ' 7' ' ' VAL . 34.6 m -71.54 132.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.42 1.075 . . . . 0.0 110.383 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.998 HD23 ' HB2' ' A' ' 6' ' ' HIS . 3.3 mm? -78.23 121.97 84.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.359 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 165' ' ' LEU . 66.9 Cg_endo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 123.583 2.855 . . . . 0.0 109.752 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.03 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 80.8 Cg_exo . . . . . 0 C--O 1.235 0.369 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.03 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -153.16 121.97 6.45 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.732 -176.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.977 HG12 ' HB2' ' A' ' 18' ' ' LEU . 7.9 p -73.79 116.74 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.427 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.782 ' HG ' ' CD ' ' A' ' 17' ' ' GLU . 6.5 mp -79.81 151.09 30.48 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.359 1.076 . . . . 0.0 110.748 169.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.152 ' O ' HG12 ' A' ' 16' ' ' ILE . 6.9 mt -160.59 96.54 1.16 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.559 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 1.206 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.0 m -88.14 79.98 7.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.637 -2.528 . . . . 0.0 107.969 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 1.065 HG22 HG12 ' A' ' 159' ' ' ILE . 37.0 p -73.24 169.72 16.48 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 125.018 1.449 . . . . 0.0 111.516 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 80.0 p -39.71 -46.24 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -60.37 -54.83 40.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.462 1.101 . . . . 0.0 110.623 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.01 173.76 39.65 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 113.767 -1.561 . . . . 0.0 113.597 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.892 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 40.7 t30 -61.82 143.54 56.16 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.451 -1.374 . . . . 0.0 110.868 175.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.152 HG12 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -144.2 -178.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.982 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.902 ' HG2' ' O ' ' A' ' 130' ' ' LYS . 6.9 mm-40 -160.13 101.88 1.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.92 -165.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 105' ' ' ILE . 2.4 mm? -85.0 161.03 19.91 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.297 0.998 . . . . 0.0 110.409 164.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.206 ' OE1' ' CD ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -127.27 110.84 13.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.529 173.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 125' ' ' PHE . 3.0 mm? -79.37 -170.9 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.826 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -164.69 87.05 0.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.011 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.131 ' HA ' HG11 ' A' ' 29' ' ' VAL . 19.8 ptpt -59.16 -34.62 72.32 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.842 1.339 . . . . 0.0 112.303 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.549 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 11.3 tp-100 -41.07 -64.36 0.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.206 0.941 . . . . 0.0 110.69 -172.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -69.97 -5.43 26.2 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.792 1.308 . . . . 0.0 113.896 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.811 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.18 71.59 3.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 O-C-N 123.818 0.699 . . . . 0.0 109.449 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 1.238 ' O ' HG22 ' A' ' 29' ' ' VAL . 57.5 Cg_exo -54.2 -64.69 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.667 2.912 . . . . 0.0 111.109 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.702 HG23 ' H ' ' A' ' 28' ' ' SER . 15.6 m -50.1 -62.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 124.734 1.271 . . . . 0.0 110.368 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.702 ' H ' HG23 ' A' ' 27' ' ' VAL . 42.1 t -41.82 -56.39 2.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.445 1.09 . . . . 0.0 110.466 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.238 HG22 ' O ' ' A' ' 26' ' ' PRO . 34.6 m -48.82 -45.07 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 124.734 1.272 . . . . 0.0 110.554 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 23.3 tp60 -45.7 -62.26 1.37 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.241 0.963 . . . . 0.0 109.551 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 1.03 ' OD1' HG21 ' A' ' 73' ' ' ILE . 11.0 m120 -47.35 -60.85 2.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.701 1.251 . . . . 0.0 109.497 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.529 ' HE1' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 t80 -43.24 -62.75 0.96 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.353 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 29' ' ' VAL . 61.3 t -49.26 -33.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 124.78 1.3 . . . . 0.0 111.452 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.939 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 55.2 m-20 -45.86 -63.68 0.92 Allowed 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.916 0.76 . . . . 0.0 109.771 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.74 ' CB ' ' HD1' ' A' ' 40' ' ' PHE . 19.7 m-85 -58.76 -61.89 2.28 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.826 1.329 . . . . 0.0 108.577 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.972 ' HA ' ' HB2' ' A' ' 40' ' ' PHE . 62.6 t -42.53 -53.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.308 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -39.99 -33.58 0.23 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.713 1.258 . . . . 0.0 111.867 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 35' ' ' TYR . 83.0 p -173.44 136.54 0.6 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.273 0.983 . . . . 0.0 110.578 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.41 43.91 35.6 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.297 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 57.1 t80 -61.38 -96.06 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.73 ' OH ' ' HB3' ' A' ' 101' ' ' SER . 22.3 m-30 -133.12 58.32 1.77 Allowed 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.149 0.905 . . . . 0.0 109.04 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 49.1 p-10 -77.92 108.8 11.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 174.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 1.231 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 28.1 t30 67.46 58.75 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.538 1.148 . . . . 0.0 109.742 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.724 ' C ' ' HB ' ' A' ' 159' ' ' ILE . 32.6 p -104.2 -128.85 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.635 169.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.845 ' HA ' HG13 ' A' ' 159' ' ' ILE . 67.2 p -162.35 -176.93 5.36 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.906 0.86 . . . . 0.0 113.077 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.904 ' CD1' HD11 ' A' ' 159' ' ' ILE . 7.4 m-30 -126.74 72.41 1.34 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.99 -1.914 . . . . 0.0 106.953 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.883 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 5.5 p-80 -58.27 -71.45 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.015 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.024 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 22.9 mmt85 -69.19 123.85 22.24 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.386 1.054 . . . . 0.0 110.833 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.761 HG22 HG12 ' A' ' 55' ' ' ILE . 90.8 t -162.0 140.05 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.976 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.852 HG22 ' SD ' ' A' ' 54' ' ' MET . 10.5 tt -155.17 126.76 3.71 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.101 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' PHE . 97.9 Cg_exo -39.45 168.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 123.555 2.836 . . . . 0.0 113.79 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -4.02 66.86 0.0 OUTLIER Glycine 0 N--CA 1.474 1.196 0 CA-C-N 114.102 -1.408 . . . . 0.0 114.051 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.4 t80 -161.16 -61.15 0.05 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.761 0.918 . . . . 0.0 108.847 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.852 ' SD ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -170.7 -175.61 1.87 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.494 1.121 . . . . 0.0 111.717 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.761 HG12 HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 174.65 113.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.549 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 1.024 ' OE1' ' O ' ' A' ' 48' ' ' ARG . 3.5 mp0 -96.8 -174.51 3.02 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.047 -169.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -166.91 178.83 41.02 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.934 165.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 1.014 ' O ' ' HB3' ' A' ' 102' ' ' GLN . . . 61.44 103.99 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 CA-C-N 113.728 -1.236 . . . . 0.0 110.712 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.81 -129.95 1.42 Allowed Glycine 0 N--CA 1.475 1.259 0 O-C-N 124.649 0.852 . . . . 0.0 111.701 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.931 ' CD1' ' HG2' ' A' ' 66' ' ' GLN . 12.6 m-30 -51.23 139.79 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.818 -1.191 . . . . 0.0 111.822 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.973 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 92.4 m -61.09 141.87 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.132 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.6 pt-20 -28.6 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.981 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 29.7 mt-30 90.58 43.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.804 1.315 . . . . 0.0 110.981 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.598 ' SD ' ' HD2' ' A' ' 60' ' ' PHE . 21.4 mmt 58.1 12.67 1.94 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.029 0.831 . . . . 0.0 113.148 174.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.973 ' O ' ' HB ' ' A' ' 61' ' ' THR . 88.0 mt-30 -79.41 65.22 4.51 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.931 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 75.5 mt-30 -39.45 132.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.181 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -58.62 -109.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.124 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.644 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 61.5 pttt -154.55 66.53 5.22 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.294 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 1.061 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 31.5 Cg_exo -70.51 -151.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.424 2.749 . . . . 0.0 112.588 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.061 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 40.2 p30 67.34 78.65 0.24 Allowed Pre-proline 0 N--CA 1.472 0.627 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.642 169.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.854 ' HB2' ' C ' ' A' ' 72' ' ' PRO . 52.6 Cg_exo -49.53 -60.39 0.87 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.316 2.677 . . . . 0.0 109.438 173.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.9 ' O ' HG23 ' A' ' 73' ' ' ILE . 45.2 Cg_exo -89.7 -160.27 1.33 Allowed 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.556 -2.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.105 HD11 ' O ' ' A' ' 99' ' ' ALA . 2.1 pp -161.7 145.1 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.902 0.858 . . . . 0.0 111.822 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 74' ' ' LYS . 28.6 mtpp -45.32 161.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.225 -1.807 . . . . 0.0 113.809 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.743 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 52.5 p-10 -74.68 -160.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.248 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.743 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 10.1 tp10 145.25 130.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.011 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.934 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -162.6 -36.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.291 0.994 . . . . 0.0 112.002 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.764 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 58.6 p30 -67.24 -37.66 83.9 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.104 0.877 . . . . 0.0 111.975 -169.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.764 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 16.7 p-10 45.13 -119.41 0.77 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.112 0.883 . . . . 0.0 109.736 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . 164.6 -55.56 0.27 Allowed Glycine 0 N--CA 1.474 1.173 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 80' ' ' GLY . 46.3 mt -39.64 177.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.692 0.877 . . . . 0.0 112.807 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.731 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 36.9 mmt180 -68.84 149.18 49.24 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.055 168.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.731 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.7 m120 -156.12 129.09 7.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.921 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' ARG . 15.8 m -169.33 157.98 7.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.843 -173.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' THR . 63.0 ttt180 -23.13 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.953 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.776 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 143.24 -17.35 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 111.433 -2.621 . . . . 0.0 110.855 -171.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.03 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 34.9 p -106.25 146.08 30.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.286 1.041 . . . . 0.0 112.755 -174.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.027 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.27 164.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.075 171.105 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.902 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -161.76 141.23 9.99 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.594 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.891 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 6.7 ttm -57.27 137.67 55.71 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.061 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 1.062 ' HB3' ' OE1' ' A' ' 102' ' ' GLN . . . -75.6 -59.43 2.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.598 ' HB3' ' CB ' ' A' ' 99' ' ' ALA . 5.3 tpm_? -32.75 169.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.39 1.056 . . . . 0.0 113.844 -172.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.708 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 9.7 t 161.94 162.44 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.634 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.743 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 83.26 130.51 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.491 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 1.365 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 42.3 m-20 101.37 -57.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.454 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.365 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 10.1 mtmp? 139.31 -94.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.821 1.326 . . . . 0.0 108.147 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -64.24 104.43 0.75 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.817 1.323 . . . . 0.0 109.013 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.924 ' OG ' ' HD3' ' A' ' 92' ' ' ARG . 18.2 t -174.13 -179.72 1.72 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.632 1.208 . . . . 0.0 111.814 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 1.598 ' CB ' ' HB3' ' A' ' 92' ' ' ARG . . . 80.33 85.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.83 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 62.9 p -79.72 -40.25 29.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.649 -168.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.73 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 50.3 m -159.27 -73.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.288 0.993 . . . . 0.0 109.338 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 1.062 ' OE1' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -38.91 163.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.168 -175.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 1.027 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -155.3 -165.28 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.1 -172.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.956 ' CZ ' ' HB3' ' A' ' 122' ' ' TYR . 49.3 p90 -154.85 119.16 4.73 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.757 0.789 . . . . 0.0 111.019 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 18' ' ' LEU . 67.1 mt -84.14 110.89 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.453 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.643 ' O ' ' HE1' ' A' ' 132' ' ' MET . 76.6 m-20 -61.11 166.79 3.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.372 1.045 . . . . 0.0 111.41 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.657 HG12 ' CE ' ' A' ' 132' ' ' MET . 28.1 m -155.45 42.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.667 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.731 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . 173.6 137.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.379 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -39.55 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.887 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.899 ' OD1' HD11 ' A' ' 113' ' ' LEU . 11.9 t-20 -70.52 -119.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.876 1.36 . . . . 0.0 110.699 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 76.5 -33.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.782 0.677 . . . . 0.0 111.774 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -38.35 -50.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.071 0.857 . . . . 0.0 110.113 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.037 ' H ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.98 40.62 0.87 Allowed 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.752 1.282 . . . . 0.0 110.729 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' ' O ' ' A' ' 113' ' ' LEU . 39.9 p30 -39.21 -117.38 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.733 0.646 . . . . 0.0 111.602 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 1.079 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 10.8 m170 179.34 109.65 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.963 0.789 . . . . 0.0 109.946 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.204 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.423 179.523 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.86 -130.48 0.01 OUTLIER Glycine 0 N--CA 1.471 1.013 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.97 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 1.079 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 71.1 m-85 -79.5 135.37 36.62 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.958 -1.121 . . . . 0.0 111.344 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.183 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -67.17 -148.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.309 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.183 HG23 ' O ' ' A' ' 123' ' ' ALA . 37.1 t 177.39 133.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.9 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 24.2 p90 -171.32 26.13 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.808 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -166.68 -149.98 6.19 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-O 122.8 1.222 . . . . 0.0 114.084 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.206 ' CD ' ' OE1' ' A' ' 19' ' ' GLU . 29.7 mtpp -169.42 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 111.597 -2.301 . . . . 0.0 110.373 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.54 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 63.3 t -156.13 159.16 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.094 -175.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.766 ' O ' ' CD ' ' A' ' 130' ' ' LYS . 62.4 t -152.54 -43.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.992 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.902 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 32.4 mmmt -167.02 101.46 0.54 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.204 1.002 . . . . 0.0 109.032 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.428 ' O ' ' OD1' ' A' ' 133' ' ' ASP . . . -179.77 141.07 4.53 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.726 0.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.824 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 22.7 mmt -47.86 -26.11 1.55 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.963 -1.118 . . . . 0.0 111.805 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 37.8 p-10 -47.93 -55.09 10.73 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.668 HG11 HG23 ' A' ' 16' ' ' ILE . 51.4 t -62.68 -68.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 124.378 1.049 . . . . 0.0 108.999 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 132' ' ' MET . . . -42.65 -47.15 5.24 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.667 1.229 . . . . 0.0 110.905 -177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 1.016 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 41.4 m-20 -50.47 -71.0 0.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.473 1.108 . . . . 0.0 109.424 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.675 ' O ' HG13 ' A' ' 141' ' ' VAL . 56.8 mtmt -42.97 -43.57 4.23 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.712 1.258 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 141' ' ' VAL . 14.5 mt -58.57 -61.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.634 ' HA ' HG11 ' A' ' 49' ' ' VAL . 84.5 p -68.54 16.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.426 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 1.016 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 17.1 mm100 -115.36 -47.05 2.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.295 0.997 . . . . 0.0 109.368 176.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.7 m -47.65 127.92 10.78 Favored Pre-proline 0 N--CA 1.472 0.662 0 O-C-N 124.443 1.089 . . . . 0.0 110.1 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 141' ' ' VAL . 86.2 Cg_exo -38.09 176.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.338 2.692 . . . . 0.0 113.374 175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.45 HG22 ' CA ' ' A' ' 153' ' ' PRO . 8.5 p -160.83 -150.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.727 1.727 . . . . 0.0 112.932 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.547 ' O ' ' O ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER 178.52 165.26 0.81 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 109.725 -3.398 . . . . 0.0 111.035 173.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.708 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 36.7 m-20 -50.86 -148.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.962 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -161.28 -148.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.729 0.643 . . . . 0.0 109.282 170.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -65.31 -100.15 0.02 OUTLIER Glycine 0 N--CA 1.471 0.97 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 168.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 98.5 Cg_endo -73.49 -61.5 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.788 2.992 . . . . 0.0 109.321 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 146' ' ' VAL . 80.2 m-85 -69.78 120.77 16.04 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.606 1.191 . . . . 0.0 111.373 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.708 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 9.8 mm100 -68.89 -157.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.861 167.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.758 ' O ' HG23 ' A' ' 152' ' ' VAL . 76.4 m-20 36.25 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.061 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 146' ' ' VAL . 70.1 t -164.56 118.89 1.01 Allowed Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.238 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.45 ' CA ' HG22 ' A' ' 143' ' ' THR . 57.2 Cg_endo -66.21 111.97 2.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.646 2.897 . . . . 0.0 109.842 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.937 ' H ' ' HA ' ' A' ' 143' ' ' THR . 69.6 p -42.66 -52.85 4.73 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.743 1.277 . . . . 0.0 109.143 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.24 132.33 93.4 Favored Pre-proline 0 N--CA 1.474 0.742 0 O-C-N 124.572 1.17 . . . . 0.0 109.503 170.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.38 161.04 43.55 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 C-N-CA 123.658 2.905 . . . . 0.0 113.436 -172.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.552 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 55.5 t -151.18 95.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.571 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 45' ' ' THR . 91.8 t -88.58 121.24 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.711 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.231 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 11.0 mt -68.93 125.36 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.906 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.206 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -79.82 -51.26 9.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.212 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.788 ' O ' HD23 ' A' ' 9' ' ' LEU . 56.0 m -158.58 177.35 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.694 1.246 . . . . 0.0 112.206 -176.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.868 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . . . -170.63 119.8 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.098 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.436 ' O ' HD13 ' A' ' 8' ' ' LEU . 21.4 ptmt -170.75 131.37 0.86 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.302 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.893 HG13 HG11 ' A' ' 36' ' ' VAL . 35.9 m -69.01 142.33 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.9 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.975 HD12 ' HD2' ' A' ' 166' ' ' PRO . 58.6 tp -58.35 123.4 65.86 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.975 ' HD2' HD12 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.583 2.856 . . . . 0.0 112.12 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.2 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 86.7 Cg_exo . . . . . 0 C--O 1.235 0.325 0 N-CA-C 113.942 0.708 . . . . 0.0 113.942 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.306 ' CD2' HG21 ' A' ' 129' ' ' VAL . 1.7 m-70 -154.55 117.75 4.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.148 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.039 HG22 ' HB2' ' A' ' 18' ' ' LEU . 30.2 m -71.76 109.19 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 124.387 1.054 . . . . 0.0 109.184 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.26 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 7.3 mp -79.26 131.08 36.05 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.383 1.052 . . . . 0.0 110.285 177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.044 ' O ' HG12 ' A' ' 16' ' ' ILE . 8.6 mp -138.45 96.76 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.333 173.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 1.186 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 95.3 m -86.2 81.98 8.21 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.768 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.978 HG22 HG12 ' A' ' 159' ' ' ILE . 33.5 p -72.91 167.6 20.66 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.931 1.394 . . . . 0.0 111.41 174.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -39.49 -43.78 1.31 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.358 -1.747 . . . . 0.0 110.61 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.777 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -53.9 -61.94 1.98 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.471 1.107 . . . . 0.0 110.228 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.34 177.64 46.38 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 113.151 -1.84 . . . . 0.0 113.365 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.765 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 38.0 t30 -77.82 89.46 4.05 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.684 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.044 HG12 ' O ' ' A' ' 9' ' ' LEU . 7.0 pt -77.9 175.01 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.308 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.917 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 6.2 mm-40 -159.73 100.08 1.43 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.4 -168.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.039 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.6 mm? -80.97 164.3 22.66 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.398 1.061 . . . . 0.0 110.712 166.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.208 ' OE1' ' HE1' ' A' ' 6' ' ' HIS . 40.0 tt0 -130.19 129.83 43.92 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.475 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.042 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.6 mp -117.53 116.56 27.37 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.964 1.415 . . . . 0.0 109.726 -169.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.37 104.9 2.84 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.314 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.71 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.9 ttmp? -69.0 -45.79 69.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.663 1.227 . . . . 0.0 111.542 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -47.77 -70.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.333 1.02 . . . . 0.0 110.256 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 1.263 ' NZ ' HD21 ' A' ' 81' ' ' LEU . 61.6 mttp -71.94 13.1 0.32 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.77 1.294 . . . . 0.0 114.016 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.659 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.63 68.7 2.69 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 124.034 0.834 . . . . 0.0 109.486 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.853 ' O ' HG22 ' A' ' 29' ' ' VAL . 51.6 Cg_exo -60.73 -63.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.475 2.784 . . . . 0.0 111.061 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.0 t -54.96 -62.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.137 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 t -42.2 -58.49 2.13 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.643 1.214 . . . . 0.0 110.472 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 26' ' ' PRO . 32.2 m -51.75 -46.97 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 124.735 1.272 . . . . 0.0 110.622 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.497 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -48.58 -69.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.239 0.962 . . . . 0.0 108.949 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 1.306 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.8 m120 -45.08 -51.71 9.88 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.557 1.161 . . . . 0.0 109.75 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' VAL . 77.4 t80 -42.54 -59.65 1.81 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.598 1.186 . . . . 0.0 109.646 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.688 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.9 t -47.44 -37.3 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.707 1.254 . . . . 0.0 111.101 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 1.306 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 15.3 m-20 -43.84 -62.6 1.06 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.012 0.82 . . . . 0.0 109.381 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -61.27 -59.37 5.41 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.152 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.933 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 59.5 t -39.4 -48.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.976 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.803 ' O ' ' HB3' ' A' ' 38' ' ' SER . 46.9 t30 -38.42 -32.38 0.07 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.779 1.299 . . . . 0.0 112.015 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.803 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.2 p 149.32 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.138 0.899 . . . . 0.0 113.005 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 42' ' ' ASN . . . 87.6 -42.46 3.12 Favored Glycine 0 N--CA 1.474 1.198 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.356 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.632 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 28.4 t80 -67.11 -74.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.527 0.78 . . . . 0.0 109.888 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.933 ' CE2' ' HA ' ' A' ' 36' ' ' VAL . 79.9 m-85 -61.69 -29.49 70.12 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.513 1.133 . . . . 0.0 112.628 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 39' ' ' GLY . 19.3 m-20 -38.6 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.011 0.819 . . . . 0.0 111.312 -169.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 1.143 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.5 m-20 44.24 47.81 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.265 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.835 ' O ' HG23 ' A' ' 45' ' ' THR . 28.6 m -78.59 -123.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 1.046 HG22 ' HA ' ' A' ' 158' ' ' VAL . 46.1 p -165.02 -143.8 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.254 1.026 . . . . 0.0 112.493 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CD2' HG21 ' A' ' 11' ' ' THR . 65.4 m-85 -159.63 66.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.5 -2.137 . . . . 0.0 106.834 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.884 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 1.4 p-80 -51.72 -68.98 0.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.191 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.884 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.2 mtt180 -69.68 124.07 23.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.51 1.131 . . . . 0.0 110.296 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 49' ' ' VAL . 34.4 m -158.21 94.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 124.74 1.275 . . . . 0.0 109.374 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.898 HG21 ' HD2' ' A' ' 53' ' ' PHE . 57.2 mt -77.27 123.75 87.04 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.334 175.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 53' ' ' PHE . 82.4 Cg_exo -37.65 144.02 0.16 Allowed 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.271 2.647 . . . . 0.0 112.525 174.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.23 55.53 0.01 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.651 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.898 ' HD2' HG21 ' A' ' 50' ' ' ILE . 1.6 t80 -144.33 -63.1 0.37 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.778 0.929 . . . . 0.0 109.05 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.701 ' HE2' HD12 ' A' ' 50' ' ' ILE . 27.2 ptt? -179.56 114.91 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.386 1.054 . . . . 0.0 111.102 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.836 ' CD1' ' HB1' ' A' ' 135' ' ' ALA . 30.7 pt -84.73 160.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.791 165.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.787 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 20.0 mt-30 -156.58 162.35 39.9 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.804 0.69 . . . . 0.0 111.781 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.79 -154.07 7.05 Favored Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.272 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 102' ' ' GLN . . . 65.85 73.88 0.57 Allowed Glycine 0 N--CA 1.47 0.952 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 1.22 ' HA2' ' CD ' ' A' ' 67' ' ' LYS . . . -179.83 -122.83 0.8 Allowed Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 68.5 m-85 -45.18 132.91 7.12 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.622 0.836 . . . . 0.0 110.499 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.781 ' HA ' HG23 ' A' ' 44' ' ' THR . 88.6 m -59.2 -57.91 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.214 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.722 ' HG2' HG21 ' A' ' 45' ' ' THR . 0.1 OUTLIER -168.46 -75.7 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.614 1.196 . . . . 0.0 108.064 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -72.93 46.81 0.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.5 1.125 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.833 ' HE1' HG21 ' A' ' 152' ' ' VAL . 53.9 mtt 39.44 36.69 0.23 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.121 0.888 . . . . 0.0 111.961 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -78.14 87.46 4.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -30.69 147.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.69 -1.595 . . . . 0.0 113.418 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 1.22 ' CD ' ' HA2' ' A' ' 59' ' ' GLY . 47.4 mtmt -56.53 -131.12 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 112.849 -1.978 . . . . 0.0 112.393 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 1.14 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 46.6 mmtm 179.27 79.66 0.17 Allowed Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 112.641 -2.072 . . . . 0.0 106.363 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.812 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 47.8 Cg_endo -71.89 -165.88 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.606 2.871 . . . . 0.0 113.345 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.998 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 91.4 m-20 -166.54 170.76 5.19 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 113.237 -1.801 . . . . 0.0 109.923 -172.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 32.9 Cg_endo -45.44 104.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.606 2.204 . . . . 0.0 109.184 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.5 Cg_exo -44.58 -146.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.818 3.012 . . . . 0.0 113.603 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 99' ' ' ALA . 27.4 pt -160.18 141.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 124.387 1.054 . . . . 0.0 110.476 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 29.1 mtpp -36.44 159.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.749 -1.569 . . . . 0.0 113.322 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 1.322 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 61.3 t30 -43.12 169.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.285 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.322 ' HG2' ' O ' ' A' ' 75' ' ' ASN . 11.4 mm-40 172.98 128.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.478 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.27 ' O ' ' CE1' ' A' ' 115' ' ' HIS . . . 174.12 -40.28 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.976 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 52.9 p-10 -67.22 -43.71 81.36 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.299 0.999 . . . . 0.0 110.649 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 22.2 p30 -51.86 132.35 31.73 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.114 0.884 . . . . 0.0 110.325 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.639 ' H ' HD12 ' A' ' 81' ' ' LEU . . . -171.78 -62.11 0.04 OUTLIER Glycine 0 N--CA 1.474 1.199 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.263 HD21 ' NZ ' ' A' ' 24' ' ' LYS . 6.2 mp 81.6 -32.25 0.1 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.632 0.843 . . . . 0.0 112.444 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 16.4 ptp180 178.89 73.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.645 1.216 . . . . 0.0 110.211 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.405 ' HA ' HG21 ' A' ' 87' ' ' THR . 14.2 p30 -72.68 142.88 48.25 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.869 1.356 . . . . 0.0 111.204 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 m -169.28 148.04 3.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.419 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.713 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 51.6 ptt85 -42.03 101.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.05 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.774 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 144.19 -29.04 1.94 Allowed Glycine 0 N--CA 1.473 1.107 0 CA-C-N 111.934 -2.393 . . . . 0.0 109.899 -169.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 20.5 p -83.56 129.85 34.98 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.716 0.77 . . . . 0.0 111.225 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.485 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -84.26 156.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.793 166.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.092 ' O ' ' CD2' ' A' ' 104' ' ' PHE . . . -165.31 128.69 2.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.659 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.78 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 32.7 ttm -59.38 173.9 0.47 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.196 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.742 ' H ' ' HG3' ' A' ' 90' ' ' MET . . . -167.57 164.14 14.68 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.507 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.867 ' CG ' ' HA ' ' A' ' 99' ' ' ALA . 2.4 mmm-85 179.65 119.08 0.05 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.486 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 93.4 m -40.47 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.532 1.145 . . . . 0.0 110.438 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 93' ' ' THR . . . 71.39 -67.9 0.24 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.858 1.349 . . . . 0.0 109.175 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.769 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 59.3 m-20 66.13 -84.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.705 1.253 . . . . 0.0 110.109 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.769 ' HB3' ' O ' ' A' ' 95' ' ' ASP . 87.4 tttt 95.02 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.865 1.353 . . . . 0.0 109.213 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -165.88 81.16 0.3 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 73' ' ' ILE . 66.3 m -163.06 -116.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.781 1.301 . . . . 0.0 110.565 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.867 ' HA ' ' CG ' ' A' ' 92' ' ' ARG . . . 54.27 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.644 1.215 . . . . 0.0 107.751 -169.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -77.71 -35.02 52.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.01 -170.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.7 p -170.31 -40.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.273 0.983 . . . . 0.0 110.14 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.738 ' CD ' ' HZ3' ' A' ' 67' ' ' LYS . 29.4 mt-30 -35.62 130.46 0.55 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.275 0.984 . . . . 0.0 111.308 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 1.014 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.32 178.87 7.44 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.793 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 1.092 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 49.1 p90 -153.2 122.63 6.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.052 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.942 HD11 HD21 ' A' ' 18' ' ' LEU . 59.4 mt -91.01 101.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.218 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.557 ' O ' HG13 ' A' ' 107' ' ' VAL . 18.1 p-10 -68.62 -173.04 0.41 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.354 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.712 HG22 ' C ' ' A' ' 53' ' ' PHE . 34.2 m -160.04 -42.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.623 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.713 ' CA ' ' HB3' ' A' ' 85' ' ' ARG . . . -74.25 139.71 44.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 124.373 1.046 . . . . 0.0 111.167 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -42.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.954 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.671 ' OD1' HD23 ' A' ' 113' ' ' LEU . 2.7 t30 -68.29 142.93 55.41 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.864 1.352 . . . . 0.0 111.026 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 110' ' ' ASN . . . 168.42 -51.21 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.922 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.762 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 47.5 p90 -66.44 60.65 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.611 1.195 . . . . 0.0 108.109 168.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.982 HD11 ' CD2' ' A' ' 122' ' ' TYR . 59.3 tp 178.31 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.807 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -38.08 125.7 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.821 0.701 . . . . 0.0 111.137 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 1.27 ' CE1' ' O ' ' A' ' 77' ' ' ALA . 19.4 m170 -42.92 108.67 0.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.379 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.026 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.288 -175.265 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 1.278 ' HZ ' ' ND2' ' A' ' 75' ' ' ASN . 21.4 p90 . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.51 -80.78 0.44 Allowed Glycine 0 N--CA 1.471 0.994 0 CA-C-N 113.638 -1.619 . . . . 0.0 113.734 -167.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 1.221 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 59.6 m-85 -76.98 130.45 37.5 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.46 0.741 . . . . 0.0 111.837 -161.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.045 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -67.37 -158.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.995 174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.048 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 62.7 t 179.48 131.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.312 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 1.042 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.1 p90 -170.79 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.007 0.817 . . . . 0.0 111.605 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 1.485 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -138.35 173.85 22.28 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.194 1.441 . . . . 0.0 113.206 -171.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 59.3 tttp 179.7 121.33 0.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 110.888 -2.656 . . . . 0.0 110.207 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 86' ' ' GLY . 59.2 t -58.94 156.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.302 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.306 HG21 ' CD2' ' A' ' 6' ' ' HIS . 57.3 t -130.7 -46.99 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.277 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.67 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER 172.59 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.118 0.886 . . . . 0.0 109.648 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.593 ' HA2' HG13 ' A' ' 128' ' ' VAL . . . 144.99 -147.46 18.64 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 119.778 -1.201 . . . . 0.0 112.426 -4.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.973 ' HG3' ' OD1' ' A' ' 136' ' ' ASP . 6.0 tpt -60.24 -31.15 69.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.939 -1.63 . . . . 0.0 111.878 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 63.7 t0 -47.49 -68.65 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.995 0.809 . . . . 0.0 109.531 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.783 ' HB ' HG22 ' A' ' 16' ' ' ILE . 78.3 t -49.78 -60.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.757 1.286 . . . . 0.0 109.296 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.836 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -44.6 -51.81 8.69 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.567 1.167 . . . . 0.0 110.05 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.973 ' OD1' ' HG3' ' A' ' 132' ' ' MET . 36.4 m-20 -51.86 -70.34 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.683 1.239 . . . . 0.0 109.255 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.536 ' N ' ' OE1' ' A' ' 140' ' ' GLN . 30.5 mtpp -38.6 -44.6 0.99 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.658 1.224 . . . . 0.0 110.708 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.359 ' O ' HG22 ' A' ' 141' ' ' VAL . 30.8 mt -55.61 -58.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 124.374 1.046 . . . . 0.0 108.367 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 136' ' ' ASP . 82.2 p -62.6 2.75 0.25 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.709 1.256 . . . . 0.0 114.129 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.872 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.0 mp0 -96.99 -50.09 4.76 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.289 0.993 . . . . 0.0 108.587 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.359 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.2 m -39.93 124.83 1.6 Allowed Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 124.435 1.084 . . . . 0.0 110.652 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 141' ' ' VAL . 83.6 Cg_exo -40.84 178.81 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.469 2.779 . . . . 0.0 113.748 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.203 HG22 ' CA ' ' A' ' 153' ' ' PRO . 6.7 p -161.02 -145.26 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.87 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.718 ' ND1' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 179.13 142.45 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.672 -2.967 . . . . 0.0 111.789 170.06 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 1.145 ' OD1' ' HG2' ' A' ' 150' ' ' GLN . 61.0 t0 -69.74 111.09 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.801 168.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.848 HG12 ' H ' ' A' ' 147' ' ' GLY . 2.3 t -78.97 -147.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.115 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.848 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -61.64 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.47 0.911 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 171.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.825 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 95.8 Cg_endo -71.32 -55.78 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.697 2.931 . . . . 0.0 109.508 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.825 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 84.0 m-85 -69.2 102.94 1.8 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.632 1.207 . . . . 0.0 110.103 -176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 1.171 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 75.2 mt-30 -86.43 55.41 3.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.065 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 1.171 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 75.1 m-20 -172.8 82.74 0.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.833 HG21 ' HE1' ' A' ' 64' ' ' MET . 62.9 t -156.04 102.04 2.11 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 124.405 1.065 . . . . 0.0 108.773 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.203 ' CA ' HG22 ' A' ' 143' ' ' THR . 75.7 Cg_exo -46.93 99.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 123.436 2.757 . . . . 0.0 110.268 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . 1.212 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.6 t -34.87 -52.93 0.55 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.467 1.104 . . . . 0.0 109.861 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -84.64 85.98 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 164.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.212 ' HD3' ' O ' ' A' ' 154' ' ' SER . 63.1 Cg_endo -79.0 140.78 16.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.606 2.871 . . . . 0.0 112.399 -168.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.567 ' O ' ' CG2' ' A' ' 45' ' ' THR . 92.2 t -68.72 155.07 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.534 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 1.046 ' HA ' HG22 ' A' ' 45' ' ' THR . 98.1 t -142.98 119.44 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.374 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.143 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 32.3 mt -68.36 133.63 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.345 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.186 ' HB2' ' O ' ' A' ' 10' ' ' THR . 86.1 mt -76.36 -52.45 9.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.511 -2.131 . . . . 0.0 108.995 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 65.7 m -163.39 -166.11 1.18 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.671 1.232 . . . . 0.0 111.848 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 1.26 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . 179.07 119.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.347 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.723 ' O ' HD13 ' A' ' 8' ' ' LEU . 65.6 mttm -163.64 126.24 2.55 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.013 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.85 HG13 HG11 ' A' ' 36' ' ' VAL . 33.9 m -67.83 140.27 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.358 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.024 HD12 ' HD2' ' A' ' 166' ' ' PRO . 56.5 tp -157.98 121.03 2.1 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.991 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 1.024 ' HD2' HD12 ' A' ' 165' ' ' LEU . 88.3 Cg_exo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.646 2.897 . . . . 0.0 112.062 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.132 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 88.3 Cg_exo . . . . . 0 C--O 1.234 0.306 0 N-CA-C 114.298 0.845 . . . . 0.0 114.298 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.132 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 1.6 m-70 -152.37 118.07 5.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.385 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.926 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.3 p -66.93 141.8 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.518 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.872 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 6.9 mp -121.11 132.53 54.92 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.424 1.078 . . . . 0.0 110.314 164.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.768 HD12 ' C ' ' A' ' 8' ' ' LEU . 8.2 mp -126.93 -177.38 4.01 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 111.929 -2.396 . . . . 0.0 109.16 164.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.841 HG22 HD12 ' A' ' 160' ' ' LEU . 99.9 m -160.61 90.29 0.86 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.844 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 1.014 HG22 HG12 ' A' ' 159' ' ' ILE . 34.8 p -78.05 169.6 18.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.398 1.686 . . . . 0.0 111.216 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -39.77 -42.98 1.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.536 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.771 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -58.22 -59.83 4.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.526 1.141 . . . . 0.0 110.572 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.59 178.51 41.36 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 113.529 -1.669 . . . . 0.0 114.201 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 16' ' ' ILE . 63.0 t-20 -61.67 153.83 27.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.08 -1.56 . . . . 0.0 111.063 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.113 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 16.0 pt -164.34 168.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.455 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 1.113 ' OE1' ' O ' ' A' ' 16' ' ' ILE . 4.3 mm-40 -145.61 113.56 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.473 -1.694 . . . . 0.0 112.059 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.013 HD21 HD11 ' A' ' 105' ' ' ILE . 2.7 mm? -94.71 147.03 23.74 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 124.481 1.113 . . . . 0.0 110.075 165.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.404 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -109.56 112.01 23.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.203 171.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.887 HD23 ' HE2' ' A' ' 125' ' ' PHE . 6.4 mp -84.33 -158.97 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.541 -170.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.804 ' OD1' ' HG3' ' A' ' 23' ' ' GLN . 61.6 t0 -175.39 110.03 0.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.118 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.667 ' HA ' HG21 ' A' ' 29' ' ' VAL . 28.5 ttpp -96.98 -35.8 10.74 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.928 1.393 . . . . 0.0 111.954 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.851 ' OE1' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -42.46 -33.68 0.71 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.179 0.925 . . . . 0.0 112.306 -171.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.851 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 17.9 tppt? -108.01 10.68 28.23 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.283 0.989 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.979 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -161.04 68.84 2.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 O-C-N 123.69 0.619 . . . . 0.0 110.162 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.6 Cg_exo -58.48 -58.46 0.73 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.57 2.847 . . . . 0.0 111.264 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 71.0 t -54.32 -69.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.835 1.334 . . . . 0.0 110.165 -175.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.518 ' OG ' ' HB1' ' A' ' 25' ' ' ALA . 72.7 p -47.5 -54.92 10.24 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.727 1.267 . . . . 0.0 110.95 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.002 ' O ' ' HB3' ' A' ' 32' ' ' PHE . 11.6 t -55.81 -45.27 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.375 1.047 . . . . 0.0 110.283 -175.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 66.5 tp60 -45.02 -63.27 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.236 0.96 . . . . 0.0 109.646 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 1.04 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.6 m120 -42.98 -48.13 5.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.61 1.194 . . . . 0.0 110.058 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 1.002 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 15.6 t80 -39.75 -69.46 0.13 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.527 1.142 . . . . 0.0 109.967 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' ND2' ' A' ' 37' ' ' ASN . 48.9 t -43.96 -39.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.722 1.264 . . . . 0.0 111.201 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 1.04 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 16.6 m-20 -44.04 -62.26 1.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.148 0.905 . . . . 0.0 109.914 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 38' ' ' SER . 98.1 m-85 -57.48 -56.23 24.6 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.877 1.361 . . . . 0.0 109.364 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.839 ' HA ' ' HE2' ' A' ' 41' ' ' TYR . 96.0 t -42.97 -63.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 124.555 1.159 . . . . 0.0 109.279 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.678 ' ND2' HG12 ' A' ' 33' ' ' VAL . 22.0 m-20 -48.23 -49.75 32.04 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.796 1.31 . . . . 0.0 110.069 176.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 37' ' ' ASN . 56.4 m -56.08 -117.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.543 1.152 . . . . 0.0 111.03 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.53 76.28 0.1 Allowed Glycine 0 N--CA 1.473 1.151 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.662 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 17.5 t80 -110.67 -56.54 2.34 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.914 -173.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.839 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 58.3 m-85 -59.59 -40.23 86.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.063 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.7 p-10 -39.23 113.64 0.34 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.919 . . . . 0.0 111.449 -173.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 29.3 t-20 58.03 35.76 25.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.313 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 45' ' ' THR . 72.8 p -79.45 -146.01 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.194 0.934 . . . . 0.0 108.684 163.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.98 HG22 ' HA ' ' A' ' 158' ' ' VAL . 72.7 p -163.6 -154.1 0.26 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.742 0.782 . . . . 0.0 112.268 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.874 ' HD1' ' O ' ' A' ' 45' ' ' THR . 6.0 m-30 -134.75 62.08 1.65 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.201 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.866 ' CE1' ' HG2' ' A' ' 48' ' ' ARG . 21.4 p-80 -53.62 -49.53 67.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.407 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.866 ' HG2' ' CE1' ' A' ' 47' ' ' HIS . 24.8 mmm180 -68.28 107.38 2.79 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.53 1.144 . . . . 0.0 109.325 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 46' ' ' PHE . 90.9 t -152.01 135.03 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 124.663 1.227 . . . . 0.0 110.308 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.093 HG21 ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -146.91 120.28 4.99 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.076 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' PHE . 85.5 Cg_exo -35.13 152.17 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.589 2.86 . . . . 0.0 113.439 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 1.67 63.91 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 CA-C-N 114.219 -1.355 . . . . 0.0 113.801 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.082 ' HB3' HD12 ' A' ' 50' ' ' ILE . 8.4 t80 -155.32 -42.93 0.08 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.783 0.931 . . . . 0.0 110.897 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.093 ' HE2' HG21 ' A' ' 50' ' ' ILE . 22.3 ptt? 176.65 163.28 0.43 Allowed 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.897 0.748 . . . . 0.0 112.026 -176.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.031 HD11 ' HB1' ' A' ' 135' ' ' ALA . 46.5 pt -165.89 129.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.912 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 1.589 ' CB ' ' HA ' ' A' ' 104' ' ' PHE . 2.6 mm-40 -173.73 -166.09 0.29 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.721 164.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.45 -146.82 6.41 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.306 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.662 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 130.62 -58.83 0.7 Allowed Glycine 0 N--CA 1.475 1.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -45.17 -117.01 0.0 OUTLIER Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.635 0.844 . . . . 0.0 112.194 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.672 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 18.7 m-30 -39.88 128.44 2.11 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.724 0.897 . . . . 0.0 111.062 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.025 ' HB ' ' CE ' ' A' ' 67' ' ' LYS . 13.1 t -59.41 -39.4 83.32 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.686 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 1.081 ' OE2' ' HG2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 174.27 121.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.201 0.938 . . . . 0.0 109.427 -174.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 1.329 ' O ' ' CG ' ' A' ' 64' ' ' MET . 87.9 mm-40 77.45 -61.36 0.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.665 1.228 . . . . 0.0 108.507 -173.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 1.329 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 146.63 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.595 1.184 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HG3' ' C ' ' A' ' 64' ' ' MET . 43.7 mt-30 -156.69 79.83 0.94 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 112.087 -2.324 . . . . 0.0 106.561 176.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' GLN . 65.1 mt-30 -25.16 133.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.095 -172.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 1.065 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 6.5 mmpt? -63.71 -117.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.369 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 33.7 mmtp -156.77 74.02 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 CA-C-N 112.92 -1.946 . . . . 0.0 107.997 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 1.149 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 83.8 Cg_exo -48.4 -166.19 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.604 2.869 . . . . 0.0 113.654 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.149 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 80.9 m-20 -171.23 165.57 4.59 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.411 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.793 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 84.8 Cg_exo -39.09 91.31 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.543 2.829 . . . . 0.0 111.422 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.871 ' HG3' ' CG2' ' A' ' 100' ' ' THR . 82.4 Cg_exo -44.38 -150.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.655 2.903 . . . . 0.0 113.043 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.33 168.3 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 124.281 0.988 . . . . 0.0 111.606 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 26.8 mtpp -48.44 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 113.336 -1.756 . . . . 0.0 113.157 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.936 ' OD1' ' OD1' ' A' ' 78' ' ' ASP . 10.1 p30 -54.93 -149.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.864 -1.516 . . . . 0.0 111.245 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.284 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 173.11 -62.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.853 0.721 . . . . 0.0 109.696 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.664 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -36.8 -37.94 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.386 1.053 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.936 ' OD1' ' OD1' ' A' ' 75' ' ' ASN . 9.6 p-10 -68.8 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.13 0.894 . . . . 0.0 113.096 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 29.5 p30 -52.67 -101.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 161.06 -71.76 0.22 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.543 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.4 pt? -40.66 132.75 2.13 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.878 0.987 . . . . 0.0 111.984 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.71 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 98.3 mtt180 -66.55 168.33 9.37 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.805 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.895 ' HB3' HG21 ' A' ' 87' ' ' THR . 87.9 m-20 -167.07 -170.47 1.53 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.581 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.801 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 15.5 m -168.26 159.39 10.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.343 -171.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.801 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 16.6 ptm180 -25.33 99.72 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.776 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 1.048 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 149.27 -24.59 1.24 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 111.346 -2.661 . . . . 0.0 110.261 -171.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.021 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.7 p -96.12 136.32 36.73 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.485 0.66 . . . . 0.0 112.049 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.135 HD12 ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -90.48 163.16 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.348 168.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.12 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -163.43 144.75 9.37 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.114 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.928 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 17.8 ttm -69.16 137.4 53.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.905 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.31 -100.71 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.531 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.252 ' O ' HG23 ' A' ' 93' ' ' THR . 17.1 ptm180 179.25 -139.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.902 0.751 . . . . 0.0 110.952 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.252 HG23 ' O ' ' A' ' 92' ' ' ARG . 22.5 p 145.82 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.678 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 44.05 -94.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.779 1.3 . . . . 0.0 110.462 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 96' ' ' LYS . 36.0 m-20 -49.53 127.46 15.54 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.196 0.935 . . . . 0.0 110.836 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -41.83 -103.85 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.645 175.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.842 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 63.0 m-20 -43.49 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.403 1.064 . . . . 0.0 109.764 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 72' ' ' PRO . 17.2 t -171.74 -113.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.588 1.18 . . . . 0.0 110.407 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.811 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . 43.74 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.226 0.954 . . . . 0.0 108.797 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.871 ' CG2' ' HG3' ' A' ' 72' ' ' PRO . 66.7 p -78.84 -44.85 22.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.342 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.9 p -170.19 92.29 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.344 1.027 . . . . 0.0 108.709 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 101' ' ' SER . 47.9 tt0 175.17 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 125.018 1.448 . . . . 0.0 109.575 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.847 ' O ' ' HB3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -146.74 -179.12 6.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.966 -177.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 1.589 ' HA ' ' CB ' ' A' ' 56' ' ' GLN . 11.7 p90 -157.32 170.54 22.24 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.346 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.013 HD11 HD21 ' A' ' 18' ' ' LEU . 85.2 mt -127.18 112.67 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 112.915 -1.948 . . . . 0.0 108.95 -170.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.817 ' OD1' ' O ' ' A' ' 87' ' ' THR . 36.0 p-10 -63.42 149.91 44.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.403 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.583 HG22 ' C ' ' A' ' 53' ' ' PHE . 31.4 m -136.3 23.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.801 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -163.91 136.24 5.0 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.763 0.664 . . . . 0.0 110.714 175.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -36.99 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.192 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 1.041 ' OD1' ' HB3' ' A' ' 113' ' ' LEU . 40.1 t30 -69.61 -95.51 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.93 1.394 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 65.08 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.176 0.922 . . . . 0.0 110.419 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.787 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 47.6 p90 -42.25 -39.87 2.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.296 0.998 . . . . 0.0 110.861 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.041 ' HB3' ' OD1' ' A' ' 110' ' ' ASN . 64.1 tp -58.68 -38.78 78.98 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.268 0.98 . . . . 0.0 110.504 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 111' ' ' ALA . 65.4 t0 -39.49 130.28 1.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.12 0.887 . . . . 0.0 111.681 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 1.025 ' ND1' ' O ' ' A' ' 120' ' ' PHE . 4.1 t60 -40.72 137.39 1.18 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.151 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.373 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.869 179.369 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 1.025 ' O ' ' ND1' ' A' ' 115' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.841 ' HA3' ' HB2' ' A' ' 115' ' ' HIS . . . 165.56 161.57 14.86 Favored Glycine 0 N--CA 1.479 1.536 0 O-C-N 123.862 0.726 . . . . 0.0 112.606 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.997 ' CE1' HD11 ' A' ' 113' ' ' LEU . 89.9 m-85 -78.83 137.11 37.54 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.043 -1.079 . . . . 0.0 110.599 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.284 ' HB1' ' OE1' ' A' ' 76' ' ' GLU . . . -56.1 -170.34 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.132 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 123' ' ' ALA . 70.3 t 178.51 144.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.352 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.887 ' HE2' HD23 ' A' ' 20' ' ' LEU . 2.5 p90 -170.42 25.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.625 ' C ' ' OE2' ' A' ' 19' ' ' GLU . . . -167.9 -139.85 2.78 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.652 1.14 . . . . 0.0 113.822 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.404 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 39.4 ttpt 179.62 -136.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 111.808 -2.196 . . . . 0.0 109.956 -172.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.091 ' N ' ' HG2' ' A' ' 127' ' ' LYS . 60.5 t -151.43 160.97 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.864 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 31.2 m -146.71 9.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.82 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 132' ' ' MET . 40.8 ttmt 173.1 -89.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.345 0.403 . . . . 0.0 111.86 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 16' ' ' ILE . . . -51.93 59.87 0.0 OUTLIER Glycine 0 N--CA 1.473 1.127 0 O-C-N 124.572 1.17 . . . . 0.0 114.75 -165.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.707 ' N ' ' O ' ' A' ' 130' ' ' LYS . 4.3 mmt -74.48 -49.73 21.06 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' LYS . 23.3 m-20 -39.72 -54.55 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.181 0.926 . . . . 0.0 109.986 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.621 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 75.0 t -52.24 -64.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.583 1.177 . . . . 0.0 109.249 175.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 1.031 ' HB1' HD11 ' A' ' 55' ' ' ILE . . . -43.78 -53.81 5.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.516 1.135 . . . . 0.0 110.258 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.868 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -58.71 -65.36 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.758 1.286 . . . . 0.0 108.636 179.155 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.998 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 2.9 tmtm? -36.86 -48.96 0.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.6 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.233 ' O ' HG22 ' A' ' 141' ' ' VAL . 12.8 mt -58.21 -56.97 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.612 1.195 . . . . 0.0 108.744 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.551 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.7 p -61.79 3.14 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.868 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.1 mp0 -94.78 -51.94 4.49 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.233 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -45.64 126.24 6.42 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.462 1.101 . . . . 0.0 110.283 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.7 Cg_exo -49.92 -178.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.679 2.919 . . . . 0.0 114.673 -176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.181 HG22 ' CA ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -161.07 -139.69 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.69 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.443 ' HB3' ' O ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -178.02 140.66 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.5 -2.136 . . . . 0.0 112.336 168.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 1.072 ' OD1' ' HG3' ' A' ' 150' ' ' GLN . 56.1 t0 -68.74 110.92 4.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 112.383 -2.19 . . . . 0.0 107.791 168.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.879 HG21 ' CG2' ' A' ' 152' ' ' VAL . 2.0 t -78.98 -142.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.737 -169.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.653 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -63.57 -108.79 0.01 OUTLIER Glycine 0 N--CA 1.471 1.02 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 171.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 1.047 ' O ' ' OE1' ' A' ' 150' ' ' GLN . 97.1 Cg_endo -68.5 -50.17 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.593 2.862 . . . . 0.0 109.649 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.555 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 78.0 m-85 -68.68 84.45 0.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.612 1.195 . . . . 0.0 109.688 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 1.072 ' HG3' ' OD1' ' A' ' 145' ' ' ASP . 3.7 mp0 -70.97 66.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.756 175.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.56 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 50.7 p30 170.51 89.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.61 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.879 ' CG2' HG21 ' A' ' 146' ' ' VAL . 75.0 t -156.24 115.87 2.15 Favored Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 124.392 1.057 . . . . 0.0 109.646 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.181 ' CA ' HG22 ' A' ' 143' ' ' THR . 83.6 Cg_exo -43.97 114.7 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.643 2.895 . . . . 0.0 111.44 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . 1.111 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 88.0 p -41.69 -36.88 1.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.438 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 1.157 ' HB2' ' CD ' ' A' ' 156' ' ' PRO . 30.3 mtpp -175.55 -71.31 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 124.134 0.896 . . . . 0.0 110.115 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.157 ' CD ' ' HB2' ' A' ' 155' ' ' LYS . 98.8 Cg_exo -51.25 72.28 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.702 2.934 . . . . 0.0 113.6 -171.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 1.128 HG23 ' O ' ' A' ' 156' ' ' PRO . 43.3 t -172.07 126.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.9 169.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.98 ' HA ' HG22 ' A' ' 45' ' ' THR . 76.7 t -168.87 118.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.014 HG12 HG22 ' A' ' 11' ' ' THR . 25.8 mt -68.1 132.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.766 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.841 HD12 HG22 ' A' ' 10' ' ' THR . 86.2 mt -81.2 -49.18 11.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.158 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -167.6 169.98 11.48 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.553 1.158 . . . . 0.0 111.992 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.8 ' O ' ' HG3' ' A' ' 163' ' ' LYS . . . -152.07 137.18 17.36 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.872 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 37.9 mtmm -170.3 136.23 1.35 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.084 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.575 ' CG1' HG11 ' A' ' 36' ' ' VAL . 33.1 m -69.49 175.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.783 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 165' ' ' LEU . 5.4 tt -143.63 119.94 6.51 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.707 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.591 ' N ' HD23 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 123.684 2.923 . . . . 0.0 112.135 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.193 ' C ' ' HD1' ' A' ' 6' ' ' HIS . 61.4 Cg_endo . . . . . 0 C--O 1.236 0.376 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.193 ' HD1' ' C ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -150.55 101.96 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.342 -175.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.942 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 7.7 p -59.85 107.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 171.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.998 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 5.2 tt -118.73 113.48 21.23 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.764 1.29 . . . . 0.0 109.79 -170.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.86 ' HG ' ' HA ' ' A' ' 162' ' ' ALA . 5.1 mp -127.67 -166.31 1.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.684 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 86.4 m -162.05 102.67 1.13 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.117 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 1.093 HG22 HG12 ' A' ' 159' ' ' ILE . 28.4 p -74.37 166.08 24.09 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.834 1.334 . . . . 0.0 111.693 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.552 ' OG ' HG13 ' A' ' 157' ' ' VAL . 80.1 p -40.93 -46.07 2.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.512 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -51.97 -59.15 4.67 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.451 1.094 . . . . 0.0 110.274 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.22 45.99 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 112.931 -1.94 . . . . 0.0 113.149 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 1.193 ' O ' HG21 ' A' ' 134' ' ' VAL . 54.5 t30 -52.31 162.28 0.54 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.69 -1.255 . . . . 0.0 111.448 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.865 HG13 ' O ' ' A' ' 15' ' ' ASN . 9.3 mt -170.16 153.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.116 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.998 ' OE1' ' CD1' ' A' ' 8' ' ' LEU . 33.5 mt-10 -163.22 110.15 1.18 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.833 -173.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.942 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 2.2 mm? -82.42 150.42 27.1 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.294 0.996 . . . . 0.0 109.804 164.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.496 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -111.43 123.63 50.6 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.298 0.999 . . . . 0.0 109.578 174.274 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.256 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 75.8 mt -104.59 -171.33 1.9 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.751 1.282 . . . . 0.0 112.74 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 1.256 ' OD1' ' O ' ' A' ' 20' ' ' LEU . 47.8 m-20 -164.08 68.04 0.17 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.204 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.435 ' HD2' ' N ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -47.33 -27.28 1.53 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.821 1.326 . . . . 0.0 113.036 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 1.435 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 36.0 tt0 -41.93 -63.99 0.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.941 0.776 . . . . 0.0 110.09 -174.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.963 ' HD3' ' HA ' ' A' ' 79' ' ' ASN . 25.3 ttmm -78.9 18.41 0.62 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.815 1.322 . . . . 0.0 112.742 -178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.067 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -161.98 69.98 2.29 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 1.01 ' O ' HG22 ' A' ' 29' ' ' VAL . 69.0 Cg_endo -71.39 -61.41 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.731 2.954 . . . . 0.0 110.124 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 28' ' ' SER . 16.0 m -48.12 -63.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 124.609 1.193 . . . . 0.0 110.152 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.743 ' H ' HG23 ' A' ' 27' ' ' VAL . 42.9 t -48.43 -59.54 3.39 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.508 1.13 . . . . 0.0 110.346 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.599 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 35.2 m -45.3 -49.13 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 124.579 1.175 . . . . 0.0 110.898 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 1.182 ' O ' HG12 ' A' ' 33' ' ' VAL . 61.7 tp60 -50.11 -56.81 9.4 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.31 1.006 . . . . 0.0 109.745 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.89 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 24.6 t-20 -50.2 -62.19 1.72 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.567 1.167 . . . . 0.0 110.587 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 1.599 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 29.1 p90 -56.08 -43.92 78.49 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.266 0.979 . . . . 0.0 110.64 -172.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.182 HG12 ' O ' ' A' ' 30' ' ' GLN . 11.5 p -51.05 -40.06 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 124.046 0.841 . . . . 0.0 110.094 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.89 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 45.4 m-20 -45.39 -61.07 1.82 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.045 0.84 . . . . 0.0 109.252 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.554 ' O ' ' OG ' ' A' ' 38' ' ' SER . 68.9 m-85 -54.52 -55.85 24.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.908 1.38 . . . . 0.0 109.491 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.726 HG22 ' CE1' ' A' ' 41' ' ' TYR . 77.1 t -46.06 -66.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 124.436 1.085 . . . . 0.0 109.537 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -43.89 -49.82 8.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.84 1.338 . . . . 0.0 110.695 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.554 ' OG ' ' O ' ' A' ' 35' ' ' TYR . 29.7 p -58.64 -107.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.53 1.144 . . . . 0.0 110.161 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.64 59.64 0.28 Allowed Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' THR . 17.7 t80 -89.27 -63.58 1.27 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.958 1.034 . . . . 0.0 109.726 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.726 ' CE1' HG22 ' A' ' 36' ' ' VAL . 35.1 m-85 -75.53 -14.24 60.4 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.524 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 1.126 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 52.7 p-10 -39.08 -41.62 0.82 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.642 0.589 . . . . 0.0 112.517 -170.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 1.126 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 19.5 m-20 -154.78 46.8 0.55 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.161 0.913 . . . . 0.0 110.296 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 45' ' ' THR . 74.3 p -78.92 -139.64 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 166.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.954 ' HA ' HG13 ' A' ' 159' ' ' ILE . 76.5 p -163.46 -153.95 0.26 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.934 0.873 . . . . 0.0 112.595 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.881 ' CE1' HD11 ' A' ' 159' ' ' ILE . 17.0 m-30 -129.65 84.39 2.21 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.845 -1.979 . . . . 0.0 106.279 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.624 ' NE2' ' O ' ' A' ' 56' ' ' GLN . 8.2 p80 -56.42 -65.57 0.58 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.3 -169.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.316 ' HD3' ' N ' ' A' ' 49' ' ' VAL . 1.2 tmt_? -164.67 160.71 20.24 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -162.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.56 ' CG1' ' HG3' ' A' ' 54' ' ' MET . 45.8 t -175.73 -77.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.045 -2.343 . . . . 0.0 106.914 164.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.919 HG22 HG12 ' A' ' 49' ' ' VAL . 11.2 tt 171.3 138.8 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.688 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.829 ' HD2' HG13 ' A' ' 50' ' ' ILE . 83.4 Cg_exo -35.04 164.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.333 -0.289 0 C-N-CA 123.507 2.805 . . . . 0.0 113.846 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.98 69.46 0.0 OUTLIER Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.876 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.286 ' CE1' ' ND2' ' A' ' 110' ' ' ASN . 9.8 t80 -160.99 -53.46 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.787 0.934 . . . . 0.0 109.843 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.56 ' HG3' ' CG1' ' A' ' 49' ' ' VAL . 24.1 ptt? -164.36 154.06 14.03 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.457 1.098 . . . . 0.0 111.912 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.772 HG13 ' HB ' ' A' ' 105' ' ' ILE . 48.4 pt -160.21 124.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.73 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 1.105 ' HG2' ' CA ' ' A' ' 104' ' ' PHE . 33.2 mt-30 -120.36 128.72 53.5 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.385 1.053 . . . . 0.0 110.334 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.0 -162.6 32.11 Favored Glycine 0 N--CA 1.477 1.404 0 O-C-N 124.631 1.207 . . . . 0.0 112.803 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 1.007 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 44.45 96.65 0.01 OUTLIER Glycine 0 N--CA 1.47 0.915 0 CA-C-N 113.725 -1.238 . . . . 0.0 111.38 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.749 ' HA2' ' OE1' ' A' ' 102' ' ' GLN . . . 174.46 -121.79 0.86 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.705 0.885 . . . . 0.0 110.925 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -46.08 146.04 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.047 -1.077 . . . . 0.0 111.636 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.6 m -58.12 -43.06 87.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.908 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 1.051 ' HG3' ' N ' ' A' ' 63' ' ' GLN . 12.6 pt-20 -172.48 -100.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.248 0.968 . . . . 0.0 109.166 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 1.172 ' O ' ' CG ' ' A' ' 64' ' ' MET . 9.7 tp-100 -46.3 -57.55 4.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.673 1.233 . . . . 0.0 109.623 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 1.172 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 20.0 mmt 165.4 27.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.614 1.196 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -78.64 84.94 4.71 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.14 133.43 1.22 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 31.2 mmmt -64.13 -119.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.283 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' PRO . 24.8 ttmm -171.14 83.4 0.51 Allowed Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.73 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 1.025 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 89.2 Cg_exo -45.55 -155.59 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.631 2.887 . . . . 0.0 113.279 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.167 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.2 m120 -166.86 167.63 7.67 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.313 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.943 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 39.4 Cg_endo -49.07 87.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.845 2.363 . . . . 0.0 108.55 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.167 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 89.7 Cg_exo -48.29 -151.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.79 2.993 . . . . 0.0 113.789 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -155.27 149.1 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.369 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 94.1 mttt -32.39 133.6 0.11 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.394 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.61 167.63 5.54 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.832 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.951 ' OE2' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -168.16 155.35 7.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.032 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.814 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 177.59 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.191 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.844 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 42.0 p-10 -67.02 -48.28 68.83 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.983 0.802 . . . . 0.0 109.809 -176.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.963 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 19.0 p-10 40.21 -73.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.078 0.861 . . . . 0.0 111.541 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . 87.76 88.43 1.11 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 80' ' ' GLY . 85.9 mt -161.46 -158.3 0.56 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.113 -1.043 . . . . 0.0 109.893 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.752 ' N ' ' HD2' ' A' ' 82' ' ' ARG . 1.3 mpt_? -59.1 -165.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.253 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.781 ' OD1' ' HB2' ' A' ' 111' ' ' ALA . 1.7 t-20 168.3 100.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.151 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' GLY . 22.8 m -170.31 134.57 1.19 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.63 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 1.411 ' HB2' ' C ' ' A' ' 107' ' ' VAL . 4.0 ppt_? -38.51 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.672 1.225 . . . . 0.0 110.299 176.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 160.59 -22.9 0.25 Allowed Glycine 0 CA--C 1.534 1.226 0 CA-C-N 111.395 -2.639 . . . . 0.0 110.478 -170.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.079 ' HA ' ' CA ' ' A' ' 127' ' ' LYS . 40.5 p -98.94 148.74 23.66 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.63 0.729 . . . . 0.0 111.793 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.104 ' CD1' ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -96.54 159.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.342 168.262 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.083 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . . . -142.89 176.96 8.67 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.08 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.899 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.3 tpt -101.95 129.92 48.33 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.766 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.88 -144.51 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.857 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.222 ' HG2' ' N ' ' A' ' 93' ' ' THR . 37.8 ttm180 -177.65 -165.52 0.11 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.84 0.828 . . . . 0.0 111.852 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.222 ' N ' ' HG2' ' A' ' 92' ' ' ARG . 25.3 p 176.07 116.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 108.239 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.806 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -17.48 120.28 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.514 1.134 . . . . 0.0 112.906 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.817 ' OD2' ' O ' ' A' ' 97' ' ' ASP . 39.0 t70 142.18 139.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HB3' ' H ' ' A' ' 97' ' ' ASP . 53.0 tptt -42.89 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.431 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.817 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 38.2 m-20 -67.3 117.7 9.67 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.688 1.243 . . . . 0.0 108.5 168.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 24.8 t -151.48 170.65 19.1 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.57 1.169 . . . . 0.0 111.973 -173.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 98' ' ' SER . . . 84.76 136.24 0.05 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.729 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 100' ' ' THR . 35.5 m -155.74 2.3 0.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.453 1.095 . . . . 0.0 113.205 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.409 ' C ' ' HE1' ' A' ' 90' ' ' MET . 34.3 p -171.73 -76.34 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.562 0.539 . . . . 0.0 110.852 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 1.007 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 3.5 mp0 -38.25 154.57 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.006 0.816 . . . . 0.0 111.9 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.992 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -160.86 167.03 27.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.545 177.038 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 1.105 ' CA ' ' HG2' ' A' ' 56' ' ' GLN . 72.4 m-85 -84.23 151.24 24.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.638 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.845 HD11 HD21 ' A' ' 18' ' ' LEU . 22.9 mt -139.58 94.24 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.617 159.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.582 ' O ' ' HE1' ' A' ' 132' ' ' MET . 48.9 m-20 -69.22 -173.29 0.51 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.309 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.411 ' C ' ' HB2' ' A' ' 85' ' ' ARG . 35.9 m -158.27 -46.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.571 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.203 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -101.49 150.46 23.04 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 124.518 1.136 . . . . 0.0 110.915 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' N ' ' CG ' ' A' ' 85' ' ' ARG . 3.1 m-20 -37.59 138.18 0.37 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.174 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 1.286 ' ND2' ' CE1' ' A' ' 53' ' ' PHE . 33.8 m120 -157.45 170.46 22.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.765 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB2' ' OD1' ' A' ' 83' ' ' ASN . . . 153.38 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.361 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -39.67 -55.51 1.87 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.152 0.907 . . . . 0.0 110.334 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.899 HD22 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -63.49 -8.86 10.43 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.837 1.336 . . . . 0.0 112.662 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.723 ' N ' HD12 ' A' ' 113' ' ' LEU . 57.6 p-10 -43.74 127.34 5.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.667 0.604 . . . . 0.0 111.657 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.765 ' CD2' ' HD1' ' A' ' 120' ' ' PHE . 0.1 OUTLIER -34.27 126.92 0.45 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.309 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.549 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . . . . . . 0 N--CA 1.474 1.168 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.485 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.765 ' HD1' ' CD2' ' A' ' 115' ' ' HIS . 25.1 m-85 . . . . . 0 N--CA 1.476 0.833 0 CA-C-O 121.219 0.533 . . . . 0.0 112.065 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.33 -134.18 1.73 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.042 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.899 ' CD2' HD22 ' A' ' 113' ' ' LEU . 58.9 m-85 -79.55 118.17 21.15 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.443 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.038 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -57.36 -162.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.784 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.083 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 75.5 t 179.95 146.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.582 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.791 ' CE2' HD22 ' A' ' 20' ' ' LEU . 21.6 p90 -171.18 25.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 1.058 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -167.13 -139.55 2.69 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 122.645 1.136 . . . . 0.0 113.436 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.496 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 94.0 mttt 179.35 -135.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.822 -2.189 . . . . 0.0 109.727 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.771 HG22 ' CD1' ' A' ' 18' ' ' LEU . 91.7 t -160.29 152.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.5 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' ' 19' ' ' GLU . 33.1 m -137.11 -27.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.69 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -170.83 86.95 0.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . -166.92 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 124.763 1.289 . . . . 0.0 110.883 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.781 ' HE3' ' HA ' ' A' ' 107' ' ' VAL . 22.9 mmt -39.32 -38.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.216 0.597 . . . . 0.0 111.3 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -47.75 -59.21 3.46 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 1.193 HG21 ' O ' ' A' ' 15' ' ' ASN . 46.6 t -58.74 -63.01 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 124.75 1.281 . . . . 0.0 108.949 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 132' ' ' MET . . . -41.28 -51.03 3.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.955 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.96 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 37.1 m-20 -50.79 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.6 1.187 . . . . 0.0 109.04 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -43.34 -45.7 6.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.463 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.201 ' O ' HG12 ' A' ' 141' ' ' VAL . 42.4 mt -57.01 -61.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.422 1.076 . . . . 0.0 108.871 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.9 p -65.31 2.44 0.85 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.96 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.1 mp0 -93.01 -49.52 5.98 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 124.232 0.958 . . . . 0.0 109.124 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.201 HG12 ' O ' ' A' ' 138' ' ' ILE . 8.6 p -39.7 135.36 1.25 Allowed Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 124.272 0.982 . . . . 0.0 111.043 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' A' ' 141' ' ' VAL . 79.9 Cg_exo -42.54 168.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.332 -0.328 0 C-N-CA 123.573 2.848 . . . . 0.0 113.658 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.545 HG22 ' CA ' ' A' ' 153' ' ' PRO . 5.9 p -160.84 -149.92 0.19 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 123.415 1.579 . . . . 0.0 112.313 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER 178.6 161.38 0.66 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 110.28 -3.145 . . . . 0.0 111.441 172.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.622 ' O ' HG22 ' A' ' 146' ' ' VAL . 35.3 m-20 -50.33 -157.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.059 164.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -160.85 -143.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.11 -110.3 0.02 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 167.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.764 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 84.8 Cg_endo -70.69 -48.78 0.48 Allowed 'Trans proline' 0 C--N 1.333 -0.286 0 C-N-CA 123.662 2.908 . . . . 0.0 109.781 169.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.874 ' O ' HG23 ' A' ' 146' ' ' VAL . 93.7 m-85 -68.95 88.48 0.39 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.584 1.177 . . . . 0.0 110.722 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 16.0 pt20 -71.73 143.1 49.73 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.855 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 1.085 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 10.0 m120 84.33 90.12 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.548 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 146' ' ' VAL . 91.2 t -160.62 97.86 1.4 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.208 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.545 ' CA ' HG22 ' A' ' 143' ' ' THR . 88.6 Cg_exo -46.15 106.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 123.52 2.813 . . . . 0.0 110.891 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . 1.092 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 65.8 p -41.35 -56.3 2.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.655 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.478 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 65.4 mttm -79.62 95.62 0.21 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.582 1.176 . . . . 0.0 108.308 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.092 ' HD3' ' O ' ' A' ' 154' ' ' SER . 61.6 Cg_endo -77.01 132.3 12.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.771 2.981 . . . . 0.0 112.246 -171.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.552 HG13 ' OG ' ' A' ' 12' ' ' SER . 47.7 t -69.32 162.72 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.723 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.924 ' HA ' HG22 ' A' ' 45' ' ' THR . 86.5 t -147.28 120.12 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.108 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.093 HG12 HG22 ' A' ' 11' ' ' THR . 34.9 mt -68.84 134.61 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.258 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 10' ' ' THR . 87.5 mt -85.72 -49.76 7.71 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 110.182 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 9' ' ' LEU . 69.2 m -146.82 178.82 8.03 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.67 1.231 . . . . 0.0 111.974 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.86 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . . . -178.7 122.94 0.09 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.364 -175.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.602 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -171.09 152.9 3.58 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.254 173.196 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.02 141.67 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.732 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 166' ' ' PRO . 5.5 tt -57.82 126.07 75.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.16 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.698 ' N ' HD23 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.607 2.872 . . . . 0.0 112.179 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.283 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 83.4 Cg_endo . . . . . 0 CA--C 1.531 0.374 0 N-CA-C 110.096 -0.771 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.283 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -154.5 88.49 1.21 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.21 0.944 . . . . 0.0 110.066 -176.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 7' ' ' VAL . 25.5 t -67.78 81.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 167.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.061 ' HG ' ' HG2' ' A' ' 17' ' ' GLU . 7.5 tt -80.38 108.92 14.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.356 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.358 HD23 ' O ' ' A' ' 161' ' ' SER . 7.3 mt -109.51 174.44 5.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 112.737 -2.029 . . . . 0.0 112.532 -173.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.895 HG22 HD12 ' A' ' 160' ' ' LEU . 94.9 m -159.91 95.11 1.16 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.078 -2.328 . . . . 0.0 108.447 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 1.022 HG22 HG12 ' A' ' 159' ' ' ILE . 19.8 p -84.53 161.2 20.31 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.997 1.436 . . . . 0.0 111.217 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 81.7 p -39.09 -43.59 1.05 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.861 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.774 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -52.84 -63.84 1.01 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.42 1.075 . . . . 0.0 110.105 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.49 171.18 43.87 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.089 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.703 ' OD1' ' O ' ' A' ' 9' ' ' LEU . 43.0 t30 -68.32 133.31 48.55 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.309 -1.445 . . . . 0.0 110.719 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 16.5 pt -143.73 -179.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.922 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 1.061 ' HG2' ' HG ' ' A' ' 8' ' ' LEU . 35.9 mt-10 -161.62 110.89 1.55 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.799 -169.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.082 HD21 HD11 ' A' ' 105' ' ' ILE . 3.1 mm? -77.36 150.65 35.11 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 124.541 1.15 . . . . 0.0 110.106 165.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.795 ' HG3' ' HB3' ' A' ' 127' ' ' LYS . 12.6 pt-20 -122.84 121.49 36.37 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.909 174.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.018 HD13 ' HE2' ' A' ' 125' ' ' PHE . 61.3 mt -104.19 173.55 6.25 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.803 1.315 . . . . 0.0 112.66 -169.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 125' ' ' PHE . 73.2 m-20 -128.83 104.5 7.65 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.569 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -76.26 -39.54 54.11 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.831 1.332 . . . . 0.0 112.055 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.889 ' HG3' ' HD2' ' A' ' 24' ' ' LYS . 8.1 tp-100 -45.08 -66.85 0.34 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.211 0.945 . . . . 0.0 110.275 -171.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.889 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -83.55 19.48 1.59 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.817 1.323 . . . . 0.0 113.804 -175.181 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.012 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -160.59 64.97 2.21 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 123.904 0.752 . . . . 0.0 111.134 173.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.8 Cg_exo -59.91 -58.72 0.51 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.517 2.811 . . . . 0.0 111.071 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.401 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 80.7 t -53.9 -69.86 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.157 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.436 ' OG ' ' HB1' ' A' ' 25' ' ' ALA . 75.2 p -48.05 -53.92 14.77 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.704 1.252 . . . . 0.0 111.023 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 25' ' ' ALA . 3.5 t -60.45 -41.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.318 1.012 . . . . 0.0 110.625 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 1.31 ' O ' HG12 ' A' ' 33' ' ' VAL . 7.3 tm0? -49.87 -62.43 1.57 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.111 0.882 . . . . 0.0 108.923 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 1.039 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.5 m120 -44.25 -52.48 7.45 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.585 1.178 . . . . 0.0 110.274 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.879 ' CD2' ' HA ' ' A' ' 29' ' ' VAL . 20.8 m-30 -41.51 -67.3 0.26 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.456 1.098 . . . . 0.0 109.806 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.31 HG12 ' O ' ' A' ' 30' ' ' GLN . 7.2 p -40.5 -40.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 124.782 1.301 . . . . 0.0 111.118 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 1.039 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 8.0 m-20 -44.96 -61.94 1.42 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.028 0.83 . . . . 0.0 109.445 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -55.53 -53.36 57.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.813 1.321 . . . . 0.0 109.317 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.629 HG11 HG13 ' A' ' 164' ' ' VAL . 76.3 t -45.15 -65.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.556 1.16 . . . . 0.0 109.464 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' SER . 22.1 m-20 -48.32 -48.63 36.01 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.803 1.314 . . . . 0.0 110.227 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 37' ' ' ASN . 54.5 m -52.98 -113.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.463 1.102 . . . . 0.0 110.913 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.1 78.05 0.08 OUTLIER Glycine 0 N--CA 1.473 1.141 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 74.4 t80 -116.22 -63.86 1.39 Allowed 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.196 1.174 . . . . 0.0 109.358 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.985 ' O ' HG23 ' A' ' 44' ' ' THR . 51.6 m-85 -59.73 -41.77 91.63 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.715 1.259 . . . . 0.0 111.605 -172.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.584 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.0 p30 -39.32 117.18 0.68 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.19 0.931 . . . . 0.0 111.333 -173.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.7 t30 60.02 35.22 21.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.011 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.985 HG23 ' O ' ' A' ' 41' ' ' TYR . 69.9 p -79.2 -143.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.159 0.912 . . . . 0.0 108.848 165.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.944 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 55.3 p -163.21 -144.0 0.08 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.822 0.82 . . . . 0.0 112.725 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.944 ' CD1' ' O ' ' A' ' 45' ' ' THR . 8.2 m-30 -154.68 67.1 0.69 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.016 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.718 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 6.3 p-80 -59.06 -65.04 0.73 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.855 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.738 ' HG2' ' OE1' ' A' ' 56' ' ' GLN . 25.3 tpt180 -69.29 119.02 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.583 1.177 . . . . 0.0 110.656 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.542 HG13 HG22 ' A' ' 55' ' ' ILE . 84.6 t -154.93 147.55 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 124.805 1.316 . . . . 0.0 110.834 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.594 ' CG2' ' CG ' ' A' ' 54' ' ' MET . 11.0 tt -157.95 125.58 2.74 Favored Pre-proline 0 N--CA 1.476 0.857 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.955 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 76.0 Cg_exo -34.22 161.78 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.67 2.913 . . . . 0.0 113.958 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -8.85 71.07 0.0 OUTLIER Glycine 0 N--CA 1.475 1.252 0 CA-C-N 114.049 -1.432 . . . . 0.0 113.548 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.112 ' HD1' ' HG2' ' A' ' 54' ' ' MET . 56.5 t80 -160.61 -58.97 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.856 0.974 . . . . 0.0 109.552 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.112 ' HG2' ' HD1' ' A' ' 53' ' ' PHE . 26.3 ptt? -169.22 159.64 9.08 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.299 0.999 . . . . 0.0 112.371 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 105' ' ' ILE . 41.7 pt -154.7 156.58 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 113.171 -1.831 . . . . 0.0 109.203 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.991 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 38.4 mt-30 -150.57 164.83 35.05 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.876 0.735 . . . . 0.0 112.142 -166.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.67 ' O ' ' CD1' ' A' ' 103' ' ' PHE . . . -162.11 155.98 27.43 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 124.06 0.85 . . . . 0.0 112.959 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.513 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 136.63 -57.29 0.67 Allowed Glycine 0 N--CA 1.475 1.271 0 CA-C-N 113.426 -1.387 . . . . 0.0 110.331 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -51.62 -125.16 0.01 OUTLIER Glycine 0 N--CA 1.471 1.033 0 O-C-N 124.593 0.819 . . . . 0.0 113.21 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -39.5 148.01 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.441 -172.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 62' ' ' GLU . 94.0 m -59.94 -92.47 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.463 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.678 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.3 pt-20 -138.85 117.04 11.81 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 124.895 1.372 . . . . 0.0 108.882 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 1.291 ' O ' ' CG ' ' A' ' 64' ' ' MET . 67.2 tt0 76.91 -56.75 0.54 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.629 1.206 . . . . 0.0 108.8 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 1.291 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 155.82 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.046 1.403 . . . . 0.0 109.163 175.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.776 ' NE2' ' O ' ' A' ' 64' ' ' MET . 88.3 mm-40 -142.87 82.21 1.76 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 110.908 -2.86 . . . . 0.0 104.965 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.825 ' C ' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -27.54 174.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -165.15 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HB3' ' H ' ' A' ' 68' ' ' LYS . 7.0 mtpm? -68.62 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 111.0 -2.818 . . . . 0.0 113.617 -169.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 67' ' ' LYS . 28.0 tptp 179.11 73.75 0.14 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 112.325 -2.216 . . . . 0.0 105.758 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.606 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 62.5 Cg_endo -83.37 -165.02 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 123.351 2.701 . . . . 0.0 113.746 -162.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.998 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 8.6 m120 -163.34 169.89 8.06 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 113.126 -1.852 . . . . 0.0 110.029 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 35.1 Cg_endo -50.74 95.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.12 2.547 . . . . 0.0 109.818 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.997 ' HG3' HG22 ' A' ' 100' ' ' THR . 82.4 Cg_exo -51.86 -146.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.908 3.072 . . . . 0.0 113.46 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.558 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.05 152.83 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 124.296 0.997 . . . . 0.0 110.981 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 61.3 mttp -37.66 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.181 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.748 ' O ' ' HB3' ' A' ' 76' ' ' GLU . 56.0 p30 -64.02 -168.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.19 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.874 ' HB2' HD21 ' A' ' 79' ' ' ASN . 0.0 OUTLIER 160.43 141.17 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.383 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.15 ' HB1' ' CE1' ' A' ' 115' ' ' HIS . . . -157.6 -51.24 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.242 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -68.28 -49.43 60.55 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.473 1.108 . . . . 0.0 110.372 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.874 HD21 ' HB2' ' A' ' 76' ' ' GLU . 45.1 p30 -43.02 -43.38 4.23 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.22 0.95 . . . . 0.0 110.103 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.672 ' N ' ' OD1' ' A' ' 79' ' ' ASN . . . -42.85 -33.32 1.61 Allowed Glycine 0 N--CA 1.471 1.029 0 O-C-N 124.411 1.069 . . . . 0.0 112.131 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 66.1 mt 98.39 -131.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 1.018 ' O ' ' NE ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -169.0 110.12 0.49 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.977 0.798 . . . . 0.0 109.673 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.734 ' HB2' HG21 ' A' ' 87' ' ' THR . 2.0 m-20 -132.74 -134.16 0.18 Allowed 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.963 1.414 . . . . 0.0 109.865 -176.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' OD1' ' A' ' 109' ' ' ASP . 10.2 m -169.6 163.77 10.21 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.822 0.82 . . . . 0.0 111.734 -167.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.937 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 58.2 ttt180 -18.67 103.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.199 165.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.946 ' O ' ' CG ' ' A' ' 127' ' ' LYS . . . 140.35 -23.19 2.7 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.256 -2.702 . . . . 0.0 110.581 -169.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.034 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.7 p -98.28 146.98 25.11 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.023 0.916 . . . . 0.0 112.94 -175.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.67 161.94 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.972 164.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.027 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -159.78 156.66 27.95 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.558 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 1.217 ' CE ' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -74.4 123.74 25.23 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.752 -176.377 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.588 ' N ' ' SD ' ' A' ' 90' ' ' MET . . . -57.75 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.089 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.824 ' NH1' ' O ' ' A' ' 93' ' ' THR . 68.0 ttp85 179.71 -104.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.743 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.824 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 97.3 m 100.71 -98.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.638 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.475 ' N ' HG22 ' A' ' 93' ' ' THR . . . -61.95 -132.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.58 1.175 . . . . 0.0 110.93 -174.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 35.2 m-20 -58.24 172.12 0.49 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -56.16 -111.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.723 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.642 ' OD1' ' CG ' ' A' ' 75' ' ' ASN . 35.2 m-20 -52.4 103.57 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.776 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.836 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 68.4 m -165.76 -34.75 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.467 1.104 . . . . 0.0 111.619 -175.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 1.217 ' HB1' ' CE ' ' A' ' 90' ' ' MET . . . -33.58 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.846 0.716 . . . . 0.0 110.701 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.997 HG22 ' HG3' ' A' ' 72' ' ' PRO . 48.8 p -78.87 -60.4 2.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.182 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.7 p -171.57 97.57 0.18 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.251 0.97 . . . . 0.0 109.274 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.914 ' OE1' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER 171.23 134.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.727 1.267 . . . . 0.0 109.109 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.927 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -140.24 -171.29 3.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.458 -177.041 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.991 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 43.6 p90 -155.93 129.06 8.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.47 -172.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.082 HD11 HD21 ' A' ' 18' ' ' LEU . 57.8 mt -93.27 111.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.515 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 104' ' ' PHE . 50.9 m-20 -65.38 155.26 35.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.398 1.061 . . . . 0.0 110.766 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 54' ' ' MET . 22.4 m -146.92 38.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.11 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 178.95 122.93 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.142 0.901 . . . . 0.0 110.067 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.937 ' OD1' ' HB3' ' A' ' 85' ' ' ARG . 34.0 m-20 -37.17 137.11 0.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.14 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.458 ' ND2' ' C ' ' A' ' 109' ' ' ASP . 4.3 m-80 -150.8 108.79 3.71 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.65 1.218 . . . . 0.0 110.097 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . -90.92 -49.96 6.14 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.893 170.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 1.251 ' O ' HD12 ' A' ' 113' ' ' LEU . 30.6 p90 -49.35 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.469 1.106 . . . . 0.0 109.235 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.251 HD12 ' O ' ' A' ' 112' ' ' PHE . 3.1 mp 179.28 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.641 -2.072 . . . . 0.0 108.519 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.67 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 6.6 m-20 -38.92 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.856 0.723 . . . . 0.0 110.657 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 1.15 ' CE1' ' HB1' ' A' ' 77' ' ' ALA . 16.8 m80 -46.92 122.27 4.23 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.901 1.375 . . . . 0.0 110.182 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.455 0 O-C-N 124.524 1.14 . . . . 0.0 112.182 -177.95 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.11 -131.34 1.31 Allowed Glycine 0 N--CA 1.476 1.318 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.864 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 89.9 m-85 -79.45 133.86 36.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.422 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.076 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -69.55 -161.65 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.519 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.076 HG23 ' O ' ' A' ' 123' ' ' ALA . 54.9 t 178.8 144.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.753 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 1.018 ' HE2' HD13 ' A' ' 20' ' ' LEU . 30.3 p90 -168.74 26.16 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.749 ' HA3' HD23 ' A' ' 20' ' ' LEU . . . -167.17 -143.98 3.96 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 122.87 1.261 . . . . 0.0 113.906 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 1.034 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 40.4 ttmt 179.76 -139.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 111.51 -2.345 . . . . 0.0 109.656 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.988 ' H ' ' CG ' ' A' ' 127' ' ' LYS . 95.8 t -159.78 117.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.952 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.846 ' O ' ' HG3' ' A' ' 130' ' ' LYS . 35.2 m -73.75 -40.99 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.739 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.846 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 8.4 mtpm? -166.19 -156.2 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.261 0.976 . . . . 0.0 111.379 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 134' ' ' VAL . . . 49.75 18.36 1.77 Allowed Glycine 0 N--CA 1.473 1.154 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.539 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 10.4 tpt -55.03 -48.04 73.95 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.72 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 2.2 m-20 -43.29 -56.07 3.7 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.437 1.085 . . . . 0.0 110.018 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.627 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.1 t -39.7 -59.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.49 1.118 . . . . 0.0 109.671 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -45.5 -52.22 10.63 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.655 1.222 . . . . 0.0 109.529 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.929 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 1.8 m-20 -50.51 -65.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.553 1.158 . . . . 0.0 109.042 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 14.5 mmmm -35.46 -55.02 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.498 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.157 ' O ' HG22 ' A' ' 141' ' ' VAL . 13.8 mt -56.95 -56.81 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.868 1.355 . . . . 0.0 109.169 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -64.23 3.25 0.46 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.929 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.9 mp0 -97.24 -51.47 4.18 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.213 0.946 . . . . 0.0 108.717 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 1.157 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -45.78 125.83 6.6 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.436 1.085 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -44.6 177.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 123.637 2.891 . . . . 0.0 114.022 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.426 HG22 ' CA ' ' A' ' 153' ' ' PRO . 1.5 p -161.23 -140.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.127 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER 179.65 164.49 1.06 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 110.485 -3.052 . . . . 0.0 111.017 169.591 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.816 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 34.7 m-20 -50.42 -143.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.652 168.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -161.68 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 168.605 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.55 -94.65 0.05 OUTLIER Glycine 0 N--CA 1.47 0.964 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 168.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.704 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 97.5 Cg_endo -76.83 -65.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.917 3.078 . . . . 0.0 109.603 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.971 ' O ' HG23 ' A' ' 146' ' ' VAL . 39.3 m-85 -69.83 124.73 24.75 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.564 1.165 . . . . 0.0 111.695 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.816 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 49.5 mm-40 -75.75 -171.84 1.71 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.744 169.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 152' ' ' VAL . 20.6 m-20 44.89 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.615 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.824 ' HB ' HG22 ' A' ' 146' ' ' VAL . 83.7 t -159.16 128.74 3.26 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 113.164 -1.835 . . . . 0.0 107.726 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 1.426 ' CA ' HG22 ' A' ' 143' ' ' THR . 96.5 Cg_exo -39.25 -145.71 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.308 2.672 . . . . 0.0 112.508 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 45.7 t -163.86 -8.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.373 1.046 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 1.107 ' HB3' ' HD3' ' A' ' 156' ' ' PRO . 87.8 tttt 178.91 -67.36 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.534 0.521 . . . . 0.0 111.667 175.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.164 ' O ' HG23 ' A' ' 157' ' ' VAL . 56.7 Cg_endo -75.04 76.84 3.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 111.672 -168.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 1.164 HG23 ' O ' ' A' ' 156' ' ' PRO . 42.8 t -172.52 127.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.679 168.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 45' ' ' THR . 81.2 t -167.29 118.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.068 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.022 HG12 HG22 ' A' ' 11' ' ' THR . 34.2 mt -68.29 133.89 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.881 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.895 HD12 HG22 ' A' ' 10' ' ' THR . 84.4 mt -87.23 -48.32 8.12 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.375 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . 1.358 ' O ' HD23 ' A' ' 9' ' ' LEU . 32.4 t -167.89 162.68 13.68 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.395 1.059 . . . . 0.0 113.128 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 1.042 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -152.75 118.08 5.24 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.835 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.7 ptpt -151.13 135.2 16.68 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.629 HG13 HG11 ' A' ' 36' ' ' VAL . 33.8 m -68.71 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.992 HD12 ' HD2' ' A' ' 166' ' ' PRO . 48.7 tp -62.12 121.5 66.34 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.795 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.992 ' HD2' HD12 ' A' ' 165' ' ' LEU . 86.1 Cg_exo . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.573 2.848 . . . . 0.0 112.074 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 55.36 -96.08 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 124.8 1.312 . . . . 0.0 109.59 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.547 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . 173.13 99.07 0.12 Allowed Glycine 0 N--CA 1.473 1.142 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.547 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 67.8 m-20 -170.13 103.83 0.44 Allowed Pre-proline 0 N--CA 1.474 0.758 0 O-C-N 124.635 0.844 . . . . 0.0 109.335 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.986 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 88.8 Cg_exo -48.61 136.75 26.83 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.837 3.025 . . . . 0.0 113.483 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.298 ' CE1' ' HG2' ' A' ' 19' ' ' GLU . 2.2 m-70 -147.8 114.23 5.95 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.093 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 164' ' ' VAL . 14.8 t -71.46 96.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.543 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.499 ' CD1' ' HG2' ' A' ' 17' ' ' GLU . 15.8 tp -79.09 131.14 36.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.772 1.295 . . . . 0.0 109.52 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.288 HD23 ' O ' ' A' ' 161' ' ' SER . 8.8 mt -141.43 131.41 24.56 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.507 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.935 HG22 HD12 ' A' ' 160' ' ' LEU . 99.5 m -116.39 94.95 4.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 111.633 -2.531 . . . . 0.0 108.206 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.958 HG22 HG12 ' A' ' 159' ' ' ILE . 22.4 p -81.12 165.25 21.76 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 125.116 1.51 . . . . 0.0 110.715 170.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -39.09 -42.34 0.91 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.62 -63.09 1.26 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.431 1.082 . . . . 0.0 110.427 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.37 172.24 44.66 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.285 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 39.3 t30 -76.97 108.21 9.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.428 -1.386 . . . . 0.0 110.006 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 134' ' ' VAL . 13.5 pt -103.35 -169.74 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 124.826 1.329 . . . . 0.0 110.959 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.499 ' HG2' ' CD1' ' A' ' 8' ' ' LEU . 37.7 mt-10 -161.87 102.45 1.16 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.817 -173.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.058 HD21 HD11 ' A' ' 105' ' ' ILE . 2.7 mm? -73.41 160.74 31.32 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.344 1.027 . . . . 0.0 110.651 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.298 ' HG2' ' CE1' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -138.37 127.55 24.29 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.167 173.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.979 HD13 ' HE2' ' A' ' 125' ' ' PHE . 80.3 mt -122.01 143.57 49.41 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.805 1.316 . . . . 0.0 111.975 -168.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 73.2 m-20 -55.48 -126.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.977 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.907 ' HA ' HG11 ' A' ' 29' ' ' VAL . 38.2 ttmt 145.64 -59.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.029 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -55.1 -57.12 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.096 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.854 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 20.3 tptm -69.09 -4.97 19.27 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.593 1.183 . . . . 0.0 113.465 -172.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.713 ' HB2' ' ND2' ' A' ' 79' ' ' ASN . . . -161.18 70.62 2.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.67 0.606 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 1.17 ' O ' HG22 ' A' ' 29' ' ' VAL . 63.6 Cg_exo -52.7 -54.17 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 111.504 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.13 -65.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 124.704 1.253 . . . . 0.0 110.21 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.4 p -47.2 -52.79 14.81 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.713 1.258 . . . . 0.0 110.886 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.608 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 32.7 m -47.44 -50.2 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.322 1.014 . . . . 0.0 110.653 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 1.039 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 58.2 tp60 -51.23 -52.48 44.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.336 1.023 . . . . 0.0 109.844 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.911 ' OD1' HG21 ' A' ' 73' ' ' ILE . 18.4 m120 -49.96 -66.05 0.46 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.579 1.175 . . . . 0.0 110.322 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 1.608 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 46.8 p90 -57.1 -46.18 82.78 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.448 1.092 . . . . 0.0 110.441 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.997 HG12 ' O ' ' A' ' 30' ' ' GLN . 12.0 p -49.33 -40.17 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.976 0.797 . . . . 0.0 110.406 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 1.039 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 2.1 m-20 -45.84 -61.51 1.7 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.097 0.873 . . . . 0.0 108.84 171.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.627 ' OH ' ' HG3' ' A' ' 71' ' ' PRO . 28.3 m-85 -58.35 -60.12 4.28 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.892 1.37 . . . . 0.0 109.302 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 32' ' ' PHE . 58.4 t -39.27 -52.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 124.589 1.18 . . . . 0.0 110.683 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 38' ' ' SER . 23.1 m120 -38.77 -33.55 0.11 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.765 1.291 . . . . 0.0 111.858 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.727 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.9 p 158.02 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.155 0.909 . . . . 0.0 112.672 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 69.01 79.37 0.28 Allowed Glycine 0 N--CA 1.471 0.984 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.737 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.92 ' O ' HG23 ' A' ' 44' ' ' THR . 15.3 t80 168.76 -75.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.711 0.889 . . . . 0.0 109.514 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' ' HD1' ' A' ' 40' ' ' PHE . 77.7 m-85 -66.69 -31.73 72.58 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.5 1.125 . . . . 0.0 112.411 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -38.72 -36.16 0.24 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.053 0.845 . . . . 0.0 112.977 -170.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.468 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 27.6 t-20 -156.5 47.31 0.45 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.064 0.853 . . . . 0.0 110.748 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.92 HG23 ' O ' ' A' ' 40' ' ' PHE . 52.7 p -83.61 -140.56 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.266 161.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 1.119 HG22 ' HA ' ' A' ' 158' ' ' VAL . 46.4 p -163.1 -141.05 0.06 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.988 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.856 ' CE1' HD11 ' A' ' 159' ' ' ILE . 15.6 m-30 -146.11 92.28 2.17 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.25 -1.795 . . . . 0.0 106.384 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 1.257 ' HB2' ' OE1' ' A' ' 56' ' ' GLN . 21.3 m80 -23.31 -67.61 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.351 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.995 ' HB2' ' HA ' ' A' ' 152' ' ' VAL . 1.8 tpm_? -172.32 -142.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.764 1.29 . . . . 0.0 111.217 169.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.991 ' H ' ' HG3' ' A' ' 48' ' ' ARG . 6.2 p -172.08 135.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.274 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.953 HG21 ' HD2' ' A' ' 53' ' ' PHE . 10.9 tt -62.49 129.74 92.84 Favored Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.483 159.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' PHE . 20.5 Cg_endo -45.2 153.04 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.014 2.476 . . . . 0.0 112.079 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 7.26 60.18 0.01 OUTLIER Glycine 0 N--CA 1.474 1.206 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.729 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.953 ' HD2' HG21 ' A' ' 50' ' ' ILE . 65.2 t80 -152.66 -54.63 0.12 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.817 0.951 . . . . 0.0 110.737 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.9 ' O ' HG23 ' A' ' 49' ' ' VAL . 43.5 ttp -171.94 113.68 0.33 Allowed 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.088 0.867 . . . . 0.0 112.124 -169.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.953 HG13 ' HB ' ' A' ' 105' ' ' ILE . 26.7 pt -90.86 155.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.755 164.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 1.319 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 78.9 mt-30 -68.61 -121.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.382 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 1.136 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -152.67 -119.96 0.81 Allowed Glycine 0 N--CA 1.47 0.932 0 O-C-N 118.624 -2.548 . . . . 0.0 110.549 3.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 61.28 106.86 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE1' ' A' ' 47' ' ' HIS . . . -179.44 -122.8 0.79 Allowed Glycine 0 N--CA 1.475 1.296 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.092 ' HB3' ' CA ' ' A' ' 64' ' ' MET . 42.4 m-85 -45.57 113.75 0.65 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.58 0.812 . . . . 0.0 110.264 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 61' ' ' THR . 9.4 t -59.52 116.75 4.2 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.484 1.115 . . . . 0.0 110.565 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.769 ' HB3' ' OE1' ' A' ' 63' ' ' GLN . 44.9 mt-10 65.02 -118.87 0.4 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.748 1.28 . . . . 0.0 110.786 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.769 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 8.0 mp0 -41.67 -58.15 2.06 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.679 1.237 . . . . 0.0 109.363 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 1.092 ' CA ' ' HB3' ' A' ' 60' ' ' PHE . 16.9 ptm 138.63 94.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.704 1.253 . . . . 0.0 107.762 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.695 ' N ' ' HB3' ' A' ' 60' ' ' PHE . 8.8 mm-40 -159.19 105.83 1.74 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.901 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.538 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 10.2 mm100 -29.28 133.39 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.807 -174.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.106 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -57.35 -97.73 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.684 168.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.639 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 4.3 ttmp? -167.85 66.92 0.79 Allowed Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.582 165.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 37.0 Cg_exo -69.18 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.58 2.853 . . . . 0.0 113.333 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.19 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 7.8 p30 102.44 38.04 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 113.377 -1.738 . . . . 0.0 115.607 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.511 ' HD2' ' CB ' ' A' ' 100' ' ' THR . 17.7 Cg_endo -95.3 80.25 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.831 3.021 . . . . 0.0 107.541 171.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.19 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 75.5 Cg_exo -66.97 110.63 1.99 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.544 2.163 . . . . 0.0 112.08 -163.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.911 HG21 ' OD1' ' A' ' 31' ' ' ASN . 18.9 pt -79.3 -123.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 124.638 1.211 . . . . 0.0 109.207 175.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.787 ' HD2' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -156.73 -151.72 0.34 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.964 0.79 . . . . 0.0 112.258 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.81 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . 51.7 p30 -39.74 145.41 0.14 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.624 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.031 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 1.8 mp0 -131.29 -92.68 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.768 1.292 . . . . 0.0 109.82 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 120' ' ' PHE . . . -38.13 -37.06 0.25 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.674 1.234 . . . . 0.0 112.384 -172.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.81 ' OD2' ' HB2' ' A' ' 75' ' ' ASN . 4.3 p30 -68.8 33.89 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.087 0.867 . . . . 0.0 112.44 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 1.031 ' OD1' ' O ' ' A' ' 76' ' ' GLU . 2.1 p-10 -172.74 82.86 0.05 Allowed 'General case' 0 N--CA 1.469 0.491 0 O-C-N 124.24 0.962 . . . . 0.0 108.766 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.812 ' C ' HD23 ' A' ' 81' ' ' LEU . . . -168.95 0.34 0.04 OUTLIER Glycine 0 N--CA 1.477 1.389 0 CA-C-N 114.711 -1.132 . . . . 0.0 113.48 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.495 HD12 ' NH1' ' A' ' 82' ' ' ARG . 1.5 pt? 31.12 172.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 1.495 ' NH1' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -60.0 158.1 11.58 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.032 -172.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.814 ' OD1' ' CG2' ' A' ' 87' ' ' THR . 1.0 OUTLIER 175.2 -146.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.464 170.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 1.456 HG21 ' NH1' ' A' ' 85' ' ' ARG . 15.8 m -170.34 162.95 8.66 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.51 0.506 . . . . 0.0 112.012 -167.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 1.456 ' NH1' HG21 ' A' ' 84' ' ' THR . 0.0 OUTLIER -34.15 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.956 1.36 . . . . 0.0 111.004 176.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 127' ' ' LYS . . . 156.6 -29.87 0.56 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-N 110.894 -2.867 . . . . 0.0 109.471 -169.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.034 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 50.1 p -81.68 144.73 30.97 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.204 0.591 . . . . 0.0 112.071 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.061 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -95.09 159.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.296 165.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.14 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -161.55 144.34 12.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.52 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 1.009 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 41.7 mtp -75.46 144.06 42.29 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.246 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.7 -118.21 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.543 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.242 ' O ' HG23 ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.54 -132.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.714 0.634 . . . . 0.0 111.011 176.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.242 HG23 ' O ' ' A' ' 92' ' ' ARG . 19.8 p 171.46 152.2 0.06 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.461 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.72 0.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.545 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 1.412 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 56.7 m-20 -40.01 -71.71 0.08 Allowed 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.654 1.221 . . . . 0.0 110.765 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.412 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 8.5 mtpm? 149.1 -94.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.91 1.381 . . . . 0.0 108.341 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.56 104.87 0.56 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.827 1.329 . . . . 0.0 109.197 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.862 ' O ' HG12 ' A' ' 73' ' ' ILE . 31.0 t -169.52 -102.19 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.664 1.228 . . . . 0.0 109.793 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 43.8 76.42 0.08 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.364 1.04 . . . . 0.0 108.6 -173.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 1.511 ' CB ' ' HD2' ' A' ' 71' ' ' PRO . 81.1 p -78.26 -43.47 28.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.105 -171.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 80.0 p -170.76 98.34 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.2 0.937 . . . . 0.0 109.54 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.9 tt0 169.48 123.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.777 1.298 . . . . 0.0 109.887 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 1.061 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.09 175.18 9.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.455 177.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 1.319 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 29.1 p90 -154.23 136.43 14.81 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.96 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.155 ' N ' ' O ' ' A' ' 56' ' ' GLN . 60.6 mt -95.46 115.06 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.663 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 52.5 m-20 -74.11 -172.61 1.41 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.514 1.134 . . . . 0.0 111.149 173.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.21 HG12 ' CE ' ' A' ' 132' ' ' MET . 32.7 m -157.84 -44.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.456 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.928 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -91.87 152.42 20.09 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.255 0.972 . . . . 0.0 112.038 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.835 ' OD1' ' HD2' ' A' ' 85' ' ' ARG . 39.1 m-20 -49.59 106.81 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.12 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.584 HD22 HD13 ' A' ' 113' ' ' LEU . 51.2 t30 -99.3 -100.59 0.23 Allowed 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.832 1.333 . . . . 0.0 109.87 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.717 ' O ' ' CG ' ' A' ' 114' ' ' ASP . . . 75.29 -43.93 0.52 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.931 0.77 . . . . 0.0 110.935 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 110' ' ' ASN . 39.8 m-85 -39.31 -50.69 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.285 0.991 . . . . 0.0 110.79 -176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.596 HD23 ' CD2' ' A' ' 122' ' ' TYR . 7.8 mp -58.41 -24.26 59.59 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.768 1.292 . . . . 0.0 111.492 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.717 ' CG ' ' O ' ' A' ' 111' ' ' ALA . 36.1 m-20 -39.17 101.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.757 0.661 . . . . 0.0 111.037 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -38.7 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.413 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 1.244 ' O ' ' HG2' ' A' ' 117' ' ' GLN . . . -179.5 66.16 0.07 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.244 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 90.5 mm-40 163.53 178.23 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.616 -0.792 . . . . 0.0 110.052 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -62.72 69.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.755 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 117' ' ' GLN . 17.9 p-10 179.0 164.07 0.85 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.72 1.263 . . . . 0.0 111.485 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.891 ' CE1' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER 170.77 119.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.175 -175.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.624 ' N ' ' HD1' ' A' ' 120' ' ' PHE . . . -156.24 -77.24 0.02 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 124.371 1.044 . . . . 0.0 112.032 -174.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.596 ' CD2' HD23 ' A' ' 113' ' ' LEU . 43.7 m-85 -77.24 120.51 22.39 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.245 0.615 . . . . 0.0 110.755 -167.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.14 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -70.62 -161.31 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.304 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.047 HG23 ' O ' ' A' ' 123' ' ' ALA . 76.1 t 177.57 141.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.173 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.979 ' HE2' HD13 ' A' ' 20' ' ' LEU . 20.2 p90 -174.34 25.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 1.199 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -156.53 -149.19 5.3 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 122.866 1.259 . . . . 0.0 113.823 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.199 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 7.2 mtpm? -179.37 -154.98 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.635 -2.283 . . . . 0.0 110.586 -170.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.716 HG22 HD13 ' A' ' 18' ' ' LEU . 94.3 t -160.04 117.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.722 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 6' ' ' HIS . 82.6 t -84.5 -75.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 114.042 -1.436 . . . . 0.0 110.448 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 132' ' ' MET . 59.6 tttp -96.18 -94.65 0.2 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.474 1.109 . . . . 0.0 112.338 -167.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -60.58 51.81 0.03 OUTLIER Glycine 0 N--CA 1.475 1.238 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.442 -165.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 1.21 ' CE ' HG12 ' A' ' 107' ' ' VAL . 12.1 tpt -60.7 -48.68 80.69 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.4 t0 -43.58 -57.99 2.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.425 1.078 . . . . 0.0 110.223 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 16' ' ' ILE . 54.5 t -39.57 -59.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.458 1.099 . . . . 0.0 109.501 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -46.13 -52.22 12.56 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.795 1.31 . . . . 0.0 109.658 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 37.0 m-20 -50.78 -69.25 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.612 1.195 . . . . 0.0 109.553 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.741 ' CA ' ' HG2' ' A' ' 140' ' ' GLN . 8.2 ttpm? -41.29 -45.94 3.09 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.634 1.208 . . . . 0.0 110.395 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.877 ' O ' HG22 ' A' ' 141' ' ' VAL . 15.6 mt -53.8 -59.2 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.629 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 79.0 p -64.59 9.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.71 1.256 . . . . 0.0 113.838 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.741 ' HG2' ' CA ' ' A' ' 137' ' ' LYS . 10.3 mm100 -96.06 -52.71 3.93 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.164 0.915 . . . . 0.0 109.432 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.9 m -49.59 123.69 14.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 124.505 1.128 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 82.6 Cg_exo -41.34 178.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.462 2.775 . . . . 0.0 113.553 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.139 HG22 ' CA ' ' A' ' 153' ' ' PRO . 4.2 p -161.31 -142.22 0.08 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 123.101 1.429 . . . . 0.0 112.137 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.496 ' H ' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER 179.33 145.37 0.17 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 110.691 -2.959 . . . . 0.0 111.941 173.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -63.38 121.67 14.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.102 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.842 HG22 ' HB ' ' A' ' 152' ' ' VAL . 1.5 t -78.09 -65.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.949 -168.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.64 -81.78 0.06 OUTLIER Glycine 0 N--CA 1.47 0.94 0 CA-C-N 111.736 -2.484 . . . . 0.0 107.998 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.692 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 73.6 Cg_endo -66.44 -73.48 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.523 2.816 . . . . 0.0 108.671 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.692 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 43.9 m-85 -76.98 102.73 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.616 1.197 . . . . 0.0 110.107 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 34.2 mt-30 -67.74 135.62 52.97 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.671 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.586 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 73.2 m-20 83.04 96.51 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.995 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 63.0 t -154.07 127.03 4.11 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.876 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.139 ' CA ' HG22 ' A' ' 143' ' ' THR . 55.7 Cg_endo -61.45 102.73 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.554 2.836 . . . . 0.0 109.324 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . 1.304 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 49.2 m -42.33 -58.62 2.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.027 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -82.31 88.46 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 O-C-N 124.832 1.332 . . . . 0.0 108.077 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.304 ' HD3' ' O ' ' A' ' 154' ' ' SER . 86.2 Cg_exo -61.65 141.36 90.76 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.531 2.821 . . . . 0.0 114.967 -166.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 158' ' ' VAL . 97.3 t -69.53 161.57 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.374 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 1.119 ' HA ' HG22 ' A' ' 45' ' ' THR . 99.1 t -147.45 118.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.144 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.958 HG12 HG22 ' A' ' 11' ' ' THR . 50.2 mt -69.35 143.5 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 113.602 -1.636 . . . . 0.0 111.705 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.935 HD12 HG22 ' A' ' 10' ' ' THR . 83.5 mt -95.44 -45.09 7.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . 1.288 ' O ' HD23 ' A' ' 9' ' ' LEU . 25.7 t -169.08 165.78 11.11 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.093 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -149.95 109.25 3.96 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.524 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -131.18 111.51 12.0 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.438 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.713 HG11 HG11 ' A' ' 36' ' ' VAL . 34.0 m -76.53 135.02 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.78 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 165' ' ' LEU . 78.5 mt -97.41 134.36 22.72 Favored Pre-proline 0 N--CA 1.479 1.015 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.025 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 165' ' ' LEU . 84.0 Cg_exo . . . . . 0 C--O 1.251 1.129 0 C-N-CA 123.539 2.826 . . . . 0.0 112.139 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -47.62 114.48 0.9 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.401 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 1.191 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 179.97 96.42 0.1 Allowed Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.505 1.128 . . . . 0.0 110.694 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.191 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 85.3 m-20 -174.05 67.75 0.31 Allowed Pre-proline 0 N--CA 1.474 0.771 0 O-C-N 124.602 0.824 . . . . 0.0 109.208 173.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.126 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 52.8 Cg_exo -58.78 107.94 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.477 2.784 . . . . 0.0 111.658 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.69 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 0.3 OUTLIER -160.04 74.62 0.58 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.492 1.12 . . . . 0.0 108.685 -178.125 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.863 HG13 HD13 ' A' ' 20' ' ' LEU . 18.7 m -61.07 100.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.185 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.182 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 37.5 mt -78.34 145.3 35.35 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.64 1.212 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.104 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.8 mt -149.15 162.49 39.88 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.027 -2.352 . . . . 0.0 110.41 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 1.292 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.2 m -160.59 78.1 0.62 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.123 -2.308 . . . . 0.0 108.523 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.979 HG22 HG12 ' A' ' 159' ' ' ILE . 35.7 p -70.78 168.63 16.28 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 125.182 1.551 . . . . 0.0 111.44 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.419 ' OG ' HG13 ' A' ' 157' ' ' VAL . 80.5 p -39.57 -44.02 1.39 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.578 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.807 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -57.75 -60.8 3.14 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.443 1.089 . . . . 0.0 110.365 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.03 -179.75 43.47 Favored Glycine 0 N--CA 1.478 1.456 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.222 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 1.104 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 9.7 t-20 -61.23 160.56 10.25 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.6 -1.3 . . . . 0.0 111.761 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 15' ' ' ASN . 10.4 pt -167.39 174.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.914 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.113 ' HG2' ' CD2' ' A' ' 8' ' ' LEU . 35.9 mt-10 -160.78 106.07 1.42 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.107 -169.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.159 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.7 mm? -87.35 105.88 17.56 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.64 1.212 . . . . 0.0 108.438 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.428 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -69.45 118.74 12.71 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.169 0.918 . . . . 0.0 108.77 174.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.159 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 6.4 mp -108.37 137.45 46.31 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.918 1.386 . . . . 0.0 110.905 -172.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.797 ' OD1' ' HG2' ' A' ' 23' ' ' GLN . 52.6 t0 -56.61 -116.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.787 174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.844 ' HA ' HG11 ' A' ' 29' ' ' VAL . 60.7 tttm 135.5 -57.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.594 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 1.013 ' OE1' ' NZ ' ' A' ' 24' ' ' LYS . 3.8 pt20 -55.75 -49.07 74.09 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.736 1.272 . . . . 0.0 110.573 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 1.013 ' NZ ' ' OE1' ' A' ' 23' ' ' GLN . 47.0 mmtm -69.11 -16.18 63.6 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.338 1.024 . . . . 0.0 113.219 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.49 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.42 71.72 2.94 Favored Pre-proline 0 N--CA 1.475 0.814 0 O-C-N 123.836 0.71 . . . . 0.0 109.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 1.067 ' O ' HG22 ' A' ' 29' ' ' VAL . 78.0 Cg_exo -51.42 -55.65 3.79 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.735 2.957 . . . . 0.0 111.538 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.6 t -46.68 -62.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 124.678 1.236 . . . . 0.0 110.125 -177.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.9 p -44.06 -54.2 5.7 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.725 1.266 . . . . 0.0 110.441 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.067 HG22 ' O ' ' A' ' 26' ' ' PRO . 29.0 m -56.8 -47.02 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 124.317 1.011 . . . . 0.0 110.617 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.72 ' OE1' ' HA ' ' A' ' 30' ' ' GLN . 3.9 tp60 -44.92 -69.48 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.196 0.935 . . . . 0.0 109.632 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.928 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 12.0 m120 -46.03 -50.43 15.05 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.594 1.184 . . . . 0.0 109.488 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.845 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 45.4 t80 -40.61 -66.01 0.36 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.685 1.241 . . . . 0.0 110.231 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.81 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.3 t -45.81 -39.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.583 1.177 . . . . 0.0 111.099 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.928 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 88.1 m-20 -44.07 -62.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.089 0.868 . . . . 0.0 109.504 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.73 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 34.1 m-85 -64.33 -55.84 18.53 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.159 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 32' ' ' PHE . 58.8 t -39.33 -48.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 124.735 1.272 . . . . 0.0 111.015 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.822 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.1 t-20 -38.43 -33.5 0.1 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.754 1.284 . . . . 0.0 111.844 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.822 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 93.6 p 145.75 176.96 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.225 0.953 . . . . 0.0 113.061 175.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.64 -43.03 3.1 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.883 ' O ' HG23 ' A' ' 44' ' ' THR . 1.4 t80 -71.12 -74.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.586 0.815 . . . . 0.0 109.513 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.667 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 16.5 m-30 -62.5 -28.23 69.7 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.552 1.158 . . . . 0.0 112.678 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.6 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 53.0 p-10 -38.76 -36.68 0.28 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.932 0.77 . . . . 0.0 112.569 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 34.7 t30 -161.25 47.58 0.2 Allowed 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.055 0.847 . . . . 0.0 110.753 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 40' ' ' PHE . 42.9 p -79.46 -136.57 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 160.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 1.041 ' HA ' HG13 ' A' ' 159' ' ' ILE . 47.7 p -163.36 -142.45 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.998 0.904 . . . . 0.0 112.024 174.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.724 ' HZ ' HD13 ' A' ' 9' ' ' LEU . 52.7 m-85 -158.85 74.16 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.242 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.714 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -42.7 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.76 -177.109 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.198 ' NH2' ' CA ' ' A' ' 51' ' ' PRO . 46.9 tpt85 -173.26 -150.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.433 1.111 . . . . 0.0 113.122 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.191 HG23 ' O ' ' A' ' 48' ' ' ARG . 48.1 t -175.83 -70.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.475 -2.148 . . . . 0.0 106.684 169.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.885 ' C ' ' NH2' ' A' ' 48' ' ' ARG . 59.2 mt -171.27 134.22 0.92 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.502 -1.681 . . . . 0.0 108.585 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.198 ' CA ' ' NH2' ' A' ' 48' ' ' ARG . 80.1 Cg_exo -35.54 155.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.068 2.512 . . . . 0.0 112.706 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -1.35 66.51 0.0 OUTLIER Glycine 0 N--CA 1.476 1.332 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.706 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.0 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -156.33 -50.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.856 0.974 . . . . 0.0 109.95 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.0 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 64.2 mtm -176.62 159.75 1.9 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.352 1.032 . . . . 0.0 111.409 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.0 HG12 ' O ' ' A' ' 105' ' ' ILE . 42.6 pt -153.68 165.31 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.815 -1.538 . . . . 0.0 110.108 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 1.195 ' CG ' ' HA ' ' A' ' 104' ' ' PHE . 76.4 mt-30 -164.49 136.55 4.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.146 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -120.93 -158.06 10.31 Favored Glycine 0 N--CA 1.479 1.537 0 O-C-N 124.828 1.33 . . . . 0.0 112.378 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 56.71 82.64 0.05 OUTLIER Glycine 0 N--CA 1.47 0.917 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.253 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.61 -118.47 0.63 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.651 0.853 . . . . 0.0 111.12 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -45.91 120.66 2.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.167 -1.017 . . . . 0.0 111.292 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.274 ' CG2' ' CD ' ' A' ' 67' ' ' LYS . 76.8 p -59.69 124.48 20.24 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.577 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 1.012 ' HG2' ' N ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 19.99 -108.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.827 -178.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 1.193 ' O ' ' CG ' ' A' ' 64' ' ' MET . 88.3 mt-30 -43.23 -58.17 2.64 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.671 1.232 . . . . 0.0 110.363 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 1.193 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 47.3 mtt 141.44 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.639 1.212 . . . . 0.0 107.893 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 64' ' ' MET . 32.6 mt-30 -159.59 78.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.513 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 65' ' ' GLN . 33.9 mt-30 -19.88 130.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.265 -173.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.274 ' CD ' ' CG2' ' A' ' 61' ' ' THR . 14.3 mmmm -62.17 -116.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.938 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -142.62 -62.7 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 112.567 -2.106 . . . . 0.0 109.734 -174.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 68' ' ' LYS . 60.7 Cg_exo -28.34 136.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.066 2.511 . . . . 0.0 112.807 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.256 ' OD1' ' HD3' ' A' ' 71' ' ' PRO . 49.4 p-10 -168.69 -41.19 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 116.881 -1.533 . . . . 0.0 114.416 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.256 ' HD3' ' OD1' ' A' ' 70' ' ' ASN . 59.7 Cg_endo -68.28 89.78 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.961 2.44 . . . . 0.0 108.406 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.246 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 84.6 Cg_exo -57.52 -155.69 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.637 2.892 . . . . 0.0 113.63 -172.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.846 ' CD1' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -160.06 151.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.776 176.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.684 ' O ' ' O ' ' A' ' 75' ' ' ASN . 74.6 mmtt -19.73 136.79 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.563 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.941 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -39.92 -120.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.536 -178.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.172 ' CG ' HD21 ' A' ' 79' ' ' ASN . 0.8 OUTLIER 102.58 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.101 0.876 . . . . 0.0 111.305 -178.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.881 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 172.8 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.667 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 1.049 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 42.5 p-10 -68.03 -48.13 66.52 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.574 1.171 . . . . 0.0 109.676 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 1.172 HD21 ' CG ' ' A' ' 76' ' ' GLU . 50.1 p-10 -58.28 77.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.229 0.956 . . . . 0.0 108.699 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . -174.22 40.73 0.13 Allowed Glycine 0 N--CA 1.474 1.222 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.105 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.601 ' N ' HD22 ' A' ' 81' ' ' LEU . 2.8 mm? 39.4 -132.29 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.333 0.666 . . . . 0.0 110.602 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 32.2 ptt-85 -174.04 131.56 0.4 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.021 0.826 . . . . 0.0 109.451 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.464 ' HB3' HG21 ' A' ' 87' ' ' THR . 49.3 t30 -150.79 -122.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.585 1.178 . . . . 0.0 109.804 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.549 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 23.0 m -160.79 159.58 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.032 0.833 . . . . 0.0 111.79 -167.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.736 ' CB ' ' N ' ' A' ' 108' ' ' ALA . 39.1 ptt180 -36.06 103.42 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.669 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.821 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 153.89 -29.6 0.74 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 111.446 -2.615 . . . . 0.0 109.718 -170.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.869 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 35.8 p -76.46 131.45 39.05 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.685 0.755 . . . . 0.0 111.514 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.479 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -80.05 159.0 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.857 164.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.275 ' O ' ' HD1' ' A' ' 104' ' ' PHE . . . -164.11 128.01 2.64 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.63 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 1.186 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 96.5 mmm -51.27 123.13 8.91 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.783 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.642 ' HA ' ' HE1' ' A' ' 104' ' ' PHE . . . -66.52 -147.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.544 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.033 ' HG2' ' H ' ' A' ' 93' ' ' THR . 56.7 ttp180 179.5 -129.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.033 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 9.0 t 136.31 87.09 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.541 1.151 . . . . 0.0 109.963 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.1 -70.7 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.821 1.325 . . . . 0.0 109.732 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.1 m-20 -40.13 110.95 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.527 1.142 . . . . 0.0 110.624 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.857 ' NZ ' ' OD1' ' A' ' 75' ' ' ASN . 27.8 tptp -46.13 -112.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.735 1.272 . . . . 0.0 110.52 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 36.0 m-20 -58.78 110.14 0.95 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.633 1.208 . . . . 0.0 109.258 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 1.242 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 70.6 m -166.53 -124.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 O-C-N 124.564 1.165 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.846 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 71.71 87.76 0.11 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.799 1.312 . . . . 0.0 108.162 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.87 HG21 ' HA ' ' A' ' 70' ' ' ASN . 81.6 p -78.88 -34.82 44.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.801 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.544 ' HB2' ' HE2' ' A' ' 40' ' ' PHE . 78.9 p -169.87 -47.9 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.132 0.895 . . . . 0.0 110.363 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.473 ' HG2' ' CB ' ' A' ' 91' ' ' ALA . 14.2 tt0 -38.93 144.02 0.14 Allowed 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.19 0.931 . . . . 0.0 111.184 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 1.017 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -160.31 159.68 31.58 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.58 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 1.275 ' HD1' ' O ' ' A' ' 89' ' ' ALA . 24.5 m-85 -81.94 155.52 25.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.774 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.0 ' O ' HG12 ' A' ' 55' ' ' ILE . 37.8 mt -146.23 91.85 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.325 158.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.945 ' O ' ' HE1' ' A' ' 132' ' ' MET . 1.8 m-20 -71.24 171.73 10.56 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 112.545 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.627 HG12 ' CE ' ' A' ' 132' ' ' MET . 35.6 m -160.68 48.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.243 -1.798 . . . . 0.0 108.377 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.749 ' HB3' ' HD1' ' A' ' 53' ' ' PHE . . . 176.82 147.48 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.233 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.705 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.5 m-20 -36.13 77.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.724 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.718 ' HB2' HD22 ' A' ' 106' ' ' ASN . 3.2 t30 -69.65 134.51 48.81 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.861 1.35 . . . . 0.0 110.364 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.632 ' H ' ' CD1' ' A' ' 113' ' ' LEU . . . 164.16 -53.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.82 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE2' ' O ' ' A' ' 109' ' ' ASP . 34.5 p90 -67.64 47.89 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.581 1.176 . . . . 0.0 110.374 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER 177.59 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.229 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.81 ' H ' HD13 ' A' ' 113' ' ' LEU . 64.6 t0 -43.45 -56.42 3.62 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.015 0.822 . . . . 0.0 110.738 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 1.049 ' ND1' ' HB3' ' A' ' 78' ' ' ASP . 9.0 t-160 179.74 111.96 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.697 1.248 . . . . 0.0 109.61 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.757 ' O ' ' N ' ' A' ' 118' ' ' ARG . . . -177.44 -118.7 0.56 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.564 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.58 ' C ' ' HG3' ' A' ' 118' ' ' ARG . 29.6 mm100 38.95 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.495 0.762 . . . . 0.0 111.327 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.757 ' N ' ' O ' ' A' ' 116' ' ' GLY . 99.1 mtt180 -161.75 -106.71 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.553 1.158 . . . . 0.0 109.091 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -59.63 72.41 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.679 1.237 . . . . 0.0 109.759 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.667 ' HA ' ' CD2' ' A' ' 115' ' ' HIS . 8.3 m-30 42.27 -150.77 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.627 1.204 . . . . 0.0 110.838 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 120' ' ' PHE . . . -171.25 -136.01 2.03 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.86 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 81.7 m-85 -79.21 127.78 32.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.583 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.186 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -53.89 -166.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.324 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 123' ' ' ALA . 60.3 t -179.69 134.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.585 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.951 ' CD1' ' HG2' ' A' ' 90' ' ' MET . 13.9 p90 -168.82 28.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.132 0.895 . . . . 0.0 111.07 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 1.479 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -147.11 176.53 25.93 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 123.321 1.511 . . . . 0.0 113.11 -173.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.428 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 8.2 ttpm? 177.81 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 110.77 -2.715 . . . . 0.0 109.989 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 86' ' ' GLY . 66.9 t -60.39 128.38 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.879 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 34.5 m -95.33 -42.18 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.699 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.476 ' N ' HG23 ' A' ' 129' ' ' VAL . 8.2 ttpm? 179.98 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.154 0.909 . . . . 0.0 109.697 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 174.52 12.45 0.02 OUTLIER Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.768 1.292 . . . . 0.0 112.993 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 1.627 ' CE ' HG12 ' A' ' 107' ' ' VAL . 11.5 tpt -54.99 -50.83 68.02 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.7 t0 -40.84 -55.62 2.41 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.449 1.093 . . . . 0.0 110.262 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.888 HG21 ' O ' ' A' ' 15' ' ' ASN . 54.8 t -41.7 -63.23 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 124.464 1.103 . . . . 0.0 109.438 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.546 ' O ' ' HB ' ' A' ' 138' ' ' ILE . . . -49.79 -50.19 45.76 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.729 1.268 . . . . 0.0 109.635 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.675 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 37.8 m-20 -51.43 -69.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.513 1.133 . . . . 0.0 109.228 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.989 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 5.9 tmtt? -38.11 -48.91 1.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.744 1.278 . . . . 0.0 110.386 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.008 ' O ' HG22 ' A' ' 141' ' ' VAL . 32.6 mt -54.06 -59.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 124.606 1.192 . . . . 0.0 108.309 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.1 p -65.76 8.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.763 1.29 . . . . 0.0 113.86 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.675 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 10.8 mm100 -97.12 -51.92 4.03 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.212 0.945 . . . . 0.0 109.096 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.008 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -48.39 132.52 13.18 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.584 1.177 . . . . 0.0 110.258 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -39.13 -178.02 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.395 2.73 . . . . 0.0 113.534 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.285 HG22 ' CA ' ' A' ' 153' ' ' PRO . 7.4 p -161.15 -151.78 0.24 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 123.2 1.476 . . . . 0.0 112.532 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 178.12 146.32 0.14 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.21 170.202 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.599 ' HB3' ' HG2' ' A' ' 150' ' ' GLN . 39.0 m-20 -67.59 114.13 5.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.68 167.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.957 ' HB ' ' O ' ' A' ' 149' ' ' TYR . 1.5 t -77.32 -159.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 124.474 1.109 . . . . 0.0 110.916 -166.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.826 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -60.6 -115.46 0.01 OUTLIER Glycine 0 N--CA 1.471 1.015 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 171.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.926 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 91.8 Cg_endo -74.51 33.9 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.603 2.868 . . . . 0.0 110.744 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.957 ' O ' ' HB ' ' A' ' 146' ' ' VAL . 27.6 m-85 -170.41 104.52 0.28 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.735 0.647 . . . . 0.0 109.686 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 1.131 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 32.1 mt-30 -71.09 -169.71 0.4 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.847 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 1.131 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 52.1 p-10 44.6 76.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.18 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.805 HG21 ' CE ' ' A' ' 64' ' ' MET . 70.8 t -157.28 102.39 1.88 Allowed Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.615 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.285 ' CA ' HG22 ' A' ' 143' ' ' THR . 81.5 Cg_exo -49.95 109.67 0.31 Allowed 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.434 2.756 . . . . 0.0 110.961 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . 1.276 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.5 t -40.0 -57.57 1.61 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.459 1.099 . . . . 0.0 108.972 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 62.6 mttp -69.61 88.25 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 164.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.276 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.2 Cg_endo -70.1 -157.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.615 2.877 . . . . 0.0 112.772 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 158' ' ' VAL . 99.4 t -153.78 153.87 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.326 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 1.018 ' HA ' HG22 ' A' ' 45' ' ' THR . 83.2 t -146.96 123.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.597 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.041 HG13 ' HA ' ' A' ' 45' ' ' THR . 36.9 mt -68.62 134.36 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.27 -175.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.292 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.9 mt -82.13 -48.61 11.12 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.771 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 32.2 t -167.1 166.42 15.09 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.521 1.138 . . . . 0.0 111.955 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.078 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -163.32 125.38 2.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.556 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 1.182 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 14.3 ptmm? -170.28 120.8 0.61 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.702 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 7' ' ' VAL . 33.7 m -68.14 131.66 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 124.762 1.289 . . . . 0.0 110.57 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.127 HD12 ' HD2' ' A' ' 166' ' ' PRO . 49.3 tp -78.0 118.33 71.51 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.801 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 1.127 ' HD2' HD12 ' A' ' 165' ' ' LEU . 87.0 Cg_exo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 123.523 2.815 . . . . 0.0 112.026 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.752 ' O ' ' CB ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.752 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 40.2 ttpt 130.36 95.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.296 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 1.261 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 54.65 95.84 0.01 OUTLIER Glycine 0 N--CA 1.471 0.976 0 O-C-N 124.795 1.309 . . . . 0.0 110.119 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.261 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 63.4 m-20 -167.63 135.52 1.95 Allowed Pre-proline 0 N--CA 1.476 0.85 0 O-C-N 124.736 0.903 . . . . 0.0 110.043 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 4' ' ' ASP . 80.6 Cg_exo -40.1 124.82 1.62 Allowed 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.595 2.863 . . . . 0.0 112.489 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -160.72 117.11 2.32 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.792 -177.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.9 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 10.4 p -59.8 137.58 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.262 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.197 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 8.4 mp -125.55 130.65 52.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.531 1.144 . . . . 0.0 109.415 166.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.923 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.5 mp -123.93 -171.99 2.44 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.936 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 1.218 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 98.7 m -160.82 84.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.827 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 1.006 HG22 HG12 ' A' ' 159' ' ' ILE . 36.9 p -76.6 172.48 12.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 125.426 1.704 . . . . 0.0 111.18 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -39.28 -44.13 1.23 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.351 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.838 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.26 -64.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.558 1.161 . . . . 0.0 110.369 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.37 41.58 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 113.248 -1.796 . . . . 0.0 113.654 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 16' ' ' ILE . 58.7 t-20 -66.29 153.33 42.88 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.12 -1.54 . . . . 0.0 111.419 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 15' ' ' ASN . 13.9 pt -163.56 174.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.15 -1.387 . . . . 0.0 111.3 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.47 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . 36.7 mt-10 -161.34 122.07 2.76 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.947 -170.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.025 HD21 HD11 ' A' ' 105' ' ' ILE . 2.5 mm? -95.64 162.96 13.4 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.817 1.323 . . . . 0.0 109.999 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.469 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -113.87 124.69 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.454 170.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.887 HD23 ' HE2' ' A' ' 125' ' ' PHE . 6.6 mp -106.01 120.05 40.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.931 1.395 . . . . 0.0 109.705 -172.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.591 ' OD2' ' HG ' ' A' ' 81' ' ' LEU . 32.2 m-20 -72.55 96.97 2.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.771 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.974 ' HA ' HG11 ' A' ' 29' ' ' VAL . 58.8 tttm -71.6 -56.15 6.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.658 1.224 . . . . 0.0 110.97 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.643 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 6.4 tp60 -46.17 -60.82 2.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.687 -171.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 51.8 tptt -68.17 -2.83 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.738 1.274 . . . . 0.0 113.138 -173.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.523 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -161.3 70.79 2.58 Favored Pre-proline 0 N--CA 1.476 0.831 0 O-C-N 123.705 0.628 . . . . 0.0 109.647 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 1.04 ' O ' HG22 ' A' ' 29' ' ' VAL . 62.9 Cg_exo -54.86 -56.18 2.62 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.635 2.89 . . . . 0.0 111.571 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.45 -64.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 124.726 1.266 . . . . 0.0 110.116 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -44.15 -58.32 2.92 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.734 1.272 . . . . 0.0 110.544 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.653 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 28.7 m -48.81 -50.14 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 124.752 1.282 . . . . 0.0 110.574 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 1.152 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -52.0 -54.18 32.96 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.358 1.036 . . . . 0.0 109.357 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.899 ' OD1' HG21 ' A' ' 73' ' ' ILE . 10.6 m120 -50.89 -64.69 0.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.549 1.156 . . . . 0.0 110.391 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 1.653 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 33.6 p90 -54.18 -43.57 70.8 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.439 1.087 . . . . 0.0 110.709 -172.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.152 HG12 ' O ' ' A' ' 30' ' ' GLN . 10.7 p -51.33 -40.29 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 124.044 0.84 . . . . 0.0 110.171 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.836 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 71.0 m-20 -46.61 -61.34 1.87 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.112 0.882 . . . . 0.0 109.285 173.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 33.5 m-85 -54.61 -56.15 22.01 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.994 1.434 . . . . 0.0 109.124 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.834 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 97.6 t -46.42 -66.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 124.639 1.212 . . . . 0.0 109.344 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 33' ' ' VAL . 1.9 m-20 -50.57 -48.74 57.43 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.814 1.321 . . . . 0.0 109.989 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.637 ' OG ' ' O ' ' A' ' 34' ' ' ASP . 67.5 m -53.97 -93.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.539 1.149 . . . . 0.0 110.284 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.42 87.41 0.07 OUTLIER Glycine 0 N--CA 1.472 1.073 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 1.098 ' O ' ' CD1' ' A' ' 41' ' ' TYR . 88.0 t80 -157.39 57.02 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.911 1.007 . . . . 0.0 108.561 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.098 ' CD1' ' O ' ' A' ' 40' ' ' PHE . 25.6 m-85 -171.68 -37.07 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -38.69 -37.21 0.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.149 0.905 . . . . 0.0 112.688 -171.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -155.04 44.89 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.061 0.851 . . . . 0.0 110.902 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 45' ' ' THR . 58.4 p -79.4 -141.97 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.387 162.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 1.062 ' HA ' HG13 ' A' ' 159' ' ' ILE . 48.7 p -163.89 -141.35 0.05 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.608 0.718 . . . . 0.0 111.644 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.82 ' CD1' ' O ' ' A' ' 45' ' ' THR . 17.2 m-30 -143.07 62.73 1.39 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.417 -1.72 . . . . 0.0 107.246 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.994 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 7.1 p-80 -51.58 -60.49 3.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.72 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.061 ' HB3' ' OE1' ' A' ' 56' ' ' GLN . 26.5 mmm180 -69.14 118.7 12.37 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.626 1.203 . . . . 0.0 110.059 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 55' ' ' ILE . 8.7 p -163.64 149.6 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 124.713 1.258 . . . . 0.0 111.023 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.84 HD13 ' HD2' ' A' ' 53' ' ' PHE . 10.1 tt -165.54 126.61 1.35 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.242 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 53' ' ' PHE . 87.4 Cg_exo -35.55 160.96 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.618 2.879 . . . . 0.0 113.729 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -7.71 70.06 0.0 OUTLIER Glycine 0 N--CA 1.474 1.225 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.684 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.082 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -160.78 -53.24 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.828 0.958 . . . . 0.0 109.712 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.082 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 61.3 mtm -177.98 161.77 1.58 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.25 0.969 . . . . 0.0 112.249 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.709 HG12 ' O ' ' A' ' 105' ' ' ILE . 36.7 pt -150.61 174.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.798 170.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 1.061 ' OE1' ' HB3' ' A' ' 48' ' ' ARG . 42.7 mt-30 -158.98 167.01 30.47 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.201 -169.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.19 -178.08 31.89 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.578 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.09 84.57 0.08 OUTLIER Glycine 0 N--CA 1.47 0.912 0 CA-C-N 113.746 -1.227 . . . . 0.0 110.217 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.801 ' C ' ' HD2' ' A' ' 67' ' ' LYS . . . 178.98 -132.58 1.91 Allowed Glycine 0 N--CA 1.475 1.274 0 O-C-N 124.656 0.856 . . . . 0.0 111.305 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 56.6 m-85 -50.96 110.71 0.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.245 -0.978 . . . . 0.0 109.554 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.213 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 9.4 t -70.33 105.11 2.89 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.398 1.061 . . . . 0.0 110.082 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 1.213 ' HG2' ' O ' ' A' ' 61' ' ' THR . 12.6 pt-20 70.84 -127.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.801 1.313 . . . . 0.0 110.922 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 1.218 ' O ' ' CG ' ' A' ' 64' ' ' MET . 59.8 mt-30 -47.22 -55.45 8.56 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.808 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 1.218 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 50.7 mtt 145.72 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.637 1.208 . . . . 0.0 108.269 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 66' ' ' GLN . 18.4 tt0 -144.03 84.51 1.78 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.981 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.554 ' O ' ' O ' ' A' ' 67' ' ' LYS . 42.4 mt-30 -24.45 135.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.067 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.166 ' CD ' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -47.91 -120.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.427 -178.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 69' ' ' PRO . 4.2 ttmp? -170.84 73.05 0.56 Allowed Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.32 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.82 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 87.9 Cg_exo -51.17 -140.11 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.573 2.848 . . . . 0.0 113.127 -172.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.917 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 93.6 m-20 164.83 168.72 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.579 -172.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.917 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 33.1 Cg_endo -44.66 98.39 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.549 2.166 . . . . 0.0 108.893 169.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.633 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.4 Cg_exo -44.11 -136.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.853 3.035 . . . . 0.0 113.336 -175.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.899 HG21 ' OD1' ' A' ' 31' ' ' ASN . 24.8 pt -152.34 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.438 1.086 . . . . 0.0 109.083 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 75' ' ' ASN . 21.6 ptmt -154.82 -148.37 0.24 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.03 0.831 . . . . 0.0 111.918 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.566 ' O ' ' O ' ' A' ' 74' ' ' LYS . 37.7 m-20 -44.93 -171.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.258 -1.792 . . . . 0.0 112.408 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.05 ' HG3' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 171.42 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.421 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.941 ' N ' ' HG2' ' A' ' 76' ' ' GLU . . . -44.72 -35.27 2.59 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.534 1.146 . . . . 0.0 111.887 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -68.89 25.81 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.058 0.848 . . . . 0.0 113.25 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.635 HD21 ' HB ' ' A' ' 124' ' ' VAL . 44.8 p-10 -63.63 -123.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.941 0.776 . . . . 0.0 109.017 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.6 -80.28 0.08 OUTLIER Glycine 0 N--CA 1.473 1.12 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.433 ' O ' ' CD ' ' A' ' 82' ' ' ARG . 2.8 mm? 40.17 -151.01 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.848 0.97 . . . . 0.0 111.185 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 1.433 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER 179.95 111.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.987 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 1.21 ' OD1' ' HD3' ' A' ' 127' ' ' LYS . 26.0 m120 -159.76 -156.77 0.52 Allowed 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.591 1.182 . . . . 0.0 111.267 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 1.126 HG22 ' HG2' ' A' ' 85' ' ' ARG . 12.0 m -169.46 166.03 10.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.283 -166.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 1.126 ' HG2' HG22 ' A' ' 84' ' ' THR . 16.4 ptm180 -18.63 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.108 1.432 . . . . 0.0 112.146 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.858 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 148.18 -26.83 1.41 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-N 110.442 -3.072 . . . . 0.0 109.676 -168.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.776 HG22 ' HG2' ' A' ' 127' ' ' LYS . 26.8 p -73.86 134.31 43.27 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.689 0.757 . . . . 0.0 112.107 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.53 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -91.32 160.05 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.062 164.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.263 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -163.41 138.89 6.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.043 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.922 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 95.7 mmm -55.82 125.62 22.11 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.769 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.226 ' HB3' ' OE1' ' A' ' 102' ' ' GLN . . . -74.74 -173.12 1.75 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.545 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.02 ' NH1' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.28 -120.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.407 175.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.02 ' HB ' ' NH1' ' A' ' 92' ' ' ARG . 20.7 m 173.79 -69.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.821 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 172.46 111.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.801 1.313 . . . . 0.0 108.89 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.821 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 88.4 m-20 161.84 145.3 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.152 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.654 ' O ' ' O ' ' A' ' 95' ' ' ASP . 53.4 mtmt -45.19 -122.5 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.043 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.33 118.16 5.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.713 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.6 m -163.87 -144.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.599 1.187 . . . . 0.0 110.938 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.726 ' O ' HD11 ' A' ' 73' ' ' ILE . . . 50.96 87.36 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.557 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 78.4 p -78.52 -41.35 32.54 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.246 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.3 m -167.88 -53.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 124.231 0.957 . . . . 0.0 109.286 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 1.226 ' OE1' ' HB3' ' A' ' 91' ' ' ALA . 2.0 pp0? -34.44 142.86 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.519 1.137 . . . . 0.0 111.823 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.761 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.91 -171.8 4.03 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.526 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.949 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 20.0 p90 -154.87 135.58 13.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.758 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.025 HD11 HD21 ' A' ' 18' ' ' LEU . 53.0 mt -102.19 101.2 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.822 -1.99 . . . . 0.0 108.923 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.642 ' OD1' ' CD1' ' A' ' 104' ' ' PHE . 18.9 m-20 -62.78 167.37 4.64 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.814 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.322 HG12 ' CE ' ' A' ' 132' ' ' MET . 33.0 m -157.93 51.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.273 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 53' ' ' PHE . . . -177.4 133.16 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.831 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.94 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 31.9 m-20 -31.68 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.458 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.697 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 46.9 t30 -68.83 -119.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.858 1.349 . . . . 0.0 109.519 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 61.21 -72.21 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.743 0.652 . . . . 0.0 110.24 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.94 ' CE1' ' O ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -67.63 56.07 0.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.377 1.048 . . . . 0.0 109.612 178.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.843 HD21 ' HD2' ' A' ' 122' ' ' TYR . 6.3 tt 177.44 -39.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.079 -173.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -39.5 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.06 0.85 . . . . 0.0 110.644 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.588 ' CD2' ' C ' ' A' ' 115' ' ' HIS . 11.4 t-160 179.27 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.739 1.274 . . . . 0.0 108.678 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -177.63 118.4 0.63 Allowed Glycine 0 N--CA 1.475 1.234 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.768 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.761 ' O ' ' CB ' ' A' ' 118' ' ' ARG . 26.4 tt0 77.97 73.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.761 ' CB ' ' O ' ' A' ' 117' ' ' GLN . 59.0 ttt85 126.92 102.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.205 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -34.96 110.0 0.09 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.771 1.294 . . . . 0.0 111.662 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 54.38 171.22 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.893 1.37 . . . . 0.0 112.521 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.69 -129.13 1.09 Allowed Glycine 0 N--CA 1.474 1.209 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.954 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.843 ' HD2' HD21 ' A' ' 113' ' ' LEU . 21.0 m-85 -79.72 116.72 20.06 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.486 0.757 . . . . 0.0 109.62 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.05 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . . . -49.01 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.569 1.168 . . . . 0.0 111.051 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.263 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 70.2 t 179.86 133.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.806 -176.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.887 ' HE2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -166.13 21.99 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.033 170.366 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 1.53 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -118.07 168.54 13.1 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 123.123 1.402 . . . . 0.0 112.753 -169.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.469 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 10.2 mtmp? 179.56 104.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 110.962 -2.619 . . . . 0.0 109.564 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 86' ' ' GLY . 66.8 t -43.56 119.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.083 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.47 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -63.91 -48.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.235 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.908 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 2.9 tmtm? 163.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.255 0.972 . . . . 0.0 109.612 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.65 32.61 0.09 OUTLIER Glycine 0 N--CA 1.476 1.33 0 O-C-N 124.817 1.323 . . . . 0.0 111.469 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 1.322 ' CE ' HG12 ' A' ' 107' ' ' VAL . 8.4 tpt -59.75 -40.91 89.71 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.162 0.566 . . . . 0.0 110.281 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 22.9 m-20 -44.05 -63.77 0.8 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.273 0.983 . . . . 0.0 109.937 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.675 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.2 t -43.89 -60.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 124.615 1.197 . . . . 0.0 109.219 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.412 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -46.18 -52.08 13.01 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.59 1.181 . . . . 0.0 109.772 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.599 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 39.9 m-20 -53.64 -65.43 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.562 1.164 . . . . 0.0 109.133 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -36.57 -49.24 0.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.711 1.257 . . . . 0.0 110.588 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.163 ' O ' HG22 ' A' ' 141' ' ' VAL . 23.5 mt -57.1 -57.39 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 124.578 1.173 . . . . 0.0 108.642 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.599 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.3 p -61.7 3.26 0.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 10.9 mm100 -96.25 -49.53 5.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.27 0.981 . . . . 0.0 109.313 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.163 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -47.28 123.85 8.68 Favored Pre-proline 0 N--CA 1.472 0.638 0 O-C-N 124.518 1.136 . . . . 0.0 110.055 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 141' ' ' VAL . 84.0 Cg_exo -41.17 179.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.517 2.811 . . . . 0.0 113.799 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.389 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.5 p -160.92 -151.48 0.24 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 123.589 1.662 . . . . 0.0 112.32 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 154' ' ' SER . 0.0 OUTLIER 178.24 165.06 0.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.148 174.176 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 146' ' ' VAL . 77.7 m-20 -51.57 -144.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.752 166.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.771 HG22 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -162.19 -63.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.903 1.335 . . . . 0.0 107.914 170.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.01 -95.52 0.1 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-N 111.119 -2.764 . . . . 0.0 107.531 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 90.5 Cg_endo -70.54 -63.19 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.639 2.893 . . . . 0.0 108.928 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.68 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 59.6 m-85 -70.12 109.42 4.59 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.703 1.252 . . . . 0.0 110.702 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.566 ' O ' ' NH1' ' A' ' 48' ' ' ARG . 22.4 mm-40 -75.9 151.21 37.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.75 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.736 ' O ' HG23 ' A' ' 152' ' ' VAL . 21.7 m-20 77.63 96.95 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.606 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.771 ' HB ' HG22 ' A' ' 146' ' ' VAL . 84.9 t -164.66 116.1 0.93 Allowed Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.409 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.389 ' CA ' HG22 ' A' ' 143' ' ' THR . 59.7 Cg_endo -65.02 108.53 1.13 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.534 2.822 . . . . 0.0 109.623 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . 1.251 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 62.2 p -43.96 -58.83 2.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.928 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 88.3 tttt -74.3 88.53 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.251 ' HD3' ' O ' ' A' ' 154' ' ' SER . 59.1 Cg_endo -77.31 131.74 11.95 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.684 2.923 . . . . 0.0 112.486 -167.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.641 HG21 HG23 ' A' ' 138' ' ' ILE . 74.1 t -68.94 157.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.765 -1.562 . . . . 0.0 110.44 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 1.039 ' HA ' HG22 ' A' ' 45' ' ' THR . 98.9 t -143.75 120.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.517 174.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.062 HG13 ' HA ' ' A' ' 45' ' ' THR . 32.3 mt -68.21 133.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.091 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.218 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.7 mt -77.99 -50.51 11.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 112.383 -2.19 . . . . 0.0 109.744 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.4 m -162.6 -165.46 1.17 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.655 1.222 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.923 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . 179.41 135.55 0.1 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.3 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 8' ' ' LEU . 61.1 pttt -171.61 136.45 0.96 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.693 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 36' ' ' VAL . 34.8 m -77.85 133.06 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.938 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.103 HD12 ' HD2' ' A' ' 166' ' ' PRO . 47.2 tp -91.98 117.24 67.62 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.29 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 1.103 ' HD2' HD12 ' A' ' 165' ' ' LEU . 88.4 Cg_exo . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.547 2.831 . . . . 0.0 111.828 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.652 ' O ' ' O ' ' A' ' 3' ' ' GLY . 55.9 tptt -50.74 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.26 -1.337 . . . . 0.0 109.587 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.686 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . -47.12 -141.34 0.0 OUTLIER Glycine 0 N--CA 1.473 1.146 0 O-C-N 124.689 1.243 . . . . 0.0 112.404 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.136 ' HB2' ' CD ' ' A' ' 5' ' ' PRO . 63.2 m-20 -179.08 -75.9 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 114.5 -0.85 . . . . 0.0 108.896 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.136 ' CD ' ' HB2' ' A' ' 4' ' ' ASP . 84.8 Cg_exo -45.76 78.76 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.776 2.984 . . . . 0.0 112.012 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.546 ' CE1' ' CG ' ' A' ' 19' ' ' GLU . 2.1 m-70 -147.47 112.82 5.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.043 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.038 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 9.1 p -67.64 143.85 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.311 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.282 HD11 ' OE1' ' A' ' 17' ' ' GLU . 6.6 mp -129.76 115.01 16.66 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.625 1.202 . . . . 0.0 110.023 166.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.056 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.5 mp -107.69 -177.8 3.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 111.174 -2.739 . . . . 0.0 108.743 160.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.647 HG23 ' N ' ' A' ' 15' ' ' ASN . 96.0 m -160.84 100.99 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.103 174.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.942 HG22 HG12 ' A' ' 159' ' ' ILE . 41.7 p -78.8 172.65 13.44 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.527 1.767 . . . . 0.0 111.446 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -41.08 -43.33 2.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.417 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.803 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.64 -59.26 4.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.497 1.123 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 10' ' ' THR . . . 169.67 -176.03 43.67 Favored Glycine 0 N--CA 1.479 1.546 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.647 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 1.329 ' O ' HG21 ' A' ' 134' ' ' VAL . 50.4 t30 -53.28 161.2 0.96 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 113.49 -1.355 . . . . 0.0 111.26 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 9' ' ' LEU . 11.8 tt -171.51 157.13 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.889 -174.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.282 ' OE1' HD11 ' A' ' 8' ' ' LEU . 39.7 tt0 -163.96 125.17 2.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.084 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 105' ' ' ILE . 2.9 mm? -93.54 -177.43 4.4 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.934 1.396 . . . . 0.0 110.542 164.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.546 ' CG ' ' CE1' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -148.3 118.5 7.29 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.646 175.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.761 ' O ' ' OE2' ' A' ' 19' ' ' GLU . 6.0 mp -90.57 -162.22 0.88 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.031 -1.441 . . . . 0.0 111.523 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.04 96.88 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.35 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.847 ' HA ' HG11 ' A' ' 29' ' ' VAL . 39.8 ttmt -62.28 -46.61 88.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.912 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -45.39 -67.34 0.29 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.483 1.114 . . . . 0.0 110.48 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HZ2' HD21 ' A' ' 81' ' ' LEU . 31.0 mmtp -70.05 -0.54 7.79 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.826 1.329 . . . . 0.0 114.17 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.628 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.21 70.14 2.98 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 123.827 0.704 . . . . 0.0 110.06 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.975 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.1 Cg_exo -56.18 -58.16 1.16 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.6 2.867 . . . . 0.0 111.043 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.9 t -50.71 -65.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 124.84 1.338 . . . . 0.0 110.173 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.1 m -43.99 -57.63 3.24 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.699 1.25 . . . . 0.0 110.675 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 26' ' ' PRO . 33.1 m -49.12 -49.08 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.642 1.214 . . . . 0.0 110.987 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.775 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 tm0? -50.85 -67.15 0.28 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.222 0.951 . . . . 0.0 109.086 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.914 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 t-20 -43.31 -53.11 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.581 1.176 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.716 ' CE2' HG21 ' A' ' 36' ' ' VAL . 48.8 t80 -43.21 -62.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.523 1.14 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 37' ' ' ASN . 62.7 t -44.22 -39.32 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.624 1.202 . . . . 0.0 111.071 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.914 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 5.1 m-20 -44.49 -62.06 1.32 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.121 0.888 . . . . 0.0 109.583 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.83 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 94.2 m-85 -60.26 -63.77 1.18 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.9 1.375 . . . . 0.0 109.202 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.716 HG21 ' CE2' ' A' ' 32' ' ' PHE . 57.4 t -39.52 -49.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 124.648 1.218 . . . . 0.0 110.869 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.751 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.7 t-20 -38.9 -31.34 0.06 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.738 1.274 . . . . 0.0 112.239 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.751 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.6 p 157.67 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.112 0.883 . . . . 0.0 112.425 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 68.69 81.62 0.2 Allowed Glycine 0 N--CA 1.47 0.928 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.401 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.83 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 1.7 t80 173.74 -81.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.819 0.953 . . . . 0.0 109.739 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -68.35 -12.41 61.06 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.344 1.027 . . . . 0.0 113.259 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 1.172 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 17.4 m-20 -38.97 -50.04 1.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.661 0.6 . . . . 0.0 111.714 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 1.172 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 20.6 m-20 -156.68 52.53 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.393 1.058 . . . . 0.0 109.782 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.891 ' O ' HG23 ' A' ' 45' ' ' THR . 27.8 m -78.62 -125.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 166.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 1.012 HG22 ' HA ' ' A' ' 158' ' ' VAL . 40.6 p -165.35 -140.05 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.222 1.011 . . . . 0.0 111.966 170.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.921 ' CD1' ' O ' ' A' ' 45' ' ' THR . 11.2 m-30 -152.98 81.31 1.21 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.49 -2.141 . . . . 0.0 105.962 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.789 ' O ' ' CD ' ' A' ' 153' ' ' PRO . 19.8 m80 -11.43 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.123 ' NH2' ' O ' ' A' ' 141' ' ' VAL . 28.0 tpt85 -172.4 -133.19 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.634 1.209 . . . . 0.0 110.098 166.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 50' ' ' ILE . 7.4 p -173.41 147.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.953 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 49' ' ' VAL . 57.0 mt -72.24 131.8 84.77 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.106 156.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' ILE . 19.2 Cg_endo -40.76 -139.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.386 0 C-N-CA 123.213 2.608 . . . . 0.0 111.582 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.63 76.49 0.01 OUTLIER Glycine 0 N--CA 1.471 0.998 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.67 ' HD2' HG21 ' A' ' 50' ' ' ILE . 1.1 t80 -162.11 -68.79 0.05 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.604 0.826 . . . . 0.0 109.833 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.902 ' O ' HG23 ' A' ' 49' ' ' VAL . 26.4 ptt? 177.16 130.77 0.05 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.212 0.945 . . . . 0.0 111.906 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.849 HG22 ' CB ' ' A' ' 49' ' ' VAL . 32.4 pt -90.2 176.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.047 169.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 1.287 ' O ' ' HA ' ' A' ' 104' ' ' PHE . 20.6 mm-40 -69.28 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.499 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 1.042 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -157.47 -133.66 1.63 Allowed Glycine 0 N--CA 1.473 1.103 0 O-C-N 118.845 -2.409 . . . . 0.0 112.046 4.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.59 105.27 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA2' ' HD3' ' A' ' 67' ' ' LYS . . . -175.5 -121.38 0.64 Allowed Glycine 0 N--CA 1.475 1.278 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.93 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 21.0 m-85 -42.58 114.09 0.54 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.577 -0.812 . . . . 0.0 110.455 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.747 ' HA ' HG23 ' A' ' 44' ' ' THR . 97.7 m -59.94 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.613 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 65.14 -106.11 0.13 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.817 1.323 . . . . 0.0 110.287 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 44.6 tp60 -71.41 50.3 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.67 1.232 . . . . 0.0 110.505 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.93 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 53.4 mtt 41.75 35.77 0.54 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.937 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' GLN . 10.7 tp-100 -77.67 87.67 3.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 172.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 67' ' ' LYS . 62.5 mt-30 -27.42 137.41 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.084 -171.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 66' ' ' GLN . 35.3 mtmm -43.85 -122.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.273 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -174.01 75.94 0.36 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 112.704 -2.044 . . . . 0.0 106.617 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 1.232 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 58.3 Cg_endo -78.21 -178.05 4.33 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.638 2.892 . . . . 0.0 113.593 -167.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.232 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 41.5 m-20 -166.0 168.98 7.18 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.887 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.863 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 99.3 Cg_exo -36.1 83.29 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.347 2.698 . . . . 0.0 111.295 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.046 ' HB3' HG22 ' A' ' 100' ' ' THR . 80.6 Cg_exo -49.82 154.17 5.2 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.846 3.031 . . . . 0.0 113.735 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.094 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 30.4 pt -78.98 162.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.923 -1.49 . . . . 0.0 112.03 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.944 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 95.7 mttt -59.84 -177.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.846 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 25.9 p30 -52.55 -169.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.31 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.22 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 157.39 122.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.924 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 167.12 -47.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.322 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 49.8 p-10 -69.03 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.485 1.116 . . . . 0.0 112.86 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 80' ' ' GLY . 43.6 p-10 -44.43 -46.94 9.81 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.996 0.81 . . . . 0.0 109.865 174.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.752 ' C ' HD12 ' A' ' 81' ' ' LEU . . . 73.53 68.24 1.62 Allowed Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.412 1.07 . . . . 0.0 111.166 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.752 HD12 ' C ' ' A' ' 80' ' ' GLY . 2.7 mp -151.36 174.32 13.47 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.854 0.973 . . . . 0.0 110.531 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.682 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 14.2 ptp180 -79.56 144.19 34.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.687 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.682 ' OD1' ' O ' ' A' ' 82' ' ' ARG . 87.0 m-20 -164.53 153.43 13.05 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.502 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' ' 109' ' ' ASP . 17.8 m -165.26 159.49 17.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.421 -169.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' THR . 67.1 ttt180 -21.21 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.792 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.851 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 146.06 -13.76 1.69 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.835 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.169 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 24.3 p -109.48 163.61 13.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.026 1.394 . . . . 0.0 112.584 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.871 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -131.37 158.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 111.28 -2.691 . . . . 0.0 108.719 -177.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -156.05 150.67 25.95 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.89 -1.504 . . . . 0.0 112.364 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 1.122 ' SD ' ' O ' ' A' ' 102' ' ' GLN . 15.6 tpt -61.77 127.3 30.77 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.676 -1.602 . . . . 0.0 110.739 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.827 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . . . -57.34 -119.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.526 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.938 ' HA ' ' H ' ' A' ' 99' ' ' ALA . 39.2 ptt180 179.21 -153.1 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.77 0.669 . . . . 0.0 111.353 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 53.7 m -176.8 -90.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.17 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 164.52 117.85 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.695 1.247 . . . . 0.0 109.098 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 50.3 t0 159.64 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.303 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.142 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 64.3 mttm 153.98 22.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.072 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 1.142 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 89.4 m-20 178.96 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 1.365 ' CA ' ' O ' ' A' ' 99' ' ' ALA . 31.2 t 178.54 108.22 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.599 1.187 . . . . 0.0 109.137 -169.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 1.365 ' O ' ' CA ' ' A' ' 98' ' ' SER . . . 34.16 135.87 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.389 -1.444 . . . . 0.0 114.025 -2.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 1.046 HG22 ' HB3' ' A' ' 72' ' ' PRO . 38.6 p -160.92 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.774 -2.012 . . . . 0.0 108.682 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.612 ' H ' ' NE2' ' A' ' 102' ' ' GLN . 78.0 p -170.36 80.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.402 1.063 . . . . 0.0 108.398 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 1.122 ' O ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER 176.46 158.64 0.3 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.73 1.269 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.949 ' HD2' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -158.45 -173.7 4.43 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.89 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 1.287 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 22.2 p90 -156.64 139.65 15.39 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.655 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.042 HD11 HD21 ' A' ' 18' ' ' LEU . 60.4 mt -100.68 113.47 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.31 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 1.169 ' OD1' ' O ' ' A' ' 87' ' ' THR . 37.5 p-10 -72.42 -167.82 0.37 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.624 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.257 HG12 ' CE ' ' A' ' 132' ' ' MET . 34.5 m -160.7 -43.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.961 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 107' ' ' VAL . . . -86.5 133.7 33.73 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.258 0.974 . . . . 0.0 111.129 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.604 ' HA ' HG23 ' A' ' 84' ' ' THR . 19.7 m-20 -51.04 112.14 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.422 174.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 113' ' ' LEU . 81.3 m-20 -163.32 75.15 0.37 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.485 1.115 . . . . 0.0 109.547 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.38 -29.42 64.05 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.215 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -38.71 -40.24 0.58 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.074 0.858 . . . . 0.0 111.533 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.724 HD13 ' O ' ' A' ' 110' ' ' ASN . 6.4 mp -57.91 -24.82 59.46 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.436 1.085 . . . . 0.0 111.773 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.4 t0 -39.18 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.752 0.658 . . . . 0.0 111.072 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 1.617 ' CD2' ' HB3' ' A' ' 120' ' ' PHE . 4.0 t-160 178.59 120.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.696 1.247 . . . . 0.0 109.626 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -168.81 -169.74 32.59 Favored Glycine 0 N--CA 1.477 1.409 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.717 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 116' ' ' GLY . 65.8 tt0 72.39 -56.34 0.65 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.488 -0.856 . . . . 0.0 109.402 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 117' ' ' GLN . 27.7 tpt180 178.29 -97.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.61 1.194 . . . . 0.0 108.958 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 120' ' ' PHE . 55.6 p-10 -73.23 89.55 1.55 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.7 1.25 . . . . 0.0 110.138 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 1.617 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 26.1 p90 -50.45 -154.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.562 1.164 . . . . 0.0 110.944 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.29 -82.94 0.05 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 123.667 0.605 . . . . 0.0 111.65 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -77.26 123.69 26.81 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.488 0.757 . . . . 0.0 110.817 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.22 ' HB1' ' OE1' ' A' ' 76' ' ' GLU . . . -68.24 -156.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.242 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.158 HG23 ' O ' ' A' ' 123' ' ' ALA . 46.2 t 176.4 136.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.949 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 35.7 p90 -170.32 23.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 118.44 -0.791 . . . . 0.0 113.064 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.804 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -155.93 -166.4 15.85 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.093 1.385 . . . . 0.0 113.725 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.851 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 27.7 ttpp 176.99 132.05 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 110.996 -2.602 . . . . 0.0 110.131 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.843 HG11 ' HB2' ' A' ' 132' ' ' MET . 60.1 t -46.88 149.36 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 124.399 1.062 . . . . 0.0 110.882 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.093 HG11 ' CG ' ' A' ' 17' ' ' GLU . 6.5 p -129.72 -45.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.453 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 1.101 ' HE3' ' HA ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER 178.44 76.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.161 0.913 . . . . 0.0 108.688 -177.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.65 -16.02 0.02 OUTLIER Glycine 0 N--CA 1.476 1.364 0 O-C-N 124.819 1.325 . . . . 0.0 112.511 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 1.257 ' CE ' HG12 ' A' ' 107' ' ' VAL . 9.6 tpt -39.54 -43.3 1.27 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.815 0.362 . . . . 0.0 110.538 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' NZ ' ' A' ' 137' ' ' LYS . 65.2 t0 -44.09 -60.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.366 1.041 . . . . 0.0 109.967 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 1.329 HG21 ' O ' ' A' ' 15' ' ' ASN . 95.5 t -43.71 -56.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 124.491 1.12 . . . . 0.0 109.377 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -45.46 -51.73 11.14 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.786 1.304 . . . . 0.0 110.457 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.886 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 5.6 m-20 -49.01 -70.06 0.1 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.468 1.105 . . . . 0.0 109.417 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 38.0 mtmm -44.77 -46.53 10.59 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.758 1.286 . . . . 0.0 110.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.106 ' O ' HG22 ' A' ' 141' ' ' VAL . 18.5 mt -55.78 -62.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.269 0.981 . . . . 0.0 108.435 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.826 ' HA ' HH12 ' A' ' 48' ' ' ARG . 78.0 p -58.53 0.29 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.886 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 10.7 mm100 -94.99 -48.97 5.76 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.25 0.969 . . . . 0.0 109.727 177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.123 ' O ' ' NH2' ' A' ' 48' ' ' ARG . 33.8 m -49.98 124.98 17.59 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.508 1.13 . . . . 0.0 110.208 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.9 Cg_exo -43.79 -177.06 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.629 2.886 . . . . 0.0 113.903 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.307 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.08 -141.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.628 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.491 ' H ' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER 179.73 143.41 0.16 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 110.698 -2.956 . . . . 0.0 111.865 170.115 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -67.74 111.91 4.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.113 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.75 ' CG2' ' HB ' ' A' ' 152' ' ' VAL . 1.3 t -77.24 -144.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 124.642 1.214 . . . . 0.0 109.355 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -63.44 -113.09 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 171.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.527 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 97.1 Cg_endo -68.97 -46.15 1.7 Allowed 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 123.596 2.864 . . . . 0.0 110.029 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.527 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 72.8 m-85 -68.67 97.82 0.84 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.454 1.096 . . . . 0.0 110.329 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -71.68 139.22 49.11 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.217 173.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 150' ' ' GLN . 17.6 m-20 81.2 82.4 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.873 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.75 ' HB ' ' CG2' ' A' ' 146' ' ' VAL . 72.9 t -140.27 121.05 9.17 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 114.167 -1.379 . . . . 0.0 107.714 168.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.307 ' CA ' HG22 ' A' ' 143' ' ' THR . 44.5 Cg_endo -62.05 102.88 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.565 2.843 . . . . 0.0 109.77 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.908 ' H ' ' HA ' ' A' ' 143' ' ' THR . 66.5 p -44.23 -54.02 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.731 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 155' ' ' LYS . 39.3 tptt -75.27 105.48 2.04 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.71 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.8 Cg_endo -78.7 122.71 5.56 Favored 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.032 -164.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 158' ' ' VAL . 93.1 t -69.44 157.79 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.054 166.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 1.012 ' HA ' HG22 ' A' ' 45' ' ' THR . 89.0 t -158.21 119.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.153 174.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.993 HG13 ' HA ' ' A' ' 45' ' ' THR . 39.5 mt -68.64 137.7 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.26 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -90.78 -47.11 7.83 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.778 -2.01 . . . . 0.0 110.471 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 28.5 t -166.83 170.12 12.6 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.424 1.077 . . . . 0.0 111.906 -175.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.056 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . -168.88 134.72 1.7 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.739 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.622 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -170.83 151.22 3.36 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.085 174.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.35 136.62 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.046 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.043 HD22 ' HD2' ' A' ' 166' ' ' PRO . 3.3 tm? -68.93 121.33 81.15 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.042 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 1.043 ' HD2' HD22 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 123.536 2.824 . . . . 0.0 112.015 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.92 ' O ' ' HG2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.92 ' HG2' ' O ' ' A' ' 1' ' ' ALA . 33.5 mmtp 112.72 -117.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.544 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 1.27 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . -47.92 164.75 0.22 Allowed Glycine 0 N--CA 1.474 1.189 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.243 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.27 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 72.3 m-20 -171.97 82.44 0.47 Allowed Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.217 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 74.5 Cg_endo -73.91 63.35 4.95 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.834 3.023 . . . . 0.0 110.169 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.217 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 1.7 m-70 -153.03 79.14 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.775 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.639 HG23 HD13 ' A' ' 20' ' ' LEU . 43.1 t -60.08 75.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.129 ' HG ' ' HB3' ' A' ' 17' ' ' GLU . 7.9 tt -79.84 105.55 11.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 113.656 -1.611 . . . . 0.0 109.557 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.191 HD23 ' O ' ' A' ' 161' ' ' SER . 10.7 mt -92.88 177.08 6.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.935 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 1.143 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 99.2 m -160.47 84.61 0.7 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.678 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.997 HG22 HG12 ' A' ' 159' ' ' ILE . 24.2 p -78.4 162.72 26.22 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 125.054 1.471 . . . . 0.0 111.662 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 158' ' ' VAL . 65.0 m -41.1 -50.41 3.44 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.263 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.693 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -47.67 -58.38 4.36 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.594 1.184 . . . . 0.0 110.531 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.67 47.02 Favored Glycine 0 N--CA 1.476 1.352 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.965 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.897 ' O ' HG23 ' A' ' 16' ' ' ILE . 46.0 t30 -65.6 151.56 46.19 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.416 -1.392 . . . . 0.0 111.799 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 15' ' ' ASN . 25.3 pt -168.81 166.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.822 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.129 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . 12.5 pt-20 -163.11 117.09 1.64 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.314 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.988 HD21 HD11 ' A' ' 105' ' ' ILE . 3.0 mm? -76.87 165.52 24.58 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.738 1.274 . . . . 0.0 110.465 164.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.217 ' OE2' ' CE1' ' A' ' 6' ' ' HIS . 39.8 tt0 -131.24 119.49 21.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.944 173.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.939 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.4 mp -99.88 115.12 28.89 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.118 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.72 98.24 0.51 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.579 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.049 ' HA ' HG11 ' A' ' 29' ' ' VAL . 10.0 mtmp? -69.67 -49.59 52.14 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.614 1.196 . . . . 0.0 111.763 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.446 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 13.8 tt0 -44.33 -62.87 1.01 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.333 1.021 . . . . 0.0 110.556 -171.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.22 9.57 0.42 Allowed 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.724 1.265 . . . . 0.0 113.543 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.68 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -161.05 68.57 2.51 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 123.855 0.722 . . . . 0.0 109.452 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 29' ' ' VAL . 52.0 Cg_exo -56.21 -63.14 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.493 2.796 . . . . 0.0 110.94 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.0 t -54.0 -61.47 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 124.832 1.333 . . . . 0.0 109.944 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 37.1 t -43.99 -58.84 2.58 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.753 1.283 . . . . 0.0 110.624 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.049 HG11 ' HA ' ' A' ' 22' ' ' LYS . 28.1 m -51.76 -49.48 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 124.629 1.206 . . . . 0.0 110.69 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.848 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.6 tm0? -47.36 -57.77 4.9 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.314 1.009 . . . . 0.0 109.313 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 1.15 ' OD1' HG21 ' A' ' 73' ' ' ILE . 10.8 m120 -42.7 -55.26 3.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.636 1.21 . . . . 0.0 110.282 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.967 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 57.9 m-85 -44.1 -62.14 1.24 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.576 1.172 . . . . 0.0 110.022 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 62.0 t -40.64 -46.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.541 1.15 . . . . 0.0 110.758 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.848 ' OD1' ' NE2' ' A' ' 30' ' ' GLN . 7.0 m-20 -45.0 -60.51 2.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.37 1.044 . . . . 0.0 109.576 174.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.484 ' O ' ' HB2' ' A' ' 38' ' ' SER . 74.0 m-85 -57.29 -55.97 27.85 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.945 1.403 . . . . 0.0 109.149 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 HG13 ' A' ' 164' ' ' VAL . 69.4 t -44.4 -64.87 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.61 1.194 . . . . 0.0 109.589 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 33' ' ' VAL . 23.2 t-20 -45.8 -49.35 15.17 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.828 1.33 . . . . 0.0 110.133 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 58.2 m -53.93 -109.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.591 1.182 . . . . 0.0 110.215 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.828 ' HA2' ' OD1' ' A' ' 42' ' ' ASN . . . -174.88 48.07 0.13 Allowed Glycine 0 N--CA 1.474 1.213 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.215 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.803 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 22.9 t80 -73.84 -64.08 1.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.629 0.84 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.747 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 39.9 m-85 -67.74 -23.18 65.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.118 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.828 ' OD1' ' HA2' ' A' ' 39' ' ' GLY . 35.2 m120 -38.74 -39.8 0.54 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.817 0.698 . . . . 0.0 112.592 -170.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -152.79 50.56 0.74 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.243 0.964 . . . . 0.0 110.133 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 45' ' ' THR . 49.4 p -79.06 -144.36 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.21 161.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.93 HG22 ' HA ' ' A' ' 158' ' ' VAL . 42.9 p -163.85 -139.21 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.746 0.784 . . . . 0.0 112.168 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 159' ' ' ILE . 51.7 m-85 -157.42 64.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.195 -1.821 . . . . 0.0 107.442 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.715 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 2.2 p-80 -61.61 -60.56 3.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.189 -1.368 . . . . 0.0 109.417 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.715 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.4 mtt180 -69.2 116.78 10.03 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.558 1.161 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 55' ' ' ILE . 68.3 t -152.21 150.74 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 124.87 1.357 . . . . 0.0 110.95 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.974 HD12 ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -158.75 122.34 2.09 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.457 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 53' ' ' PHE . 88.0 Cg_exo -37.54 160.61 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.637 2.891 . . . . 0.0 113.941 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.03 68.45 0.0 OUTLIER Glycine 0 N--CA 1.474 1.207 0 CA-C-N 114.022 -1.445 . . . . 0.0 113.831 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.018 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.6 t80 -161.15 -59.12 0.05 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.782 0.931 . . . . 0.0 109.495 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.018 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 57.5 mtm -163.29 157.21 19.92 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.54 1.15 . . . . 0.0 112.29 -171.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.894 ' CD1' ' HB1' ' A' ' 135' ' ' ALA . 42.4 pt -161.56 145.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.932 174.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.75 ' HG2' ' CB ' ' A' ' 104' ' ' PHE . 18.2 mt-30 -146.1 168.75 20.2 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.147 0.904 . . . . 0.0 112.079 -166.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.36 -158.95 9.91 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.672 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.803 ' HA2' ' CE1' ' A' ' 40' ' ' PHE . . . 65.97 78.23 0.24 Allowed Glycine 0 N--CA 1.47 0.93 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.159 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 1.569 ' CA ' ' HE3' ' A' ' 67' ' ' LYS . . . 177.89 -133.79 2.27 Favored Glycine 0 N--CA 1.475 1.267 0 O-C-N 124.669 0.864 . . . . 0.0 111.231 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 64.0 m-85 -42.54 128.02 3.9 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.282 -0.959 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.655 ' OG1' ' OE2' ' A' ' 62' ' ' GLU . 78.3 p -59.01 -149.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.344 1.027 . . . . 0.0 110.733 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 1.161 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -59.91 -89.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.282 178.083 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 1.161 ' H ' ' CG ' ' A' ' 62' ' ' GLU . 32.9 mt-30 -72.28 52.52 0.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.77 1.294 . . . . 0.0 110.018 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.635 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 50.4 mtt 40.84 35.74 0.36 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.071 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.574 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 58.0 tp60 -77.72 99.97 6.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' LYS . 88.7 mt-30 -27.03 140.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.446 -172.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.569 ' HE3' ' CA ' ' A' ' 59' ' ' GLY . 52.7 mttp -51.44 -127.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.84 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 1.178 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 98.1 mttt 179.57 84.79 0.18 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 112.683 -2.053 . . . . 0.0 106.897 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 1.048 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 52.9 Cg_endo -71.73 -167.93 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.639 2.893 . . . . 0.0 113.297 -171.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.048 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 79.1 m-20 -165.09 170.41 6.39 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 113.327 -1.761 . . . . 0.0 109.984 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.981 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 34.7 Cg_endo -45.77 103.78 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.631 2.221 . . . . 0.0 108.977 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 71' ' ' PRO . 97.7 Cg_exo -45.45 -147.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.859 3.04 . . . . 0.0 113.711 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.208 HG13 ' O ' ' A' ' 98' ' ' SER . 26.4 pt -156.33 -126.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.044 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.504 ' N ' HG13 ' A' ' 73' ' ' ILE . 57.0 mtpt -146.71 133.36 19.91 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.045 0.841 . . . . 0.0 110.789 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.748 ' H ' ' HA ' ' A' ' 97' ' ' ASP . 61.9 t30 -59.36 170.16 1.05 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.886 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.02 165.78 1.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.412 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.758 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 175.65 -34.11 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.255 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 1.005 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 48.7 p-10 -67.17 -44.97 78.39 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.025 0.828 . . . . 0.0 110.319 -176.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 1.005 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 33.6 p-10 41.9 -101.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.221 0.951 . . . . 0.0 110.337 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 170.46 -69.97 0.13 Allowed Glycine 0 N--CA 1.473 1.116 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.762 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -38.47 159.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.693 0.878 . . . . 0.0 112.285 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 38.3 ptt180 -58.93 -139.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.569 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 45.4 t30 171.14 130.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.133 -174.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -167.55 152.64 7.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.202 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.643 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 39.8 ptt180 -40.69 125.51 2.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.585 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 1.007 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 113.33 -28.98 8.25 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.776 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.136 HG22 ' NZ ' ' A' ' 127' ' ' LYS . 17.8 p -79.97 131.0 35.72 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.824 0.821 . . . . 0.0 111.484 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.569 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -87.42 160.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.005 167.033 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.07 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -162.1 141.46 9.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.473 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 1.265 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -66.86 122.03 16.79 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.67 -176.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.14 ' O ' ' SD ' ' A' ' 90' ' ' MET . . . -81.0 -166.38 1.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.278 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.086 ' CD ' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.71 -149.7 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.83 175.342 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.086 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 55.3 m -167.2 -108.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.765 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.495 ' N ' HG22 ' A' ' 93' ' ' THR . . . -70.69 -93.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.467 1.104 . . . . 0.0 110.538 -171.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 97' ' ' ASP . 32.7 m-20 -43.9 117.06 1.1 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.133 0.896 . . . . 0.0 110.954 -175.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.127 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 53.6 mtmt -71.35 42.18 0.07 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.696 1.247 . . . . 0.0 111.087 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 1.127 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 90.7 m-20 179.27 86.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 1.208 ' O ' HG13 ' A' ' 73' ' ' ILE . 67.1 m -168.12 -96.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.679 1.237 . . . . 0.0 109.759 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 1.061 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 58.99 94.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.794 1.309 . . . . 0.0 107.947 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.7 p -77.88 -42.77 32.23 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.552 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -170.93 -44.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.247 0.967 . . . . 0.0 110.479 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.791 ' O ' ' HE2' ' A' ' 90' ' ' MET . 3.9 pt20 -36.15 146.05 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.295 0.997 . . . . 0.0 112.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.945 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -157.22 -179.52 8.27 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.881 -1.508 . . . . 0.0 110.405 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.769 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 35.7 p90 -151.03 122.44 7.87 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.271 -169.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.988 HD11 HD21 ' A' ' 18' ' ' LEU . 58.1 mt -94.2 101.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.365 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' OD1' ' HD1' ' A' ' 104' ' ' PHE . 7.3 m-20 -67.14 -175.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.778 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.608 HG12 ' CE ' ' A' ' 132' ' ' MET . 35.1 m -155.6 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.68 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -83.95 145.59 28.47 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.421 1.076 . . . . 0.0 110.874 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.1 m-20 -45.9 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.847 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 1.103 ' OD1' HD11 ' A' ' 113' ' ' LEU . 7.1 t-20 -68.81 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.864 1.353 . . . . 0.0 109.936 -170.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 110' ' ' ASN . . . 70.52 -19.26 0.22 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.857 0.723 . . . . 0.0 112.251 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' HD13 ' A' ' 113' ' ' LEU . 35.5 m-85 -69.38 36.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.68 0.612 . . . . 0.0 111.414 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.103 HD11 ' OD1' ' A' ' 110' ' ' ASN . 0.0 OUTLIER 179.22 -17.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.783 0.677 . . . . 0.0 111.815 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.764 ' N ' HD22 ' A' ' 113' ' ' LEU . 57.4 p-10 -47.85 138.83 8.25 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.683 0.614 . . . . 0.0 111.139 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 1.245 ' CB ' ' O ' ' A' ' 120' ' ' PHE . 17.1 t-160 -31.61 131.9 0.11 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.862 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.617 ' N ' ' CD2' ' A' ' 115' ' ' HIS . . . -171.4 163.97 36.81 Favored Glycine 0 N--CA 1.477 1.392 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.062 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.531 ' O ' ' HB3' ' A' ' 118' ' ' ARG . 10.3 pt20 -39.32 119.93 0.98 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.229 -0.986 . . . . 0.0 110.995 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.808 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 58.0 ttp180 71.58 27.15 3.04 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.279 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 65.4 t0 177.9 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.011 0.819 . . . . 0.0 109.409 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 1.245 ' O ' ' CB ' ' A' ' 115' ' ' HIS . 1.7 t80 -43.89 -45.61 7.64 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.643 1.215 . . . . 0.0 110.68 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' N ' ' A' ' 115' ' ' HIS . . . 89.97 176.68 45.18 Favored Glycine 0 N--CA 1.477 1.42 0 O-C-N 124.475 1.109 . . . . 0.0 113.108 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.835 ' CD1' HD23 ' A' ' 113' ' ' LEU . 68.1 m-85 -78.65 143.24 36.51 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.229 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.265 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -54.68 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.59 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.07 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 72.2 t -175.85 128.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.92 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.939 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.3 p90 -161.77 21.62 0.11 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.608 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 1.569 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -113.26 155.89 15.99 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 122.939 1.3 . . . . 0.0 112.507 -169.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.136 ' NZ ' HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -171.07 110.99 0.34 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 110.985 -2.608 . . . . 0.0 110.261 173.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.007 HG23 ' O ' ' A' ' 86' ' ' GLY . 58.3 t -58.11 157.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.223 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.052 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 33.1 m -154.44 32.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.231 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 1.052 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 74.5 mmtt 120.92 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.773 0.671 . . . . 0.0 109.508 174.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.861 ' CA ' HG22 ' A' ' 16' ' ' ILE . . . 171.78 -26.12 0.09 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.04 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 1.608 ' CE ' HG12 ' A' ' 107' ' ' VAL . 12.1 tpt -39.52 -51.17 2.2 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.975 0.456 . . . . 0.0 110.921 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.653 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 36.6 m-20 -43.88 -61.6 1.39 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.37 1.044 . . . . 0.0 109.541 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 15' ' ' ASN . 54.4 t -41.45 -60.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 124.739 1.274 . . . . 0.0 109.551 173.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.894 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -44.41 -53.09 7.2 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.654 1.221 . . . . 0.0 109.709 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.922 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 38.2 m-20 -50.69 -66.97 0.3 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.771 1.294 . . . . 0.0 109.03 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.541 ' O ' HG13 ' A' ' 141' ' ' VAL . 56.4 mtpt -40.2 -49.38 2.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.789 1.306 . . . . 0.0 110.539 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.27 ' O ' HG22 ' A' ' 141' ' ' VAL . 16.2 mt -57.84 -58.29 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.444 1.09 . . . . 0.0 108.837 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.658 ' HB3' HG21 ' A' ' 55' ' ' ILE . 84.9 p -65.51 3.42 0.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.922 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.5 mp0 -99.07 -49.39 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.168 0.917 . . . . 0.0 108.741 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.27 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.4 m -41.29 123.25 2.15 Favored Pre-proline 0 N--CA 1.473 0.711 0 O-C-N 124.349 1.031 . . . . 0.0 110.306 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.8 Cg_exo -38.83 -178.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.35 2.7 . . . . 0.0 113.575 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.41 HG22 ' CA ' ' A' ' 153' ' ' PRO . 6.0 p -160.96 -150.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.735 1.731 . . . . 0.0 112.688 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.57 ' ND1' ' O ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER 178.02 167.34 0.75 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 109.726 -3.397 . . . . 0.0 111.312 174.053 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 146' ' ' VAL . 36.8 m-20 -52.37 -149.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.819 165.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -161.99 -61.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.673 1.225 . . . . 0.0 108.347 171.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.59 -92.18 0.08 OUTLIER Glycine 0 N--CA 1.471 1.001 0 CA-C-N 111.335 -2.666 . . . . 0.0 107.687 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.699 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 80.2 Cg_endo -68.4 -67.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.479 2.786 . . . . 0.0 108.761 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.699 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 96.0 m-85 -72.0 117.05 13.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.583 1.177 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.755 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 4.3 pm0 -95.03 83.77 4.0 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.75 1.281 . . . . 0.0 107.945 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.917 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 0.3 OUTLIER 169.3 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.548 -177.035 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.672 ' CG2' HG21 ' A' ' 146' ' ' VAL . 95.9 t -160.31 116.25 1.45 Allowed Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.739 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.41 ' CA ' HG22 ' A' ' 143' ' ' THR . 58.1 Cg_endo -63.08 106.92 0.58 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 109.304 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.996 ' H ' ' HA ' ' A' ' 143' ' ' THR . 77.5 p -40.59 -51.64 2.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.289 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 1.234 ' HB3' ' CD ' ' A' ' 156' ' ' PRO . 10.8 mptt -61.45 -166.71 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.459 1.099 . . . . 0.0 111.933 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.234 ' CD ' ' HB3' ' A' ' 155' ' ' LYS . 78.3 Cg_endo -85.12 145.85 9.89 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.789 2.993 . . . . 0.0 112.733 -170.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.98 HG23 ' O ' ' A' ' 156' ' ' PRO . 38.3 t -170.55 115.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.794 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.93 ' HA ' HG22 ' A' ' 45' ' ' THR . 92.1 t -153.57 120.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.24 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.997 HG12 HG22 ' A' ' 11' ' ' THR . 43.3 mt -68.58 134.3 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.274 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.143 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.2 mt -79.67 -51.62 9.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 112.39 -2.186 . . . . 0.0 109.284 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . 1.191 ' O ' HD23 ' A' ' 9' ' ' LEU . 68.0 m -165.27 174.95 9.65 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.57 1.169 . . . . 0.0 112.697 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.905 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -157.73 100.77 1.78 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.104 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.951 ' O ' ' CD1' ' A' ' 165' ' ' LEU . 32.4 mmmt -125.32 125.81 44.09 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.15 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.845 ' C ' HD12 ' A' ' 165' ' ' LEU . 34.4 m -67.93 131.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.597 1.186 . . . . 0.0 109.824 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.026 HD22 HD13 ' A' ' 8' ' ' LEU . 6.8 mp -133.65 135.63 25.3 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.925 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.72 ' HD3' ' OD2' ' A' ' 4' ' ' ASP . 87.8 Cg_exo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.638 2.892 . . . . 0.0 112.027 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.715 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 2.0 tmtp? -48.49 -44.27 35.76 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.703 1.252 . . . . 0.0 110.422 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 1.192 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 179.6 112.53 0.35 Allowed Glycine 0 N--CA 1.475 1.251 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.192 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 85.9 m-20 -171.36 89.64 0.45 Allowed Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.433 0.725 . . . . 0.0 109.303 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.039 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 71.1 Cg_exo -54.94 127.45 26.35 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.832 3.022 . . . . 0.0 113.353 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.039 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 3.1 m-70 -150.48 118.11 6.15 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.86 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.2 p -73.98 138.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.208 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.096 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 6.4 mp -127.78 116.12 19.71 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.471 1.107 . . . . 0.0 109.619 166.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.83 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.1 mp -110.73 -175.96 2.85 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.049 -2.341 . . . . 0.0 108.726 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.762 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 52.6 m -161.48 99.9 1.17 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.359 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.926 HG22 HG12 ' A' ' 159' ' ' ILE . 40.7 p -76.29 169.01 19.03 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 125.307 1.629 . . . . 0.0 111.407 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -40.71 -42.17 1.69 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.338 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.825 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.48 -60.54 3.21 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.483 1.115 . . . . 0.0 110.759 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 179.65 44.29 Favored Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.345 -1.752 . . . . 0.0 114.012 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 1.146 ' O ' HG21 ' A' ' 134' ' ' VAL . 58.6 t-20 -55.55 159.3 2.95 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.948 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' OD1' ' A' ' 15' ' ' ASN . 10.1 tt -171.36 160.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.289 -172.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.096 ' HG2' ' CG ' ' A' ' 8' ' ' LEU . 35.4 mt-10 -162.92 121.48 2.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.109 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.007 HD21 HD11 ' A' ' 105' ' ' ILE . 2.8 mm? -92.01 173.86 7.62 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.403 1.064 . . . . 0.0 110.322 161.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.429 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -134.57 124.12 24.94 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.047 175.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 20' ' ' LEU . 6.5 mp -109.39 141.8 41.26 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.814 1.321 . . . . 0.0 111.735 -168.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.738 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 63.0 m-20 -55.86 -118.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.892 170.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.995 ' HD3' ' O ' ' A' ' 22' ' ' LYS . 5.8 tmtt? 124.66 -48.62 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.131 -1.85 . . . . 0.0 109.517 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -45.81 -65.3 0.56 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.625 1.203 . . . . 0.0 109.727 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.906 ' HD3' HD21 ' A' ' 81' ' ' LEU . 53.3 mtpt -90.61 21.92 3.75 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.704 1.253 . . . . 0.0 113.87 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.584 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.85 65.18 2.16 Favored Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 124.205 0.941 . . . . 0.0 110.57 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.95 ' O ' HG22 ' A' ' 29' ' ' VAL . 52.4 Cg_exo -59.66 -59.76 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.533 2.822 . . . . 0.0 110.965 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.1 t -50.4 -63.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.151 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -42.67 -57.55 2.67 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.7 1.25 . . . . 0.0 110.51 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.95 HG22 ' O ' ' A' ' 26' ' ' PRO . 26.8 m -52.75 -47.14 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.666 1.229 . . . . 0.0 110.871 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 29' ' ' VAL . 42.6 tp60 -46.93 -70.36 0.1 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.179 0.924 . . . . 0.0 109.931 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 1.218 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.7 m120 -42.07 -48.39 4.67 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.454 1.096 . . . . 0.0 110.312 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.718 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 69.7 t80 -42.98 -63.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.504 1.128 . . . . 0.0 109.759 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.0 t -45.51 -37.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.602 1.189 . . . . 0.0 111.021 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 1.218 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 84.2 m-20 -43.02 -63.44 0.8 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.063 0.852 . . . . 0.0 109.705 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.671 ' HB3' ' CD2' ' A' ' 40' ' ' PHE . 96.2 m-85 -61.13 -59.27 5.6 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.796 1.31 . . . . 0.0 109.095 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.722 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 59.9 t -39.41 -48.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 124.69 1.243 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.771 ' O ' ' HB3' ' A' ' 38' ' ' SER . 50.4 t30 -38.56 -31.23 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.725 1.266 . . . . 0.0 112.401 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.771 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.0 p 154.89 159.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.103 0.877 . . . . 0.0 113.151 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.44 -39.64 3.1 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.117 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.671 ' CD2' ' HB3' ' A' ' 35' ' ' TYR . 2.1 t80 -67.78 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.361 0.683 . . . . 0.0 110.92 -173.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 81.6 m-85 -60.87 -36.74 79.97 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.336 1.022 . . . . 0.0 112.669 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 52.2 p-10 -38.95 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.089 0.868 . . . . 0.0 110.767 -171.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.956 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 10.7 m-20 76.59 39.47 0.25 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 113.49 -1.687 . . . . 0.0 111.633 175.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 45' ' ' THR . 48.9 p -78.66 -129.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 166.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.986 ' HA ' HG13 ' A' ' 159' ' ' ILE . 61.7 p -163.44 -147.42 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.824 1.297 . . . . 0.0 113.59 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.727 ' CD1' HD11 ' A' ' 159' ' ' ILE . 16.7 m-85 -161.54 59.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 111.579 -2.555 . . . . 0.0 105.222 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 1.208 ' CE1' ' OE1' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -38.68 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.489 -173.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.143 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.0 mmm180 -173.35 -155.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 123.081 1.42 . . . . 0.0 113.33 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.044 HG12 ' HA ' ' A' ' 55' ' ' ILE . 7.6 p -179.7 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 111.682 -2.508 . . . . 0.0 107.539 159.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.886 HG22 ' HB2' ' A' ' 54' ' ' MET . 9.3 tt -171.75 131.3 0.74 Allowed Pre-proline 0 N--CA 1.476 0.873 0 O-C-N 124.451 1.094 . . . . 0.0 109.983 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.682 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 81.9 Cg_exo -48.85 157.7 1.5 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.893 3.062 . . . . 0.0 114.398 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.24 53.38 0.01 OUTLIER Glycine 0 N--CA 1.475 1.284 0 CA-C-N 114.02 -1.445 . . . . 0.0 114.192 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.047 ' CE2' ' HE3' ' A' ' 54' ' ' MET . 1.5 t80 -162.14 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.665 0.862 . . . . 0.0 110.037 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.047 ' HE3' ' CE2' ' A' ' 53' ' ' PHE . 45.0 mtt -160.18 147.57 16.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.231 0.957 . . . . 0.0 111.611 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.044 ' HA ' HG12 ' A' ' 49' ' ' VAL . 38.4 pt -148.62 141.66 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.276 -1.783 . . . . 0.0 108.19 167.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 1.468 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 62.5 mt-30 -64.75 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.146 -163.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 1.11 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -129.3 -121.17 2.32 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 118.667 -2.521 . . . . 0.0 109.928 0.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . 52.97 109.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.063 0 CA-C-N 114.271 -0.965 . . . . 0.0 111.22 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.86 -126.01 1.11 Allowed Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.525 0.779 . . . . 0.0 111.717 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.862 ' CE2' ' HG2' ' A' ' 66' ' ' GLN . 29.8 m-85 -43.08 134.02 3.65 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.788 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.967 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 61.7 p -59.36 124.67 20.8 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.265 0.978 . . . . 0.0 109.837 169.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 1.129 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 13.11 -104.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.757 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 1.24 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.5 mm100 -38.11 -59.99 0.8 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.778 1.299 . . . . 0.0 111.445 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 1.24 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 14.6 mmt 145.11 98.43 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 1.071 ' NE2' ' O ' ' A' ' 64' ' ' MET . 90.0 mm-40 -160.65 71.04 0.42 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 112.621 -2.081 . . . . 0.0 106.966 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.862 ' HG2' ' CE2' ' A' ' 60' ' ' PHE . 39.6 mt-30 -28.52 130.73 0.06 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.24 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.967 ' HE3' ' CG2' ' A' ' 61' ' ' THR . 18.6 mmtp -72.57 153.7 41.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.396 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.775 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 7.5 mmpt? -48.03 95.33 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.799 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.865 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 71.4 Cg_exo -59.12 -69.79 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.593 2.862 . . . . 0.0 113.192 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.925 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 34.8 m120 89.75 163.28 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 O-C-N 124.402 1.064 . . . . 0.0 111.132 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.925 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 58.6 Cg_endo -67.71 112.04 2.54 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.875 3.05 . . . . 0.0 110.88 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.212 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 88.5 Cg_exo -52.1 -150.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.798 2.998 . . . . 0.0 112.957 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.569 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.52 156.79 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 1.043 ' HD2' ' H ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -33.3 135.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.192 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' LYS . 56.6 p30 -45.7 -164.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.44 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB3' HD21 ' A' ' 79' ' ' ASN . 8.4 mm-40 161.67 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.589 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.848 ' HB3' ' CE1' ' A' ' 120' ' ' PHE . . . -71.29 -43.26 67.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.251 0.969 . . . . 0.0 109.791 171.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 1.064 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 20.9 p-10 -67.41 -53.5 28.61 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.424 1.077 . . . . 0.0 109.907 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 76' ' ' GLU . 38.5 p-10 -63.51 99.26 0.2 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.237 1.018 . . . . 0.0 108.876 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 1.232 ' O ' HD13 ' A' ' 81' ' ' LEU . . . 172.22 46.87 0.04 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.359 -1.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.232 HD13 ' O ' ' A' ' 80' ' ' GLY . 1.7 mm? -146.14 -149.29 0.28 Allowed 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.626 0.839 . . . . 0.0 109.499 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -179.74 150.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -169.49 -124.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.519 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 1.114 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 16.2 m -168.6 163.46 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.025 0.828 . . . . 0.0 112.004 -162.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 1.114 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 8.3 ptm85 -19.92 108.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.19 164.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.743 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 137.2 -27.03 2.92 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 111.575 -2.557 . . . . 0.0 110.233 -168.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.153 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.2 p -92.66 142.82 26.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.91 0.862 . . . . 0.0 112.191 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.894 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.74 162.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.094 166.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.117 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -156.01 140.97 17.26 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 113.943 -1.48 . . . . 0.0 111.829 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.916 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.1 tpt -56.88 140.3 48.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.507 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . . . -109.38 129.3 55.54 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.457 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.28 ' HG2' ' N ' ' A' ' 99' ' ' ALA . 29.9 tpt180 179.15 175.98 0.62 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.765 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.707 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 89.6 m -168.3 115.86 0.7 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.563 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.796 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 165.01 -50.69 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.025 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.796 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 16.0 p30 74.37 -177.39 0.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.541 1.151 . . . . 0.0 112.323 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.174 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 0.4 OUTLIER 79.94 -49.29 0.36 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.763 -172.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 1.174 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 73.7 m-20 -162.45 61.32 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.617 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 21.6 t -74.22 173.75 9.72 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.773 1.296 . . . . 0.0 113.333 -170.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 1.28 ' N ' ' HG2' ' A' ' 92' ' ' ARG . . . 65.01 170.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.76 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.996 HG22 ' HG3' ' A' ' 72' ' ' PRO . 72.8 p -150.93 -48.41 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.297 -174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.0 p -171.07 -52.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.257 0.973 . . . . 0.0 110.179 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.694 ' O ' ' SD ' ' A' ' 90' ' ' MET . 14.1 pt20 -42.83 154.22 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.353 1.033 . . . . 0.0 112.183 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.894 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -159.28 168.73 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.456 175.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 1.468 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 17.1 p90 -144.49 137.68 27.07 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.326 -170.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.069 ' N ' ' O ' ' A' ' 56' ' ' GLN . 63.1 mt -93.95 116.65 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 112.057 -2.338 . . . . 0.0 110.612 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -64.86 116.51 6.41 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.5 1.125 . . . . 0.0 109.572 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.871 ' HB ' ' C ' ' A' ' 53' ' ' PHE . 51.9 t -90.44 22.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 124.488 1.118 . . . . 0.0 112.133 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.852 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . 169.21 172.53 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.609 0.719 . . . . 0.0 112.108 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.558 ' N ' ' HB3' ' A' ' 85' ' ' ARG . 71.7 m-20 -38.62 144.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.596 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.548 HD21 ' HB2' ' A' ' 113' ' ' LEU . 26.6 t-20 -170.57 155.95 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.435 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 176.13 -50.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.465 -1.698 . . . . 0.0 108.296 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.953 ' O ' ' HD1' ' A' ' 112' ' ' PHE . 3.2 p90 -61.26 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 167.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.76 HD11 ' CE1' ' A' ' 122' ' ' TYR . 36.9 tp 177.92 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.103 -171.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 122' ' ' TYR . 34.0 m-20 -38.47 -60.91 0.75 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.282 0.989 . . . . 0.0 111.182 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.601 ' ND1' ' HA ' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 179.05 84.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.587 1.179 . . . . 0.0 108.547 -175.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 117' ' ' GLN . . . 171.22 100.96 0.14 Allowed Glycine 0 N--CA 1.473 1.157 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.584 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 24.8 tt0 176.14 -92.14 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.602 0.824 . . . . 0.0 109.292 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -69.57 -46.29 66.73 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.08 0.862 . . . . 0.0 111.023 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -173.29 -47.56 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.295 0.997 . . . . 0.0 111.092 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.848 ' CE1' ' HB3' ' A' ' 77' ' ' ALA . 1.3 t80 -178.03 83.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.36 -130.44 0.09 OUTLIER Glycine 0 N--CA 1.473 1.156 0 CA-C-N 113.829 -1.532 . . . . 0.0 114.137 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.76 ' CE1' HD11 ' A' ' 113' ' ' LEU . 76.3 m-85 -78.93 150.41 32.1 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.499 -1.351 . . . . 0.0 112.674 -167.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.117 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -81.11 -163.15 0.56 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.6 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.993 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 73.9 t 179.39 140.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.111 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.681 ' CZ ' ' HD2' ' A' ' 103' ' ' PHE . 9.8 p90 -164.76 22.56 0.06 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 1.217 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -171.73 -136.3 2.1 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 122.976 1.32 . . . . 0.0 113.745 173.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.429 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 8.7 mtpm? 179.6 -133.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 111.275 -2.463 . . . . 0.0 109.162 -172.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.903 HG22 ' CD1' ' A' ' 18' ' ' LEU . 80.4 t -153.36 120.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.573 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.933 ' CG1' ' CB ' ' A' ' 17' ' ' GLU . 7.7 p -69.85 -46.49 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.104 172.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.809 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 58.5 mtpt -166.66 -135.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.449 1.093 . . . . 0.0 108.87 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . 62.36 -17.36 0.07 OUTLIER Glycine 0 N--CA 1.474 1.212 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.01 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.542 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 8.3 tpt -39.57 -42.88 1.23 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.009 0.404 . . . . 0.0 110.355 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 12.1 m-20 -45.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.438 1.087 . . . . 0.0 109.72 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 1.146 HG21 ' O ' ' A' ' 15' ' ' ASN . 59.5 t -46.5 -57.17 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.474 1.109 . . . . 0.0 109.167 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -44.4 -53.69 6.6 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.618 1.199 . . . . 0.0 109.672 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.819 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 42.0 m-20 -51.96 -64.37 0.84 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.623 1.202 . . . . 0.0 108.854 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 56.0 tptt -39.83 -54.07 2.18 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.86 1.35 . . . . 0.0 110.552 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.199 ' O ' HG12 ' A' ' 141' ' ' VAL . 21.0 mt -59.74 -58.68 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.561 1.163 . . . . 0.0 109.363 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.3 p -55.13 -8.73 0.32 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.819 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 11.5 mm100 -96.2 -44.69 7.16 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.356 1.035 . . . . 0.0 110.082 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.199 HG12 ' O ' ' A' ' 138' ' ' ILE . 8.0 p -48.96 131.48 15.02 Favored Pre-proline 0 N--CA 1.474 0.741 0 O-C-N 124.417 1.073 . . . . 0.0 110.444 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 86.3 Cg_exo -46.9 172.02 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.649 2.9 . . . . 0.0 113.795 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.366 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.06 -140.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.225 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.5 ' H ' ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER 179.0 158.43 0.56 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 110.942 -2.844 . . . . 0.0 112.696 169.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 146' ' ' VAL . 45.1 t0 -50.38 -179.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.734 165.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.924 HG21 ' CG2' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -158.03 -143.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.59 -110.33 0.01 OUTLIER Glycine 0 N--CA 1.472 1.059 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.982 ' HG2' ' HD1' ' A' ' 149' ' ' TYR . 94.6 Cg_endo -71.81 -46.7 0.54 Allowed 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 123.8 3.0 . . . . 0.0 110.259 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.982 ' HD1' ' HG2' ' A' ' 148' ' ' PRO . 34.9 m-85 -68.56 109.43 3.74 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.429 1.081 . . . . 0.0 110.933 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.569 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 7.6 mm-40 -84.94 64.47 8.68 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.213 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.839 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 54.7 p30 178.74 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.284 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.924 ' CG2' HG21 ' A' ' 146' ' ' VAL . 94.1 t -154.84 118.26 2.51 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.803 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.366 ' CA ' HG22 ' A' ' 143' ' ' THR . 61.0 Cg_endo -67.18 110.37 1.98 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.656 2.904 . . . . 0.0 109.736 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.728 ' H ' ' HA ' ' A' ' 143' ' ' THR . 40.0 t -44.95 -62.46 1.22 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.383 175.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 153' ' ' PRO . 67.3 mttm -66.99 140.65 96.18 Favored Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.633 1.208 . . . . 0.0 109.513 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 73.4 Cg_endo -88.11 114.82 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.107 2.538 . . . . 0.0 113.346 -161.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 158' ' ' VAL . 44.7 t -76.97 148.72 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.7 157.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.883 ' HA ' HG22 ' A' ' 45' ' ' THR . 95.8 t -163.67 122.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.88 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.986 HG13 ' HA ' ' A' ' 45' ' ' THR . 20.6 mt -68.01 130.49 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.361 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.762 ' HB2' ' O ' ' A' ' 10' ' ' THR . 84.7 mt -79.83 -48.05 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 112.535 -2.12 . . . . 0.0 110.171 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.7 m -162.84 -167.78 1.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.564 1.165 . . . . 0.0 112.484 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.83 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . -178.99 139.66 0.16 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.283 -1.781 . . . . 0.0 109.703 -175.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 8' ' ' LEU . 22.0 ptmt -170.85 126.27 0.71 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.743 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.39 145.48 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.989 -1.46 . . . . 0.0 110.617 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.989 ' HB3' ' HD3' ' A' ' 166' ' ' PRO . 55.2 tp -58.52 -59.87 12.14 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.974 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.989 ' HD3' ' HB3' ' A' ' 165' ' ' LEU . 82.1 Cg_exo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 123.242 2.628 . . . . 0.0 111.985 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.733 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 63.1 pttt 151.34 163.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.733 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 1.252 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . -168.69 -69.52 0.03 OUTLIER Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.252 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 73.1 m-20 -169.74 86.18 0.59 Allowed Pre-proline 0 N--CA 1.473 0.704 0 O-C-N 124.561 0.8 . . . . 0.0 108.989 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.253 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 71.9 Cg_endo -62.53 118.65 5.54 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.496 2.798 . . . . 0.0 109.653 173.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.253 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -158.23 97.99 1.54 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.621 -175.054 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.992 ' HA ' HG12 ' A' ' 164' ' ' VAL . 87.1 t -61.02 79.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 165.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.095 ' HB3' ' O ' ' A' ' 163' ' ' LYS . 7.3 tt -79.86 106.91 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.356 -169.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.155 HD23 ' O ' ' A' ' 161' ' ' SER . 12.3 mt -103.64 171.88 7.12 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 113.163 -1.835 . . . . 0.0 112.331 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 1.274 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 94.6 m -160.52 79.08 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.9 -2.409 . . . . 0.0 107.084 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.956 HG22 HG12 ' A' ' 159' ' ' ILE . 32.4 p -74.73 167.1 22.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 125.132 1.52 . . . . 0.0 111.952 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.558 ' OG ' HG13 ' A' ' 157' ' ' VAL . 78.3 p -41.41 -49.52 3.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.459 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.681 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.47 -55.88 24.44 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.424 1.078 . . . . 0.0 110.289 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' HG11 ' A' ' 134' ' ' VAL . . . 171.48 -179.95 42.92 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.911 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.883 ' O ' HG21 ' A' ' 134' ' ' VAL . 49.7 t30 -57.82 159.14 5.65 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.545 -1.328 . . . . 0.0 111.97 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.786 HG13 ' HB2' ' A' ' 9' ' ' LEU . 19.3 pt -162.59 -173.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.903 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.892 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 7.2 mm-40 -161.27 126.81 3.7 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.284 -170.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.953 HD21 HD11 ' A' ' 105' ' ' ILE . 2.9 mm? -112.0 114.04 26.69 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.547 1.154 . . . . 0.0 108.925 164.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.947 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 11.9 pt-20 -79.53 111.13 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.503 1.127 . . . . 0.0 108.53 169.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.811 HD23 ' CE2' ' A' ' 125' ' ' PHE . 7.2 mp -108.56 131.58 54.71 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.881 1.363 . . . . 0.0 110.775 -174.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.954 ' OD1' ' NZ ' ' A' ' 127' ' ' LYS . 40.1 m-20 -57.33 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.037 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.739 ' HG3' ' N ' ' A' ' 23' ' ' GLN . 22.2 ptmt 142.65 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.372 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.739 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 3.9 pt20 -49.74 -44.31 48.47 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.72 1.262 . . . . 0.0 110.473 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 1.078 ' HE3' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -68.55 -15.07 63.41 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.305 1.003 . . . . 0.0 112.906 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.008 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -160.73 72.36 2.81 Favored Pre-proline 0 N--CA 1.475 0.81 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 75.6 Cg_exo -55.91 -64.44 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.633 2.889 . . . . 0.0 111.73 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 66.4 t -53.18 -67.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.68 1.237 . . . . 0.0 109.911 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.742 ' HA ' HG13 ' A' ' 73' ' ' ILE . 58.8 m -44.67 -61.71 1.47 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.579 1.174 . . . . 0.0 109.853 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 25' ' ' ALA . 47.3 t -49.25 -52.56 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 124.786 1.304 . . . . 0.0 109.92 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.537 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 38.6 tp60 -41.81 -61.47 1.1 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.475 1.109 . . . . 0.0 110.049 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.698 ' CG ' HG21 ' A' ' 73' ' ' ILE . 11.9 m120 -42.91 -51.91 5.35 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.564 1.165 . . . . 0.0 109.765 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.958 ' O ' HG23 ' A' ' 36' ' ' VAL . 78.9 t80 -40.64 -57.76 1.79 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.629 1.206 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.823 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 57.6 t -51.18 -38.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.754 1.283 . . . . 0.0 111.316 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.789 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 8.4 p-10 -44.9 -55.51 5.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.951 0.782 . . . . 0.0 109.362 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.88 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 54.5 m-85 -69.64 -53.73 17.3 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.09 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 32' ' ' PHE . 61.9 t -39.39 -50.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.164 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.789 ' CG ' ' O ' ' A' ' 34' ' ' ASP . 51.0 p30 -37.92 -33.4 0.08 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.703 1.252 . . . . 0.0 112.098 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.766 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.3 p 146.4 136.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.239 0.962 . . . . 0.0 112.028 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 1.064 ' N ' ' OD1' ' A' ' 42' ' ' ASN . . . 131.14 -59.25 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.51 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.896 ' O ' HG23 ' A' ' 44' ' ' THR . 61.1 t80 -62.99 -74.35 0.1 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.291 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.446 ' CG ' ' HD1' ' A' ' 40' ' ' PHE . 68.5 m-85 -66.75 -25.08 66.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.485 1.115 . . . . 0.0 112.913 -173.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 1.064 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 14.0 m120 -38.75 -36.59 0.27 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.902 0.751 . . . . 0.0 112.467 -173.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -157.97 47.46 0.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.124 0.89 . . . . 0.0 110.325 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.896 HG23 ' O ' ' A' ' 40' ' ' PHE . 46.2 p -79.71 -133.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.314 164.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.959 ' HA ' HG13 ' A' ' 159' ' ' ILE . 77.8 p -162.96 -153.03 0.23 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.87 0.843 . . . . 0.0 111.817 173.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.072 ' HZ ' HD13 ' A' ' 9' ' ' LEU . 14.4 m-30 -141.85 63.42 1.42 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.174 -1.83 . . . . 0.0 106.585 174.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 1.085 ' CE1' ' HA2' ' A' ' 59' ' ' GLY . 1.1 p-80 -51.94 -72.67 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.684 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.896 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 84.2 mtm180 -71.49 130.48 41.37 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.42 1.075 . . . . 0.0 111.075 -173.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.926 HG23 ' HB ' ' A' ' 55' ' ' ILE . 10.9 p -159.96 157.36 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.844 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.078 HD13 ' HD2' ' A' ' 53' ' ' PHE . 9.9 tt -155.7 127.04 3.66 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.484 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 94.2 Cg_exo -38.7 155.14 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.577 2.851 . . . . 0.0 113.486 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -3.23 66.59 0.0 OUTLIER Glycine 0 N--CA 1.475 1.266 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.888 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.078 ' HD2' HD13 ' A' ' 50' ' ' ILE . 10.9 t80 -161.02 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.808 0.946 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.866 ' HG2' ' N ' ' A' ' 55' ' ' ILE . 54.2 ttp -167.62 177.45 5.87 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.484 1.115 . . . . 0.0 111.958 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.926 ' HB ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 171.39 113.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.12 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 18.6 mt-30 -98.62 -170.65 1.98 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.232 -166.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.22 28.79 Favored Glycine 0 N--CA 1.477 1.377 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.533 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.762 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 93.27 -59.69 2.28 Favored Glycine 0 N--CA 1.474 1.206 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 -165.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 1.085 ' HA2' ' CE1' ' A' ' 47' ' ' HIS . . . 41.34 143.65 0.0 OUTLIER Glycine 0 N--CA 1.472 1.074 0 CA-C-N 114.212 -0.994 . . . . 0.0 114.014 168.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.905 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 14.1 m-30 -46.89 150.7 0.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.406 -1.397 . . . . 0.0 110.673 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.273 HG21 ' OE1' ' A' ' 65' ' ' GLN . 94.8 m -59.08 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.316 -174.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 1.129 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 1.5 mp0 48.51 116.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.758 1.286 . . . . 0.0 110.745 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 1.31 ' O ' ' CG ' ' A' ' 64' ' ' MET . 8.5 pt20 69.02 -48.83 0.59 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.558 1.161 . . . . 0.0 111.0 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 1.31 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 25.0 mmt 158.38 98.22 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.981 1.372 . . . . 0.0 108.715 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 1.273 ' OE1' HG21 ' A' ' 61' ' ' THR . 48.4 tt0 -150.46 79.71 1.34 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.014 -2.812 . . . . 0.0 105.187 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.792 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -27.04 176.81 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.404 -1.725 . . . . 0.0 115.627 -166.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.199 ' H ' ' CD ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -48.07 -140.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 111.412 -2.631 . . . . 0.0 112.271 -174.143 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 1.06 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 40.2 ttpt 178.31 -70.94 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.076 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 1.06 ' CD ' ' HB3' ' A' ' 68' ' ' LYS . 59.8 Cg_endo -62.56 133.09 40.85 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.589 2.859 . . . . 0.0 111.011 173.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.518 ' HA ' ' CG2' ' A' ' 100' ' ' THR . 92.2 m-20 -168.61 72.14 0.8 Allowed Pre-proline 0 N--CA 1.474 0.725 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.033 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 80.0 Cg_exo -48.29 -64.06 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.391 2.728 . . . . 0.0 110.937 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.15 ' CB ' ' HA ' ' A' ' 98' ' ' SER . 50.3 Cg_exo -87.71 -140.63 0.16 OUTLIER 'Cis proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.798 -1.751 . . . . 0.0 110.835 -2.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.318 HD11 ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -158.6 150.95 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 74.4 mmtt -30.14 145.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.877 -1.51 . . . . 0.0 113.049 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 1.219 ' OD1' ' HB3' ' A' ' 96' ' ' LYS . 40.4 m-80 -42.77 -167.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.272 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.223 ' OE1' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 161.19 118.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.231 -177.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.882 ' HB2' HH11 ' A' ' 92' ' ' ARG . . . 174.06 -51.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.897 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 1.008 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 59.8 p30 -70.35 39.07 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.501 1.126 . . . . 0.0 111.693 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 77' ' ' ALA . 4.6 p30 -40.6 -41.43 1.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.281 0.988 . . . . 0.0 110.976 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.819 ' O ' HD23 ' A' ' 81' ' ' LEU . . . 64.02 71.06 0.91 Allowed Glycine 0 N--CA 1.47 0.916 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.819 HD23 ' O ' ' A' ' 80' ' ' GLY . 79.9 mt -163.94 -179.54 6.33 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.871 0.983 . . . . 0.0 111.022 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.566 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 35.4 mmt180 -72.72 138.63 46.69 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.321 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.566 ' OD1' ' O ' ' A' ' 82' ' ' ARG . 85.4 m-20 -155.12 132.8 11.31 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.827 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 m -166.75 154.82 9.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.967 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.872 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 78.2 ttt180 -34.12 110.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 113.932 -1.486 . . . . 0.0 110.687 169.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 1.372 ' HA2' ' ND2' ' A' ' 106' ' ' ASN . . . -137.53 79.22 0.31 Allowed Glycine 0 N--CA 1.469 0.844 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.564 3.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.098 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 48.1 p -60.55 139.47 57.76 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.823 0.954 . . . . 0.0 111.107 172.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.385 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -79.82 158.16 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.474 162.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.986 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -160.41 129.95 5.08 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.633 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 1.267 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -60.67 122.05 13.76 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.422 -177.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.194 ' O ' ' HG3' ' A' ' 92' ' ' ARG . . . -51.41 -173.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.441 1.088 . . . . 0.0 111.795 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.194 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 81.9 mtp180 179.43 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.738 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.3 m -52.67 -86.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.763 1.289 . . . . 0.0 110.14 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.9 -71.54 0.41 Allowed 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.946 1.404 . . . . 0.0 108.525 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.8 m-20 -46.14 128.35 9.39 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.41 1.069 . . . . 0.0 110.433 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.219 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 8.3 mtpm? -42.15 -103.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.531 1.145 . . . . 0.0 110.582 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.9 ' OD1' ' ND2' ' A' ' 75' ' ' ASN . 33.0 m-20 -53.06 114.22 1.38 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.64 1.212 . . . . 0.0 109.21 175.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 1.15 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 40.3 t -175.28 -44.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.562 1.164 . . . . 0.0 111.093 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 1.318 ' O ' HD11 ' A' ' 73' ' ' ILE . . . -34.81 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.096 0.873 . . . . 0.0 110.411 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 1.518 ' CG2' ' HA ' ' A' ' 70' ' ' ASN . 74.3 p -78.85 -37.04 41.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.608 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.417 ' C ' ' HE2' ' A' ' 90' ' ' MET . 78.7 p -170.07 -48.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.092 0.87 . . . . 0.0 110.634 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.899 ' HG3' ' HB3' ' A' ' 91' ' ' ALA . 3.9 pt20 -36.9 151.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.215 0.947 . . . . 0.0 112.114 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.904 ' HB2' HD11 ' A' ' 88' ' ' ILE . 11.6 p90 -157.18 -167.71 2.41 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.415 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.935 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.7 p90 -158.15 121.1 3.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.927 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.953 HD11 HD21 ' A' ' 18' ' ' LEU . 65.1 mt -90.0 104.87 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.74 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 1.372 ' ND2' ' HA2' ' A' ' 86' ' ' GLY . 5.0 p-10 -63.87 153.21 37.5 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.259 0.974 . . . . 0.0 110.408 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.969 HG12 ' SD ' ' A' ' 132' ' ' MET . 32.6 m -141.53 47.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.026 176.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.618 ' O ' ' OD1' ' A' ' 110' ' ' ASN . . . 170.15 140.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.528 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 1.123 ' O ' ' OD1' ' A' ' 110' ' ' ASN . 32.3 m-20 -30.93 138.72 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 1.123 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 15.9 m-20 -158.18 157.3 32.42 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.049 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.155 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . 172.31 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.722 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.515 ' CE1' ' HA ' ' A' ' 110' ' ' ASN . 32.6 p90 -39.64 -42.65 1.23 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.58 1.175 . . . . 0.0 110.238 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.958 HD11 ' CD2' ' A' ' 122' ' ' TYR . 68.1 tp -58.98 -52.33 66.23 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 0.0 109.619 175.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 1.155 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 57.4 p-10 -40.08 138.4 0.84 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.523 1.139 . . . . 0.0 111.815 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 1.008 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 4.0 t60 -36.62 113.52 0.24 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.809 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -176.56 -96.17 0.1 Allowed Glycine 0 N--CA 1.472 1.092 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.728 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 6.3 tp60 -47.79 110.77 0.35 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.673 0.867 . . . . 0.0 109.775 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 117' ' ' GLN . 99.0 mtt180 91.76 -74.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.043 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 59.0 p30 179.04 -174.15 0.18 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.806 1.316 . . . . 0.0 111.794 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.918 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 78.7 m-85 -45.17 172.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.87 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.35 -110.34 0.26 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.328 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.958 ' CD2' HD11 ' A' ' 113' ' ' LEU . 89.1 m-85 -78.77 116.3 19.02 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.808 0.946 . . . . 0.0 109.937 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.267 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -49.94 -158.41 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.247 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.085 HG23 ' O ' ' A' ' 123' ' ' ALA . 45.7 t 179.28 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.811 ' CE2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.11 27.74 0.07 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.251 0.97 . . . . 0.0 111.135 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 1.385 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -150.92 -173.07 20.59 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 122.983 1.324 . . . . 0.0 112.223 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.174 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 36.2 mtmm 177.8 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 111.47 -2.365 . . . . 0.0 108.864 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.128 HG21 ' CE ' ' A' ' 132' ' ' MET . 62.8 t -40.03 116.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.59 1.181 . . . . 0.0 110.311 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.923 HG21 ' CD2' ' A' ' 6' ' ' HIS . 85.0 t -58.35 -51.43 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.392 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER 162.26 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.609 1.193 . . . . 0.0 108.798 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -166.38 22.46 0.12 Allowed Glycine 0 N--CA 1.475 1.237 0 O-C-N 124.826 1.329 . . . . 0.0 112.713 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 1.128 ' CE ' HG21 ' A' ' 128' ' ' VAL . 20.9 mmt -53.51 -22.22 7.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.439 171.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 63.2 t0 -47.88 -60.58 2.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.883 HG21 ' O ' ' A' ' 15' ' ' ASN . 87.2 t -62.31 -73.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.735 1.272 . . . . 0.0 109.423 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.705 ' O ' ' OG ' ' A' ' 139' ' ' SER . . . -39.95 -52.47 2.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.473 1.108 . . . . 0.0 110.373 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 1.013 ' OD2' ' HB3' ' A' ' 132' ' ' MET . 49.1 m-20 -60.8 -66.64 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.821 1.325 . . . . 0.0 108.382 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.97 ' O ' HG13 ' A' ' 141' ' ' VAL . 24.8 ttmm -34.49 -49.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.607 1.192 . . . . 0.0 110.363 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.252 ' O ' HG22 ' A' ' 141' ' ' VAL . 49.6 mt -60.31 -55.47 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 124.755 1.285 . . . . 0.0 107.909 168.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.89 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . 39.0 m -64.42 0.68 0.96 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.774 -1.557 . . . . 0.0 114.828 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.805 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 3.7 mp0 -107.03 -44.87 4.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.345 1.028 . . . . 0.0 109.017 173.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.252 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.3 m -40.07 127.97 1.64 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.287 0.992 . . . . 0.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.9 Cg_exo -37.57 177.13 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.355 2.703 . . . . 0.0 113.418 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.345 HG22 ' CA ' ' A' ' 153' ' ' PRO . 10.1 p -160.83 -151.18 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.56 1.648 . . . . 0.0 112.74 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 178.38 165.26 0.78 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 110.03 -3.259 . . . . 0.0 111.488 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.668 ' O ' HG22 ' A' ' 146' ' ' VAL . 46.4 t0 -52.14 -150.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.501 166.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.841 HG22 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -161.16 -142.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -67.05 -102.97 0.02 OUTLIER Glycine 0 N--CA 1.471 0.991 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 166.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.55 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 86.4 Cg_endo -77.5 -53.91 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.919 3.079 . . . . 0.0 109.917 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 146' ' ' VAL . 61.7 m-85 -69.25 122.44 18.86 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.587 1.179 . . . . 0.0 111.604 -172.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 29.5 mm-40 -74.48 -176.66 2.81 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.063 170.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.61 ' O ' HG23 ' A' ' 152' ' ' VAL . 76.9 m-20 48.73 86.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.716 175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.841 ' HB ' HG22 ' A' ' 146' ' ' VAL . 88.1 t -161.94 105.28 1.15 Allowed Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.337 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.345 ' CA ' HG22 ' A' ' 143' ' ' THR . 85.9 Cg_exo -45.12 139.83 8.12 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.409 2.739 . . . . 0.0 112.119 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . 1.068 ' N ' ' HA ' ' A' ' 143' ' ' THR . 80.2 p -73.74 44.64 0.17 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.604 174.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.615 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 17.2 tppt? -178.51 72.71 0.21 Allowed Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 155' ' ' LYS . 80.9 Cg_exo -46.37 108.38 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.73 2.953 . . . . 0.0 112.362 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG13 ' OG ' ' A' ' 12' ' ' SER . 89.3 t -68.98 154.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.505 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.858 ' HA ' HG22 ' A' ' 45' ' ' THR . 76.7 t -141.45 118.03 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.997 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.959 HG13 ' HA ' ' A' ' 45' ' ' THR . 35.3 mt -69.06 135.38 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.035 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.274 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.8 mt -85.22 -49.16 8.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.701 -2.045 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . 1.155 ' O ' HD23 ' A' ' 9' ' ' LEU . 34.7 t -170.46 161.04 7.75 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.434 1.084 . . . . 0.0 112.245 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.979 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -137.53 61.08 1.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.534 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 1.095 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 47.9 mmtm -69.92 93.15 0.75 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.49 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.992 HG12 ' HA ' ' A' ' 7' ' ' VAL . 34.6 m -71.54 132.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.42 1.075 . . . . 0.0 110.383 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.998 HD23 ' HB2' ' A' ' 6' ' ' HIS . 3.3 mm? -78.23 121.97 84.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.359 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 165' ' ' LEU . 66.9 Cg_endo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 123.583 2.855 . . . . 0.0 109.752 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -46.51 153.97 0.33 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.819 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.76 -129.04 1.15 Allowed Glycine 0 N--CA 1.474 1.209 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.959 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.3 ' O ' ' CE1' ' A' ' 6' ' ' HIS . 2.3 m-20 -46.65 152.09 0.96 Allowed Pre-proline 0 N--CA 1.473 0.705 0 CA-C-N 114.425 -0.887 . . . . 0.0 111.873 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.03 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 80.8 Cg_exo -41.38 173.49 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.631 2.887 . . . . 0.0 113.864 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.3 ' CE1' ' O ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -153.16 121.97 6.45 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.732 -176.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.977 HG12 ' HB2' ' A' ' 18' ' ' LEU . 7.9 p -73.79 116.74 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.427 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.782 ' HG ' ' CD ' ' A' ' 17' ' ' GLU . 6.5 mp -79.81 151.09 30.48 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.359 1.076 . . . . 0.0 110.748 169.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.152 ' O ' HG12 ' A' ' 16' ' ' ILE . 6.9 mt -160.59 96.54 1.16 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.559 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 1.206 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.0 m -88.14 79.98 7.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.637 -2.528 . . . . 0.0 107.969 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 1.065 HG22 HG12 ' A' ' 159' ' ' ILE . 37.0 p -73.24 169.72 16.48 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 125.018 1.449 . . . . 0.0 111.516 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 80.0 p -39.71 -46.24 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -60.37 -54.83 40.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.462 1.101 . . . . 0.0 110.623 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.01 173.76 39.65 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 113.767 -1.561 . . . . 0.0 113.597 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.892 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 40.7 t30 -61.82 143.54 56.16 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.451 -1.374 . . . . 0.0 110.868 175.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.152 HG12 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -144.2 -178.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.982 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.902 ' HG2' ' O ' ' A' ' 130' ' ' LYS . 6.9 mm-40 -160.13 101.88 1.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.92 -165.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 105' ' ' ILE . 2.4 mm? -85.0 161.03 19.91 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.297 0.998 . . . . 0.0 110.409 164.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.206 ' OE1' ' CD ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -127.27 110.84 13.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.529 173.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 125' ' ' PHE . 3.0 mm? -79.37 -170.9 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.826 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -164.69 87.05 0.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.011 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.131 ' HA ' HG11 ' A' ' 29' ' ' VAL . 19.8 ptpt -59.16 -34.62 72.32 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.842 1.339 . . . . 0.0 112.303 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.549 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 11.3 tp-100 -41.07 -64.36 0.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.206 0.941 . . . . 0.0 110.69 -172.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -69.97 -5.43 26.2 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.792 1.308 . . . . 0.0 113.896 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.811 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.18 71.59 3.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 O-C-N 123.818 0.699 . . . . 0.0 109.449 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 1.238 ' O ' HG22 ' A' ' 29' ' ' VAL . 57.5 Cg_exo -54.2 -64.69 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.667 2.912 . . . . 0.0 111.109 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.702 HG23 ' H ' ' A' ' 28' ' ' SER . 15.6 m -50.1 -62.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 124.734 1.271 . . . . 0.0 110.368 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.702 ' H ' HG23 ' A' ' 27' ' ' VAL . 42.1 t -41.82 -56.39 2.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.445 1.09 . . . . 0.0 110.466 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.238 HG22 ' O ' ' A' ' 26' ' ' PRO . 34.6 m -48.82 -45.07 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 124.734 1.272 . . . . 0.0 110.554 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 23.3 tp60 -45.7 -62.26 1.37 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.241 0.963 . . . . 0.0 109.551 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 1.03 ' OD1' HG21 ' A' ' 73' ' ' ILE . 11.0 m120 -47.35 -60.85 2.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.701 1.251 . . . . 0.0 109.497 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.529 ' HE1' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 t80 -43.24 -62.75 0.96 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.353 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 29' ' ' VAL . 61.3 t -49.26 -33.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 124.78 1.3 . . . . 0.0 111.452 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.939 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 55.2 m-20 -45.86 -63.68 0.92 Allowed 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.916 0.76 . . . . 0.0 109.771 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.74 ' CB ' ' HD1' ' A' ' 40' ' ' PHE . 19.7 m-85 -58.76 -61.89 2.28 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.826 1.329 . . . . 0.0 108.577 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.972 ' HA ' ' HB2' ' A' ' 40' ' ' PHE . 62.6 t -42.53 -53.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.308 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -39.99 -33.58 0.23 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.713 1.258 . . . . 0.0 111.867 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 35' ' ' TYR . 83.0 p -173.44 136.54 0.6 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.273 0.983 . . . . 0.0 110.578 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.41 43.91 35.6 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.297 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 57.1 t80 -61.38 -96.06 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.73 ' OH ' ' HB3' ' A' ' 101' ' ' SER . 22.3 m-30 -133.12 58.32 1.77 Allowed 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.149 0.905 . . . . 0.0 109.04 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 49.1 p-10 -77.92 108.8 11.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 174.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 1.231 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 28.1 t30 67.46 58.75 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.538 1.148 . . . . 0.0 109.742 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.724 ' C ' ' HB ' ' A' ' 159' ' ' ILE . 32.6 p -104.2 -128.85 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.635 169.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.845 ' HA ' HG13 ' A' ' 159' ' ' ILE . 67.2 p -162.35 -176.93 5.36 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.906 0.86 . . . . 0.0 113.077 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.904 ' CD1' HD11 ' A' ' 159' ' ' ILE . 7.4 m-30 -126.74 72.41 1.34 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.99 -1.914 . . . . 0.0 106.953 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.883 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 5.5 p-80 -58.27 -71.45 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.015 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.024 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 22.9 mmt85 -69.19 123.85 22.24 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.386 1.054 . . . . 0.0 110.833 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG22 HG12 ' A' ' 55' ' ' ILE . 90.8 t -162.0 140.05 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.976 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.852 HG22 ' SD ' ' A' ' 54' ' ' MET . 10.5 tt -155.17 126.76 3.71 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.101 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' PHE . 97.9 Cg_exo -39.45 168.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 123.555 2.836 . . . . 0.0 113.79 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -4.02 66.86 0.0 OUTLIER Glycine 0 N--CA 1.474 1.196 0 CA-C-N 114.102 -1.408 . . . . 0.0 114.051 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.4 t80 -161.16 -61.15 0.05 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.761 0.918 . . . . 0.0 108.847 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.852 ' SD ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -170.7 -175.61 1.87 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.494 1.121 . . . . 0.0 111.717 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.761 HG12 HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 174.65 113.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.549 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 1.024 ' OE1' ' O ' ' A' ' 48' ' ' ARG . 3.5 mp0 -96.8 -174.51 3.02 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.047 -169.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -166.91 178.83 41.02 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.934 165.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 1.014 ' O ' ' HB3' ' A' ' 102' ' ' GLN . . . 61.44 103.99 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 CA-C-N 113.728 -1.236 . . . . 0.0 110.712 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.81 -129.95 1.42 Allowed Glycine 0 N--CA 1.475 1.259 0 O-C-N 124.649 0.852 . . . . 0.0 111.701 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.931 ' CD1' ' HG2' ' A' ' 66' ' ' GLN . 12.6 m-30 -51.23 139.79 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.818 -1.191 . . . . 0.0 111.822 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.973 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 92.4 m -61.09 141.87 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.132 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.6 pt-20 -28.6 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.981 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 29.7 mt-30 90.58 43.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.804 1.315 . . . . 0.0 110.981 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.598 ' SD ' ' HD2' ' A' ' 60' ' ' PHE . 21.4 mmt 58.1 12.67 1.94 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.029 0.831 . . . . 0.0 113.148 174.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.973 ' O ' ' HB ' ' A' ' 61' ' ' THR . 88.0 mt-30 -79.41 65.22 4.51 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.931 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 75.5 mt-30 -39.45 132.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.181 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -58.62 -109.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.124 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.644 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 61.5 pttt -154.55 66.53 5.22 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.294 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 1.061 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 31.5 Cg_exo -70.51 -151.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.424 2.749 . . . . 0.0 112.588 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.061 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 40.2 p30 67.34 78.65 0.24 Allowed Pre-proline 0 N--CA 1.472 0.627 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.642 169.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.854 ' HB2' ' C ' ' A' ' 72' ' ' PRO . 52.6 Cg_exo -49.53 -60.39 0.87 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.316 2.677 . . . . 0.0 109.438 173.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.9 ' O ' HG23 ' A' ' 73' ' ' ILE . 45.2 Cg_exo -89.7 -160.27 1.33 Allowed 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.556 -2.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.105 HD11 ' O ' ' A' ' 99' ' ' ALA . 2.1 pp -161.7 145.1 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.902 0.858 . . . . 0.0 111.822 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 74' ' ' LYS . 28.6 mtpp -45.32 161.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.225 -1.807 . . . . 0.0 113.809 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.743 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 52.5 p-10 -74.68 -160.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.248 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.743 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 10.1 tp10 145.25 130.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.011 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.934 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -162.6 -36.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.291 0.994 . . . . 0.0 112.002 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.764 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 58.6 p30 -67.24 -37.66 83.9 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.104 0.877 . . . . 0.0 111.975 -169.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.764 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 16.7 p-10 45.13 -119.41 0.77 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.112 0.883 . . . . 0.0 109.736 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . 164.6 -55.56 0.27 Allowed Glycine 0 N--CA 1.474 1.173 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 80' ' ' GLY . 46.3 mt -39.64 177.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.692 0.877 . . . . 0.0 112.807 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.731 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 36.9 mmt180 -68.84 149.18 49.24 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.055 168.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.731 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.7 m120 -156.12 129.09 7.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.921 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' ARG . 15.8 m -169.33 157.98 7.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.843 -173.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' THR . 63.0 ttt180 -23.13 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.953 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.776 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 143.24 -17.35 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 111.433 -2.621 . . . . 0.0 110.855 -171.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.03 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 34.9 p -106.25 146.08 30.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.286 1.041 . . . . 0.0 112.755 -174.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.027 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.27 164.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.075 171.105 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.902 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -161.76 141.23 9.99 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.594 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.891 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 6.7 ttm -57.27 137.67 55.71 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.061 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.062 ' HB3' ' OE1' ' A' ' 102' ' ' GLN . . . -75.6 -59.43 2.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.598 ' HB3' ' CB ' ' A' ' 99' ' ' ALA . 5.3 tpm_? -32.75 169.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.39 1.056 . . . . 0.0 113.844 -172.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.708 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 9.7 t 161.94 162.44 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.634 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.743 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 83.26 130.51 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.491 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 1.365 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 42.3 m-20 101.37 -57.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.454 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.365 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 10.1 mtmp? 139.31 -94.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.821 1.326 . . . . 0.0 108.147 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -64.24 104.43 0.75 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.817 1.323 . . . . 0.0 109.013 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.924 ' OG ' ' HD3' ' A' ' 92' ' ' ARG . 18.2 t -174.13 -179.72 1.72 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.632 1.208 . . . . 0.0 111.814 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 1.598 ' CB ' ' HB3' ' A' ' 92' ' ' ARG . . . 80.33 85.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.83 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 62.9 p -79.72 -40.25 29.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.649 -168.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.73 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 50.3 m -159.27 -73.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.288 0.993 . . . . 0.0 109.338 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 1.062 ' OE1' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -38.91 163.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.168 -175.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 1.027 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -155.3 -165.28 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.1 -172.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.956 ' CZ ' ' HB3' ' A' ' 122' ' ' TYR . 49.3 p90 -154.85 119.16 4.73 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.757 0.789 . . . . 0.0 111.019 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 18' ' ' LEU . 67.1 mt -84.14 110.89 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.453 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.643 ' O ' ' HE1' ' A' ' 132' ' ' MET . 76.6 m-20 -61.11 166.79 3.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.372 1.045 . . . . 0.0 111.41 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.657 HG12 ' CE ' ' A' ' 132' ' ' MET . 28.1 m -155.45 42.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.667 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.731 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . 173.6 137.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.379 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -39.55 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.887 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.899 ' OD1' HD11 ' A' ' 113' ' ' LEU . 11.9 t-20 -70.52 -119.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.876 1.36 . . . . 0.0 110.699 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 76.5 -33.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.782 0.677 . . . . 0.0 111.774 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -38.35 -50.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.071 0.857 . . . . 0.0 110.113 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.037 ' H ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.98 40.62 0.87 Allowed 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.752 1.282 . . . . 0.0 110.729 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' ' O ' ' A' ' 113' ' ' LEU . 39.9 p30 -39.21 -117.38 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.733 0.646 . . . . 0.0 111.602 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 1.079 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 10.8 m170 179.34 109.65 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.963 0.789 . . . . 0.0 109.946 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 117' ' ' GLN . . . 173.41 109.76 0.23 Allowed Glycine 0 N--CA 1.474 1.204 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.423 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.24 ' O ' ' CG ' ' A' ' 118' ' ' ARG . 71.1 tp60 167.32 -57.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.559 0.8 . . . . 0.0 109.533 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 1.24 ' CG ' ' O ' ' A' ' 117' ' ' GLN . 37.7 mmt180 159.41 61.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.574 1.171 . . . . 0.0 109.375 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 1.069 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 97.4 m-20 -179.99 -55.9 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.337 1.023 . . . . 0.0 110.301 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 7.0 m-85 81.36 102.23 0.06 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.43 1.081 . . . . 0.0 108.422 -170.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.86 -130.48 0.01 OUTLIER Glycine 0 N--CA 1.471 1.013 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.97 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.079 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 71.1 m-85 -79.5 135.37 36.62 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.958 -1.121 . . . . 0.0 111.344 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.183 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -67.17 -148.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.309 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.183 HG23 ' O ' ' A' ' 123' ' ' ALA . 37.1 t 177.39 133.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.9 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 24.2 p90 -171.32 26.13 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.808 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -166.68 -149.98 6.19 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-O 122.8 1.222 . . . . 0.0 114.084 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.206 ' CD ' ' OE1' ' A' ' 19' ' ' GLU . 29.7 mtpp -169.42 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 111.597 -2.301 . . . . 0.0 110.373 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.54 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 63.3 t -156.13 159.16 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.094 -175.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.766 ' O ' ' CD ' ' A' ' 130' ' ' LYS . 62.4 t -152.54 -43.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.992 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.902 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 32.4 mmmt -167.02 101.46 0.54 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.204 1.002 . . . . 0.0 109.032 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.428 ' O ' ' OD1' ' A' ' 133' ' ' ASP . . . -179.77 141.07 4.53 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.726 0.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.824 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 22.7 mmt -47.86 -26.11 1.55 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.963 -1.118 . . . . 0.0 111.805 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 37.8 p-10 -47.93 -55.09 10.73 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.668 HG11 HG23 ' A' ' 16' ' ' ILE . 51.4 t -62.68 -68.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 124.378 1.049 . . . . 0.0 108.999 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 132' ' ' MET . . . -42.65 -47.15 5.24 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.667 1.229 . . . . 0.0 110.905 -177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 1.016 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 41.4 m-20 -50.47 -71.0 0.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.473 1.108 . . . . 0.0 109.424 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.675 ' O ' HG13 ' A' ' 141' ' ' VAL . 56.8 mtmt -42.97 -43.57 4.23 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.712 1.258 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 141' ' ' VAL . 14.5 mt -58.57 -61.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.634 ' HA ' HG11 ' A' ' 49' ' ' VAL . 84.5 p -68.54 16.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.426 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 1.016 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 17.1 mm100 -115.36 -47.05 2.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.295 0.997 . . . . 0.0 109.368 176.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.7 m -47.65 127.92 10.78 Favored Pre-proline 0 N--CA 1.472 0.662 0 O-C-N 124.443 1.089 . . . . 0.0 110.1 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 141' ' ' VAL . 86.2 Cg_exo -38.09 176.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.338 2.692 . . . . 0.0 113.374 175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.45 HG22 ' CA ' ' A' ' 153' ' ' PRO . 8.5 p -160.83 -150.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.727 1.727 . . . . 0.0 112.932 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.547 ' O ' ' O ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER 178.52 165.26 0.81 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 109.725 -3.398 . . . . 0.0 111.035 173.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.708 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 36.7 m-20 -50.86 -148.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.962 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -161.28 -148.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.729 0.643 . . . . 0.0 109.282 170.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -65.31 -100.15 0.02 OUTLIER Glycine 0 N--CA 1.471 0.97 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 168.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 98.5 Cg_endo -73.49 -61.5 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.788 2.992 . . . . 0.0 109.321 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 146' ' ' VAL . 80.2 m-85 -69.78 120.77 16.04 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.606 1.191 . . . . 0.0 111.373 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.708 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 9.8 mm100 -68.89 -157.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.861 167.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.758 ' O ' HG23 ' A' ' 152' ' ' VAL . 76.4 m-20 36.25 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.061 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 146' ' ' VAL . 70.1 t -164.56 118.89 1.01 Allowed Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.238 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.45 ' CA ' HG22 ' A' ' 143' ' ' THR . 57.2 Cg_endo -66.21 111.97 2.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.646 2.897 . . . . 0.0 109.842 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.937 ' H ' ' HA ' ' A' ' 143' ' ' THR . 69.6 p -42.66 -52.85 4.73 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.743 1.277 . . . . 0.0 109.143 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.24 132.33 93.4 Favored Pre-proline 0 N--CA 1.474 0.742 0 O-C-N 124.572 1.17 . . . . 0.0 109.503 170.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.38 161.04 43.55 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 C-N-CA 123.658 2.905 . . . . 0.0 113.436 -172.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.552 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 55.5 t -151.18 95.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.571 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 45' ' ' THR . 91.8 t -88.58 121.24 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.711 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.231 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 11.0 mt -68.93 125.36 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.906 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.206 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -79.82 -51.26 9.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.212 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.788 ' O ' HD23 ' A' ' 9' ' ' LEU . 56.0 m -158.58 177.35 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.694 1.246 . . . . 0.0 112.206 -176.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.868 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . . . -170.63 119.8 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.098 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.436 ' O ' HD13 ' A' ' 8' ' ' LEU . 21.4 ptmt -170.75 131.37 0.86 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.302 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.893 HG13 HG11 ' A' ' 36' ' ' VAL . 35.9 m -69.01 142.33 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.9 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.975 HD12 ' HD2' ' A' ' 166' ' ' PRO . 58.6 tp -58.35 123.4 65.86 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.975 ' HD2' HD12 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.583 2.856 . . . . 0.0 112.12 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.851 ' O ' ' HB2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.851 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER 140.89 41.81 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.702 1.251 . . . . 0.0 110.566 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 1.273 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 157.5 127.86 1.0 Allowed Glycine 0 N--CA 1.476 1.334 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.273 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 52.4 m-20 -165.43 102.49 0.76 Allowed Pre-proline 0 N--CA 1.475 0.775 0 O-C-N 124.492 0.76 . . . . 0.0 109.301 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.4 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 86.7 Cg_exo -45.04 179.0 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.639 2.893 . . . . 0.0 113.942 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.4 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 22.1 m170 -154.55 117.75 4.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.148 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.039 HG22 ' HB2' ' A' ' 18' ' ' LEU . 30.2 m -71.76 109.19 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 124.387 1.054 . . . . 0.0 109.184 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.26 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 7.3 mp -79.26 131.08 36.05 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.383 1.052 . . . . 0.0 110.285 177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.044 ' O ' HG12 ' A' ' 16' ' ' ILE . 8.6 mp -138.45 96.76 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.333 173.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 1.186 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 95.3 m -86.2 81.98 8.21 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.768 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.978 HG22 HG12 ' A' ' 159' ' ' ILE . 33.5 p -72.91 167.6 20.66 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.931 1.394 . . . . 0.0 111.41 174.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -39.49 -43.78 1.31 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.358 -1.747 . . . . 0.0 110.61 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.777 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -53.9 -61.94 1.98 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.471 1.107 . . . . 0.0 110.228 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.34 177.64 46.38 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 113.151 -1.84 . . . . 0.0 113.365 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.765 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 38.0 t30 -77.82 89.46 4.05 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.684 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.044 HG12 ' O ' ' A' ' 9' ' ' LEU . 7.0 pt -77.9 175.01 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.308 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.917 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 6.2 mm-40 -159.73 100.08 1.43 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.4 -168.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.039 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.6 mm? -80.97 164.3 22.66 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.398 1.061 . . . . 0.0 110.712 166.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.948 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 40.0 tt0 -130.19 129.83 43.92 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.475 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.042 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.6 mp -117.53 116.56 27.37 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.964 1.415 . . . . 0.0 109.726 -169.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.37 104.9 2.84 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.314 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.71 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.9 ttmp? -69.0 -45.79 69.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.663 1.227 . . . . 0.0 111.542 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -47.77 -70.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.333 1.02 . . . . 0.0 110.256 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 1.263 ' NZ ' HD21 ' A' ' 81' ' ' LEU . 61.6 mttp -71.94 13.1 0.32 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.77 1.294 . . . . 0.0 114.016 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.659 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.63 68.7 2.69 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 124.034 0.834 . . . . 0.0 109.486 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.853 ' O ' HG22 ' A' ' 29' ' ' VAL . 51.6 Cg_exo -60.73 -63.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.475 2.784 . . . . 0.0 111.061 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.0 t -54.96 -62.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.137 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 t -42.2 -58.49 2.13 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.643 1.214 . . . . 0.0 110.472 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 26' ' ' PRO . 32.2 m -51.75 -46.97 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 124.735 1.272 . . . . 0.0 110.622 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.497 ' N ' HG23 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -48.58 -69.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.239 0.962 . . . . 0.0 108.949 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 1.306 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.8 m120 -45.08 -51.71 9.88 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.557 1.161 . . . . 0.0 109.75 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' VAL . 77.4 t80 -42.54 -59.65 1.81 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.598 1.186 . . . . 0.0 109.646 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.688 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.9 t -47.44 -37.3 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.707 1.254 . . . . 0.0 111.101 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 1.306 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 15.3 m-20 -43.84 -62.6 1.06 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.012 0.82 . . . . 0.0 109.381 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -61.27 -59.37 5.41 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.152 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.933 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 59.5 t -39.4 -48.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.976 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.803 ' O ' ' HB3' ' A' ' 38' ' ' SER . 46.9 t30 -38.42 -32.38 0.07 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.779 1.299 . . . . 0.0 112.015 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.803 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.2 p 149.32 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.138 0.899 . . . . 0.0 113.005 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 42' ' ' ASN . . . 87.6 -42.46 3.12 Favored Glycine 0 N--CA 1.474 1.198 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.356 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.632 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 28.4 t80 -67.11 -74.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.527 0.78 . . . . 0.0 109.888 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.933 ' CE2' ' HA ' ' A' ' 36' ' ' VAL . 79.9 m-85 -61.69 -29.49 70.12 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.513 1.133 . . . . 0.0 112.628 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 39' ' ' GLY . 19.3 m-20 -38.6 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.011 0.819 . . . . 0.0 111.312 -169.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 1.143 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.5 m-20 44.24 47.81 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.265 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.835 ' O ' HG23 ' A' ' 45' ' ' THR . 28.6 m -78.59 -123.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 1.046 HG22 ' HA ' ' A' ' 158' ' ' VAL . 46.1 p -165.02 -143.8 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.254 1.026 . . . . 0.0 112.493 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CD2' HG21 ' A' ' 11' ' ' THR . 65.4 m-85 -159.63 66.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.5 -2.137 . . . . 0.0 106.834 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.884 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 1.4 p-80 -51.72 -68.98 0.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.191 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.884 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.2 mtt180 -69.68 124.07 23.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.51 1.131 . . . . 0.0 110.296 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 49' ' ' VAL . 34.4 m -158.21 94.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 124.74 1.275 . . . . 0.0 109.374 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.898 HG21 ' HD2' ' A' ' 53' ' ' PHE . 57.2 mt -77.27 123.75 87.04 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.334 175.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 53' ' ' PHE . 82.4 Cg_exo -37.65 144.02 0.16 Allowed 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.271 2.647 . . . . 0.0 112.525 174.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.23 55.53 0.01 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.651 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.898 ' HD2' HG21 ' A' ' 50' ' ' ILE . 1.6 t80 -144.33 -63.1 0.37 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.778 0.929 . . . . 0.0 109.05 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.701 ' HE2' HD12 ' A' ' 50' ' ' ILE . 27.2 ptt? -179.56 114.91 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.386 1.054 . . . . 0.0 111.102 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.836 ' CD1' ' HB1' ' A' ' 135' ' ' ALA . 30.7 pt -84.73 160.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.791 165.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.787 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 20.0 mt-30 -156.58 162.35 39.9 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.804 0.69 . . . . 0.0 111.781 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.79 -154.07 7.05 Favored Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.272 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 102' ' ' GLN . . . 65.85 73.88 0.57 Allowed Glycine 0 N--CA 1.47 0.952 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 1.22 ' HA2' ' CD ' ' A' ' 67' ' ' LYS . . . -179.83 -122.83 0.8 Allowed Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 68.5 m-85 -45.18 132.91 7.12 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.622 0.836 . . . . 0.0 110.499 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.781 ' HA ' HG23 ' A' ' 44' ' ' THR . 88.6 m -59.2 -57.91 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.214 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.722 ' HG2' HG21 ' A' ' 45' ' ' THR . 0.1 OUTLIER -168.46 -75.7 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.614 1.196 . . . . 0.0 108.064 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -72.93 46.81 0.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.5 1.125 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.833 ' HE1' HG21 ' A' ' 152' ' ' VAL . 53.9 mtt 39.44 36.69 0.23 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.121 0.888 . . . . 0.0 111.961 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -78.14 87.46 4.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -30.69 147.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.69 -1.595 . . . . 0.0 113.418 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.22 ' CD ' ' HA2' ' A' ' 59' ' ' GLY . 47.4 mtmt -56.53 -131.12 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 112.849 -1.978 . . . . 0.0 112.393 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 1.14 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 46.6 mmtm 179.27 79.66 0.17 Allowed Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 112.641 -2.072 . . . . 0.0 106.363 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.812 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 47.8 Cg_endo -71.89 -165.88 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.606 2.871 . . . . 0.0 113.345 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.998 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 91.4 m-20 -166.54 170.76 5.19 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 113.237 -1.801 . . . . 0.0 109.923 -172.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 32.9 Cg_endo -45.44 104.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.606 2.204 . . . . 0.0 109.184 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.5 Cg_exo -44.58 -146.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.818 3.012 . . . . 0.0 113.603 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 99' ' ' ALA . 27.4 pt -160.18 141.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 124.387 1.054 . . . . 0.0 110.476 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 29.1 mtpp -36.44 159.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.749 -1.569 . . . . 0.0 113.322 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 1.322 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 61.3 t30 -43.12 169.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.285 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.322 ' HG2' ' O ' ' A' ' 75' ' ' ASN . 11.4 mm-40 172.98 128.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.478 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.27 ' O ' ' CE1' ' A' ' 115' ' ' HIS . . . 174.12 -40.28 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.976 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 52.9 p-10 -67.22 -43.71 81.36 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.299 0.999 . . . . 0.0 110.649 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 22.2 p30 -51.86 132.35 31.73 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.114 0.884 . . . . 0.0 110.325 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.639 ' H ' HD12 ' A' ' 81' ' ' LEU . . . -171.78 -62.11 0.04 OUTLIER Glycine 0 N--CA 1.474 1.199 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.263 HD21 ' NZ ' ' A' ' 24' ' ' LYS . 6.2 mp 81.6 -32.25 0.1 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.632 0.843 . . . . 0.0 112.444 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 16.4 ptp180 178.89 73.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.645 1.216 . . . . 0.0 110.211 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.405 ' HA ' HG21 ' A' ' 87' ' ' THR . 14.2 p30 -72.68 142.88 48.25 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.869 1.356 . . . . 0.0 111.204 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 m -169.28 148.04 3.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.419 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.713 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 51.6 ptt85 -42.03 101.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.05 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.774 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 144.19 -29.04 1.94 Allowed Glycine 0 N--CA 1.473 1.107 0 CA-C-N 111.934 -2.393 . . . . 0.0 109.899 -169.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 20.5 p -83.56 129.85 34.98 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.716 0.77 . . . . 0.0 111.225 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.485 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -84.26 156.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.793 166.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.092 ' O ' ' CD2' ' A' ' 104' ' ' PHE . . . -165.31 128.69 2.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.659 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.78 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 32.7 ttm -59.38 173.9 0.47 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.196 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.742 ' H ' ' HG3' ' A' ' 90' ' ' MET . . . -167.57 164.14 14.68 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.507 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.867 ' CG ' ' HA ' ' A' ' 99' ' ' ALA . 2.4 mmm-85 179.65 119.08 0.05 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.486 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 93.4 m -40.47 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.532 1.145 . . . . 0.0 110.438 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 93' ' ' THR . . . 71.39 -67.9 0.24 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.858 1.349 . . . . 0.0 109.175 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.769 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 59.3 m-20 66.13 -84.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.705 1.253 . . . . 0.0 110.109 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.769 ' HB3' ' O ' ' A' ' 95' ' ' ASP . 87.4 tttt 95.02 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.865 1.353 . . . . 0.0 109.213 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -165.88 81.16 0.3 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 73' ' ' ILE . 66.3 m -163.06 -116.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.781 1.301 . . . . 0.0 110.565 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.867 ' HA ' ' CG ' ' A' ' 92' ' ' ARG . . . 54.27 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.644 1.215 . . . . 0.0 107.751 -169.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -77.71 -35.02 52.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.01 -170.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.7 p -170.31 -40.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.273 0.983 . . . . 0.0 110.14 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.738 ' CD ' ' HZ3' ' A' ' 67' ' ' LYS . 29.4 mt-30 -35.62 130.46 0.55 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.275 0.984 . . . . 0.0 111.308 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 1.014 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.32 178.87 7.44 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.793 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 1.092 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 49.1 p90 -153.2 122.63 6.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.052 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.942 HD11 HD21 ' A' ' 18' ' ' LEU . 59.4 mt -91.01 101.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.218 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.557 ' O ' HG13 ' A' ' 107' ' ' VAL . 18.1 p-10 -68.62 -173.04 0.41 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.354 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.712 HG22 ' C ' ' A' ' 53' ' ' PHE . 34.2 m -160.04 -42.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.623 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.713 ' CA ' ' HB3' ' A' ' 85' ' ' ARG . . . -74.25 139.71 44.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 124.373 1.046 . . . . 0.0 111.167 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -42.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.954 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.671 ' OD1' HD23 ' A' ' 113' ' ' LEU . 2.7 t30 -68.29 142.93 55.41 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.864 1.352 . . . . 0.0 111.026 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 110' ' ' ASN . . . 168.42 -51.21 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.922 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.762 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 47.5 p90 -66.44 60.65 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.611 1.195 . . . . 0.0 108.109 168.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.982 HD11 ' CD2' ' A' ' 122' ' ' TYR . 59.3 tp 178.31 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.807 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -38.08 125.7 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.821 0.701 . . . . 0.0 111.137 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 1.27 ' CE1' ' O ' ' A' ' 77' ' ' ALA . 19.4 m170 -42.92 108.67 0.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.379 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -34.23 -79.18 0.03 OUTLIER Glycine 0 N--CA 1.471 1.026 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.288 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.862 ' OE1' ' NH1' ' A' ' 118' ' ' ARG . 64.4 tt0 177.54 -64.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.677 0.869 . . . . 0.0 108.811 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.862 ' NH1' ' OE1' ' A' ' 117' ' ' GLN . 0.0 OUTLIER -52.2 -100.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.545 1.153 . . . . 0.0 108.75 178.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.76 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 64.0 t0 -64.73 -56.99 10.19 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.83 1.331 . . . . 0.0 110.082 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 1.278 ' HZ ' ' ND2' ' A' ' 75' ' ' ASN . 21.4 p90 57.28 108.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.763 1.29 . . . . 0.0 109.255 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.51 -80.78 0.44 Allowed Glycine 0 N--CA 1.471 0.994 0 CA-C-N 113.638 -1.619 . . . . 0.0 113.734 -167.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.221 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 59.6 m-85 -76.98 130.45 37.5 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.46 0.741 . . . . 0.0 111.837 -161.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.045 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -67.37 -158.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.995 174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.048 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 62.7 t 179.48 131.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.312 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 1.042 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.1 p90 -170.79 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.007 0.817 . . . . 0.0 111.605 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 1.485 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -138.35 173.85 22.28 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.194 1.441 . . . . 0.0 113.206 -171.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 59.3 tttp 179.7 121.33 0.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 110.888 -2.656 . . . . 0.0 110.207 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 86' ' ' GLY . 59.2 t -58.94 156.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.302 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.106 HG21 ' ND1' ' A' ' 6' ' ' HIS . 57.3 t -130.7 -46.99 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.277 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.67 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 0.0 OUTLIER 172.59 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.118 0.886 . . . . 0.0 109.648 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.593 ' HA2' HG13 ' A' ' 128' ' ' VAL . . . 144.99 -147.46 18.64 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 119.778 -1.201 . . . . 0.0 112.426 -4.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.973 ' HG3' ' OD1' ' A' ' 136' ' ' ASP . 6.0 tpt -60.24 -31.15 69.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.939 -1.63 . . . . 0.0 111.878 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 63.7 t0 -47.49 -68.65 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.995 0.809 . . . . 0.0 109.531 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.783 ' HB ' HG22 ' A' ' 16' ' ' ILE . 78.3 t -49.78 -60.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.757 1.286 . . . . 0.0 109.296 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.836 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -44.6 -51.81 8.69 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.567 1.167 . . . . 0.0 110.05 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.973 ' OD1' ' HG3' ' A' ' 132' ' ' MET . 36.4 m-20 -51.86 -70.34 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.683 1.239 . . . . 0.0 109.255 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.536 ' N ' ' OE1' ' A' ' 140' ' ' GLN . 30.5 mtpp -38.6 -44.6 0.99 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.658 1.224 . . . . 0.0 110.708 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.359 ' O ' HG22 ' A' ' 141' ' ' VAL . 30.8 mt -55.61 -58.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 124.374 1.046 . . . . 0.0 108.367 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 136' ' ' ASP . 82.2 p -62.6 2.75 0.25 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.709 1.256 . . . . 0.0 114.129 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.872 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.0 mp0 -96.99 -50.09 4.76 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.289 0.993 . . . . 0.0 108.587 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.359 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.2 m -39.93 124.83 1.6 Allowed Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 124.435 1.084 . . . . 0.0 110.652 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 141' ' ' VAL . 83.6 Cg_exo -40.84 178.81 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.469 2.779 . . . . 0.0 113.748 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.203 HG22 ' CA ' ' A' ' 153' ' ' PRO . 6.7 p -161.02 -145.26 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.87 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.718 ' ND1' ' O ' ' A' ' 152' ' ' VAL . 0.0 OUTLIER 179.13 142.45 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.672 -2.967 . . . . 0.0 111.789 170.06 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 1.145 ' OD1' ' HG2' ' A' ' 150' ' ' GLN . 61.0 t0 -69.74 111.09 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.801 168.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.848 HG12 ' H ' ' A' ' 147' ' ' GLY . 2.3 t -78.97 -147.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.115 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.848 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -61.64 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.47 0.911 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 171.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.825 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 95.8 Cg_endo -71.32 -55.78 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.697 2.931 . . . . 0.0 109.508 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.825 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 84.0 m-85 -69.2 102.94 1.8 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.632 1.207 . . . . 0.0 110.103 -176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 1.171 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 75.2 mt-30 -86.43 55.41 3.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.065 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 1.171 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 75.1 m-20 -172.8 82.74 0.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.833 HG21 ' HE1' ' A' ' 64' ' ' MET . 62.9 t -156.04 102.04 2.11 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 124.405 1.065 . . . . 0.0 108.773 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.203 ' CA ' HG22 ' A' ' 143' ' ' THR . 75.7 Cg_exo -46.93 99.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 123.436 2.757 . . . . 0.0 110.268 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . 1.212 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.6 t -34.87 -52.93 0.55 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.467 1.104 . . . . 0.0 109.861 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -84.64 85.98 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 164.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.212 ' HD3' ' O ' ' A' ' 154' ' ' SER . 63.1 Cg_endo -79.0 140.78 16.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.606 2.871 . . . . 0.0 112.399 -168.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.567 ' O ' ' CG2' ' A' ' 45' ' ' THR . 92.2 t -68.72 155.07 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.534 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 1.046 ' HA ' HG22 ' A' ' 45' ' ' THR . 98.1 t -142.98 119.44 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.374 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.143 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 32.3 mt -68.36 133.63 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.345 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.186 ' HB2' ' O ' ' A' ' 10' ' ' THR . 86.1 mt -76.36 -52.45 9.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.511 -2.131 . . . . 0.0 108.995 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 65.7 m -163.39 -166.11 1.18 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.671 1.232 . . . . 0.0 111.848 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.26 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . 179.07 119.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.347 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.723 ' O ' HD13 ' A' ' 8' ' ' LEU . 65.6 mttm -163.64 126.24 2.55 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.013 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.85 HG13 HG11 ' A' ' 36' ' ' VAL . 33.9 m -67.83 140.27 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.358 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.024 HD12 ' HD2' ' A' ' 166' ' ' PRO . 56.5 tp -157.98 121.03 2.1 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.991 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 1.024 ' HD2' HD12 ' A' ' 165' ' ' LEU . 88.3 Cg_exo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.646 2.897 . . . . 0.0 112.062 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.733 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 24.9 ttmm 89.71 -111.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.709 1.256 . . . . 0.0 110.44 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 1.224 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . -174.8 -118.03 0.5 Allowed Glycine 0 N--CA 1.475 1.248 0 O-C-N 124.554 1.159 . . . . 0.0 110.986 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.224 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 71.4 m-20 -167.29 130.08 1.38 Allowed Pre-proline 0 N--CA 1.476 0.871 0 O-C-N 124.506 0.768 . . . . 0.0 110.274 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.132 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 88.3 Cg_exo -50.35 154.78 5.59 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.86 3.04 . . . . 0.0 114.298 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.132 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 1.6 m-70 -152.37 118.07 5.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.385 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.926 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.3 p -66.93 141.8 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.518 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.872 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 6.9 mp -121.11 132.53 54.92 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.424 1.078 . . . . 0.0 110.314 164.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.768 HD12 ' C ' ' A' ' 8' ' ' LEU . 8.2 mp -126.93 -177.38 4.01 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 111.929 -2.396 . . . . 0.0 109.16 164.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.841 HG22 HD12 ' A' ' 160' ' ' LEU . 99.9 m -160.61 90.29 0.86 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.844 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 1.014 HG22 HG12 ' A' ' 159' ' ' ILE . 34.8 p -78.05 169.6 18.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.398 1.686 . . . . 0.0 111.216 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -39.77 -42.98 1.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.536 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.771 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -58.22 -59.83 4.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.526 1.141 . . . . 0.0 110.572 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.59 178.51 41.36 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 113.529 -1.669 . . . . 0.0 114.201 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 16' ' ' ILE . 63.0 t-20 -61.67 153.83 27.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.08 -1.56 . . . . 0.0 111.063 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.113 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 16.0 pt -164.34 168.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.455 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.113 ' OE1' ' O ' ' A' ' 16' ' ' ILE . 4.3 mm-40 -145.61 113.56 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.473 -1.694 . . . . 0.0 112.059 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.013 HD21 HD11 ' A' ' 105' ' ' ILE . 2.7 mm? -94.71 147.03 23.74 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 124.481 1.113 . . . . 0.0 110.075 165.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.404 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -109.56 112.01 23.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.203 171.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.887 HD23 ' HE2' ' A' ' 125' ' ' PHE . 6.4 mp -84.33 -158.97 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.541 -170.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.804 ' OD1' ' HG3' ' A' ' 23' ' ' GLN . 61.6 t0 -175.39 110.03 0.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.118 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.667 ' HA ' HG21 ' A' ' 29' ' ' VAL . 28.5 ttpp -96.98 -35.8 10.74 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.928 1.393 . . . . 0.0 111.954 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.851 ' OE1' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -42.46 -33.68 0.71 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.179 0.925 . . . . 0.0 112.306 -171.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.851 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 17.9 tppt? -108.01 10.68 28.23 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.283 0.989 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.979 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -161.04 68.84 2.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 O-C-N 123.69 0.619 . . . . 0.0 110.162 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.6 Cg_exo -58.48 -58.46 0.73 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.57 2.847 . . . . 0.0 111.264 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 71.0 t -54.32 -69.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.835 1.334 . . . . 0.0 110.165 -175.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.518 ' OG ' ' HB1' ' A' ' 25' ' ' ALA . 72.7 p -47.5 -54.92 10.24 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.727 1.267 . . . . 0.0 110.95 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.002 ' O ' ' HB3' ' A' ' 32' ' ' PHE . 11.6 t -55.81 -45.27 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.375 1.047 . . . . 0.0 110.283 -175.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 66.5 tp60 -45.02 -63.27 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.236 0.96 . . . . 0.0 109.646 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 1.04 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.6 m120 -42.98 -48.13 5.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.61 1.194 . . . . 0.0 110.058 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 1.002 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 15.6 t80 -39.75 -69.46 0.13 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.527 1.142 . . . . 0.0 109.967 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' ND2' ' A' ' 37' ' ' ASN . 48.9 t -43.96 -39.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.722 1.264 . . . . 0.0 111.201 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 1.04 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 16.6 m-20 -44.04 -62.26 1.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.148 0.905 . . . . 0.0 109.914 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 38' ' ' SER . 98.1 m-85 -57.48 -56.23 24.6 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.877 1.361 . . . . 0.0 109.364 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.839 ' HA ' ' HE2' ' A' ' 41' ' ' TYR . 96.0 t -42.97 -63.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 124.555 1.159 . . . . 0.0 109.279 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.678 ' ND2' HG12 ' A' ' 33' ' ' VAL . 22.0 m-20 -48.23 -49.75 32.04 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.796 1.31 . . . . 0.0 110.069 176.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 37' ' ' ASN . 56.4 m -56.08 -117.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.543 1.152 . . . . 0.0 111.03 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.53 76.28 0.1 Allowed Glycine 0 N--CA 1.473 1.151 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.662 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 17.5 t80 -110.67 -56.54 2.34 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.914 -173.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.839 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 58.3 m-85 -59.59 -40.23 86.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.063 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.7 p-10 -39.23 113.64 0.34 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.919 . . . . 0.0 111.449 -173.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 29.3 t-20 58.03 35.76 25.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.313 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 45' ' ' THR . 72.8 p -79.45 -146.01 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.194 0.934 . . . . 0.0 108.684 163.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.98 HG22 ' HA ' ' A' ' 158' ' ' VAL . 72.7 p -163.6 -154.1 0.26 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.742 0.782 . . . . 0.0 112.268 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.874 ' HD1' ' O ' ' A' ' 45' ' ' THR . 6.0 m-30 -134.75 62.08 1.65 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.201 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.866 ' CE1' ' HG2' ' A' ' 48' ' ' ARG . 21.4 p-80 -53.62 -49.53 67.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.407 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.866 ' HG2' ' CE1' ' A' ' 47' ' ' HIS . 24.8 mmm180 -68.28 107.38 2.79 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.53 1.144 . . . . 0.0 109.325 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 46' ' ' PHE . 90.9 t -152.01 135.03 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 124.663 1.227 . . . . 0.0 110.308 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.093 HG21 ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -146.91 120.28 4.99 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.076 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' PHE . 85.5 Cg_exo -35.13 152.17 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.589 2.86 . . . . 0.0 113.439 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 1.67 63.91 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 CA-C-N 114.219 -1.355 . . . . 0.0 113.801 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.082 ' HB3' HD12 ' A' ' 50' ' ' ILE . 8.4 t80 -155.32 -42.93 0.08 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.783 0.931 . . . . 0.0 110.897 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.093 ' HE2' HG21 ' A' ' 50' ' ' ILE . 22.3 ptt? 176.65 163.28 0.43 Allowed 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.897 0.748 . . . . 0.0 112.026 -176.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.031 HD11 ' HB1' ' A' ' 135' ' ' ALA . 46.5 pt -165.89 129.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.912 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 1.589 ' CB ' ' HA ' ' A' ' 104' ' ' PHE . 2.6 mm-40 -173.73 -166.09 0.29 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.721 164.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.45 -146.82 6.41 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.306 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.662 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 130.62 -58.83 0.7 Allowed Glycine 0 N--CA 1.475 1.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -45.17 -117.01 0.0 OUTLIER Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.635 0.844 . . . . 0.0 112.194 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.672 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 18.7 m-30 -39.88 128.44 2.11 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.724 0.897 . . . . 0.0 111.062 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.025 ' HB ' ' CE ' ' A' ' 67' ' ' LYS . 13.1 t -59.41 -39.4 83.32 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.686 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 1.081 ' OE2' ' HG2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 174.27 121.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.201 0.938 . . . . 0.0 109.427 -174.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 1.329 ' O ' ' CG ' ' A' ' 64' ' ' MET . 87.9 mm-40 77.45 -61.36 0.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.665 1.228 . . . . 0.0 108.507 -173.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 1.329 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 146.63 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.595 1.184 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HG3' ' C ' ' A' ' 64' ' ' MET . 43.7 mt-30 -156.69 79.83 0.94 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 112.087 -2.324 . . . . 0.0 106.561 176.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' GLN . 65.1 mt-30 -25.16 133.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.095 -172.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.065 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 6.5 mmpt? -63.71 -117.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.369 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 33.7 mmtp -156.77 74.02 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 CA-C-N 112.92 -1.946 . . . . 0.0 107.997 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 1.149 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 83.8 Cg_exo -48.4 -166.19 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.604 2.869 . . . . 0.0 113.654 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.149 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 80.9 m-20 -171.23 165.57 4.59 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.411 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.793 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 84.8 Cg_exo -39.09 91.31 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.543 2.829 . . . . 0.0 111.422 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.871 ' HG3' ' CG2' ' A' ' 100' ' ' THR . 82.4 Cg_exo -44.38 -150.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.655 2.903 . . . . 0.0 113.043 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.33 168.3 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 124.281 0.988 . . . . 0.0 111.606 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 26.8 mtpp -48.44 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 113.336 -1.756 . . . . 0.0 113.157 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.936 ' OD1' ' OD1' ' A' ' 78' ' ' ASP . 10.1 p30 -54.93 -149.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.864 -1.516 . . . . 0.0 111.245 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.284 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 173.11 -62.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.853 0.721 . . . . 0.0 109.696 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.664 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -36.8 -37.94 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.386 1.053 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.936 ' OD1' ' OD1' ' A' ' 75' ' ' ASN . 9.6 p-10 -68.8 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.13 0.894 . . . . 0.0 113.096 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 29.5 p30 -52.67 -101.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 161.06 -71.76 0.22 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.543 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.4 pt? -40.66 132.75 2.13 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.878 0.987 . . . . 0.0 111.984 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.71 ' O ' ' OD1' ' A' ' 83' ' ' ASN . 98.3 mtt180 -66.55 168.33 9.37 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.805 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.895 ' HB3' HG21 ' A' ' 87' ' ' THR . 87.9 m-20 -167.07 -170.47 1.53 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.581 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.801 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 15.5 m -168.26 159.39 10.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.343 -171.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.801 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 16.6 ptm180 -25.33 99.72 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.776 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 1.048 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 149.27 -24.59 1.24 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 111.346 -2.661 . . . . 0.0 110.261 -171.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.021 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.7 p -96.12 136.32 36.73 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.485 0.66 . . . . 0.0 112.049 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.135 HD12 ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -90.48 163.16 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.348 168.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.12 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -163.43 144.75 9.37 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.114 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.928 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 17.8 ttm -69.16 137.4 53.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.905 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.31 -100.71 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.531 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.252 ' O ' HG23 ' A' ' 93' ' ' THR . 17.1 ptm180 179.25 -139.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.902 0.751 . . . . 0.0 110.952 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.252 HG23 ' O ' ' A' ' 92' ' ' ARG . 22.5 p 145.82 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.678 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 44.05 -94.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.779 1.3 . . . . 0.0 110.462 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 96' ' ' LYS . 36.0 m-20 -49.53 127.46 15.54 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.196 0.935 . . . . 0.0 110.836 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -41.83 -103.85 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.645 175.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.842 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 63.0 m-20 -43.49 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.403 1.064 . . . . 0.0 109.764 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 72' ' ' PRO . 17.2 t -171.74 -113.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.588 1.18 . . . . 0.0 110.407 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.811 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . 43.74 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.226 0.954 . . . . 0.0 108.797 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.871 ' CG2' ' HG3' ' A' ' 72' ' ' PRO . 66.7 p -78.84 -44.85 22.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.342 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.9 p -170.19 92.29 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.344 1.027 . . . . 0.0 108.709 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 101' ' ' SER . 47.9 tt0 175.17 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 125.018 1.448 . . . . 0.0 109.575 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.847 ' O ' ' HB3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -146.74 -179.12 6.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.966 -177.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 1.589 ' HA ' ' CB ' ' A' ' 56' ' ' GLN . 11.7 p90 -157.32 170.54 22.24 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.346 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.013 HD11 HD21 ' A' ' 18' ' ' LEU . 85.2 mt -127.18 112.67 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 112.915 -1.948 . . . . 0.0 108.95 -170.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.817 ' OD1' ' O ' ' A' ' 87' ' ' THR . 36.0 p-10 -63.42 149.91 44.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.403 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.583 HG22 ' C ' ' A' ' 53' ' ' PHE . 31.4 m -136.3 23.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.801 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -163.91 136.24 5.0 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.763 0.664 . . . . 0.0 110.714 175.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -36.99 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.192 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 1.041 ' OD1' ' HB3' ' A' ' 113' ' ' LEU . 40.1 t30 -69.61 -95.51 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.93 1.394 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 65.08 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.176 0.922 . . . . 0.0 110.419 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.787 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 47.6 p90 -42.25 -39.87 2.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.296 0.998 . . . . 0.0 110.861 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.041 ' HB3' ' OD1' ' A' ' 110' ' ' ASN . 64.1 tp -58.68 -38.78 78.98 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.268 0.98 . . . . 0.0 110.504 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 111' ' ' ALA . 65.4 t0 -39.49 130.28 1.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.12 0.887 . . . . 0.0 111.681 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 1.025 ' ND1' ' O ' ' A' ' 120' ' ' PHE . 4.1 t60 -40.72 137.39 1.18 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.151 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.02 -147.9 5.58 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.869 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.598 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 4.4 pt20 -49.23 124.22 8.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.267 -0.967 . . . . 0.0 110.854 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 117' ' ' GLN . 75.2 mtp180 82.63 -120.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.481 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 120' ' ' PHE . 75.0 m-20 -46.21 127.27 8.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.676 1.235 . . . . 0.0 110.547 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 1.025 ' O ' ' ND1' ' A' ' 115' ' ' HIS . 1.0 OUTLIER -45.49 -102.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.98 -176.334 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.841 ' HA3' ' HB2' ' A' ' 115' ' ' HIS . . . 165.56 161.57 14.86 Favored Glycine 0 N--CA 1.479 1.536 0 O-C-N 123.862 0.726 . . . . 0.0 112.606 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.997 ' CE1' HD11 ' A' ' 113' ' ' LEU . 89.9 m-85 -78.83 137.11 37.54 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.043 -1.079 . . . . 0.0 110.599 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.284 ' HB1' ' OE1' ' A' ' 76' ' ' GLU . . . -56.1 -170.34 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.132 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 123' ' ' ALA . 70.3 t 178.51 144.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.352 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.887 ' HE2' HD23 ' A' ' 20' ' ' LEU . 2.5 p90 -170.42 25.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.625 ' C ' ' OE2' ' A' ' 19' ' ' GLU . . . -167.9 -139.85 2.78 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.652 1.14 . . . . 0.0 113.822 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.404 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 39.4 ttpt 179.62 -136.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 111.808 -2.196 . . . . 0.0 109.956 -172.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.091 ' N ' ' HG2' ' A' ' 127' ' ' LYS . 60.5 t -151.43 160.97 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.864 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 31.2 m -146.71 9.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.82 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 132' ' ' MET . 40.8 ttmt 173.1 -89.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.345 0.403 . . . . 0.0 111.86 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 16' ' ' ILE . . . -51.93 59.87 0.0 OUTLIER Glycine 0 N--CA 1.473 1.127 0 O-C-N 124.572 1.17 . . . . 0.0 114.75 -165.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.707 ' N ' ' O ' ' A' ' 130' ' ' LYS . 4.3 mmt -74.48 -49.73 21.06 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' LYS . 23.3 m-20 -39.72 -54.55 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.181 0.926 . . . . 0.0 109.986 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.621 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 75.0 t -52.24 -64.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.583 1.177 . . . . 0.0 109.249 175.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 1.031 ' HB1' HD11 ' A' ' 55' ' ' ILE . . . -43.78 -53.81 5.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.516 1.135 . . . . 0.0 110.258 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.868 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -58.71 -65.36 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.758 1.286 . . . . 0.0 108.636 179.155 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.998 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 2.9 tmtm? -36.86 -48.96 0.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.6 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.233 ' O ' HG22 ' A' ' 141' ' ' VAL . 12.8 mt -58.21 -56.97 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.612 1.195 . . . . 0.0 108.744 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.551 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.7 p -61.79 3.14 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.868 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.1 mp0 -94.78 -51.94 4.49 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.233 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -45.64 126.24 6.42 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.462 1.101 . . . . 0.0 110.283 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.7 Cg_exo -49.92 -178.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.679 2.919 . . . . 0.0 114.673 -176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.181 HG22 ' CA ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -161.07 -139.69 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.69 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.443 ' HB3' ' O ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -178.02 140.66 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.5 -2.136 . . . . 0.0 112.336 168.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 1.072 ' OD1' ' HG3' ' A' ' 150' ' ' GLN . 56.1 t0 -68.74 110.92 4.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 112.383 -2.19 . . . . 0.0 107.791 168.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.879 HG21 ' CG2' ' A' ' 152' ' ' VAL . 2.0 t -78.98 -142.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.737 -169.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.653 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -63.57 -108.79 0.01 OUTLIER Glycine 0 N--CA 1.471 1.02 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 171.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 1.047 ' O ' ' OE1' ' A' ' 150' ' ' GLN . 97.1 Cg_endo -68.5 -50.17 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.593 2.862 . . . . 0.0 109.649 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.555 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 78.0 m-85 -68.68 84.45 0.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.612 1.195 . . . . 0.0 109.688 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 1.072 ' HG3' ' OD1' ' A' ' 145' ' ' ASP . 3.7 mp0 -70.97 66.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.756 175.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.56 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 50.7 p30 170.51 89.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.61 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.879 ' CG2' HG21 ' A' ' 146' ' ' VAL . 75.0 t -156.24 115.87 2.15 Favored Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 124.392 1.057 . . . . 0.0 109.646 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.181 ' CA ' HG22 ' A' ' 143' ' ' THR . 83.6 Cg_exo -43.97 114.7 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.643 2.895 . . . . 0.0 111.44 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . 1.111 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 88.0 p -41.69 -36.88 1.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.438 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 1.157 ' HB2' ' CD ' ' A' ' 156' ' ' PRO . 30.3 mtpp -175.55 -71.31 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 124.134 0.896 . . . . 0.0 110.115 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.157 ' CD ' ' HB2' ' A' ' 155' ' ' LYS . 98.8 Cg_exo -51.25 72.28 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.702 2.934 . . . . 0.0 113.6 -171.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 1.128 HG23 ' O ' ' A' ' 156' ' ' PRO . 43.3 t -172.07 126.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.9 169.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.98 ' HA ' HG22 ' A' ' 45' ' ' THR . 76.7 t -168.87 118.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.014 HG12 HG22 ' A' ' 11' ' ' THR . 25.8 mt -68.1 132.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.766 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.841 HD12 HG22 ' A' ' 10' ' ' THR . 86.2 mt -81.2 -49.18 11.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.158 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -167.6 169.98 11.48 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.553 1.158 . . . . 0.0 111.992 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.8 ' O ' ' HG3' ' A' ' 163' ' ' LYS . . . -152.07 137.18 17.36 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.872 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 37.9 mtmm -170.3 136.23 1.35 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.084 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.575 ' CG1' HG11 ' A' ' 36' ' ' VAL . 33.1 m -69.49 175.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.783 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 165' ' ' LEU . 5.4 tt -143.63 119.94 6.51 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.707 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.591 ' N ' HD23 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 123.684 2.923 . . . . 0.0 112.135 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 120.902 0.382 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 3.4 tppp? 176.12 -94.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.676 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 1.135 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 179.48 146.15 6.65 Favored Glycine 0 N--CA 1.477 1.376 0 O-C-N 124.403 1.064 . . . . 0.0 111.901 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.135 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 89.7 m-20 -170.33 122.76 0.6 Allowed Pre-proline 0 N--CA 1.476 0.842 0 CA-C-N 114.459 -0.87 . . . . 0.0 109.714 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.193 ' C ' ' HD1' ' A' ' 6' ' ' HIS . 61.4 Cg_endo -68.99 117.37 4.99 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.894 3.063 . . . . 0.0 110.929 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.193 ' HD1' ' C ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -150.55 101.96 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.342 -175.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.942 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 7.7 p -59.85 107.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 171.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.998 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 5.2 tt -118.73 113.48 21.23 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.764 1.29 . . . . 0.0 109.79 -170.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.86 ' HG ' ' HA ' ' A' ' 162' ' ' ALA . 5.1 mp -127.67 -166.31 1.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.684 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 86.4 m -162.05 102.67 1.13 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.117 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 1.093 HG22 HG12 ' A' ' 159' ' ' ILE . 28.4 p -74.37 166.08 24.09 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.834 1.334 . . . . 0.0 111.693 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.552 ' OG ' HG13 ' A' ' 157' ' ' VAL . 80.1 p -40.93 -46.07 2.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.512 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -51.97 -59.15 4.67 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.451 1.094 . . . . 0.0 110.274 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.22 45.99 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 112.931 -1.94 . . . . 0.0 113.149 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 1.193 ' O ' HG21 ' A' ' 134' ' ' VAL . 54.5 t30 -52.31 162.28 0.54 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.69 -1.255 . . . . 0.0 111.448 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.865 HG13 ' O ' ' A' ' 15' ' ' ASN . 9.3 mt -170.16 153.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.116 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.998 ' OE1' ' CD1' ' A' ' 8' ' ' LEU . 33.5 mt-10 -163.22 110.15 1.18 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.833 -173.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.942 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 2.2 mm? -82.42 150.42 27.1 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.294 0.996 . . . . 0.0 109.804 164.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.496 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -111.43 123.63 50.6 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.298 0.999 . . . . 0.0 109.578 174.274 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.256 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 75.8 mt -104.59 -171.33 1.9 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.751 1.282 . . . . 0.0 112.74 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 1.256 ' OD1' ' O ' ' A' ' 20' ' ' LEU . 47.8 m-20 -164.08 68.04 0.17 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.204 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.435 ' HD2' ' N ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -47.33 -27.28 1.53 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.821 1.326 . . . . 0.0 113.036 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 1.435 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 36.0 tt0 -41.93 -63.99 0.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.941 0.776 . . . . 0.0 110.09 -174.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.963 ' HD3' ' HA ' ' A' ' 79' ' ' ASN . 25.3 ttmm -78.9 18.41 0.62 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.815 1.322 . . . . 0.0 112.742 -178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.067 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -161.98 69.98 2.29 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 1.01 ' O ' HG22 ' A' ' 29' ' ' VAL . 69.0 Cg_endo -71.39 -61.41 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.731 2.954 . . . . 0.0 110.124 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 28' ' ' SER . 16.0 m -48.12 -63.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 124.609 1.193 . . . . 0.0 110.152 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.743 ' H ' HG23 ' A' ' 27' ' ' VAL . 42.9 t -48.43 -59.54 3.39 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.508 1.13 . . . . 0.0 110.346 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.599 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 35.2 m -45.3 -49.13 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 124.579 1.175 . . . . 0.0 110.898 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 1.182 ' O ' HG12 ' A' ' 33' ' ' VAL . 61.7 tp60 -50.11 -56.81 9.4 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.31 1.006 . . . . 0.0 109.745 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.89 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 24.6 t-20 -50.2 -62.19 1.72 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.567 1.167 . . . . 0.0 110.587 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 1.599 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 29.1 p90 -56.08 -43.92 78.49 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.266 0.979 . . . . 0.0 110.64 -172.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.182 HG12 ' O ' ' A' ' 30' ' ' GLN . 11.5 p -51.05 -40.06 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 124.046 0.841 . . . . 0.0 110.094 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.89 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 45.4 m-20 -45.39 -61.07 1.82 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.045 0.84 . . . . 0.0 109.252 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.554 ' O ' ' OG ' ' A' ' 38' ' ' SER . 68.9 m-85 -54.52 -55.85 24.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.908 1.38 . . . . 0.0 109.491 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.726 HG22 ' CE1' ' A' ' 41' ' ' TYR . 77.1 t -46.06 -66.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 124.436 1.085 . . . . 0.0 109.537 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -43.89 -49.82 8.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.84 1.338 . . . . 0.0 110.695 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.554 ' OG ' ' O ' ' A' ' 35' ' ' TYR . 29.7 p -58.64 -107.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.53 1.144 . . . . 0.0 110.161 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.64 59.64 0.28 Allowed Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' THR . 17.7 t80 -89.27 -63.58 1.27 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.958 1.034 . . . . 0.0 109.726 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.726 ' CE1' HG22 ' A' ' 36' ' ' VAL . 35.1 m-85 -75.53 -14.24 60.4 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.524 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 1.126 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 52.7 p-10 -39.08 -41.62 0.82 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.642 0.589 . . . . 0.0 112.517 -170.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 1.126 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 19.5 m-20 -154.78 46.8 0.55 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.161 0.913 . . . . 0.0 110.296 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 45' ' ' THR . 74.3 p -78.92 -139.64 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 166.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.954 ' HA ' HG13 ' A' ' 159' ' ' ILE . 76.5 p -163.46 -153.95 0.26 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.934 0.873 . . . . 0.0 112.595 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.881 ' CE1' HD11 ' A' ' 159' ' ' ILE . 17.0 m-30 -129.65 84.39 2.21 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.845 -1.979 . . . . 0.0 106.279 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.624 ' NE2' ' O ' ' A' ' 56' ' ' GLN . 8.2 p80 -56.42 -65.57 0.58 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.3 -169.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.316 ' HD3' ' N ' ' A' ' 49' ' ' VAL . 1.2 tmt_? -164.67 160.71 20.24 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -162.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.56 ' CG1' ' HG3' ' A' ' 54' ' ' MET . 45.8 t -175.73 -77.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.045 -2.343 . . . . 0.0 106.914 164.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.919 HG22 HG12 ' A' ' 49' ' ' VAL . 11.2 tt 171.3 138.8 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.688 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.829 ' HD2' HG13 ' A' ' 50' ' ' ILE . 83.4 Cg_exo -35.04 164.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.333 -0.289 0 C-N-CA 123.507 2.805 . . . . 0.0 113.846 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.98 69.46 0.0 OUTLIER Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.876 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.286 ' CE1' ' ND2' ' A' ' 110' ' ' ASN . 9.8 t80 -160.99 -53.46 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.787 0.934 . . . . 0.0 109.843 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.56 ' HG3' ' CG1' ' A' ' 49' ' ' VAL . 24.1 ptt? -164.36 154.06 14.03 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.457 1.098 . . . . 0.0 111.912 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.772 HG13 ' HB ' ' A' ' 105' ' ' ILE . 48.4 pt -160.21 124.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.73 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 1.105 ' HG2' ' CA ' ' A' ' 104' ' ' PHE . 33.2 mt-30 -120.36 128.72 53.5 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.385 1.053 . . . . 0.0 110.334 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.0 -162.6 32.11 Favored Glycine 0 N--CA 1.477 1.404 0 O-C-N 124.631 1.207 . . . . 0.0 112.803 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 1.007 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 44.45 96.65 0.01 OUTLIER Glycine 0 N--CA 1.47 0.915 0 CA-C-N 113.725 -1.238 . . . . 0.0 111.38 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.749 ' HA2' ' OE1' ' A' ' 102' ' ' GLN . . . 174.46 -121.79 0.86 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.705 0.885 . . . . 0.0 110.925 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -46.08 146.04 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.047 -1.077 . . . . 0.0 111.636 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.6 m -58.12 -43.06 87.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.908 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 1.051 ' HG3' ' N ' ' A' ' 63' ' ' GLN . 12.6 pt-20 -172.48 -100.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.248 0.968 . . . . 0.0 109.166 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 1.172 ' O ' ' CG ' ' A' ' 64' ' ' MET . 9.7 tp-100 -46.3 -57.55 4.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.673 1.233 . . . . 0.0 109.623 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 1.172 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 20.0 mmt 165.4 27.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.614 1.196 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -78.64 84.94 4.71 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.14 133.43 1.22 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 31.2 mmmt -64.13 -119.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.283 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' PRO . 24.8 ttmm -171.14 83.4 0.51 Allowed Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.73 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 1.025 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 89.2 Cg_exo -45.55 -155.59 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.631 2.887 . . . . 0.0 113.279 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.167 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.2 m120 -166.86 167.63 7.67 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.313 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.943 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 39.4 Cg_endo -49.07 87.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.845 2.363 . . . . 0.0 108.55 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.167 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 89.7 Cg_exo -48.29 -151.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.79 2.993 . . . . 0.0 113.789 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -155.27 149.1 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.369 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 94.1 mttt -32.39 133.6 0.11 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.394 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.61 167.63 5.54 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.832 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.951 ' OE2' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -168.16 155.35 7.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.032 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.814 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 177.59 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.191 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.844 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 42.0 p-10 -67.02 -48.28 68.83 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.983 0.802 . . . . 0.0 109.809 -176.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.963 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 19.0 p-10 40.21 -73.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.078 0.861 . . . . 0.0 111.541 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . 87.76 88.43 1.11 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 80' ' ' GLY . 85.9 mt -161.46 -158.3 0.56 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.113 -1.043 . . . . 0.0 109.893 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.752 ' N ' ' HD2' ' A' ' 82' ' ' ARG . 1.3 mpt_? -59.1 -165.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.253 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.781 ' OD1' ' HB2' ' A' ' 111' ' ' ALA . 1.7 t-20 168.3 100.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.151 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' GLY . 22.8 m -170.31 134.57 1.19 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.63 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 1.411 ' HB2' ' C ' ' A' ' 107' ' ' VAL . 4.0 ppt_? -38.51 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.672 1.225 . . . . 0.0 110.299 176.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 160.59 -22.9 0.25 Allowed Glycine 0 CA--C 1.534 1.226 0 CA-C-N 111.395 -2.639 . . . . 0.0 110.478 -170.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.079 ' HA ' ' CA ' ' A' ' 127' ' ' LYS . 40.5 p -98.94 148.74 23.66 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.63 0.729 . . . . 0.0 111.793 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.104 ' CD1' ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -96.54 159.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.342 168.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.083 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . . . -142.89 176.96 8.67 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.08 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.899 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.3 tpt -101.95 129.92 48.33 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.766 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.88 -144.51 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.857 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.222 ' HG2' ' N ' ' A' ' 93' ' ' THR . 37.8 ttm180 -177.65 -165.52 0.11 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.84 0.828 . . . . 0.0 111.852 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.222 ' N ' ' HG2' ' A' ' 92' ' ' ARG . 25.3 p 176.07 116.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 108.239 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.806 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -17.48 120.28 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.514 1.134 . . . . 0.0 112.906 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.817 ' OD2' ' O ' ' A' ' 97' ' ' ASP . 39.0 t70 142.18 139.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HB3' ' H ' ' A' ' 97' ' ' ASP . 53.0 tptt -42.89 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.431 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.817 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 38.2 m-20 -67.3 117.7 9.67 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.688 1.243 . . . . 0.0 108.5 168.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 24.8 t -151.48 170.65 19.1 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.57 1.169 . . . . 0.0 111.973 -173.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 98' ' ' SER . . . 84.76 136.24 0.05 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.729 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 100' ' ' THR . 35.5 m -155.74 2.3 0.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.453 1.095 . . . . 0.0 113.205 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.409 ' C ' ' HE1' ' A' ' 90' ' ' MET . 34.3 p -171.73 -76.34 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.562 0.539 . . . . 0.0 110.852 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 1.007 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 3.5 mp0 -38.25 154.57 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.006 0.816 . . . . 0.0 111.9 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.992 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -160.86 167.03 27.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.545 177.038 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 1.105 ' CA ' ' HG2' ' A' ' 56' ' ' GLN . 72.4 m-85 -84.23 151.24 24.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.638 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.845 HD11 HD21 ' A' ' 18' ' ' LEU . 22.9 mt -139.58 94.24 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.617 159.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.582 ' O ' ' HE1' ' A' ' 132' ' ' MET . 48.9 m-20 -69.22 -173.29 0.51 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.309 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.411 ' C ' ' HB2' ' A' ' 85' ' ' ARG . 35.9 m -158.27 -46.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.571 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.203 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -101.49 150.46 23.04 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 124.518 1.136 . . . . 0.0 110.915 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' N ' ' CG ' ' A' ' 85' ' ' ARG . 3.1 m-20 -37.59 138.18 0.37 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.174 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 1.286 ' ND2' ' CE1' ' A' ' 53' ' ' PHE . 33.8 m120 -157.45 170.46 22.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.765 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB2' ' OD1' ' A' ' 83' ' ' ASN . . . 153.38 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.361 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -39.67 -55.51 1.87 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.152 0.907 . . . . 0.0 110.334 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.899 HD22 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -63.49 -8.86 10.43 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.837 1.336 . . . . 0.0 112.662 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.723 ' N ' HD12 ' A' ' 113' ' ' LEU . 57.6 p-10 -43.74 127.34 5.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.667 0.604 . . . . 0.0 111.657 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.765 ' CD2' ' HD1' ' A' ' 120' ' ' PHE . 0.1 OUTLIER -34.27 126.92 0.45 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.309 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . -176.71 -114.87 0.4 Allowed Glycine 0 N--CA 1.474 1.168 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.485 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.687 ' O ' ' CB ' ' A' ' 118' ' ' ARG . 29.8 tt0 -50.7 123.64 9.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.48 -0.86 . . . . 0.0 111.013 -176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.875 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 73.7 ttt-85 106.14 -81.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.177 173.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.875 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 88.3 m-20 -176.54 101.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.445 1.09 . . . . 0.0 109.425 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.765 ' HD1' ' CD2' ' A' ' 115' ' ' HIS . 25.1 m-85 42.37 -166.39 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.671 1.232 . . . . 0.0 112.065 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.33 -134.18 1.73 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.042 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.899 ' CD2' HD22 ' A' ' 113' ' ' LEU . 58.9 m-85 -79.55 118.17 21.15 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.443 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.038 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -57.36 -162.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.784 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.083 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 75.5 t 179.95 146.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.582 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.791 ' CE2' HD22 ' A' ' 20' ' ' LEU . 21.6 p90 -171.18 25.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 1.058 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -167.13 -139.55 2.69 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 122.645 1.136 . . . . 0.0 113.436 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.496 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 94.0 mttt 179.35 -135.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.822 -2.189 . . . . 0.0 109.727 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.771 HG22 ' CD1' ' A' ' 18' ' ' LEU . 91.7 t -160.29 152.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.5 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' ' 19' ' ' GLU . 33.1 m -137.11 -27.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.69 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -170.83 86.95 0.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . -166.92 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 124.763 1.289 . . . . 0.0 110.883 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.781 ' HE3' ' HA ' ' A' ' 107' ' ' VAL . 22.9 mmt -39.32 -38.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.216 0.597 . . . . 0.0 111.3 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -47.75 -59.21 3.46 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 1.193 HG21 ' O ' ' A' ' 15' ' ' ASN . 46.6 t -58.74 -63.01 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 124.75 1.281 . . . . 0.0 108.949 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 132' ' ' MET . . . -41.28 -51.03 3.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.955 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.96 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 37.1 m-20 -50.79 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.6 1.187 . . . . 0.0 109.04 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -43.34 -45.7 6.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.463 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.201 ' O ' HG12 ' A' ' 141' ' ' VAL . 42.4 mt -57.01 -61.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.422 1.076 . . . . 0.0 108.871 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.9 p -65.31 2.44 0.85 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.96 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.1 mp0 -93.01 -49.52 5.98 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 124.232 0.958 . . . . 0.0 109.124 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.201 HG12 ' O ' ' A' ' 138' ' ' ILE . 8.6 p -39.7 135.36 1.25 Allowed Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 124.272 0.982 . . . . 0.0 111.043 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' A' ' 141' ' ' VAL . 79.9 Cg_exo -42.54 168.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.332 -0.328 0 C-N-CA 123.573 2.848 . . . . 0.0 113.658 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.545 HG22 ' CA ' ' A' ' 153' ' ' PRO . 5.9 p -160.84 -149.92 0.19 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 123.415 1.579 . . . . 0.0 112.313 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER 178.6 161.38 0.66 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 110.28 -3.145 . . . . 0.0 111.441 172.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.622 ' O ' HG22 ' A' ' 146' ' ' VAL . 35.3 m-20 -50.33 -157.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.059 164.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -160.85 -143.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.11 -110.3 0.02 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 167.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.764 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 84.8 Cg_endo -70.69 -48.78 0.48 Allowed 'Trans proline' 0 C--N 1.333 -0.286 0 C-N-CA 123.662 2.908 . . . . 0.0 109.781 169.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.874 ' O ' HG23 ' A' ' 146' ' ' VAL . 93.7 m-85 -68.95 88.48 0.39 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.584 1.177 . . . . 0.0 110.722 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 16.0 pt20 -71.73 143.1 49.73 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.855 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 1.085 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 10.0 m120 84.33 90.12 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.548 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 146' ' ' VAL . 91.2 t -160.62 97.86 1.4 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.208 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.545 ' CA ' HG22 ' A' ' 143' ' ' THR . 88.6 Cg_exo -46.15 106.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 123.52 2.813 . . . . 0.0 110.891 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . 1.092 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 65.8 p -41.35 -56.3 2.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.655 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.478 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 65.4 mttm -79.62 95.62 0.21 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.582 1.176 . . . . 0.0 108.308 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.092 ' HD3' ' O ' ' A' ' 154' ' ' SER . 61.6 Cg_endo -77.01 132.3 12.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.771 2.981 . . . . 0.0 112.246 -171.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.552 HG13 ' OG ' ' A' ' 12' ' ' SER . 47.7 t -69.32 162.72 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.723 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.924 ' HA ' HG22 ' A' ' 45' ' ' THR . 86.5 t -147.28 120.12 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.108 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.093 HG12 HG22 ' A' ' 11' ' ' THR . 34.9 mt -68.84 134.61 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.258 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 10' ' ' THR . 87.5 mt -85.72 -49.76 7.71 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 110.182 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 9' ' ' LEU . 69.2 m -146.82 178.82 8.03 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.67 1.231 . . . . 0.0 111.974 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.86 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . . . -178.7 122.94 0.09 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.364 -175.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.602 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -171.09 152.9 3.58 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.254 173.196 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.02 141.67 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.732 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 166' ' ' PRO . 5.5 tt -57.82 126.07 75.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.16 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.698 ' N ' HD23 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.607 2.872 . . . . 0.0 112.179 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 22.1 ptmt 169.02 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.633 1.208 . . . . 0.0 110.529 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 1.034 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 160.63 -133.96 3.43 Favored Glycine 0 N--CA 1.476 1.351 0 O-C-N 124.467 1.105 . . . . 0.0 111.025 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.034 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 97.9 m-20 -175.11 69.28 0.27 Allowed Pre-proline 0 N--CA 1.474 0.768 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.283 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 83.4 Cg_endo -89.8 60.94 1.99 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.657 2.905 . . . . 0.0 110.096 -171.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.283 ' ND1' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -154.5 88.49 1.21 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.21 0.944 . . . . 0.0 110.066 -176.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 7' ' ' VAL . 25.5 t -67.78 81.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 167.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.061 ' HG ' ' HG2' ' A' ' 17' ' ' GLU . 7.5 tt -80.38 108.92 14.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.356 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.358 HD23 ' O ' ' A' ' 161' ' ' SER . 7.3 mt -109.51 174.44 5.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 112.737 -2.029 . . . . 0.0 112.532 -173.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.895 HG22 HD12 ' A' ' 160' ' ' LEU . 94.9 m -159.91 95.11 1.16 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.078 -2.328 . . . . 0.0 108.447 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 1.022 HG22 HG12 ' A' ' 159' ' ' ILE . 19.8 p -84.53 161.2 20.31 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.997 1.436 . . . . 0.0 111.217 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 81.7 p -39.09 -43.59 1.05 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.861 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.774 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -52.84 -63.84 1.01 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.42 1.075 . . . . 0.0 110.105 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.49 171.18 43.87 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.089 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.703 ' OD1' ' O ' ' A' ' 9' ' ' LEU . 43.0 t30 -68.32 133.31 48.55 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.309 -1.445 . . . . 0.0 110.719 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 16.5 pt -143.73 -179.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.922 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 1.061 ' HG2' ' HG ' ' A' ' 8' ' ' LEU . 35.9 mt-10 -161.62 110.89 1.55 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.799 -169.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.082 HD21 HD11 ' A' ' 105' ' ' ILE . 3.1 mm? -77.36 150.65 35.11 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 124.541 1.15 . . . . 0.0 110.106 165.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.795 ' HG3' ' HB3' ' A' ' 127' ' ' LYS . 12.6 pt-20 -122.84 121.49 36.37 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.909 174.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.018 HD13 ' HE2' ' A' ' 125' ' ' PHE . 61.3 mt -104.19 173.55 6.25 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.803 1.315 . . . . 0.0 112.66 -169.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 125' ' ' PHE . 73.2 m-20 -128.83 104.5 7.65 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.569 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -76.26 -39.54 54.11 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.831 1.332 . . . . 0.0 112.055 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.889 ' HG3' ' HD2' ' A' ' 24' ' ' LYS . 8.1 tp-100 -45.08 -66.85 0.34 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.211 0.945 . . . . 0.0 110.275 -171.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.889 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -83.55 19.48 1.59 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.817 1.323 . . . . 0.0 113.804 -175.181 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.012 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -160.59 64.97 2.21 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 123.904 0.752 . . . . 0.0 111.134 173.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.8 Cg_exo -59.91 -58.72 0.51 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.517 2.811 . . . . 0.0 111.071 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.401 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 80.7 t -53.9 -69.86 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.157 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.436 ' OG ' ' HB1' ' A' ' 25' ' ' ALA . 75.2 p -48.05 -53.92 14.77 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.704 1.252 . . . . 0.0 111.023 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 25' ' ' ALA . 3.5 t -60.45 -41.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.318 1.012 . . . . 0.0 110.625 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 1.31 ' O ' HG12 ' A' ' 33' ' ' VAL . 7.3 tm0? -49.87 -62.43 1.57 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.111 0.882 . . . . 0.0 108.923 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 1.039 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.5 m120 -44.25 -52.48 7.45 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.585 1.178 . . . . 0.0 110.274 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.879 ' CD2' ' HA ' ' A' ' 29' ' ' VAL . 20.8 m-30 -41.51 -67.3 0.26 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.456 1.098 . . . . 0.0 109.806 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.31 HG12 ' O ' ' A' ' 30' ' ' GLN . 7.2 p -40.5 -40.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 124.782 1.301 . . . . 0.0 111.118 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 1.039 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 8.0 m-20 -44.96 -61.94 1.42 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.028 0.83 . . . . 0.0 109.445 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -55.53 -53.36 57.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.813 1.321 . . . . 0.0 109.317 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.629 HG11 HG13 ' A' ' 164' ' ' VAL . 76.3 t -45.15 -65.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.556 1.16 . . . . 0.0 109.464 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' SER . 22.1 m-20 -48.32 -48.63 36.01 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.803 1.314 . . . . 0.0 110.227 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 37' ' ' ASN . 54.5 m -52.98 -113.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.463 1.102 . . . . 0.0 110.913 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.1 78.05 0.08 OUTLIER Glycine 0 N--CA 1.473 1.141 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 74.4 t80 -116.22 -63.86 1.39 Allowed 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.196 1.174 . . . . 0.0 109.358 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.985 ' O ' HG23 ' A' ' 44' ' ' THR . 51.6 m-85 -59.73 -41.77 91.63 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.715 1.259 . . . . 0.0 111.605 -172.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.584 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.0 p30 -39.32 117.18 0.68 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.19 0.931 . . . . 0.0 111.333 -173.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.7 t30 60.02 35.22 21.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.011 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.985 HG23 ' O ' ' A' ' 41' ' ' TYR . 69.9 p -79.2 -143.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.159 0.912 . . . . 0.0 108.848 165.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.944 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 55.3 p -163.21 -144.0 0.08 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.822 0.82 . . . . 0.0 112.725 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.944 ' CD1' ' O ' ' A' ' 45' ' ' THR . 8.2 m-30 -154.68 67.1 0.69 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.016 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.718 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 6.3 p-80 -59.06 -65.04 0.73 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.855 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.738 ' HG2' ' OE1' ' A' ' 56' ' ' GLN . 25.3 tpt180 -69.29 119.02 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.583 1.177 . . . . 0.0 110.656 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.542 HG13 HG22 ' A' ' 55' ' ' ILE . 84.6 t -154.93 147.55 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 124.805 1.316 . . . . 0.0 110.834 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.594 ' CG2' ' CG ' ' A' ' 54' ' ' MET . 11.0 tt -157.95 125.58 2.74 Favored Pre-proline 0 N--CA 1.476 0.857 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.955 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 76.0 Cg_exo -34.22 161.78 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.67 2.913 . . . . 0.0 113.958 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -8.85 71.07 0.0 OUTLIER Glycine 0 N--CA 1.475 1.252 0 CA-C-N 114.049 -1.432 . . . . 0.0 113.548 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.112 ' HD1' ' HG2' ' A' ' 54' ' ' MET . 56.5 t80 -160.61 -58.97 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.856 0.974 . . . . 0.0 109.552 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.112 ' HG2' ' HD1' ' A' ' 53' ' ' PHE . 26.3 ptt? -169.22 159.64 9.08 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.299 0.999 . . . . 0.0 112.371 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 105' ' ' ILE . 41.7 pt -154.7 156.58 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 113.171 -1.831 . . . . 0.0 109.203 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.991 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 38.4 mt-30 -150.57 164.83 35.05 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.876 0.735 . . . . 0.0 112.142 -166.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.67 ' O ' ' CD1' ' A' ' 103' ' ' PHE . . . -162.11 155.98 27.43 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 124.06 0.85 . . . . 0.0 112.959 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.513 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 136.63 -57.29 0.67 Allowed Glycine 0 N--CA 1.475 1.271 0 CA-C-N 113.426 -1.387 . . . . 0.0 110.331 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -51.62 -125.16 0.01 OUTLIER Glycine 0 N--CA 1.471 1.033 0 O-C-N 124.593 0.819 . . . . 0.0 113.21 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -39.5 148.01 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.441 -172.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 62' ' ' GLU . 94.0 m -59.94 -92.47 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.463 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.678 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.3 pt-20 -138.85 117.04 11.81 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 124.895 1.372 . . . . 0.0 108.882 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 1.291 ' O ' ' CG ' ' A' ' 64' ' ' MET . 67.2 tt0 76.91 -56.75 0.54 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.629 1.206 . . . . 0.0 108.8 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 1.291 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 155.82 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.046 1.403 . . . . 0.0 109.163 175.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.776 ' NE2' ' O ' ' A' ' 64' ' ' MET . 88.3 mm-40 -142.87 82.21 1.76 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 110.908 -2.86 . . . . 0.0 104.965 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.825 ' C ' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -27.54 174.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -165.15 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HB3' ' H ' ' A' ' 68' ' ' LYS . 7.0 mtpm? -68.62 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 111.0 -2.818 . . . . 0.0 113.617 -169.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 67' ' ' LYS . 28.0 tptp 179.11 73.75 0.14 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 112.325 -2.216 . . . . 0.0 105.758 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.606 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 62.5 Cg_endo -83.37 -165.02 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 123.351 2.701 . . . . 0.0 113.746 -162.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.998 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 8.6 m120 -163.34 169.89 8.06 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 113.126 -1.852 . . . . 0.0 110.029 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 35.1 Cg_endo -50.74 95.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.12 2.547 . . . . 0.0 109.818 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.997 ' HG3' HG22 ' A' ' 100' ' ' THR . 82.4 Cg_exo -51.86 -146.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.908 3.072 . . . . 0.0 113.46 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.558 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.05 152.83 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 124.296 0.997 . . . . 0.0 110.981 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 61.3 mttp -37.66 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.181 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.748 ' O ' ' HB3' ' A' ' 76' ' ' GLU . 56.0 p30 -64.02 -168.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.19 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.874 ' HB2' HD21 ' A' ' 79' ' ' ASN . 0.0 OUTLIER 160.43 141.17 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.383 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.15 ' HB1' ' CE1' ' A' ' 115' ' ' HIS . . . -157.6 -51.24 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.242 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -68.28 -49.43 60.55 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.473 1.108 . . . . 0.0 110.372 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.874 HD21 ' HB2' ' A' ' 76' ' ' GLU . 45.1 p30 -43.02 -43.38 4.23 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.22 0.95 . . . . 0.0 110.103 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.672 ' N ' ' OD1' ' A' ' 79' ' ' ASN . . . -42.85 -33.32 1.61 Allowed Glycine 0 N--CA 1.471 1.029 0 O-C-N 124.411 1.069 . . . . 0.0 112.131 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 66.1 mt 98.39 -131.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 1.018 ' O ' ' NE ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -169.0 110.12 0.49 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.977 0.798 . . . . 0.0 109.673 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.734 ' HB2' HG21 ' A' ' 87' ' ' THR . 2.0 m-20 -132.74 -134.16 0.18 Allowed 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.963 1.414 . . . . 0.0 109.865 -176.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' OD1' ' A' ' 109' ' ' ASP . 10.2 m -169.6 163.77 10.21 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.822 0.82 . . . . 0.0 111.734 -167.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.937 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 58.2 ttt180 -18.67 103.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.199 165.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.946 ' O ' ' CG ' ' A' ' 127' ' ' LYS . . . 140.35 -23.19 2.7 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.256 -2.702 . . . . 0.0 110.581 -169.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.034 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.7 p -98.28 146.98 25.11 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.023 0.916 . . . . 0.0 112.94 -175.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.67 161.94 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.972 164.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.027 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -159.78 156.66 27.95 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.558 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 1.217 ' CE ' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -74.4 123.74 25.23 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.752 -176.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.588 ' N ' ' SD ' ' A' ' 90' ' ' MET . . . -57.75 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.089 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.824 ' NH1' ' O ' ' A' ' 93' ' ' THR . 68.0 ttp85 179.71 -104.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.743 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.824 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 97.3 m 100.71 -98.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.638 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.475 ' N ' HG22 ' A' ' 93' ' ' THR . . . -61.95 -132.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.58 1.175 . . . . 0.0 110.93 -174.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 35.2 m-20 -58.24 172.12 0.49 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -56.16 -111.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.723 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.642 ' OD1' ' CG ' ' A' ' 75' ' ' ASN . 35.2 m-20 -52.4 103.57 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.776 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.836 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 68.4 m -165.76 -34.75 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.467 1.104 . . . . 0.0 111.619 -175.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 1.217 ' HB1' ' CE ' ' A' ' 90' ' ' MET . . . -33.58 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.846 0.716 . . . . 0.0 110.701 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.997 HG22 ' HG3' ' A' ' 72' ' ' PRO . 48.8 p -78.87 -60.4 2.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.182 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.7 p -171.57 97.57 0.18 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.251 0.97 . . . . 0.0 109.274 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.914 ' OE1' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER 171.23 134.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.727 1.267 . . . . 0.0 109.109 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.927 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -140.24 -171.29 3.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.458 -177.041 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.991 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 43.6 p90 -155.93 129.06 8.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.47 -172.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.082 HD11 HD21 ' A' ' 18' ' ' LEU . 57.8 mt -93.27 111.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.515 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 104' ' ' PHE . 50.9 m-20 -65.38 155.26 35.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.398 1.061 . . . . 0.0 110.766 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 54' ' ' MET . 22.4 m -146.92 38.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.11 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 178.95 122.93 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.142 0.901 . . . . 0.0 110.067 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.937 ' OD1' ' HB3' ' A' ' 85' ' ' ARG . 34.0 m-20 -37.17 137.11 0.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.14 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.458 ' ND2' ' C ' ' A' ' 109' ' ' ASP . 4.3 m-80 -150.8 108.79 3.71 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.65 1.218 . . . . 0.0 110.097 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . -90.92 -49.96 6.14 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.893 170.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 1.251 ' O ' HD12 ' A' ' 113' ' ' LEU . 30.6 p90 -49.35 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.469 1.106 . . . . 0.0 109.235 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.251 HD12 ' O ' ' A' ' 112' ' ' PHE . 3.1 mp 179.28 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.641 -2.072 . . . . 0.0 108.519 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.67 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 6.6 m-20 -38.92 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.856 0.723 . . . . 0.0 110.657 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 1.15 ' CE1' ' HB1' ' A' ' 77' ' ' ALA . 16.8 m80 -46.92 122.27 4.23 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.901 1.375 . . . . 0.0 110.182 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.78 172.41 40.48 Favored Glycine 0 N--CA 1.478 1.455 0 O-C-N 124.524 1.14 . . . . 0.0 112.182 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 118' ' ' ARG . 3.0 mp0 53.25 -148.76 0.43 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.08 -1.06 . . . . 0.0 109.847 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.486 ' O ' ' O ' ' A' ' 117' ' ' GLN . 83.8 mtm180 -51.1 -115.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.726 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 120' ' ' PHE . 37.0 m-20 -60.28 126.68 28.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.625 1.203 . . . . 0.0 111.943 -175.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' A' ' 119' ' ' ASP . 24.3 m-85 -54.02 -140.82 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.446 173.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.11 -131.34 1.31 Allowed Glycine 0 N--CA 1.476 1.318 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.864 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 89.9 m-85 -79.45 133.86 36.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.422 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.076 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -69.55 -161.65 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.519 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.076 HG23 ' O ' ' A' ' 123' ' ' ALA . 54.9 t 178.8 144.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.753 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 1.018 ' HE2' HD13 ' A' ' 20' ' ' LEU . 30.3 p90 -168.74 26.16 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.749 ' HA3' HD23 ' A' ' 20' ' ' LEU . . . -167.17 -143.98 3.96 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 122.87 1.261 . . . . 0.0 113.906 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 1.034 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 40.4 ttmt 179.76 -139.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 111.51 -2.345 . . . . 0.0 109.656 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.988 ' H ' ' CG ' ' A' ' 127' ' ' LYS . 95.8 t -159.78 117.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.952 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.846 ' O ' ' HG3' ' A' ' 130' ' ' LYS . 35.2 m -73.75 -40.99 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.739 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.846 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 8.4 mtpm? -166.19 -156.2 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.261 0.976 . . . . 0.0 111.379 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 134' ' ' VAL . . . 49.75 18.36 1.77 Allowed Glycine 0 N--CA 1.473 1.154 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.539 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 10.4 tpt -55.03 -48.04 73.95 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.72 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 2.2 m-20 -43.29 -56.07 3.7 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.437 1.085 . . . . 0.0 110.018 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.627 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.1 t -39.7 -59.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.49 1.118 . . . . 0.0 109.671 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -45.5 -52.22 10.63 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.655 1.222 . . . . 0.0 109.529 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.929 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 1.8 m-20 -50.51 -65.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.553 1.158 . . . . 0.0 109.042 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 14.5 mmmm -35.46 -55.02 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.498 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.157 ' O ' HG22 ' A' ' 141' ' ' VAL . 13.8 mt -56.95 -56.81 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.868 1.355 . . . . 0.0 109.169 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -64.23 3.25 0.46 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.929 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.9 mp0 -97.24 -51.47 4.18 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.213 0.946 . . . . 0.0 108.717 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 1.157 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -45.78 125.83 6.6 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.436 1.085 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -44.6 177.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 123.637 2.891 . . . . 0.0 114.022 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.426 HG22 ' CA ' ' A' ' 153' ' ' PRO . 1.5 p -161.23 -140.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.127 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER 179.65 164.49 1.06 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 110.485 -3.052 . . . . 0.0 111.017 169.591 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.816 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 34.7 m-20 -50.42 -143.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.652 168.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -161.68 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 168.605 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.55 -94.65 0.05 OUTLIER Glycine 0 N--CA 1.47 0.964 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 168.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.704 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 97.5 Cg_endo -76.83 -65.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.917 3.078 . . . . 0.0 109.603 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.971 ' O ' HG23 ' A' ' 146' ' ' VAL . 39.3 m-85 -69.83 124.73 24.75 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.564 1.165 . . . . 0.0 111.695 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.816 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 49.5 mm-40 -75.75 -171.84 1.71 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.744 169.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 152' ' ' VAL . 20.6 m-20 44.89 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.615 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.824 ' HB ' HG22 ' A' ' 146' ' ' VAL . 83.7 t -159.16 128.74 3.26 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 113.164 -1.835 . . . . 0.0 107.726 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 1.426 ' CA ' HG22 ' A' ' 143' ' ' THR . 96.5 Cg_exo -39.25 -145.71 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.308 2.672 . . . . 0.0 112.508 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 45.7 t -163.86 -8.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.373 1.046 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 1.107 ' HB3' ' HD3' ' A' ' 156' ' ' PRO . 87.8 tttt 178.91 -67.36 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.534 0.521 . . . . 0.0 111.667 175.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.164 ' O ' HG23 ' A' ' 157' ' ' VAL . 56.7 Cg_endo -75.04 76.84 3.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 111.672 -168.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 1.164 HG23 ' O ' ' A' ' 156' ' ' PRO . 42.8 t -172.52 127.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.679 168.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 45' ' ' THR . 81.2 t -167.29 118.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.068 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.022 HG12 HG22 ' A' ' 11' ' ' THR . 34.2 mt -68.29 133.89 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.881 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.895 HD12 HG22 ' A' ' 10' ' ' THR . 84.4 mt -87.23 -48.32 8.12 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.375 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . 1.358 ' O ' HD23 ' A' ' 9' ' ' LEU . 32.4 t -167.89 162.68 13.68 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.395 1.059 . . . . 0.0 113.128 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.042 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -152.75 118.08 5.24 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.835 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.7 ptpt -151.13 135.2 16.68 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.629 HG13 HG11 ' A' ' 36' ' ' VAL . 33.8 m -68.71 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.992 HD12 ' HD2' ' A' ' 166' ' ' PRO . 48.7 tp -62.12 121.5 66.34 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.795 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.992 ' HD2' HD12 ' A' ' 165' ' ' LEU . 86.1 Cg_exo . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.573 2.848 . . . . 0.0 112.074 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.296 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 88.8 Cg_exo . . . . . 0 C--O 1.235 0.373 0 N-CA-C 113.483 0.532 . . . . 0.0 113.483 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.455 ' CD2' ' HG2' ' A' ' 19' ' ' GLU . 37.3 m170 -147.8 114.23 5.95 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.093 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 164' ' ' VAL . 14.8 t -71.46 96.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.543 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.499 ' CD1' ' HG2' ' A' ' 17' ' ' GLU . 15.8 tp -79.09 131.14 36.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.772 1.295 . . . . 0.0 109.52 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.288 HD23 ' O ' ' A' ' 161' ' ' SER . 8.8 mt -141.43 131.41 24.56 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.507 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.935 HG22 HD12 ' A' ' 160' ' ' LEU . 99.5 m -116.39 94.95 4.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 111.633 -2.531 . . . . 0.0 108.206 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.958 HG22 HG12 ' A' ' 159' ' ' ILE . 22.4 p -81.12 165.25 21.76 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 125.116 1.51 . . . . 0.0 110.715 170.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -39.09 -42.34 0.91 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.62 -63.09 1.26 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.431 1.082 . . . . 0.0 110.427 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.37 172.24 44.66 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.285 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 1.2 t-20 -76.97 108.21 9.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.428 -1.386 . . . . 0.0 110.006 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 134' ' ' VAL . 13.5 pt -103.35 -169.74 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 124.826 1.329 . . . . 0.0 110.959 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 1.499 ' HG2' ' CD1' ' A' ' 8' ' ' LEU . 37.7 mt-10 -161.87 102.45 1.16 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.817 -173.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.058 HD21 HD11 ' A' ' 105' ' ' ILE . 2.7 mm? -73.41 160.74 31.32 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.344 1.027 . . . . 0.0 110.651 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.455 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -138.37 127.55 24.29 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.167 173.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.979 HD13 ' HE2' ' A' ' 125' ' ' PHE . 80.3 mt -122.01 143.57 49.41 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.805 1.316 . . . . 0.0 111.975 -168.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 73.2 m-20 -55.48 -126.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.977 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.907 ' HA ' HG11 ' A' ' 29' ' ' VAL . 38.2 ttmt 145.64 -59.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.029 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -55.1 -57.12 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.096 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.854 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 20.3 tptm -69.09 -4.97 19.27 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.593 1.183 . . . . 0.0 113.465 -172.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.713 ' HB2' ' ND2' ' A' ' 79' ' ' ASN . . . -161.18 70.62 2.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.67 0.606 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 1.17 ' O ' HG22 ' A' ' 29' ' ' VAL . 63.6 Cg_exo -52.7 -54.17 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 111.504 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.13 -65.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 124.704 1.253 . . . . 0.0 110.21 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.4 p -47.2 -52.79 14.81 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.713 1.258 . . . . 0.0 110.886 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.608 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 32.7 m -47.44 -50.2 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.322 1.014 . . . . 0.0 110.653 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 1.039 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 58.2 tp60 -51.23 -52.48 44.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.336 1.023 . . . . 0.0 109.844 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.911 ' OD1' HG21 ' A' ' 73' ' ' ILE . 18.4 m120 -49.96 -66.05 0.46 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.579 1.175 . . . . 0.0 110.322 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 1.608 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 46.8 p90 -57.1 -46.18 82.78 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.448 1.092 . . . . 0.0 110.441 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.997 HG12 ' O ' ' A' ' 30' ' ' GLN . 12.0 p -49.33 -40.17 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.976 0.797 . . . . 0.0 110.406 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 1.039 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 2.1 m-20 -45.84 -61.51 1.7 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.097 0.873 . . . . 0.0 108.84 171.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.627 ' OH ' ' HG3' ' A' ' 71' ' ' PRO . 28.3 m-85 -58.35 -60.12 4.28 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.892 1.37 . . . . 0.0 109.302 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 32' ' ' PHE . 58.4 t -39.27 -52.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 124.589 1.18 . . . . 0.0 110.683 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 38' ' ' SER . 23.1 m120 -38.77 -33.55 0.11 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.765 1.291 . . . . 0.0 111.858 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.727 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.9 p 158.02 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.155 0.909 . . . . 0.0 112.672 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 69.01 79.37 0.28 Allowed Glycine 0 N--CA 1.471 0.984 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.737 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.92 ' O ' HG23 ' A' ' 44' ' ' THR . 15.3 t80 168.76 -75.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.711 0.889 . . . . 0.0 109.514 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' ' HD1' ' A' ' 40' ' ' PHE . 77.7 m-85 -66.69 -31.73 72.58 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.5 1.125 . . . . 0.0 112.411 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -38.72 -36.16 0.24 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.053 0.845 . . . . 0.0 112.977 -170.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.616 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 9.5 t30 -156.5 47.31 0.45 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.064 0.853 . . . . 0.0 110.748 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.92 HG23 ' O ' ' A' ' 40' ' ' PHE . 52.7 p -83.61 -140.56 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.266 161.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 1.119 HG22 ' HA ' ' A' ' 158' ' ' VAL . 46.4 p -163.1 -141.05 0.06 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.988 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.856 ' CE1' HD11 ' A' ' 159' ' ' ILE . 15.6 m-30 -146.11 92.28 2.17 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.25 -1.795 . . . . 0.0 106.384 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 1.257 ' HB2' ' OE1' ' A' ' 56' ' ' GLN . 21.3 m80 -23.31 -67.61 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.351 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.995 ' HB2' ' HA ' ' A' ' 152' ' ' VAL . 1.8 tpm_? -172.32 -142.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.764 1.29 . . . . 0.0 111.217 169.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.991 ' H ' ' HG3' ' A' ' 48' ' ' ARG . 6.2 p -172.08 135.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.274 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.953 HG21 ' HD2' ' A' ' 53' ' ' PHE . 10.9 tt -62.49 129.74 92.84 Favored Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.483 159.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' PHE . 20.5 Cg_endo -45.2 153.04 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.014 2.476 . . . . 0.0 112.079 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 7.26 60.18 0.01 OUTLIER Glycine 0 N--CA 1.474 1.206 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.729 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.953 ' HD2' HG21 ' A' ' 50' ' ' ILE . 65.2 t80 -152.66 -54.63 0.12 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.817 0.951 . . . . 0.0 110.737 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.9 ' O ' HG23 ' A' ' 49' ' ' VAL . 43.5 ttp -171.94 113.68 0.33 Allowed 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.088 0.867 . . . . 0.0 112.124 -169.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.953 HG13 ' HB ' ' A' ' 105' ' ' ILE . 26.7 pt -90.86 155.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.755 164.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 1.319 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 78.9 mt-30 -68.61 -121.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.382 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 1.136 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -152.67 -119.96 0.81 Allowed Glycine 0 N--CA 1.47 0.932 0 O-C-N 118.624 -2.548 . . . . 0.0 110.549 3.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 61.28 106.86 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE1' ' A' ' 47' ' ' HIS . . . -179.44 -122.8 0.79 Allowed Glycine 0 N--CA 1.475 1.296 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.092 ' HB3' ' CA ' ' A' ' 64' ' ' MET . 42.4 m-85 -45.57 113.75 0.65 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.58 0.812 . . . . 0.0 110.264 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 61' ' ' THR . 9.4 t -59.52 116.75 4.2 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.484 1.115 . . . . 0.0 110.565 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.769 ' HB3' ' OE1' ' A' ' 63' ' ' GLN . 44.9 mt-10 65.02 -118.87 0.4 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.748 1.28 . . . . 0.0 110.786 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.769 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 8.0 mp0 -41.67 -58.15 2.06 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.679 1.237 . . . . 0.0 109.363 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 1.092 ' CA ' ' HB3' ' A' ' 60' ' ' PHE . 16.9 ptm 138.63 94.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.704 1.253 . . . . 0.0 107.762 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.695 ' N ' ' HB3' ' A' ' 60' ' ' PHE . 8.8 mm-40 -159.19 105.83 1.74 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.901 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.705 HE21 ' HA ' ' A' ' 66' ' ' GLN . 1.2 mm-40 -29.28 133.39 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.807 -174.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 1.106 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -57.35 -97.73 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.684 168.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.639 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 4.3 ttmp? -167.85 66.92 0.79 Allowed Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.582 165.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 1.244 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 37.0 Cg_exo -69.18 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.58 2.853 . . . . 0.0 113.333 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.244 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 2.1 p-10 102.44 38.04 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 113.377 -1.738 . . . . 0.0 115.607 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.511 ' HD2' ' CB ' ' A' ' 100' ' ' THR . 17.7 Cg_endo -95.3 80.25 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.831 3.021 . . . . 0.0 107.541 171.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.19 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 75.5 Cg_exo -66.97 110.63 1.99 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.544 2.163 . . . . 0.0 112.08 -163.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.911 HG21 ' OD1' ' A' ' 31' ' ' ASN . 18.9 pt -79.3 -123.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 124.638 1.211 . . . . 0.0 109.207 175.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.787 ' HD2' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -156.73 -151.72 0.34 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.964 0.79 . . . . 0.0 112.258 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.81 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . 51.7 p30 -39.74 145.41 0.14 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.624 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.031 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 1.8 mp0 -131.29 -92.68 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.768 1.292 . . . . 0.0 109.82 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 120' ' ' PHE . . . -38.13 -37.06 0.25 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.674 1.234 . . . . 0.0 112.384 -172.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.81 ' OD2' ' HB2' ' A' ' 75' ' ' ASN . 4.3 p30 -68.8 33.89 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.087 0.867 . . . . 0.0 112.44 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 1.031 ' OD1' ' O ' ' A' ' 76' ' ' GLU . 2.1 p-10 -172.74 82.86 0.05 Allowed 'General case' 0 N--CA 1.469 0.491 0 O-C-N 124.24 0.962 . . . . 0.0 108.766 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.812 ' C ' HD23 ' A' ' 81' ' ' LEU . . . -168.95 0.34 0.04 OUTLIER Glycine 0 N--CA 1.477 1.389 0 CA-C-N 114.711 -1.132 . . . . 0.0 113.48 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.495 HD12 ' NH1' ' A' ' 82' ' ' ARG . 1.5 pt? 31.12 172.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 1.495 ' NH1' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -60.0 158.1 11.58 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.032 -172.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.814 ' OD1' ' CG2' ' A' ' 87' ' ' THR . 1.0 OUTLIER 175.2 -146.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.464 170.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 1.456 HG21 ' NH1' ' A' ' 85' ' ' ARG . 15.8 m -170.34 162.95 8.66 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.51 0.506 . . . . 0.0 112.012 -167.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 1.456 ' NH1' HG21 ' A' ' 84' ' ' THR . 0.0 OUTLIER -34.15 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.956 1.36 . . . . 0.0 111.004 176.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 127' ' ' LYS . . . 156.6 -29.87 0.56 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-N 110.894 -2.867 . . . . 0.0 109.471 -169.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.034 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 50.1 p -81.68 144.73 30.97 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.204 0.591 . . . . 0.0 112.071 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.061 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -95.09 159.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.296 165.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.14 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -161.55 144.34 12.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.52 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 1.009 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 41.7 mtp -75.46 144.06 42.29 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.246 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.7 -118.21 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.543 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.242 ' O ' HG23 ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.54 -132.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.714 0.634 . . . . 0.0 111.011 176.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.242 HG23 ' O ' ' A' ' 92' ' ' ARG . 19.8 p 171.46 152.2 0.06 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.461 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.72 0.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.545 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 1.412 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 56.7 m-20 -40.01 -71.71 0.08 Allowed 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.654 1.221 . . . . 0.0 110.765 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.412 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 8.5 mtpm? 149.1 -94.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.91 1.381 . . . . 0.0 108.341 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.56 104.87 0.56 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.827 1.329 . . . . 0.0 109.197 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.862 ' O ' HG12 ' A' ' 73' ' ' ILE . 31.0 t -169.52 -102.19 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.664 1.228 . . . . 0.0 109.793 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 43.8 76.42 0.08 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.364 1.04 . . . . 0.0 108.6 -173.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 1.511 ' CB ' ' HD2' ' A' ' 71' ' ' PRO . 81.1 p -78.26 -43.47 28.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.105 -171.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 80.0 p -170.76 98.34 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.2 0.937 . . . . 0.0 109.54 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.9 tt0 169.48 123.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.777 1.298 . . . . 0.0 109.887 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 1.061 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.09 175.18 9.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.455 177.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 1.319 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 29.1 p90 -154.23 136.43 14.81 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.96 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.155 ' N ' ' O ' ' A' ' 56' ' ' GLN . 60.6 mt -95.46 115.06 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.663 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 52.5 m-20 -74.11 -172.61 1.41 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.514 1.134 . . . . 0.0 111.149 173.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.21 HG12 ' CE ' ' A' ' 132' ' ' MET . 32.7 m -157.84 -44.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.456 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.928 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -91.87 152.42 20.09 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.255 0.972 . . . . 0.0 112.038 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.835 ' OD1' ' HD2' ' A' ' 85' ' ' ARG . 39.1 m-20 -49.59 106.81 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.12 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.976 HD21 HD13 ' A' ' 113' ' ' LEU . 2.8 t-20 -99.3 -100.59 0.23 Allowed 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.832 1.333 . . . . 0.0 109.87 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.717 ' O ' ' CG ' ' A' ' 114' ' ' ASP . . . 75.29 -43.93 0.52 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.931 0.77 . . . . 0.0 110.935 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.595 ' HD2' HD22 ' A' ' 110' ' ' ASN . 39.8 m-85 -39.31 -50.69 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.285 0.991 . . . . 0.0 110.79 -176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.976 HD13 HD21 ' A' ' 110' ' ' ASN . 7.8 mp -58.41 -24.26 59.59 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.768 1.292 . . . . 0.0 111.492 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.717 ' CG ' ' O ' ' A' ' 111' ' ' ALA . 36.1 m-20 -39.17 101.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.757 0.661 . . . . 0.0 111.037 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -38.7 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.413 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.619 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.891 ' CE1' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.624 ' N ' ' HD1' ' A' ' 120' ' ' PHE . . . -156.24 -77.24 0.02 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 124.371 1.044 . . . . 0.0 112.032 -174.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.596 ' CD2' HD23 ' A' ' 113' ' ' LEU . 43.7 m-85 -77.24 120.51 22.39 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.245 0.615 . . . . 0.0 110.755 -167.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.14 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -70.62 -161.31 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.304 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.047 HG23 ' O ' ' A' ' 123' ' ' ALA . 76.1 t 177.57 141.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.173 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.979 ' HE2' HD13 ' A' ' 20' ' ' LEU . 20.2 p90 -174.34 25.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 1.199 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -156.53 -149.19 5.3 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 122.866 1.259 . . . . 0.0 113.823 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.199 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 7.2 mtpm? -179.37 -154.98 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.635 -2.283 . . . . 0.0 110.586 -170.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.716 HG22 HD13 ' A' ' 18' ' ' LEU . 94.3 t -160.04 117.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.722 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.684 HG21 ' CE1' ' A' ' 6' ' ' HIS . 82.6 t -84.5 -75.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 114.042 -1.436 . . . . 0.0 110.448 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 132' ' ' MET . 59.6 tttp -96.18 -94.65 0.2 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.474 1.109 . . . . 0.0 112.338 -167.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -60.58 51.81 0.03 OUTLIER Glycine 0 N--CA 1.475 1.238 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.442 -165.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 1.21 ' CE ' HG12 ' A' ' 107' ' ' VAL . 12.1 tpt -60.7 -48.68 80.69 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.4 t0 -43.58 -57.99 2.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.425 1.078 . . . . 0.0 110.223 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 16' ' ' ILE . 54.5 t -39.57 -59.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.458 1.099 . . . . 0.0 109.501 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -46.13 -52.22 12.56 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.795 1.31 . . . . 0.0 109.658 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 37.0 m-20 -50.78 -69.25 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.612 1.195 . . . . 0.0 109.553 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.741 ' CA ' ' HG2' ' A' ' 140' ' ' GLN . 8.2 ttpm? -41.29 -45.94 3.09 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.634 1.208 . . . . 0.0 110.395 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.877 ' O ' HG22 ' A' ' 141' ' ' VAL . 15.6 mt -53.8 -59.2 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.629 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 79.0 p -64.59 9.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.71 1.256 . . . . 0.0 113.838 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.741 ' HG2' ' CA ' ' A' ' 137' ' ' LYS . 39.6 mm-40 -96.06 -52.71 3.93 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.164 0.915 . . . . 0.0 109.432 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.9 m -49.59 123.69 14.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 124.505 1.128 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 82.6 Cg_exo -41.34 178.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.462 2.775 . . . . 0.0 113.553 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.139 HG22 ' CA ' ' A' ' 153' ' ' PRO . 4.2 p -161.31 -142.22 0.08 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 123.101 1.429 . . . . 0.0 112.137 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.818 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 179.33 145.37 0.17 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 110.691 -2.959 . . . . 0.0 111.941 173.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -63.38 121.67 14.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.102 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.842 HG22 ' HB ' ' A' ' 152' ' ' VAL . 1.5 t -78.09 -65.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.949 -168.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.64 -81.78 0.06 OUTLIER Glycine 0 N--CA 1.47 0.94 0 CA-C-N 111.736 -2.484 . . . . 0.0 107.998 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.692 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 73.6 Cg_endo -66.44 -73.48 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.523 2.816 . . . . 0.0 108.671 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.692 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 43.9 m-85 -76.98 102.73 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.616 1.197 . . . . 0.0 110.107 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 34.2 mt-30 -67.74 135.62 52.97 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.671 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.586 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 10.3 m120 83.04 96.51 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.995 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 63.0 t -154.07 127.03 4.11 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.876 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.139 ' CA ' HG22 ' A' ' 143' ' ' THR . 55.7 Cg_endo -61.45 102.73 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.554 2.836 . . . . 0.0 109.324 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 1.304 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 49.2 m -42.33 -58.62 2.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.027 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -82.31 88.46 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 O-C-N 124.832 1.332 . . . . 0.0 108.077 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.304 ' HD3' ' O ' ' A' ' 154' ' ' SER . 86.2 Cg_exo -61.65 141.36 90.76 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.531 2.821 . . . . 0.0 114.967 -166.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 158' ' ' VAL . 97.3 t -69.53 161.57 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.374 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 1.119 ' HA ' HG22 ' A' ' 45' ' ' THR . 99.1 t -147.45 118.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.144 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.958 HG12 HG22 ' A' ' 11' ' ' THR . 50.2 mt -69.35 143.5 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 113.602 -1.636 . . . . 0.0 111.705 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.935 HD12 HG22 ' A' ' 10' ' ' THR . 83.5 mt -95.44 -45.09 7.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 1.288 ' O ' HD23 ' A' ' 9' ' ' LEU . 25.7 t -169.08 165.78 11.11 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 1.093 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -149.95 109.25 3.96 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.524 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -131.18 111.51 12.0 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.438 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.713 HG11 HG11 ' A' ' 36' ' ' VAL . 34.0 m -76.53 135.02 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.78 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 165' ' ' LEU . 78.5 mt -97.41 134.36 22.72 Favored Pre-proline 0 N--CA 1.479 1.015 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.025 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 165' ' ' LEU . 84.0 Cg_exo . . . . . 0 C--O 1.251 1.129 0 C-N-CA 123.539 2.826 . . . . 0.0 112.139 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.126 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 52.8 Cg_exo . . . . . 0 C--O 1.234 0.323 0 CA-C-O 120.679 0.2 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.69 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 12.9 m170 -160.04 74.62 0.58 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.492 1.12 . . . . 0.0 108.685 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.863 HG13 HD13 ' A' ' 20' ' ' LEU . 18.7 m -61.07 100.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.185 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.182 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 37.5 mt -78.34 145.3 35.35 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.64 1.212 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.104 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.8 mt -149.15 162.49 39.88 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.027 -2.352 . . . . 0.0 110.41 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 1.292 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.2 m -160.59 78.1 0.62 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.123 -2.308 . . . . 0.0 108.523 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.979 HG22 HG12 ' A' ' 159' ' ' ILE . 35.7 p -70.78 168.63 16.28 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 125.182 1.551 . . . . 0.0 111.44 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.419 ' OG ' HG13 ' A' ' 157' ' ' VAL . 80.5 p -39.57 -44.02 1.39 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.578 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.807 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -57.75 -60.8 3.14 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.443 1.089 . . . . 0.0 110.365 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.03 -179.75 43.47 Favored Glycine 0 N--CA 1.478 1.456 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.222 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 1.104 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 9.7 t-20 -61.23 160.56 10.25 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.6 -1.3 . . . . 0.0 111.761 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 15' ' ' ASN . 10.4 pt -167.39 174.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.914 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 1.113 ' HG2' ' CD2' ' A' ' 8' ' ' LEU . 35.9 mt-10 -160.78 106.07 1.42 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.107 -169.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.159 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.7 mm? -87.35 105.88 17.56 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.64 1.212 . . . . 0.0 108.438 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.428 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -69.45 118.74 12.71 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.169 0.918 . . . . 0.0 108.77 174.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.159 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 6.4 mp -108.37 137.45 46.31 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.918 1.386 . . . . 0.0 110.905 -172.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.797 ' OD1' ' HG2' ' A' ' 23' ' ' GLN . 52.6 t0 -56.61 -116.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.787 174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.844 ' HA ' HG11 ' A' ' 29' ' ' VAL . 60.7 tttm 135.5 -57.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.594 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 1.013 ' OE1' ' NZ ' ' A' ' 24' ' ' LYS . 3.8 pt20 -55.75 -49.07 74.09 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.736 1.272 . . . . 0.0 110.573 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 1.013 ' NZ ' ' OE1' ' A' ' 23' ' ' GLN . 47.0 mmtm -69.11 -16.18 63.6 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.338 1.024 . . . . 0.0 113.219 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.49 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.42 71.72 2.94 Favored Pre-proline 0 N--CA 1.475 0.814 0 O-C-N 123.836 0.71 . . . . 0.0 109.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 1.067 ' O ' HG22 ' A' ' 29' ' ' VAL . 78.0 Cg_exo -51.42 -55.65 3.79 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.735 2.957 . . . . 0.0 111.538 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.6 t -46.68 -62.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 124.678 1.236 . . . . 0.0 110.125 -177.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.9 p -44.06 -54.2 5.7 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.725 1.266 . . . . 0.0 110.441 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.067 HG22 ' O ' ' A' ' 26' ' ' PRO . 29.0 m -56.8 -47.02 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 124.317 1.011 . . . . 0.0 110.617 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.969 HE21 ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -44.92 -69.48 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.196 0.935 . . . . 0.0 109.632 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.928 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.6 m-80 -46.03 -50.43 15.05 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.594 1.184 . . . . 0.0 109.488 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.845 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 45.4 t80 -40.61 -66.01 0.36 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.685 1.241 . . . . 0.0 110.231 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.81 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.3 t -45.81 -39.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.583 1.177 . . . . 0.0 111.099 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.928 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 88.1 m-20 -44.07 -62.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.089 0.868 . . . . 0.0 109.504 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.73 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 34.1 m-85 -64.33 -55.84 18.53 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.159 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 32' ' ' PHE . 58.8 t -39.33 -48.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 124.735 1.272 . . . . 0.0 111.015 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.822 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.1 t-20 -38.43 -33.5 0.1 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.754 1.284 . . . . 0.0 111.844 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.822 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 93.6 p 145.75 176.96 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.225 0.953 . . . . 0.0 113.061 175.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.64 -43.03 3.1 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.883 ' O ' HG23 ' A' ' 44' ' ' THR . 1.4 t80 -71.12 -74.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.586 0.815 . . . . 0.0 109.513 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.667 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 16.5 m-30 -62.5 -28.23 69.7 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.552 1.158 . . . . 0.0 112.678 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.6 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 53.0 p-10 -38.76 -36.68 0.28 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.932 0.77 . . . . 0.0 112.569 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 2.1 t-20 -161.25 47.58 0.2 Allowed 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.055 0.847 . . . . 0.0 110.753 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 40' ' ' PHE . 42.9 p -79.46 -136.57 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 160.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 1.041 ' HA ' HG13 ' A' ' 159' ' ' ILE . 47.7 p -163.36 -142.45 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.998 0.904 . . . . 0.0 112.024 174.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.724 ' HZ ' HD13 ' A' ' 9' ' ' LEU . 52.7 m-85 -158.85 74.16 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.242 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.714 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 2.4 p-80 -42.7 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.76 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.198 ' NH2' ' CA ' ' A' ' 51' ' ' PRO . 46.9 tpt85 -173.26 -150.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.433 1.111 . . . . 0.0 113.122 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.191 HG23 ' O ' ' A' ' 48' ' ' ARG . 48.1 t -175.83 -70.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.475 -2.148 . . . . 0.0 106.684 169.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.885 ' C ' ' NH2' ' A' ' 48' ' ' ARG . 59.2 mt -171.27 134.22 0.92 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.502 -1.681 . . . . 0.0 108.585 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.198 ' CA ' ' NH2' ' A' ' 48' ' ' ARG . 80.1 Cg_exo -35.54 155.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.068 2.512 . . . . 0.0 112.706 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -1.35 66.51 0.0 OUTLIER Glycine 0 N--CA 1.476 1.332 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.706 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.0 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -156.33 -50.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.856 0.974 . . . . 0.0 109.95 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.0 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 64.2 mtm -176.62 159.75 1.9 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.352 1.032 . . . . 0.0 111.409 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.0 HG12 ' O ' ' A' ' 105' ' ' ILE . 42.6 pt -153.68 165.31 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.815 -1.538 . . . . 0.0 110.108 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 1.195 ' CG ' ' HA ' ' A' ' 104' ' ' PHE . 33.5 mt-30 -164.49 136.55 4.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.146 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -120.93 -158.06 10.31 Favored Glycine 0 N--CA 1.479 1.537 0 O-C-N 124.828 1.33 . . . . 0.0 112.378 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 56.71 82.64 0.05 OUTLIER Glycine 0 N--CA 1.47 0.917 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.253 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.61 -118.47 0.63 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.651 0.853 . . . . 0.0 111.12 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -45.91 120.66 2.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.167 -1.017 . . . . 0.0 111.292 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.274 ' CG2' ' CD ' ' A' ' 67' ' ' LYS . 76.8 p -59.69 124.48 20.24 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.577 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 1.012 ' HG2' ' N ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 19.99 -108.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.827 -178.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 1.193 ' O ' ' CG ' ' A' ' 64' ' ' MET . 88.3 mt-30 -43.23 -58.17 2.64 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.671 1.232 . . . . 0.0 110.363 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 1.193 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 47.3 mtt 141.44 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.639 1.212 . . . . 0.0 107.893 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 64' ' ' MET . 32.6 mt-30 -159.59 78.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.513 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 65' ' ' GLN . 33.9 mt-30 -19.88 130.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.265 -173.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 1.274 ' CD ' ' CG2' ' A' ' 61' ' ' THR . 14.3 mmmm -62.17 -116.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.938 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -142.62 -62.7 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 112.567 -2.106 . . . . 0.0 109.734 -174.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 68' ' ' LYS . 60.7 Cg_exo -28.34 136.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.066 2.511 . . . . 0.0 112.807 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.256 ' OD1' ' HD3' ' A' ' 71' ' ' PRO . 49.4 p-10 -168.69 -41.19 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 116.881 -1.533 . . . . 0.0 114.416 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.256 ' HD3' ' OD1' ' A' ' 70' ' ' ASN . 59.7 Cg_endo -68.28 89.78 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.961 2.44 . . . . 0.0 108.406 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.246 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 84.6 Cg_exo -57.52 -155.69 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.637 2.892 . . . . 0.0 113.63 -172.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.846 ' CD1' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -160.06 151.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.776 176.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.684 ' O ' ' O ' ' A' ' 75' ' ' ASN . 74.6 mmtt -19.73 136.79 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.563 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 1.353 HD22 ' NZ ' ' A' ' 96' ' ' LYS . 45.9 p-10 -39.92 -120.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.536 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.172 ' CG ' HD21 ' A' ' 79' ' ' ASN . 0.8 OUTLIER 102.58 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.101 0.876 . . . . 0.0 111.305 -178.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.881 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 172.8 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.667 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 1.249 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 42.5 p-10 -68.03 -48.13 66.52 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.574 1.171 . . . . 0.0 109.676 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 1.172 HD21 ' CG ' ' A' ' 76' ' ' GLU . 50.1 p-10 -58.28 77.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.229 0.956 . . . . 0.0 108.699 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . -174.22 40.73 0.13 Allowed Glycine 0 N--CA 1.474 1.222 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.105 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.601 HD22 ' N ' ' A' ' 81' ' ' LEU . 2.8 mm? 39.4 -132.29 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.333 0.666 . . . . 0.0 110.602 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 32.2 ptt-85 -174.04 131.56 0.4 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.021 0.826 . . . . 0.0 109.451 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.464 ' HB3' HG21 ' A' ' 87' ' ' THR . 1.2 t-20 -150.79 -122.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.585 1.178 . . . . 0.0 109.804 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.549 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 23.0 m -160.79 159.58 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.032 0.833 . . . . 0.0 111.79 -167.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.736 ' CB ' ' N ' ' A' ' 108' ' ' ALA . 39.1 ptt180 -36.06 103.42 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.669 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.821 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 153.89 -29.6 0.74 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 111.446 -2.615 . . . . 0.0 109.718 -170.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.869 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 35.8 p -76.46 131.45 39.05 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.685 0.755 . . . . 0.0 111.514 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.479 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -80.05 159.0 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.857 164.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.275 ' O ' ' HD1' ' A' ' 104' ' ' PHE . . . -164.11 128.01 2.64 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.63 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 1.186 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 96.5 mmm -51.27 123.13 8.91 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.783 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.687 ' HB2' ' NE2' ' A' ' 56' ' ' GLN . . . -66.52 -147.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.544 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.033 ' HG2' ' H ' ' A' ' 93' ' ' THR . 56.7 ttp180 179.5 -129.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.033 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 9.0 t 136.31 87.09 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.541 1.151 . . . . 0.0 109.963 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.1 -70.7 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.821 1.325 . . . . 0.0 109.732 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.1 m-20 -40.13 110.95 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.527 1.142 . . . . 0.0 110.624 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.353 ' NZ ' HD22 ' A' ' 75' ' ' ASN . 27.8 tptp -46.13 -112.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.735 1.272 . . . . 0.0 110.52 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 36.0 m-20 -58.78 110.14 0.95 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.633 1.208 . . . . 0.0 109.258 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 1.242 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 70.6 m -166.53 -124.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 O-C-N 124.564 1.165 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.846 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 71.71 87.76 0.11 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.799 1.312 . . . . 0.0 108.162 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.87 HG21 ' HA ' ' A' ' 70' ' ' ASN . 81.6 p -78.88 -34.82 44.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.801 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.544 ' HB2' ' HE2' ' A' ' 40' ' ' PHE . 78.9 p -169.87 -47.9 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.132 0.895 . . . . 0.0 110.363 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.473 ' HG2' ' CB ' ' A' ' 91' ' ' ALA . 14.2 tt0 -38.93 144.02 0.14 Allowed 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.19 0.931 . . . . 0.0 111.184 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 1.017 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -160.31 159.68 31.58 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.58 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 1.275 ' HD1' ' O ' ' A' ' 89' ' ' ALA . 24.5 m-85 -81.94 155.52 25.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.774 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.0 ' O ' HG12 ' A' ' 55' ' ' ILE . 37.8 mt -146.23 91.85 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.325 158.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.945 ' O ' ' HE1' ' A' ' 132' ' ' MET . 1.8 m-20 -71.24 171.73 10.56 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 112.545 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.627 HG12 ' CE ' ' A' ' 132' ' ' MET . 35.6 m -160.68 48.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.243 -1.798 . . . . 0.0 108.377 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.749 ' HB3' ' HD1' ' A' ' 53' ' ' PHE . . . 176.82 147.48 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.233 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.705 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.5 m-20 -36.13 77.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.724 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.718 ' HB2' HD22 ' A' ' 106' ' ' ASN . 3.2 t30 -69.65 134.51 48.81 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.861 1.35 . . . . 0.0 110.364 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.632 ' H ' ' CD1' ' A' ' 113' ' ' LEU . . . 164.16 -53.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.82 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE2' ' O ' ' A' ' 109' ' ' ASP . 34.5 p90 -67.64 47.89 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.581 1.176 . . . . 0.0 110.374 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER 177.59 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.229 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.81 ' H ' HD13 ' A' ' 113' ' ' LEU . 64.6 t0 -43.45 -56.42 3.62 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.015 0.822 . . . . 0.0 110.738 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 1.249 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 0.2 OUTLIER 179.74 111.96 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.697 1.248 . . . . 0.0 109.61 -176.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.564 178.754 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 115' ' ' HIS . 8.3 m-30 . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 120.447 0.165 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 120' ' ' PHE . . . -171.25 -136.01 2.03 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.86 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 81.7 m-85 -79.21 127.78 32.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.583 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.186 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -53.89 -166.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.324 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 123' ' ' ALA . 60.3 t -179.69 134.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.585 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.951 ' CD1' ' HG2' ' A' ' 90' ' ' MET . 13.9 p90 -168.82 28.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.132 0.895 . . . . 0.0 111.07 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 1.479 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -147.11 176.53 25.93 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 123.321 1.511 . . . . 0.0 113.11 -173.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.428 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 8.2 ttpm? 177.81 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 110.77 -2.715 . . . . 0.0 109.989 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 86' ' ' GLY . 66.9 t -60.39 128.38 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.879 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 34.5 m -95.33 -42.18 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.699 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.476 ' N ' HG23 ' A' ' 129' ' ' VAL . 8.2 ttpm? 179.98 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.154 0.909 . . . . 0.0 109.697 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 174.52 12.45 0.02 OUTLIER Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.768 1.292 . . . . 0.0 112.993 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 1.627 ' CE ' HG12 ' A' ' 107' ' ' VAL . 11.5 tpt -54.99 -50.83 68.02 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.7 t0 -40.84 -55.62 2.41 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.449 1.093 . . . . 0.0 110.262 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.888 HG21 ' O ' ' A' ' 15' ' ' ASN . 54.8 t -41.7 -63.23 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 124.464 1.103 . . . . 0.0 109.438 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.546 ' O ' ' HB ' ' A' ' 138' ' ' ILE . . . -49.79 -50.19 45.76 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.729 1.268 . . . . 0.0 109.635 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.675 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 37.8 m-20 -51.43 -69.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.513 1.133 . . . . 0.0 109.228 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.989 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 5.9 tmtt? -38.11 -48.91 1.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.744 1.278 . . . . 0.0 110.386 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.008 ' O ' HG22 ' A' ' 141' ' ' VAL . 32.6 mt -54.06 -59.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 124.606 1.192 . . . . 0.0 108.309 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.1 p -65.76 8.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.763 1.29 . . . . 0.0 113.86 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.675 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 41.2 mm-40 -97.12 -51.92 4.03 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.212 0.945 . . . . 0.0 109.096 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.008 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -48.39 132.52 13.18 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.584 1.177 . . . . 0.0 110.258 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -39.13 -178.02 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.395 2.73 . . . . 0.0 113.534 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.285 HG22 ' CA ' ' A' ' 153' ' ' PRO . 7.4 p -161.15 -151.78 0.24 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 123.2 1.476 . . . . 0.0 112.532 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.703 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 178.12 146.32 0.14 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.21 170.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.599 ' HB3' ' HG2' ' A' ' 150' ' ' GLN . 39.0 m-20 -67.59 114.13 5.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.68 167.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.957 ' HB ' ' O ' ' A' ' 149' ' ' TYR . 1.5 t -77.32 -159.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 124.474 1.109 . . . . 0.0 110.916 -166.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.826 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -60.6 -115.46 0.01 OUTLIER Glycine 0 N--CA 1.471 1.015 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 171.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.926 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 91.8 Cg_endo -74.51 33.9 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.603 2.868 . . . . 0.0 110.744 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.957 ' O ' ' HB ' ' A' ' 146' ' ' VAL . 27.6 m-85 -170.41 104.52 0.28 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.735 0.647 . . . . 0.0 109.686 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 1.131 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 32.1 mt-30 -71.09 -169.71 0.4 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.847 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 1.131 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 52.1 p-10 44.6 76.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.18 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.805 HG21 ' CE ' ' A' ' 64' ' ' MET . 70.8 t -157.28 102.39 1.88 Allowed Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.615 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.285 ' CA ' HG22 ' A' ' 143' ' ' THR . 81.5 Cg_exo -49.95 109.67 0.31 Allowed 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.434 2.756 . . . . 0.0 110.961 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 1.276 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.5 t -40.0 -57.57 1.61 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.459 1.099 . . . . 0.0 108.972 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 62.6 mttp -69.61 88.25 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 164.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.276 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.2 Cg_endo -70.1 -157.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.615 2.877 . . . . 0.0 112.772 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 158' ' ' VAL . 99.4 t -153.78 153.87 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.326 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 1.018 ' HA ' HG22 ' A' ' 45' ' ' THR . 83.2 t -146.96 123.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.597 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.041 HG13 ' HA ' ' A' ' 45' ' ' THR . 36.9 mt -68.62 134.36 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.27 -175.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.292 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.9 mt -82.13 -48.61 11.12 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.771 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 32.2 t -167.1 166.42 15.09 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.521 1.138 . . . . 0.0 111.955 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 1.078 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -163.32 125.38 2.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.556 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 1.182 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 14.3 ptmm? -170.28 120.8 0.61 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.702 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 7' ' ' VAL . 33.7 m -68.14 131.66 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 124.762 1.289 . . . . 0.0 110.57 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.127 HD12 ' HD2' ' A' ' 166' ' ' PRO . 49.3 tp -78.0 118.33 71.51 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.801 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 1.127 ' HD2' HD12 ' A' ' 165' ' ' LEU . 87.0 Cg_exo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 123.523 2.815 . . . . 0.0 112.026 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo . . . . . 0 C--O 1.235 0.371 0 CA-C-O 120.946 0.311 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 18.4 m170 -160.72 117.11 2.32 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.792 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.9 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 10.4 p -59.8 137.58 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.262 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.197 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 8.4 mp -125.55 130.65 52.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.531 1.144 . . . . 0.0 109.415 166.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.923 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.5 mp -123.93 -171.99 2.44 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.936 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 1.218 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 98.7 m -160.82 84.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.827 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 1.006 HG22 HG12 ' A' ' 159' ' ' ILE . 36.9 p -76.6 172.48 12.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 125.426 1.704 . . . . 0.0 111.18 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -39.28 -44.13 1.23 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.351 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.838 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.26 -64.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.558 1.161 . . . . 0.0 110.369 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.37 41.58 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 113.248 -1.796 . . . . 0.0 113.654 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 16' ' ' ILE . 58.7 t-20 -66.29 153.33 42.88 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.12 -1.54 . . . . 0.0 111.419 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 15' ' ' ASN . 13.9 pt -163.56 174.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.15 -1.387 . . . . 0.0 111.3 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 1.47 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . 36.7 mt-10 -161.34 122.07 2.76 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.947 -170.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.025 HD21 HD11 ' A' ' 105' ' ' ILE . 2.5 mm? -95.64 162.96 13.4 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.817 1.323 . . . . 0.0 109.999 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.469 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -113.87 124.69 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.454 170.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.887 HD23 ' HE2' ' A' ' 125' ' ' PHE . 6.6 mp -106.01 120.05 40.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.931 1.395 . . . . 0.0 109.705 -172.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.591 ' OD2' ' HG ' ' A' ' 81' ' ' LEU . 32.2 m-20 -72.55 96.97 2.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.771 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.974 ' HA ' HG11 ' A' ' 29' ' ' VAL . 58.8 tttm -71.6 -56.15 6.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.658 1.224 . . . . 0.0 110.97 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.643 ' OE1' ' HA ' ' A' ' 23' ' ' GLN . 6.4 tp60 -46.17 -60.82 2.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.687 -171.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 51.8 tptt -68.17 -2.83 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.738 1.274 . . . . 0.0 113.138 -173.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.523 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -161.3 70.79 2.58 Favored Pre-proline 0 N--CA 1.476 0.831 0 O-C-N 123.705 0.628 . . . . 0.0 109.647 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 1.04 ' O ' HG22 ' A' ' 29' ' ' VAL . 62.9 Cg_exo -54.86 -56.18 2.62 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.635 2.89 . . . . 0.0 111.571 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.45 -64.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 124.726 1.266 . . . . 0.0 110.116 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -44.15 -58.32 2.92 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.734 1.272 . . . . 0.0 110.544 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.653 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 28.7 m -48.81 -50.14 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 124.752 1.282 . . . . 0.0 110.574 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 1.152 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.6 tm0? -52.0 -54.18 32.96 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.358 1.036 . . . . 0.0 109.357 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.899 ' OD1' HG21 ' A' ' 73' ' ' ILE . 10.6 m120 -50.89 -64.69 0.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.549 1.156 . . . . 0.0 110.391 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 1.653 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 33.6 p90 -54.18 -43.57 70.8 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.439 1.087 . . . . 0.0 110.709 -172.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.152 HG12 ' O ' ' A' ' 30' ' ' GLN . 10.7 p -51.33 -40.29 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 124.044 0.84 . . . . 0.0 110.171 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.836 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 71.0 m-20 -46.61 -61.34 1.87 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.112 0.882 . . . . 0.0 109.285 173.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 33.5 m-85 -54.61 -56.15 22.01 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.994 1.434 . . . . 0.0 109.124 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.834 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 97.6 t -46.42 -66.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 124.639 1.212 . . . . 0.0 109.344 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 33' ' ' VAL . 1.9 m-20 -50.57 -48.74 57.43 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.814 1.321 . . . . 0.0 109.989 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.637 ' OG ' ' O ' ' A' ' 34' ' ' ASP . 67.5 m -53.97 -93.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.539 1.149 . . . . 0.0 110.284 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.42 87.41 0.07 OUTLIER Glycine 0 N--CA 1.472 1.073 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 1.098 ' O ' ' CD1' ' A' ' 41' ' ' TYR . 88.0 t80 -157.39 57.02 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.911 1.007 . . . . 0.0 108.561 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.098 ' CD1' ' O ' ' A' ' 40' ' ' PHE . 25.6 m-85 -171.68 -37.07 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -38.69 -37.21 0.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.149 0.905 . . . . 0.0 112.688 -171.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 13.9 t30 -155.04 44.89 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.061 0.851 . . . . 0.0 110.902 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 45' ' ' THR . 58.4 p -79.4 -141.97 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.387 162.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 1.062 ' HA ' HG13 ' A' ' 159' ' ' ILE . 48.7 p -163.89 -141.35 0.05 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.608 0.718 . . . . 0.0 111.644 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.82 ' CD1' ' O ' ' A' ' 45' ' ' THR . 17.2 m-30 -143.07 62.73 1.39 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.417 -1.72 . . . . 0.0 107.246 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.994 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 7.1 p-80 -51.58 -60.49 3.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.72 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.211 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 26.5 mmm180 -69.14 118.7 12.37 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.626 1.203 . . . . 0.0 110.059 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 55' ' ' ILE . 8.7 p -163.64 149.6 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 124.713 1.258 . . . . 0.0 111.023 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.84 HD13 ' HD2' ' A' ' 53' ' ' PHE . 10.1 tt -165.54 126.61 1.35 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.242 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 53' ' ' PHE . 87.4 Cg_exo -35.55 160.96 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.618 2.879 . . . . 0.0 113.729 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -7.71 70.06 0.0 OUTLIER Glycine 0 N--CA 1.474 1.225 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.684 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.082 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -160.78 -53.24 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.828 0.958 . . . . 0.0 109.712 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.082 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 61.3 mtm -177.98 161.77 1.58 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.25 0.969 . . . . 0.0 112.249 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.709 HG12 ' O ' ' A' ' 105' ' ' ILE . 36.7 pt -150.61 174.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.798 170.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 1.211 ' NE2' ' HB3' ' A' ' 48' ' ' ARG . 31.8 mt-30 -158.98 167.01 30.47 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.201 -169.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.19 -178.08 31.89 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.578 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.09 84.57 0.08 OUTLIER Glycine 0 N--CA 1.47 0.912 0 CA-C-N 113.746 -1.227 . . . . 0.0 110.217 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.801 ' C ' ' HD2' ' A' ' 67' ' ' LYS . . . 178.98 -132.58 1.91 Allowed Glycine 0 N--CA 1.475 1.274 0 O-C-N 124.656 0.856 . . . . 0.0 111.305 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 56.6 m-85 -50.96 110.71 0.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.245 -0.978 . . . . 0.0 109.554 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.213 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 9.4 t -70.33 105.11 2.89 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.398 1.061 . . . . 0.0 110.082 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 1.213 ' HG2' ' O ' ' A' ' 61' ' ' THR . 12.6 pt-20 70.84 -127.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.801 1.313 . . . . 0.0 110.922 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 1.218 ' O ' ' CG ' ' A' ' 64' ' ' MET . 59.8 mt-30 -47.22 -55.45 8.56 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.808 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 1.218 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 50.7 mtt 145.72 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.637 1.208 . . . . 0.0 108.269 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 66' ' ' GLN . 18.4 tt0 -144.03 84.51 1.78 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.981 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.554 ' O ' ' O ' ' A' ' 67' ' ' LYS . 42.4 mt-30 -24.45 135.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.067 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 1.166 ' H ' ' CD ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -47.91 -120.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.427 -178.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 69' ' ' PRO . 4.2 ttmp? -170.84 73.05 0.56 Allowed Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.32 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.82 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 87.9 Cg_exo -51.17 -140.11 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.573 2.848 . . . . 0.0 113.127 -172.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.917 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 7.7 m120 164.83 168.72 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.579 -172.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.917 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 33.1 Cg_endo -44.66 98.39 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.549 2.166 . . . . 0.0 108.893 169.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.633 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.4 Cg_exo -44.11 -136.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.853 3.035 . . . . 0.0 113.336 -175.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.899 HG21 ' OD1' ' A' ' 31' ' ' ASN . 24.8 pt -152.34 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.438 1.086 . . . . 0.0 109.083 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 75' ' ' ASN . 21.6 ptmt -154.82 -148.37 0.24 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.03 0.831 . . . . 0.0 111.918 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.566 ' O ' ' O ' ' A' ' 74' ' ' LYS . 37.7 m-20 -44.93 -171.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.258 -1.792 . . . . 0.0 112.408 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.05 ' HG3' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 171.42 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.421 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.941 ' N ' ' HG2' ' A' ' 76' ' ' GLU . . . -44.72 -35.27 2.59 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.534 1.146 . . . . 0.0 111.887 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -68.89 25.81 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.058 0.848 . . . . 0.0 113.25 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.635 HD21 ' HB ' ' A' ' 124' ' ' VAL . 44.8 p-10 -63.63 -123.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.941 0.776 . . . . 0.0 109.017 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.6 -80.28 0.08 OUTLIER Glycine 0 N--CA 1.473 1.12 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.433 ' O ' ' CD ' ' A' ' 82' ' ' ARG . 2.8 mm? 40.17 -151.01 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.848 0.97 . . . . 0.0 111.185 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 1.433 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER 179.95 111.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.987 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 1.21 ' OD1' ' HD3' ' A' ' 127' ' ' LYS . 26.0 m120 -159.76 -156.77 0.52 Allowed 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.591 1.182 . . . . 0.0 111.267 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 1.126 HG22 ' HG2' ' A' ' 85' ' ' ARG . 12.0 m -169.46 166.03 10.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.283 -166.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 1.126 ' HG2' HG22 ' A' ' 84' ' ' THR . 16.4 ptm180 -18.63 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.108 1.432 . . . . 0.0 112.146 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.858 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 148.18 -26.83 1.41 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-N 110.442 -3.072 . . . . 0.0 109.676 -168.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.776 HG22 ' HG2' ' A' ' 127' ' ' LYS . 26.8 p -73.86 134.31 43.27 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.689 0.757 . . . . 0.0 112.107 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.53 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -91.32 160.05 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.062 164.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.263 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -163.41 138.89 6.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.043 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.922 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 95.7 mmm -55.82 125.62 22.11 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.769 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 1.226 ' HB3' ' OE1' ' A' ' 102' ' ' GLN . . . -74.74 -173.12 1.75 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.545 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.02 ' NH1' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.28 -120.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.407 175.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.02 ' HB ' ' NH1' ' A' ' 92' ' ' ARG . 20.7 m 173.79 -69.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.821 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 172.46 111.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.801 1.313 . . . . 0.0 108.89 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.821 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 88.4 m-20 161.84 145.3 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.152 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.654 ' O ' ' O ' ' A' ' 95' ' ' ASP . 53.4 mtmt -45.19 -122.5 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.043 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.33 118.16 5.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.713 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.6 m -163.87 -144.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.599 1.187 . . . . 0.0 110.938 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.726 ' O ' HD11 ' A' ' 73' ' ' ILE . . . 50.96 87.36 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.557 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 78.4 p -78.52 -41.35 32.54 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.246 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.3 m -167.88 -53.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 124.231 0.957 . . . . 0.0 109.286 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 1.226 ' OE1' ' HB3' ' A' ' 91' ' ' ALA . 2.0 pp0? -34.44 142.86 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.519 1.137 . . . . 0.0 111.823 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.761 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.91 -171.8 4.03 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.526 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.949 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 20.0 p90 -154.87 135.58 13.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.758 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.025 HD11 HD21 ' A' ' 18' ' ' LEU . 53.0 mt -102.19 101.2 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.822 -1.99 . . . . 0.0 108.923 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.642 ' OD1' ' CD1' ' A' ' 104' ' ' PHE . 18.9 m-20 -62.78 167.37 4.64 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.814 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.322 HG12 ' CE ' ' A' ' 132' ' ' MET . 33.0 m -157.93 51.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.273 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 53' ' ' PHE . . . -177.4 133.16 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.831 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.94 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 31.9 m-20 -31.68 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.458 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.83 ' ND2' ' HB3' ' A' ' 113' ' ' LEU . 1.1 t-20 -68.83 -119.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.858 1.349 . . . . 0.0 109.519 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 61.21 -72.21 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.743 0.652 . . . . 0.0 110.24 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.94 ' CE1' ' O ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -67.63 56.07 0.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.377 1.048 . . . . 0.0 109.612 178.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.843 HD21 ' HD2' ' A' ' 122' ' ' TYR . 6.3 tt 177.44 -39.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.079 -173.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -39.5 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.06 0.85 . . . . 0.0 110.644 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.27 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.739 1.274 . . . . 0.0 108.678 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.234 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.768 -178.438 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.93 0.871 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.69 -129.13 1.09 Allowed Glycine 0 N--CA 1.474 1.209 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.954 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.843 ' HD2' HD21 ' A' ' 113' ' ' LEU . 21.0 m-85 -79.72 116.72 20.06 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.486 0.757 . . . . 0.0 109.62 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.05 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . . . -49.01 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.569 1.168 . . . . 0.0 111.051 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.263 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 70.2 t 179.86 133.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.806 -176.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.887 ' HE2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -166.13 21.99 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.033 170.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 1.53 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -118.07 168.54 13.1 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 123.123 1.402 . . . . 0.0 112.753 -169.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.469 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 10.2 mtmp? 179.56 104.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 110.962 -2.619 . . . . 0.0 109.564 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 86' ' ' GLY . 66.8 t -43.56 119.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.083 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.47 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -63.91 -48.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.235 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.908 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 2.9 tmtm? 163.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.255 0.972 . . . . 0.0 109.612 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.65 32.61 0.09 OUTLIER Glycine 0 N--CA 1.476 1.33 0 O-C-N 124.817 1.323 . . . . 0.0 111.469 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 1.322 ' CE ' HG12 ' A' ' 107' ' ' VAL . 8.4 tpt -59.75 -40.91 89.71 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.162 0.566 . . . . 0.0 110.281 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 22.9 m-20 -44.05 -63.77 0.8 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.273 0.983 . . . . 0.0 109.937 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.675 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.2 t -43.89 -60.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 124.615 1.197 . . . . 0.0 109.219 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.412 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -46.18 -52.08 13.01 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.59 1.181 . . . . 0.0 109.772 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.599 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 39.9 m-20 -53.64 -65.43 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.562 1.164 . . . . 0.0 109.133 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -36.57 -49.24 0.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.711 1.257 . . . . 0.0 110.588 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.163 ' O ' HG22 ' A' ' 141' ' ' VAL . 23.5 mt -57.1 -57.39 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 124.578 1.173 . . . . 0.0 108.642 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.599 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.3 p -61.7 3.26 0.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 41.0 mm-40 -96.25 -49.53 5.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.27 0.981 . . . . 0.0 109.313 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.163 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -47.28 123.85 8.68 Favored Pre-proline 0 N--CA 1.472 0.638 0 O-C-N 124.518 1.136 . . . . 0.0 110.055 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 141' ' ' VAL . 84.0 Cg_exo -41.17 179.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.517 2.811 . . . . 0.0 113.799 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.389 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.5 p -160.92 -151.48 0.24 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 123.589 1.662 . . . . 0.0 112.32 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.717 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.8 OUTLIER 178.24 165.06 0.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.148 174.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.691 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 77.7 m-20 -51.57 -144.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.752 166.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.771 HG22 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -162.19 -63.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.903 1.335 . . . . 0.0 107.914 170.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.01 -95.52 0.1 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-N 111.119 -2.764 . . . . 0.0 107.531 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 90.5 Cg_endo -70.54 -63.19 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.639 2.893 . . . . 0.0 108.928 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.68 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 59.6 m-85 -70.12 109.42 4.59 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.703 1.252 . . . . 0.0 110.702 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.566 ' O ' ' NH1' ' A' ' 48' ' ' ARG . 22.4 mm-40 -75.9 151.21 37.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.75 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.736 ' O ' HG23 ' A' ' 152' ' ' VAL . 21.7 m-20 77.63 96.95 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.606 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.771 ' HB ' HG22 ' A' ' 146' ' ' VAL . 84.9 t -164.66 116.1 0.93 Allowed Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.409 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.389 ' CA ' HG22 ' A' ' 143' ' ' THR . 59.7 Cg_endo -65.02 108.53 1.13 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.534 2.822 . . . . 0.0 109.623 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 1.251 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 62.2 p -43.96 -58.83 2.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.928 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 88.3 tttt -74.3 88.53 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.251 ' HD3' ' O ' ' A' ' 154' ' ' SER . 59.1 Cg_endo -77.31 131.74 11.95 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.684 2.923 . . . . 0.0 112.486 -167.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.641 HG21 HG23 ' A' ' 138' ' ' ILE . 74.1 t -68.94 157.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.765 -1.562 . . . . 0.0 110.44 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 1.039 ' HA ' HG22 ' A' ' 45' ' ' THR . 98.9 t -143.75 120.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.517 174.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.062 HG13 ' HA ' ' A' ' 45' ' ' THR . 32.3 mt -68.21 133.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.091 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.218 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.7 mt -77.99 -50.51 11.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 112.383 -2.19 . . . . 0.0 109.744 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.4 m -162.6 -165.46 1.17 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.655 1.222 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.923 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . 179.41 135.55 0.1 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.3 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 8' ' ' LEU . 61.1 pttt -171.61 136.45 0.96 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.693 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 36' ' ' VAL . 34.8 m -77.85 133.06 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.938 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.103 HD12 ' HD2' ' A' ' 166' ' ' PRO . 47.2 tp -91.98 117.24 67.62 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.29 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 1.103 ' HD2' HD12 ' A' ' 165' ' ' LEU . 88.4 Cg_exo . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.547 2.831 . . . . 0.0 111.828 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.222 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 84.8 Cg_exo . . . . . 0 C--O 1.235 0.338 0 CA-C-O 121.107 0.378 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.569 ' CD2' ' HG2' ' A' ' 19' ' ' GLU . 37.9 m170 -147.47 112.82 5.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.043 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.038 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 9.1 p -67.64 143.85 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.311 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.282 HD11 ' OE1' ' A' ' 17' ' ' GLU . 6.6 mp -129.76 115.01 16.66 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.625 1.202 . . . . 0.0 110.023 166.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.056 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.5 mp -107.69 -177.8 3.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 111.174 -2.739 . . . . 0.0 108.743 160.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.647 HG23 ' N ' ' A' ' 15' ' ' ASN . 96.0 m -160.84 100.99 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.103 174.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.942 HG22 HG12 ' A' ' 159' ' ' ILE . 41.7 p -78.8 172.65 13.44 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.527 1.767 . . . . 0.0 111.446 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -41.08 -43.33 2.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.417 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.803 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.64 -59.26 4.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.497 1.123 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 10' ' ' THR . . . 169.67 -176.03 43.67 Favored Glycine 0 N--CA 1.479 1.546 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.647 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 1.329 ' O ' HG21 ' A' ' 134' ' ' VAL . 10.2 t-20 -53.28 161.2 0.96 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 113.49 -1.355 . . . . 0.0 111.26 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 9' ' ' LEU . 11.8 tt -171.51 157.13 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.889 -174.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 1.282 ' OE1' HD11 ' A' ' 8' ' ' LEU . 39.7 tt0 -163.96 125.17 2.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.084 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 105' ' ' ILE . 2.9 mm? -93.54 -177.43 4.4 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.934 1.396 . . . . 0.0 110.542 164.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.569 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -148.3 118.5 7.29 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.646 175.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.761 ' O ' ' OE2' ' A' ' 19' ' ' GLU . 6.0 mp -90.57 -162.22 0.88 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.031 -1.441 . . . . 0.0 111.523 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.04 96.88 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.35 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.847 ' HA ' HG11 ' A' ' 29' ' ' VAL . 39.8 ttmt -62.28 -46.61 88.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.912 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -45.39 -67.34 0.29 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.483 1.114 . . . . 0.0 110.48 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HZ2' HD21 ' A' ' 81' ' ' LEU . 31.0 mmtp -70.05 -0.54 7.79 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.826 1.329 . . . . 0.0 114.17 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.628 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.21 70.14 2.98 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 123.827 0.704 . . . . 0.0 110.06 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.975 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.1 Cg_exo -56.18 -58.16 1.16 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.6 2.867 . . . . 0.0 111.043 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.9 t -50.71 -65.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 124.84 1.338 . . . . 0.0 110.173 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.1 m -43.99 -57.63 3.24 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.699 1.25 . . . . 0.0 110.675 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 26' ' ' PRO . 33.1 m -49.12 -49.08 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.642 1.214 . . . . 0.0 110.987 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.775 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 tm0? -50.85 -67.15 0.28 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.222 0.951 . . . . 0.0 109.086 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.914 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 t-20 -43.31 -53.11 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.581 1.176 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.716 ' CE2' HG21 ' A' ' 36' ' ' VAL . 48.8 t80 -43.21 -62.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.523 1.14 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 37' ' ' ASN . 62.7 t -44.22 -39.32 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.624 1.202 . . . . 0.0 111.071 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.914 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 5.1 m-20 -44.49 -62.06 1.32 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.121 0.888 . . . . 0.0 109.583 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.83 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 94.2 m-85 -60.26 -63.77 1.18 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.9 1.375 . . . . 0.0 109.202 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.716 HG21 ' CE2' ' A' ' 32' ' ' PHE . 57.4 t -39.52 -49.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 124.648 1.218 . . . . 0.0 110.869 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.751 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.7 t-20 -38.9 -31.34 0.06 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.738 1.274 . . . . 0.0 112.239 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.751 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.6 p 157.67 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.112 0.883 . . . . 0.0 112.425 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 68.69 81.62 0.2 Allowed Glycine 0 N--CA 1.47 0.928 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.401 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.83 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 1.7 t80 173.74 -81.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.819 0.953 . . . . 0.0 109.739 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -68.35 -12.41 61.06 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.344 1.027 . . . . 0.0 113.259 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 1.172 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 17.4 m-20 -38.97 -50.04 1.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.661 0.6 . . . . 0.0 111.714 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 1.172 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 20.6 m-20 -156.68 52.53 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.393 1.058 . . . . 0.0 109.782 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.891 ' O ' HG23 ' A' ' 45' ' ' THR . 27.8 m -78.62 -125.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 166.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 1.012 HG22 ' HA ' ' A' ' 158' ' ' VAL . 40.6 p -165.35 -140.05 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.222 1.011 . . . . 0.0 111.966 170.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.921 ' CD1' ' O ' ' A' ' 45' ' ' THR . 11.2 m-30 -152.98 81.31 1.21 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.49 -2.141 . . . . 0.0 105.962 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.789 ' O ' ' CD ' ' A' ' 153' ' ' PRO . 19.8 m80 -11.43 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.123 ' NH2' ' O ' ' A' ' 141' ' ' VAL . 28.0 tpt85 -172.4 -133.19 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.634 1.209 . . . . 0.0 110.098 166.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 50' ' ' ILE . 7.4 p -173.41 147.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.953 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 49' ' ' VAL . 57.0 mt -72.24 131.8 84.77 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.106 156.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' ILE . 19.2 Cg_endo -40.76 -139.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.386 0 C-N-CA 123.213 2.608 . . . . 0.0 111.582 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.63 76.49 0.01 OUTLIER Glycine 0 N--CA 1.471 0.998 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.67 ' HD2' HG21 ' A' ' 50' ' ' ILE . 1.1 t80 -162.11 -68.79 0.05 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.604 0.826 . . . . 0.0 109.833 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.902 ' O ' HG23 ' A' ' 49' ' ' VAL . 26.4 ptt? 177.16 130.77 0.05 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.212 0.945 . . . . 0.0 111.906 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.849 HG22 ' CB ' ' A' ' 49' ' ' VAL . 32.4 pt -90.2 176.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.047 169.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 1.287 ' O ' ' HA ' ' A' ' 104' ' ' PHE . 20.6 mm-40 -69.28 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.499 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 1.042 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -157.47 -133.66 1.63 Allowed Glycine 0 N--CA 1.473 1.103 0 O-C-N 118.845 -2.409 . . . . 0.0 112.046 4.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.59 105.27 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA2' ' HD3' ' A' ' 67' ' ' LYS . . . -175.5 -121.38 0.64 Allowed Glycine 0 N--CA 1.475 1.278 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.93 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 21.0 m-85 -42.58 114.09 0.54 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.577 -0.812 . . . . 0.0 110.455 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.747 ' HA ' HG23 ' A' ' 44' ' ' THR . 97.7 m -59.94 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.613 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 65.14 -106.11 0.13 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.817 1.323 . . . . 0.0 110.287 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 44.6 tp60 -71.41 50.3 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.67 1.232 . . . . 0.0 110.505 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.93 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 53.4 mtt 41.75 35.77 0.54 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.937 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' GLN . 10.7 tp-100 -77.67 87.67 3.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 172.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 67' ' ' LYS . 62.5 mt-30 -27.42 137.41 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.084 -171.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 66' ' ' GLN . 35.3 mtmm -43.85 -122.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.273 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -174.01 75.94 0.36 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 112.704 -2.044 . . . . 0.0 106.617 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 1.232 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 58.3 Cg_endo -78.21 -178.05 4.33 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.638 2.892 . . . . 0.0 113.593 -167.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.232 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 41.5 m-20 -166.0 168.98 7.18 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.887 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.863 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 99.3 Cg_exo -36.1 83.29 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.347 2.698 . . . . 0.0 111.295 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.046 ' HB3' HG22 ' A' ' 100' ' ' THR . 80.6 Cg_exo -49.82 154.17 5.2 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.846 3.031 . . . . 0.0 113.735 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.094 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 30.4 pt -78.98 162.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.923 -1.49 . . . . 0.0 112.03 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.944 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 95.7 mttt -59.84 -177.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.846 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 25.9 p30 -52.55 -169.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.31 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.22 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 157.39 122.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.924 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 167.12 -47.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.322 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.701 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 49.8 p-10 -69.03 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.485 1.116 . . . . 0.0 112.86 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 80' ' ' GLY . 43.6 p-10 -44.43 -46.94 9.81 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.996 0.81 . . . . 0.0 109.865 174.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.752 ' C ' HD12 ' A' ' 81' ' ' LEU . . . 73.53 68.24 1.62 Allowed Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.412 1.07 . . . . 0.0 111.166 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.752 HD12 ' C ' ' A' ' 80' ' ' GLY . 2.7 mp -151.36 174.32 13.47 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.854 0.973 . . . . 0.0 110.531 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.832 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 14.2 ptp180 -79.56 144.19 34.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.687 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.832 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.3 m120 -164.53 153.43 13.05 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.502 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' ' 109' ' ' ASP . 17.8 m -165.26 159.49 17.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.421 -169.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' THR . 67.1 ttt180 -21.21 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.792 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.851 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 146.06 -13.76 1.69 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.835 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.169 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 24.3 p -109.48 163.61 13.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.026 1.394 . . . . 0.0 112.584 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.871 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -131.37 158.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 111.28 -2.691 . . . . 0.0 108.719 -177.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -156.05 150.67 25.95 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.89 -1.504 . . . . 0.0 112.364 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 1.122 ' SD ' ' O ' ' A' ' 102' ' ' GLN . 15.6 tpt -61.77 127.3 30.77 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.676 -1.602 . . . . 0.0 110.739 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.827 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . . . -57.34 -119.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.526 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.938 ' HA ' ' H ' ' A' ' 99' ' ' ALA . 39.2 ptt180 179.21 -153.1 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.77 0.669 . . . . 0.0 111.353 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 53.7 m -176.8 -90.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.17 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 164.52 117.85 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.695 1.247 . . . . 0.0 109.098 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 50.3 t0 159.64 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.303 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.142 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 64.3 mttm 153.98 22.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.072 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 1.142 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 89.4 m-20 178.96 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 1.365 ' CA ' ' O ' ' A' ' 99' ' ' ALA . 31.2 t 178.54 108.22 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.599 1.187 . . . . 0.0 109.137 -169.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 1.365 ' O ' ' CA ' ' A' ' 98' ' ' SER . . . 34.16 135.87 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.389 -1.444 . . . . 0.0 114.025 -2.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 1.046 HG22 ' HB3' ' A' ' 72' ' ' PRO . 38.6 p -160.92 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.774 -2.012 . . . . 0.0 108.682 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.612 ' H ' ' NE2' ' A' ' 102' ' ' GLN . 78.0 p -170.36 80.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.402 1.063 . . . . 0.0 108.398 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 1.122 ' O ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER 176.46 158.64 0.3 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.73 1.269 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.949 ' HD2' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -158.45 -173.7 4.43 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.89 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 1.287 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 22.2 p90 -156.64 139.65 15.39 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.655 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.042 HD11 HD21 ' A' ' 18' ' ' LEU . 60.4 mt -100.68 113.47 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.31 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 1.169 ' OD1' ' O ' ' A' ' 87' ' ' THR . 37.5 p-10 -72.42 -167.82 0.37 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.624 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.257 HG12 ' CE ' ' A' ' 132' ' ' MET . 34.5 m -160.7 -43.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.961 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 107' ' ' VAL . . . -86.5 133.7 33.73 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.258 0.974 . . . . 0.0 111.129 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.657 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 19.7 m-20 -51.04 112.14 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.422 174.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 113' ' ' LEU . 31.9 m120 -163.32 75.15 0.37 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.485 1.115 . . . . 0.0 109.547 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.38 -29.42 64.05 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.215 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -38.71 -40.24 0.58 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.074 0.858 . . . . 0.0 111.533 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.724 HD13 ' O ' ' A' ' 110' ' ' ASN . 6.4 mp -57.91 -24.82 59.46 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.436 1.085 . . . . 0.0 111.773 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.4 t0 -39.18 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.752 0.658 . . . . 0.0 111.072 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 1.417 ' ND1' ' HB3' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 178.59 120.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.696 1.247 . . . . 0.0 109.626 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.409 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.717 179.588 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 1.417 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 26.1 p90 . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.196 0.046 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.29 -82.94 0.05 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 123.667 0.605 . . . . 0.0 111.65 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -77.26 123.69 26.81 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.488 0.757 . . . . 0.0 110.817 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.22 ' HB1' ' OE1' ' A' ' 76' ' ' GLU . . . -68.24 -156.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.242 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.158 HG23 ' O ' ' A' ' 123' ' ' ALA . 46.2 t 176.4 136.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.949 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 35.7 p90 -170.32 23.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 118.44 -0.791 . . . . 0.0 113.064 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.804 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -155.93 -166.4 15.85 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.093 1.385 . . . . 0.0 113.725 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.851 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 27.7 ttpp 176.99 132.05 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 110.996 -2.602 . . . . 0.0 110.131 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.843 HG11 ' HB2' ' A' ' 132' ' ' MET . 60.1 t -46.88 149.36 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 124.399 1.062 . . . . 0.0 110.882 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.093 HG11 ' CG ' ' A' ' 17' ' ' GLU . 6.5 p -129.72 -45.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.453 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 1.101 ' HE3' ' HA ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER 178.44 76.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.161 0.913 . . . . 0.0 108.688 -177.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.65 -16.02 0.02 OUTLIER Glycine 0 N--CA 1.476 1.364 0 O-C-N 124.819 1.325 . . . . 0.0 112.511 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 1.257 ' CE ' HG12 ' A' ' 107' ' ' VAL . 9.6 tpt -39.54 -43.3 1.27 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.815 0.362 . . . . 0.0 110.538 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' NZ ' ' A' ' 137' ' ' LYS . 65.2 t0 -44.09 -60.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.366 1.041 . . . . 0.0 109.967 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 1.329 HG21 ' O ' ' A' ' 15' ' ' ASN . 95.5 t -43.71 -56.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 124.491 1.12 . . . . 0.0 109.377 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -45.46 -51.73 11.14 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.786 1.304 . . . . 0.0 110.457 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.886 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 5.6 m-20 -49.01 -70.06 0.1 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.468 1.105 . . . . 0.0 109.417 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 38.0 mtmm -44.77 -46.53 10.59 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.758 1.286 . . . . 0.0 110.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.106 ' O ' HG22 ' A' ' 141' ' ' VAL . 18.5 mt -55.78 -62.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.269 0.981 . . . . 0.0 108.435 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.826 ' HA ' HH12 ' A' ' 48' ' ' ARG . 78.0 p -58.53 0.29 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.886 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 39.9 mm-40 -94.99 -48.97 5.76 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.25 0.969 . . . . 0.0 109.727 177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.123 ' O ' ' NH2' ' A' ' 48' ' ' ARG . 33.8 m -49.98 124.98 17.59 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.508 1.13 . . . . 0.0 110.208 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.9 Cg_exo -43.79 -177.06 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.629 2.886 . . . . 0.0 113.903 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.307 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.08 -141.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.628 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.643 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 179.73 143.41 0.16 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 110.698 -2.956 . . . . 0.0 111.865 170.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -67.74 111.91 4.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.113 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.75 ' CG2' ' HB ' ' A' ' 152' ' ' VAL . 1.3 t -77.24 -144.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 124.642 1.214 . . . . 0.0 109.355 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -63.44 -113.09 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 171.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.527 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 97.1 Cg_endo -68.97 -46.15 1.7 Allowed 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 123.596 2.864 . . . . 0.0 110.029 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.527 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 72.8 m-85 -68.67 97.82 0.84 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.454 1.096 . . . . 0.0 110.329 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -71.68 139.22 49.11 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.217 173.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 150' ' ' GLN . 17.6 m-20 81.2 82.4 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.873 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.75 ' HB ' ' CG2' ' A' ' 146' ' ' VAL . 72.9 t -140.27 121.05 9.17 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 114.167 -1.379 . . . . 0.0 107.714 168.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.307 ' CA ' HG22 ' A' ' 143' ' ' THR . 44.5 Cg_endo -62.05 102.88 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.565 2.843 . . . . 0.0 109.77 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.908 ' H ' ' HA ' ' A' ' 143' ' ' THR . 66.5 p -44.23 -54.02 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.731 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 155' ' ' LYS . 39.3 tptt -75.27 105.48 2.04 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.71 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.8 Cg_endo -78.7 122.71 5.56 Favored 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.032 -164.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 158' ' ' VAL . 93.1 t -69.44 157.79 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.054 166.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 1.012 ' HA ' HG22 ' A' ' 45' ' ' THR . 89.0 t -158.21 119.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.153 174.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.993 HG13 ' HA ' ' A' ' 45' ' ' THR . 39.5 mt -68.64 137.7 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.26 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -90.78 -47.11 7.83 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.778 -2.01 . . . . 0.0 110.471 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 28.5 t -166.83 170.12 12.6 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.424 1.077 . . . . 0.0 111.906 -175.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 1.056 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . -168.88 134.72 1.7 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.739 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.622 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -170.83 151.22 3.36 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.085 174.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.35 136.62 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.046 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.043 HD22 ' HD2' ' A' ' 166' ' ' PRO . 3.3 tm? -68.93 121.33 81.15 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.042 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 1.043 ' HD2' HD22 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 123.536 2.824 . . . . 0.0 112.015 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.417 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 74.5 Cg_endo . . . . . 0 C--O 1.235 0.325 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.417 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 28.4 m170 -153.03 79.14 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.775 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.639 HG23 HD13 ' A' ' 20' ' ' LEU . 43.1 t -60.08 75.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.129 ' HG ' ' HB3' ' A' ' 17' ' ' GLU . 7.9 tt -79.84 105.55 11.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 113.656 -1.611 . . . . 0.0 109.557 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.191 HD23 ' O ' ' A' ' 161' ' ' SER . 10.7 mt -92.88 177.08 6.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.935 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 1.143 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 99.2 m -160.47 84.61 0.7 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.678 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.997 HG22 HG12 ' A' ' 159' ' ' ILE . 24.2 p -78.4 162.72 26.22 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 125.054 1.471 . . . . 0.0 111.662 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 158' ' ' VAL . 65.0 m -41.1 -50.41 3.44 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.263 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.693 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -47.67 -58.38 4.36 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.594 1.184 . . . . 0.0 110.531 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.67 47.02 Favored Glycine 0 N--CA 1.476 1.352 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.965 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.897 ' O ' HG23 ' A' ' 16' ' ' ILE . 9.4 t-20 -65.6 151.56 46.19 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.416 -1.392 . . . . 0.0 111.799 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 15' ' ' ASN . 25.3 pt -168.81 166.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.822 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 1.129 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . 12.5 pt-20 -163.11 117.09 1.64 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.314 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.988 HD21 HD11 ' A' ' 105' ' ' ILE . 3.0 mm? -76.87 165.52 24.58 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.738 1.274 . . . . 0.0 110.465 164.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.017 ' OE2' ' NE2' ' A' ' 6' ' ' HIS . 39.8 tt0 -131.24 119.49 21.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.944 173.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.939 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.4 mp -99.88 115.12 28.89 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.118 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.72 98.24 0.51 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.579 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.049 ' HA ' HG11 ' A' ' 29' ' ' VAL . 10.0 mtmp? -69.67 -49.59 52.14 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.614 1.196 . . . . 0.0 111.763 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.53 ' NE2' ' HE2' ' A' ' 24' ' ' LYS . 47.4 tt0 -44.33 -62.87 1.01 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.333 1.021 . . . . 0.0 110.556 -171.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.53 ' HE2' ' NE2' ' A' ' 23' ' ' GLN . 4.2 mptp? -69.22 9.57 0.42 Allowed 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.724 1.265 . . . . 0.0 113.543 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.68 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -161.05 68.57 2.51 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 123.855 0.722 . . . . 0.0 109.452 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 29' ' ' VAL . 52.0 Cg_exo -56.21 -63.14 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.493 2.796 . . . . 0.0 110.94 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.0 t -54.0 -61.47 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 124.832 1.333 . . . . 0.0 109.944 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 37.1 t -43.99 -58.84 2.58 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.753 1.283 . . . . 0.0 110.624 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.049 HG11 ' HA ' ' A' ' 22' ' ' LYS . 28.1 m -51.76 -49.48 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 124.629 1.206 . . . . 0.0 110.69 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.848 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.6 tm0? -47.36 -57.77 4.9 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.314 1.009 . . . . 0.0 109.313 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 1.15 ' OD1' HG21 ' A' ' 73' ' ' ILE . 10.8 m120 -42.7 -55.26 3.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.636 1.21 . . . . 0.0 110.282 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.967 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 57.9 m-85 -44.1 -62.14 1.24 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.576 1.172 . . . . 0.0 110.022 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 62.0 t -40.64 -46.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.541 1.15 . . . . 0.0 110.758 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.848 ' OD1' ' NE2' ' A' ' 30' ' ' GLN . 7.0 m-20 -45.0 -60.51 2.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.37 1.044 . . . . 0.0 109.576 174.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.484 ' O ' ' HB2' ' A' ' 38' ' ' SER . 74.0 m-85 -57.29 -55.97 27.85 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.945 1.403 . . . . 0.0 109.149 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 HG13 ' A' ' 164' ' ' VAL . 69.4 t -44.4 -64.87 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.61 1.194 . . . . 0.0 109.589 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.4 t30 -45.8 -49.35 15.17 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.828 1.33 . . . . 0.0 110.133 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 58.2 m -53.93 -109.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.591 1.182 . . . . 0.0 110.215 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.828 ' HA2' ' OD1' ' A' ' 42' ' ' ASN . . . -174.88 48.07 0.13 Allowed Glycine 0 N--CA 1.474 1.213 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.215 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.803 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 22.9 t80 -73.84 -64.08 1.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.629 0.84 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.747 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 39.9 m-85 -67.74 -23.18 65.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.118 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.828 ' OD1' ' HA2' ' A' ' 39' ' ' GLY . 35.2 m120 -38.74 -39.8 0.54 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.817 0.698 . . . . 0.0 112.592 -170.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -152.79 50.56 0.74 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.243 0.964 . . . . 0.0 110.133 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 45' ' ' THR . 49.4 p -79.06 -144.36 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.21 161.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.93 HG22 ' HA ' ' A' ' 158' ' ' VAL . 42.9 p -163.85 -139.21 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.746 0.784 . . . . 0.0 112.168 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 159' ' ' ILE . 51.7 m-85 -157.42 64.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.195 -1.821 . . . . 0.0 107.442 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.715 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 2.2 p-80 -61.61 -60.56 3.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.189 -1.368 . . . . 0.0 109.417 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.715 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.4 mtt180 -69.2 116.78 10.03 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.558 1.161 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 55' ' ' ILE . 68.3 t -152.21 150.74 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 124.87 1.357 . . . . 0.0 110.95 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.974 HD12 ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -158.75 122.34 2.09 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.457 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 53' ' ' PHE . 88.0 Cg_exo -37.54 160.61 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.637 2.891 . . . . 0.0 113.941 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.03 68.45 0.0 OUTLIER Glycine 0 N--CA 1.474 1.207 0 CA-C-N 114.022 -1.445 . . . . 0.0 113.831 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.018 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.6 t80 -161.15 -59.12 0.05 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.782 0.931 . . . . 0.0 109.495 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.018 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 57.5 mtm -163.29 157.21 19.92 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.54 1.15 . . . . 0.0 112.29 -171.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.894 ' CD1' ' HB1' ' A' ' 135' ' ' ALA . 42.4 pt -161.56 145.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.932 174.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.75 ' HG2' ' CB ' ' A' ' 104' ' ' PHE . 18.2 mt-30 -146.1 168.75 20.2 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.147 0.904 . . . . 0.0 112.079 -166.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.36 -158.95 9.91 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.672 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.803 ' HA2' ' CE1' ' A' ' 40' ' ' PHE . . . 65.97 78.23 0.24 Allowed Glycine 0 N--CA 1.47 0.93 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.159 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 1.569 ' CA ' ' HE3' ' A' ' 67' ' ' LYS . . . 177.89 -133.79 2.27 Favored Glycine 0 N--CA 1.475 1.267 0 O-C-N 124.669 0.864 . . . . 0.0 111.231 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 64.0 m-85 -42.54 128.02 3.9 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.282 -0.959 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.655 ' OG1' ' OE2' ' A' ' 62' ' ' GLU . 78.3 p -59.01 -149.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.344 1.027 . . . . 0.0 110.733 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 1.161 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -59.91 -89.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.282 178.083 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 1.161 ' H ' ' CG ' ' A' ' 62' ' ' GLU . 32.9 mt-30 -72.28 52.52 0.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.77 1.294 . . . . 0.0 110.018 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.635 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 50.4 mtt 40.84 35.74 0.36 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.071 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.574 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 58.0 tp60 -77.72 99.97 6.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' LYS . 88.7 mt-30 -27.03 140.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.446 -172.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 1.569 ' HE3' ' CA ' ' A' ' 59' ' ' GLY . 52.7 mttp -51.44 -127.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.84 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 1.178 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 98.1 mttt 179.57 84.79 0.18 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 112.683 -2.053 . . . . 0.0 106.897 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 1.048 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 52.9 Cg_endo -71.73 -167.93 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.639 2.893 . . . . 0.0 113.297 -171.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.048 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 79.1 m-20 -165.09 170.41 6.39 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 113.327 -1.761 . . . . 0.0 109.984 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.981 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 34.7 Cg_endo -45.77 103.78 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.631 2.221 . . . . 0.0 108.977 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 71' ' ' PRO . 97.7 Cg_exo -45.45 -147.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.859 3.04 . . . . 0.0 113.711 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.208 HG13 ' O ' ' A' ' 98' ' ' SER . 26.4 pt -156.33 -126.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.044 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.504 ' N ' HG13 ' A' ' 73' ' ' ILE . 57.0 mtpt -146.71 133.36 19.91 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.045 0.841 . . . . 0.0 110.789 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.748 ' H ' ' HA ' ' A' ' 97' ' ' ASP . 7.4 t-20 -59.36 170.16 1.05 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.886 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.49 ' H ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -178.02 165.78 1.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.412 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.758 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 175.65 -34.11 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.255 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 1.005 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 48.7 p-10 -67.17 -44.97 78.39 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.025 0.828 . . . . 0.0 110.319 -176.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 1.005 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 33.6 p-10 41.9 -101.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.221 0.951 . . . . 0.0 110.337 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 170.46 -69.97 0.13 Allowed Glycine 0 N--CA 1.473 1.116 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.762 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -38.47 159.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.693 0.878 . . . . 0.0 112.285 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 38.3 ptt180 -58.93 -139.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.569 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.8 t-20 171.14 130.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.133 -174.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -167.55 152.64 7.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.202 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.643 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 39.8 ptt180 -40.69 125.51 2.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.585 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 1.007 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 113.33 -28.98 8.25 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.776 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.136 HG22 ' NZ ' ' A' ' 127' ' ' LYS . 17.8 p -79.97 131.0 35.72 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.824 0.821 . . . . 0.0 111.484 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.569 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -87.42 160.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.005 167.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.07 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -162.1 141.46 9.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.473 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 1.265 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -66.86 122.03 16.79 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.67 -176.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 1.14 ' O ' ' SD ' ' A' ' 90' ' ' MET . . . -81.0 -166.38 1.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.278 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.086 ' CD ' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.71 -149.7 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.83 175.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.086 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 55.3 m -167.2 -108.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.765 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.495 ' N ' HG22 ' A' ' 93' ' ' THR . . . -70.69 -93.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.467 1.104 . . . . 0.0 110.538 -171.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 97' ' ' ASP . 32.7 m-20 -43.9 117.06 1.1 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.133 0.896 . . . . 0.0 110.954 -175.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.127 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 53.6 mtmt -71.35 42.18 0.07 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.696 1.247 . . . . 0.0 111.087 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 1.127 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 90.7 m-20 179.27 86.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 1.208 ' O ' HG13 ' A' ' 73' ' ' ILE . 67.1 m -168.12 -96.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.679 1.237 . . . . 0.0 109.759 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 1.061 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 58.99 94.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.794 1.309 . . . . 0.0 107.947 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.7 p -77.88 -42.77 32.23 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.552 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -170.93 -44.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.247 0.967 . . . . 0.0 110.479 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.791 ' O ' ' HE2' ' A' ' 90' ' ' MET . 3.9 pt20 -36.15 146.05 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.295 0.997 . . . . 0.0 112.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.945 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -157.22 -179.52 8.27 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.881 -1.508 . . . . 0.0 110.405 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.769 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 35.7 p90 -151.03 122.44 7.87 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.271 -169.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.988 HD11 HD21 ' A' ' 18' ' ' LEU . 58.1 mt -94.2 101.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.365 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.576 ' OD1' ' HD1' ' A' ' 104' ' ' PHE . 7.3 m-20 -67.14 -175.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.778 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.608 HG12 ' CE ' ' A' ' 132' ' ' MET . 35.1 m -155.6 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.68 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -83.95 145.59 28.47 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.421 1.076 . . . . 0.0 110.874 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.1 m-20 -45.9 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.847 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 1.103 ' OD1' HD11 ' A' ' 113' ' ' LEU . 7.1 t-20 -68.81 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.864 1.353 . . . . 0.0 109.936 -170.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 110' ' ' ASN . . . 70.52 -19.26 0.22 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.857 0.723 . . . . 0.0 112.251 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' HD13 ' A' ' 113' ' ' LEU . 35.5 m-85 -69.38 36.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.68 0.612 . . . . 0.0 111.414 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.103 HD11 ' OD1' ' A' ' 110' ' ' ASN . 0.0 OUTLIER 179.22 -17.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.783 0.677 . . . . 0.0 111.815 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.764 ' N ' HD22 ' A' ' 113' ' ' LEU . 57.4 p-10 -47.85 138.83 8.25 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.683 0.614 . . . . 0.0 111.139 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 1.245 ' CB ' ' O ' ' A' ' 120' ' ' PHE . 1.7 t60 -31.61 131.9 0.11 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.862 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.418 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . . . . . . 0 N--CA 1.477 1.392 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.062 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 1.245 ' O ' ' CB ' ' A' ' 115' ' ' HIS . 1.7 t80 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.68 -0.119 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' N ' ' A' ' 115' ' ' HIS . . . 89.97 176.68 45.18 Favored Glycine 0 N--CA 1.477 1.42 0 O-C-N 124.475 1.109 . . . . 0.0 113.108 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.835 ' CD1' HD23 ' A' ' 113' ' ' LEU . 68.1 m-85 -78.65 143.24 36.51 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.229 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.265 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -54.68 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.59 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.07 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 72.2 t -175.85 128.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.92 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.939 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.3 p90 -161.77 21.62 0.11 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.608 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 1.569 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -113.26 155.89 15.99 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 122.939 1.3 . . . . 0.0 112.507 -169.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.136 ' NZ ' HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -171.07 110.99 0.34 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 110.985 -2.608 . . . . 0.0 110.261 173.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.007 HG23 ' O ' ' A' ' 86' ' ' GLY . 58.3 t -58.11 157.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.223 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.052 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 33.1 m -154.44 32.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.231 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 1.052 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 74.5 mmtt 120.92 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.773 0.671 . . . . 0.0 109.508 174.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.861 ' CA ' HG22 ' A' ' 16' ' ' ILE . . . 171.78 -26.12 0.09 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.04 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 1.608 ' CE ' HG12 ' A' ' 107' ' ' VAL . 12.1 tpt -39.52 -51.17 2.2 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.975 0.456 . . . . 0.0 110.921 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.653 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 36.6 m-20 -43.88 -61.6 1.39 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.37 1.044 . . . . 0.0 109.541 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 15' ' ' ASN . 54.4 t -41.45 -60.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 124.739 1.274 . . . . 0.0 109.551 173.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.894 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -44.41 -53.09 7.2 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.654 1.221 . . . . 0.0 109.709 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.922 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 38.2 m-20 -50.69 -66.97 0.3 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.771 1.294 . . . . 0.0 109.03 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.541 ' O ' HG13 ' A' ' 141' ' ' VAL . 56.4 mtpt -40.2 -49.38 2.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.789 1.306 . . . . 0.0 110.539 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.27 ' O ' HG22 ' A' ' 141' ' ' VAL . 16.2 mt -57.84 -58.29 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.444 1.09 . . . . 0.0 108.837 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.658 ' HB3' HG21 ' A' ' 55' ' ' ILE . 84.9 p -65.51 3.42 0.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.922 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.5 mp0 -99.07 -49.39 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.168 0.917 . . . . 0.0 108.741 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.27 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.4 m -41.29 123.25 2.15 Favored Pre-proline 0 N--CA 1.473 0.711 0 O-C-N 124.349 1.031 . . . . 0.0 110.306 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.8 Cg_exo -38.83 -178.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.35 2.7 . . . . 0.0 113.575 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.41 HG22 ' CA ' ' A' ' 153' ' ' PRO . 6.0 p -160.96 -150.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.735 1.731 . . . . 0.0 112.688 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.77 ' CD2' ' O ' ' A' ' 145' ' ' ASP . 0.8 OUTLIER 178.02 167.34 0.75 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 109.726 -3.397 . . . . 0.0 111.312 174.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.77 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 36.8 m-20 -52.37 -149.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.819 165.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -161.99 -61.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.673 1.225 . . . . 0.0 108.347 171.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.59 -92.18 0.08 OUTLIER Glycine 0 N--CA 1.471 1.001 0 CA-C-N 111.335 -2.666 . . . . 0.0 107.687 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.699 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 80.2 Cg_endo -68.4 -67.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.479 2.786 . . . . 0.0 108.761 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.699 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 96.0 m-85 -72.0 117.05 13.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.583 1.177 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.755 ' O ' ' HG2' ' A' ' 150' ' ' GLN . 4.3 pm0 -95.03 83.77 4.0 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.75 1.281 . . . . 0.0 107.945 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.767 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 27.6 p30 169.3 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.548 -177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.672 ' CG2' HG21 ' A' ' 146' ' ' VAL . 95.9 t -160.31 116.25 1.45 Allowed Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.739 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.41 ' CA ' HG22 ' A' ' 143' ' ' THR . 58.1 Cg_endo -63.08 106.92 0.58 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 109.304 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.996 ' H ' ' HA ' ' A' ' 143' ' ' THR . 77.5 p -40.59 -51.64 2.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.289 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 1.234 ' HB3' ' CD ' ' A' ' 156' ' ' PRO . 10.8 mptt -61.45 -166.71 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.459 1.099 . . . . 0.0 111.933 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.234 ' CD ' ' HB3' ' A' ' 155' ' ' LYS . 78.3 Cg_endo -85.12 145.85 9.89 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.789 2.993 . . . . 0.0 112.733 -170.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.98 HG23 ' O ' ' A' ' 156' ' ' PRO . 38.3 t -170.55 115.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.794 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.93 ' HA ' HG22 ' A' ' 45' ' ' THR . 92.1 t -153.57 120.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.24 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.997 HG12 HG22 ' A' ' 11' ' ' THR . 43.3 mt -68.58 134.3 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.274 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.143 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.2 mt -79.67 -51.62 9.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 112.39 -2.186 . . . . 0.0 109.284 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 1.191 ' O ' HD23 ' A' ' 9' ' ' LEU . 68.0 m -165.27 174.95 9.65 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.57 1.169 . . . . 0.0 112.697 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.905 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -157.73 100.77 1.78 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.104 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.951 ' O ' ' CD1' ' A' ' 165' ' ' LEU . 32.4 mmmt -125.32 125.81 44.09 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.15 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.845 ' C ' HD12 ' A' ' 165' ' ' LEU . 34.4 m -67.93 131.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.597 1.186 . . . . 0.0 109.824 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.026 HD22 HD13 ' A' ' 8' ' ' LEU . 6.8 mp -133.65 135.63 25.3 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.925 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 165' ' ' LEU . 87.8 Cg_exo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.638 2.892 . . . . 0.0 112.027 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.25 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 71.1 Cg_exo . . . . . 0 C--O 1.235 0.361 0 N-CA-C 113.353 0.482 . . . . 0.0 113.353 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.25 ' HD2' ' O ' ' A' ' 5' ' ' PRO . 51.9 m170 -150.48 118.11 6.15 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.86 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.2 p -73.98 138.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.208 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.096 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 6.4 mp -127.78 116.12 19.71 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.471 1.107 . . . . 0.0 109.619 166.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.83 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.1 mp -110.73 -175.96 2.85 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.049 -2.341 . . . . 0.0 108.726 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.762 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 52.6 m -161.48 99.9 1.17 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.359 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.926 HG22 HG12 ' A' ' 159' ' ' ILE . 40.7 p -76.29 169.01 19.03 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 125.307 1.629 . . . . 0.0 111.407 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -40.71 -42.17 1.69 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.338 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.825 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.48 -60.54 3.21 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.483 1.115 . . . . 0.0 110.759 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 179.65 44.29 Favored Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.345 -1.752 . . . . 0.0 114.012 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 1.146 ' O ' HG21 ' A' ' 134' ' ' VAL . 58.6 t-20 -55.55 159.3 2.95 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.948 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' OD1' ' A' ' 15' ' ' ASN . 10.1 tt -171.36 160.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.289 -172.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 1.096 ' HG2' ' CG ' ' A' ' 8' ' ' LEU . 35.4 mt-10 -162.92 121.48 2.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.109 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.007 HD21 HD11 ' A' ' 105' ' ' ILE . 2.8 mm? -92.01 173.86 7.62 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.403 1.064 . . . . 0.0 110.322 161.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.429 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -134.57 124.12 24.94 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.047 175.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 20' ' ' LEU . 6.5 mp -109.39 141.8 41.26 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.814 1.321 . . . . 0.0 111.735 -168.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.738 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 63.0 m-20 -55.86 -118.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.892 170.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.995 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 5.8 tmtt? 124.66 -48.62 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.131 -1.85 . . . . 0.0 109.517 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -45.81 -65.3 0.56 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.625 1.203 . . . . 0.0 109.727 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.906 ' HD3' HD21 ' A' ' 81' ' ' LEU . 53.3 mtpt -90.61 21.92 3.75 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.704 1.253 . . . . 0.0 113.87 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.584 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.85 65.18 2.16 Favored Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 124.205 0.941 . . . . 0.0 110.57 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.95 ' O ' HG22 ' A' ' 29' ' ' VAL . 52.4 Cg_exo -59.66 -59.76 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.533 2.822 . . . . 0.0 110.965 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.1 t -50.4 -63.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.151 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -42.67 -57.55 2.67 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.7 1.25 . . . . 0.0 110.51 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.95 HG22 ' O ' ' A' ' 26' ' ' PRO . 26.8 m -52.75 -47.14 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.666 1.229 . . . . 0.0 110.871 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 29' ' ' VAL . 42.6 tp60 -46.93 -70.36 0.1 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.179 0.924 . . . . 0.0 109.931 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 1.218 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 12.3 m-80 -42.07 -48.39 4.67 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.454 1.096 . . . . 0.0 110.312 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.718 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 69.7 t80 -42.98 -63.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.504 1.128 . . . . 0.0 109.759 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.0 t -45.51 -37.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.602 1.189 . . . . 0.0 111.021 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 1.218 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 84.2 m-20 -43.02 -63.44 0.8 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.063 0.852 . . . . 0.0 109.705 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.671 ' HB3' ' CD2' ' A' ' 40' ' ' PHE . 96.2 m-85 -61.13 -59.27 5.6 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.796 1.31 . . . . 0.0 109.095 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.722 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 59.9 t -39.41 -48.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 124.69 1.243 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.771 ' O ' ' HB3' ' A' ' 38' ' ' SER . 50.4 t30 -38.56 -31.23 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.725 1.266 . . . . 0.0 112.401 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.771 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.0 p 154.89 159.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.103 0.877 . . . . 0.0 113.151 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.44 -39.64 3.1 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.117 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.671 ' CD2' ' HB3' ' A' ' 35' ' ' TYR . 2.1 t80 -67.78 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.361 0.683 . . . . 0.0 110.92 -173.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 81.6 m-85 -60.87 -36.74 79.97 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.336 1.022 . . . . 0.0 112.669 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 52.2 p-10 -38.95 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.089 0.868 . . . . 0.0 110.767 -171.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.956 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 10.7 m-20 76.59 39.47 0.25 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 113.49 -1.687 . . . . 0.0 111.633 175.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 45' ' ' THR . 48.9 p -78.66 -129.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 166.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.986 ' HA ' HG13 ' A' ' 159' ' ' ILE . 61.7 p -163.44 -147.42 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.824 1.297 . . . . 0.0 113.59 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.727 ' CD1' HD11 ' A' ' 159' ' ' ILE . 16.7 m-85 -161.54 59.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 111.579 -2.555 . . . . 0.0 105.222 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 1.208 ' CE1' ' OE1' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -38.68 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.489 -173.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.143 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.0 mmm180 -173.35 -155.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 123.081 1.42 . . . . 0.0 113.33 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.044 HG12 ' HA ' ' A' ' 55' ' ' ILE . 7.6 p -179.7 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 111.682 -2.508 . . . . 0.0 107.539 159.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.886 HG22 ' HB2' ' A' ' 54' ' ' MET . 9.3 tt -171.75 131.3 0.74 Allowed Pre-proline 0 N--CA 1.476 0.873 0 O-C-N 124.451 1.094 . . . . 0.0 109.983 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.682 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 81.9 Cg_exo -48.85 157.7 1.5 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.893 3.062 . . . . 0.0 114.398 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.24 53.38 0.01 OUTLIER Glycine 0 N--CA 1.475 1.284 0 CA-C-N 114.02 -1.445 . . . . 0.0 114.192 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.047 ' CE2' ' HE3' ' A' ' 54' ' ' MET . 1.5 t80 -162.14 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.665 0.862 . . . . 0.0 110.037 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.047 ' HE3' ' CE2' ' A' ' 53' ' ' PHE . 45.0 mtt -160.18 147.57 16.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.231 0.957 . . . . 0.0 111.611 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.044 ' HA ' HG12 ' A' ' 49' ' ' VAL . 38.4 pt -148.62 141.66 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.276 -1.783 . . . . 0.0 108.19 167.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 1.468 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 62.5 mt-30 -64.75 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.146 -163.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 1.11 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -129.3 -121.17 2.32 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 118.667 -2.521 . . . . 0.0 109.928 0.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . 52.97 109.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.063 0 CA-C-N 114.271 -0.965 . . . . 0.0 111.22 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.86 -126.01 1.11 Allowed Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.525 0.779 . . . . 0.0 111.717 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.862 ' CE2' ' HG2' ' A' ' 66' ' ' GLN . 29.8 m-85 -43.08 134.02 3.65 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.788 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.967 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 61.7 p -59.36 124.67 20.8 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.265 0.978 . . . . 0.0 109.837 169.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 1.129 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 13.11 -104.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.757 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 1.24 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.5 mm100 -38.11 -59.99 0.8 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.778 1.299 . . . . 0.0 111.445 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 1.24 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 14.6 mmt 145.11 98.43 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.925 ' OE1' ' O ' ' A' ' 64' ' ' MET . 29.4 mm100 -160.65 71.04 0.42 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 112.621 -2.081 . . . . 0.0 106.966 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.862 ' HG2' ' CE2' ' A' ' 60' ' ' PHE . 39.6 mt-30 -28.52 130.73 0.06 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.24 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.967 ' HE3' ' CG2' ' A' ' 61' ' ' THR . 18.6 mmtp -72.57 153.7 41.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.396 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 7.5 mmpt? -48.03 95.33 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.799 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.865 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 71.4 Cg_exo -59.12 -69.79 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.593 2.862 . . . . 0.0 113.192 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.925 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 34.8 m120 89.75 163.28 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 O-C-N 124.402 1.064 . . . . 0.0 111.132 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.925 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 58.6 Cg_endo -67.71 112.04 2.54 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.875 3.05 . . . . 0.0 110.88 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.212 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 88.5 Cg_exo -52.1 -150.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.798 2.998 . . . . 0.0 112.957 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.569 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.52 156.79 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 1.043 ' H ' ' HD2' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -33.3 135.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.192 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' LYS . 56.6 p30 -45.7 -164.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.44 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB3' HD21 ' A' ' 79' ' ' ASN . 8.4 mm-40 161.67 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.589 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.848 ' HB3' ' CE1' ' A' ' 120' ' ' PHE . . . -71.29 -43.26 67.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.251 0.969 . . . . 0.0 109.791 171.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 1.064 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 20.9 p-10 -67.41 -53.5 28.61 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.424 1.077 . . . . 0.0 109.907 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 76' ' ' GLU . 38.5 p-10 -63.51 99.26 0.2 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.237 1.018 . . . . 0.0 108.876 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 1.232 ' O ' HD13 ' A' ' 81' ' ' LEU . . . 172.22 46.87 0.04 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.359 -1.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.232 HD13 ' O ' ' A' ' 80' ' ' GLY . 1.7 mm? -146.14 -149.29 0.28 Allowed 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.626 0.839 . . . . 0.0 109.499 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -179.74 150.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -169.49 -124.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.519 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 1.114 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 16.2 m -168.6 163.46 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.025 0.828 . . . . 0.0 112.004 -162.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 1.114 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 8.3 ptm85 -19.92 108.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.19 164.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.743 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 137.2 -27.03 2.92 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 111.575 -2.557 . . . . 0.0 110.233 -168.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.153 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.2 p -92.66 142.82 26.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.91 0.862 . . . . 0.0 112.191 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.894 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.74 162.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.094 166.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.117 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -156.01 140.97 17.26 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 113.943 -1.48 . . . . 0.0 111.829 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.916 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.1 tpt -56.88 140.3 48.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.507 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . . . -109.38 129.3 55.54 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.457 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.28 ' HG2' ' N ' ' A' ' 99' ' ' ALA . 29.9 tpt180 179.15 175.98 0.62 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.765 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.707 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 89.6 m -168.3 115.86 0.7 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.563 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.796 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 165.01 -50.69 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.025 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.796 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 16.0 p30 74.37 -177.39 0.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.541 1.151 . . . . 0.0 112.323 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.174 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 0.4 OUTLIER 79.94 -49.29 0.36 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.763 -172.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 1.174 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 73.7 m-20 -162.45 61.32 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.617 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 21.6 t -74.22 173.75 9.72 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.773 1.296 . . . . 0.0 113.333 -170.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 1.28 ' N ' ' HG2' ' A' ' 92' ' ' ARG . . . 65.01 170.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.76 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.996 HG22 ' HG3' ' A' ' 72' ' ' PRO . 72.8 p -150.93 -48.41 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.297 -174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.0 p -171.07 -52.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.257 0.973 . . . . 0.0 110.179 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.694 ' O ' ' SD ' ' A' ' 90' ' ' MET . 19.3 pt20 -42.83 154.22 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.353 1.033 . . . . 0.0 112.183 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.894 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -159.28 168.73 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.456 175.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 1.468 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 17.1 p90 -144.49 137.68 27.07 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.326 -170.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.069 ' N ' ' O ' ' A' ' 56' ' ' GLN . 63.1 mt -93.95 116.65 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 112.057 -2.338 . . . . 0.0 110.612 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.86 116.51 6.41 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.5 1.125 . . . . 0.0 109.572 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.871 ' HB ' ' C ' ' A' ' 53' ' ' PHE . 51.9 t -90.44 22.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 124.488 1.118 . . . . 0.0 112.133 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.852 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . 169.21 172.53 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.609 0.719 . . . . 0.0 112.108 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.558 ' N ' ' HB3' ' A' ' 85' ' ' ARG . 71.7 m-20 -38.62 144.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.596 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.548 HD21 ' HB2' ' A' ' 113' ' ' LEU . 26.6 t-20 -170.57 155.95 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.435 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 176.13 -50.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.465 -1.698 . . . . 0.0 108.296 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.953 ' HD1' ' O ' ' A' ' 112' ' ' PHE . 3.2 p90 -61.26 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 167.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.76 HD11 ' CE1' ' A' ' 122' ' ' TYR . 36.9 tp 177.92 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.103 -171.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 122' ' ' TYR . 34.0 m-20 -38.47 -60.91 0.75 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.282 0.989 . . . . 0.0 111.182 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.601 ' ND1' ' HA ' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 179.05 84.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.587 1.179 . . . . 0.0 108.547 -175.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.157 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.584 179.686 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.848 ' CE1' ' HB3' ' A' ' 77' ' ' ALA . 1.3 t80 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.36 -130.44 0.09 OUTLIER Glycine 0 N--CA 1.473 1.156 0 CA-C-N 113.829 -1.532 . . . . 0.0 114.137 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.76 ' CE1' HD11 ' A' ' 113' ' ' LEU . 76.3 m-85 -78.93 150.41 32.1 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.499 -1.351 . . . . 0.0 112.674 -167.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.117 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -81.11 -163.15 0.56 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.6 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.993 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 73.9 t 179.39 140.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.111 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.681 ' CZ ' ' HD2' ' A' ' 103' ' ' PHE . 9.8 p90 -164.76 22.56 0.06 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 1.217 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -171.73 -136.3 2.1 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 122.976 1.32 . . . . 0.0 113.745 173.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.429 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 8.7 mtpm? 179.6 -133.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 111.275 -2.463 . . . . 0.0 109.162 -172.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.903 HG22 ' CD1' ' A' ' 18' ' ' LEU . 80.4 t -153.36 120.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.573 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.933 ' CG1' ' CB ' ' A' ' 17' ' ' GLU . 7.7 p -69.85 -46.49 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.104 172.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.809 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 58.5 mtpt -166.66 -135.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.449 1.093 . . . . 0.0 108.87 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . 62.36 -17.36 0.07 OUTLIER Glycine 0 N--CA 1.474 1.212 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.01 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.542 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 8.3 tpt -39.57 -42.88 1.23 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.009 0.404 . . . . 0.0 110.355 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 12.1 m-20 -45.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.438 1.087 . . . . 0.0 109.72 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 1.146 HG21 ' O ' ' A' ' 15' ' ' ASN . 59.5 t -46.5 -57.17 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.474 1.109 . . . . 0.0 109.167 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -44.4 -53.69 6.6 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.618 1.199 . . . . 0.0 109.672 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.819 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 42.0 m-20 -51.96 -64.37 0.84 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.623 1.202 . . . . 0.0 108.854 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 56.0 tptt -39.83 -54.07 2.18 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.86 1.35 . . . . 0.0 110.552 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.199 ' O ' HG12 ' A' ' 141' ' ' VAL . 21.0 mt -59.74 -58.68 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.561 1.163 . . . . 0.0 109.363 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.3 p -55.13 -8.73 0.32 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.819 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mm-40 -96.2 -44.69 7.16 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.356 1.035 . . . . 0.0 110.082 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.199 HG12 ' O ' ' A' ' 138' ' ' ILE . 8.0 p -48.96 131.48 15.02 Favored Pre-proline 0 N--CA 1.474 0.741 0 O-C-N 124.417 1.073 . . . . 0.0 110.444 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 86.3 Cg_exo -46.9 172.02 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.649 2.9 . . . . 0.0 113.795 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.366 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.06 -140.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.225 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.679 ' HD2' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 179.0 158.43 0.56 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 110.942 -2.844 . . . . 0.0 112.696 169.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 45.1 t0 -50.38 -179.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.734 165.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.924 HG21 ' CG2' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -158.03 -143.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.59 -110.33 0.01 OUTLIER Glycine 0 N--CA 1.472 1.059 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.982 ' HG2' ' HD1' ' A' ' 149' ' ' TYR . 94.6 Cg_endo -71.81 -46.7 0.54 Allowed 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 123.8 3.0 . . . . 0.0 110.259 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.982 ' HD1' ' HG2' ' A' ' 148' ' ' PRO . 34.9 m-85 -68.56 109.43 3.74 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.429 1.081 . . . . 0.0 110.933 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.569 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 7.6 mm-40 -84.94 64.47 8.68 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.213 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.839 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 54.7 p30 178.74 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.284 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.924 ' CG2' HG21 ' A' ' 146' ' ' VAL . 94.1 t -154.84 118.26 2.51 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.803 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.366 ' CA ' HG22 ' A' ' 143' ' ' THR . 61.0 Cg_endo -67.18 110.37 1.98 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.656 2.904 . . . . 0.0 109.736 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.728 ' H ' ' HA ' ' A' ' 143' ' ' THR . 40.0 t -44.95 -62.46 1.22 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.383 175.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 153' ' ' PRO . 67.3 mttm -66.99 140.65 96.18 Favored Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.633 1.208 . . . . 0.0 109.513 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 73.4 Cg_endo -88.11 114.82 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.107 2.538 . . . . 0.0 113.346 -161.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 158' ' ' VAL . 44.7 t -76.97 148.72 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.7 157.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.883 ' HA ' HG22 ' A' ' 45' ' ' THR . 95.8 t -163.67 122.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.88 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.986 HG13 ' HA ' ' A' ' 45' ' ' THR . 20.6 mt -68.01 130.49 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.361 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.762 ' HB2' ' O ' ' A' ' 10' ' ' THR . 84.7 mt -79.83 -48.05 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 112.535 -2.12 . . . . 0.0 110.171 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.7 m -162.84 -167.78 1.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.564 1.165 . . . . 0.0 112.484 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.83 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . -178.99 139.66 0.16 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.283 -1.781 . . . . 0.0 109.703 -175.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 8' ' ' LEU . 22.0 ptmt -170.85 126.27 0.71 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.743 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.39 145.48 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.989 -1.46 . . . . 0.0 110.617 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.989 ' HB3' ' HD3' ' A' ' 166' ' ' PRO . 55.2 tp -58.52 -59.87 12.14 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.974 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.989 ' HD3' ' HB3' ' A' ' 165' ' ' LEU . 82.1 Cg_exo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 123.242 2.628 . . . . 0.0 111.985 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.453 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 71.9 Cg_endo . . . . . 0 C--O 1.234 0.3 0 N-CA-C 109.653 -0.941 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.453 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.1 m170 -158.23 97.99 1.54 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.621 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.992 ' HA ' HG12 ' A' ' 164' ' ' VAL . 87.1 t -61.02 79.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 165.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.095 ' HB3' ' O ' ' A' ' 163' ' ' LYS . 7.3 tt -79.86 106.91 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.356 -169.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.155 HD23 ' O ' ' A' ' 161' ' ' SER . 12.3 mt -103.64 171.88 7.12 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 113.163 -1.835 . . . . 0.0 112.331 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 1.274 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 94.6 m -160.52 79.08 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.9 -2.409 . . . . 0.0 107.084 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.956 HG22 HG12 ' A' ' 159' ' ' ILE . 32.4 p -74.73 167.1 22.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 125.132 1.52 . . . . 0.0 111.952 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.558 ' OG ' HG13 ' A' ' 157' ' ' VAL . 78.3 p -41.41 -49.52 3.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.459 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.681 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.47 -55.88 24.44 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.424 1.078 . . . . 0.0 110.289 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' HG11 ' A' ' 134' ' ' VAL . . . 171.48 -179.95 42.92 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.911 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.887 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 10.4 t-20 -57.82 159.14 5.65 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.545 -1.328 . . . . 0.0 111.97 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.786 HG13 ' HB2' ' A' ' 9' ' ' LEU . 19.3 pt -162.59 -173.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.903 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.892 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 7.2 mm-40 -161.27 126.81 3.7 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.284 -170.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.953 HD21 HD11 ' A' ' 105' ' ' ILE . 2.9 mm? -112.0 114.04 26.69 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.547 1.154 . . . . 0.0 108.925 164.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.947 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 11.9 pt-20 -79.53 111.13 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.503 1.127 . . . . 0.0 108.53 169.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.811 HD23 ' CE2' ' A' ' 125' ' ' PHE . 7.2 mp -108.56 131.58 54.71 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.881 1.363 . . . . 0.0 110.775 -174.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.954 ' OD1' ' NZ ' ' A' ' 127' ' ' LYS . 40.1 m-20 -57.33 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.037 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.739 ' HG3' ' N ' ' A' ' 23' ' ' GLN . 22.2 ptmt 142.65 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.372 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.739 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 3.9 pt20 -49.74 -44.31 48.47 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.72 1.262 . . . . 0.0 110.473 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 1.078 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -68.55 -15.07 63.41 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.305 1.003 . . . . 0.0 112.906 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.008 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -160.73 72.36 2.81 Favored Pre-proline 0 N--CA 1.475 0.81 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 75.6 Cg_exo -55.91 -64.44 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.633 2.889 . . . . 0.0 111.73 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.673 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 66.4 t -53.18 -67.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.68 1.237 . . . . 0.0 109.911 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.742 ' HA ' HG13 ' A' ' 73' ' ' ILE . 58.8 m -44.67 -61.71 1.47 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.579 1.174 . . . . 0.0 109.853 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 25' ' ' ALA . 47.3 t -49.25 -52.56 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 124.786 1.304 . . . . 0.0 109.92 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.537 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 38.6 tp60 -41.81 -61.47 1.1 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.475 1.109 . . . . 0.0 110.049 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.698 ' CG ' HG21 ' A' ' 73' ' ' ILE . 13.2 m-80 -42.91 -51.91 5.35 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.564 1.165 . . . . 0.0 109.765 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.958 ' O ' HG23 ' A' ' 36' ' ' VAL . 78.9 t80 -40.64 -57.76 1.79 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.629 1.206 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.823 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 57.6 t -51.18 -38.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.754 1.283 . . . . 0.0 111.316 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.789 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 8.4 p-10 -44.9 -55.51 5.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.951 0.782 . . . . 0.0 109.362 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.88 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 54.5 m-85 -69.64 -53.73 17.3 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.09 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 32' ' ' PHE . 61.9 t -39.39 -50.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.164 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.789 ' CG ' ' O ' ' A' ' 34' ' ' ASP . 51.0 p30 -37.92 -33.4 0.08 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.703 1.252 . . . . 0.0 112.098 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.766 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.3 p 146.4 136.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.239 0.962 . . . . 0.0 112.028 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 1.064 ' N ' ' OD1' ' A' ' 42' ' ' ASN . . . 131.14 -59.25 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.51 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.896 ' O ' HG23 ' A' ' 44' ' ' THR . 61.1 t80 -62.99 -74.35 0.1 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.291 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.446 ' CG ' ' HD1' ' A' ' 40' ' ' PHE . 68.5 m-85 -66.75 -25.08 66.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.485 1.115 . . . . 0.0 112.913 -173.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 1.064 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 14.0 m120 -38.75 -36.59 0.27 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.902 0.751 . . . . 0.0 112.467 -173.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.615 HD21 HG13 ' A' ' 158' ' ' VAL . 2.0 t-20 -157.97 47.46 0.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.124 0.89 . . . . 0.0 110.325 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.896 HG23 ' O ' ' A' ' 40' ' ' PHE . 46.2 p -79.71 -133.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.314 164.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.959 ' HA ' HG13 ' A' ' 159' ' ' ILE . 77.8 p -162.96 -153.03 0.23 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.87 0.843 . . . . 0.0 111.817 173.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.072 ' HZ ' HD13 ' A' ' 9' ' ' LEU . 14.4 m-30 -141.85 63.42 1.42 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.174 -1.83 . . . . 0.0 106.585 174.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 1.085 ' CE1' ' HA2' ' A' ' 59' ' ' GLY . 1.1 p-80 -51.94 -72.67 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.684 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.896 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 84.2 mtm180 -71.49 130.48 41.37 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.42 1.075 . . . . 0.0 111.075 -173.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.926 HG23 ' HB ' ' A' ' 55' ' ' ILE . 10.9 p -159.96 157.36 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.844 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.078 HD13 ' HD2' ' A' ' 53' ' ' PHE . 9.9 tt -155.7 127.04 3.66 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.484 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 94.2 Cg_exo -38.7 155.14 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.577 2.851 . . . . 0.0 113.486 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -3.23 66.59 0.0 OUTLIER Glycine 0 N--CA 1.475 1.266 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.888 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.078 ' HD2' HD13 ' A' ' 50' ' ' ILE . 10.9 t80 -161.02 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.808 0.946 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.866 ' HG2' ' N ' ' A' ' 55' ' ' ILE . 54.2 ttp -167.62 177.45 5.87 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.484 1.115 . . . . 0.0 111.958 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.926 ' HB ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 171.39 113.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.12 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 66.6 mt-30 -98.62 -170.65 1.98 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.232 -166.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.22 28.79 Favored Glycine 0 N--CA 1.477 1.377 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.533 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.762 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 93.27 -59.69 2.28 Favored Glycine 0 N--CA 1.474 1.206 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 -165.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 1.085 ' HA2' ' CE1' ' A' ' 47' ' ' HIS . . . 41.34 143.65 0.0 OUTLIER Glycine 0 N--CA 1.472 1.074 0 CA-C-N 114.212 -0.994 . . . . 0.0 114.014 168.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.905 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 14.1 m-30 -46.89 150.7 0.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.406 -1.397 . . . . 0.0 110.673 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.273 HG21 ' OE1' ' A' ' 65' ' ' GLN . 94.8 m -59.08 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.316 -174.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 1.129 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 1.5 mp0 48.51 116.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.758 1.286 . . . . 0.0 110.745 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 1.31 ' O ' ' CG ' ' A' ' 64' ' ' MET . 8.5 pt20 69.02 -48.83 0.59 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.558 1.161 . . . . 0.0 111.0 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 1.31 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 25.0 mmt 158.38 98.22 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.981 1.372 . . . . 0.0 108.715 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 1.273 ' OE1' HG21 ' A' ' 61' ' ' THR . 48.4 tt0 -150.46 79.71 1.34 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.014 -2.812 . . . . 0.0 105.187 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.792 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -27.04 176.81 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.404 -1.725 . . . . 0.0 115.627 -166.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 1.199 ' H ' ' CD ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -48.07 -140.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 111.412 -2.631 . . . . 0.0 112.271 -174.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 1.06 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 40.2 ttpt 178.31 -70.94 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.076 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 1.06 ' CD ' ' HB3' ' A' ' 68' ' ' LYS . 59.8 Cg_endo -62.56 133.09 40.85 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.589 2.859 . . . . 0.0 111.011 173.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.518 ' HA ' ' CG2' ' A' ' 100' ' ' THR . 92.2 m-20 -168.61 72.14 0.8 Allowed Pre-proline 0 N--CA 1.474 0.725 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.033 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 80.0 Cg_exo -48.29 -64.06 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.391 2.728 . . . . 0.0 110.937 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.15 ' CB ' ' HA ' ' A' ' 98' ' ' SER . 50.3 Cg_exo -87.71 -140.63 0.16 OUTLIER 'Cis proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.798 -1.751 . . . . 0.0 110.835 -2.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.318 HD11 ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -158.6 150.95 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 74.4 mmtt -30.14 145.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.877 -1.51 . . . . 0.0 113.049 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 1.219 ' OD1' ' HB3' ' A' ' 96' ' ' LYS . 40.4 m-80 -42.77 -167.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.272 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.223 ' OE1' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 161.19 118.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.231 -177.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.882 ' HB2' HH11 ' A' ' 92' ' ' ARG . . . 174.06 -51.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.897 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 1.008 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 59.8 p30 -70.35 39.07 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.501 1.126 . . . . 0.0 111.693 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 77' ' ' ALA . 4.6 p30 -40.6 -41.43 1.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.281 0.988 . . . . 0.0 110.976 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.819 ' O ' HD23 ' A' ' 81' ' ' LEU . . . 64.02 71.06 0.91 Allowed Glycine 0 N--CA 1.47 0.916 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.819 HD23 ' O ' ' A' ' 80' ' ' GLY . 79.9 mt -163.94 -179.54 6.33 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.871 0.983 . . . . 0.0 111.022 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.716 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 35.4 mmt180 -72.72 138.63 46.69 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.321 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.0 m120 -155.12 132.8 11.31 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.827 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 m -166.75 154.82 9.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.967 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.872 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 78.2 ttt180 -34.12 110.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 113.932 -1.486 . . . . 0.0 110.687 169.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 1.372 ' HA2' ' ND2' ' A' ' 106' ' ' ASN . . . -137.53 79.22 0.31 Allowed Glycine 0 N--CA 1.469 0.844 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.564 3.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.098 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 48.1 p -60.55 139.47 57.76 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.823 0.954 . . . . 0.0 111.107 172.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.385 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -79.82 158.16 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.474 162.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.986 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -160.41 129.95 5.08 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.633 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 1.267 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -60.67 122.05 13.76 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.422 -177.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 1.194 ' O ' ' HG3' ' A' ' 92' ' ' ARG . . . -51.41 -173.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.441 1.088 . . . . 0.0 111.795 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.194 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 81.9 mtp180 179.43 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.738 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.3 m -52.67 -86.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.763 1.289 . . . . 0.0 110.14 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.9 -71.54 0.41 Allowed 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.946 1.404 . . . . 0.0 108.525 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.8 m-20 -46.14 128.35 9.39 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.41 1.069 . . . . 0.0 110.433 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.219 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 8.3 mtpm? -42.15 -103.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.531 1.145 . . . . 0.0 110.582 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.9 ' OD1' ' ND2' ' A' ' 75' ' ' ASN . 33.0 m-20 -53.06 114.22 1.38 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.64 1.212 . . . . 0.0 109.21 175.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 1.15 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 40.3 t -175.28 -44.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.562 1.164 . . . . 0.0 111.093 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 1.318 ' O ' HD11 ' A' ' 73' ' ' ILE . . . -34.81 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.096 0.873 . . . . 0.0 110.411 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 1.518 ' CG2' ' HA ' ' A' ' 70' ' ' ASN . 74.3 p -78.85 -37.04 41.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.608 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.417 ' C ' ' HE2' ' A' ' 90' ' ' MET . 78.7 p -170.07 -48.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.092 0.87 . . . . 0.0 110.634 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.899 ' HG3' ' HB3' ' A' ' 91' ' ' ALA . 3.9 pt20 -36.9 151.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.215 0.947 . . . . 0.0 112.114 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.904 ' HB2' HD11 ' A' ' 88' ' ' ILE . 11.6 p90 -157.18 -167.71 2.41 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.415 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.935 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.7 p90 -158.15 121.1 3.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.927 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.953 HD11 HD21 ' A' ' 18' ' ' LEU . 65.1 mt -90.0 104.87 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.74 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 1.372 ' ND2' ' HA2' ' A' ' 86' ' ' GLY . 5.0 p-10 -63.87 153.21 37.5 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.259 0.974 . . . . 0.0 110.408 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.969 HG12 ' SD ' ' A' ' 132' ' ' MET . 32.6 m -141.53 47.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.026 176.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.618 ' O ' ' OD1' ' A' ' 110' ' ' ASN . . . 170.15 140.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.528 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 1.123 ' O ' ' OD1' ' A' ' 110' ' ' ASN . 32.3 m-20 -30.93 138.72 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 1.123 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 15.9 m-20 -158.18 157.3 32.42 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.049 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.155 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . 172.31 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.722 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.515 ' CE1' ' HA ' ' A' ' 110' ' ' ASN . 32.6 p90 -39.64 -42.65 1.23 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.58 1.175 . . . . 0.0 110.238 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.958 HD11 ' CD2' ' A' ' 122' ' ' TYR . 68.1 tp -58.98 -52.33 66.23 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 0.0 109.619 175.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 1.155 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 57.4 p-10 -40.08 138.4 0.84 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.523 1.139 . . . . 0.0 111.815 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 1.008 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 4.0 t60 -36.62 113.52 0.24 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.809 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.743 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.918 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 78.7 m-85 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.38 0.61 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.35 -110.34 0.26 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.328 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.958 ' CD2' HD11 ' A' ' 113' ' ' LEU . 89.1 m-85 -78.77 116.3 19.02 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.808 0.946 . . . . 0.0 109.937 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.267 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -49.94 -158.41 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.247 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.085 HG23 ' O ' ' A' ' 123' ' ' ALA . 45.7 t 179.28 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.811 ' CE2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.11 27.74 0.07 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.251 0.97 . . . . 0.0 111.135 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 1.385 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -150.92 -173.07 20.59 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 122.983 1.324 . . . . 0.0 112.223 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.174 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 36.2 mtmm 177.8 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 111.47 -2.365 . . . . 0.0 108.864 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.128 HG21 ' CE ' ' A' ' 132' ' ' MET . 62.8 t -40.03 116.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.59 1.181 . . . . 0.0 110.311 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.721 HG21 ' ND1' ' A' ' 6' ' ' HIS . 85.0 t -58.35 -51.43 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.392 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER 162.26 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.609 1.193 . . . . 0.0 108.798 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -166.38 22.46 0.12 Allowed Glycine 0 N--CA 1.475 1.237 0 O-C-N 124.826 1.329 . . . . 0.0 112.713 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 1.128 ' CE ' HG21 ' A' ' 128' ' ' VAL . 20.9 mmt -53.51 -22.22 7.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.439 171.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 63.2 t0 -47.88 -60.58 2.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.883 HG21 ' O ' ' A' ' 15' ' ' ASN . 87.2 t -62.31 -73.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.735 1.272 . . . . 0.0 109.423 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.705 ' O ' ' OG ' ' A' ' 139' ' ' SER . . . -39.95 -52.47 2.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.473 1.108 . . . . 0.0 110.373 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 1.013 ' OD2' ' HB3' ' A' ' 132' ' ' MET . 49.1 m-20 -60.8 -66.64 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.821 1.325 . . . . 0.0 108.382 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.97 ' O ' HG13 ' A' ' 141' ' ' VAL . 24.8 ttmm -34.49 -49.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.607 1.192 . . . . 0.0 110.363 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.252 ' O ' HG22 ' A' ' 141' ' ' VAL . 49.6 mt -60.31 -55.47 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 124.755 1.285 . . . . 0.0 107.909 168.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.89 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . 39.0 m -64.42 0.68 0.96 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.774 -1.557 . . . . 0.0 114.828 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.805 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 3.7 mp0 -107.03 -44.87 4.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.345 1.028 . . . . 0.0 109.017 173.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.252 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.3 m -40.07 127.97 1.64 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.287 0.992 . . . . 0.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.9 Cg_exo -37.57 177.13 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.355 2.703 . . . . 0.0 113.418 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.345 HG22 ' CA ' ' A' ' 153' ' ' PRO . 10.1 p -160.83 -151.18 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.56 1.648 . . . . 0.0 112.74 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.747 ' HD2' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 178.38 165.26 0.78 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 110.03 -3.259 . . . . 0.0 111.488 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.668 ' O ' HG22 ' A' ' 146' ' ' VAL . 46.4 t0 -52.14 -150.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.501 166.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.841 HG22 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -161.16 -142.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -67.05 -102.97 0.02 OUTLIER Glycine 0 N--CA 1.471 0.991 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 166.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.55 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 86.4 Cg_endo -77.5 -53.91 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.919 3.079 . . . . 0.0 109.917 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 146' ' ' VAL . 61.7 m-85 -69.25 122.44 18.86 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.587 1.179 . . . . 0.0 111.604 -172.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 29.5 mm-40 -74.48 -176.66 2.81 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.063 170.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.61 ' O ' HG23 ' A' ' 152' ' ' VAL . 10.6 m120 48.73 86.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.716 175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.841 ' HB ' HG22 ' A' ' 146' ' ' VAL . 88.1 t -161.94 105.28 1.15 Allowed Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.337 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.345 ' CA ' HG22 ' A' ' 143' ' ' THR . 85.9 Cg_exo -45.12 139.83 8.12 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.409 2.739 . . . . 0.0 112.119 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 1.068 ' N ' ' HA ' ' A' ' 143' ' ' THR . 80.2 p -73.74 44.64 0.17 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.604 174.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.615 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 17.2 tppt? -178.51 72.71 0.21 Allowed Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 155' ' ' LYS . 80.9 Cg_exo -46.37 108.38 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.73 2.953 . . . . 0.0 112.362 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG13 ' OG ' ' A' ' 12' ' ' SER . 89.3 t -68.98 154.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.505 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.858 ' HA ' HG22 ' A' ' 45' ' ' THR . 76.7 t -141.45 118.03 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.997 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.959 HG13 ' HA ' ' A' ' 45' ' ' THR . 35.3 mt -69.06 135.38 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.035 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.274 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.8 mt -85.22 -49.16 8.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.701 -2.045 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 1.155 ' O ' HD23 ' A' ' 9' ' ' LEU . 34.7 t -170.46 161.04 7.75 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.434 1.084 . . . . 0.0 112.245 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.979 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -137.53 61.08 1.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.534 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 1.095 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 47.9 mmtm -69.92 93.15 0.75 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.49 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.992 HG12 ' HA ' ' A' ' 7' ' ' VAL . 34.6 m -71.54 132.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.42 1.075 . . . . 0.0 110.383 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.998 HD23 ' HB2' ' A' ' 6' ' ' HIS . 3.3 mm? -78.23 121.97 84.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.359 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 165' ' ' LEU . 66.9 Cg_endo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 123.583 2.855 . . . . 0.0 109.752 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.44 ' C ' ' HD2' ' A' ' 6' ' ' HIS . 80.8 Cg_exo . . . . . 0 C--O 1.235 0.369 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.44 ' HD2' ' C ' ' A' ' 5' ' ' PRO . 8.0 m170 -153.16 121.97 6.45 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.732 -176.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.977 HG12 ' HB2' ' A' ' 18' ' ' LEU . 7.9 p -73.79 116.74 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.427 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.782 ' HG ' ' CD ' ' A' ' 17' ' ' GLU . 6.5 mp -79.81 151.09 30.48 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.359 1.076 . . . . 0.0 110.748 169.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.152 ' O ' HG12 ' A' ' 16' ' ' ILE . 6.9 mt -160.59 96.54 1.16 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.559 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 1.206 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.0 m -88.14 79.98 7.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.637 -2.528 . . . . 0.0 107.969 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 1.065 HG22 HG12 ' A' ' 159' ' ' ILE . 37.0 p -73.24 169.72 16.48 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 125.018 1.449 . . . . 0.0 111.516 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 80.0 p -39.71 -46.24 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -60.37 -54.83 40.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.462 1.101 . . . . 0.0 110.623 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.01 173.76 39.65 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 113.767 -1.561 . . . . 0.0 113.597 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.892 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 5.5 t-20 -61.82 143.54 56.16 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.451 -1.374 . . . . 0.0 110.868 175.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.152 HG12 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -144.2 -178.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.982 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.902 ' HG2' ' O ' ' A' ' 130' ' ' LYS . 6.9 mm-40 -160.13 101.88 1.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.92 -165.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 105' ' ' ILE . 2.4 mm? -85.0 161.03 19.91 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.297 0.998 . . . . 0.0 110.409 164.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.206 ' OE1' ' CD ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -127.27 110.84 13.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.529 173.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 125' ' ' PHE . 3.0 mm? -79.37 -170.9 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.826 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -164.69 87.05 0.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.011 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.131 ' HA ' HG11 ' A' ' 29' ' ' VAL . 19.8 ptpt -59.16 -34.62 72.32 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.842 1.339 . . . . 0.0 112.303 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.549 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 11.3 tp-100 -41.07 -64.36 0.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.206 0.941 . . . . 0.0 110.69 -172.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -69.97 -5.43 26.2 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.792 1.308 . . . . 0.0 113.896 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.811 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.18 71.59 3.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 O-C-N 123.818 0.699 . . . . 0.0 109.449 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 1.238 ' O ' HG22 ' A' ' 29' ' ' VAL . 57.5 Cg_exo -54.2 -64.69 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.667 2.912 . . . . 0.0 111.109 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.702 HG23 ' H ' ' A' ' 28' ' ' SER . 15.6 m -50.1 -62.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 124.734 1.271 . . . . 0.0 110.368 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.702 ' H ' HG23 ' A' ' 27' ' ' VAL . 42.1 t -41.82 -56.39 2.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.445 1.09 . . . . 0.0 110.466 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.238 HG22 ' O ' ' A' ' 26' ' ' PRO . 34.6 m -48.82 -45.07 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 124.734 1.272 . . . . 0.0 110.554 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 23.3 tp60 -45.7 -62.26 1.37 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.241 0.963 . . . . 0.0 109.551 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 1.03 ' OD1' HG21 ' A' ' 73' ' ' ILE . 11.0 m120 -47.35 -60.85 2.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.701 1.251 . . . . 0.0 109.497 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.529 ' HE1' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 t80 -43.24 -62.75 0.96 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.353 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 29' ' ' VAL . 61.3 t -49.26 -33.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 124.78 1.3 . . . . 0.0 111.452 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.939 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 55.2 m-20 -45.86 -63.68 0.92 Allowed 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.916 0.76 . . . . 0.0 109.771 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.74 ' CB ' ' HD1' ' A' ' 40' ' ' PHE . 19.7 m-85 -58.76 -61.89 2.28 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.826 1.329 . . . . 0.0 108.577 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.972 ' HA ' ' HB2' ' A' ' 40' ' ' PHE . 62.6 t -42.53 -53.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.308 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -39.99 -33.58 0.23 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.713 1.258 . . . . 0.0 111.867 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 35' ' ' TYR . 83.0 p -173.44 136.54 0.6 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.273 0.983 . . . . 0.0 110.578 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.41 43.91 35.6 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.297 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 57.1 t80 -61.38 -96.06 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.73 ' OH ' ' HB3' ' A' ' 101' ' ' SER . 22.3 m-30 -133.12 58.32 1.77 Allowed 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.149 0.905 . . . . 0.0 109.04 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 49.1 p-10 -77.92 108.8 11.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 174.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 1.231 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 1.8 t-20 67.46 58.75 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.538 1.148 . . . . 0.0 109.742 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.724 ' C ' ' HB ' ' A' ' 159' ' ' ILE . 32.6 p -104.2 -128.85 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.635 169.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.845 ' HA ' HG13 ' A' ' 159' ' ' ILE . 67.2 p -162.35 -176.93 5.36 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.906 0.86 . . . . 0.0 113.077 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.904 ' CD1' HD11 ' A' ' 159' ' ' ILE . 7.4 m-30 -126.74 72.41 1.34 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.99 -1.914 . . . . 0.0 106.953 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.883 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 5.5 p-80 -58.27 -71.45 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.015 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.024 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 22.9 mmt85 -69.19 123.85 22.24 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.386 1.054 . . . . 0.0 110.833 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.761 HG22 HG12 ' A' ' 55' ' ' ILE . 90.8 t -162.0 140.05 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.976 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.852 HG22 ' SD ' ' A' ' 54' ' ' MET . 10.5 tt -155.17 126.76 3.71 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.101 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' PHE . 97.9 Cg_exo -39.45 168.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 123.555 2.836 . . . . 0.0 113.79 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -4.02 66.86 0.0 OUTLIER Glycine 0 N--CA 1.474 1.196 0 CA-C-N 114.102 -1.408 . . . . 0.0 114.051 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.4 t80 -161.16 -61.15 0.05 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.761 0.918 . . . . 0.0 108.847 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.852 ' SD ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -170.7 -175.61 1.87 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.494 1.121 . . . . 0.0 111.717 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.761 HG12 HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 174.65 113.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.549 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 1.024 ' OE1' ' O ' ' A' ' 48' ' ' ARG . 3.5 mp0 -96.8 -174.51 3.02 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.047 -169.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -166.91 178.83 41.02 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.934 165.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 1.014 ' O ' ' HB3' ' A' ' 102' ' ' GLN . . . 61.44 103.99 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 CA-C-N 113.728 -1.236 . . . . 0.0 110.712 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.81 -129.95 1.42 Allowed Glycine 0 N--CA 1.475 1.259 0 O-C-N 124.649 0.852 . . . . 0.0 111.701 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.931 ' CD1' ' HG2' ' A' ' 66' ' ' GLN . 12.6 m-30 -51.23 139.79 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.818 -1.191 . . . . 0.0 111.822 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.973 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 92.4 m -61.09 141.87 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.132 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.6 pt-20 -28.6 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.981 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 29.7 mt-30 90.58 43.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.804 1.315 . . . . 0.0 110.981 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.598 ' SD ' ' HD2' ' A' ' 60' ' ' PHE . 21.4 mmt 58.1 12.67 1.94 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.029 0.831 . . . . 0.0 113.148 174.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.973 ' O ' ' HB ' ' A' ' 61' ' ' THR . 88.0 mt-30 -79.41 65.22 4.51 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.931 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 30.2 mt-30 -39.45 132.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.181 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -58.62 -109.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.124 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.644 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 61.5 pttt -154.55 66.53 5.22 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.294 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 1.061 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 31.5 Cg_exo -70.51 -151.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.424 2.749 . . . . 0.0 112.588 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.061 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 40.2 p30 67.34 78.65 0.24 Allowed Pre-proline 0 N--CA 1.472 0.627 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.642 169.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.854 ' HB2' ' C ' ' A' ' 72' ' ' PRO . 52.6 Cg_exo -49.53 -60.39 0.87 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.316 2.677 . . . . 0.0 109.438 173.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.9 ' O ' HG23 ' A' ' 73' ' ' ILE . 45.2 Cg_exo -89.7 -160.27 1.33 Allowed 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.556 -2.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.105 HD11 ' O ' ' A' ' 99' ' ' ALA . 2.1 pp -161.7 145.1 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.902 0.858 . . . . 0.0 111.822 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 74' ' ' LYS . 28.6 mtpp -45.32 161.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.225 -1.807 . . . . 0.0 113.809 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.743 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 52.5 p-10 -74.68 -160.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.248 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.743 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 10.1 tp10 145.25 130.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.011 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.934 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -162.6 -36.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.291 0.994 . . . . 0.0 112.002 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.764 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 58.6 p30 -67.24 -37.66 83.9 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.104 0.877 . . . . 0.0 111.975 -169.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.764 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 16.7 p-10 45.13 -119.41 0.77 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.112 0.883 . . . . 0.0 109.736 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . 164.6 -55.56 0.27 Allowed Glycine 0 N--CA 1.474 1.173 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 80' ' ' GLY . 46.3 mt -39.64 177.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.692 0.877 . . . . 0.0 112.807 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.731 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 36.9 mmt180 -68.84 149.18 49.24 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.055 168.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.731 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.7 m120 -156.12 129.09 7.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.921 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' ARG . 15.8 m -169.33 157.98 7.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.843 -173.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' THR . 63.0 ttt180 -23.13 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.953 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.776 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 143.24 -17.35 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 111.433 -2.621 . . . . 0.0 110.855 -171.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.03 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 34.9 p -106.25 146.08 30.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.286 1.041 . . . . 0.0 112.755 -174.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.027 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.27 164.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.075 171.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.902 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -161.76 141.23 9.99 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.594 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.891 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 6.7 ttm -57.27 137.67 55.71 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.061 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 1.062 ' HB3' ' OE1' ' A' ' 102' ' ' GLN . . . -75.6 -59.43 2.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.598 ' HB3' ' CB ' ' A' ' 99' ' ' ALA . 5.3 tpm_? -32.75 169.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.39 1.056 . . . . 0.0 113.844 -172.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.708 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 9.7 t 161.94 162.44 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.634 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.743 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 83.26 130.51 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.491 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 1.365 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 42.3 m-20 101.37 -57.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.454 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.365 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 10.1 mtmp? 139.31 -94.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.821 1.326 . . . . 0.0 108.147 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -64.24 104.43 0.75 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.817 1.323 . . . . 0.0 109.013 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.924 ' OG ' ' HD3' ' A' ' 92' ' ' ARG . 18.2 t -174.13 -179.72 1.72 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.632 1.208 . . . . 0.0 111.814 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 1.598 ' CB ' ' HB3' ' A' ' 92' ' ' ARG . . . 80.33 85.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.83 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 62.9 p -79.72 -40.25 29.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.649 -168.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.73 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 50.3 m -159.27 -73.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.288 0.993 . . . . 0.0 109.338 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 1.062 ' OE1' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -38.91 163.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.168 -175.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 1.027 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -155.3 -165.28 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.1 -172.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.956 ' CZ ' ' HB3' ' A' ' 122' ' ' TYR . 49.3 p90 -154.85 119.16 4.73 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.757 0.789 . . . . 0.0 111.019 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 18' ' ' LEU . 67.1 mt -84.14 110.89 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.453 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.654 HD21 ' HE1' ' A' ' 104' ' ' PHE . 10.7 m120 -61.11 166.79 3.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.372 1.045 . . . . 0.0 111.41 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.657 HG12 ' CE ' ' A' ' 132' ' ' MET . 28.1 m -155.45 42.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.667 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.731 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . 173.6 137.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.379 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -39.55 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.887 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.899 ' OD1' HD11 ' A' ' 113' ' ' LEU . 11.9 t-20 -70.52 -119.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.876 1.36 . . . . 0.0 110.699 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 76.5 -33.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.782 0.677 . . . . 0.0 111.774 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -38.35 -50.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.071 0.857 . . . . 0.0 110.113 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.037 ' H ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.98 40.62 0.87 Allowed 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.752 1.282 . . . . 0.0 110.729 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' ' O ' ' A' ' 113' ' ' LEU . 39.9 p30 -39.21 -117.38 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.733 0.646 . . . . 0.0 111.602 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.9 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 12.1 m-70 179.34 109.65 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.963 0.789 . . . . 0.0 109.946 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.204 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.423 179.523 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.86 -130.48 0.01 OUTLIER Glycine 0 N--CA 1.471 1.013 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.97 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.956 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 71.1 m-85 -79.5 135.37 36.62 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.958 -1.121 . . . . 0.0 111.344 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.183 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -67.17 -148.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.309 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.183 HG23 ' O ' ' A' ' 123' ' ' ALA . 37.1 t 177.39 133.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.9 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 24.2 p90 -171.32 26.13 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.808 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -166.68 -149.98 6.19 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-O 122.8 1.222 . . . . 0.0 114.084 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.206 ' CD ' ' OE1' ' A' ' 19' ' ' GLU . 29.7 mtpp -169.42 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 111.597 -2.301 . . . . 0.0 110.373 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.54 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 63.3 t -156.13 159.16 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.094 -175.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.766 ' O ' ' CD ' ' A' ' 130' ' ' LYS . 62.4 t -152.54 -43.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.992 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.902 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 32.4 mmmt -167.02 101.46 0.54 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.204 1.002 . . . . 0.0 109.032 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.428 ' O ' ' OD1' ' A' ' 133' ' ' ASP . . . -179.77 141.07 4.53 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.726 0.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.824 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 22.7 mmt -47.86 -26.11 1.55 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.963 -1.118 . . . . 0.0 111.805 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 37.8 p-10 -47.93 -55.09 10.73 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.668 HG11 HG23 ' A' ' 16' ' ' ILE . 51.4 t -62.68 -68.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 124.378 1.049 . . . . 0.0 108.999 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 132' ' ' MET . . . -42.65 -47.15 5.24 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.667 1.229 . . . . 0.0 110.905 -177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 1.016 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 41.4 m-20 -50.47 -71.0 0.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.473 1.108 . . . . 0.0 109.424 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.675 ' O ' HG13 ' A' ' 141' ' ' VAL . 56.8 mtmt -42.97 -43.57 4.23 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.712 1.258 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 141' ' ' VAL . 14.5 mt -58.57 -61.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.634 ' HA ' HG11 ' A' ' 49' ' ' VAL . 84.5 p -68.54 16.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.426 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 1.016 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 60.6 mm-40 -115.36 -47.05 2.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.295 0.997 . . . . 0.0 109.368 176.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.7 m -47.65 127.92 10.78 Favored Pre-proline 0 N--CA 1.472 0.662 0 O-C-N 124.443 1.089 . . . . 0.0 110.1 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 141' ' ' VAL . 86.2 Cg_exo -38.09 176.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.338 2.692 . . . . 0.0 113.374 175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.45 HG22 ' CA ' ' A' ' 153' ' ' PRO . 8.5 p -160.83 -150.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.727 1.727 . . . . 0.0 112.932 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.701 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 178.52 165.26 0.81 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 109.725 -3.398 . . . . 0.0 111.035 173.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.708 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 36.7 m-20 -50.86 -148.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.962 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -161.28 -148.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.729 0.643 . . . . 0.0 109.282 170.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -65.31 -100.15 0.02 OUTLIER Glycine 0 N--CA 1.471 0.97 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 168.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 98.5 Cg_endo -73.49 -61.5 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.788 2.992 . . . . 0.0 109.321 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 146' ' ' VAL . 80.2 m-85 -69.78 120.77 16.04 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.606 1.191 . . . . 0.0 111.373 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.708 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 9.8 mm100 -68.89 -157.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.861 167.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.758 ' O ' HG23 ' A' ' 152' ' ' VAL . 10.7 m120 36.25 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.061 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 146' ' ' VAL . 70.1 t -164.56 118.89 1.01 Allowed Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.238 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.45 ' CA ' HG22 ' A' ' 143' ' ' THR . 57.2 Cg_endo -66.21 111.97 2.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.646 2.897 . . . . 0.0 109.842 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.937 ' H ' ' HA ' ' A' ' 143' ' ' THR . 69.6 p -42.66 -52.85 4.73 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.743 1.277 . . . . 0.0 109.143 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.24 132.33 93.4 Favored Pre-proline 0 N--CA 1.474 0.742 0 O-C-N 124.572 1.17 . . . . 0.0 109.503 170.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.38 161.04 43.55 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 C-N-CA 123.658 2.905 . . . . 0.0 113.436 -172.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.552 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 55.5 t -151.18 95.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.571 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 45' ' ' THR . 91.8 t -88.58 121.24 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.711 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.231 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 11.0 mt -68.93 125.36 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.906 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.206 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -79.82 -51.26 9.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.212 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.788 ' O ' HD23 ' A' ' 9' ' ' LEU . 56.0 m -158.58 177.35 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.694 1.246 . . . . 0.0 112.206 -176.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.868 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . . . -170.63 119.8 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.098 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.436 ' O ' HD13 ' A' ' 8' ' ' LEU . 21.4 ptmt -170.75 131.37 0.86 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.302 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.893 HG13 HG11 ' A' ' 36' ' ' VAL . 35.9 m -69.01 142.33 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.9 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.975 HD12 ' HD2' ' A' ' 166' ' ' PRO . 58.6 tp -58.35 123.4 65.86 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.975 ' HD2' HD12 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.583 2.856 . . . . 0.0 112.12 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.4 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 86.7 Cg_exo . . . . . 0 C--O 1.235 0.325 0 N-CA-C 113.942 0.708 . . . . 0.0 113.942 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.4 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 22.1 m170 -154.55 117.75 4.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.148 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.039 HG22 ' HB2' ' A' ' 18' ' ' LEU . 30.2 m -71.76 109.19 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 124.387 1.054 . . . . 0.0 109.184 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.26 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 7.3 mp -79.26 131.08 36.05 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.383 1.052 . . . . 0.0 110.285 177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.044 ' O ' HG12 ' A' ' 16' ' ' ILE . 8.6 mp -138.45 96.76 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.333 173.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 1.186 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 95.3 m -86.2 81.98 8.21 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.768 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.978 HG22 HG12 ' A' ' 159' ' ' ILE . 33.5 p -72.91 167.6 20.66 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.931 1.394 . . . . 0.0 111.41 174.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -39.49 -43.78 1.31 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.358 -1.747 . . . . 0.0 110.61 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.777 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -53.9 -61.94 1.98 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.471 1.107 . . . . 0.0 110.228 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.34 177.64 46.38 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 113.151 -1.84 . . . . 0.0 113.365 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.765 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 1.2 t-20 -77.82 89.46 4.05 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.684 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.044 HG12 ' O ' ' A' ' 9' ' ' LEU . 7.0 pt -77.9 175.01 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.308 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.917 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 6.2 mm-40 -159.73 100.08 1.43 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.4 -168.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.039 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.6 mm? -80.97 164.3 22.66 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.398 1.061 . . . . 0.0 110.712 166.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.948 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 40.0 tt0 -130.19 129.83 43.92 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.475 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.042 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.6 mp -117.53 116.56 27.37 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.964 1.415 . . . . 0.0 109.726 -169.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.37 104.9 2.84 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.314 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.71 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.9 ttmp? -69.0 -45.79 69.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.663 1.227 . . . . 0.0 111.542 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -47.77 -70.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.333 1.02 . . . . 0.0 110.256 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 1.263 ' NZ ' HD21 ' A' ' 81' ' ' LEU . 61.6 mttp -71.94 13.1 0.32 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.77 1.294 . . . . 0.0 114.016 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.659 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.63 68.7 2.69 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 124.034 0.834 . . . . 0.0 109.486 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.853 ' O ' HG22 ' A' ' 29' ' ' VAL . 51.6 Cg_exo -60.73 -63.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.475 2.784 . . . . 0.0 111.061 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.0 t -54.96 -62.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.137 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 t -42.2 -58.49 2.13 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.643 1.214 . . . . 0.0 110.472 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 26' ' ' PRO . 32.2 m -51.75 -46.97 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 124.735 1.272 . . . . 0.0 110.622 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.497 ' N ' HG23 ' A' ' 29' ' ' VAL . 1.2 tm0? -48.58 -69.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.239 0.962 . . . . 0.0 108.949 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 1.306 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 12.7 m-80 -45.08 -51.71 9.88 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.557 1.161 . . . . 0.0 109.75 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' VAL . 77.4 t80 -42.54 -59.65 1.81 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.598 1.186 . . . . 0.0 109.646 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.688 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.9 t -47.44 -37.3 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.707 1.254 . . . . 0.0 111.101 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 1.306 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 15.3 m-20 -43.84 -62.6 1.06 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.012 0.82 . . . . 0.0 109.381 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -61.27 -59.37 5.41 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.152 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.933 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 59.5 t -39.4 -48.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.976 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.803 ' O ' ' HB3' ' A' ' 38' ' ' SER . 1.9 t-20 -38.42 -32.38 0.07 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.779 1.299 . . . . 0.0 112.015 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.803 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.2 p 149.32 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.138 0.899 . . . . 0.0 113.005 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 42' ' ' ASN . . . 87.6 -42.46 3.12 Favored Glycine 0 N--CA 1.474 1.198 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.356 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.632 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 28.4 t80 -67.11 -74.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.527 0.78 . . . . 0.0 109.888 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.933 ' CE2' ' HA ' ' A' ' 36' ' ' VAL . 79.9 m-85 -61.69 -29.49 70.12 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.513 1.133 . . . . 0.0 112.628 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 39' ' ' GLY . 19.3 m-20 -38.6 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.011 0.819 . . . . 0.0 111.312 -169.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 1.143 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.5 m-20 44.24 47.81 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.265 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.835 ' O ' HG23 ' A' ' 45' ' ' THR . 28.6 m -78.59 -123.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 1.046 HG22 ' HA ' ' A' ' 158' ' ' VAL . 46.1 p -165.02 -143.8 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.254 1.026 . . . . 0.0 112.493 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CD2' HG21 ' A' ' 11' ' ' THR . 65.4 m-85 -159.63 66.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.5 -2.137 . . . . 0.0 106.834 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.884 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 1.4 p-80 -51.72 -68.98 0.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.191 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.884 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.2 mtt180 -69.68 124.07 23.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.51 1.131 . . . . 0.0 110.296 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 49' ' ' VAL . 34.4 m -158.21 94.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 124.74 1.275 . . . . 0.0 109.374 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.898 HG21 ' HD2' ' A' ' 53' ' ' PHE . 57.2 mt -77.27 123.75 87.04 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.334 175.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 53' ' ' PHE . 82.4 Cg_exo -37.65 144.02 0.16 Allowed 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.271 2.647 . . . . 0.0 112.525 174.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.23 55.53 0.01 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.651 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.898 ' HD2' HG21 ' A' ' 50' ' ' ILE . 1.6 t80 -144.33 -63.1 0.37 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.778 0.929 . . . . 0.0 109.05 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.701 ' HE2' HD12 ' A' ' 50' ' ' ILE . 27.2 ptt? -179.56 114.91 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.386 1.054 . . . . 0.0 111.102 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.836 ' CD1' ' HB1' ' A' ' 135' ' ' ALA . 30.7 pt -84.73 160.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.791 165.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.787 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 20.0 mt-30 -156.58 162.35 39.9 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.804 0.69 . . . . 0.0 111.781 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.79 -154.07 7.05 Favored Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.272 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 102' ' ' GLN . . . 65.85 73.88 0.57 Allowed Glycine 0 N--CA 1.47 0.952 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 1.22 ' HA2' ' CD ' ' A' ' 67' ' ' LYS . . . -179.83 -122.83 0.8 Allowed Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 68.5 m-85 -45.18 132.91 7.12 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.622 0.836 . . . . 0.0 110.499 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.781 ' HA ' HG23 ' A' ' 44' ' ' THR . 88.6 m -59.2 -57.91 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.214 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.722 ' HG2' HG21 ' A' ' 45' ' ' THR . 0.1 OUTLIER -168.46 -75.7 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.614 1.196 . . . . 0.0 108.064 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -72.93 46.81 0.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.5 1.125 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.833 ' HE1' HG21 ' A' ' 152' ' ' VAL . 53.9 mtt 39.44 36.69 0.23 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.121 0.888 . . . . 0.0 111.961 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -78.14 87.46 4.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -30.69 147.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.69 -1.595 . . . . 0.0 113.418 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 1.22 ' CD ' ' HA2' ' A' ' 59' ' ' GLY . 47.4 mtmt -56.53 -131.12 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 112.849 -1.978 . . . . 0.0 112.393 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 1.14 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 46.6 mmtm 179.27 79.66 0.17 Allowed Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 112.641 -2.072 . . . . 0.0 106.363 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.812 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 47.8 Cg_endo -71.89 -165.88 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.606 2.871 . . . . 0.0 113.345 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.998 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 91.4 m-20 -166.54 170.76 5.19 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 113.237 -1.801 . . . . 0.0 109.923 -172.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 32.9 Cg_endo -45.44 104.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.606 2.204 . . . . 0.0 109.184 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.5 Cg_exo -44.58 -146.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.818 3.012 . . . . 0.0 113.603 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 99' ' ' ALA . 27.4 pt -160.18 141.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 124.387 1.054 . . . . 0.0 110.476 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 29.1 mtpp -36.44 159.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.749 -1.569 . . . . 0.0 113.322 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 1.322 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 8.2 t-20 -43.12 169.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.285 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.322 ' HG2' ' O ' ' A' ' 75' ' ' ASN . 11.4 mm-40 172.98 128.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.478 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.439 ' HB1' ' CD2' ' A' ' 115' ' ' HIS . . . 174.12 -40.28 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.976 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 52.9 p-10 -67.22 -43.71 81.36 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.299 0.999 . . . . 0.0 110.649 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 22.2 p30 -51.86 132.35 31.73 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.114 0.884 . . . . 0.0 110.325 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.639 ' H ' HD12 ' A' ' 81' ' ' LEU . . . -171.78 -62.11 0.04 OUTLIER Glycine 0 N--CA 1.474 1.199 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.263 HD21 ' NZ ' ' A' ' 24' ' ' LYS . 6.2 mp 81.6 -32.25 0.1 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.632 0.843 . . . . 0.0 112.444 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 16.4 ptp180 178.89 73.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.645 1.216 . . . . 0.0 110.211 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.61 HD22 ' HB3' ' A' ' 110' ' ' ASN . 1.2 p-10 -72.68 142.88 48.25 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.869 1.356 . . . . 0.0 111.204 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 m -169.28 148.04 3.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.419 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.713 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 51.6 ptt85 -42.03 101.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.05 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.774 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 144.19 -29.04 1.94 Allowed Glycine 0 N--CA 1.473 1.107 0 CA-C-N 111.934 -2.393 . . . . 0.0 109.899 -169.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 20.5 p -83.56 129.85 34.98 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.716 0.77 . . . . 0.0 111.225 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.485 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -84.26 156.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.793 166.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.092 ' O ' ' CD2' ' A' ' 104' ' ' PHE . . . -165.31 128.69 2.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.659 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.78 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 32.7 ttm -59.38 173.9 0.47 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.196 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.742 ' H ' ' HG3' ' A' ' 90' ' ' MET . . . -167.57 164.14 14.68 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.507 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.867 ' CG ' ' HA ' ' A' ' 99' ' ' ALA . 2.4 mmm-85 179.65 119.08 0.05 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.486 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 93.4 m -40.47 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.532 1.145 . . . . 0.0 110.438 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 93' ' ' THR . . . 71.39 -67.9 0.24 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.858 1.349 . . . . 0.0 109.175 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.769 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 59.3 m-20 66.13 -84.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.705 1.253 . . . . 0.0 110.109 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.769 ' HB3' ' O ' ' A' ' 95' ' ' ASP . 87.4 tttt 95.02 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.865 1.353 . . . . 0.0 109.213 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -165.88 81.16 0.3 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 73' ' ' ILE . 66.3 m -163.06 -116.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.781 1.301 . . . . 0.0 110.565 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.867 ' HA ' ' CG ' ' A' ' 92' ' ' ARG . . . 54.27 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.644 1.215 . . . . 0.0 107.751 -169.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -77.71 -35.02 52.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.01 -170.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.7 p -170.31 -40.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.273 0.983 . . . . 0.0 110.14 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.738 ' CD ' ' HZ3' ' A' ' 67' ' ' LYS . 29.4 mt-30 -35.62 130.46 0.55 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.275 0.984 . . . . 0.0 111.308 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 1.014 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.32 178.87 7.44 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.793 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 1.092 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 49.1 p90 -153.2 122.63 6.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.052 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.942 HD11 HD21 ' A' ' 18' ' ' LEU . 59.4 mt -91.01 101.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.218 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.557 ' O ' HG13 ' A' ' 107' ' ' VAL . 18.1 p-10 -68.62 -173.04 0.41 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.354 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.712 HG22 ' C ' ' A' ' 53' ' ' PHE . 34.2 m -160.04 -42.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.623 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.713 ' CA ' ' HB3' ' A' ' 85' ' ' ARG . . . -74.25 139.71 44.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 124.373 1.046 . . . . 0.0 111.167 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -42.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.954 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.671 ' OD1' HD23 ' A' ' 113' ' ' LEU . 2.7 t30 -68.29 142.93 55.41 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.864 1.352 . . . . 0.0 111.026 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 110' ' ' ASN . . . 168.42 -51.21 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.922 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.762 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 47.5 p90 -66.44 60.65 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.611 1.195 . . . . 0.0 108.109 168.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.982 HD11 ' CD2' ' A' ' 122' ' ' TYR . 59.3 tp 178.31 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.807 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -38.08 125.7 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.821 0.701 . . . . 0.0 111.137 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 1.439 ' CD2' ' HB1' ' A' ' 77' ' ' ALA . 2.0 m-70 -42.92 108.67 0.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.379 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.026 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.288 -175.265 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 1.128 ' HZ ' ' OD1' ' A' ' 75' ' ' ASN . 21.4 p90 . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.51 -80.78 0.44 Allowed Glycine 0 N--CA 1.471 0.994 0 CA-C-N 113.638 -1.619 . . . . 0.0 113.734 -167.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 1.328 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 59.6 m-85 -76.98 130.45 37.5 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.46 0.741 . . . . 0.0 111.837 -161.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.045 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -67.37 -158.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.995 174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.048 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 62.7 t 179.48 131.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.312 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 1.042 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.1 p90 -170.79 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.007 0.817 . . . . 0.0 111.605 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 1.485 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -138.35 173.85 22.28 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.194 1.441 . . . . 0.0 113.206 -171.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 59.3 tttp 179.7 121.33 0.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 110.888 -2.656 . . . . 0.0 110.207 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 86' ' ' GLY . 59.2 t -58.94 156.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.302 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.106 HG21 ' ND1' ' A' ' 6' ' ' HIS . 57.3 t -130.7 -46.99 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.277 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.67 ' HE3' ' C ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER 172.59 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.118 0.886 . . . . 0.0 109.648 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.593 ' HA2' HG13 ' A' ' 128' ' ' VAL . . . 144.99 -147.46 18.64 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 119.778 -1.201 . . . . 0.0 112.426 -4.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.973 ' HG3' ' OD1' ' A' ' 136' ' ' ASP . 6.0 tpt -60.24 -31.15 69.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.939 -1.63 . . . . 0.0 111.878 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 63.7 t0 -47.49 -68.65 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.995 0.809 . . . . 0.0 109.531 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.783 ' HB ' HG22 ' A' ' 16' ' ' ILE . 78.3 t -49.78 -60.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.757 1.286 . . . . 0.0 109.296 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.836 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -44.6 -51.81 8.69 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.567 1.167 . . . . 0.0 110.05 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.973 ' OD1' ' HG3' ' A' ' 132' ' ' MET . 36.4 m-20 -51.86 -70.34 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.683 1.239 . . . . 0.0 109.255 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.536 ' N ' ' OE1' ' A' ' 140' ' ' GLN . 30.5 mtpp -38.6 -44.6 0.99 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.658 1.224 . . . . 0.0 110.708 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.359 ' O ' HG22 ' A' ' 141' ' ' VAL . 30.8 mt -55.61 -58.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 124.374 1.046 . . . . 0.0 108.367 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 136' ' ' ASP . 82.2 p -62.6 2.75 0.25 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.709 1.256 . . . . 0.0 114.129 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.872 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.0 mp0 -96.99 -50.09 4.76 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.289 0.993 . . . . 0.0 108.587 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.359 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.2 m -39.93 124.83 1.6 Allowed Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 124.435 1.084 . . . . 0.0 110.652 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 141' ' ' VAL . 83.6 Cg_exo -40.84 178.81 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.469 2.779 . . . . 0.0 113.748 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.203 HG22 ' CA ' ' A' ' 153' ' ' PRO . 6.7 p -161.02 -145.26 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.87 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.92 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER 179.13 142.45 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.672 -2.967 . . . . 0.0 111.789 170.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 1.145 ' OD1' ' HG2' ' A' ' 150' ' ' GLN . 61.0 t0 -69.74 111.09 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.801 168.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.848 HG12 ' H ' ' A' ' 147' ' ' GLY . 2.3 t -78.97 -147.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.115 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.848 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -61.64 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.47 0.911 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 171.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.825 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 95.8 Cg_endo -71.32 -55.78 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.697 2.931 . . . . 0.0 109.508 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.825 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 84.0 m-85 -69.2 102.94 1.8 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.632 1.207 . . . . 0.0 110.103 -176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 1.171 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 31.9 mt-30 -86.43 55.41 3.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.065 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 1.171 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 75.1 m-20 -172.8 82.74 0.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.92 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 62.9 t -156.04 102.04 2.11 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 124.405 1.065 . . . . 0.0 108.773 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.203 ' CA ' HG22 ' A' ' 143' ' ' THR . 75.7 Cg_exo -46.93 99.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 123.436 2.757 . . . . 0.0 110.268 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 1.212 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.6 t -34.87 -52.93 0.55 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.467 1.104 . . . . 0.0 109.861 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -84.64 85.98 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 164.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.212 ' HD3' ' O ' ' A' ' 154' ' ' SER . 63.1 Cg_endo -79.0 140.78 16.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.606 2.871 . . . . 0.0 112.399 -168.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.567 ' O ' ' CG2' ' A' ' 45' ' ' THR . 92.2 t -68.72 155.07 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.534 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 1.046 ' HA ' HG22 ' A' ' 45' ' ' THR . 98.1 t -142.98 119.44 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.374 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.143 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 32.3 mt -68.36 133.63 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.345 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.186 ' HB2' ' O ' ' A' ' 10' ' ' THR . 86.1 mt -76.36 -52.45 9.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.511 -2.131 . . . . 0.0 108.995 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 65.7 m -163.39 -166.11 1.18 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.671 1.232 . . . . 0.0 111.848 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 1.26 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . 179.07 119.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.347 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.723 ' O ' HD13 ' A' ' 8' ' ' LEU . 65.6 mttm -163.64 126.24 2.55 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.013 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.85 HG13 HG11 ' A' ' 36' ' ' VAL . 33.9 m -67.83 140.27 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.358 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.024 HD12 ' HD2' ' A' ' 166' ' ' PRO . 56.5 tp -157.98 121.03 2.1 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.991 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 1.024 ' HD2' HD12 ' A' ' 165' ' ' LEU . 88.3 Cg_exo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.646 2.897 . . . . 0.0 112.062 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.332 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 88.3 Cg_exo . . . . . 0 C--O 1.234 0.306 0 N-CA-C 114.298 0.845 . . . . 0.0 114.298 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.332 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 28.4 m170 -152.37 118.07 5.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.385 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.926 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.3 p -66.93 141.8 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.518 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.872 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 6.9 mp -121.11 132.53 54.92 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.424 1.078 . . . . 0.0 110.314 164.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.768 HD12 ' C ' ' A' ' 8' ' ' LEU . 8.2 mp -126.93 -177.38 4.01 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 111.929 -2.396 . . . . 0.0 109.16 164.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.841 HG22 HD12 ' A' ' 160' ' ' LEU . 99.9 m -160.61 90.29 0.86 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.844 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 1.014 HG22 HG12 ' A' ' 159' ' ' ILE . 34.8 p -78.05 169.6 18.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.398 1.686 . . . . 0.0 111.216 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -39.77 -42.98 1.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.536 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.771 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -58.22 -59.83 4.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.526 1.141 . . . . 0.0 110.572 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.59 178.51 41.36 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 113.529 -1.669 . . . . 0.0 114.201 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 16' ' ' ILE . 63.0 t-20 -61.67 153.83 27.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.08 -1.56 . . . . 0.0 111.063 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.113 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 16.0 pt -164.34 168.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.455 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 1.113 ' OE1' ' O ' ' A' ' 16' ' ' ILE . 4.3 mm-40 -145.61 113.56 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.473 -1.694 . . . . 0.0 112.059 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.013 HD21 HD11 ' A' ' 105' ' ' ILE . 2.7 mm? -94.71 147.03 23.74 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 124.481 1.113 . . . . 0.0 110.075 165.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.404 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -109.56 112.01 23.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.203 171.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.887 HD23 ' HE2' ' A' ' 125' ' ' PHE . 6.4 mp -84.33 -158.97 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.541 -170.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.804 ' OD1' ' HG3' ' A' ' 23' ' ' GLN . 61.6 t0 -175.39 110.03 0.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.118 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.667 ' HA ' HG21 ' A' ' 29' ' ' VAL . 28.5 ttpp -96.98 -35.8 10.74 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.928 1.393 . . . . 0.0 111.954 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.851 ' OE1' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -42.46 -33.68 0.71 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.179 0.925 . . . . 0.0 112.306 -171.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.851 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 17.9 tppt? -108.01 10.68 28.23 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.283 0.989 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.979 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -161.04 68.84 2.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 O-C-N 123.69 0.619 . . . . 0.0 110.162 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.6 Cg_exo -58.48 -58.46 0.73 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.57 2.847 . . . . 0.0 111.264 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 71.0 t -54.32 -69.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.835 1.334 . . . . 0.0 110.165 -175.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.518 ' OG ' ' HB1' ' A' ' 25' ' ' ALA . 72.7 p -47.5 -54.92 10.24 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.727 1.267 . . . . 0.0 110.95 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.002 ' O ' ' HB3' ' A' ' 32' ' ' PHE . 11.6 t -55.81 -45.27 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.375 1.047 . . . . 0.0 110.283 -175.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 66.5 tp60 -45.02 -63.27 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.236 0.96 . . . . 0.0 109.646 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 1.04 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 m-80 -42.98 -48.13 5.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.61 1.194 . . . . 0.0 110.058 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 1.002 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 15.6 t80 -39.75 -69.46 0.13 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.527 1.142 . . . . 0.0 109.967 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' ND2' ' A' ' 37' ' ' ASN . 48.9 t -43.96 -39.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.722 1.264 . . . . 0.0 111.201 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 1.04 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 16.6 m-20 -44.04 -62.26 1.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.148 0.905 . . . . 0.0 109.914 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 38' ' ' SER . 98.1 m-85 -57.48 -56.23 24.6 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.877 1.361 . . . . 0.0 109.364 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.839 ' HA ' ' HE2' ' A' ' 41' ' ' TYR . 96.0 t -42.97 -63.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 124.555 1.159 . . . . 0.0 109.279 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.678 ' ND2' HG12 ' A' ' 33' ' ' VAL . 22.0 m-20 -48.23 -49.75 32.04 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.796 1.31 . . . . 0.0 110.069 176.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 56.4 m -56.08 -117.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.543 1.152 . . . . 0.0 111.03 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.53 76.28 0.1 Allowed Glycine 0 N--CA 1.473 1.151 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.662 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 17.5 t80 -110.67 -56.54 2.34 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.914 -173.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.839 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 58.3 m-85 -59.59 -40.23 86.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.063 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.7 p-10 -39.23 113.64 0.34 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.919 . . . . 0.0 111.449 -173.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.598 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 10.7 t30 58.03 35.76 25.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.313 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 45' ' ' THR . 72.8 p -79.45 -146.01 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.194 0.934 . . . . 0.0 108.684 163.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.98 HG22 ' HA ' ' A' ' 158' ' ' VAL . 72.7 p -163.6 -154.1 0.26 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.742 0.782 . . . . 0.0 112.268 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.874 ' HD1' ' O ' ' A' ' 45' ' ' THR . 6.0 m-30 -134.75 62.08 1.65 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.201 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.866 ' CE1' ' HG2' ' A' ' 48' ' ' ARG . 21.4 p-80 -53.62 -49.53 67.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.407 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.866 ' HG2' ' CE1' ' A' ' 47' ' ' HIS . 24.8 mmm180 -68.28 107.38 2.79 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.53 1.144 . . . . 0.0 109.325 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 46' ' ' PHE . 90.9 t -152.01 135.03 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 124.663 1.227 . . . . 0.0 110.308 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.093 HG21 ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -146.91 120.28 4.99 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.076 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' PHE . 85.5 Cg_exo -35.13 152.17 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.589 2.86 . . . . 0.0 113.439 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 1.67 63.91 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 CA-C-N 114.219 -1.355 . . . . 0.0 113.801 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.082 ' HB3' HD12 ' A' ' 50' ' ' ILE . 8.4 t80 -155.32 -42.93 0.08 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.783 0.931 . . . . 0.0 110.897 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.093 ' HE2' HG21 ' A' ' 50' ' ' ILE . 22.3 ptt? 176.65 163.28 0.43 Allowed 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.897 0.748 . . . . 0.0 112.026 -176.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.031 HD11 ' HB1' ' A' ' 135' ' ' ALA . 46.5 pt -165.89 129.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.912 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 1.589 ' CB ' ' HA ' ' A' ' 104' ' ' PHE . 2.6 mm-40 -173.73 -166.09 0.29 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.721 164.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.45 -146.82 6.41 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.306 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.662 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 130.62 -58.83 0.7 Allowed Glycine 0 N--CA 1.475 1.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -45.17 -117.01 0.0 OUTLIER Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.635 0.844 . . . . 0.0 112.194 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.672 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 18.7 m-30 -39.88 128.44 2.11 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.724 0.897 . . . . 0.0 111.062 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.025 ' HB ' ' CE ' ' A' ' 67' ' ' LYS . 13.1 t -59.41 -39.4 83.32 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.686 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 1.081 ' OE2' ' HG2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 174.27 121.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.201 0.938 . . . . 0.0 109.427 -174.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 1.329 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.3 mm100 77.45 -61.36 0.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.665 1.228 . . . . 0.0 108.507 -173.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 1.329 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 146.63 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.595 1.184 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HG3' ' C ' ' A' ' 64' ' ' MET . 43.7 mt-30 -156.69 79.83 0.94 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 112.087 -2.324 . . . . 0.0 106.561 176.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' GLN . 65.1 mt-30 -25.16 133.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.095 -172.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 1.065 ' HE2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 mmpt? -63.71 -117.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.369 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 33.7 mmtp -156.77 74.02 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 CA-C-N 112.92 -1.946 . . . . 0.0 107.997 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 1.149 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 83.8 Cg_exo -48.4 -166.19 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.604 2.869 . . . . 0.0 113.654 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.149 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 80.9 m-20 -171.23 165.57 4.59 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.411 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.793 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 84.8 Cg_exo -39.09 91.31 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.543 2.829 . . . . 0.0 111.422 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.871 ' HG3' ' CG2' ' A' ' 100' ' ' THR . 82.4 Cg_exo -44.38 -150.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.655 2.903 . . . . 0.0 113.043 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.33 168.3 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 124.281 0.988 . . . . 0.0 111.606 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 26.8 mtpp -48.44 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 113.336 -1.756 . . . . 0.0 113.157 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.936 ' OD1' ' OD1' ' A' ' 78' ' ' ASP . 10.1 p30 -54.93 -149.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.864 -1.516 . . . . 0.0 111.245 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.284 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 173.11 -62.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.853 0.721 . . . . 0.0 109.696 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.664 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -36.8 -37.94 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.386 1.053 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.936 ' OD1' ' OD1' ' A' ' 75' ' ' ASN . 9.6 p-10 -68.8 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.13 0.894 . . . . 0.0 113.096 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 29.5 p30 -52.67 -101.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 161.06 -71.76 0.22 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.4 pt? -40.66 132.75 2.13 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.878 0.987 . . . . 0.0 111.984 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.858 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 98.3 mtt180 -66.55 168.33 9.37 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.805 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.895 ' HB3' HG21 ' A' ' 87' ' ' THR . 21.9 m120 -167.07 -170.47 1.53 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.581 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.801 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 15.5 m -168.26 159.39 10.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.343 -171.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.801 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 16.6 ptm180 -25.33 99.72 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.776 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 1.048 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 149.27 -24.59 1.24 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 111.346 -2.661 . . . . 0.0 110.261 -171.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.021 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.7 p -96.12 136.32 36.73 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.485 0.66 . . . . 0.0 112.049 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.135 HD12 ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -90.48 163.16 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.348 168.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.12 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -163.43 144.75 9.37 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.114 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.928 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 17.8 ttm -69.16 137.4 53.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.905 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.31 -100.71 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.531 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.252 ' O ' HG23 ' A' ' 93' ' ' THR . 17.1 ptm180 179.25 -139.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.902 0.751 . . . . 0.0 110.952 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.252 HG23 ' O ' ' A' ' 92' ' ' ARG . 22.5 p 145.82 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.678 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 44.05 -94.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.779 1.3 . . . . 0.0 110.462 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 96' ' ' LYS . 36.0 m-20 -49.53 127.46 15.54 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.196 0.935 . . . . 0.0 110.836 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -41.83 -103.85 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.645 175.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.842 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 63.0 m-20 -43.49 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.403 1.064 . . . . 0.0 109.764 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 72' ' ' PRO . 17.2 t -171.74 -113.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.588 1.18 . . . . 0.0 110.407 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.811 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . 43.74 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.226 0.954 . . . . 0.0 108.797 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.871 ' CG2' ' HG3' ' A' ' 72' ' ' PRO . 66.7 p -78.84 -44.85 22.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.342 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.9 p -170.19 92.29 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.344 1.027 . . . . 0.0 108.709 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.7 tt0 175.17 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 125.018 1.448 . . . . 0.0 109.575 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.847 ' O ' ' HB3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -146.74 -179.12 6.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.966 -177.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 1.589 ' HA ' ' CB ' ' A' ' 56' ' ' GLN . 11.7 p90 -157.32 170.54 22.24 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.346 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.013 HD11 HD21 ' A' ' 18' ' ' LEU . 85.2 mt -127.18 112.67 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 112.915 -1.948 . . . . 0.0 108.95 -170.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.817 ' OD1' ' O ' ' A' ' 87' ' ' THR . 36.0 p-10 -63.42 149.91 44.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.403 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.583 HG22 ' C ' ' A' ' 53' ' ' PHE . 31.4 m -136.3 23.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.801 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -163.91 136.24 5.0 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.763 0.664 . . . . 0.0 110.714 175.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -36.99 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.192 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 1.041 ' OD1' ' HB3' ' A' ' 113' ' ' LEU . 40.1 t30 -69.61 -95.51 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.93 1.394 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 65.08 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.176 0.922 . . . . 0.0 110.419 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.787 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 47.6 p90 -42.25 -39.87 2.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.296 0.998 . . . . 0.0 110.861 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.041 ' HB3' ' OD1' ' A' ' 110' ' ' ASN . 64.1 tp -58.68 -38.78 78.98 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.268 0.98 . . . . 0.0 110.504 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 111' ' ' ALA . 65.4 t0 -39.49 130.28 1.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.12 0.887 . . . . 0.0 111.681 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 1.025 ' ND1' ' O ' ' A' ' 120' ' ' PHE . 4.1 t60 -40.72 137.39 1.18 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.151 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.373 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.869 179.369 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 1.025 ' O ' ' ND1' ' A' ' 115' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.841 ' HA3' ' HB2' ' A' ' 115' ' ' HIS . . . 165.56 161.57 14.86 Favored Glycine 0 N--CA 1.479 1.536 0 O-C-N 123.862 0.726 . . . . 0.0 112.606 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.997 ' CE1' HD11 ' A' ' 113' ' ' LEU . 89.9 m-85 -78.83 137.11 37.54 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.043 -1.079 . . . . 0.0 110.599 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.284 ' HB1' ' OE1' ' A' ' 76' ' ' GLU . . . -56.1 -170.34 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.132 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 123' ' ' ALA . 70.3 t 178.51 144.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.352 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.887 ' HE2' HD23 ' A' ' 20' ' ' LEU . 2.5 p90 -170.42 25.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.625 ' C ' ' OE2' ' A' ' 19' ' ' GLU . . . -167.9 -139.85 2.78 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.652 1.14 . . . . 0.0 113.822 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.404 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 39.4 ttpt 179.62 -136.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 111.808 -2.196 . . . . 0.0 109.956 -172.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.091 ' N ' ' HG2' ' A' ' 127' ' ' LYS . 60.5 t -151.43 160.97 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.864 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 31.2 m -146.71 9.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.82 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 132' ' ' MET . 40.8 ttmt 173.1 -89.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.345 0.403 . . . . 0.0 111.86 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 16' ' ' ILE . . . -51.93 59.87 0.0 OUTLIER Glycine 0 N--CA 1.473 1.127 0 O-C-N 124.572 1.17 . . . . 0.0 114.75 -165.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.707 ' N ' ' O ' ' A' ' 130' ' ' LYS . 4.3 mmt -74.48 -49.73 21.06 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' LYS . 23.3 m-20 -39.72 -54.55 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.181 0.926 . . . . 0.0 109.986 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.621 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 75.0 t -52.24 -64.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.583 1.177 . . . . 0.0 109.249 175.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 1.031 ' HB1' HD11 ' A' ' 55' ' ' ILE . . . -43.78 -53.81 5.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.516 1.135 . . . . 0.0 110.258 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.868 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -58.71 -65.36 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.758 1.286 . . . . 0.0 108.636 179.155 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.998 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 2.9 tmtm? -36.86 -48.96 0.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.6 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.233 ' O ' HG22 ' A' ' 141' ' ' VAL . 12.8 mt -58.21 -56.97 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.612 1.195 . . . . 0.0 108.744 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.551 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.7 p -61.79 3.14 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.868 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.1 mp0 -94.78 -51.94 4.49 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.233 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -45.64 126.24 6.42 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.462 1.101 . . . . 0.0 110.283 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.7 Cg_exo -49.92 -178.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.679 2.919 . . . . 0.0 114.673 -176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.181 HG22 ' CA ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -161.07 -139.69 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.69 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.672 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER -178.02 140.66 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.5 -2.136 . . . . 0.0 112.336 168.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 1.072 ' OD1' ' HG3' ' A' ' 150' ' ' GLN . 56.1 t0 -68.74 110.92 4.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 112.383 -2.19 . . . . 0.0 107.791 168.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.879 HG21 ' CG2' ' A' ' 152' ' ' VAL . 2.0 t -78.98 -142.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.737 -169.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.653 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -63.57 -108.79 0.01 OUTLIER Glycine 0 N--CA 1.471 1.02 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 171.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 1.047 ' O ' ' OE1' ' A' ' 150' ' ' GLN . 97.1 Cg_endo -68.5 -50.17 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.593 2.862 . . . . 0.0 109.649 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.555 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 78.0 m-85 -68.68 84.45 0.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.612 1.195 . . . . 0.0 109.688 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 1.072 ' HG3' ' OD1' ' A' ' 145' ' ' ASP . 3.7 mp0 -70.97 66.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.756 175.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.56 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 50.7 p30 170.51 89.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.61 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.879 ' CG2' HG21 ' A' ' 146' ' ' VAL . 75.0 t -156.24 115.87 2.15 Favored Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 124.392 1.057 . . . . 0.0 109.646 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.181 ' CA ' HG22 ' A' ' 143' ' ' THR . 83.6 Cg_exo -43.97 114.7 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.643 2.895 . . . . 0.0 111.44 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 1.111 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 88.0 p -41.69 -36.88 1.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.438 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 1.157 ' HB2' ' CD ' ' A' ' 156' ' ' PRO . 30.3 mtpp -175.55 -71.31 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 124.134 0.896 . . . . 0.0 110.115 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.157 ' CD ' ' HB2' ' A' ' 155' ' ' LYS . 98.8 Cg_exo -51.25 72.28 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.702 2.934 . . . . 0.0 113.6 -171.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 1.128 HG23 ' O ' ' A' ' 156' ' ' PRO . 43.3 t -172.07 126.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.9 169.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.98 ' HA ' HG22 ' A' ' 45' ' ' THR . 76.7 t -168.87 118.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.014 HG12 HG22 ' A' ' 11' ' ' THR . 25.8 mt -68.1 132.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.766 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.841 HD12 HG22 ' A' ' 10' ' ' THR . 86.2 mt -81.2 -49.18 11.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.158 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -167.6 169.98 11.48 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.553 1.158 . . . . 0.0 111.992 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.8 ' O ' ' HG3' ' A' ' 163' ' ' LYS . . . -152.07 137.18 17.36 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.872 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 37.9 mtmm -170.3 136.23 1.35 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.084 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.575 ' CG1' HG11 ' A' ' 36' ' ' VAL . 33.1 m -69.49 175.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.783 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.629 ' C ' HD23 ' A' ' 165' ' ' LEU . 5.4 tt -143.63 119.94 6.51 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.707 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.591 ' N ' HD23 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 123.684 2.923 . . . . 0.0 112.135 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.323 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 61.4 Cg_endo . . . . . 0 C--O 1.236 0.376 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.323 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 22.1 m170 -150.55 101.96 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.342 -175.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.942 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 7.7 p -59.85 107.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 171.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.998 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 5.2 tt -118.73 113.48 21.23 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.764 1.29 . . . . 0.0 109.79 -170.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.86 ' HG ' ' HA ' ' A' ' 162' ' ' ALA . 5.1 mp -127.67 -166.31 1.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.684 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 86.4 m -162.05 102.67 1.13 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.117 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 1.093 HG22 HG12 ' A' ' 159' ' ' ILE . 28.4 p -74.37 166.08 24.09 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.834 1.334 . . . . 0.0 111.693 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.552 ' OG ' HG13 ' A' ' 157' ' ' VAL . 80.1 p -40.93 -46.07 2.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.512 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -51.97 -59.15 4.67 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.451 1.094 . . . . 0.0 110.274 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.22 45.99 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 112.931 -1.94 . . . . 0.0 113.149 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 1.193 ' O ' HG21 ' A' ' 134' ' ' VAL . 9.0 t-20 -52.31 162.28 0.54 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.69 -1.255 . . . . 0.0 111.448 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.865 HG13 ' O ' ' A' ' 15' ' ' ASN . 9.3 mt -170.16 153.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.116 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.998 ' OE1' ' CD1' ' A' ' 8' ' ' LEU . 33.5 mt-10 -163.22 110.15 1.18 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.833 -173.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.942 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 2.2 mm? -82.42 150.42 27.1 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.294 0.996 . . . . 0.0 109.804 164.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.496 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -111.43 123.63 50.6 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.298 0.999 . . . . 0.0 109.578 174.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.256 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 75.8 mt -104.59 -171.33 1.9 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.751 1.282 . . . . 0.0 112.74 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 1.256 ' OD1' ' O ' ' A' ' 20' ' ' LEU . 47.8 m-20 -164.08 68.04 0.17 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.204 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.435 ' HD2' ' N ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -47.33 -27.28 1.53 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.821 1.326 . . . . 0.0 113.036 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 1.435 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 36.0 tt0 -41.93 -63.99 0.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.941 0.776 . . . . 0.0 110.09 -174.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.963 ' HD3' ' HA ' ' A' ' 79' ' ' ASN . 25.3 ttmm -78.9 18.41 0.62 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.815 1.322 . . . . 0.0 112.742 -178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.067 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -161.98 69.98 2.29 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 1.01 ' O ' HG22 ' A' ' 29' ' ' VAL . 69.0 Cg_endo -71.39 -61.41 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.731 2.954 . . . . 0.0 110.124 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 28' ' ' SER . 16.0 m -48.12 -63.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 124.609 1.193 . . . . 0.0 110.152 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.743 ' H ' HG23 ' A' ' 27' ' ' VAL . 42.9 t -48.43 -59.54 3.39 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.508 1.13 . . . . 0.0 110.346 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.599 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 35.2 m -45.3 -49.13 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 124.579 1.175 . . . . 0.0 110.898 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 1.182 ' O ' HG12 ' A' ' 33' ' ' VAL . 61.7 tp60 -50.11 -56.81 9.4 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.31 1.006 . . . . 0.0 109.745 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.89 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 3.4 t30 -50.2 -62.19 1.72 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.567 1.167 . . . . 0.0 110.587 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 1.599 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 29.1 p90 -56.08 -43.92 78.49 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.266 0.979 . . . . 0.0 110.64 -172.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.182 HG12 ' O ' ' A' ' 30' ' ' GLN . 11.5 p -51.05 -40.06 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 124.046 0.841 . . . . 0.0 110.094 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.89 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 45.4 m-20 -45.39 -61.07 1.82 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.045 0.84 . . . . 0.0 109.252 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.84 ' HE2' HD21 ' A' ' 31' ' ' ASN . 68.9 m-85 -54.52 -55.85 24.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.908 1.38 . . . . 0.0 109.491 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.726 HG22 ' CE1' ' A' ' 41' ' ' TYR . 77.1 t -46.06 -66.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 124.436 1.085 . . . . 0.0 109.537 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -43.89 -49.82 8.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.84 1.338 . . . . 0.0 110.695 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.554 ' OG ' ' O ' ' A' ' 35' ' ' TYR . 29.7 p -58.64 -107.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.53 1.144 . . . . 0.0 110.161 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.64 59.64 0.28 Allowed Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' THR . 17.7 t80 -89.27 -63.58 1.27 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.958 1.034 . . . . 0.0 109.726 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.726 ' CE1' HG22 ' A' ' 36' ' ' VAL . 35.1 m-85 -75.53 -14.24 60.4 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.524 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 1.126 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 52.7 p-10 -39.08 -41.62 0.82 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.642 0.589 . . . . 0.0 112.517 -170.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 1.126 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 19.5 m-20 -154.78 46.8 0.55 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.161 0.913 . . . . 0.0 110.296 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 45' ' ' THR . 74.3 p -78.92 -139.64 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 166.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.954 ' HA ' HG13 ' A' ' 159' ' ' ILE . 76.5 p -163.46 -153.95 0.26 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.934 0.873 . . . . 0.0 112.595 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.881 ' CE1' HD11 ' A' ' 159' ' ' ILE . 17.0 m-30 -129.65 84.39 2.21 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.845 -1.979 . . . . 0.0 106.279 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.824 ' CE1' ' O ' ' A' ' 56' ' ' GLN . 36.8 p-80 -56.42 -65.57 0.58 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.3 -169.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.316 ' HD3' ' N ' ' A' ' 49' ' ' VAL . 1.2 tmt_? -164.67 160.71 20.24 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -162.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.56 ' CG1' ' HG3' ' A' ' 54' ' ' MET . 45.8 t -175.73 -77.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.045 -2.343 . . . . 0.0 106.914 164.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.919 HG22 HG12 ' A' ' 49' ' ' VAL . 11.2 tt 171.3 138.8 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.688 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.829 ' HD2' HG13 ' A' ' 50' ' ' ILE . 83.4 Cg_exo -35.04 164.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.333 -0.289 0 C-N-CA 123.507 2.805 . . . . 0.0 113.846 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.98 69.46 0.0 OUTLIER Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.876 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.176 ' CE1' ' OD1' ' A' ' 110' ' ' ASN . 9.8 t80 -160.99 -53.46 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.787 0.934 . . . . 0.0 109.843 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.56 ' HG3' ' CG1' ' A' ' 49' ' ' VAL . 24.1 ptt? -164.36 154.06 14.03 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.457 1.098 . . . . 0.0 111.912 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.772 HG13 ' HB ' ' A' ' 105' ' ' ILE . 48.4 pt -160.21 124.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.73 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 1.105 ' HG2' ' CA ' ' A' ' 104' ' ' PHE . 33.2 mt-30 -120.36 128.72 53.5 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.385 1.053 . . . . 0.0 110.334 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.0 -162.6 32.11 Favored Glycine 0 N--CA 1.477 1.404 0 O-C-N 124.631 1.207 . . . . 0.0 112.803 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 1.007 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 44.45 96.65 0.01 OUTLIER Glycine 0 N--CA 1.47 0.915 0 CA-C-N 113.725 -1.238 . . . . 0.0 111.38 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.749 ' HA2' ' OE1' ' A' ' 102' ' ' GLN . . . 174.46 -121.79 0.86 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.705 0.885 . . . . 0.0 110.925 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -46.08 146.04 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.047 -1.077 . . . . 0.0 111.636 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.6 m -58.12 -43.06 87.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.908 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 1.051 ' HG3' ' N ' ' A' ' 63' ' ' GLN . 12.6 pt-20 -172.48 -100.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.248 0.968 . . . . 0.0 109.166 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 1.172 ' O ' ' CG ' ' A' ' 64' ' ' MET . 9.7 tp-100 -46.3 -57.55 4.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.673 1.233 . . . . 0.0 109.623 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 1.172 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 20.0 mmt 165.4 27.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.614 1.196 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -78.64 84.94 4.71 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.14 133.43 1.22 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 31.2 mmmt -64.13 -119.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.283 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' PRO . 24.8 ttmm -171.14 83.4 0.51 Allowed Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.73 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 1.025 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 89.2 Cg_exo -45.55 -155.59 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.631 2.887 . . . . 0.0 113.279 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.167 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.2 m120 -166.86 167.63 7.67 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.313 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.943 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 39.4 Cg_endo -49.07 87.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.845 2.363 . . . . 0.0 108.55 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.167 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 89.7 Cg_exo -48.29 -151.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.79 2.993 . . . . 0.0 113.789 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -155.27 149.1 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.369 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 94.1 mttt -32.39 133.6 0.11 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.394 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.61 167.63 5.54 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.832 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.951 ' OE2' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -168.16 155.35 7.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.032 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.814 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 177.59 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.191 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.844 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 42.0 p-10 -67.02 -48.28 68.83 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.983 0.802 . . . . 0.0 109.809 -176.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.963 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 19.0 p-10 40.21 -73.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.078 0.861 . . . . 0.0 111.541 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . 87.76 88.43 1.11 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 80' ' ' GLY . 85.9 mt -161.46 -158.3 0.56 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.113 -1.043 . . . . 0.0 109.893 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.752 ' N ' ' HD2' ' A' ' 82' ' ' ARG . 1.3 mpt_? -59.1 -165.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.253 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.781 ' OD1' ' HB2' ' A' ' 111' ' ' ALA . 1.7 t-20 168.3 100.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.151 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' GLY . 22.8 m -170.31 134.57 1.19 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.63 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 1.411 ' HB2' ' C ' ' A' ' 107' ' ' VAL . 4.0 ppt_? -38.51 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.672 1.225 . . . . 0.0 110.299 176.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 160.59 -22.9 0.25 Allowed Glycine 0 CA--C 1.534 1.226 0 CA-C-N 111.395 -2.639 . . . . 0.0 110.478 -170.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.079 ' HA ' ' CA ' ' A' ' 127' ' ' LYS . 40.5 p -98.94 148.74 23.66 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.63 0.729 . . . . 0.0 111.793 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.104 ' CD1' ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -96.54 159.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.342 168.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.083 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . . . -142.89 176.96 8.67 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.08 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.899 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.3 tpt -101.95 129.92 48.33 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.766 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.88 -144.51 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.857 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.222 ' HG2' ' N ' ' A' ' 93' ' ' THR . 37.8 ttm180 -177.65 -165.52 0.11 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.84 0.828 . . . . 0.0 111.852 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.222 ' N ' ' HG2' ' A' ' 92' ' ' ARG . 25.3 p 176.07 116.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 108.239 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.806 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -17.48 120.28 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.514 1.134 . . . . 0.0 112.906 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.817 ' OD2' ' O ' ' A' ' 97' ' ' ASP . 39.0 t70 142.18 139.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HB3' ' H ' ' A' ' 97' ' ' ASP . 53.0 tptt -42.89 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.431 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.817 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 38.2 m-20 -67.3 117.7 9.67 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.688 1.243 . . . . 0.0 108.5 168.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 24.8 t -151.48 170.65 19.1 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.57 1.169 . . . . 0.0 111.973 -173.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 98' ' ' SER . . . 84.76 136.24 0.05 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.729 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 100' ' ' THR . 35.5 m -155.74 2.3 0.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.453 1.095 . . . . 0.0 113.205 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.409 ' C ' ' HE1' ' A' ' 90' ' ' MET . 34.3 p -171.73 -76.34 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.562 0.539 . . . . 0.0 110.852 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 1.007 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 3.5 mp0 -38.25 154.57 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.006 0.816 . . . . 0.0 111.9 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.992 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -160.86 167.03 27.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.545 177.038 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 1.105 ' CA ' ' HG2' ' A' ' 56' ' ' GLN . 72.4 m-85 -84.23 151.24 24.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.638 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.845 HD11 HD21 ' A' ' 18' ' ' LEU . 22.9 mt -139.58 94.24 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.617 159.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.582 ' O ' ' HE1' ' A' ' 132' ' ' MET . 48.9 m-20 -69.22 -173.29 0.51 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.309 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.411 ' C ' ' HB2' ' A' ' 85' ' ' ARG . 35.9 m -158.27 -46.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.571 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.203 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -101.49 150.46 23.04 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 124.518 1.136 . . . . 0.0 110.915 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' N ' ' CG ' ' A' ' 85' ' ' ARG . 3.1 m-20 -37.59 138.18 0.37 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.174 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 1.176 ' OD1' ' CE1' ' A' ' 53' ' ' PHE . 64.9 m-80 -157.45 170.46 22.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.765 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB2' ' OD1' ' A' ' 83' ' ' ASN . . . 153.38 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.361 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -39.67 -55.51 1.87 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.152 0.907 . . . . 0.0 110.334 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.899 HD22 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -63.49 -8.86 10.43 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.837 1.336 . . . . 0.0 112.662 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.723 ' N ' HD12 ' A' ' 113' ' ' LEU . 57.6 p-10 -43.74 127.34 5.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.667 0.604 . . . . 0.0 111.657 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.765 ' CD2' ' HD1' ' A' ' 120' ' ' PHE . 0.1 OUTLIER -34.27 126.92 0.45 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.309 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.549 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . . . . . . 0 N--CA 1.474 1.168 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.485 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.765 ' HD1' ' CD2' ' A' ' 115' ' ' HIS . 25.1 m-85 . . . . . 0 N--CA 1.476 0.833 0 CA-C-O 121.219 0.533 . . . . 0.0 112.065 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.33 -134.18 1.73 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.042 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.899 ' CD2' HD22 ' A' ' 113' ' ' LEU . 58.9 m-85 -79.55 118.17 21.15 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.443 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.038 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -57.36 -162.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.784 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.083 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 75.5 t 179.95 146.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.582 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.791 ' CE2' HD22 ' A' ' 20' ' ' LEU . 21.6 p90 -171.18 25.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 1.058 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -167.13 -139.55 2.69 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 122.645 1.136 . . . . 0.0 113.436 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.496 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 94.0 mttt 179.35 -135.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.822 -2.189 . . . . 0.0 109.727 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.771 HG22 ' CD1' ' A' ' 18' ' ' LEU . 91.7 t -160.29 152.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.5 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' ' 19' ' ' GLU . 33.1 m -137.11 -27.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.69 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -170.83 86.95 0.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . -166.92 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 124.763 1.289 . . . . 0.0 110.883 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.781 ' HE3' ' HA ' ' A' ' 107' ' ' VAL . 22.9 mmt -39.32 -38.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.216 0.597 . . . . 0.0 111.3 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -47.75 -59.21 3.46 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 1.193 HG21 ' O ' ' A' ' 15' ' ' ASN . 46.6 t -58.74 -63.01 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 124.75 1.281 . . . . 0.0 108.949 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 132' ' ' MET . . . -41.28 -51.03 3.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.955 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.96 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 37.1 m-20 -50.79 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.6 1.187 . . . . 0.0 109.04 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -43.34 -45.7 6.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.463 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.201 ' O ' HG12 ' A' ' 141' ' ' VAL . 42.4 mt -57.01 -61.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.422 1.076 . . . . 0.0 108.871 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.9 p -65.31 2.44 0.85 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.96 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.1 mp0 -93.01 -49.52 5.98 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 124.232 0.958 . . . . 0.0 109.124 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.201 HG12 ' O ' ' A' ' 138' ' ' ILE . 8.6 p -39.7 135.36 1.25 Allowed Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 124.272 0.982 . . . . 0.0 111.043 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' A' ' 141' ' ' VAL . 79.9 Cg_exo -42.54 168.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.332 -0.328 0 C-N-CA 123.573 2.848 . . . . 0.0 113.658 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.545 HG22 ' CA ' ' A' ' 153' ' ' PRO . 5.9 p -160.84 -149.92 0.19 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 123.415 1.579 . . . . 0.0 112.313 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.749 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.8 OUTLIER 178.6 161.38 0.66 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 110.28 -3.145 . . . . 0.0 111.441 172.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.719 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 35.3 m-20 -50.33 -157.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.059 164.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -160.85 -143.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.11 -110.3 0.02 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 167.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.764 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 84.8 Cg_endo -70.69 -48.78 0.48 Allowed 'Trans proline' 0 C--N 1.333 -0.286 0 C-N-CA 123.662 2.908 . . . . 0.0 109.781 169.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.874 ' O ' HG23 ' A' ' 146' ' ' VAL . 93.7 m-85 -68.95 88.48 0.39 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.584 1.177 . . . . 0.0 110.722 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 16.0 pt20 -71.73 143.1 49.73 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.855 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 1.085 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 10.0 m120 84.33 90.12 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.548 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 146' ' ' VAL . 91.2 t -160.62 97.86 1.4 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.208 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.545 ' CA ' HG22 ' A' ' 143' ' ' THR . 88.6 Cg_exo -46.15 106.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 123.52 2.813 . . . . 0.0 110.891 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 1.092 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 65.8 p -41.35 -56.3 2.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.655 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.478 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 65.4 mttm -79.62 95.62 0.21 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.582 1.176 . . . . 0.0 108.308 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.092 ' HD3' ' O ' ' A' ' 154' ' ' SER . 61.6 Cg_endo -77.01 132.3 12.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.771 2.981 . . . . 0.0 112.246 -171.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.552 HG13 ' OG ' ' A' ' 12' ' ' SER . 47.7 t -69.32 162.72 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.723 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.924 ' HA ' HG22 ' A' ' 45' ' ' THR . 86.5 t -147.28 120.12 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.108 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.093 HG12 HG22 ' A' ' 11' ' ' THR . 34.9 mt -68.84 134.61 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.258 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 10' ' ' THR . 87.5 mt -85.72 -49.76 7.71 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 110.182 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 9' ' ' LEU . 69.2 m -146.82 178.82 8.03 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.67 1.231 . . . . 0.0 111.974 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.86 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . . . -178.7 122.94 0.09 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.364 -175.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.602 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -171.09 152.9 3.58 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.254 173.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.02 141.67 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.732 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 166' ' ' PRO . 5.5 tt -57.82 126.07 75.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.16 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.698 ' N ' HD23 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.607 2.872 . . . . 0.0 112.179 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.483 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 83.4 Cg_endo . . . . . 0 CA--C 1.531 0.374 0 N-CA-C 110.096 -0.771 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.483 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.4 m170 -154.5 88.49 1.21 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.21 0.944 . . . . 0.0 110.066 -176.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 7' ' ' VAL . 25.5 t -67.78 81.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 167.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.061 ' HG ' ' HG2' ' A' ' 17' ' ' GLU . 7.5 tt -80.38 108.92 14.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.356 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.358 HD23 ' O ' ' A' ' 161' ' ' SER . 7.3 mt -109.51 174.44 5.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 112.737 -2.029 . . . . 0.0 112.532 -173.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.895 HG22 HD12 ' A' ' 160' ' ' LEU . 94.9 m -159.91 95.11 1.16 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.078 -2.328 . . . . 0.0 108.447 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 1.022 HG22 HG12 ' A' ' 159' ' ' ILE . 19.8 p -84.53 161.2 20.31 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.997 1.436 . . . . 0.0 111.217 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 81.7 p -39.09 -43.59 1.05 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.861 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.774 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -52.84 -63.84 1.01 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.42 1.075 . . . . 0.0 110.105 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.49 171.18 43.87 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.089 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.853 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 2.1 t-20 -68.32 133.31 48.55 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.309 -1.445 . . . . 0.0 110.719 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.666 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 16.5 pt -143.73 -179.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.922 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 1.061 ' HG2' ' HG ' ' A' ' 8' ' ' LEU . 35.9 mt-10 -161.62 110.89 1.55 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.799 -169.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.082 HD21 HD11 ' A' ' 105' ' ' ILE . 3.1 mm? -77.36 150.65 35.11 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 124.541 1.15 . . . . 0.0 110.106 165.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.795 ' HG3' ' HB3' ' A' ' 127' ' ' LYS . 12.6 pt-20 -122.84 121.49 36.37 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.909 174.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.018 HD13 ' HE2' ' A' ' 125' ' ' PHE . 61.3 mt -104.19 173.55 6.25 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.803 1.315 . . . . 0.0 112.66 -169.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 125' ' ' PHE . 73.2 m-20 -128.83 104.5 7.65 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.569 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -76.26 -39.54 54.11 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.831 1.332 . . . . 0.0 112.055 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.889 ' HG3' ' HD2' ' A' ' 24' ' ' LYS . 8.1 tp-100 -45.08 -66.85 0.34 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.211 0.945 . . . . 0.0 110.275 -171.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.889 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -83.55 19.48 1.59 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.817 1.323 . . . . 0.0 113.804 -175.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.012 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -160.59 64.97 2.21 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 123.904 0.752 . . . . 0.0 111.134 173.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.8 Cg_exo -59.91 -58.72 0.51 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.517 2.811 . . . . 0.0 111.071 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.551 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 80.7 t -53.9 -69.86 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.157 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.436 ' OG ' ' HB1' ' A' ' 25' ' ' ALA . 75.2 p -48.05 -53.92 14.77 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.704 1.252 . . . . 0.0 111.023 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 25' ' ' ALA . 3.5 t -60.45 -41.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.318 1.012 . . . . 0.0 110.625 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 1.31 ' O ' HG12 ' A' ' 33' ' ' VAL . 7.3 tm0? -49.87 -62.43 1.57 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.111 0.882 . . . . 0.0 108.923 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 1.039 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 m-80 -44.25 -52.48 7.45 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.585 1.178 . . . . 0.0 110.274 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.879 ' CD2' ' HA ' ' A' ' 29' ' ' VAL . 20.8 m-30 -41.51 -67.3 0.26 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.456 1.098 . . . . 0.0 109.806 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.31 HG12 ' O ' ' A' ' 30' ' ' GLN . 7.2 p -40.5 -40.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 124.782 1.301 . . . . 0.0 111.118 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 1.039 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 8.0 m-20 -44.96 -61.94 1.42 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.028 0.83 . . . . 0.0 109.445 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -55.53 -53.36 57.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.813 1.321 . . . . 0.0 109.317 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.629 HG11 HG13 ' A' ' 164' ' ' VAL . 76.3 t -45.15 -65.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.556 1.16 . . . . 0.0 109.464 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' SER . 22.1 m-20 -48.32 -48.63 36.01 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.803 1.314 . . . . 0.0 110.227 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 37' ' ' ASN . 54.5 m -52.98 -113.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.463 1.102 . . . . 0.0 110.913 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.1 78.05 0.08 OUTLIER Glycine 0 N--CA 1.473 1.141 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 74.4 t80 -116.22 -63.86 1.39 Allowed 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.196 1.174 . . . . 0.0 109.358 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.985 ' O ' HG23 ' A' ' 44' ' ' THR . 51.6 m-85 -59.73 -41.77 91.63 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.715 1.259 . . . . 0.0 111.605 -172.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.584 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.0 p30 -39.32 117.18 0.68 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.19 0.931 . . . . 0.0 111.333 -173.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.7 t30 60.02 35.22 21.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.011 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.985 HG23 ' O ' ' A' ' 41' ' ' TYR . 69.9 p -79.2 -143.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.159 0.912 . . . . 0.0 108.848 165.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.944 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 55.3 p -163.21 -144.0 0.08 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.822 0.82 . . . . 0.0 112.725 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.944 ' CD1' ' O ' ' A' ' 45' ' ' THR . 8.2 m-30 -154.68 67.1 0.69 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.016 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.718 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 6.3 p-80 -59.06 -65.04 0.73 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.855 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.894 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 25.3 tpt180 -69.29 119.02 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.583 1.177 . . . . 0.0 110.656 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.542 HG13 HG22 ' A' ' 55' ' ' ILE . 84.6 t -154.93 147.55 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 124.805 1.316 . . . . 0.0 110.834 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.594 ' CG2' ' CG ' ' A' ' 54' ' ' MET . 11.0 tt -157.95 125.58 2.74 Favored Pre-proline 0 N--CA 1.476 0.857 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.955 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 76.0 Cg_exo -34.22 161.78 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.67 2.913 . . . . 0.0 113.958 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -8.85 71.07 0.0 OUTLIER Glycine 0 N--CA 1.475 1.252 0 CA-C-N 114.049 -1.432 . . . . 0.0 113.548 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.112 ' HD1' ' HG2' ' A' ' 54' ' ' MET . 56.5 t80 -160.61 -58.97 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.856 0.974 . . . . 0.0 109.552 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.112 ' HG2' ' HD1' ' A' ' 53' ' ' PHE . 26.3 ptt? -169.22 159.64 9.08 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.299 0.999 . . . . 0.0 112.371 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 105' ' ' ILE . 41.7 pt -154.7 156.58 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 113.171 -1.831 . . . . 0.0 109.203 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.991 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 11.5 mt-30 -150.57 164.83 35.05 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.876 0.735 . . . . 0.0 112.142 -166.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.67 ' O ' ' CD1' ' A' ' 103' ' ' PHE . . . -162.11 155.98 27.43 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 124.06 0.85 . . . . 0.0 112.959 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.513 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 136.63 -57.29 0.67 Allowed Glycine 0 N--CA 1.475 1.271 0 CA-C-N 113.426 -1.387 . . . . 0.0 110.331 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -51.62 -125.16 0.01 OUTLIER Glycine 0 N--CA 1.471 1.033 0 O-C-N 124.593 0.819 . . . . 0.0 113.21 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -39.5 148.01 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.441 -172.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 62' ' ' GLU . 94.0 m -59.94 -92.47 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.463 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.678 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.3 pt-20 -138.85 117.04 11.81 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 124.895 1.372 . . . . 0.0 108.882 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 1.291 ' O ' ' CG ' ' A' ' 64' ' ' MET . 67.2 tt0 76.91 -56.75 0.54 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.629 1.206 . . . . 0.0 108.8 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 1.291 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 155.82 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.046 1.403 . . . . 0.0 109.163 175.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.775 ' O ' ' O ' ' A' ' 66' ' ' GLN . 29.1 mm100 -142.87 82.21 1.76 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 110.908 -2.86 . . . . 0.0 104.965 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.825 ' C ' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -27.54 174.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -165.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HB3' ' H ' ' A' ' 68' ' ' LYS . 7.0 mtpm? -68.62 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 111.0 -2.818 . . . . 0.0 113.617 -169.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 67' ' ' LYS . 28.0 tptp 179.11 73.75 0.14 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 112.325 -2.216 . . . . 0.0 105.758 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.606 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 62.5 Cg_endo -83.37 -165.02 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 123.351 2.701 . . . . 0.0 113.746 -162.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.998 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 8.6 m120 -163.34 169.89 8.06 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 113.126 -1.852 . . . . 0.0 110.029 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 35.1 Cg_endo -50.74 95.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.12 2.547 . . . . 0.0 109.818 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.997 ' HG3' HG22 ' A' ' 100' ' ' THR . 82.4 Cg_exo -51.86 -146.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.908 3.072 . . . . 0.0 113.46 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.558 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.05 152.83 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 124.296 0.997 . . . . 0.0 110.981 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 61.3 mttp -37.66 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.181 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.748 ' O ' ' HB3' ' A' ' 76' ' ' GLU . 56.0 p30 -64.02 -168.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.19 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.874 ' HB2' HD21 ' A' ' 79' ' ' ASN . 0.0 OUTLIER 160.43 141.17 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.383 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.004 ' HB1' ' CD2' ' A' ' 115' ' ' HIS . . . -157.6 -51.24 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.242 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -68.28 -49.43 60.55 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.473 1.108 . . . . 0.0 110.372 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.874 HD21 ' HB2' ' A' ' 76' ' ' GLU . 45.1 p30 -43.02 -43.38 4.23 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.22 0.95 . . . . 0.0 110.103 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.672 ' N ' ' OD1' ' A' ' 79' ' ' ASN . . . -42.85 -33.32 1.61 Allowed Glycine 0 N--CA 1.471 1.029 0 O-C-N 124.411 1.069 . . . . 0.0 112.131 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 66.1 mt 98.39 -131.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 1.018 ' O ' ' NE ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -169.0 110.12 0.49 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.977 0.798 . . . . 0.0 109.673 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.734 ' HB2' HG21 ' A' ' 87' ' ' THR . 2.0 m-20 -132.74 -134.16 0.18 Allowed 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.963 1.414 . . . . 0.0 109.865 -176.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' OD1' ' A' ' 109' ' ' ASP . 10.2 m -169.6 163.77 10.21 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.822 0.82 . . . . 0.0 111.734 -167.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.937 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 58.2 ttt180 -18.67 103.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.199 165.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.946 ' O ' ' CG ' ' A' ' 127' ' ' LYS . . . 140.35 -23.19 2.7 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.256 -2.702 . . . . 0.0 110.581 -169.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.034 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.7 p -98.28 146.98 25.11 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.023 0.916 . . . . 0.0 112.94 -175.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.67 161.94 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.972 164.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.027 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -159.78 156.66 27.95 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.558 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 1.217 ' CE ' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -74.4 123.74 25.23 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.752 -176.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.588 ' N ' ' SD ' ' A' ' 90' ' ' MET . . . -57.75 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.089 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.824 ' NH1' ' O ' ' A' ' 93' ' ' THR . 68.0 ttp85 179.71 -104.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.743 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.824 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 97.3 m 100.71 -98.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.638 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.475 ' N ' HG22 ' A' ' 93' ' ' THR . . . -61.95 -132.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.58 1.175 . . . . 0.0 110.93 -174.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 35.2 m-20 -58.24 172.12 0.49 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -56.16 -111.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.723 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.642 ' OD1' ' CG ' ' A' ' 75' ' ' ASN . 35.2 m-20 -52.4 103.57 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.776 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.836 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 68.4 m -165.76 -34.75 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.467 1.104 . . . . 0.0 111.619 -175.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 1.217 ' HB1' ' CE ' ' A' ' 90' ' ' MET . . . -33.58 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.846 0.716 . . . . 0.0 110.701 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.997 HG22 ' HG3' ' A' ' 72' ' ' PRO . 48.8 p -78.87 -60.4 2.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.182 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.7 p -171.57 97.57 0.18 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.251 0.97 . . . . 0.0 109.274 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.914 ' OE1' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER 171.23 134.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.727 1.267 . . . . 0.0 109.109 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.927 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -140.24 -171.29 3.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.458 -177.041 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.991 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 43.6 p90 -155.93 129.06 8.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.47 -172.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.082 HD11 HD21 ' A' ' 18' ' ' LEU . 57.8 mt -93.27 111.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.515 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 104' ' ' PHE . 50.9 m-20 -65.38 155.26 35.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.398 1.061 . . . . 0.0 110.766 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 54' ' ' MET . 22.4 m -146.92 38.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.11 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 178.95 122.93 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.142 0.901 . . . . 0.0 110.067 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.937 ' OD1' ' HB3' ' A' ' 85' ' ' ARG . 34.0 m-20 -37.17 137.11 0.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.14 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -150.8 108.79 3.71 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.65 1.218 . . . . 0.0 110.097 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . -90.92 -49.96 6.14 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.893 170.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 1.251 ' O ' HD12 ' A' ' 113' ' ' LEU . 30.6 p90 -49.35 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.469 1.106 . . . . 0.0 109.235 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.251 HD12 ' O ' ' A' ' 112' ' ' PHE . 3.1 mp 179.28 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.641 -2.072 . . . . 0.0 108.519 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.67 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 6.6 m-20 -38.92 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.856 0.723 . . . . 0.0 110.657 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 1.054 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 44.5 m-70 -46.92 122.27 4.23 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.901 1.375 . . . . 0.0 110.182 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.455 0 O-C-N 124.524 1.14 . . . . 0.0 112.182 -177.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.11 -131.34 1.31 Allowed Glycine 0 N--CA 1.476 1.318 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 1.054 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 89.9 m-85 -79.45 133.86 36.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.422 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.076 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -69.55 -161.65 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.519 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.076 HG23 ' O ' ' A' ' 123' ' ' ALA . 54.9 t 178.8 144.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.753 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 1.018 ' HE2' HD13 ' A' ' 20' ' ' LEU . 30.3 p90 -168.74 26.16 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.749 ' HA3' HD23 ' A' ' 20' ' ' LEU . . . -167.17 -143.98 3.96 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 122.87 1.261 . . . . 0.0 113.906 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 1.034 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 40.4 ttmt 179.76 -139.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 111.51 -2.345 . . . . 0.0 109.656 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.988 ' H ' ' CG ' ' A' ' 127' ' ' LYS . 95.8 t -159.78 117.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.952 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.846 ' O ' ' HG3' ' A' ' 130' ' ' LYS . 35.2 m -73.75 -40.99 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.739 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.846 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 8.4 mtpm? -166.19 -156.2 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.261 0.976 . . . . 0.0 111.379 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 134' ' ' VAL . . . 49.75 18.36 1.77 Allowed Glycine 0 N--CA 1.473 1.154 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.539 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 10.4 tpt -55.03 -48.04 73.95 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.72 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 2.2 m-20 -43.29 -56.07 3.7 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.437 1.085 . . . . 0.0 110.018 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.627 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.1 t -39.7 -59.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.49 1.118 . . . . 0.0 109.671 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -45.5 -52.22 10.63 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.655 1.222 . . . . 0.0 109.529 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.929 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 1.8 m-20 -50.51 -65.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.553 1.158 . . . . 0.0 109.042 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 14.5 mmmm -35.46 -55.02 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.498 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.157 ' O ' HG22 ' A' ' 141' ' ' VAL . 13.8 mt -56.95 -56.81 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.868 1.355 . . . . 0.0 109.169 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -64.23 3.25 0.46 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.929 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.9 mp0 -97.24 -51.47 4.18 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.213 0.946 . . . . 0.0 108.717 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 1.157 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -45.78 125.83 6.6 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.436 1.085 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -44.6 177.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 123.637 2.891 . . . . 0.0 114.022 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.426 HG22 ' CA ' ' A' ' 153' ' ' PRO . 1.5 p -161.23 -140.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.127 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' ASP . 0.7 OUTLIER 179.65 164.49 1.06 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 110.485 -3.052 . . . . 0.0 111.017 169.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.816 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 34.7 m-20 -50.42 -143.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.652 168.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -161.68 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 168.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.55 -94.65 0.05 OUTLIER Glycine 0 N--CA 1.47 0.964 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 168.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.704 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 97.5 Cg_endo -76.83 -65.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.917 3.078 . . . . 0.0 109.603 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.971 ' O ' HG23 ' A' ' 146' ' ' VAL . 39.3 m-85 -69.83 124.73 24.75 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.564 1.165 . . . . 0.0 111.695 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.816 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 49.5 mm-40 -75.75 -171.84 1.71 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.744 169.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 152' ' ' VAL . 20.6 m-20 44.89 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.615 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.824 ' HB ' HG22 ' A' ' 146' ' ' VAL . 83.7 t -159.16 128.74 3.26 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 113.164 -1.835 . . . . 0.0 107.726 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 1.426 ' CA ' HG22 ' A' ' 143' ' ' THR . 96.5 Cg_exo -39.25 -145.71 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.308 2.672 . . . . 0.0 112.508 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 45.7 t -163.86 -8.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.373 1.046 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 1.107 ' HB3' ' HD3' ' A' ' 156' ' ' PRO . 87.8 tttt 178.91 -67.36 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.534 0.521 . . . . 0.0 111.667 175.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.164 ' O ' HG23 ' A' ' 157' ' ' VAL . 56.7 Cg_endo -75.04 76.84 3.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 111.672 -168.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 1.164 HG23 ' O ' ' A' ' 156' ' ' PRO . 42.8 t -172.52 127.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.679 168.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 45' ' ' THR . 81.2 t -167.29 118.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.068 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.022 HG12 HG22 ' A' ' 11' ' ' THR . 34.2 mt -68.29 133.89 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.881 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.895 HD12 HG22 ' A' ' 10' ' ' THR . 84.4 mt -87.23 -48.32 8.12 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.375 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 1.358 ' O ' HD23 ' A' ' 9' ' ' LEU . 32.4 t -167.89 162.68 13.68 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.395 1.059 . . . . 0.0 113.128 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 1.042 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -152.75 118.08 5.24 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.835 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 163' ' ' LYS . 19.7 ptpt -151.13 135.2 16.68 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.629 HG13 HG11 ' A' ' 36' ' ' VAL . 33.8 m -68.71 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.992 HD12 ' HD2' ' A' ' 166' ' ' PRO . 48.7 tp -62.12 121.5 66.34 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.795 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.992 ' HD2' HD12 ' A' ' 165' ' ' LEU . 86.1 Cg_exo . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.573 2.848 . . . . 0.0 112.074 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 55.36 -96.08 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 124.8 1.312 . . . . 0.0 109.59 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.547 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . 173.13 99.07 0.12 Allowed Glycine 0 N--CA 1.473 1.142 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.547 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 67.8 m-20 -170.13 103.83 0.44 Allowed Pre-proline 0 N--CA 1.474 0.758 0 O-C-N 124.635 0.844 . . . . 0.0 109.335 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.296 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 88.8 Cg_exo -48.61 136.75 26.83 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.837 3.025 . . . . 0.0 113.483 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.455 ' CD2' ' HG2' ' A' ' 19' ' ' GLU . 37.3 m170 -147.8 114.23 5.95 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.093 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 164' ' ' VAL . 14.8 t -71.46 96.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.543 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.499 ' CD1' ' HG2' ' A' ' 17' ' ' GLU . 15.8 tp -79.09 131.14 36.15 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.772 1.295 . . . . 0.0 109.52 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.288 HD23 ' O ' ' A' ' 161' ' ' SER . 8.8 mt -141.43 131.41 24.56 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.507 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.935 HG22 HD12 ' A' ' 160' ' ' LEU . 99.5 m -116.39 94.95 4.84 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 111.633 -2.531 . . . . 0.0 108.206 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.958 HG22 HG12 ' A' ' 159' ' ' ILE . 22.4 p -81.12 165.25 21.76 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 125.116 1.51 . . . . 0.0 110.715 170.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -39.09 -42.34 0.91 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.62 -63.09 1.26 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.431 1.082 . . . . 0.0 110.427 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.37 172.24 44.66 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-N 113.262 -1.79 . . . . 0.0 113.285 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 1.2 t-20 -76.97 108.21 9.87 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.428 -1.386 . . . . 0.0 110.006 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 134' ' ' VAL . 13.5 pt -103.35 -169.74 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 124.826 1.329 . . . . 0.0 110.959 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.499 ' HG2' ' CD1' ' A' ' 8' ' ' LEU . 37.7 mt-10 -161.87 102.45 1.16 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.817 -173.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.058 HD21 HD11 ' A' ' 105' ' ' ILE . 2.7 mm? -73.41 160.74 31.32 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.344 1.027 . . . . 0.0 110.651 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.455 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -138.37 127.55 24.29 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.167 173.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.979 HD13 ' HE2' ' A' ' 125' ' ' PHE . 80.3 mt -122.01 143.57 49.41 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.805 1.316 . . . . 0.0 111.975 -168.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 73.2 m-20 -55.48 -126.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.977 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.907 ' HA ' HG11 ' A' ' 29' ' ' VAL . 38.2 ttmt 145.64 -59.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.029 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -55.1 -57.12 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.096 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.854 ' HG3' ' HB2' ' A' ' 79' ' ' ASN . 20.3 tptm -69.09 -4.97 19.27 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.593 1.183 . . . . 0.0 113.465 -172.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.713 ' HB2' ' ND2' ' A' ' 79' ' ' ASN . . . -161.18 70.62 2.61 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.67 0.606 . . . . 0.0 110.089 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 1.17 ' O ' HG22 ' A' ' 29' ' ' VAL . 63.6 Cg_exo -52.7 -54.17 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 111.504 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.13 -65.79 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 124.704 1.253 . . . . 0.0 110.21 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.4 p -47.2 -52.79 14.81 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.713 1.258 . . . . 0.0 110.886 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.608 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 32.7 m -47.44 -50.2 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.322 1.014 . . . . 0.0 110.653 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 1.039 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 58.2 tp60 -51.23 -52.48 44.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.336 1.023 . . . . 0.0 109.844 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.911 ' OD1' HG21 ' A' ' 73' ' ' ILE . 18.4 m120 -49.96 -66.05 0.46 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.579 1.175 . . . . 0.0 110.322 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 1.608 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 46.8 p90 -57.1 -46.18 82.78 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.448 1.092 . . . . 0.0 110.441 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.997 HG12 ' O ' ' A' ' 30' ' ' GLN . 12.0 p -49.33 -40.17 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.976 0.797 . . . . 0.0 110.406 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 1.039 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 2.1 m-20 -45.84 -61.51 1.7 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.097 0.873 . . . . 0.0 108.84 171.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.627 ' OH ' ' HG3' ' A' ' 71' ' ' PRO . 28.3 m-85 -58.35 -60.12 4.28 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.892 1.37 . . . . 0.0 109.302 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 32' ' ' PHE . 58.4 t -39.27 -52.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 124.589 1.18 . . . . 0.0 110.683 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 38' ' ' SER . 23.1 m120 -38.77 -33.55 0.11 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.765 1.291 . . . . 0.0 111.858 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.727 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.9 p 158.02 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.155 0.909 . . . . 0.0 112.672 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 69.01 79.37 0.28 Allowed Glycine 0 N--CA 1.471 0.984 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.737 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.92 ' O ' HG23 ' A' ' 44' ' ' THR . 15.3 t80 168.76 -75.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.711 0.889 . . . . 0.0 109.514 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' ' HD1' ' A' ' 40' ' ' PHE . 77.7 m-85 -66.69 -31.73 72.58 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.5 1.125 . . . . 0.0 112.411 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -38.72 -36.16 0.24 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.053 0.845 . . . . 0.0 112.977 -170.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.616 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 9.5 t30 -156.5 47.31 0.45 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.064 0.853 . . . . 0.0 110.748 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.92 HG23 ' O ' ' A' ' 40' ' ' PHE . 52.7 p -83.61 -140.56 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.266 161.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 1.119 HG22 ' HA ' ' A' ' 158' ' ' VAL . 46.4 p -163.1 -141.05 0.06 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.988 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.856 ' CE1' HD11 ' A' ' 159' ' ' ILE . 15.6 m-30 -146.11 92.28 2.17 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.25 -1.795 . . . . 0.0 106.384 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 1.257 ' HB2' ' OE1' ' A' ' 56' ' ' GLN . 21.3 m80 -23.31 -67.61 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.351 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.995 ' HB2' ' HA ' ' A' ' 152' ' ' VAL . 1.8 tpm_? -172.32 -142.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.764 1.29 . . . . 0.0 111.217 169.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.991 ' H ' ' HG3' ' A' ' 48' ' ' ARG . 6.2 p -172.08 135.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.274 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.953 HG21 ' HD2' ' A' ' 53' ' ' PHE . 10.9 tt -62.49 129.74 92.84 Favored Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 113.732 -1.576 . . . . 0.0 107.483 159.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 53' ' ' PHE . 20.5 Cg_endo -45.2 153.04 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.014 2.476 . . . . 0.0 112.079 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 7.26 60.18 0.01 OUTLIER Glycine 0 N--CA 1.474 1.206 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.729 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.953 ' HD2' HG21 ' A' ' 50' ' ' ILE . 65.2 t80 -152.66 -54.63 0.12 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.817 0.951 . . . . 0.0 110.737 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.9 ' O ' HG23 ' A' ' 49' ' ' VAL . 43.5 ttp -171.94 113.68 0.33 Allowed 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.088 0.867 . . . . 0.0 112.124 -169.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.953 HG13 ' HB ' ' A' ' 105' ' ' ILE . 26.7 pt -90.86 155.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.755 164.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 1.319 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 78.9 mt-30 -68.61 -121.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.382 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 1.136 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -152.67 -119.96 0.81 Allowed Glycine 0 N--CA 1.47 0.932 0 O-C-N 118.624 -2.548 . . . . 0.0 110.549 3.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 61.28 106.86 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE1' ' A' ' 47' ' ' HIS . . . -179.44 -122.8 0.79 Allowed Glycine 0 N--CA 1.475 1.296 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.092 ' HB3' ' CA ' ' A' ' 64' ' ' MET . 42.4 m-85 -45.57 113.75 0.65 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.58 0.812 . . . . 0.0 110.264 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 61' ' ' THR . 9.4 t -59.52 116.75 4.2 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.484 1.115 . . . . 0.0 110.565 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.769 ' HB3' ' OE1' ' A' ' 63' ' ' GLN . 44.9 mt-10 65.02 -118.87 0.4 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.748 1.28 . . . . 0.0 110.786 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.769 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 8.0 mp0 -41.67 -58.15 2.06 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.679 1.237 . . . . 0.0 109.363 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 1.092 ' CA ' ' HB3' ' A' ' 60' ' ' PHE . 16.9 ptm 138.63 94.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.704 1.253 . . . . 0.0 107.762 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.695 ' N ' ' HB3' ' A' ' 60' ' ' PHE . 8.8 mm-40 -159.19 105.83 1.74 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.901 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.705 HE21 ' HA ' ' A' ' 66' ' ' GLN . 1.2 mm-40 -29.28 133.39 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.807 -174.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.106 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -57.35 -97.73 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 113.767 -1.56 . . . . 0.0 107.684 168.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.639 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 4.3 ttmp? -167.85 66.92 0.79 Allowed Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.582 165.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 1.244 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 37.0 Cg_exo -69.18 -160.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.58 2.853 . . . . 0.0 113.333 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.244 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 2.1 p-10 102.44 38.04 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 113.377 -1.738 . . . . 0.0 115.607 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.511 ' HD2' ' CB ' ' A' ' 100' ' ' THR . 17.7 Cg_endo -95.3 80.25 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.831 3.021 . . . . 0.0 107.541 171.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.19 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 75.5 Cg_exo -66.97 110.63 1.99 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.544 2.163 . . . . 0.0 112.08 -163.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.911 HG21 ' OD1' ' A' ' 31' ' ' ASN . 18.9 pt -79.3 -123.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 124.638 1.211 . . . . 0.0 109.207 175.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.787 ' HD2' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -156.73 -151.72 0.34 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.964 0.79 . . . . 0.0 112.258 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.81 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . 51.7 p30 -39.74 145.41 0.14 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.624 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.031 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 1.8 mp0 -131.29 -92.68 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.768 1.292 . . . . 0.0 109.82 -173.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.891 ' HB3' ' CE1' ' A' ' 120' ' ' PHE . . . -38.13 -37.06 0.25 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.674 1.234 . . . . 0.0 112.384 -172.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.81 ' OD2' ' HB2' ' A' ' 75' ' ' ASN . 4.3 p30 -68.8 33.89 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.087 0.867 . . . . 0.0 112.44 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 1.031 ' OD1' ' O ' ' A' ' 76' ' ' GLU . 2.1 p-10 -172.74 82.86 0.05 Allowed 'General case' 0 N--CA 1.469 0.491 0 O-C-N 124.24 0.962 . . . . 0.0 108.766 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.812 ' C ' HD23 ' A' ' 81' ' ' LEU . . . -168.95 0.34 0.04 OUTLIER Glycine 0 N--CA 1.477 1.389 0 CA-C-N 114.711 -1.132 . . . . 0.0 113.48 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.495 HD12 ' NH1' ' A' ' 82' ' ' ARG . 1.5 pt? 31.12 172.84 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 1.495 ' NH1' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -60.0 158.1 11.58 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.929 -1.487 . . . . 0.0 113.032 -172.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.814 ' OD1' ' CG2' ' A' ' 87' ' ' THR . 1.0 OUTLIER 175.2 -146.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.464 170.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 1.456 HG21 ' NH1' ' A' ' 85' ' ' ARG . 15.8 m -170.34 162.95 8.66 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.51 0.506 . . . . 0.0 112.012 -167.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 1.456 ' NH1' HG21 ' A' ' 84' ' ' THR . 0.0 OUTLIER -34.15 100.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 122.956 1.36 . . . . 0.0 111.004 176.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 127' ' ' LYS . . . 156.6 -29.87 0.56 Allowed Glycine 0 CA--C 1.53 1.004 0 CA-C-N 110.894 -2.867 . . . . 0.0 109.471 -169.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.034 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 50.1 p -81.68 144.73 30.97 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.204 0.591 . . . . 0.0 112.071 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.061 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -95.09 159.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.296 165.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.14 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -161.55 144.34 12.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.52 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 1.009 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 41.7 mtp -75.46 144.06 42.29 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.152 -1.385 . . . . 0.0 112.246 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.7 -118.21 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.543 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.242 ' O ' HG23 ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.54 -132.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.714 0.634 . . . . 0.0 111.011 176.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.242 HG23 ' O ' ' A' ' 92' ' ' ARG . 19.8 p 171.46 152.2 0.06 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.461 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.72 0.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.545 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 1.412 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 56.7 m-20 -40.01 -71.71 0.08 Allowed 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.654 1.221 . . . . 0.0 110.765 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.412 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 8.5 mtpm? 149.1 -94.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.91 1.381 . . . . 0.0 108.341 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -62.56 104.87 0.56 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.827 1.329 . . . . 0.0 109.197 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.862 ' O ' HG12 ' A' ' 73' ' ' ILE . 31.0 t -169.52 -102.19 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.664 1.228 . . . . 0.0 109.793 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 43.8 76.42 0.08 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.364 1.04 . . . . 0.0 108.6 -173.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 1.511 ' CB ' ' HD2' ' A' ' 71' ' ' PRO . 81.1 p -78.26 -43.47 28.08 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.105 -171.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 80.0 p -170.76 98.34 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.2 0.937 . . . . 0.0 109.54 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.9 tt0 169.48 123.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.777 1.298 . . . . 0.0 109.887 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 1.061 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.09 175.18 9.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.455 177.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 1.319 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 29.1 p90 -154.23 136.43 14.81 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.96 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.155 ' N ' ' O ' ' A' ' 56' ' ' GLN . 60.6 mt -95.46 115.06 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.663 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 52.5 m-20 -74.11 -172.61 1.41 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.514 1.134 . . . . 0.0 111.149 173.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.21 HG12 ' CE ' ' A' ' 132' ' ' MET . 32.7 m -157.84 -44.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.456 174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.928 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -91.87 152.42 20.09 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.255 0.972 . . . . 0.0 112.038 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.835 ' OD1' ' HD2' ' A' ' 85' ' ' ARG . 39.1 m-20 -49.59 106.81 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.12 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.976 HD21 HD13 ' A' ' 113' ' ' LEU . 2.8 t-20 -99.3 -100.59 0.23 Allowed 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.832 1.333 . . . . 0.0 109.87 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.717 ' O ' ' CG ' ' A' ' 114' ' ' ASP . . . 75.29 -43.93 0.52 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.931 0.77 . . . . 0.0 110.935 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.595 ' HD2' HD22 ' A' ' 110' ' ' ASN . 39.8 m-85 -39.31 -50.69 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.285 0.991 . . . . 0.0 110.79 -176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.976 HD13 HD21 ' A' ' 110' ' ' ASN . 7.8 mp -58.41 -24.26 59.59 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.768 1.292 . . . . 0.0 111.492 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.717 ' CG ' ' O ' ' A' ' 111' ' ' ALA . 36.1 m-20 -39.17 101.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.757 0.661 . . . . 0.0 111.037 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -38.7 105.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.042 -1.435 . . . . 0.0 110.413 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 1.244 ' O ' ' HG2' ' A' ' 117' ' ' GLN . . . -179.5 66.16 0.07 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.244 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 90.5 mm-40 163.53 178.23 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.616 -0.792 . . . . 0.0 110.052 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -62.72 69.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.755 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 117' ' ' GLN . 17.9 p-10 179.0 164.07 0.85 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.72 1.263 . . . . 0.0 111.485 -177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.891 ' CE1' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER 170.77 119.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.175 -175.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.624 ' N ' ' HD1' ' A' ' 120' ' ' PHE . . . -156.24 -77.24 0.02 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 124.371 1.044 . . . . 0.0 112.032 -174.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.596 ' CD2' HD23 ' A' ' 113' ' ' LEU . 43.7 m-85 -77.24 120.51 22.39 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.245 0.615 . . . . 0.0 110.755 -167.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.14 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -70.62 -161.31 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.304 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.047 HG23 ' O ' ' A' ' 123' ' ' ALA . 76.1 t 177.57 141.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.173 -174.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.979 ' HE2' HD13 ' A' ' 20' ' ' LEU . 20.2 p90 -174.34 25.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 1.199 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -156.53 -149.19 5.3 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 122.866 1.259 . . . . 0.0 113.823 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.199 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 7.2 mtpm? -179.37 -154.98 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.635 -2.283 . . . . 0.0 110.586 -170.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.716 HG22 HD13 ' A' ' 18' ' ' LEU . 94.3 t -160.04 117.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.722 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.684 HG21 ' CE1' ' A' ' 6' ' ' HIS . 82.6 t -84.5 -75.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 114.042 -1.436 . . . . 0.0 110.448 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 132' ' ' MET . 59.6 tttp -96.18 -94.65 0.2 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.474 1.109 . . . . 0.0 112.338 -167.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 16' ' ' ILE . . . -60.58 51.81 0.03 OUTLIER Glycine 0 N--CA 1.475 1.238 0 CA-C-N 114.434 -1.257 . . . . 0.0 114.442 -165.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 1.21 ' CE ' HG12 ' A' ' 107' ' ' VAL . 12.1 tpt -60.7 -48.68 80.69 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.4 t0 -43.58 -57.99 2.87 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.425 1.078 . . . . 0.0 110.223 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 16' ' ' ILE . 54.5 t -39.57 -59.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.458 1.099 . . . . 0.0 109.501 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 55' ' ' ILE . . . -46.13 -52.22 12.56 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.795 1.31 . . . . 0.0 109.658 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 37.0 m-20 -50.78 -69.25 0.12 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 124.612 1.195 . . . . 0.0 109.553 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.741 ' CA ' ' HG2' ' A' ' 140' ' ' GLN . 8.2 ttpm? -41.29 -45.94 3.09 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.634 1.208 . . . . 0.0 110.395 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.877 ' O ' HG22 ' A' ' 141' ' ' VAL . 15.6 mt -53.8 -59.2 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.629 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 79.0 p -64.59 9.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.71 1.256 . . . . 0.0 113.838 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.741 ' HG2' ' CA ' ' A' ' 137' ' ' LYS . 39.6 mm-40 -96.06 -52.71 3.93 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.164 0.915 . . . . 0.0 109.432 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.9 m -49.59 123.69 14.55 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 124.505 1.128 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 82.6 Cg_exo -41.34 178.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.462 2.775 . . . . 0.0 113.553 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.139 HG22 ' CA ' ' A' ' 153' ' ' PRO . 4.2 p -161.31 -142.22 0.08 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 123.101 1.429 . . . . 0.0 112.137 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.818 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 179.33 145.37 0.17 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 110.691 -2.959 . . . . 0.0 111.941 173.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -63.38 121.67 14.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.102 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.842 HG22 ' HB ' ' A' ' 152' ' ' VAL . 1.5 t -78.09 -65.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.949 -168.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.64 -81.78 0.06 OUTLIER Glycine 0 N--CA 1.47 0.94 0 CA-C-N 111.736 -2.484 . . . . 0.0 107.998 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.692 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 73.6 Cg_endo -66.44 -73.48 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.523 2.816 . . . . 0.0 108.671 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.692 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 43.9 m-85 -76.98 102.73 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.616 1.197 . . . . 0.0 110.107 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 34.2 mt-30 -67.74 135.62 52.97 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.671 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.586 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 10.3 m120 83.04 96.51 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.995 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 63.0 t -154.07 127.03 4.11 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.876 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.139 ' CA ' HG22 ' A' ' 143' ' ' THR . 55.7 Cg_endo -61.45 102.73 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.554 2.836 . . . . 0.0 109.324 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 1.304 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 49.2 m -42.33 -58.62 2.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.027 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -82.31 88.46 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 O-C-N 124.832 1.332 . . . . 0.0 108.077 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.304 ' HD3' ' O ' ' A' ' 154' ' ' SER . 86.2 Cg_exo -61.65 141.36 90.76 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.531 2.821 . . . . 0.0 114.967 -166.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 158' ' ' VAL . 97.3 t -69.53 161.57 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.374 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 1.119 ' HA ' HG22 ' A' ' 45' ' ' THR . 99.1 t -147.45 118.99 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.144 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.958 HG12 HG22 ' A' ' 11' ' ' THR . 50.2 mt -69.35 143.5 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 113.602 -1.636 . . . . 0.0 111.705 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.935 HD12 HG22 ' A' ' 10' ' ' THR . 83.5 mt -95.44 -45.09 7.25 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 1.288 ' O ' HD23 ' A' ' 9' ' ' LEU . 25.7 t -169.08 165.78 11.11 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.093 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -149.95 109.25 3.96 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.222 -1.808 . . . . 0.0 107.524 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -131.18 111.51 12.0 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.438 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.713 HG11 HG11 ' A' ' 36' ' ' VAL . 34.0 m -76.53 135.02 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.78 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 165' ' ' LEU . 78.5 mt -97.41 134.36 22.72 Favored Pre-proline 0 N--CA 1.479 1.015 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.025 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 165' ' ' LEU . 84.0 Cg_exo . . . . . 0 C--O 1.251 1.129 0 C-N-CA 123.539 2.826 . . . . 0.0 112.139 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -47.62 114.48 0.9 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.401 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 1.191 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 179.97 96.42 0.1 Allowed Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.505 1.128 . . . . 0.0 110.694 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.191 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 85.3 m-20 -174.05 67.75 0.31 Allowed Pre-proline 0 N--CA 1.474 0.771 0 O-C-N 124.602 0.824 . . . . 0.0 109.208 173.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.126 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 52.8 Cg_exo -58.78 107.94 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.477 2.784 . . . . 0.0 111.658 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.69 ' O ' ' HA ' ' A' ' 164' ' ' VAL . 12.9 m170 -160.04 74.62 0.58 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.492 1.12 . . . . 0.0 108.685 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.863 HG13 HD13 ' A' ' 20' ' ' LEU . 18.7 m -61.07 100.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.185 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.182 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 37.5 mt -78.34 145.3 35.35 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.64 1.212 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.104 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 13.8 mt -149.15 162.49 39.88 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.027 -2.352 . . . . 0.0 110.41 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 1.292 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.2 m -160.59 78.1 0.62 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 112.123 -2.308 . . . . 0.0 108.523 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.979 HG22 HG12 ' A' ' 159' ' ' ILE . 35.7 p -70.78 168.63 16.28 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 125.182 1.551 . . . . 0.0 111.44 173.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.419 ' OG ' HG13 ' A' ' 157' ' ' VAL . 80.5 p -39.57 -44.02 1.39 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 113.349 -1.75 . . . . 0.0 110.578 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.807 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -57.75 -60.8 3.14 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.443 1.089 . . . . 0.0 110.365 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.03 -179.75 43.47 Favored Glycine 0 N--CA 1.478 1.456 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.222 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 1.104 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 9.7 t-20 -61.23 160.56 10.25 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.6 -1.3 . . . . 0.0 111.761 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 15' ' ' ASN . 10.4 pt -167.39 174.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.914 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.113 ' HG2' ' CD2' ' A' ' 8' ' ' LEU . 35.9 mt-10 -160.78 106.07 1.42 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.107 -169.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.159 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.7 mm? -87.35 105.88 17.56 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.64 1.212 . . . . 0.0 108.438 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.428 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -69.45 118.74 12.71 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.169 0.918 . . . . 0.0 108.77 174.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.159 ' CD1' ' O ' ' A' ' 18' ' ' LEU . 6.4 mp -108.37 137.45 46.31 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 124.918 1.386 . . . . 0.0 110.905 -172.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.797 ' OD1' ' HG2' ' A' ' 23' ' ' GLN . 52.6 t0 -56.61 -116.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.787 174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.844 ' HA ' HG11 ' A' ' 29' ' ' VAL . 60.7 tttm 135.5 -57.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.594 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.013 ' OE1' ' NZ ' ' A' ' 24' ' ' LYS . 3.8 pt20 -55.75 -49.07 74.09 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.736 1.272 . . . . 0.0 110.573 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 1.013 ' NZ ' ' OE1' ' A' ' 23' ' ' GLN . 47.0 mmtm -69.11 -16.18 63.6 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 124.338 1.024 . . . . 0.0 113.219 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.49 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.42 71.72 2.94 Favored Pre-proline 0 N--CA 1.475 0.814 0 O-C-N 123.836 0.71 . . . . 0.0 109.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 1.067 ' O ' HG22 ' A' ' 29' ' ' VAL . 78.0 Cg_exo -51.42 -55.65 3.79 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.735 2.957 . . . . 0.0 111.538 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.6 t -46.68 -62.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 124.678 1.236 . . . . 0.0 110.125 -177.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.9 p -44.06 -54.2 5.7 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.725 1.266 . . . . 0.0 110.441 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.067 HG22 ' O ' ' A' ' 26' ' ' PRO . 29.0 m -56.8 -47.02 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 124.317 1.011 . . . . 0.0 110.617 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.969 HE21 ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -44.92 -69.48 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.196 0.935 . . . . 0.0 109.632 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.928 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.6 m-80 -46.03 -50.43 15.05 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.594 1.184 . . . . 0.0 109.488 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.845 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 45.4 t80 -40.61 -66.01 0.36 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.685 1.241 . . . . 0.0 110.231 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.81 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.3 t -45.81 -39.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.583 1.177 . . . . 0.0 111.099 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.928 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 88.1 m-20 -44.07 -62.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.089 0.868 . . . . 0.0 109.504 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.73 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 34.1 m-85 -64.33 -55.84 18.53 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.159 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 32' ' ' PHE . 58.8 t -39.33 -48.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 O-C-N 124.735 1.272 . . . . 0.0 111.015 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.822 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.1 t-20 -38.43 -33.5 0.1 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.754 1.284 . . . . 0.0 111.844 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.822 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 93.6 p 145.75 176.96 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.225 0.953 . . . . 0.0 113.061 175.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.64 -43.03 3.1 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.883 ' O ' HG23 ' A' ' 44' ' ' THR . 1.4 t80 -71.12 -74.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.586 0.815 . . . . 0.0 109.513 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.667 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 16.5 m-30 -62.5 -28.23 69.7 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.552 1.158 . . . . 0.0 112.678 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.6 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 53.0 p-10 -38.76 -36.68 0.28 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.932 0.77 . . . . 0.0 112.569 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 2.1 t-20 -161.25 47.58 0.2 Allowed 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.055 0.847 . . . . 0.0 110.753 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 40' ' ' PHE . 42.9 p -79.46 -136.57 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 160.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 1.041 ' HA ' HG13 ' A' ' 159' ' ' ILE . 47.7 p -163.36 -142.45 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.998 0.904 . . . . 0.0 112.024 174.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.724 ' HZ ' HD13 ' A' ' 9' ' ' LEU . 52.7 m-85 -158.85 74.16 0.65 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.242 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.714 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 2.4 p-80 -42.7 -78.87 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.76 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.198 ' NH2' ' CA ' ' A' ' 51' ' ' PRO . 46.9 tpt85 -173.26 -150.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.433 1.111 . . . . 0.0 113.122 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.191 HG23 ' O ' ' A' ' 48' ' ' ARG . 48.1 t -175.83 -70.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.475 -2.148 . . . . 0.0 106.684 169.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.885 ' C ' ' NH2' ' A' ' 48' ' ' ARG . 59.2 mt -171.27 134.22 0.92 Allowed Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.502 -1.681 . . . . 0.0 108.585 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.198 ' CA ' ' NH2' ' A' ' 48' ' ' ARG . 80.1 Cg_exo -35.54 155.52 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.068 2.512 . . . . 0.0 112.706 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -1.35 66.51 0.0 OUTLIER Glycine 0 N--CA 1.476 1.332 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.706 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.0 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -156.33 -50.1 0.08 Allowed 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.856 0.974 . . . . 0.0 109.95 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.0 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 64.2 mtm -176.62 159.75 1.9 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.352 1.032 . . . . 0.0 111.409 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.0 HG12 ' O ' ' A' ' 105' ' ' ILE . 42.6 pt -153.68 165.31 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.815 -1.538 . . . . 0.0 110.108 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 1.195 ' CG ' ' HA ' ' A' ' 104' ' ' PHE . 33.5 mt-30 -164.49 136.55 4.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.146 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -120.93 -158.06 10.31 Favored Glycine 0 N--CA 1.479 1.537 0 O-C-N 124.828 1.33 . . . . 0.0 112.378 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 56.71 82.64 0.05 OUTLIER Glycine 0 N--CA 1.47 0.917 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.253 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.61 -118.47 0.63 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.651 0.853 . . . . 0.0 111.12 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -45.91 120.66 2.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.167 -1.017 . . . . 0.0 111.292 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.274 ' CG2' ' CD ' ' A' ' 67' ' ' LYS . 76.8 p -59.69 124.48 20.24 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.577 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 1.012 ' HG2' ' N ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 19.99 -108.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.827 -178.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 1.193 ' O ' ' CG ' ' A' ' 64' ' ' MET . 88.3 mt-30 -43.23 -58.17 2.64 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.671 1.232 . . . . 0.0 110.363 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 1.193 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 47.3 mtt 141.44 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.639 1.212 . . . . 0.0 107.893 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 64' ' ' MET . 32.6 mt-30 -159.59 78.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.513 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 65' ' ' GLN . 33.9 mt-30 -19.88 130.78 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.265 -173.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.274 ' CD ' ' CG2' ' A' ' 61' ' ' THR . 14.3 mmmm -62.17 -116.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.938 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.995 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -142.62 -62.7 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 CA-C-N 112.567 -2.106 . . . . 0.0 109.734 -174.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 68' ' ' LYS . 60.7 Cg_exo -28.34 136.06 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.066 2.511 . . . . 0.0 112.807 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.256 ' OD1' ' HD3' ' A' ' 71' ' ' PRO . 49.4 p-10 -168.69 -41.19 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.722 0 CA-C-O 116.881 -1.533 . . . . 0.0 114.416 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.256 ' HD3' ' OD1' ' A' ' 70' ' ' ASN . 59.7 Cg_endo -68.28 89.78 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.961 2.44 . . . . 0.0 108.406 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.246 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 84.6 Cg_exo -57.52 -155.69 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.637 2.892 . . . . 0.0 113.63 -172.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.846 ' CD1' ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -160.06 151.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.776 176.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.684 ' O ' ' O ' ' A' ' 75' ' ' ASN . 74.6 mmtt -19.73 136.79 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.563 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 1.353 HD22 ' NZ ' ' A' ' 96' ' ' LYS . 45.9 p-10 -39.92 -120.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.536 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.172 ' CG ' HD21 ' A' ' 79' ' ' ASN . 0.8 OUTLIER 102.58 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 124.101 0.876 . . . . 0.0 111.305 -178.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.881 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 172.8 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.667 -176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 1.249 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 42.5 p-10 -68.03 -48.13 66.52 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.574 1.171 . . . . 0.0 109.676 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 1.172 HD21 ' CG ' ' A' ' 76' ' ' GLU . 50.1 p-10 -58.28 77.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.229 0.956 . . . . 0.0 108.699 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . -174.22 40.73 0.13 Allowed Glycine 0 N--CA 1.474 1.222 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.105 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.601 HD22 ' N ' ' A' ' 81' ' ' LEU . 2.8 mm? 39.4 -132.29 0.22 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.333 0.666 . . . . 0.0 110.602 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 32.2 ptt-85 -174.04 131.56 0.4 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.021 0.826 . . . . 0.0 109.451 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.464 ' HB3' HG21 ' A' ' 87' ' ' THR . 1.2 t-20 -150.79 -122.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.585 1.178 . . . . 0.0 109.804 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.549 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 23.0 m -160.79 159.58 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.032 0.833 . . . . 0.0 111.79 -167.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.736 ' CB ' ' N ' ' A' ' 108' ' ' ALA . 39.1 ptt180 -36.06 103.42 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.669 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.821 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 153.89 -29.6 0.74 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 111.446 -2.615 . . . . 0.0 109.718 -170.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.869 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 35.8 p -76.46 131.45 39.05 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.685 0.755 . . . . 0.0 111.514 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.479 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -80.05 159.0 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 112.938 -1.937 . . . . 0.0 108.857 164.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.275 ' O ' ' HD1' ' A' ' 104' ' ' PHE . . . -164.11 128.01 2.64 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.63 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 1.186 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 96.5 mmm -51.27 123.13 8.91 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.783 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.687 ' HB2' ' NE2' ' A' ' 56' ' ' GLN . . . -66.52 -147.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.544 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.033 ' HG2' ' H ' ' A' ' 93' ' ' THR . 56.7 ttp180 179.5 -129.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.983 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.033 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 9.0 t 136.31 87.09 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.541 1.151 . . . . 0.0 109.963 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 61.1 -70.7 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.821 1.325 . . . . 0.0 109.732 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.1 m-20 -40.13 110.95 0.17 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.527 1.142 . . . . 0.0 110.624 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.353 ' NZ ' HD22 ' A' ' 75' ' ' ASN . 27.8 tptp -46.13 -112.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.735 1.272 . . . . 0.0 110.52 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 75' ' ' ASN . 36.0 m-20 -58.78 110.14 0.95 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.633 1.208 . . . . 0.0 109.258 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 1.242 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 70.6 m -166.53 -124.67 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 O-C-N 124.564 1.165 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.846 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 71.71 87.76 0.11 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.799 1.312 . . . . 0.0 108.162 -174.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.87 HG21 ' HA ' ' A' ' 70' ' ' ASN . 81.6 p -78.88 -34.82 44.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.801 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.544 ' HB2' ' HE2' ' A' ' 40' ' ' PHE . 78.9 p -169.87 -47.9 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.132 0.895 . . . . 0.0 110.363 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.473 ' HG2' ' CB ' ' A' ' 91' ' ' ALA . 14.2 tt0 -38.93 144.02 0.14 Allowed 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.19 0.931 . . . . 0.0 111.184 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 1.017 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -160.31 159.68 31.58 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.58 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 1.275 ' HD1' ' O ' ' A' ' 89' ' ' ALA . 24.5 m-85 -81.94 155.52 25.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.774 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.0 ' O ' HG12 ' A' ' 55' ' ' ILE . 37.8 mt -146.23 91.85 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 111.85 -2.432 . . . . 0.0 106.325 158.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.945 ' O ' ' HE1' ' A' ' 132' ' ' MET . 1.8 m-20 -71.24 171.73 10.56 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 112.545 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.627 HG12 ' CE ' ' A' ' 132' ' ' MET . 35.6 m -160.68 48.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 113.243 -1.798 . . . . 0.0 108.377 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.749 ' HB3' ' HD1' ' A' ' 53' ' ' PHE . . . 176.82 147.48 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.233 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.705 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.5 m-20 -36.13 77.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.724 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.718 ' HB2' HD22 ' A' ' 106' ' ' ASN . 3.2 t30 -69.65 134.51 48.81 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.861 1.35 . . . . 0.0 110.364 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.632 ' H ' ' CD1' ' A' ' 113' ' ' LEU . . . 164.16 -53.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.82 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE2' ' O ' ' A' ' 109' ' ' ASP . 34.5 p90 -67.64 47.89 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.581 1.176 . . . . 0.0 110.374 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER 177.59 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.229 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.81 ' H ' HD13 ' A' ' 113' ' ' LEU . 64.6 t0 -43.45 -56.42 3.62 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.015 0.822 . . . . 0.0 110.738 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 1.249 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 0.2 OUTLIER 179.74 111.96 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.697 1.248 . . . . 0.0 109.61 -176.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.757 ' O ' ' N ' ' A' ' 118' ' ' ARG . . . -177.44 -118.7 0.56 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.564 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.58 ' C ' ' HG3' ' A' ' 118' ' ' ARG . 29.6 mm100 38.95 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.495 0.762 . . . . 0.0 111.327 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.757 ' N ' ' O ' ' A' ' 116' ' ' GLY . 99.1 mtt180 -161.75 -106.71 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.553 1.158 . . . . 0.0 109.091 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -59.63 72.41 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.679 1.237 . . . . 0.0 109.759 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 115' ' ' HIS . 8.3 m-30 42.27 -150.77 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.627 1.204 . . . . 0.0 110.838 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.411 ' H ' ' HB3' ' A' ' 120' ' ' PHE . . . -171.25 -136.01 2.03 Favored Glycine 0 N--CA 1.476 1.305 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.86 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 81.7 m-85 -79.21 127.78 32.47 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.408 -0.896 . . . . 0.0 110.583 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.186 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -53.89 -166.15 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.324 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 123' ' ' ALA . 60.3 t -179.69 134.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.585 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.951 ' CD1' ' HG2' ' A' ' 90' ' ' MET . 13.9 p90 -168.82 28.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.132 0.895 . . . . 0.0 111.07 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 1.479 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -147.11 176.53 25.93 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 123.321 1.511 . . . . 0.0 113.11 -173.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.428 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 8.2 ttpm? 177.81 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 110.77 -2.715 . . . . 0.0 109.989 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 86' ' ' GLY . 66.9 t -60.39 128.38 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.879 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 34.5 m -95.33 -42.18 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.699 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.476 ' N ' HG23 ' A' ' 129' ' ' VAL . 8.2 ttpm? 179.98 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.154 0.909 . . . . 0.0 109.697 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 16' ' ' ILE . . . 174.52 12.45 0.02 OUTLIER Glycine 0 N--CA 1.477 1.384 0 O-C-N 124.768 1.292 . . . . 0.0 112.993 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 1.627 ' CE ' HG12 ' A' ' 107' ' ' VAL . 11.5 tpt -54.99 -50.83 68.02 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 64.7 t0 -40.84 -55.62 2.41 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.449 1.093 . . . . 0.0 110.262 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.888 HG21 ' O ' ' A' ' 15' ' ' ASN . 54.8 t -41.7 -63.23 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 124.464 1.103 . . . . 0.0 109.438 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.546 ' O ' ' HB ' ' A' ' 138' ' ' ILE . . . -49.79 -50.19 45.76 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.729 1.268 . . . . 0.0 109.635 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.675 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 37.8 m-20 -51.43 -69.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.513 1.133 . . . . 0.0 109.228 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.989 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 5.9 tmtt? -38.11 -48.91 1.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.744 1.278 . . . . 0.0 110.386 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.008 ' O ' HG22 ' A' ' 141' ' ' VAL . 32.6 mt -54.06 -59.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 124.606 1.192 . . . . 0.0 108.309 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.1 p -65.76 8.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.763 1.29 . . . . 0.0 113.86 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.675 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 41.2 mm-40 -97.12 -51.92 4.03 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.212 0.945 . . . . 0.0 109.096 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.008 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -48.39 132.52 13.18 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.584 1.177 . . . . 0.0 110.258 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -39.13 -178.02 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.395 2.73 . . . . 0.0 113.534 176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.285 HG22 ' CA ' ' A' ' 153' ' ' PRO . 7.4 p -161.15 -151.78 0.24 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 123.2 1.476 . . . . 0.0 112.532 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.703 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 178.12 146.32 0.14 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.21 170.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.599 ' HB3' ' HG2' ' A' ' 150' ' ' GLN . 39.0 m-20 -67.59 114.13 5.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.68 167.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.957 ' HB ' ' O ' ' A' ' 149' ' ' TYR . 1.5 t -77.32 -159.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 124.474 1.109 . . . . 0.0 110.916 -166.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.826 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -60.6 -115.46 0.01 OUTLIER Glycine 0 N--CA 1.471 1.015 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 171.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.926 ' O ' ' CD1' ' A' ' 149' ' ' TYR . 91.8 Cg_endo -74.51 33.9 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.603 2.868 . . . . 0.0 110.744 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.957 ' O ' ' HB ' ' A' ' 146' ' ' VAL . 27.6 m-85 -170.41 104.52 0.28 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 123.735 0.647 . . . . 0.0 109.686 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 1.131 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 32.1 mt-30 -71.09 -169.71 0.4 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.847 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 1.131 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 52.1 p-10 44.6 76.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.18 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.805 HG21 ' CE ' ' A' ' 64' ' ' MET . 70.8 t -157.28 102.39 1.88 Allowed Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.615 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.285 ' CA ' HG22 ' A' ' 143' ' ' THR . 81.5 Cg_exo -49.95 109.67 0.31 Allowed 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.434 2.756 . . . . 0.0 110.961 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 1.276 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.5 t -40.0 -57.57 1.61 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.459 1.099 . . . . 0.0 108.972 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 62.6 mttp -69.61 88.25 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 164.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.276 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.2 Cg_endo -70.1 -157.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.615 2.877 . . . . 0.0 112.772 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 158' ' ' VAL . 99.4 t -153.78 153.87 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.326 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 1.018 ' HA ' HG22 ' A' ' 45' ' ' THR . 83.2 t -146.96 123.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.597 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.041 HG13 ' HA ' ' A' ' 45' ' ' THR . 36.9 mt -68.62 134.36 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 113.783 -1.553 . . . . 0.0 111.27 -175.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.292 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.9 mt -82.13 -48.61 11.12 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.771 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 32.2 t -167.1 166.42 15.09 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.521 1.138 . . . . 0.0 111.955 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.078 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . -163.32 125.38 2.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.556 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 1.182 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 14.3 ptmm? -170.28 120.8 0.61 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.702 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 7' ' ' VAL . 33.7 m -68.14 131.66 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 124.762 1.289 . . . . 0.0 110.57 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.127 HD12 ' HD2' ' A' ' 166' ' ' PRO . 49.3 tp -78.0 118.33 71.51 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.801 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 1.127 ' HD2' HD12 ' A' ' 165' ' ' LEU . 87.0 Cg_exo . . . . . 0 C--O 1.25 1.105 0 C-N-CA 123.523 2.815 . . . . 0.0 112.026 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.752 ' O ' ' CB ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.752 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 40.2 ttpt 130.36 95.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.296 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 1.261 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 54.65 95.84 0.01 OUTLIER Glycine 0 N--CA 1.471 0.976 0 O-C-N 124.795 1.309 . . . . 0.0 110.119 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.261 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 63.4 m-20 -167.63 135.52 1.95 Allowed Pre-proline 0 N--CA 1.476 0.85 0 O-C-N 124.736 0.903 . . . . 0.0 110.043 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 4' ' ' ASP . 80.6 Cg_exo -40.1 124.82 1.62 Allowed 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.595 2.863 . . . . 0.0 112.489 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 4' ' ' ASP . 18.4 m170 -160.72 117.11 2.32 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.792 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.9 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 10.4 p -59.8 137.58 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.262 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.197 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 8.4 mp -125.55 130.65 52.14 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.531 1.144 . . . . 0.0 109.415 166.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.923 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.5 mp -123.93 -171.99 2.44 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.684 -2.053 . . . . 0.0 108.936 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 1.218 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 98.7 m -160.82 84.95 0.69 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.827 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 1.006 HG22 HG12 ' A' ' 159' ' ' ILE . 36.9 p -76.6 172.48 12.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 125.426 1.704 . . . . 0.0 111.18 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -39.28 -44.13 1.23 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.351 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.838 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.26 -64.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.558 1.161 . . . . 0.0 110.369 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.37 41.58 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 113.248 -1.796 . . . . 0.0 113.654 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 16' ' ' ILE . 58.7 t-20 -66.29 153.33 42.88 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.12 -1.54 . . . . 0.0 111.419 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 15' ' ' ASN . 13.9 pt -163.56 174.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.15 -1.387 . . . . 0.0 111.3 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.47 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . 36.7 mt-10 -161.34 122.07 2.76 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.947 -170.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.025 HD21 HD11 ' A' ' 105' ' ' ILE . 2.5 mm? -95.64 162.96 13.4 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.817 1.323 . . . . 0.0 109.999 165.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.469 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -113.87 124.69 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.454 170.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.887 HD23 ' HE2' ' A' ' 125' ' ' PHE . 6.6 mp -106.01 120.05 40.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.931 1.395 . . . . 0.0 109.705 -172.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.591 ' OD2' ' HG ' ' A' ' 81' ' ' LEU . 32.2 m-20 -72.55 96.97 2.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.771 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.974 ' HA ' HG11 ' A' ' 29' ' ' VAL . 58.8 tttm -71.6 -56.15 6.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.658 1.224 . . . . 0.0 110.97 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.643 ' OE1' ' HA ' ' A' ' 23' ' ' GLN . 6.4 tp60 -46.17 -60.82 2.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.687 -171.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 51.8 tptt -68.17 -2.83 8.79 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.738 1.274 . . . . 0.0 113.138 -173.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.523 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -161.3 70.79 2.58 Favored Pre-proline 0 N--CA 1.476 0.831 0 O-C-N 123.705 0.628 . . . . 0.0 109.647 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 1.04 ' O ' HG22 ' A' ' 29' ' ' VAL . 62.9 Cg_exo -54.86 -56.18 2.62 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.635 2.89 . . . . 0.0 111.571 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.45 -64.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 124.726 1.266 . . . . 0.0 110.116 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -44.15 -58.32 2.92 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.734 1.272 . . . . 0.0 110.544 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.653 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 28.7 m -48.81 -50.14 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 124.752 1.282 . . . . 0.0 110.574 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 1.152 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.6 tm0? -52.0 -54.18 32.96 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.358 1.036 . . . . 0.0 109.357 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.899 ' OD1' HG21 ' A' ' 73' ' ' ILE . 10.6 m120 -50.89 -64.69 0.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.549 1.156 . . . . 0.0 110.391 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 1.653 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 33.6 p90 -54.18 -43.57 70.8 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.439 1.087 . . . . 0.0 110.709 -172.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.152 HG12 ' O ' ' A' ' 30' ' ' GLN . 10.7 p -51.33 -40.29 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 124.044 0.84 . . . . 0.0 110.171 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.836 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 71.0 m-20 -46.61 -61.34 1.87 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.112 0.882 . . . . 0.0 109.285 173.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 33.5 m-85 -54.61 -56.15 22.01 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.994 1.434 . . . . 0.0 109.124 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.834 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 97.6 t -46.42 -66.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 124.639 1.212 . . . . 0.0 109.344 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 33' ' ' VAL . 1.9 m-20 -50.57 -48.74 57.43 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.814 1.321 . . . . 0.0 109.989 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.637 ' OG ' ' O ' ' A' ' 34' ' ' ASP . 67.5 m -53.97 -93.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.539 1.149 . . . . 0.0 110.284 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.42 87.41 0.07 OUTLIER Glycine 0 N--CA 1.472 1.073 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 1.098 ' O ' ' CD1' ' A' ' 41' ' ' TYR . 88.0 t80 -157.39 57.02 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.911 1.007 . . . . 0.0 108.561 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.098 ' CD1' ' O ' ' A' ' 40' ' ' PHE . 25.6 m-85 -171.68 -37.07 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -38.69 -37.21 0.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.149 0.905 . . . . 0.0 112.688 -171.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 13.9 t30 -155.04 44.89 0.49 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.061 0.851 . . . . 0.0 110.902 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 45' ' ' THR . 58.4 p -79.4 -141.97 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.387 162.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 1.062 ' HA ' HG13 ' A' ' 159' ' ' ILE . 48.7 p -163.89 -141.35 0.05 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.608 0.718 . . . . 0.0 111.644 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.82 ' CD1' ' O ' ' A' ' 45' ' ' THR . 17.2 m-30 -143.07 62.73 1.39 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.417 -1.72 . . . . 0.0 107.246 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.994 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 7.1 p-80 -51.58 -60.49 3.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.72 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.211 ' HB3' ' NE2' ' A' ' 56' ' ' GLN . 26.5 mmm180 -69.14 118.7 12.37 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.626 1.203 . . . . 0.0 110.059 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 55' ' ' ILE . 8.7 p -163.64 149.6 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 124.713 1.258 . . . . 0.0 111.023 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.84 HD13 ' HD2' ' A' ' 53' ' ' PHE . 10.1 tt -165.54 126.61 1.35 Allowed Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.242 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 53' ' ' PHE . 87.4 Cg_exo -35.55 160.96 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.618 2.879 . . . . 0.0 113.729 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -7.71 70.06 0.0 OUTLIER Glycine 0 N--CA 1.474 1.225 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.684 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.082 ' O ' ' HG3' ' A' ' 54' ' ' MET . 1.9 t80 -160.78 -53.24 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.828 0.958 . . . . 0.0 109.712 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.082 ' HG3' ' O ' ' A' ' 53' ' ' PHE . 61.3 mtm -177.98 161.77 1.58 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.25 0.969 . . . . 0.0 112.249 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.709 HG12 ' O ' ' A' ' 105' ' ' ILE . 36.7 pt -150.61 174.34 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.798 170.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 1.211 ' NE2' ' HB3' ' A' ' 48' ' ' ARG . 31.8 mt-30 -158.98 167.01 30.47 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.201 -169.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.19 -178.08 31.89 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.578 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.09 84.57 0.08 OUTLIER Glycine 0 N--CA 1.47 0.912 0 CA-C-N 113.746 -1.227 . . . . 0.0 110.217 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.801 ' C ' ' HD2' ' A' ' 67' ' ' LYS . . . 178.98 -132.58 1.91 Allowed Glycine 0 N--CA 1.475 1.274 0 O-C-N 124.656 0.856 . . . . 0.0 111.305 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 56.6 m-85 -50.96 110.71 0.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.245 -0.978 . . . . 0.0 109.554 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.213 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 9.4 t -70.33 105.11 2.89 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.398 1.061 . . . . 0.0 110.082 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 1.213 ' HG2' ' O ' ' A' ' 61' ' ' THR . 12.6 pt-20 70.84 -127.22 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.801 1.313 . . . . 0.0 110.922 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 1.218 ' O ' ' CG ' ' A' ' 64' ' ' MET . 59.8 mt-30 -47.22 -55.45 8.56 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.808 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 1.218 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 50.7 mtt 145.72 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 122.637 1.208 . . . . 0.0 108.269 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 66' ' ' GLN . 18.4 tt0 -144.03 84.51 1.78 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.981 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.554 ' O ' ' O ' ' A' ' 67' ' ' LYS . 42.4 mt-30 -24.45 135.12 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.067 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.166 ' H ' ' CD ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -47.91 -120.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.427 -178.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 69' ' ' PRO . 4.2 ttmp? -170.84 73.05 0.56 Allowed Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.32 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.82 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 87.9 Cg_exo -51.17 -140.11 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.573 2.848 . . . . 0.0 113.127 -172.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.917 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 7.7 m120 164.83 168.72 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.579 -172.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.917 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 33.1 Cg_endo -44.66 98.39 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.549 2.166 . . . . 0.0 108.893 169.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.633 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.4 Cg_exo -44.11 -136.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.853 3.035 . . . . 0.0 113.336 -175.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.899 HG21 ' OD1' ' A' ' 31' ' ' ASN . 24.8 pt -152.34 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.438 1.086 . . . . 0.0 109.083 -174.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.566 ' O ' ' O ' ' A' ' 75' ' ' ASN . 21.6 ptmt -154.82 -148.37 0.24 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.03 0.831 . . . . 0.0 111.918 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.566 ' O ' ' O ' ' A' ' 74' ' ' LYS . 37.7 m-20 -44.93 -171.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.258 -1.792 . . . . 0.0 112.408 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.05 ' HG3' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 171.42 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.421 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.941 ' N ' ' HG2' ' A' ' 76' ' ' GLU . . . -44.72 -35.27 2.59 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.534 1.146 . . . . 0.0 111.887 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.5 p30 -68.89 25.81 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.058 0.848 . . . . 0.0 113.25 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.635 HD21 ' HB ' ' A' ' 124' ' ' VAL . 44.8 p-10 -63.63 -123.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.941 0.776 . . . . 0.0 109.017 174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.6 -80.28 0.08 OUTLIER Glycine 0 N--CA 1.473 1.12 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.433 ' O ' ' CD ' ' A' ' 82' ' ' ARG . 2.8 mm? 40.17 -151.01 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.848 0.97 . . . . 0.0 111.185 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 1.433 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER 179.95 111.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.987 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 1.21 ' OD1' ' HD3' ' A' ' 127' ' ' LYS . 26.0 m120 -159.76 -156.77 0.52 Allowed 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.591 1.182 . . . . 0.0 111.267 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 1.126 HG22 ' HG2' ' A' ' 85' ' ' ARG . 12.0 m -169.46 166.03 10.35 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.283 -166.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 1.126 ' HG2' HG22 ' A' ' 84' ' ' THR . 16.4 ptm180 -18.63 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.108 1.432 . . . . 0.0 112.146 172.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.858 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 148.18 -26.83 1.41 Allowed Glycine 0 CA--C 1.532 1.116 0 CA-C-N 110.442 -3.072 . . . . 0.0 109.676 -168.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.776 HG22 ' HG2' ' A' ' 127' ' ' LYS . 26.8 p -73.86 134.31 43.27 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.689 0.757 . . . . 0.0 112.107 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.53 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -91.32 160.05 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.062 164.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.263 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -163.41 138.89 6.56 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.043 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.922 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 95.7 mmm -55.82 125.62 22.11 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.769 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.226 ' HB3' ' OE1' ' A' ' 102' ' ' GLN . . . -74.74 -173.12 1.75 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.545 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.02 ' NH1' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.28 -120.53 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.407 175.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.02 ' HB ' ' NH1' ' A' ' 92' ' ' ARG . 20.7 m 173.79 -69.87 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.821 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 172.46 111.43 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.801 1.313 . . . . 0.0 108.89 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.821 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 88.4 m-20 161.84 145.3 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.152 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.654 ' O ' ' O ' ' A' ' 95' ' ' ASP . 53.4 mtmt -45.19 -122.5 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.043 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -58.33 118.16 5.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.713 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.6 m -163.87 -144.09 0.08 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.599 1.187 . . . . 0.0 110.938 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.726 ' O ' HD11 ' A' ' 73' ' ' ILE . . . 50.96 87.36 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.557 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 78.4 p -78.52 -41.35 32.54 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.246 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.3 m -167.88 -53.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 124.231 0.957 . . . . 0.0 109.286 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 1.226 ' OE1' ' HB3' ' A' ' 91' ' ' ALA . 2.0 pp0? -34.44 142.86 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.519 1.137 . . . . 0.0 111.823 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.761 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -150.91 -171.8 4.03 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.526 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.949 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 20.0 p90 -154.87 135.58 13.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.758 -172.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.025 HD11 HD21 ' A' ' 18' ' ' LEU . 53.0 mt -102.19 101.2 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.822 -1.99 . . . . 0.0 108.923 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.642 ' OD1' ' CD1' ' A' ' 104' ' ' PHE . 18.9 m-20 -62.78 167.37 4.64 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.814 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.322 HG12 ' CE ' ' A' ' 132' ' ' MET . 33.0 m -157.93 51.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.273 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 53' ' ' PHE . . . -177.4 133.16 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.831 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.94 ' O ' ' CE1' ' A' ' 112' ' ' PHE . 31.9 m-20 -31.68 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.458 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.83 ' ND2' ' HB3' ' A' ' 113' ' ' LEU . 1.1 t-20 -68.83 -119.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.858 1.349 . . . . 0.0 109.519 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 61.21 -72.21 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.743 0.652 . . . . 0.0 110.24 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.94 ' CE1' ' O ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -67.63 56.07 0.06 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.377 1.048 . . . . 0.0 109.612 178.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.843 HD21 ' HD2' ' A' ' 122' ' ' TYR . 6.3 tt 177.44 -39.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.079 -173.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -39.5 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.06 0.85 . . . . 0.0 110.644 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.733 ' CE1' ' H ' ' A' ' 120' ' ' PHE . 0.4 OUTLIER 179.27 103.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.739 1.274 . . . . 0.0 108.678 179.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -177.63 118.4 0.63 Allowed Glycine 0 N--CA 1.475 1.234 0 CA-C-N 113.923 -1.489 . . . . 0.0 109.768 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.761 ' O ' ' CB ' ' A' ' 118' ' ' ARG . 26.4 tt0 77.97 73.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.761 ' CB ' ' O ' ' A' ' 117' ' ' GLN . 59.0 ttt85 126.92 102.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.205 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -34.96 110.0 0.09 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.771 1.294 . . . . 0.0 111.662 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.733 ' H ' ' CE1' ' A' ' 115' ' ' HIS . 47.6 m-85 54.38 171.22 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.893 1.37 . . . . 0.0 112.521 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.69 -129.13 1.09 Allowed Glycine 0 N--CA 1.474 1.209 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.954 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.843 ' HD2' HD21 ' A' ' 113' ' ' LEU . 21.0 m-85 -79.72 116.72 20.06 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.486 0.757 . . . . 0.0 109.62 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.05 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . . . -49.01 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.569 1.168 . . . . 0.0 111.051 176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.263 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 70.2 t 179.86 133.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.806 -176.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.887 ' HE2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -166.13 21.99 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.033 170.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 1.53 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -118.07 168.54 13.1 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 123.123 1.402 . . . . 0.0 112.753 -169.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.469 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 10.2 mtmp? 179.56 104.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 110.962 -2.619 . . . . 0.0 109.564 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 86' ' ' GLY . 66.8 t -43.56 119.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.083 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.47 ' CG1' ' HB2' ' A' ' 17' ' ' GLU . 7.3 p -63.91 -48.44 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.235 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.908 ' HD3' ' C ' ' A' ' 130' ' ' LYS . 2.9 tmtm? 163.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.255 0.972 . . . . 0.0 109.612 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.65 32.61 0.09 OUTLIER Glycine 0 N--CA 1.476 1.33 0 O-C-N 124.817 1.323 . . . . 0.0 111.469 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 1.322 ' CE ' HG12 ' A' ' 107' ' ' VAL . 8.4 tpt -59.75 -40.91 89.71 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.162 0.566 . . . . 0.0 110.281 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 22.9 m-20 -44.05 -63.77 0.8 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.273 0.983 . . . . 0.0 109.937 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.675 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.2 t -43.89 -60.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 124.615 1.197 . . . . 0.0 109.219 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.412 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -46.18 -52.08 13.01 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.59 1.181 . . . . 0.0 109.772 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.599 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 39.9 m-20 -53.64 -65.43 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.562 1.164 . . . . 0.0 109.133 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -36.57 -49.24 0.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.711 1.257 . . . . 0.0 110.588 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.163 ' O ' HG22 ' A' ' 141' ' ' VAL . 23.5 mt -57.1 -57.39 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 124.578 1.173 . . . . 0.0 108.642 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.599 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.3 p -61.7 3.26 0.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 41.0 mm-40 -96.25 -49.53 5.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.27 0.981 . . . . 0.0 109.313 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.163 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -47.28 123.85 8.68 Favored Pre-proline 0 N--CA 1.472 0.638 0 O-C-N 124.518 1.136 . . . . 0.0 110.055 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 141' ' ' VAL . 84.0 Cg_exo -41.17 179.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.517 2.811 . . . . 0.0 113.799 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.389 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.5 p -160.92 -151.48 0.24 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 123.589 1.662 . . . . 0.0 112.32 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.717 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.8 OUTLIER 178.24 165.06 0.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 110.055 -3.248 . . . . 0.0 111.148 174.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.691 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 77.7 m-20 -51.57 -144.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.752 166.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.771 HG22 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -162.19 -63.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.903 1.335 . . . . 0.0 107.914 170.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.01 -95.52 0.1 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-N 111.119 -2.764 . . . . 0.0 107.531 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 90.5 Cg_endo -70.54 -63.19 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.639 2.893 . . . . 0.0 108.928 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.68 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 59.6 m-85 -70.12 109.42 4.59 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.703 1.252 . . . . 0.0 110.702 -177.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.566 ' O ' ' NH1' ' A' ' 48' ' ' ARG . 22.4 mm-40 -75.9 151.21 37.41 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.75 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.736 ' O ' HG23 ' A' ' 152' ' ' VAL . 21.7 m-20 77.63 96.95 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.606 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.771 ' HB ' HG22 ' A' ' 146' ' ' VAL . 84.9 t -164.66 116.1 0.93 Allowed Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.409 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.389 ' CA ' HG22 ' A' ' 143' ' ' THR . 59.7 Cg_endo -65.02 108.53 1.13 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.534 2.822 . . . . 0.0 109.623 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 1.251 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 62.2 p -43.96 -58.83 2.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.928 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 88.3 tttt -74.3 88.53 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.251 ' HD3' ' O ' ' A' ' 154' ' ' SER . 59.1 Cg_endo -77.31 131.74 11.95 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.684 2.923 . . . . 0.0 112.486 -167.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.641 HG21 HG23 ' A' ' 138' ' ' ILE . 74.1 t -68.94 157.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.765 -1.562 . . . . 0.0 110.44 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 1.039 ' HA ' HG22 ' A' ' 45' ' ' THR . 98.9 t -143.75 120.0 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.517 174.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.062 HG13 ' HA ' ' A' ' 45' ' ' THR . 32.3 mt -68.21 133.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.091 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.218 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.7 mt -77.99 -50.51 11.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 112.383 -2.19 . . . . 0.0 109.744 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 61.4 m -162.6 -165.46 1.17 Allowed 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.655 1.222 . . . . 0.0 112.027 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.923 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . 179.41 135.55 0.1 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.3 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 8' ' ' LEU . 61.1 pttt -171.61 136.45 0.96 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.693 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 36' ' ' VAL . 34.8 m -77.85 133.06 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.938 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.103 HD12 ' HD2' ' A' ' 166' ' ' PRO . 47.2 tp -91.98 117.24 67.62 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 114.211 -1.358 . . . . 0.0 109.29 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 1.103 ' HD2' HD12 ' A' ' 165' ' ' LEU . 88.4 Cg_exo . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.547 2.831 . . . . 0.0 111.828 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 3' ' ' GLY . . . . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.652 ' O ' ' O ' ' A' ' 3' ' ' GLY . 55.9 tptt -50.74 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.26 -1.337 . . . . 0.0 109.587 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.686 ' O ' ' CG ' ' A' ' 4' ' ' ASP . . . -47.12 -141.34 0.0 OUTLIER Glycine 0 N--CA 1.473 1.146 0 O-C-N 124.689 1.243 . . . . 0.0 112.404 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.136 ' HB2' ' CD ' ' A' ' 5' ' ' PRO . 63.2 m-20 -179.08 -75.9 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 114.5 -0.85 . . . . 0.0 108.896 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.222 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 84.8 Cg_exo -45.76 78.76 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.776 2.984 . . . . 0.0 112.012 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.569 ' CD2' ' HG2' ' A' ' 19' ' ' GLU . 37.9 m170 -147.47 112.82 5.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.043 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.038 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 9.1 p -67.64 143.85 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.311 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.282 HD11 ' OE1' ' A' ' 17' ' ' GLU . 6.6 mp -129.76 115.01 16.66 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.625 1.202 . . . . 0.0 110.023 166.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.056 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.5 mp -107.69 -177.8 3.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 111.174 -2.739 . . . . 0.0 108.743 160.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.647 HG23 ' N ' ' A' ' 15' ' ' ASN . 96.0 m -160.84 100.99 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.103 174.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.942 HG22 HG12 ' A' ' 159' ' ' ILE . 41.7 p -78.8 172.65 13.44 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 125.527 1.767 . . . . 0.0 111.446 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -41.08 -43.33 2.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.417 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.803 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.64 -59.26 4.94 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.497 1.123 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 10' ' ' THR . . . 169.67 -176.03 43.67 Favored Glycine 0 N--CA 1.479 1.546 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.647 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 1.329 ' O ' HG21 ' A' ' 134' ' ' VAL . 10.2 t-20 -53.28 161.2 0.96 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 113.49 -1.355 . . . . 0.0 111.26 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 9' ' ' LEU . 11.8 tt -171.51 157.13 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.889 -174.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.282 ' OE1' HD11 ' A' ' 8' ' ' LEU . 39.7 tt0 -163.96 125.17 2.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.084 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 105' ' ' ILE . 2.9 mm? -93.54 -177.43 4.4 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.934 1.396 . . . . 0.0 110.542 164.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.569 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -148.3 118.5 7.29 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.646 175.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.761 ' O ' ' OE2' ' A' ' 19' ' ' GLU . 6.0 mp -90.57 -162.22 0.88 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.031 -1.441 . . . . 0.0 111.523 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.04 96.88 1.36 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.35 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.847 ' HA ' HG11 ' A' ' 29' ' ' VAL . 39.8 ttmt -62.28 -46.61 88.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.912 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -45.39 -67.34 0.29 Allowed 'General case' 0 N--CA 1.472 0.634 0 O-C-N 124.483 1.114 . . . . 0.0 110.48 -170.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.536 ' HZ2' HD21 ' A' ' 81' ' ' LEU . 31.0 mmtp -70.05 -0.54 7.79 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.826 1.329 . . . . 0.0 114.17 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.628 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.21 70.14 2.98 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 123.827 0.704 . . . . 0.0 110.06 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.975 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.1 Cg_exo -56.18 -58.16 1.16 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.6 2.867 . . . . 0.0 111.043 176.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.9 t -50.71 -65.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 124.84 1.338 . . . . 0.0 110.173 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.1 m -43.99 -57.63 3.24 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.699 1.25 . . . . 0.0 110.675 -175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 26' ' ' PRO . 33.1 m -49.12 -49.08 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 124.642 1.214 . . . . 0.0 110.987 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.775 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 tm0? -50.85 -67.15 0.28 Allowed 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.222 0.951 . . . . 0.0 109.086 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.914 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 t-20 -43.31 -53.11 5.44 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.581 1.176 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.716 ' CE2' HG21 ' A' ' 36' ' ' VAL . 48.8 t80 -43.21 -62.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.523 1.14 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 37' ' ' ASN . 62.7 t -44.22 -39.32 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.624 1.202 . . . . 0.0 111.071 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.914 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 5.1 m-20 -44.49 -62.06 1.32 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.121 0.888 . . . . 0.0 109.583 174.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.83 ' HB3' ' HD2' ' A' ' 40' ' ' PHE . 94.2 m-85 -60.26 -63.77 1.18 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.9 1.375 . . . . 0.0 109.202 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.716 HG21 ' CE2' ' A' ' 32' ' ' PHE . 57.4 t -39.52 -49.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 124.648 1.218 . . . . 0.0 110.869 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.751 ' O ' ' HB3' ' A' ' 38' ' ' SER . 58.7 t-20 -38.9 -31.34 0.06 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.738 1.274 . . . . 0.0 112.239 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.751 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 88.6 p 157.67 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.112 0.883 . . . . 0.0 112.425 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . 68.69 81.62 0.2 Allowed Glycine 0 N--CA 1.47 0.928 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.401 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.83 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 1.7 t80 173.74 -81.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 O-C-N 124.819 0.953 . . . . 0.0 109.739 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -68.35 -12.41 61.06 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.344 1.027 . . . . 0.0 113.259 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 1.172 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 17.4 m-20 -38.97 -50.04 1.73 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.661 0.6 . . . . 0.0 111.714 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 1.172 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 20.6 m-20 -156.68 52.53 0.52 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.393 1.058 . . . . 0.0 109.782 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.891 ' O ' HG23 ' A' ' 45' ' ' THR . 27.8 m -78.62 -125.84 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 166.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 1.012 HG22 ' HA ' ' A' ' 158' ' ' VAL . 40.6 p -165.35 -140.05 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.222 1.011 . . . . 0.0 111.966 170.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.921 ' CD1' ' O ' ' A' ' 45' ' ' THR . 11.2 m-30 -152.98 81.31 1.21 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.49 -2.141 . . . . 0.0 105.962 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.789 ' O ' ' CD ' ' A' ' 153' ' ' PRO . 19.8 m80 -11.43 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.123 ' NH2' ' O ' ' A' ' 141' ' ' VAL . 28.0 tpt85 -172.4 -133.19 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.634 1.209 . . . . 0.0 110.098 166.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 50' ' ' ILE . 7.4 p -173.41 147.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.953 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 49' ' ' VAL . 57.0 mt -72.24 131.8 84.77 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.106 156.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' ILE . 19.2 Cg_endo -40.76 -139.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.386 0 C-N-CA 123.213 2.608 . . . . 0.0 111.582 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.63 76.49 0.01 OUTLIER Glycine 0 N--CA 1.471 0.998 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.67 ' HD2' HG21 ' A' ' 50' ' ' ILE . 1.1 t80 -162.11 -68.79 0.05 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.604 0.826 . . . . 0.0 109.833 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.902 ' O ' HG23 ' A' ' 49' ' ' VAL . 26.4 ptt? 177.16 130.77 0.05 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.212 0.945 . . . . 0.0 111.906 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.849 HG22 ' CB ' ' A' ' 49' ' ' VAL . 32.4 pt -90.2 176.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.047 169.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 1.287 ' O ' ' HA ' ' A' ' 104' ' ' PHE . 20.6 mm-40 -69.28 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.499 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 1.042 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -157.47 -133.66 1.63 Allowed Glycine 0 N--CA 1.473 1.103 0 O-C-N 118.845 -2.409 . . . . 0.0 112.046 4.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.59 105.27 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA2' ' HD3' ' A' ' 67' ' ' LYS . . . -175.5 -121.38 0.64 Allowed Glycine 0 N--CA 1.475 1.278 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.93 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 21.0 m-85 -42.58 114.09 0.54 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.577 -0.812 . . . . 0.0 110.455 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.747 ' HA ' HG23 ' A' ' 44' ' ' THR . 97.7 m -59.94 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.613 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 65.14 -106.11 0.13 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.817 1.323 . . . . 0.0 110.287 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 44.6 tp60 -71.41 50.3 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.67 1.232 . . . . 0.0 110.505 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.93 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 53.4 mtt 41.75 35.77 0.54 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.937 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' GLN . 10.7 tp-100 -77.67 87.67 3.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 172.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.594 ' O ' ' O ' ' A' ' 67' ' ' LYS . 62.5 mt-30 -27.42 137.41 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.694 -1.594 . . . . 0.0 113.084 -171.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.594 ' O ' ' O ' ' A' ' 66' ' ' GLN . 35.3 mtmm -43.85 -122.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.273 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -174.01 75.94 0.36 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 112.704 -2.044 . . . . 0.0 106.617 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 1.232 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 58.3 Cg_endo -78.21 -178.05 4.33 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 123.638 2.892 . . . . 0.0 113.593 -167.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.232 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 41.5 m-20 -166.0 168.98 7.18 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.887 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.863 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 99.3 Cg_exo -36.1 83.29 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.347 2.698 . . . . 0.0 111.295 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.046 ' HB3' HG22 ' A' ' 100' ' ' THR . 80.6 Cg_exo -49.82 154.17 5.2 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.846 3.031 . . . . 0.0 113.735 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.094 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 30.4 pt -78.98 162.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.923 -1.49 . . . . 0.0 112.03 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.944 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 95.7 mttt -59.84 -177.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.846 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 25.9 p30 -52.55 -169.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.31 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.22 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 157.39 122.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.924 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 167.12 -47.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.322 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.701 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 49.8 p-10 -69.03 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.485 1.116 . . . . 0.0 112.86 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 80' ' ' GLY . 43.6 p-10 -44.43 -46.94 9.81 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.996 0.81 . . . . 0.0 109.865 174.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.752 ' C ' HD12 ' A' ' 81' ' ' LEU . . . 73.53 68.24 1.62 Allowed Glycine 0 N--CA 1.472 1.069 0 O-C-N 124.412 1.07 . . . . 0.0 111.166 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.752 HD12 ' C ' ' A' ' 80' ' ' GLY . 2.7 mp -151.36 174.32 13.47 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.854 0.973 . . . . 0.0 110.531 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.832 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 14.2 ptp180 -79.56 144.19 34.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.687 175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.832 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.3 m120 -164.53 153.43 13.05 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.502 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' ' 109' ' ' ASP . 17.8 m -165.26 159.49 17.41 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.421 -169.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' THR . 67.1 ttt180 -21.21 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.792 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.851 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 146.06 -13.76 1.69 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-N 111.383 -2.644 . . . . 0.0 110.835 -169.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.169 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 24.3 p -109.48 163.61 13.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.026 1.394 . . . . 0.0 112.584 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.871 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -131.37 158.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 111.28 -2.691 . . . . 0.0 108.719 -177.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.884 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -156.05 150.67 25.95 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.89 -1.504 . . . . 0.0 112.364 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 1.122 ' SD ' ' O ' ' A' ' 102' ' ' GLN . 15.6 tpt -61.77 127.3 30.77 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.676 -1.602 . . . . 0.0 110.739 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.827 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . . . -57.34 -119.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.526 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.938 ' HA ' ' H ' ' A' ' 99' ' ' ALA . 39.2 ptt180 179.21 -153.1 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.77 0.669 . . . . 0.0 111.353 177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 53.7 m -176.8 -90.62 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.17 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 164.52 117.85 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.695 1.247 . . . . 0.0 109.098 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 50.3 t0 159.64 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.303 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.142 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 64.3 mttm 153.98 22.25 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.072 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 1.142 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 89.4 m-20 178.96 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 1.365 ' CA ' ' O ' ' A' ' 99' ' ' ALA . 31.2 t 178.54 108.22 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.599 1.187 . . . . 0.0 109.137 -169.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 1.365 ' O ' ' CA ' ' A' ' 98' ' ' SER . . . 34.16 135.87 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.389 -1.444 . . . . 0.0 114.025 -2.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 1.046 HG22 ' HB3' ' A' ' 72' ' ' PRO . 38.6 p -160.92 -46.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.774 -2.012 . . . . 0.0 108.682 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.612 ' H ' ' NE2' ' A' ' 102' ' ' GLN . 78.0 p -170.36 80.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.402 1.063 . . . . 0.0 108.398 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 1.122 ' O ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER 176.46 158.64 0.3 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.73 1.269 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.949 ' HD2' ' HZ ' ' A' ' 125' ' ' PHE . 0.1 OUTLIER -158.45 -173.7 4.43 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.89 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 1.287 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 22.2 p90 -156.64 139.65 15.39 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.655 -174.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.042 HD11 HD21 ' A' ' 18' ' ' LEU . 60.4 mt -100.68 113.47 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 113.06 -1.882 . . . . 0.0 110.31 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 1.169 ' OD1' ' O ' ' A' ' 87' ' ' THR . 37.5 p-10 -72.42 -167.82 0.37 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.624 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.257 HG12 ' CE ' ' A' ' 132' ' ' MET . 34.5 m -160.7 -43.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.961 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 107' ' ' VAL . . . -86.5 133.7 33.73 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.258 0.974 . . . . 0.0 111.129 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.657 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 19.7 m-20 -51.04 112.14 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.422 174.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 113' ' ' LEU . 31.9 m120 -163.32 75.15 0.37 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.485 1.115 . . . . 0.0 109.547 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.38 -29.42 64.05 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.215 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -38.71 -40.24 0.58 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.074 0.858 . . . . 0.0 111.533 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.724 HD13 ' O ' ' A' ' 110' ' ' ASN . 6.4 mp -57.91 -24.82 59.46 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.436 1.085 . . . . 0.0 111.773 -176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.4 t0 -39.18 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.752 0.658 . . . . 0.0 111.072 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 1.417 ' ND1' ' HB3' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 178.59 120.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.696 1.247 . . . . 0.0 109.626 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -168.81 -169.74 32.59 Favored Glycine 0 N--CA 1.477 1.409 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.717 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 116' ' ' GLY . 65.8 tt0 72.39 -56.34 0.65 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.488 -0.856 . . . . 0.0 109.402 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.437 ' O ' ' HE1' ' A' ' 115' ' ' HIS . 27.7 tpt180 178.29 -97.23 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.61 1.194 . . . . 0.0 108.958 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 120' ' ' PHE . 55.6 p-10 -73.23 89.55 1.55 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.7 1.25 . . . . 0.0 110.138 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 1.417 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 26.1 p90 -50.45 -154.34 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.562 1.164 . . . . 0.0 110.944 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.29 -82.94 0.05 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 123.667 0.605 . . . . 0.0 111.65 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -77.26 123.69 26.81 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 124.488 0.757 . . . . 0.0 110.817 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.22 ' HB1' ' OE1' ' A' ' 76' ' ' GLU . . . -68.24 -156.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.01 -1.45 . . . . 0.0 111.242 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.158 HG23 ' O ' ' A' ' 123' ' ' ALA . 46.2 t 176.4 136.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.949 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 35.7 p90 -170.32 23.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 118.44 -0.791 . . . . 0.0 113.064 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.804 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -155.93 -166.4 15.85 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.093 1.385 . . . . 0.0 113.725 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.851 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 27.7 ttpp 176.99 132.05 0.05 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 110.996 -2.602 . . . . 0.0 110.131 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.843 HG11 ' HB2' ' A' ' 132' ' ' MET . 60.1 t -46.88 149.36 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 124.399 1.062 . . . . 0.0 110.882 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.093 HG11 ' CG ' ' A' ' 17' ' ' GLU . 6.5 p -129.72 -45.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.453 -175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 1.101 ' HE3' ' HA ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER 178.44 76.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.161 0.913 . . . . 0.0 108.688 -177.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.65 -16.02 0.02 OUTLIER Glycine 0 N--CA 1.476 1.364 0 O-C-N 124.819 1.325 . . . . 0.0 112.511 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 1.257 ' CE ' HG12 ' A' ' 107' ' ' VAL . 9.6 tpt -39.54 -43.3 1.27 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.815 0.362 . . . . 0.0 110.538 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' NZ ' ' A' ' 137' ' ' LYS . 65.2 t0 -44.09 -60.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.366 1.041 . . . . 0.0 109.967 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 1.329 HG21 ' O ' ' A' ' 15' ' ' ASN . 95.5 t -43.71 -56.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 124.491 1.12 . . . . 0.0 109.377 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -45.46 -51.73 11.14 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.786 1.304 . . . . 0.0 110.457 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.886 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 5.6 m-20 -49.01 -70.06 0.1 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.468 1.105 . . . . 0.0 109.417 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 38.0 mtmm -44.77 -46.53 10.59 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.758 1.286 . . . . 0.0 110.38 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.106 ' O ' HG22 ' A' ' 141' ' ' VAL . 18.5 mt -55.78 -62.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.269 0.981 . . . . 0.0 108.435 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.826 ' HA ' HH12 ' A' ' 48' ' ' ARG . 78.0 p -58.53 0.29 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.886 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 39.9 mm-40 -94.99 -48.97 5.76 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.25 0.969 . . . . 0.0 109.727 177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.123 ' O ' ' NH2' ' A' ' 48' ' ' ARG . 33.8 m -49.98 124.98 17.59 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.508 1.13 . . . . 0.0 110.208 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.9 Cg_exo -43.79 -177.06 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.629 2.886 . . . . 0.0 113.903 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.307 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.08 -141.11 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.628 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.643 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 179.73 143.41 0.16 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 110.698 -2.956 . . . . 0.0 111.865 170.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -67.74 111.91 4.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.113 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.75 ' CG2' ' HB ' ' A' ' 152' ' ' VAL . 1.3 t -77.24 -144.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 124.642 1.214 . . . . 0.0 109.355 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -63.44 -113.09 0.01 OUTLIER Glycine 0 N--CA 1.471 1.008 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 171.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.527 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 97.1 Cg_endo -68.97 -46.15 1.7 Allowed 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 123.596 2.864 . . . . 0.0 110.029 171.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.527 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 72.8 m-85 -68.67 97.82 0.84 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.454 1.096 . . . . 0.0 110.329 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -71.68 139.22 49.11 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.217 173.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 150' ' ' GLN . 17.6 m-20 81.2 82.4 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.873 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.75 ' HB ' ' CG2' ' A' ' 146' ' ' VAL . 72.9 t -140.27 121.05 9.17 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-N 114.167 -1.379 . . . . 0.0 107.714 168.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.307 ' CA ' HG22 ' A' ' 143' ' ' THR . 44.5 Cg_endo -62.05 102.88 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.565 2.843 . . . . 0.0 109.77 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.908 ' H ' ' HA ' ' A' ' 143' ' ' THR . 66.5 p -44.23 -54.02 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.731 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 155' ' ' LYS . 39.3 tptt -75.27 105.48 2.04 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.71 ' HD3' ' O ' ' A' ' 154' ' ' SER . 55.8 Cg_endo -78.7 122.71 5.56 Favored 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.032 -164.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 158' ' ' VAL . 93.1 t -69.44 157.79 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.054 166.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 1.012 ' HA ' HG22 ' A' ' 45' ' ' THR . 89.0 t -158.21 119.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.153 174.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.993 HG13 ' HA ' ' A' ' 45' ' ' THR . 39.5 mt -68.64 137.7 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.26 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -90.78 -47.11 7.83 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 112.778 -2.01 . . . . 0.0 110.471 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 28.5 t -166.83 170.12 12.6 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.424 1.077 . . . . 0.0 111.906 -175.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.056 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . -168.88 134.72 1.7 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.739 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.622 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -170.83 151.22 3.36 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.085 174.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.35 136.62 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.046 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.043 HD22 ' HD2' ' A' ' 166' ' ' PRO . 3.3 tm? -68.93 121.33 81.15 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.042 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 1.043 ' HD2' HD22 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.252 1.179 0 C-N-CA 123.536 2.824 . . . . 0.0 112.015 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.92 ' O ' ' HG2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.92 ' HG2' ' O ' ' A' ' 1' ' ' ALA . 33.5 mmtp 112.72 -117.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.544 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 1.27 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . -47.92 164.75 0.22 Allowed Glycine 0 N--CA 1.474 1.189 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.243 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.27 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 72.3 m-20 -171.97 82.44 0.47 Allowed Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.417 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 74.5 Cg_endo -73.91 63.35 4.95 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.834 3.023 . . . . 0.0 110.169 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.417 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 28.4 m170 -153.03 79.14 1.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.775 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.639 HG23 HD13 ' A' ' 20' ' ' LEU . 43.1 t -60.08 75.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.129 ' HG ' ' HB3' ' A' ' 17' ' ' GLU . 7.9 tt -79.84 105.55 11.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 113.656 -1.611 . . . . 0.0 109.557 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.191 HD23 ' O ' ' A' ' 161' ' ' SER . 10.7 mt -92.88 177.08 6.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.935 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 1.143 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 99.2 m -160.47 84.61 0.7 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.678 175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.997 HG22 HG12 ' A' ' 159' ' ' ILE . 24.2 p -78.4 162.72 26.22 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 125.054 1.471 . . . . 0.0 111.662 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 158' ' ' VAL . 65.0 m -41.1 -50.41 3.44 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.366 -1.743 . . . . 0.0 110.263 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.693 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -47.67 -58.38 4.36 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.594 1.184 . . . . 0.0 110.531 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.07 -177.67 47.02 Favored Glycine 0 N--CA 1.476 1.352 0 CA-C-N 112.975 -1.92 . . . . 0.0 112.965 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.897 ' O ' HG23 ' A' ' 16' ' ' ILE . 9.4 t-20 -65.6 151.56 46.19 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.416 -1.392 . . . . 0.0 111.799 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 15' ' ' ASN . 25.3 pt -168.81 166.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.822 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.129 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . 12.5 pt-20 -163.11 117.09 1.64 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.042 -1.435 . . . . 0.0 112.314 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.988 HD21 HD11 ' A' ' 105' ' ' ILE . 3.0 mm? -76.87 165.52 24.58 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.738 1.274 . . . . 0.0 110.465 164.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.017 ' OE2' ' NE2' ' A' ' 6' ' ' HIS . 39.8 tt0 -131.24 119.49 21.88 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.944 173.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.939 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.4 mp -99.88 115.12 28.89 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.118 -168.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.72 98.24 0.51 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.579 176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.049 ' HA ' HG11 ' A' ' 29' ' ' VAL . 10.0 mtmp? -69.67 -49.59 52.14 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.614 1.196 . . . . 0.0 111.763 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.53 ' NE2' ' HE2' ' A' ' 24' ' ' LYS . 47.4 tt0 -44.33 -62.87 1.01 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.333 1.021 . . . . 0.0 110.556 -171.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.53 ' HE2' ' NE2' ' A' ' 23' ' ' GLN . 4.2 mptp? -69.22 9.57 0.42 Allowed 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.724 1.265 . . . . 0.0 113.543 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.68 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -161.05 68.57 2.51 Favored Pre-proline 0 N--CA 1.475 0.795 0 O-C-N 123.855 0.722 . . . . 0.0 109.452 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.788 ' O ' HG22 ' A' ' 29' ' ' VAL . 52.0 Cg_exo -56.21 -63.14 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.493 2.796 . . . . 0.0 110.94 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.0 t -54.0 -61.47 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 124.832 1.333 . . . . 0.0 109.944 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 37.1 t -43.99 -58.84 2.58 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.753 1.283 . . . . 0.0 110.624 -176.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.049 HG11 ' HA ' ' A' ' 22' ' ' LYS . 28.1 m -51.76 -49.48 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 124.629 1.206 . . . . 0.0 110.69 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.848 ' NE2' ' OD1' ' A' ' 34' ' ' ASP . 2.6 tm0? -47.36 -57.77 4.9 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.314 1.009 . . . . 0.0 109.313 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 1.15 ' OD1' HG21 ' A' ' 73' ' ' ILE . 10.8 m120 -42.7 -55.26 3.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.636 1.21 . . . . 0.0 110.282 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.967 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 57.9 m-85 -44.1 -62.14 1.24 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.576 1.172 . . . . 0.0 110.022 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 62.0 t -40.64 -46.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.541 1.15 . . . . 0.0 110.758 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.848 ' OD1' ' NE2' ' A' ' 30' ' ' GLN . 7.0 m-20 -45.0 -60.51 2.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.37 1.044 . . . . 0.0 109.576 174.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.484 ' O ' ' HB2' ' A' ' 38' ' ' SER . 74.0 m-85 -57.29 -55.97 27.85 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.945 1.403 . . . . 0.0 109.149 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 HG13 ' A' ' 164' ' ' VAL . 69.4 t -44.4 -64.87 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 124.61 1.194 . . . . 0.0 109.589 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.4 t30 -45.8 -49.35 15.17 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.828 1.33 . . . . 0.0 110.133 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 58.2 m -53.93 -109.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.591 1.182 . . . . 0.0 110.215 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.828 ' HA2' ' OD1' ' A' ' 42' ' ' ASN . . . -174.88 48.07 0.13 Allowed Glycine 0 N--CA 1.474 1.213 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.215 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.803 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 22.9 t80 -73.84 -64.08 1.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.629 0.84 . . . . 0.0 109.637 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.747 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 39.9 m-85 -67.74 -23.18 65.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.223 -1.353 . . . . 0.0 113.118 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.828 ' OD1' ' HA2' ' A' ' 39' ' ' GLY . 35.2 m120 -38.74 -39.8 0.54 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.817 0.698 . . . . 0.0 112.592 -170.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -152.79 50.56 0.74 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.243 0.964 . . . . 0.0 110.133 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 45' ' ' THR . 49.4 p -79.06 -144.36 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.21 161.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.93 HG22 ' HA ' ' A' ' 158' ' ' VAL . 42.9 p -163.85 -139.21 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.746 0.784 . . . . 0.0 112.168 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 159' ' ' ILE . 51.7 m-85 -157.42 64.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.195 -1.821 . . . . 0.0 107.442 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.715 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 2.2 p-80 -61.61 -60.56 3.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.189 -1.368 . . . . 0.0 109.417 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.715 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.4 mtt180 -69.2 116.78 10.03 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.558 1.161 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 55' ' ' ILE . 68.3 t -152.21 150.74 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 124.87 1.357 . . . . 0.0 110.95 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.974 HD12 ' HB3' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -158.75 122.34 2.09 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 113.811 -1.541 . . . . 0.0 108.457 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 53' ' ' PHE . 88.0 Cg_exo -37.54 160.61 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.637 2.891 . . . . 0.0 113.941 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.03 68.45 0.0 OUTLIER Glycine 0 N--CA 1.474 1.207 0 CA-C-N 114.022 -1.445 . . . . 0.0 113.831 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.018 ' CE2' ' HE1' ' A' ' 54' ' ' MET . 1.6 t80 -161.15 -59.12 0.05 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.782 0.931 . . . . 0.0 109.495 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.018 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 57.5 mtm -163.29 157.21 19.92 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.54 1.15 . . . . 0.0 112.29 -171.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.894 ' CD1' ' HB1' ' A' ' 135' ' ' ALA . 42.4 pt -161.56 145.83 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.932 174.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.75 ' HG2' ' CB ' ' A' ' 104' ' ' PHE . 18.2 mt-30 -146.1 168.75 20.2 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.147 0.904 . . . . 0.0 112.079 -166.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.36 -158.95 9.91 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.672 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.803 ' HA2' ' CE1' ' A' ' 40' ' ' PHE . . . 65.97 78.23 0.24 Allowed Glycine 0 N--CA 1.47 0.93 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.159 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 1.569 ' CA ' ' HE3' ' A' ' 67' ' ' LYS . . . 177.89 -133.79 2.27 Favored Glycine 0 N--CA 1.475 1.267 0 O-C-N 124.669 0.864 . . . . 0.0 111.231 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 64.0 m-85 -42.54 128.02 3.9 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.282 -0.959 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.655 ' OG1' ' OE2' ' A' ' 62' ' ' GLU . 78.3 p -59.01 -149.19 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.344 1.027 . . . . 0.0 110.733 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 1.161 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -59.91 -89.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.282 178.083 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 1.161 ' H ' ' CG ' ' A' ' 62' ' ' GLU . 32.9 mt-30 -72.28 52.52 0.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.77 1.294 . . . . 0.0 110.018 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.635 ' HA ' ' HB3' ' A' ' 60' ' ' PHE . 50.4 mtt 40.84 35.74 0.36 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.071 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.574 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 58.0 tp60 -77.72 99.97 6.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' LYS . 88.7 mt-30 -27.03 140.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.446 -172.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.569 ' HE3' ' CA ' ' A' ' 59' ' ' GLY . 52.7 mttp -51.44 -127.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.84 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 1.178 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 98.1 mttt 179.57 84.79 0.18 Allowed Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 112.683 -2.053 . . . . 0.0 106.897 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 1.048 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 52.9 Cg_endo -71.73 -167.93 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.639 2.893 . . . . 0.0 113.297 -171.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.048 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 79.1 m-20 -165.09 170.41 6.39 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 113.327 -1.761 . . . . 0.0 109.984 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.981 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 34.7 Cg_endo -45.77 103.78 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.631 2.221 . . . . 0.0 108.977 169.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 71' ' ' PRO . 97.7 Cg_exo -45.45 -147.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.859 3.04 . . . . 0.0 113.711 -174.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.208 HG13 ' O ' ' A' ' 98' ' ' SER . 26.4 pt -156.33 -126.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.044 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.504 ' N ' HG13 ' A' ' 73' ' ' ILE . 57.0 mtpt -146.71 133.36 19.91 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.045 0.841 . . . . 0.0 110.789 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.748 ' H ' ' HA ' ' A' ' 97' ' ' ASP . 7.4 t-20 -59.36 170.16 1.05 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.886 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.49 ' H ' ' ND2' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -178.02 165.78 1.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.412 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.758 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 175.65 -34.11 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.255 -176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 1.005 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 48.7 p-10 -67.17 -44.97 78.39 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.025 0.828 . . . . 0.0 110.319 -176.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 1.005 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 33.6 p-10 41.9 -101.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.221 0.951 . . . . 0.0 110.337 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 170.46 -69.97 0.13 Allowed Glycine 0 N--CA 1.473 1.116 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.762 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -38.47 159.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.693 0.878 . . . . 0.0 112.285 179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 38.3 ptt180 -58.93 -139.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.569 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.8 t-20 171.14 130.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.133 -174.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -167.55 152.64 7.08 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.202 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.643 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 39.8 ptt180 -40.69 125.51 2.25 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.585 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 1.007 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 113.33 -28.98 8.25 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.776 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.136 HG22 ' NZ ' ' A' ' 127' ' ' LYS . 17.8 p -79.97 131.0 35.72 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.824 0.821 . . . . 0.0 111.484 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.569 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -87.42 160.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.005 167.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.07 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -162.1 141.46 9.64 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.473 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 1.265 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -66.86 122.03 16.79 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.67 -176.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.14 ' O ' ' SD ' ' A' ' 90' ' ' MET . . . -81.0 -166.38 1.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.278 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.086 ' CD ' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER 179.71 -149.7 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.83 175.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.086 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 55.3 m -167.2 -108.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.765 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.495 ' N ' HG22 ' A' ' 93' ' ' THR . . . -70.69 -93.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.467 1.104 . . . . 0.0 110.538 -171.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 97' ' ' ASP . 32.7 m-20 -43.9 117.06 1.1 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.133 0.896 . . . . 0.0 110.954 -175.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.127 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 53.6 mtmt -71.35 42.18 0.07 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.696 1.247 . . . . 0.0 111.087 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 1.127 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 90.7 m-20 179.27 86.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 1.208 ' O ' HG13 ' A' ' 73' ' ' ILE . 67.1 m -168.12 -96.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.679 1.237 . . . . 0.0 109.759 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 1.061 ' O ' ' CD1' ' A' ' 73' ' ' ILE . . . 58.99 94.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.794 1.309 . . . . 0.0 107.947 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.7 p -77.88 -42.77 32.23 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.552 -175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.1 p -170.93 -44.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.247 0.967 . . . . 0.0 110.479 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.791 ' O ' ' HE2' ' A' ' 90' ' ' MET . 3.9 pt20 -36.15 146.05 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.295 0.997 . . . . 0.0 112.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.945 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -157.22 -179.52 8.27 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.881 -1.508 . . . . 0.0 110.405 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.769 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 35.7 p90 -151.03 122.44 7.87 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.271 -169.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.988 HD11 HD21 ' A' ' 18' ' ' LEU . 58.1 mt -94.2 101.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.365 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' OD1' ' HD1' ' A' ' 104' ' ' PHE . 7.3 m-20 -67.14 -175.85 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.778 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.608 HG12 ' CE ' ' A' ' 132' ' ' MET . 35.1 m -155.6 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.68 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -83.95 145.59 28.47 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.421 1.076 . . . . 0.0 110.874 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 36.1 m-20 -45.9 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.847 175.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 1.103 ' OD1' HD11 ' A' ' 113' ' ' LEU . 7.1 t-20 -68.81 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.864 1.353 . . . . 0.0 109.936 -170.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 110' ' ' ASN . . . 70.52 -19.26 0.22 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.857 0.723 . . . . 0.0 112.251 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' HD13 ' A' ' 113' ' ' LEU . 35.5 m-85 -69.38 36.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.68 0.612 . . . . 0.0 111.414 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.103 HD11 ' OD1' ' A' ' 110' ' ' ASN . 0.0 OUTLIER 179.22 -17.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.783 0.677 . . . . 0.0 111.815 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.764 ' N ' HD22 ' A' ' 113' ' ' LEU . 57.4 p-10 -47.85 138.83 8.25 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.683 0.614 . . . . 0.0 111.139 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 1.245 ' CB ' ' O ' ' A' ' 120' ' ' PHE . 1.7 t60 -31.61 131.9 0.11 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.862 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.418 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . -171.4 163.97 36.81 Favored Glycine 0 N--CA 1.477 1.392 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.062 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.531 ' O ' ' HB3' ' A' ' 118' ' ' ARG . 10.3 pt20 -39.32 119.93 0.98 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.229 -0.986 . . . . 0.0 110.995 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.808 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 58.0 ttp180 71.58 27.15 3.04 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.279 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 65.4 t0 177.9 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.011 0.819 . . . . 0.0 109.409 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 1.245 ' O ' ' CB ' ' A' ' 115' ' ' HIS . 1.7 t80 -43.89 -45.61 7.64 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.643 1.215 . . . . 0.0 110.68 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA3' ' N ' ' A' ' 115' ' ' HIS . . . 89.97 176.68 45.18 Favored Glycine 0 N--CA 1.477 1.42 0 O-C-N 124.475 1.109 . . . . 0.0 113.108 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.835 ' CD1' HD23 ' A' ' 113' ' ' LEU . 68.1 m-85 -78.65 143.24 36.51 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.708 -1.246 . . . . 0.0 111.229 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.265 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -54.68 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.59 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.07 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 72.2 t -175.85 128.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.92 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.939 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 21.3 p90 -161.77 21.62 0.11 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.608 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 1.569 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -113.26 155.89 15.99 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 122.939 1.3 . . . . 0.0 112.507 -169.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.136 ' NZ ' HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -171.07 110.99 0.34 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 110.985 -2.608 . . . . 0.0 110.261 173.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.007 HG23 ' O ' ' A' ' 86' ' ' GLY . 58.3 t -58.11 157.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.223 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.052 ' O ' ' HG2' ' A' ' 130' ' ' LYS . 33.1 m -154.44 32.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.231 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 1.052 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 74.5 mmtt 120.92 88.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.773 0.671 . . . . 0.0 109.508 174.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.861 ' CA ' HG22 ' A' ' 16' ' ' ILE . . . 171.78 -26.12 0.09 OUTLIER Glycine 0 N--CA 1.475 1.259 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.04 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 1.608 ' CE ' HG12 ' A' ' 107' ' ' VAL . 12.1 tpt -39.52 -51.17 2.2 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.975 0.456 . . . . 0.0 110.921 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.653 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 36.6 m-20 -43.88 -61.6 1.39 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.37 1.044 . . . . 0.0 109.541 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.835 HG21 ' O ' ' A' ' 15' ' ' ASN . 54.4 t -41.45 -60.7 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 124.739 1.274 . . . . 0.0 109.551 173.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.894 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -44.41 -53.09 7.2 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.654 1.221 . . . . 0.0 109.709 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.922 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 38.2 m-20 -50.69 -66.97 0.3 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.771 1.294 . . . . 0.0 109.03 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.541 ' O ' HG13 ' A' ' 141' ' ' VAL . 56.4 mtpt -40.2 -49.38 2.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.789 1.306 . . . . 0.0 110.539 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.27 ' O ' HG22 ' A' ' 141' ' ' VAL . 16.2 mt -57.84 -58.29 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.444 1.09 . . . . 0.0 108.837 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.658 ' HB3' HG21 ' A' ' 55' ' ' ILE . 84.9 p -65.51 3.42 0.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.922 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.5 mp0 -99.07 -49.39 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.168 0.917 . . . . 0.0 108.741 173.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.27 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.4 m -41.29 123.25 2.15 Favored Pre-proline 0 N--CA 1.473 0.711 0 O-C-N 124.349 1.031 . . . . 0.0 110.306 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.8 Cg_exo -38.83 -178.92 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.35 2.7 . . . . 0.0 113.575 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.41 HG22 ' CA ' ' A' ' 153' ' ' PRO . 6.0 p -160.96 -150.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.735 1.731 . . . . 0.0 112.688 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.77 ' CD2' ' O ' ' A' ' 145' ' ' ASP . 0.8 OUTLIER 178.02 167.34 0.75 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 109.726 -3.397 . . . . 0.0 111.312 174.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.77 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 36.8 m-20 -52.37 -149.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.819 165.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -161.99 -61.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.673 1.225 . . . . 0.0 108.347 171.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.59 -92.18 0.08 OUTLIER Glycine 0 N--CA 1.471 1.001 0 CA-C-N 111.335 -2.666 . . . . 0.0 107.687 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.699 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 80.2 Cg_endo -68.4 -67.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.479 2.786 . . . . 0.0 108.761 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.699 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 96.0 m-85 -72.0 117.05 13.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.583 1.177 . . . . 0.0 110.647 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.755 ' O ' ' HG2' ' A' ' 150' ' ' GLN . 4.3 pm0 -95.03 83.77 4.0 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.75 1.281 . . . . 0.0 107.945 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.767 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 27.6 p30 169.3 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.548 -177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.672 ' CG2' HG21 ' A' ' 146' ' ' VAL . 95.9 t -160.31 116.25 1.45 Allowed Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.739 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.41 ' CA ' HG22 ' A' ' 143' ' ' THR . 58.1 Cg_endo -63.08 106.92 0.58 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 109.304 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.996 ' H ' ' HA ' ' A' ' 143' ' ' THR . 77.5 p -40.59 -51.64 2.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.289 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 1.234 ' HB3' ' CD ' ' A' ' 156' ' ' PRO . 10.8 mptt -61.45 -166.71 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.459 1.099 . . . . 0.0 111.933 176.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.234 ' CD ' ' HB3' ' A' ' 155' ' ' LYS . 78.3 Cg_endo -85.12 145.85 9.89 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.789 2.993 . . . . 0.0 112.733 -170.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.98 HG23 ' O ' ' A' ' 156' ' ' PRO . 38.3 t -170.55 115.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 113.261 -1.79 . . . . 0.0 107.794 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.93 ' HA ' HG22 ' A' ' 45' ' ' THR . 92.1 t -153.57 120.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.24 177.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.997 HG12 HG22 ' A' ' 11' ' ' THR . 43.3 mt -68.58 134.3 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.274 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.143 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.2 mt -79.67 -51.62 9.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 112.39 -2.186 . . . . 0.0 109.284 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 1.191 ' O ' HD23 ' A' ' 9' ' ' LEU . 68.0 m -165.27 174.95 9.65 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.57 1.169 . . . . 0.0 112.697 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.905 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -157.73 100.77 1.78 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.104 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.951 ' O ' ' CD1' ' A' ' 165' ' ' LEU . 32.4 mmmt -125.32 125.81 44.09 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.15 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.845 ' C ' HD12 ' A' ' 165' ' ' LEU . 34.4 m -67.93 131.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.597 1.186 . . . . 0.0 109.824 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.026 HD22 HD13 ' A' ' 8' ' ' LEU . 6.8 mp -133.65 135.63 25.3 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.925 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.72 ' HD3' ' OD2' ' A' ' 4' ' ' ASP . 87.8 Cg_exo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 123.638 2.892 . . . . 0.0 112.027 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.715 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 2.0 tmtp? -48.49 -44.27 35.76 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.703 1.252 . . . . 0.0 110.422 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 1.192 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 179.6 112.53 0.35 Allowed Glycine 0 N--CA 1.475 1.251 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.192 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 85.9 m-20 -171.36 89.64 0.45 Allowed Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.433 0.725 . . . . 0.0 109.303 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.25 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 71.1 Cg_exo -54.94 127.45 26.35 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.832 3.022 . . . . 0.0 113.353 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.25 ' HD2' ' O ' ' A' ' 5' ' ' PRO . 51.9 m170 -150.48 118.11 6.15 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.86 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.2 p -73.98 138.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.208 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.096 ' CG ' ' HG2' ' A' ' 17' ' ' GLU . 6.4 mp -127.78 116.12 19.71 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.471 1.107 . . . . 0.0 109.619 166.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.83 ' HG ' ' HB2' ' A' ' 162' ' ' ALA . 7.1 mp -110.73 -175.96 2.85 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.049 -2.341 . . . . 0.0 108.726 160.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.762 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 52.6 m -161.48 99.9 1.17 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.359 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.926 HG22 HG12 ' A' ' 159' ' ' ILE . 40.7 p -76.29 169.01 19.03 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 125.307 1.629 . . . . 0.0 111.407 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -40.71 -42.17 1.69 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.246 -1.797 . . . . 0.0 110.338 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.825 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.48 -60.54 3.21 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.483 1.115 . . . . 0.0 110.759 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.49 179.65 44.29 Favored Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.345 -1.752 . . . . 0.0 114.012 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 1.146 ' O ' HG21 ' A' ' 134' ' ' VAL . 58.6 t-20 -55.55 159.3 2.95 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.268 -1.466 . . . . 0.0 110.948 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.662 ' N ' ' OD1' ' A' ' 15' ' ' ASN . 10.1 tt -171.36 160.28 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.289 -172.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.096 ' HG2' ' CG ' ' A' ' 8' ' ' LEU . 35.4 mt-10 -162.92 121.48 2.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.109 -170.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.007 HD21 HD11 ' A' ' 105' ' ' ILE . 2.8 mm? -92.01 173.86 7.62 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.403 1.064 . . . . 0.0 110.322 161.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.429 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -134.57 124.12 24.94 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.047 175.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 20' ' ' LEU . 6.5 mp -109.39 141.8 41.26 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.814 1.321 . . . . 0.0 111.735 -168.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.738 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 63.0 m-20 -55.86 -118.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.892 170.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.995 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 5.8 tmtt? 124.66 -48.62 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.131 -1.85 . . . . 0.0 109.517 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -45.81 -65.3 0.56 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.625 1.203 . . . . 0.0 109.727 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.906 ' HD3' HD21 ' A' ' 81' ' ' LEU . 53.3 mtpt -90.61 21.92 3.75 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.704 1.253 . . . . 0.0 113.87 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.584 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . -160.85 65.18 2.16 Favored Pre-proline 0 N--CA 1.476 0.838 0 O-C-N 124.205 0.941 . . . . 0.0 110.57 173.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.95 ' O ' HG22 ' A' ' 29' ' ' VAL . 52.4 Cg_exo -59.66 -59.76 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.533 2.822 . . . . 0.0 110.965 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.1 t -50.4 -63.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.151 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -42.67 -57.55 2.67 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.7 1.25 . . . . 0.0 110.51 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.95 HG22 ' O ' ' A' ' 26' ' ' PRO . 26.8 m -52.75 -47.14 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 124.666 1.229 . . . . 0.0 110.871 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 29' ' ' VAL . 42.6 tp60 -46.93 -70.36 0.1 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.179 0.924 . . . . 0.0 109.931 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 1.218 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 12.3 m-80 -42.07 -48.39 4.67 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.454 1.096 . . . . 0.0 110.312 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.718 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 69.7 t80 -42.98 -63.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.504 1.128 . . . . 0.0 109.759 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.0 t -45.51 -37.42 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.602 1.189 . . . . 0.0 111.021 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 1.218 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 84.2 m-20 -43.02 -63.44 0.8 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.063 0.852 . . . . 0.0 109.705 174.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.671 ' HB3' ' CD2' ' A' ' 40' ' ' PHE . 96.2 m-85 -61.13 -59.27 5.6 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.796 1.31 . . . . 0.0 109.095 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.722 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 59.9 t -39.41 -48.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 124.69 1.243 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.771 ' O ' ' HB3' ' A' ' 38' ' ' SER . 50.4 t30 -38.56 -31.23 0.05 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.725 1.266 . . . . 0.0 112.401 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.771 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.0 p 154.89 159.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.103 0.877 . . . . 0.0 113.151 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.44 -39.64 3.1 Favored Glycine 0 N--CA 1.474 1.212 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.117 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.671 ' CD2' ' HB3' ' A' ' 35' ' ' TYR . 2.1 t80 -67.78 -81.93 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.361 0.683 . . . . 0.0 110.92 -173.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 81.6 m-85 -60.87 -36.74 79.97 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.336 1.022 . . . . 0.0 112.669 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 52.2 p-10 -38.95 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.089 0.868 . . . . 0.0 110.767 -171.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.956 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 10.7 m-20 76.59 39.47 0.25 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 113.49 -1.687 . . . . 0.0 111.633 175.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 45' ' ' THR . 48.9 p -78.66 -129.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 166.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.986 ' HA ' HG13 ' A' ' 159' ' ' ILE . 61.7 p -163.44 -147.42 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.824 1.297 . . . . 0.0 113.59 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.727 ' CD1' HD11 ' A' ' 159' ' ' ILE . 16.7 m-85 -161.54 59.52 0.27 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 111.579 -2.555 . . . . 0.0 105.222 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 1.208 ' CE1' ' OE1' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -38.68 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.489 -173.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.143 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.0 mmm180 -173.35 -155.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 123.081 1.42 . . . . 0.0 113.33 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.044 HG12 ' HA ' ' A' ' 55' ' ' ILE . 7.6 p -179.7 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 111.682 -2.508 . . . . 0.0 107.539 159.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.886 HG22 ' HB2' ' A' ' 54' ' ' MET . 9.3 tt -171.75 131.3 0.74 Allowed Pre-proline 0 N--CA 1.476 0.873 0 O-C-N 124.451 1.094 . . . . 0.0 109.983 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.682 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 81.9 Cg_exo -48.85 157.7 1.5 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.893 3.062 . . . . 0.0 114.398 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.24 53.38 0.01 OUTLIER Glycine 0 N--CA 1.475 1.284 0 CA-C-N 114.02 -1.445 . . . . 0.0 114.192 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.047 ' CE2' ' HE3' ' A' ' 54' ' ' MET . 1.5 t80 -162.14 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.665 0.862 . . . . 0.0 110.037 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.047 ' HE3' ' CE2' ' A' ' 53' ' ' PHE . 45.0 mtt -160.18 147.57 16.3 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.231 0.957 . . . . 0.0 111.611 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.044 ' HA ' HG12 ' A' ' 49' ' ' VAL . 38.4 pt -148.62 141.66 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.276 -1.783 . . . . 0.0 108.19 167.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 1.468 ' C ' ' HA ' ' A' ' 104' ' ' PHE . 62.5 mt-30 -64.75 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.146 -163.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 1.11 ' HA2' ' CB ' ' A' ' 56' ' ' GLN . . . -129.3 -121.17 2.32 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 118.667 -2.521 . . . . 0.0 109.928 0.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . 52.97 109.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.063 0 CA-C-N 114.271 -0.965 . . . . 0.0 111.22 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.86 -126.01 1.11 Allowed Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.525 0.779 . . . . 0.0 111.717 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.862 ' CE2' ' HG2' ' A' ' 66' ' ' GLN . 29.8 m-85 -43.08 134.02 3.65 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.788 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.967 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 61.7 p -59.36 124.67 20.8 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.265 0.978 . . . . 0.0 109.837 169.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 1.129 ' CG ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 13.11 -104.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.757 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 1.24 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.5 mm100 -38.11 -59.99 0.8 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.778 1.299 . . . . 0.0 111.445 -175.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 1.24 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 14.6 mmt 145.11 98.43 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.925 ' OE1' ' O ' ' A' ' 64' ' ' MET . 29.4 mm100 -160.65 71.04 0.42 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 112.621 -2.081 . . . . 0.0 106.966 177.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.862 ' HG2' ' CE2' ' A' ' 60' ' ' PHE . 39.6 mt-30 -28.52 130.73 0.06 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.24 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.967 ' HE3' ' CG2' ' A' ' 61' ' ' THR . 18.6 mmtp -72.57 153.7 41.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.396 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 7.5 mmpt? -48.03 95.33 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.799 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.865 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 71.4 Cg_exo -59.12 -69.79 0.04 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.593 2.862 . . . . 0.0 113.192 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.925 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 34.8 m120 89.75 163.28 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.998 0 O-C-N 124.402 1.064 . . . . 0.0 111.132 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.925 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 58.6 Cg_endo -67.71 112.04 2.54 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.875 3.05 . . . . 0.0 110.88 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.212 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 88.5 Cg_exo -52.1 -150.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.798 2.998 . . . . 0.0 112.957 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.569 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.52 156.79 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 1.043 ' H ' ' HD2' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -33.3 135.89 0.1 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.192 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' LYS . 56.6 p30 -45.7 -164.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.44 176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB3' HD21 ' A' ' 79' ' ' ASN . 8.4 mm-40 161.67 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.589 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.848 ' HB3' ' CE1' ' A' ' 120' ' ' PHE . . . -71.29 -43.26 67.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.251 0.969 . . . . 0.0 109.791 171.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 1.064 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 20.9 p-10 -67.41 -53.5 28.61 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.424 1.077 . . . . 0.0 109.907 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 76' ' ' GLU . 38.5 p-10 -63.51 99.26 0.2 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.237 1.018 . . . . 0.0 108.876 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 1.232 ' O ' HD13 ' A' ' 81' ' ' LEU . . . 172.22 46.87 0.04 OUTLIER Glycine 0 N--CA 1.468 0.771 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.359 -1.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.232 HD13 ' O ' ' A' ' 80' ' ' GLY . 1.7 mm? -146.14 -149.29 0.28 Allowed 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.626 0.839 . . . . 0.0 109.499 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -179.74 150.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.327 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -169.49 -124.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.519 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 1.114 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 16.2 m -168.6 163.46 12.25 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.025 0.828 . . . . 0.0 112.004 -162.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 1.114 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 8.3 ptm85 -19.92 108.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.19 164.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.743 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 137.2 -27.03 2.92 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 111.575 -2.557 . . . . 0.0 110.233 -168.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.153 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.2 p -92.66 142.82 26.95 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.91 0.862 . . . . 0.0 112.191 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.894 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.74 162.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 112.69 -2.05 . . . . 0.0 109.094 166.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.117 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -156.01 140.97 17.26 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 113.943 -1.48 . . . . 0.0 111.829 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.916 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.1 tpt -56.88 140.3 48.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.507 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . . . -109.38 129.3 55.54 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.457 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.28 ' HG2' ' N ' ' A' ' 99' ' ' ALA . 29.9 tpt180 179.15 175.98 0.62 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.765 175.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.707 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 89.6 m -168.3 115.86 0.7 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.563 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.796 ' O ' ' CG ' ' A' ' 95' ' ' ASP . . . 165.01 -50.69 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.255 -1.338 . . . . 0.0 109.025 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.796 ' CG ' ' O ' ' A' ' 94' ' ' ALA . 16.0 p30 74.37 -177.39 0.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.541 1.151 . . . . 0.0 112.323 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.174 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 0.4 OUTLIER 79.94 -49.29 0.36 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.763 -172.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 1.174 ' OD1' ' O ' ' A' ' 96' ' ' LYS . 73.7 m-20 -162.45 61.32 0.22 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.617 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . 21.6 t -74.22 173.75 9.72 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.773 1.296 . . . . 0.0 113.333 -170.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 1.28 ' N ' ' HG2' ' A' ' 92' ' ' ARG . . . 65.01 170.93 0.2 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.76 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.996 HG22 ' HG3' ' A' ' 72' ' ' PRO . 72.8 p -150.93 -48.41 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.297 -174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.0 p -171.07 -52.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.257 0.973 . . . . 0.0 110.179 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.694 ' O ' ' SD ' ' A' ' 90' ' ' MET . 19.3 pt20 -42.83 154.22 0.07 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.353 1.033 . . . . 0.0 112.183 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.894 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -159.28 168.73 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.456 175.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 1.468 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 17.1 p90 -144.49 137.68 27.07 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.326 -170.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.069 ' N ' ' O ' ' A' ' 56' ' ' GLN . 63.1 mt -93.95 116.65 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 112.057 -2.338 . . . . 0.0 110.612 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -64.86 116.51 6.41 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.5 1.125 . . . . 0.0 109.572 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.871 ' HB ' ' C ' ' A' ' 53' ' ' PHE . 51.9 t -90.44 22.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 124.488 1.118 . . . . 0.0 112.133 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.852 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . 169.21 172.53 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.609 0.719 . . . . 0.0 112.108 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.558 ' N ' ' HB3' ' A' ' 85' ' ' ARG . 71.7 m-20 -38.62 144.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.596 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.548 HD21 ' HB2' ' A' ' 113' ' ' LEU . 26.6 t-20 -170.57 155.95 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.435 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . 176.13 -50.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.465 -1.698 . . . . 0.0 108.296 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.953 ' HD1' ' O ' ' A' ' 112' ' ' PHE . 3.2 p90 -61.26 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 167.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.76 HD11 ' CE1' ' A' ' 122' ' ' TYR . 36.9 tp 177.92 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.103 -171.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 122' ' ' TYR . 34.0 m-20 -38.47 -60.91 0.75 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.282 0.989 . . . . 0.0 111.182 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.601 ' ND1' ' HA ' ' A' ' 120' ' ' PHE . 0.5 OUTLIER 179.05 84.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.587 1.179 . . . . 0.0 108.547 -175.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 117' ' ' GLN . . . 171.22 100.96 0.14 Allowed Glycine 0 N--CA 1.473 1.157 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.584 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.568 HE21 ' HG2' ' A' ' 118' ' ' ARG . 35.1 tt0 176.14 -92.14 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.602 0.824 . . . . 0.0 109.292 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.568 ' HG2' HE21 ' A' ' 117' ' ' GLN . 26.4 mmm180 -69.57 -46.29 66.73 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.08 0.862 . . . . 0.0 111.023 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -173.29 -47.56 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.295 0.997 . . . . 0.0 111.092 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.848 ' CE1' ' HB3' ' A' ' 77' ' ' ALA . 1.3 t80 -178.03 83.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.36 -130.44 0.09 OUTLIER Glycine 0 N--CA 1.473 1.156 0 CA-C-N 113.829 -1.532 . . . . 0.0 114.137 -167.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.76 ' CE1' HD11 ' A' ' 113' ' ' LEU . 76.3 m-85 -78.93 150.41 32.1 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.499 -1.351 . . . . 0.0 112.674 -167.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.117 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -81.11 -163.15 0.56 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.6 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.993 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 73.9 t 179.39 140.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.111 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.681 ' CZ ' ' HD2' ' A' ' 103' ' ' PHE . 9.8 p90 -164.76 22.56 0.06 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 1.217 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -171.73 -136.3 2.1 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-O 122.976 1.32 . . . . 0.0 113.745 173.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.429 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 8.7 mtpm? 179.6 -133.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 111.275 -2.463 . . . . 0.0 109.162 -172.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.903 HG22 ' CD1' ' A' ' 18' ' ' LEU . 80.4 t -153.36 120.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.573 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.933 ' CG1' ' CB ' ' A' ' 17' ' ' GLU . 7.7 p -69.85 -46.49 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.104 172.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.809 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 58.5 mtpt -166.66 -135.43 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.449 1.093 . . . . 0.0 108.87 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . 62.36 -17.36 0.07 OUTLIER Glycine 0 N--CA 1.474 1.212 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.01 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.542 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 8.3 tpt -39.57 -42.88 1.23 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 117.009 0.404 . . . . 0.0 110.355 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 12.1 m-20 -45.02 -56.92 4.2 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.438 1.087 . . . . 0.0 109.72 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 1.146 HG21 ' O ' ' A' ' 15' ' ' ASN . 59.5 t -46.5 -57.17 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 124.474 1.109 . . . . 0.0 109.167 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -44.4 -53.69 6.6 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.618 1.199 . . . . 0.0 109.672 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.819 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 42.0 m-20 -51.96 -64.37 0.84 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.623 1.202 . . . . 0.0 108.854 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 134' ' ' VAL . 56.0 tptt -39.83 -54.07 2.18 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.86 1.35 . . . . 0.0 110.552 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.199 ' O ' HG12 ' A' ' 141' ' ' VAL . 21.0 mt -59.74 -58.68 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.561 1.163 . . . . 0.0 109.363 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.3 p -55.13 -8.73 0.32 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.819 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 40.4 mm-40 -96.2 -44.69 7.16 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 124.356 1.035 . . . . 0.0 110.082 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.199 HG12 ' O ' ' A' ' 138' ' ' ILE . 8.0 p -48.96 131.48 15.02 Favored Pre-proline 0 N--CA 1.474 0.741 0 O-C-N 124.417 1.073 . . . . 0.0 110.444 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 86.3 Cg_exo -46.9 172.02 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.649 2.9 . . . . 0.0 113.795 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.366 HG22 ' CA ' ' A' ' 153' ' ' PRO . 2.9 p -161.06 -140.74 0.06 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.225 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.679 ' HD2' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 179.0 158.43 0.56 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 110.942 -2.844 . . . . 0.0 112.696 169.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 45.1 t0 -50.38 -179.68 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.734 165.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.924 HG21 ' CG2' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -158.03 -143.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -178.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.59 -110.33 0.01 OUTLIER Glycine 0 N--CA 1.472 1.059 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 171.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.982 ' HG2' ' HD1' ' A' ' 149' ' ' TYR . 94.6 Cg_endo -71.81 -46.7 0.54 Allowed 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 123.8 3.0 . . . . 0.0 110.259 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.982 ' HD1' ' HG2' ' A' ' 148' ' ' PRO . 34.9 m-85 -68.56 109.43 3.74 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.429 1.081 . . . . 0.0 110.933 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.569 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 7.6 mm-40 -84.94 64.47 8.68 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.213 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.839 ' HB2' ' HB2' ' A' ' 48' ' ' ARG . 54.7 p30 178.74 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.284 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.924 ' CG2' HG21 ' A' ' 146' ' ' VAL . 94.1 t -154.84 118.26 2.51 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.803 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.366 ' CA ' HG22 ' A' ' 143' ' ' THR . 61.0 Cg_endo -67.18 110.37 1.98 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.656 2.904 . . . . 0.0 109.736 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.728 ' H ' ' HA ' ' A' ' 143' ' ' THR . 40.0 t -44.95 -62.46 1.22 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.383 175.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.582 ' O ' ' HB2' ' A' ' 153' ' ' PRO . 67.3 mttm -66.99 140.65 96.18 Favored Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 124.633 1.208 . . . . 0.0 109.513 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 73.4 Cg_endo -88.11 114.82 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.107 2.538 . . . . 0.0 113.346 -161.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 158' ' ' VAL . 44.7 t -76.97 148.72 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.7 157.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.883 ' HA ' HG22 ' A' ' 45' ' ' THR . 95.8 t -163.67 122.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.88 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.986 HG13 ' HA ' ' A' ' 45' ' ' THR . 20.6 mt -68.01 130.49 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.361 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.762 ' HB2' ' O ' ' A' ' 10' ' ' THR . 84.7 mt -79.83 -48.05 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 112.535 -2.12 . . . . 0.0 110.171 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.7 m -162.84 -167.78 1.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 124.564 1.165 . . . . 0.0 112.484 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.83 ' HB2' ' HG ' ' A' ' 9' ' ' LEU . . . -178.99 139.66 0.16 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.283 -1.781 . . . . 0.0 109.703 -175.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 8' ' ' LEU . 22.0 ptmt -170.85 126.27 0.71 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.743 -175.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.39 145.48 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.989 -1.46 . . . . 0.0 110.617 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.989 ' HB3' ' HD3' ' A' ' 166' ' ' PRO . 55.2 tp -58.52 -59.87 12.14 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.974 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.989 ' HD3' ' HB3' ' A' ' 165' ' ' LEU . 82.1 Cg_exo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 123.242 2.628 . . . . 0.0 111.985 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.733 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 63.1 pttt 151.34 163.46 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.733 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 1.252 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . -168.69 -69.52 0.03 OUTLIER Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.252 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 73.1 m-20 -169.74 86.18 0.59 Allowed Pre-proline 0 N--CA 1.473 0.704 0 O-C-N 124.561 0.8 . . . . 0.0 108.989 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.453 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 71.9 Cg_endo -62.53 118.65 5.54 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.496 2.798 . . . . 0.0 109.653 173.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.453 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.1 m170 -158.23 97.99 1.54 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.621 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.992 ' HA ' HG12 ' A' ' 164' ' ' VAL . 87.1 t -61.02 79.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 165.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.095 ' HB3' ' O ' ' A' ' 163' ' ' LYS . 7.3 tt -79.86 106.91 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.356 -169.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.155 HD23 ' O ' ' A' ' 161' ' ' SER . 12.3 mt -103.64 171.88 7.12 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 113.163 -1.835 . . . . 0.0 112.331 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 1.274 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 94.6 m -160.52 79.08 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.9 -2.409 . . . . 0.0 107.084 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.956 HG22 HG12 ' A' ' 159' ' ' ILE . 32.4 p -74.73 167.1 22.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 125.132 1.52 . . . . 0.0 111.952 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.558 ' OG ' HG13 ' A' ' 157' ' ' VAL . 78.3 p -41.41 -49.52 3.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.459 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.681 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -54.47 -55.88 24.44 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.424 1.078 . . . . 0.0 110.289 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' HG11 ' A' ' 134' ' ' VAL . . . 171.48 -179.95 42.92 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.911 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.887 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 10.4 t-20 -57.82 159.14 5.65 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.545 -1.328 . . . . 0.0 111.97 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.786 HG13 ' HB2' ' A' ' 9' ' ' LEU . 19.3 pt -162.59 -173.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.903 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.892 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 7.2 mm-40 -161.27 126.81 3.7 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.284 -170.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.953 HD21 HD11 ' A' ' 105' ' ' ILE . 2.9 mm? -112.0 114.04 26.69 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.547 1.154 . . . . 0.0 108.925 164.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.947 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 11.9 pt-20 -79.53 111.13 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.503 1.127 . . . . 0.0 108.53 169.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.811 HD23 ' CE2' ' A' ' 125' ' ' PHE . 7.2 mp -108.56 131.58 54.71 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.881 1.363 . . . . 0.0 110.775 -174.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.954 ' OD1' ' NZ ' ' A' ' 127' ' ' LYS . 40.1 m-20 -57.33 -123.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.037 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.739 ' HG3' ' N ' ' A' ' 23' ' ' GLN . 22.2 ptmt 142.65 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.372 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.739 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 3.9 pt20 -49.74 -44.31 48.47 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.72 1.262 . . . . 0.0 110.473 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 1.078 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -68.55 -15.07 63.41 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.305 1.003 . . . . 0.0 112.906 -178.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.008 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -160.73 72.36 2.81 Favored Pre-proline 0 N--CA 1.475 0.81 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 75.6 Cg_exo -55.91 -64.44 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.633 2.889 . . . . 0.0 111.73 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.673 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 66.4 t -53.18 -67.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 124.68 1.237 . . . . 0.0 109.911 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.742 ' HA ' HG13 ' A' ' 73' ' ' ILE . 58.8 m -44.67 -61.71 1.47 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.579 1.174 . . . . 0.0 109.853 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 25' ' ' ALA . 47.3 t -49.25 -52.56 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 124.786 1.304 . . . . 0.0 109.92 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.537 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 38.6 tp60 -41.81 -61.47 1.1 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.475 1.109 . . . . 0.0 110.049 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.698 ' CG ' HG21 ' A' ' 73' ' ' ILE . 13.2 m-80 -42.91 -51.91 5.35 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.564 1.165 . . . . 0.0 109.765 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.958 ' O ' HG23 ' A' ' 36' ' ' VAL . 78.9 t80 -40.64 -57.76 1.79 Allowed 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.629 1.206 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.823 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 57.6 t -51.18 -38.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.754 1.283 . . . . 0.0 111.316 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.789 ' O ' ' CG ' ' A' ' 37' ' ' ASN . 8.4 p-10 -44.9 -55.51 5.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.951 0.782 . . . . 0.0 109.362 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.88 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 54.5 m-85 -69.64 -53.73 17.3 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 112.921 -1.945 . . . . 0.0 109.09 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.958 HG23 ' O ' ' A' ' 32' ' ' PHE . 61.9 t -39.39 -50.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.164 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.789 ' CG ' ' O ' ' A' ' 34' ' ' ASP . 51.0 p30 -37.92 -33.4 0.08 Allowed 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.703 1.252 . . . . 0.0 112.098 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.766 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.3 p 146.4 136.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.239 0.962 . . . . 0.0 112.028 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 1.064 ' N ' ' OD1' ' A' ' 42' ' ' ASN . . . 131.14 -59.25 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.51 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.896 ' O ' HG23 ' A' ' 44' ' ' THR . 61.1 t80 -62.99 -74.35 0.1 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.164 -1.018 . . . . 0.0 110.291 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.446 ' CG ' ' HD1' ' A' ' 40' ' ' PHE . 68.5 m-85 -66.75 -25.08 66.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.485 1.115 . . . . 0.0 112.913 -173.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 1.064 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 14.0 m120 -38.75 -36.59 0.27 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.902 0.751 . . . . 0.0 112.467 -173.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.615 HD21 HG13 ' A' ' 158' ' ' VAL . 2.0 t-20 -157.97 47.46 0.37 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.124 0.89 . . . . 0.0 110.325 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.896 HG23 ' O ' ' A' ' 40' ' ' PHE . 46.2 p -79.71 -133.17 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.314 164.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.959 ' HA ' HG13 ' A' ' 159' ' ' ILE . 77.8 p -162.96 -153.03 0.23 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.87 0.843 . . . . 0.0 111.817 173.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.072 ' HZ ' HD13 ' A' ' 9' ' ' LEU . 14.4 m-30 -141.85 63.42 1.42 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.174 -1.83 . . . . 0.0 106.585 174.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 1.085 ' CE1' ' HA2' ' A' ' 59' ' ' GLY . 1.1 p-80 -51.94 -72.67 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.684 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.896 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 84.2 mtm180 -71.49 130.48 41.37 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.42 1.075 . . . . 0.0 111.075 -173.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.926 HG23 ' HB ' ' A' ' 55' ' ' ILE . 10.9 p -159.96 157.36 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.844 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.078 HD13 ' HD2' ' A' ' 53' ' ' PHE . 9.9 tt -155.7 127.04 3.66 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.484 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 94.2 Cg_exo -38.7 155.14 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.577 2.851 . . . . 0.0 113.486 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -3.23 66.59 0.0 OUTLIER Glycine 0 N--CA 1.475 1.266 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.888 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.078 ' HD2' HD13 ' A' ' 50' ' ' ILE . 10.9 t80 -161.02 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.808 0.946 . . . . 0.0 109.443 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.866 ' HG2' ' N ' ' A' ' 55' ' ' ILE . 54.2 ttp -167.62 177.45 5.87 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.484 1.115 . . . . 0.0 111.958 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.926 ' HB ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 171.39 113.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 113.686 -1.597 . . . . 0.0 108.12 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 66.6 mt-30 -98.62 -170.65 1.98 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.232 -166.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.22 28.79 Favored Glycine 0 N--CA 1.477 1.377 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.533 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.762 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 93.27 -59.69 2.28 Favored Glycine 0 N--CA 1.474 1.206 0 N-CA-C 107.414 -2.274 . . . . 0.0 107.414 -165.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 1.085 ' HA2' ' CE1' ' A' ' 47' ' ' HIS . . . 41.34 143.65 0.0 OUTLIER Glycine 0 N--CA 1.472 1.074 0 CA-C-N 114.212 -0.994 . . . . 0.0 114.014 168.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.905 ' HD2' ' SD ' ' A' ' 64' ' ' MET . 14.1 m-30 -46.89 150.7 0.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.406 -1.397 . . . . 0.0 110.673 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.273 HG21 ' OE1' ' A' ' 65' ' ' GLN . 94.8 m -59.08 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.316 -174.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 1.129 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 1.5 mp0 48.51 116.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.758 1.286 . . . . 0.0 110.745 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 1.31 ' O ' ' CG ' ' A' ' 64' ' ' MET . 8.5 pt20 69.02 -48.83 0.59 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.558 1.161 . . . . 0.0 111.0 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 1.31 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 25.0 mmt 158.38 98.22 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.981 1.372 . . . . 0.0 108.715 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 1.273 ' OE1' HG21 ' A' ' 61' ' ' THR . 48.4 tt0 -150.46 79.71 1.34 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 111.014 -2.812 . . . . 0.0 105.187 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.792 ' O ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -27.04 176.81 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.404 -1.725 . . . . 0.0 115.627 -166.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.199 ' H ' ' CD ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -48.07 -140.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 111.412 -2.631 . . . . 0.0 112.271 -174.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 1.06 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 40.2 ttpt 178.31 -70.94 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 113.3 -1.773 . . . . 0.0 108.076 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 1.06 ' CD ' ' HB3' ' A' ' 68' ' ' LYS . 59.8 Cg_endo -62.56 133.09 40.85 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.589 2.859 . . . . 0.0 111.011 173.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.518 ' HA ' ' CG2' ' A' ' 100' ' ' THR . 92.2 m-20 -168.61 72.14 0.8 Allowed Pre-proline 0 N--CA 1.474 0.725 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.033 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 80.0 Cg_exo -48.29 -64.06 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.391 2.728 . . . . 0.0 110.937 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.15 ' CB ' ' HA ' ' A' ' 98' ' ' SER . 50.3 Cg_exo -87.71 -140.63 0.16 OUTLIER 'Cis proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.798 -1.751 . . . . 0.0 110.835 -2.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.318 HD11 ' O ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -158.6 150.95 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.564 0.697 . . . . 0.0 110.94 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HA ' ' CG ' ' A' ' 97' ' ' ASP . 74.4 mmtt -30.14 145.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.877 -1.51 . . . . 0.0 113.049 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 1.219 ' OD1' ' HB3' ' A' ' 96' ' ' LYS . 40.4 m-80 -42.77 -167.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.22 -1.355 . . . . 0.0 112.272 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.223 ' OE1' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER 161.19 118.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.231 -177.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.882 ' HB2' HH11 ' A' ' 92' ' ' ARG . . . 174.06 -51.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.897 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 1.008 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 59.8 p30 -70.35 39.07 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.501 1.126 . . . . 0.0 111.693 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 77' ' ' ALA . 4.6 p30 -40.6 -41.43 1.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.281 0.988 . . . . 0.0 110.976 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.819 ' O ' HD23 ' A' ' 81' ' ' LEU . . . 64.02 71.06 0.91 Allowed Glycine 0 N--CA 1.47 0.916 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.819 HD23 ' O ' ' A' ' 80' ' ' GLY . 79.9 mt -163.94 -179.54 6.33 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.871 0.983 . . . . 0.0 111.022 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.716 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 35.4 mmt180 -72.72 138.63 46.69 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.321 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.0 m120 -155.12 132.8 11.31 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.827 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 m -166.75 154.82 9.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.967 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.872 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 78.2 ttt180 -34.12 110.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 113.932 -1.486 . . . . 0.0 110.687 169.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 1.372 ' HA2' ' ND2' ' A' ' 106' ' ' ASN . . . -137.53 79.22 0.31 Allowed Glycine 0 N--CA 1.469 0.844 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.564 3.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.098 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 48.1 p -60.55 139.47 57.76 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.823 0.954 . . . . 0.0 111.107 172.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.385 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -79.82 158.16 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 113.598 -1.637 . . . . 0.0 108.474 162.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.986 ' CB ' ' HA ' ' A' ' 124' ' ' VAL . . . -160.41 129.95 5.08 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.633 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 1.267 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -60.67 122.05 13.76 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.422 -177.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.194 ' O ' ' HG3' ' A' ' 92' ' ' ARG . . . -51.41 -173.52 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.441 1.088 . . . . 0.0 111.795 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.194 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 81.9 mtp180 179.43 105.84 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.738 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.3 m -52.67 -86.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.763 1.289 . . . . 0.0 110.14 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.9 -71.54 0.41 Allowed 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.946 1.404 . . . . 0.0 108.525 -177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 96' ' ' LYS . 35.8 m-20 -46.14 128.35 9.39 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.41 1.069 . . . . 0.0 110.433 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.219 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 8.3 mtpm? -42.15 -103.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.531 1.145 . . . . 0.0 110.582 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.9 ' OD1' ' ND2' ' A' ' 75' ' ' ASN . 33.0 m-20 -53.06 114.22 1.38 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.64 1.212 . . . . 0.0 109.21 175.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 1.15 ' HA ' ' CB ' ' A' ' 72' ' ' PRO . 40.3 t -175.28 -44.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.562 1.164 . . . . 0.0 111.093 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 1.318 ' O ' HD11 ' A' ' 73' ' ' ILE . . . -34.81 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.096 0.873 . . . . 0.0 110.411 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 1.518 ' CG2' ' HA ' ' A' ' 70' ' ' ASN . 74.3 p -78.85 -37.04 41.41 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.608 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.417 ' C ' ' HE2' ' A' ' 90' ' ' MET . 78.7 p -170.07 -48.52 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.092 0.87 . . . . 0.0 110.634 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.899 ' HG3' ' HB3' ' A' ' 91' ' ' ALA . 3.9 pt20 -36.9 151.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.215 0.947 . . . . 0.0 112.114 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.904 ' HB2' HD11 ' A' ' 88' ' ' ILE . 11.6 p90 -157.18 -167.71 2.41 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.415 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.935 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 27.7 p90 -158.15 121.1 3.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.927 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.953 HD11 HD21 ' A' ' 18' ' ' LEU . 65.1 mt -90.0 104.87 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.74 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 1.372 ' ND2' ' HA2' ' A' ' 86' ' ' GLY . 5.0 p-10 -63.87 153.21 37.5 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.259 0.974 . . . . 0.0 110.408 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.969 HG12 ' SD ' ' A' ' 132' ' ' MET . 32.6 m -141.53 47.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.026 176.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.618 ' O ' ' OD1' ' A' ' 110' ' ' ASN . . . 170.15 140.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.528 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 1.123 ' O ' ' OD1' ' A' ' 110' ' ' ASN . 32.3 m-20 -30.93 138.72 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 1.123 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 15.9 m-20 -158.18 157.3 32.42 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.049 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.155 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . 172.31 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.722 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.515 ' CE1' ' HA ' ' A' ' 110' ' ' ASN . 32.6 p90 -39.64 -42.65 1.23 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.58 1.175 . . . . 0.0 110.238 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.958 HD11 ' CD2' ' A' ' 122' ' ' TYR . 68.1 tp -58.98 -52.33 66.23 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.396 1.06 . . . . 0.0 109.619 175.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 1.155 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 57.4 p-10 -40.08 138.4 0.84 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.523 1.139 . . . . 0.0 111.815 -176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 1.008 ' CD2' ' HB3' ' A' ' 78' ' ' ASP . 4.0 t60 -36.62 113.52 0.24 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.809 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -176.56 -96.17 0.1 Allowed Glycine 0 N--CA 1.472 1.092 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.728 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 6.3 tp60 -47.79 110.77 0.35 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.673 0.867 . . . . 0.0 109.775 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 117' ' ' GLN . 99.0 mtt180 91.76 -74.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.043 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 59.0 p30 179.04 -174.15 0.18 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.806 1.316 . . . . 0.0 111.794 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.918 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 78.7 m-85 -45.17 172.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.87 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.35 -110.34 0.26 Allowed Glycine 0 N--CA 1.474 1.206 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.328 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.958 ' CD2' HD11 ' A' ' 113' ' ' LEU . 89.1 m-85 -78.77 116.3 19.02 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.808 0.946 . . . . 0.0 109.937 -176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.267 ' HB3' ' O ' ' A' ' 90' ' ' MET . . . -49.94 -158.41 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.247 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.085 HG23 ' O ' ' A' ' 123' ' ' ALA . 45.7 t 179.28 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.811 ' CE2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -164.11 27.74 0.07 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.251 0.97 . . . . 0.0 111.135 178.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 1.385 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -150.92 -173.07 20.59 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 122.983 1.324 . . . . 0.0 112.223 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.174 ' HG3' ' O ' ' A' ' 126' ' ' GLY . 36.2 mtmm 177.8 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 111.47 -2.365 . . . . 0.0 108.864 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.128 HG21 ' CE ' ' A' ' 132' ' ' MET . 62.8 t -40.03 116.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.59 1.181 . . . . 0.0 110.311 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.721 HG21 ' ND1' ' A' ' 6' ' ' HIS . 85.0 t -58.35 -51.43 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.392 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER 162.26 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.609 1.193 . . . . 0.0 108.798 179.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -166.38 22.46 0.12 Allowed Glycine 0 N--CA 1.475 1.237 0 O-C-N 124.826 1.329 . . . . 0.0 112.713 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 1.128 ' CE ' HG21 ' A' ' 128' ' ' VAL . 20.9 mmt -53.51 -22.22 7.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.439 171.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.742 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 63.2 t0 -47.88 -60.58 2.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.883 HG21 ' O ' ' A' ' 15' ' ' ASN . 87.2 t -62.31 -73.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 124.735 1.272 . . . . 0.0 109.423 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.705 ' O ' ' OG ' ' A' ' 139' ' ' SER . . . -39.95 -52.47 2.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.473 1.108 . . . . 0.0 110.373 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 1.013 ' OD2' ' HB3' ' A' ' 132' ' ' MET . 49.1 m-20 -60.8 -66.64 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 124.821 1.325 . . . . 0.0 108.382 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.97 ' O ' HG13 ' A' ' 141' ' ' VAL . 24.8 ttmm -34.49 -49.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.607 1.192 . . . . 0.0 110.363 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.252 ' O ' HG22 ' A' ' 141' ' ' VAL . 49.6 mt -60.31 -55.47 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 124.755 1.285 . . . . 0.0 107.909 168.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.89 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . 39.0 m -64.42 0.68 0.96 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.774 -1.557 . . . . 0.0 114.828 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.805 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 3.7 mp0 -107.03 -44.87 4.28 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.345 1.028 . . . . 0.0 109.017 173.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.252 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.3 m -40.07 127.97 1.64 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.287 0.992 . . . . 0.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 141' ' ' VAL . 89.9 Cg_exo -37.57 177.13 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.355 2.703 . . . . 0.0 113.418 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.345 HG22 ' CA ' ' A' ' 153' ' ' PRO . 10.1 p -160.83 -151.18 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 123.56 1.648 . . . . 0.0 112.74 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.747 ' HD2' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 178.38 165.26 0.78 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 110.03 -3.259 . . . . 0.0 111.488 171.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.668 ' O ' HG22 ' A' ' 146' ' ' VAL . 46.4 t0 -52.14 -150.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.501 166.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.841 HG22 ' HB ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -161.16 -142.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 171.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -67.05 -102.97 0.02 OUTLIER Glycine 0 N--CA 1.471 0.991 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 166.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.55 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 86.4 Cg_endo -77.5 -53.91 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.919 3.079 . . . . 0.0 109.917 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 146' ' ' VAL . 61.7 m-85 -69.25 122.44 18.86 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.587 1.179 . . . . 0.0 111.604 -172.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' A' ' 150' ' ' GLN . 29.5 mm-40 -74.48 -176.66 2.81 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.063 170.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.61 ' O ' HG23 ' A' ' 152' ' ' VAL . 10.6 m120 48.73 86.78 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.716 175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.841 ' HB ' HG22 ' A' ' 146' ' ' VAL . 88.1 t -161.94 105.28 1.15 Allowed Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.337 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.345 ' CA ' HG22 ' A' ' 143' ' ' THR . 85.9 Cg_exo -45.12 139.83 8.12 Favored 'Trans proline' 0 C--N 1.331 -0.383 0 C-N-CA 123.409 2.739 . . . . 0.0 112.119 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 1.068 ' N ' ' HA ' ' A' ' 143' ' ' THR . 80.2 p -73.74 44.64 0.17 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.604 174.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.615 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 17.2 tppt? -178.51 72.71 0.21 Allowed Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 155' ' ' LYS . 80.9 Cg_exo -46.37 108.38 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.73 2.953 . . . . 0.0 112.362 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG13 ' OG ' ' A' ' 12' ' ' SER . 89.3 t -68.98 154.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.505 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.858 ' HA ' HG22 ' A' ' 45' ' ' THR . 76.7 t -141.45 118.03 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.997 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.959 HG13 ' HA ' ' A' ' 45' ' ' THR . 35.3 mt -69.06 135.38 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.035 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.274 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.8 mt -85.22 -49.16 8.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.701 -2.045 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 1.155 ' O ' HD23 ' A' ' 9' ' ' LEU . 34.7 t -170.46 161.04 7.75 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.434 1.084 . . . . 0.0 112.245 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.979 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -137.53 61.08 1.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.534 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 1.095 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 47.9 mmtm -69.92 93.15 0.75 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.49 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.992 HG12 ' HA ' ' A' ' 7' ' ' VAL . 34.6 m -71.54 132.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.42 1.075 . . . . 0.0 110.383 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.998 HD23 ' HB2' ' A' ' 6' ' ' HIS . 3.3 mm? -78.23 121.97 84.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.359 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 165' ' ' LEU . 66.9 Cg_endo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 123.583 2.855 . . . . 0.0 109.752 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -46.51 153.97 0.33 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.819 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.76 -129.04 1.15 Allowed Glycine 0 N--CA 1.474 1.209 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.959 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.1 ' O ' ' NE2' ' A' ' 6' ' ' HIS . 2.3 m-20 -46.65 152.09 0.96 Allowed Pre-proline 0 N--CA 1.473 0.705 0 CA-C-N 114.425 -0.887 . . . . 0.0 111.873 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.44 ' C ' ' HD2' ' A' ' 6' ' ' HIS . 80.8 Cg_exo -41.38 173.49 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.631 2.887 . . . . 0.0 113.864 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.44 ' HD2' ' C ' ' A' ' 5' ' ' PRO . 8.0 m170 -153.16 121.97 6.45 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.732 -176.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.977 HG12 ' HB2' ' A' ' 18' ' ' LEU . 7.9 p -73.79 116.74 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.427 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.782 ' HG ' ' CD ' ' A' ' 17' ' ' GLU . 6.5 mp -79.81 151.09 30.48 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.359 1.076 . . . . 0.0 110.748 169.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.152 ' O ' HG12 ' A' ' 16' ' ' ILE . 6.9 mt -160.59 96.54 1.16 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.559 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 1.206 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 97.0 m -88.14 79.98 7.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.637 -2.528 . . . . 0.0 107.969 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 1.065 HG22 HG12 ' A' ' 159' ' ' ILE . 37.0 p -73.24 169.72 16.48 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 125.018 1.449 . . . . 0.0 111.516 176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 80.0 p -39.71 -46.24 1.84 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 113.235 -1.802 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -60.37 -54.83 40.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.462 1.101 . . . . 0.0 110.623 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.01 173.76 39.65 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 113.767 -1.561 . . . . 0.0 113.597 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.892 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 5.5 t-20 -61.82 143.54 56.16 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.451 -1.374 . . . . 0.0 110.868 175.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.152 HG12 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -144.2 -178.12 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.982 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.902 ' HG2' ' O ' ' A' ' 130' ' ' LYS . 6.9 mm-40 -160.13 101.88 1.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.92 -165.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 105' ' ' ILE . 2.4 mm? -85.0 161.03 19.91 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.297 0.998 . . . . 0.0 110.409 164.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.206 ' OE1' ' CD ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -127.27 110.84 13.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.529 173.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 125' ' ' PHE . 3.0 mm? -79.37 -170.9 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.826 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -164.69 87.05 0.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.011 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.131 ' HA ' HG11 ' A' ' 29' ' ' VAL . 19.8 ptpt -59.16 -34.62 72.32 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.842 1.339 . . . . 0.0 112.303 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.549 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 11.3 tp-100 -41.07 -64.36 0.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.206 0.941 . . . . 0.0 110.69 -172.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -69.97 -5.43 26.2 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.792 1.308 . . . . 0.0 113.896 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.811 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.18 71.59 3.05 Favored Pre-proline 0 N--CA 1.475 0.812 0 O-C-N 123.818 0.699 . . . . 0.0 109.449 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 1.238 ' O ' HG22 ' A' ' 29' ' ' VAL . 57.5 Cg_exo -54.2 -64.69 0.15 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.667 2.912 . . . . 0.0 111.109 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.702 HG23 ' H ' ' A' ' 28' ' ' SER . 15.6 m -50.1 -62.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 124.734 1.271 . . . . 0.0 110.368 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.702 ' H ' HG23 ' A' ' 27' ' ' VAL . 42.1 t -41.82 -56.39 2.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.445 1.09 . . . . 0.0 110.466 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.238 HG22 ' O ' ' A' ' 26' ' ' PRO . 34.6 m -48.82 -45.07 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 124.734 1.272 . . . . 0.0 110.554 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 23.3 tp60 -45.7 -62.26 1.37 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.241 0.963 . . . . 0.0 109.551 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 1.03 ' OD1' HG21 ' A' ' 73' ' ' ILE . 11.0 m120 -47.35 -60.85 2.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.701 1.251 . . . . 0.0 109.497 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.529 ' HE1' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 t80 -43.24 -62.75 0.96 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.353 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 29' ' ' VAL . 61.3 t -49.26 -33.13 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 124.78 1.3 . . . . 0.0 111.452 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.939 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 55.2 m-20 -45.86 -63.68 0.92 Allowed 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.916 0.76 . . . . 0.0 109.771 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.74 ' CB ' ' HD1' ' A' ' 40' ' ' PHE . 19.7 m-85 -58.76 -61.89 2.28 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.826 1.329 . . . . 0.0 108.577 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.972 ' HA ' ' HB2' ' A' ' 40' ' ' PHE . 62.6 t -42.53 -53.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.308 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -39.99 -33.58 0.23 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.713 1.258 . . . . 0.0 111.867 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 35' ' ' TYR . 83.0 p -173.44 136.54 0.6 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.273 0.983 . . . . 0.0 110.578 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.41 43.91 35.6 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.297 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.972 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . 57.1 t80 -61.38 -96.06 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.73 ' OH ' ' HB3' ' A' ' 101' ' ' SER . 22.3 m-30 -133.12 58.32 1.77 Allowed 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.149 0.905 . . . . 0.0 109.04 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 49.1 p-10 -77.92 108.8 11.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.186 174.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 1.231 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 1.8 t-20 67.46 58.75 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.538 1.148 . . . . 0.0 109.742 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.724 ' C ' ' HB ' ' A' ' 159' ' ' ILE . 32.6 p -104.2 -128.85 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.635 169.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.845 ' HA ' HG13 ' A' ' 159' ' ' ILE . 67.2 p -162.35 -176.93 5.36 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.906 0.86 . . . . 0.0 113.077 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.904 ' CD1' HD11 ' A' ' 159' ' ' ILE . 7.4 m-30 -126.74 72.41 1.34 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 112.99 -1.914 . . . . 0.0 106.953 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.883 ' CD2' ' HG2' ' A' ' 48' ' ' ARG . 5.5 p-80 -58.27 -71.45 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.015 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.024 ' O ' ' OE1' ' A' ' 56' ' ' GLN . 22.9 mmt85 -69.19 123.85 22.24 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.386 1.054 . . . . 0.0 110.833 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG22 HG12 ' A' ' 55' ' ' ILE . 90.8 t -162.0 140.05 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.976 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.852 HG22 ' SD ' ' A' ' 54' ' ' MET . 10.5 tt -155.17 126.76 3.71 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.101 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' PHE . 97.9 Cg_exo -39.45 168.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 123.555 2.836 . . . . 0.0 113.79 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -4.02 66.86 0.0 OUTLIER Glycine 0 N--CA 1.474 1.196 0 CA-C-N 114.102 -1.408 . . . . 0.0 114.051 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' PRO . 1.4 t80 -161.16 -61.15 0.05 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.761 0.918 . . . . 0.0 108.847 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.852 ' SD ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -170.7 -175.61 1.87 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.494 1.121 . . . . 0.0 111.717 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.761 HG12 HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER 174.65 113.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.549 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 1.024 ' OE1' ' O ' ' A' ' 48' ' ' ARG . 3.5 mp0 -96.8 -174.51 3.02 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.047 -169.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 46' ' ' PHE . . . -166.91 178.83 41.02 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.934 165.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 1.014 ' O ' ' HB3' ' A' ' 102' ' ' GLN . . . 61.44 103.99 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 CA-C-N 113.728 -1.236 . . . . 0.0 110.712 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.81 -129.95 1.42 Allowed Glycine 0 N--CA 1.475 1.259 0 O-C-N 124.649 0.852 . . . . 0.0 111.701 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.931 ' CD1' ' HG2' ' A' ' 66' ' ' GLN . 12.6 m-30 -51.23 139.79 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.818 -1.191 . . . . 0.0 111.822 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.973 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 92.4 m -61.09 141.87 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.132 171.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.6 pt-20 -28.6 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.981 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 29.7 mt-30 90.58 43.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.804 1.315 . . . . 0.0 110.981 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.598 ' SD ' ' HD2' ' A' ' 60' ' ' PHE . 21.4 mmt 58.1 12.67 1.94 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.029 0.831 . . . . 0.0 113.148 174.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.973 ' O ' ' HB ' ' A' ' 61' ' ' THR . 88.0 mt-30 -79.41 65.22 4.51 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.931 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 30.2 mt-30 -39.45 132.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.181 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -58.62 -109.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.124 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.644 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 61.5 pttt -154.55 66.53 5.22 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.294 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 1.061 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 31.5 Cg_exo -70.51 -151.31 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.424 2.749 . . . . 0.0 112.588 -175.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.061 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 40.2 p30 67.34 78.65 0.24 Allowed Pre-proline 0 N--CA 1.472 0.627 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.642 169.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.854 ' HB2' ' C ' ' A' ' 72' ' ' PRO . 52.6 Cg_exo -49.53 -60.39 0.87 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.316 2.677 . . . . 0.0 109.438 173.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.9 ' O ' HG23 ' A' ' 73' ' ' ILE . 45.2 Cg_exo -89.7 -160.27 1.33 Allowed 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.556 -2.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.105 HD11 ' O ' ' A' ' 99' ' ' ALA . 2.1 pp -161.7 145.1 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.902 0.858 . . . . 0.0 111.822 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 74' ' ' LYS . 28.6 mtpp -45.32 161.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.225 -1.807 . . . . 0.0 113.809 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.743 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 52.5 p-10 -74.68 -160.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.248 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.743 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 10.1 tp10 145.25 130.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.011 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.934 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -162.6 -36.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.291 0.994 . . . . 0.0 112.002 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.764 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 58.6 p30 -67.24 -37.66 83.9 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.104 0.877 . . . . 0.0 111.975 -169.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.764 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 16.7 p-10 45.13 -119.41 0.77 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.112 0.883 . . . . 0.0 109.736 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . 164.6 -55.56 0.27 Allowed Glycine 0 N--CA 1.474 1.173 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' O ' ' A' ' 80' ' ' GLY . 46.3 mt -39.64 177.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.692 0.877 . . . . 0.0 112.807 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.731 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 36.9 mmt180 -68.84 149.18 49.24 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.5 -1.682 . . . . 0.0 110.055 168.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.731 ' ND2' ' O ' ' A' ' 82' ' ' ARG . 23.7 m120 -156.12 129.09 7.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.921 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 85' ' ' ARG . 15.8 m -169.33 157.98 7.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.843 -173.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' THR . 63.0 ttt180 -23.13 99.13 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.953 170.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.776 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 143.24 -17.35 2.31 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 111.433 -2.621 . . . . 0.0 110.855 -171.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.03 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 34.9 p -106.25 146.08 30.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.286 1.041 . . . . 0.0 112.755 -174.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.027 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.27 164.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 112.354 -2.203 . . . . 0.0 109.075 171.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.902 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -161.76 141.23 9.99 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.594 -176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.891 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 6.7 ttm -57.27 137.67 55.71 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.061 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.062 ' HB3' ' OE1' ' A' ' 102' ' ' GLN . . . -75.6 -59.43 2.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.598 ' HB3' ' CB ' ' A' ' 99' ' ' ALA . 5.3 tpm_? -32.75 169.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.39 1.056 . . . . 0.0 113.844 -172.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.708 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 9.7 t 161.94 162.44 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.634 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.743 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . 83.26 130.51 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.491 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 1.365 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 42.3 m-20 101.37 -57.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.454 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.365 ' CG ' ' O ' ' A' ' 95' ' ' ASP . 10.1 mtmp? 139.31 -94.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.821 1.326 . . . . 0.0 108.147 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -64.24 104.43 0.75 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.817 1.323 . . . . 0.0 109.013 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.924 ' OG ' ' HD3' ' A' ' 92' ' ' ARG . 18.2 t -174.13 -179.72 1.72 Allowed 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.632 1.208 . . . . 0.0 111.814 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 1.598 ' CB ' ' HB3' ' A' ' 92' ' ' ARG . . . 80.33 85.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.83 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 62.9 p -79.72 -40.25 29.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.649 -168.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.73 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 50.3 m -159.27 -73.6 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.288 0.993 . . . . 0.0 109.338 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 1.062 ' OE1' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -38.91 163.44 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.168 -175.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 1.027 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -155.3 -165.28 1.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.1 -172.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.956 ' CZ ' ' HB3' ' A' ' 122' ' ' TYR . 49.3 p90 -154.85 119.16 4.73 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.757 0.789 . . . . 0.0 111.019 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 18' ' ' LEU . 67.1 mt -84.14 110.89 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.453 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.654 HD21 ' HE1' ' A' ' 104' ' ' PHE . 10.7 m120 -61.11 166.79 3.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.372 1.045 . . . . 0.0 111.41 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.657 HG12 ' CE ' ' A' ' 132' ' ' MET . 28.1 m -155.45 42.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.667 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.731 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . 173.6 137.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.379 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -39.55 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.887 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.899 ' OD1' HD11 ' A' ' 113' ' ' LEU . 11.9 t-20 -70.52 -119.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.876 1.36 . . . . 0.0 110.699 -170.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 76.5 -33.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.782 0.677 . . . . 0.0 111.774 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -38.35 -50.46 1.48 Allowed 'General case' 0 N--CA 1.472 0.665 0 O-C-N 124.071 0.857 . . . . 0.0 110.113 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.037 ' H ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -85.98 40.62 0.87 Allowed 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.752 1.282 . . . . 0.0 110.729 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.682 ' O ' ' O ' ' A' ' 113' ' ' LEU . 39.9 p30 -39.21 -117.38 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.733 0.646 . . . . 0.0 111.602 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.9 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 12.1 m-70 179.34 109.65 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.963 0.789 . . . . 0.0 109.946 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 117' ' ' GLN . . . 173.41 109.76 0.23 Allowed Glycine 0 N--CA 1.474 1.204 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.423 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.24 ' O ' ' CG ' ' A' ' 118' ' ' ARG . 71.1 tp60 167.32 -57.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.559 0.8 . . . . 0.0 109.533 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 1.24 ' CG ' ' O ' ' A' ' 117' ' ' GLN . 37.7 mmt180 159.41 61.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.574 1.171 . . . . 0.0 109.375 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 1.069 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 97.4 m-20 -179.99 -55.9 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.337 1.023 . . . . 0.0 110.301 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.659 ' HB2' ' O ' ' A' ' 119' ' ' ASP . 7.0 m-85 81.36 102.23 0.06 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.43 1.081 . . . . 0.0 108.422 -170.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.86 -130.48 0.01 OUTLIER Glycine 0 N--CA 1.471 1.013 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.97 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.956 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 71.1 m-85 -79.5 135.37 36.62 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.958 -1.121 . . . . 0.0 111.344 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.183 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -67.17 -148.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.309 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.183 HG23 ' O ' ' A' ' 123' ' ' ALA . 37.1 t 177.39 133.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.9 ' HZ ' ' HD2' ' A' ' 103' ' ' PHE . 24.2 p90 -171.32 26.13 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.808 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -166.68 -149.98 6.19 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-O 122.8 1.222 . . . . 0.0 114.084 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.206 ' CD ' ' OE1' ' A' ' 19' ' ' GLU . 29.7 mtpp -169.42 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 111.597 -2.301 . . . . 0.0 110.373 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.54 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 63.3 t -156.13 159.16 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.094 -175.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.766 ' O ' ' CD ' ' A' ' 130' ' ' LYS . 62.4 t -152.54 -43.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.992 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.902 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 32.4 mmmt -167.02 101.46 0.54 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 122.204 1.002 . . . . 0.0 109.032 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.428 ' O ' ' OD1' ' A' ' 133' ' ' ASP . . . -179.77 141.07 4.53 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.726 0.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.824 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 22.7 mmt -47.86 -26.11 1.55 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.963 -1.118 . . . . 0.0 111.805 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 37.8 p-10 -47.93 -55.09 10.73 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.668 HG11 HG23 ' A' ' 16' ' ' ILE . 51.4 t -62.68 -68.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 124.378 1.049 . . . . 0.0 108.999 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 132' ' ' MET . . . -42.65 -47.15 5.24 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.667 1.229 . . . . 0.0 110.905 -177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 1.016 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 41.4 m-20 -50.47 -71.0 0.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.473 1.108 . . . . 0.0 109.424 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.675 ' O ' HG13 ' A' ' 141' ' ' VAL . 56.8 mtmt -42.97 -43.57 4.23 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.712 1.258 . . . . 0.0 110.463 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 141' ' ' VAL . 14.5 mt -58.57 -61.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.634 ' HA ' HG11 ' A' ' 49' ' ' VAL . 84.5 p -68.54 16.83 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.426 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 1.016 ' HG2' ' O ' ' A' ' 136' ' ' ASP . 60.6 mm-40 -115.36 -47.05 2.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.295 0.997 . . . . 0.0 109.368 176.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.7 m -47.65 127.92 10.78 Favored Pre-proline 0 N--CA 1.472 0.662 0 O-C-N 124.443 1.089 . . . . 0.0 110.1 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 141' ' ' VAL . 86.2 Cg_exo -38.09 176.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.338 2.692 . . . . 0.0 113.374 175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.45 HG22 ' CA ' ' A' ' 153' ' ' PRO . 8.5 p -160.83 -150.03 0.2 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 123.727 1.727 . . . . 0.0 112.932 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.701 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER 178.52 165.26 0.81 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 109.725 -3.398 . . . . 0.0 111.035 173.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.708 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 36.7 m-20 -50.86 -148.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.962 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -161.28 -148.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.729 0.643 . . . . 0.0 109.282 170.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -65.31 -100.15 0.02 OUTLIER Glycine 0 N--CA 1.471 0.97 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 168.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.68 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 98.5 Cg_endo -73.49 -61.5 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.788 2.992 . . . . 0.0 109.321 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 146' ' ' VAL . 80.2 m-85 -69.78 120.77 16.04 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 124.606 1.191 . . . . 0.0 111.373 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.708 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 9.8 mm100 -68.89 -157.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.861 167.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.758 ' O ' HG23 ' A' ' 152' ' ' VAL . 10.7 m120 36.25 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.061 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 146' ' ' VAL . 70.1 t -164.56 118.89 1.01 Allowed Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.238 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.45 ' CA ' HG22 ' A' ' 143' ' ' THR . 57.2 Cg_endo -66.21 111.97 2.18 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.646 2.897 . . . . 0.0 109.842 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.937 ' H ' ' HA ' ' A' ' 143' ' ' THR . 69.6 p -42.66 -52.85 4.73 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 124.743 1.277 . . . . 0.0 109.143 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -67.24 132.33 93.4 Favored Pre-proline 0 N--CA 1.474 0.742 0 O-C-N 124.572 1.17 . . . . 0.0 109.503 170.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.38 161.04 43.55 Favored 'Trans proline' 0 N--CA 1.474 0.345 0 C-N-CA 123.658 2.905 . . . . 0.0 113.436 -172.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.552 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 55.5 t -151.18 95.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.571 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 45' ' ' THR . 91.8 t -88.58 121.24 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.711 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.231 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 11.0 mt -68.93 125.36 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.906 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.206 ' HB2' ' O ' ' A' ' 10' ' ' THR . 85.3 mt -79.82 -51.26 9.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.212 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.788 ' O ' HD23 ' A' ' 9' ' ' LEU . 56.0 m -158.58 177.35 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.694 1.246 . . . . 0.0 112.206 -176.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.868 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . . . -170.63 119.8 0.55 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.098 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.436 ' O ' HD13 ' A' ' 8' ' ' LEU . 21.4 ptmt -170.75 131.37 0.86 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.302 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.893 HG13 HG11 ' A' ' 36' ' ' VAL . 35.9 m -69.01 142.33 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.9 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.975 HD12 ' HD2' ' A' ' 166' ' ' PRO . 58.6 tp -58.35 123.4 65.86 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.735 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.975 ' HD2' HD12 ' A' ' 165' ' ' LEU . 85.6 Cg_exo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 123.583 2.856 . . . . 0.0 112.12 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.851 ' O ' ' HB2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.851 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER 140.89 41.81 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.702 1.251 . . . . 0.0 110.566 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 1.273 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 157.5 127.86 1.0 Allowed Glycine 0 N--CA 1.476 1.334 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.273 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 52.4 m-20 -165.43 102.49 0.76 Allowed Pre-proline 0 N--CA 1.475 0.775 0 O-C-N 124.492 0.76 . . . . 0.0 109.301 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.4 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 86.7 Cg_exo -45.04 179.0 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.639 2.893 . . . . 0.0 113.942 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.4 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 22.1 m170 -154.55 117.75 4.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.148 -176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.039 HG22 ' HB2' ' A' ' 18' ' ' LEU . 30.2 m -71.76 109.19 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 124.387 1.054 . . . . 0.0 109.184 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.26 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 7.3 mp -79.26 131.08 36.05 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.383 1.052 . . . . 0.0 110.285 177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.044 ' O ' HG12 ' A' ' 16' ' ' ILE . 8.6 mp -138.45 96.76 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.333 173.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 1.186 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 95.3 m -86.2 81.98 8.21 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.768 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.978 HG22 HG12 ' A' ' 159' ' ' ILE . 33.5 p -72.91 167.6 20.66 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.931 1.394 . . . . 0.0 111.41 174.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.8 p -39.49 -43.78 1.31 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.358 -1.747 . . . . 0.0 110.61 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.777 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -53.9 -61.94 1.98 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.471 1.107 . . . . 0.0 110.228 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.34 177.64 46.38 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 113.151 -1.84 . . . . 0.0 113.365 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.765 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 1.2 t-20 -77.82 89.46 4.05 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.476 -1.362 . . . . 0.0 109.684 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.044 HG12 ' O ' ' A' ' 9' ' ' LEU . 7.0 pt -77.9 175.01 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.308 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.917 ' OE2' ' HG ' ' A' ' 8' ' ' LEU . 6.2 mm-40 -159.73 100.08 1.43 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.4 -168.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.039 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.6 mm? -80.97 164.3 22.66 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.398 1.061 . . . . 0.0 110.712 166.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.948 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 40.0 tt0 -130.19 129.83 43.92 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.312 -1.767 . . . . 0.0 108.475 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.042 ' HA ' ' O ' ' A' ' 125' ' ' PHE . 6.6 mp -117.53 116.56 27.37 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.964 1.415 . . . . 0.0 109.726 -169.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -70.37 104.9 2.84 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.314 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.71 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.9 ttmp? -69.0 -45.79 69.65 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.663 1.227 . . . . 0.0 111.542 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -47.77 -70.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.333 1.02 . . . . 0.0 110.256 -171.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 1.263 ' NZ ' HD21 ' A' ' 81' ' ' LEU . 61.6 mttp -71.94 13.1 0.32 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.77 1.294 . . . . 0.0 114.016 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.659 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -160.63 68.7 2.69 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 124.034 0.834 . . . . 0.0 109.486 174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.853 ' O ' HG22 ' A' ' 29' ' ' VAL . 51.6 Cg_exo -60.73 -63.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.475 2.784 . . . . 0.0 111.061 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 67.0 t -54.96 -62.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.137 -176.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 t -42.2 -58.49 2.13 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.643 1.214 . . . . 0.0 110.472 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 26' ' ' PRO . 32.2 m -51.75 -46.97 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 O-C-N 124.735 1.272 . . . . 0.0 110.622 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.497 ' N ' HG23 ' A' ' 29' ' ' VAL . 1.2 tm0? -48.58 -69.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.239 0.962 . . . . 0.0 108.949 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 1.306 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 12.7 m-80 -45.08 -51.71 9.88 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.557 1.161 . . . . 0.0 109.75 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' VAL . 77.4 t80 -42.54 -59.65 1.81 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.598 1.186 . . . . 0.0 109.646 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.688 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 60.9 t -47.44 -37.3 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.707 1.254 . . . . 0.0 111.101 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 1.306 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 15.3 m-20 -43.84 -62.6 1.06 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.012 0.82 . . . . 0.0 109.381 174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -61.27 -59.37 5.41 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.152 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.933 ' HA ' ' CE2' ' A' ' 41' ' ' TYR . 59.5 t -39.4 -48.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.976 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.803 ' O ' ' HB3' ' A' ' 38' ' ' SER . 1.9 t-20 -38.42 -32.38 0.07 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.779 1.299 . . . . 0.0 112.015 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.803 ' HB3' ' O ' ' A' ' 37' ' ' ASN . 89.2 p 149.32 165.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.138 0.899 . . . . 0.0 113.005 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 42' ' ' ASN . . . 87.6 -42.46 3.12 Favored Glycine 0 N--CA 1.474 1.198 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.356 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.632 ' CE1' ' HA2' ' A' ' 58' ' ' GLY . 28.4 t80 -67.11 -74.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.527 0.78 . . . . 0.0 109.888 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.933 ' CE2' ' HA ' ' A' ' 36' ' ' VAL . 79.9 m-85 -61.69 -29.49 70.12 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.513 1.133 . . . . 0.0 112.628 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 39' ' ' GLY . 19.3 m-20 -38.6 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.011 0.819 . . . . 0.0 111.312 -169.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 1.143 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.5 m-20 44.24 47.81 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.265 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.835 ' O ' HG23 ' A' ' 45' ' ' THR . 28.6 m -78.59 -123.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 168.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 1.046 HG22 ' HA ' ' A' ' 158' ' ' VAL . 46.1 p -165.02 -143.8 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.254 1.026 . . . . 0.0 112.493 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CD2' HG21 ' A' ' 11' ' ' THR . 65.4 m-85 -159.63 66.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.5 -2.137 . . . . 0.0 106.834 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.884 ' CD2' ' HG3' ' A' ' 48' ' ' ARG . 1.4 p-80 -51.72 -68.98 0.13 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.191 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.884 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 99.2 mtt180 -69.68 124.07 23.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.51 1.131 . . . . 0.0 110.296 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 49' ' ' VAL . 34.4 m -158.21 94.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 124.74 1.275 . . . . 0.0 109.374 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.898 HG21 ' HD2' ' A' ' 53' ' ' PHE . 57.2 mt -77.27 123.75 87.04 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.334 175.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 53' ' ' PHE . 82.4 Cg_exo -37.65 144.02 0.16 Allowed 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.271 2.647 . . . . 0.0 112.525 174.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 12.23 55.53 0.01 OUTLIER Glycine 0 N--CA 1.474 1.218 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.651 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.898 ' HD2' HG21 ' A' ' 50' ' ' ILE . 1.6 t80 -144.33 -63.1 0.37 Allowed 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.778 0.929 . . . . 0.0 109.05 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.701 ' HE2' HD12 ' A' ' 50' ' ' ILE . 27.2 ptt? -179.56 114.91 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.386 1.054 . . . . 0.0 111.102 -176.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.836 ' CD1' ' HB1' ' A' ' 135' ' ' ALA . 30.7 pt -84.73 160.29 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.791 165.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.787 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 20.0 mt-30 -156.58 162.35 39.9 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.804 0.69 . . . . 0.0 111.781 -173.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.79 -154.07 7.05 Favored Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.272 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 102' ' ' GLN . . . 65.85 73.88 0.57 Allowed Glycine 0 N--CA 1.47 0.952 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 1.22 ' HA2' ' CD ' ' A' ' 67' ' ' LYS . . . -179.83 -122.83 0.8 Allowed Glycine 0 N--CA 1.474 1.216 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.507 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 68.5 m-85 -45.18 132.91 7.12 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.622 0.836 . . . . 0.0 110.499 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.781 ' HA ' HG23 ' A' ' 44' ' ' THR . 88.6 m -59.2 -57.91 10.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.214 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.722 ' HG2' HG21 ' A' ' 45' ' ' THR . 0.1 OUTLIER -168.46 -75.7 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.614 1.196 . . . . 0.0 108.064 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -72.93 46.81 0.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.5 1.125 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.833 ' HE1' HG21 ' A' ' 152' ' ' VAL . 53.9 mtt 39.44 36.69 0.23 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.121 0.888 . . . . 0.0 111.961 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -78.14 87.46 4.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -30.69 147.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.69 -1.595 . . . . 0.0 113.418 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.22 ' CD ' ' HA2' ' A' ' 59' ' ' GLY . 47.4 mtmt -56.53 -131.12 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 112.849 -1.978 . . . . 0.0 112.393 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 1.14 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 46.6 mmtm 179.27 79.66 0.17 Allowed Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 112.641 -2.072 . . . . 0.0 106.363 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.812 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 47.8 Cg_endo -71.89 -165.88 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.606 2.871 . . . . 0.0 113.345 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.998 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 91.4 m-20 -166.54 170.76 5.19 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 113.237 -1.801 . . . . 0.0 109.923 -172.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 32.9 Cg_endo -45.44 104.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.606 2.204 . . . . 0.0 109.184 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' O ' ' A' ' 71' ' ' PRO . 96.5 Cg_exo -44.58 -146.36 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.818 3.012 . . . . 0.0 113.603 -175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 99' ' ' ALA . 27.4 pt -160.18 141.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 124.387 1.054 . . . . 0.0 110.476 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 29.1 mtpp -36.44 159.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.749 -1.569 . . . . 0.0 113.322 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 1.322 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 8.2 t-20 -43.12 169.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.285 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.322 ' HG2' ' O ' ' A' ' 75' ' ' ASN . 11.4 mm-40 172.98 128.84 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.478 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.439 ' HB1' ' CD2' ' A' ' 115' ' ' HIS . . . 174.12 -40.28 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.976 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 52.9 p-10 -67.22 -43.71 81.36 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.299 0.999 . . . . 0.0 110.649 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 22.2 p30 -51.86 132.35 31.73 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.114 0.884 . . . . 0.0 110.325 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.639 ' H ' HD12 ' A' ' 81' ' ' LEU . . . -171.78 -62.11 0.04 OUTLIER Glycine 0 N--CA 1.474 1.199 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.263 HD21 ' NZ ' ' A' ' 24' ' ' LYS . 6.2 mp 81.6 -32.25 0.1 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.632 0.843 . . . . 0.0 112.444 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 16.4 ptp180 178.89 73.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.645 1.216 . . . . 0.0 110.211 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.61 HD22 ' HB3' ' A' ' 110' ' ' ASN . 1.2 p-10 -72.68 142.88 48.25 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.869 1.356 . . . . 0.0 111.204 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 m -169.28 148.04 3.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.419 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.713 ' HB3' ' CA ' ' A' ' 108' ' ' ALA . 51.6 ptt85 -42.03 101.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.05 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.774 ' O ' HG23 ' A' ' 128' ' ' VAL . . . 144.19 -29.04 1.94 Allowed Glycine 0 N--CA 1.473 1.107 0 CA-C-N 111.934 -2.393 . . . . 0.0 109.899 -169.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 20.5 p -83.56 129.85 34.98 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.716 0.77 . . . . 0.0 111.225 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.485 HG23 ' CA ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER -84.26 156.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 112.808 -1.996 . . . . 0.0 108.793 166.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.092 ' O ' ' CD2' ' A' ' 104' ' ' PHE . . . -165.31 128.69 2.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.332 -1.758 . . . . 0.0 110.659 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.78 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 32.7 ttm -59.38 173.9 0.47 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.196 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.742 ' H ' ' HG3' ' A' ' 90' ' ' MET . . . -167.57 164.14 14.68 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.507 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.867 ' CG ' ' HA ' ' A' ' 99' ' ' ALA . 2.4 mmm-85 179.65 119.08 0.05 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.486 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 93.4 m -40.47 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.532 1.145 . . . . 0.0 110.438 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 93' ' ' THR . . . 71.39 -67.9 0.24 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.858 1.349 . . . . 0.0 109.175 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.769 ' O ' ' HB3' ' A' ' 96' ' ' LYS . 59.3 m-20 66.13 -84.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.705 1.253 . . . . 0.0 110.109 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.769 ' HB3' ' O ' ' A' ' 95' ' ' ASP . 87.4 tttt 95.02 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.865 1.353 . . . . 0.0 109.213 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -165.88 81.16 0.3 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 73' ' ' ILE . 66.3 m -163.06 -116.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.781 1.301 . . . . 0.0 110.565 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.867 ' HA ' ' CG ' ' A' ' 92' ' ' ARG . . . 54.27 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.644 1.215 . . . . 0.0 107.751 -169.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.4 p -77.71 -35.02 52.52 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.416 -1.265 . . . . 0.0 112.01 -170.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.7 p -170.31 -40.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.273 0.983 . . . . 0.0 110.14 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.738 ' CD ' ' HZ3' ' A' ' 67' ' ' LYS . 29.4 mt-30 -35.62 130.46 0.55 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.275 0.984 . . . . 0.0 111.308 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 1.014 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -143.32 178.87 7.44 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.793 176.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 1.092 ' CD2' ' O ' ' A' ' 89' ' ' ALA . 49.1 p90 -153.2 122.63 6.7 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.052 -170.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.942 HD11 HD21 ' A' ' 18' ' ' LEU . 59.4 mt -91.01 101.1 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.218 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.557 ' O ' HG13 ' A' ' 107' ' ' VAL . 18.1 p-10 -68.62 -173.04 0.41 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.354 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.712 HG22 ' C ' ' A' ' 53' ' ' PHE . 34.2 m -160.04 -42.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.623 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.713 ' CA ' ' HB3' ' A' ' 85' ' ' ARG . . . -74.25 139.71 44.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 124.373 1.046 . . . . 0.0 111.167 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -42.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.954 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.671 ' OD1' HD23 ' A' ' 113' ' ' LEU . 2.7 t30 -68.29 142.93 55.41 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.864 1.352 . . . . 0.0 111.026 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 110' ' ' ASN . . . 168.42 -51.21 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.922 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.762 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 47.5 p90 -66.44 60.65 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.611 1.195 . . . . 0.0 108.109 168.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.982 HD11 ' CD2' ' A' ' 122' ' ' TYR . 59.3 tp 178.31 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.807 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -38.08 125.7 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.821 0.701 . . . . 0.0 111.137 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 1.439 ' CD2' ' HB1' ' A' ' 77' ' ' ALA . 2.0 m-70 -42.92 108.67 0.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.379 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -34.23 -79.18 0.03 OUTLIER Glycine 0 N--CA 1.471 1.026 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.288 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.862 ' OE1' ' NH1' ' A' ' 118' ' ' ARG . 64.4 tt0 177.54 -64.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.677 0.869 . . . . 0.0 108.811 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.862 ' NH1' ' OE1' ' A' ' 117' ' ' GLN . 0.0 OUTLIER -52.2 -100.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.545 1.153 . . . . 0.0 108.75 178.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.76 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 64.0 t0 -64.73 -56.99 10.19 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.83 1.331 . . . . 0.0 110.082 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 1.128 ' HZ ' ' OD1' ' A' ' 75' ' ' ASN . 21.4 p90 57.28 108.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.763 1.29 . . . . 0.0 109.255 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.51 -80.78 0.44 Allowed Glycine 0 N--CA 1.471 0.994 0 CA-C-N 113.638 -1.619 . . . . 0.0 113.734 -167.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.328 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 59.6 m-85 -76.98 130.45 37.5 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.46 0.741 . . . . 0.0 111.837 -161.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.045 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -67.37 -158.29 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.995 174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.048 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 62.7 t 179.48 131.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.312 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 1.042 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 27.1 p90 -170.79 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.007 0.817 . . . . 0.0 111.605 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 1.485 ' CA ' HG23 ' A' ' 88' ' ' ILE . . . -138.35 173.85 22.28 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 123.194 1.441 . . . . 0.0 113.206 -171.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 59.3 tttp 179.7 121.33 0.06 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 110.888 -2.656 . . . . 0.0 110.207 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 86' ' ' GLY . 59.2 t -58.94 156.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.302 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.106 HG21 ' ND1' ' A' ' 6' ' ' HIS . 57.3 t -130.7 -46.99 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.277 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.67 ' HE3' ' C ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER 172.59 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.118 0.886 . . . . 0.0 109.648 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.593 ' HA2' HG13 ' A' ' 128' ' ' VAL . . . 144.99 -147.46 18.64 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 119.778 -1.201 . . . . 0.0 112.426 -4.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.973 ' HG3' ' OD1' ' A' ' 136' ' ' ASP . 6.0 tpt -60.24 -31.15 69.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.939 -1.63 . . . . 0.0 111.878 -173.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 63.7 t0 -47.49 -68.65 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.995 0.809 . . . . 0.0 109.531 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.783 ' HB ' HG22 ' A' ' 16' ' ' ILE . 78.3 t -49.78 -60.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.757 1.286 . . . . 0.0 109.296 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.836 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -44.6 -51.81 8.69 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.567 1.167 . . . . 0.0 110.05 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.973 ' OD1' ' HG3' ' A' ' 132' ' ' MET . 36.4 m-20 -51.86 -70.34 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.683 1.239 . . . . 0.0 109.255 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.536 ' N ' ' OE1' ' A' ' 140' ' ' GLN . 30.5 mtpp -38.6 -44.6 0.99 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.658 1.224 . . . . 0.0 110.708 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.359 ' O ' HG22 ' A' ' 141' ' ' VAL . 30.8 mt -55.61 -58.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 124.374 1.046 . . . . 0.0 108.367 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 136' ' ' ASP . 82.2 p -62.6 2.75 0.25 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.709 1.256 . . . . 0.0 114.129 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.872 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.0 mp0 -96.99 -50.09 4.76 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.289 0.993 . . . . 0.0 108.587 171.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.359 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.2 m -39.93 124.83 1.6 Allowed Pre-proline 0 N--CA 1.473 0.678 0 O-C-N 124.435 1.084 . . . . 0.0 110.652 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 141' ' ' VAL . 83.6 Cg_exo -40.84 178.81 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.469 2.779 . . . . 0.0 113.748 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.203 HG22 ' CA ' ' A' ' 153' ' ' PRO . 6.7 p -161.02 -145.26 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.87 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.92 ' CD2' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER 179.13 142.45 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 110.672 -2.967 . . . . 0.0 111.789 170.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 1.145 ' OD1' ' HG2' ' A' ' 150' ' ' GLN . 61.0 t0 -69.74 111.09 5.27 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.068 -1.878 . . . . 0.0 107.801 168.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.848 HG12 ' H ' ' A' ' 147' ' ' GLY . 2.3 t -78.97 -147.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.115 -169.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.848 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -61.64 -101.96 0.01 OUTLIER Glycine 0 N--CA 1.47 0.911 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 171.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.825 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 95.8 Cg_endo -71.32 -55.78 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.697 2.931 . . . . 0.0 109.508 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.825 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 84.0 m-85 -69.2 102.94 1.8 Allowed 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.632 1.207 . . . . 0.0 110.103 -176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 1.171 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 31.9 mt-30 -86.43 55.41 3.54 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.065 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 1.171 ' OD1' ' O ' ' A' ' 150' ' ' GLN . 75.1 m-20 -172.8 82.74 0.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.92 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 62.9 t -156.04 102.04 2.11 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 124.405 1.065 . . . . 0.0 108.773 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.203 ' CA ' HG22 ' A' ' 143' ' ' THR . 75.7 Cg_exo -46.93 99.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.33 -0.395 0 C-N-CA 123.436 2.757 . . . . 0.0 110.268 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 1.212 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 40.6 t -34.87 -52.93 0.55 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.467 1.104 . . . . 0.0 109.861 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -84.64 85.98 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 164.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.212 ' HD3' ' O ' ' A' ' 154' ' ' SER . 63.1 Cg_endo -79.0 140.78 16.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.606 2.871 . . . . 0.0 112.399 -168.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.567 ' O ' ' CG2' ' A' ' 45' ' ' THR . 92.2 t -68.72 155.07 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.534 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 1.046 ' HA ' HG22 ' A' ' 45' ' ' THR . 98.1 t -142.98 119.44 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.374 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.143 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 32.3 mt -68.36 133.63 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.345 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.186 ' HB2' ' O ' ' A' ' 10' ' ' THR . 86.1 mt -76.36 -52.45 9.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 112.511 -2.131 . . . . 0.0 108.995 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 65.7 m -163.39 -166.11 1.18 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.671 1.232 . . . . 0.0 111.848 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.26 ' HA ' ' O ' ' A' ' 8' ' ' LEU . . . 179.07 119.98 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.347 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.723 ' O ' HD13 ' A' ' 8' ' ' LEU . 65.6 mttm -163.64 126.24 2.55 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.013 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.85 HG13 HG11 ' A' ' 36' ' ' VAL . 33.9 m -67.83 140.27 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.358 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.024 HD12 ' HD2' ' A' ' 166' ' ' PRO . 56.5 tp -157.98 121.03 2.1 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.991 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 1.024 ' HD2' HD12 ' A' ' 165' ' ' LEU . 88.3 Cg_exo . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.646 2.897 . . . . 0.0 112.062 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.733 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.733 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 24.9 ttmm 89.71 -111.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.709 1.256 . . . . 0.0 110.44 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 1.224 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . -174.8 -118.03 0.5 Allowed Glycine 0 N--CA 1.475 1.248 0 O-C-N 124.554 1.159 . . . . 0.0 110.986 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.224 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 71.4 m-20 -167.29 130.08 1.38 Allowed Pre-proline 0 N--CA 1.476 0.871 0 O-C-N 124.506 0.768 . . . . 0.0 110.274 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.332 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 88.3 Cg_exo -50.35 154.78 5.59 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.86 3.04 . . . . 0.0 114.298 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.332 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 28.4 m170 -152.37 118.07 5.38 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.385 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.926 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 9.3 p -66.93 141.8 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.518 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.872 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 6.9 mp -121.11 132.53 54.92 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.424 1.078 . . . . 0.0 110.314 164.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.768 HD12 ' C ' ' A' ' 8' ' ' LEU . 8.2 mp -126.93 -177.38 4.01 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 111.929 -2.396 . . . . 0.0 109.16 164.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.841 HG22 HD12 ' A' ' 160' ' ' LEU . 99.9 m -160.61 90.29 0.86 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.844 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 1.014 HG22 HG12 ' A' ' 159' ' ' ILE . 34.8 p -78.05 169.6 18.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 125.398 1.686 . . . . 0.0 111.216 174.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -39.77 -42.98 1.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.536 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.771 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -58.22 -59.83 4.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.526 1.141 . . . . 0.0 110.572 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.59 178.51 41.36 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 113.529 -1.669 . . . . 0.0 114.201 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 16' ' ' ILE . 63.0 t-20 -61.67 153.83 27.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.08 -1.56 . . . . 0.0 111.063 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.113 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 16.0 pt -164.34 168.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.455 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.113 ' OE1' ' O ' ' A' ' 16' ' ' ILE . 4.3 mm-40 -145.61 113.56 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.473 -1.694 . . . . 0.0 112.059 -163.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.013 HD21 HD11 ' A' ' 105' ' ' ILE . 2.7 mm? -94.71 147.03 23.74 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 124.481 1.113 . . . . 0.0 110.075 165.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.404 ' CD ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -109.56 112.01 23.85 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.203 171.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.887 HD23 ' HE2' ' A' ' 125' ' ' PHE . 6.4 mp -84.33 -158.97 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.541 -170.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.804 ' OD1' ' HG3' ' A' ' 23' ' ' GLN . 61.6 t0 -175.39 110.03 0.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.118 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.667 ' HA ' HG21 ' A' ' 29' ' ' VAL . 28.5 ttpp -96.98 -35.8 10.74 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 124.928 1.393 . . . . 0.0 111.954 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.851 ' OE1' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -42.46 -33.68 0.71 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.179 0.925 . . . . 0.0 112.306 -171.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.851 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 17.9 tppt? -108.01 10.68 28.23 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.283 0.989 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.979 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -161.04 68.84 2.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 O-C-N 123.69 0.619 . . . . 0.0 110.162 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.6 Cg_exo -58.48 -58.46 0.73 Allowed 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.57 2.847 . . . . 0.0 111.264 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 71.0 t -54.32 -69.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.835 1.334 . . . . 0.0 110.165 -175.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.518 ' OG ' ' HB1' ' A' ' 25' ' ' ALA . 72.7 p -47.5 -54.92 10.24 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.727 1.267 . . . . 0.0 110.95 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.002 ' O ' ' HB3' ' A' ' 32' ' ' PHE . 11.6 t -55.81 -45.27 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 124.375 1.047 . . . . 0.0 110.283 -175.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 66.5 tp60 -45.02 -63.27 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.236 0.96 . . . . 0.0 109.646 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 1.04 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 m-80 -42.98 -48.13 5.88 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.61 1.194 . . . . 0.0 110.058 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 1.002 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 15.6 t80 -39.75 -69.46 0.13 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.527 1.142 . . . . 0.0 109.967 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' ND2' ' A' ' 37' ' ' ASN . 48.9 t -43.96 -39.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 124.722 1.264 . . . . 0.0 111.201 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 1.04 ' OD2' ' HA ' ' A' ' 31' ' ' ASN . 16.6 m-20 -44.04 -62.26 1.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.148 0.905 . . . . 0.0 109.914 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 38' ' ' SER . 98.1 m-85 -57.48 -56.23 24.6 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.877 1.361 . . . . 0.0 109.364 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.839 ' HA ' ' HE2' ' A' ' 41' ' ' TYR . 96.0 t -42.97 -63.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 124.555 1.159 . . . . 0.0 109.279 177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.678 ' ND2' HG12 ' A' ' 33' ' ' VAL . 22.0 m-20 -48.23 -49.75 32.04 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.796 1.31 . . . . 0.0 110.069 176.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 56.4 m -56.08 -117.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.543 1.152 . . . . 0.0 111.03 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.53 76.28 0.1 Allowed Glycine 0 N--CA 1.473 1.151 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.662 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 17.5 t80 -110.67 -56.54 2.34 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.914 -173.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.839 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 58.3 m-85 -59.59 -40.23 86.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.063 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.7 p-10 -39.23 113.64 0.34 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.919 . . . . 0.0 111.449 -173.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.598 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 10.7 t30 58.03 35.76 25.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.313 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 45' ' ' THR . 72.8 p -79.45 -146.01 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.194 0.934 . . . . 0.0 108.684 163.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.98 HG22 ' HA ' ' A' ' 158' ' ' VAL . 72.7 p -163.6 -154.1 0.26 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.742 0.782 . . . . 0.0 112.268 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.874 ' HD1' ' O ' ' A' ' 45' ' ' THR . 6.0 m-30 -134.75 62.08 1.65 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.201 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.866 ' CE1' ' HG2' ' A' ' 48' ' ' ARG . 21.4 p-80 -53.62 -49.53 67.65 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.407 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.866 ' HG2' ' CE1' ' A' ' 47' ' ' HIS . 24.8 mmm180 -68.28 107.38 2.79 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.53 1.144 . . . . 0.0 109.325 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 46' ' ' PHE . 90.9 t -152.01 135.03 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 124.663 1.227 . . . . 0.0 110.308 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.093 HG21 ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -146.91 120.28 4.99 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.076 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' PHE . 85.5 Cg_exo -35.13 152.17 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.589 2.86 . . . . 0.0 113.439 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . 1.67 63.91 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 CA-C-N 114.219 -1.355 . . . . 0.0 113.801 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.082 ' HB3' HD12 ' A' ' 50' ' ' ILE . 8.4 t80 -155.32 -42.93 0.08 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.783 0.931 . . . . 0.0 110.897 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.093 ' HE2' HG21 ' A' ' 50' ' ' ILE . 22.3 ptt? 176.65 163.28 0.43 Allowed 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.897 0.748 . . . . 0.0 112.026 -176.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.031 HD11 ' HB1' ' A' ' 135' ' ' ALA . 46.5 pt -165.89 129.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.912 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 1.589 ' CB ' ' HA ' ' A' ' 104' ' ' PHE . 2.6 mm-40 -173.73 -166.09 0.29 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.721 164.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.45 -146.82 6.41 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.306 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.662 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 130.62 -58.83 0.7 Allowed Glycine 0 N--CA 1.475 1.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -45.17 -117.01 0.0 OUTLIER Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.635 0.844 . . . . 0.0 112.194 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.672 ' HB3' ' HA ' ' A' ' 64' ' ' MET . 18.7 m-30 -39.88 128.44 2.11 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 124.724 0.897 . . . . 0.0 111.062 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.025 ' HB ' ' CE ' ' A' ' 67' ' ' LYS . 13.1 t -59.41 -39.4 83.32 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.686 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 1.081 ' OE2' ' HG2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 174.27 121.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.201 0.938 . . . . 0.0 109.427 -174.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 1.329 ' O ' ' CG ' ' A' ' 64' ' ' MET . 29.3 mm100 77.45 -61.36 0.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.665 1.228 . . . . 0.0 108.507 -173.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 1.329 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 146.63 101.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.595 1.184 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HG3' ' C ' ' A' ' 64' ' ' MET . 43.7 mt-30 -156.69 79.83 0.94 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 112.087 -2.324 . . . . 0.0 106.561 176.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' GLN . 65.1 mt-30 -25.16 133.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.095 -172.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.065 ' HE2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 mmpt? -63.71 -117.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.369 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 33.7 mmtp -156.77 74.02 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 CA-C-N 112.92 -1.946 . . . . 0.0 107.997 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 1.149 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 83.8 Cg_exo -48.4 -166.19 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.604 2.869 . . . . 0.0 113.654 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.149 ' OD1' ' O ' ' A' ' 69' ' ' PRO . 80.9 m-20 -171.23 165.57 4.59 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.411 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.793 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 84.8 Cg_exo -39.09 91.31 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.543 2.829 . . . . 0.0 111.422 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.871 ' HG3' ' CG2' ' A' ' 100' ' ' THR . 82.4 Cg_exo -44.38 -150.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.655 2.903 . . . . 0.0 113.043 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.33 168.3 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 124.281 0.988 . . . . 0.0 111.606 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 26.8 mtpp -48.44 -171.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 113.336 -1.756 . . . . 0.0 113.157 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.936 ' OD1' ' OD1' ' A' ' 78' ' ' ASP . 10.1 p30 -54.93 -149.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.864 -1.516 . . . . 0.0 111.245 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.284 ' OE1' ' HB1' ' A' ' 123' ' ' ALA . 0.2 OUTLIER 173.11 -62.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.853 0.721 . . . . 0.0 109.696 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.664 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . -36.8 -37.94 0.16 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.386 1.053 . . . . 0.0 112.025 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.936 ' OD1' ' OD1' ' A' ' 75' ' ' ASN . 9.6 p-10 -68.8 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.13 0.894 . . . . 0.0 113.096 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 29.5 p30 -52.67 -101.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' H ' ' CG ' ' A' ' 79' ' ' ASN . . . 161.06 -71.76 0.22 Allowed Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.4 pt? -40.66 132.75 2.13 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.878 0.987 . . . . 0.0 111.984 -175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.858 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 98.3 mtt180 -66.55 168.33 9.37 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.805 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.895 ' HB3' HG21 ' A' ' 87' ' ' THR . 21.9 m120 -167.07 -170.47 1.53 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.581 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.801 ' CG2' ' HG2' ' A' ' 85' ' ' ARG . 15.5 m -168.26 159.39 10.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.343 -171.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.801 ' HG2' ' CG2' ' A' ' 84' ' ' THR . 16.6 ptm180 -25.33 99.72 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.776 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 1.048 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . 149.27 -24.59 1.24 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 111.346 -2.661 . . . . 0.0 110.261 -171.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.021 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 37.7 p -96.12 136.32 36.73 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.485 0.66 . . . . 0.0 112.049 -176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.135 HD12 ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -90.48 163.16 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.348 168.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.12 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -163.43 144.75 9.37 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.114 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.928 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 17.8 ttm -69.16 137.4 53.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.905 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.31 -100.71 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.531 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.252 ' O ' HG23 ' A' ' 93' ' ' THR . 17.1 ptm180 179.25 -139.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.902 0.751 . . . . 0.0 110.952 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.252 HG23 ' O ' ' A' ' 92' ' ' ARG . 22.5 p 145.82 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.678 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 44.05 -94.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.779 1.3 . . . . 0.0 110.462 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 96' ' ' LYS . 36.0 m-20 -49.53 127.46 15.54 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.196 0.935 . . . . 0.0 110.836 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -41.83 -103.85 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.645 175.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.842 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 63.0 m-20 -43.49 98.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.403 1.064 . . . . 0.0 109.764 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 72' ' ' PRO . 17.2 t -171.74 -113.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.588 1.18 . . . . 0.0 110.407 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.811 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . 43.74 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.226 0.954 . . . . 0.0 108.797 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.871 ' CG2' ' HG3' ' A' ' 72' ' ' PRO . 66.7 p -78.84 -44.85 22.07 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.342 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.9 p -170.19 92.29 0.2 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.344 1.027 . . . . 0.0 108.709 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 101' ' ' SER . 13.7 tt0 175.17 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 125.018 1.448 . . . . 0.0 109.575 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.847 ' O ' ' HB3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -146.74 -179.12 6.56 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.966 -177.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 1.589 ' HA ' ' CB ' ' A' ' 56' ' ' GLN . 11.7 p90 -157.32 170.54 22.24 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.346 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.013 HD11 HD21 ' A' ' 18' ' ' LEU . 85.2 mt -127.18 112.67 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 112.915 -1.948 . . . . 0.0 108.95 -170.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.817 ' OD1' ' O ' ' A' ' 87' ' ' THR . 36.0 p-10 -63.42 149.91 44.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.403 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.583 HG22 ' C ' ' A' ' 53' ' ' PHE . 31.4 m -136.3 23.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.801 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 110' ' ' ASN . . . -163.91 136.24 5.0 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.763 0.664 . . . . 0.0 110.714 175.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -36.99 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.192 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 1.041 ' OD1' ' HB3' ' A' ' 113' ' ' LEU . 40.1 t30 -69.61 -95.51 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.93 1.394 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ASP . . . 65.08 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.176 0.922 . . . . 0.0 110.419 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.787 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 47.6 p90 -42.25 -39.87 2.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.296 0.998 . . . . 0.0 110.861 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.041 ' HB3' ' OD1' ' A' ' 110' ' ' ASN . 64.1 tp -58.68 -38.78 78.98 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.268 0.98 . . . . 0.0 110.504 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 111' ' ' ALA . 65.4 t0 -39.49 130.28 1.8 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.12 0.887 . . . . 0.0 111.681 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 1.025 ' ND1' ' O ' ' A' ' 120' ' ' PHE . 4.1 t60 -40.72 137.39 1.18 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.132 -1.395 . . . . 0.0 111.151 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.02 -147.9 5.58 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.869 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.598 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 4.4 pt20 -49.23 124.22 8.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.267 -0.967 . . . . 0.0 110.854 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 117' ' ' GLN . 75.2 mtp180 82.63 -120.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.481 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 120' ' ' PHE . 75.0 m-20 -46.21 127.27 8.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.676 1.235 . . . . 0.0 110.547 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 1.025 ' O ' ' ND1' ' A' ' 115' ' ' HIS . 1.0 OUTLIER -45.49 -102.74 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.98 -176.334 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.841 ' HA3' ' HB2' ' A' ' 115' ' ' HIS . . . 165.56 161.57 14.86 Favored Glycine 0 N--CA 1.479 1.536 0 O-C-N 123.862 0.726 . . . . 0.0 112.606 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.997 ' CE1' HD11 ' A' ' 113' ' ' LEU . 89.9 m-85 -78.83 137.11 37.54 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.043 -1.079 . . . . 0.0 110.599 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.284 ' HB1' ' OE1' ' A' ' 76' ' ' GLU . . . -56.1 -170.34 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.132 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 123' ' ' ALA . 70.3 t 178.51 144.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.352 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.887 ' HE2' HD23 ' A' ' 20' ' ' LEU . 2.5 p90 -170.42 25.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 172.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.625 ' C ' ' OE2' ' A' ' 19' ' ' GLU . . . -167.9 -139.85 2.78 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-O 122.652 1.14 . . . . 0.0 113.822 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.404 ' HB3' ' CD ' ' A' ' 19' ' ' GLU . 39.4 ttpt 179.62 -136.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 111.808 -2.196 . . . . 0.0 109.956 -172.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.091 ' N ' ' HG2' ' A' ' 127' ' ' LYS . 60.5 t -151.43 160.97 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.864 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 19' ' ' GLU . 31.2 m -146.71 9.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.82 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.707 ' O ' ' N ' ' A' ' 132' ' ' MET . 40.8 ttmt 173.1 -89.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.345 0.403 . . . . 0.0 111.86 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 16' ' ' ILE . . . -51.93 59.87 0.0 OUTLIER Glycine 0 N--CA 1.473 1.127 0 O-C-N 124.572 1.17 . . . . 0.0 114.75 -165.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.707 ' N ' ' O ' ' A' ' 130' ' ' LYS . 4.3 mmt -74.48 -49.73 21.06 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' LYS . 23.3 m-20 -39.72 -54.55 2.05 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.181 0.926 . . . . 0.0 109.986 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.621 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 75.0 t -52.24 -64.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 124.583 1.177 . . . . 0.0 109.249 175.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 1.031 ' HB1' HD11 ' A' ' 55' ' ' ILE . . . -43.78 -53.81 5.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.516 1.135 . . . . 0.0 110.258 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.868 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -58.71 -65.36 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.758 1.286 . . . . 0.0 108.636 179.155 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.998 ' HD3' ' O ' ' A' ' 137' ' ' LYS . 2.9 tmtm? -36.86 -48.96 0.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.6 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.233 ' O ' HG22 ' A' ' 141' ' ' VAL . 12.8 mt -58.21 -56.97 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.612 1.195 . . . . 0.0 108.744 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.551 ' OG ' ' HA ' ' A' ' 136' ' ' ASP . 80.7 p -61.79 3.14 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.868 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 2.1 mp0 -94.78 -51.94 4.49 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.233 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.6 m -45.64 126.24 6.42 Favored Pre-proline 0 N--CA 1.473 0.694 0 O-C-N 124.462 1.101 . . . . 0.0 110.283 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 80.7 Cg_exo -49.92 -178.29 0.01 OUTLIER 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.679 2.919 . . . . 0.0 114.673 -176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.181 HG22 ' CA ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -161.07 -139.69 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 113.115 -1.857 . . . . 0.0 109.69 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.672 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.7 OUTLIER -178.02 140.66 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 112.5 -2.136 . . . . 0.0 112.336 168.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 1.072 ' OD1' ' HG3' ' A' ' 150' ' ' GLN . 56.1 t0 -68.74 110.92 4.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 112.383 -2.19 . . . . 0.0 107.791 168.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.879 HG21 ' CG2' ' A' ' 152' ' ' VAL . 2.0 t -78.98 -142.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.139 -1.846 . . . . 0.0 109.737 -169.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.653 ' H ' HG12 ' A' ' 146' ' ' VAL . . . -63.57 -108.79 0.01 OUTLIER Glycine 0 N--CA 1.471 1.02 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 171.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 1.047 ' O ' ' OE1' ' A' ' 150' ' ' GLN . 97.1 Cg_endo -68.5 -50.17 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.593 2.862 . . . . 0.0 109.649 171.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.555 ' CD2' ' HG2' ' A' ' 148' ' ' PRO . 78.0 m-85 -68.68 84.45 0.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.612 1.195 . . . . 0.0 109.688 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 1.072 ' HG3' ' OD1' ' A' ' 145' ' ' ASP . 3.7 mp0 -70.97 66.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.756 175.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.56 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 50.7 p30 170.51 89.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.61 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.879 ' CG2' HG21 ' A' ' 146' ' ' VAL . 75.0 t -156.24 115.87 2.15 Favored Pre-proline 0 N--CA 1.477 0.902 0 O-C-N 124.392 1.057 . . . . 0.0 109.646 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.181 ' CA ' HG22 ' A' ' 143' ' ' THR . 83.6 Cg_exo -43.97 114.7 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.643 2.895 . . . . 0.0 111.44 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 1.111 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 88.0 p -41.69 -36.88 1.06 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.438 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 1.157 ' HB2' ' CD ' ' A' ' 156' ' ' PRO . 30.3 mtpp -175.55 -71.31 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.643 0 O-C-N 124.134 0.896 . . . . 0.0 110.115 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.157 ' CD ' ' HB2' ' A' ' 155' ' ' LYS . 98.8 Cg_exo -51.25 72.28 0.02 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.702 2.934 . . . . 0.0 113.6 -171.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 1.128 HG23 ' O ' ' A' ' 156' ' ' PRO . 43.3 t -172.07 126.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.9 169.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.98 ' HA ' HG22 ' A' ' 45' ' ' THR . 76.7 t -168.87 118.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 113.28 -1.782 . . . . 0.0 107.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.014 HG12 HG22 ' A' ' 11' ' ' THR . 25.8 mt -68.1 132.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.766 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.841 HD12 HG22 ' A' ' 10' ' ' THR . 86.2 mt -81.2 -49.18 11.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.158 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.7 t -167.6 169.98 11.48 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.553 1.158 . . . . 0.0 111.992 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.8 ' O ' ' HG3' ' A' ' 163' ' ' LYS . . . -152.07 137.18 17.36 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.189 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.872 ' O ' ' HB2' ' A' ' 8' ' ' LEU . 37.9 mtmm -170.3 136.23 1.35 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.084 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.575 ' CG1' HG11 ' A' ' 36' ' ' VAL . 33.1 m -69.49 175.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.783 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.629 ' C ' HD23 ' A' ' 165' ' ' LEU . 5.4 tt -143.63 119.94 6.51 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 114.0 -1.455 . . . . 0.0 108.707 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.591 ' N ' HD23 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 123.684 2.923 . . . . 0.0 112.135 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 120.902 0.382 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 3.4 tppp? 176.12 -94.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.676 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 1.135 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 179.48 146.15 6.65 Favored Glycine 0 N--CA 1.477 1.376 0 O-C-N 124.403 1.064 . . . . 0.0 111.901 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.135 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 89.7 m-20 -170.33 122.76 0.6 Allowed Pre-proline 0 N--CA 1.476 0.842 0 CA-C-N 114.459 -0.87 . . . . 0.0 109.714 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.323 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 61.4 Cg_endo -68.99 117.37 4.99 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.894 3.063 . . . . 0.0 110.929 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.323 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 22.1 m170 -150.55 101.96 2.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.342 -175.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.942 ' CG1' ' HB2' ' A' ' 18' ' ' LEU . 7.7 p -59.85 107.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 171.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.998 ' CD1' ' OE1' ' A' ' 17' ' ' GLU . 5.2 tt -118.73 113.48 21.23 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.764 1.29 . . . . 0.0 109.79 -170.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.86 ' HG ' ' HA ' ' A' ' 162' ' ' ALA . 5.1 mp -127.67 -166.31 1.59 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 112.778 -2.01 . . . . 0.0 109.684 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 86.4 m -162.05 102.67 1.13 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.117 175.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 1.093 HG22 HG12 ' A' ' 159' ' ' ILE . 28.4 p -74.37 166.08 24.09 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.834 1.334 . . . . 0.0 111.693 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.552 ' OG ' HG13 ' A' ' 157' ' ' VAL . 80.1 p -40.93 -46.07 2.7 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.288 -1.778 . . . . 0.0 110.512 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -51.97 -59.15 4.67 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.451 1.094 . . . . 0.0 110.274 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.43 -174.22 45.99 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-N 112.931 -1.94 . . . . 0.0 113.149 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 1.193 ' O ' HG21 ' A' ' 134' ' ' VAL . 9.0 t-20 -52.31 162.28 0.54 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.69 -1.255 . . . . 0.0 111.448 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.865 HG13 ' O ' ' A' ' 15' ' ' ASN . 9.3 mt -170.16 153.92 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.116 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.998 ' OE1' ' CD1' ' A' ' 8' ' ' LEU . 33.5 mt-10 -163.22 110.15 1.18 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.833 -173.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.942 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 2.2 mm? -82.42 150.42 27.1 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.294 0.996 . . . . 0.0 109.804 164.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.496 ' CD ' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -111.43 123.63 50.6 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.298 0.999 . . . . 0.0 109.578 174.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.256 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 75.8 mt -104.59 -171.33 1.9 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.751 1.282 . . . . 0.0 112.74 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 1.256 ' OD1' ' O ' ' A' ' 20' ' ' LEU . 47.8 m-20 -164.08 68.04 0.17 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.204 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.435 ' HD2' ' N ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -47.33 -27.28 1.53 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.821 1.326 . . . . 0.0 113.036 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.435 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 36.0 tt0 -41.93 -63.99 0.65 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.941 0.776 . . . . 0.0 110.09 -174.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.963 ' HD3' ' HA ' ' A' ' 79' ' ' ASN . 25.3 ttmm -78.9 18.41 0.62 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.815 1.322 . . . . 0.0 112.742 -178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.067 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -161.98 69.98 2.29 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 1.01 ' O ' HG22 ' A' ' 29' ' ' VAL . 69.0 Cg_endo -71.39 -61.41 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.731 2.954 . . . . 0.0 110.124 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 28' ' ' SER . 16.0 m -48.12 -63.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 124.609 1.193 . . . . 0.0 110.152 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.743 ' H ' HG23 ' A' ' 27' ' ' VAL . 42.9 t -48.43 -59.54 3.39 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.508 1.13 . . . . 0.0 110.346 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.599 ' HA ' ' CE2' ' A' ' 32' ' ' PHE . 35.2 m -45.3 -49.13 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 124.579 1.175 . . . . 0.0 110.898 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 1.182 ' O ' HG12 ' A' ' 33' ' ' VAL . 61.7 tp60 -50.11 -56.81 9.4 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.31 1.006 . . . . 0.0 109.745 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.89 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 3.4 t30 -50.2 -62.19 1.72 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.567 1.167 . . . . 0.0 110.587 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 1.599 ' CE2' ' HA ' ' A' ' 29' ' ' VAL . 29.1 p90 -56.08 -43.92 78.49 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.266 0.979 . . . . 0.0 110.64 -172.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.182 HG12 ' O ' ' A' ' 30' ' ' GLN . 11.5 p -51.05 -40.06 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 124.046 0.841 . . . . 0.0 110.094 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.89 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 45.4 m-20 -45.39 -61.07 1.82 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.045 0.84 . . . . 0.0 109.252 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.84 ' HE2' HD21 ' A' ' 31' ' ' ASN . 68.9 m-85 -54.52 -55.85 24.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.908 1.38 . . . . 0.0 109.491 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.726 HG22 ' CE1' ' A' ' 41' ' ' TYR . 77.1 t -46.06 -66.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 124.436 1.085 . . . . 0.0 109.537 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -43.89 -49.82 8.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.84 1.338 . . . . 0.0 110.695 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.554 ' OG ' ' O ' ' A' ' 35' ' ' TYR . 29.7 p -58.64 -107.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.53 1.144 . . . . 0.0 110.161 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.64 59.64 0.28 Allowed Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' THR . 17.7 t80 -89.27 -63.58 1.27 Allowed 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.958 1.034 . . . . 0.0 109.726 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.726 ' CE1' HG22 ' A' ' 36' ' ' VAL . 35.1 m-85 -75.53 -14.24 60.4 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.524 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 1.126 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 52.7 p-10 -39.08 -41.62 0.82 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.642 0.589 . . . . 0.0 112.517 -170.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 1.126 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 19.5 m-20 -154.78 46.8 0.55 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.161 0.913 . . . . 0.0 110.296 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 45' ' ' THR . 74.3 p -78.92 -139.64 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 166.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.954 ' HA ' HG13 ' A' ' 159' ' ' ILE . 76.5 p -163.46 -153.95 0.26 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.934 0.873 . . . . 0.0 112.595 174.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.881 ' CE1' HD11 ' A' ' 159' ' ' ILE . 17.0 m-30 -129.65 84.39 2.21 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.845 -1.979 . . . . 0.0 106.279 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.824 ' CE1' ' O ' ' A' ' 56' ' ' GLN . 36.8 p-80 -56.42 -65.57 0.58 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.3 -169.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.316 ' HD3' ' N ' ' A' ' 49' ' ' VAL . 1.2 tmt_? -164.67 160.71 20.24 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -162.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.56 ' CG1' ' HG3' ' A' ' 54' ' ' MET . 45.8 t -175.73 -77.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.045 -2.343 . . . . 0.0 106.914 164.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.919 HG22 HG12 ' A' ' 49' ' ' VAL . 11.2 tt 171.3 138.8 0.09 OUTLIER Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.688 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.829 ' HD2' HG13 ' A' ' 50' ' ' ILE . 83.4 Cg_exo -35.04 164.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.333 -0.289 0 C-N-CA 123.507 2.805 . . . . 0.0 113.846 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -6.98 69.46 0.0 OUTLIER Glycine 0 N--CA 1.474 1.185 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.876 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.176 ' CE1' ' OD1' ' A' ' 110' ' ' ASN . 9.8 t80 -160.99 -53.46 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.787 0.934 . . . . 0.0 109.843 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.56 ' HG3' ' CG1' ' A' ' 49' ' ' VAL . 24.1 ptt? -164.36 154.06 14.03 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.457 1.098 . . . . 0.0 111.912 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.772 HG13 ' HB ' ' A' ' 105' ' ' ILE . 48.4 pt -160.21 124.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.73 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 1.105 ' HG2' ' CA ' ' A' ' 104' ' ' PHE . 33.2 mt-30 -120.36 128.72 53.5 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.385 1.053 . . . . 0.0 110.334 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.0 -162.6 32.11 Favored Glycine 0 N--CA 1.477 1.404 0 O-C-N 124.631 1.207 . . . . 0.0 112.803 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 1.007 ' O ' ' HG3' ' A' ' 102' ' ' GLN . . . 44.45 96.65 0.01 OUTLIER Glycine 0 N--CA 1.47 0.915 0 CA-C-N 113.725 -1.238 . . . . 0.0 111.38 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.749 ' HA2' ' OE1' ' A' ' 102' ' ' GLN . . . 174.46 -121.79 0.86 Allowed Glycine 0 N--CA 1.474 1.193 0 O-C-N 124.705 0.885 . . . . 0.0 110.925 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -46.08 146.04 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.047 -1.077 . . . . 0.0 111.636 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.6 m -58.12 -43.06 87.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.908 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 1.051 ' HG3' ' N ' ' A' ' 63' ' ' GLN . 12.6 pt-20 -172.48 -100.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.248 0.968 . . . . 0.0 109.166 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 1.172 ' O ' ' CG ' ' A' ' 64' ' ' MET . 9.7 tp-100 -46.3 -57.55 4.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.673 1.233 . . . . 0.0 109.623 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 1.172 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 20.0 mmt 165.4 27.34 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.614 1.196 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -78.64 84.94 4.71 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.14 133.43 1.22 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.458 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 31.2 mmmt -64.13 -119.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.283 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.573 ' O ' ' O ' ' A' ' 69' ' ' PRO . 24.8 ttmm -171.14 83.4 0.51 Allowed Pre-proline 0 N--CA 1.471 0.589 0 CA-C-N 113.307 -1.77 . . . . 0.0 108.73 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 1.025 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 89.2 Cg_exo -45.55 -155.59 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.631 2.887 . . . . 0.0 113.279 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.167 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.2 m120 -166.86 167.63 7.67 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.313 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.943 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 39.4 Cg_endo -49.07 87.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.845 2.363 . . . . 0.0 108.55 171.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.167 ' HD3' ' O ' ' A' ' 70' ' ' ASN . 89.7 Cg_exo -48.29 -151.74 0.0 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.79 2.993 . . . . 0.0 113.789 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -155.27 149.1 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.369 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 94.1 mttt -32.39 133.6 0.11 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.394 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -63.61 167.63 5.54 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.832 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.951 ' OE2' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -168.16 155.35 7.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.032 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.814 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . . . 177.59 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.191 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.844 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 42.0 p-10 -67.02 -48.28 68.83 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.983 0.802 . . . . 0.0 109.809 -176.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.963 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 19.0 p-10 40.21 -73.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.078 0.861 . . . . 0.0 111.541 175.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 78' ' ' ASP . . . 87.76 88.43 1.11 Allowed Glycine 0 N--CA 1.474 1.17 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 80' ' ' GLY . 85.9 mt -161.46 -158.3 0.56 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.113 -1.043 . . . . 0.0 109.893 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.752 ' N ' ' HD2' ' A' ' 82' ' ' ARG . 1.3 mpt_? -59.1 -165.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.253 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.781 ' OD1' ' HB2' ' A' ' 111' ' ' ALA . 1.7 t-20 168.3 100.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.151 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' GLY . 22.8 m -170.31 134.57 1.19 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.63 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 1.411 ' HB2' ' C ' ' A' ' 107' ' ' VAL . 4.0 ppt_? -38.51 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.672 1.225 . . . . 0.0 110.299 176.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' ' CA ' ' A' ' 127' ' ' LYS . . . 160.59 -22.9 0.25 Allowed Glycine 0 CA--C 1.534 1.226 0 CA-C-N 111.395 -2.639 . . . . 0.0 110.478 -170.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.079 ' HA ' ' CA ' ' A' ' 127' ' ' LYS . 40.5 p -98.94 148.74 23.66 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.63 0.729 . . . . 0.0 111.793 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.104 ' CD1' ' O ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -96.54 159.71 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.342 168.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.083 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . . . -142.89 176.96 8.67 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.08 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.899 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . 15.3 tpt -101.95 129.92 48.33 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.766 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.88 -144.51 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.857 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.222 ' HG2' ' N ' ' A' ' 93' ' ' THR . 37.8 ttm180 -177.65 -165.52 0.11 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.84 0.828 . . . . 0.0 111.852 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.222 ' N ' ' HG2' ' A' ' 92' ' ' ARG . 25.3 p 176.07 116.35 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 108.239 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.806 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -17.48 120.28 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 124.514 1.134 . . . . 0.0 112.906 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.817 ' OD2' ' O ' ' A' ' 97' ' ' ASP . 39.0 t70 142.18 139.32 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.681 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HB3' ' H ' ' A' ' 97' ' ' ASP . 53.0 tptt -42.89 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.431 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.817 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 38.2 m-20 -67.3 117.7 9.67 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.688 1.243 . . . . 0.0 108.5 168.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 24.8 t -151.48 170.65 19.1 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.57 1.169 . . . . 0.0 111.973 -173.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 98' ' ' SER . . . 84.76 136.24 0.05 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.729 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 100' ' ' THR . 35.5 m -155.74 2.3 0.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.453 1.095 . . . . 0.0 113.205 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.409 ' C ' ' HE1' ' A' ' 90' ' ' MET . 34.3 p -171.73 -76.34 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.562 0.539 . . . . 0.0 110.852 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 1.007 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 3.5 mp0 -38.25 154.57 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.006 0.816 . . . . 0.0 111.9 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.992 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -160.86 167.03 27.5 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.545 177.038 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 1.105 ' CA ' ' HG2' ' A' ' 56' ' ' GLN . 72.4 m-85 -84.23 151.24 24.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.638 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.845 HD11 HD21 ' A' ' 18' ' ' LEU . 22.9 mt -139.58 94.24 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.117 -1.856 . . . . 0.0 107.617 159.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.582 ' O ' ' HE1' ' A' ' 132' ' ' MET . 48.9 m-20 -69.22 -173.29 0.51 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.309 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.411 ' C ' ' HB2' ' A' ' 85' ' ' ARG . 35.9 m -158.27 -46.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.571 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.203 ' C ' ' HB3' ' A' ' 85' ' ' ARG . . . -101.49 150.46 23.04 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 124.518 1.136 . . . . 0.0 110.915 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' N ' ' CG ' ' A' ' 85' ' ' ARG . 3.1 m-20 -37.59 138.18 0.37 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.174 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 1.176 ' OD1' ' CE1' ' A' ' 53' ' ' PHE . 64.9 m-80 -157.45 170.46 22.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.765 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB2' ' OD1' ' A' ' 83' ' ' ASN . . . 153.38 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.361 -172.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -39.67 -55.51 1.87 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.152 0.907 . . . . 0.0 110.334 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.899 HD22 ' CD2' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -63.49 -8.86 10.43 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.837 1.336 . . . . 0.0 112.662 177.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.723 ' N ' HD12 ' A' ' 113' ' ' LEU . 57.6 p-10 -43.74 127.34 5.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.667 0.604 . . . . 0.0 111.657 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.765 ' CD2' ' HD1' ' A' ' 120' ' ' PHE . 0.1 OUTLIER -34.27 126.92 0.45 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.309 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' N ' ' ND1' ' A' ' 115' ' ' HIS . . . -176.71 -114.87 0.4 Allowed Glycine 0 N--CA 1.474 1.168 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.485 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.687 ' O ' ' CB ' ' A' ' 118' ' ' ARG . 29.8 tt0 -50.7 123.64 9.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.48 -0.86 . . . . 0.0 111.013 -176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.875 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 73.7 ttt-85 106.14 -81.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.177 173.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.875 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 88.3 m-20 -176.54 101.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.445 1.09 . . . . 0.0 109.425 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.765 ' HD1' ' CD2' ' A' ' 115' ' ' HIS . 25.1 m-85 42.37 -166.39 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.671 1.232 . . . . 0.0 112.065 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -171.33 -134.18 1.73 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.042 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.899 ' CD2' HD22 ' A' ' 113' ' ' LEU . 58.9 m-85 -79.55 118.17 21.15 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.443 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.038 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . -57.36 -162.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.784 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.083 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 75.5 t 179.95 146.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.582 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.791 ' CE2' HD22 ' A' ' 20' ' ' LEU . 21.6 p90 -171.18 25.0 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 1.058 ' O ' ' HG3' ' A' ' 127' ' ' LYS . . . -167.13 -139.55 2.69 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 122.645 1.136 . . . . 0.0 113.436 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.496 ' HB2' ' CD ' ' A' ' 19' ' ' GLU . 94.0 mttt 179.35 -135.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 111.822 -2.189 . . . . 0.0 109.727 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.771 HG22 ' CD1' ' A' ' 18' ' ' LEU . 91.7 t -160.29 152.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.5 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' ' 19' ' ' GLU . 33.1 m -137.11 -27.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.69 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -170.83 86.95 0.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' VAL . . . -166.92 -45.49 0.02 OUTLIER Glycine 0 N--CA 1.474 1.186 0 O-C-N 124.763 1.289 . . . . 0.0 110.883 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.781 ' HE3' ' HA ' ' A' ' 107' ' ' VAL . 22.9 mmt -39.32 -38.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.216 0.597 . . . . 0.0 111.3 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -47.75 -59.21 3.46 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 1.193 HG21 ' O ' ' A' ' 15' ' ' ASN . 46.6 t -58.74 -63.01 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 124.75 1.281 . . . . 0.0 108.949 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 132' ' ' MET . . . -41.28 -51.03 3.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.955 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.96 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 37.1 m-20 -50.79 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.6 1.187 . . . . 0.0 109.04 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -43.34 -45.7 6.15 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.463 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.201 ' O ' HG12 ' A' ' 141' ' ' VAL . 42.4 mt -57.01 -61.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.422 1.076 . . . . 0.0 108.871 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.9 p -65.31 2.44 0.85 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.96 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.1 mp0 -93.01 -49.52 5.98 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 124.232 0.958 . . . . 0.0 109.124 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.201 HG12 ' O ' ' A' ' 138' ' ' ILE . 8.6 p -39.7 135.36 1.25 Allowed Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 124.272 0.982 . . . . 0.0 111.043 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' A' ' 141' ' ' VAL . 79.9 Cg_exo -42.54 168.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.332 -0.328 0 C-N-CA 123.573 2.848 . . . . 0.0 113.658 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.545 HG22 ' CA ' ' A' ' 153' ' ' PRO . 5.9 p -160.84 -149.92 0.19 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 123.415 1.579 . . . . 0.0 112.313 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.749 ' HD2' ' O ' ' A' ' 144' ' ' HIS . 0.8 OUTLIER 178.6 161.38 0.66 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 110.28 -3.145 . . . . 0.0 111.441 172.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.719 ' O ' ' CD2' ' A' ' 144' ' ' HIS . 35.3 m-20 -50.33 -157.06 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.194 -1.367 . . . . 0.0 109.059 164.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -160.85 -143.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.11 -110.3 0.02 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 167.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.764 ' HG2' ' CD2' ' A' ' 149' ' ' TYR . 84.8 Cg_endo -70.69 -48.78 0.48 Allowed 'Trans proline' 0 C--N 1.333 -0.286 0 C-N-CA 123.662 2.908 . . . . 0.0 109.781 169.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.874 ' O ' HG23 ' A' ' 146' ' ' VAL . 93.7 m-85 -68.95 88.48 0.39 Allowed 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.584 1.177 . . . . 0.0 110.722 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 151' ' ' ASN . 16.0 pt20 -71.73 143.1 49.73 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.855 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 1.085 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 10.0 m120 84.33 90.12 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.548 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.809 HG21 HG21 ' A' ' 146' ' ' VAL . 91.2 t -160.62 97.86 1.4 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.208 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.545 ' CA ' HG22 ' A' ' 143' ' ' THR . 88.6 Cg_exo -46.15 106.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 123.52 2.813 . . . . 0.0 110.891 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 1.092 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 65.8 p -41.35 -56.3 2.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.655 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.478 ' HA ' ' HD2' ' A' ' 156' ' ' PRO . 65.4 mttm -79.62 95.62 0.21 Allowed Pre-proline 0 N--CA 1.473 0.709 0 O-C-N 124.582 1.176 . . . . 0.0 108.308 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.092 ' HD3' ' O ' ' A' ' 154' ' ' SER . 61.6 Cg_endo -77.01 132.3 12.71 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.771 2.981 . . . . 0.0 112.246 -171.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.552 HG13 ' OG ' ' A' ' 12' ' ' SER . 47.7 t -69.32 162.72 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.723 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.924 ' HA ' HG22 ' A' ' 45' ' ' THR . 86.5 t -147.28 120.12 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.108 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.093 HG12 HG22 ' A' ' 11' ' ' THR . 34.9 mt -68.84 134.61 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.258 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 10' ' ' THR . 87.5 mt -85.72 -49.76 7.71 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 110.182 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 9' ' ' LEU . 69.2 m -146.82 178.82 8.03 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.67 1.231 . . . . 0.0 111.974 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.86 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . . . -178.7 122.94 0.09 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.364 -175.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.602 ' N ' ' HD3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -171.09 152.9 3.58 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.254 173.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.02 141.67 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.732 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 166' ' ' PRO . 5.5 tt -57.82 126.07 75.25 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.16 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.698 ' N ' HD23 ' A' ' 165' ' ' LEU . 85.4 Cg_exo . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.607 2.872 . . . . 0.0 112.179 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 22.1 ptmt 169.02 46.75 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.633 1.208 . . . . 0.0 110.529 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 1.034 ' O ' ' OD1' ' A' ' 4' ' ' ASP . . . 160.63 -133.96 3.43 Favored Glycine 0 N--CA 1.476 1.351 0 O-C-N 124.467 1.105 . . . . 0.0 111.025 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.034 ' OD1' ' O ' ' A' ' 3' ' ' GLY . 97.9 m-20 -175.11 69.28 0.27 Allowed Pre-proline 0 N--CA 1.474 0.768 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.483 ' O ' ' CD2' ' A' ' 6' ' ' HIS . 83.4 Cg_endo -89.8 60.94 1.99 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.657 2.905 . . . . 0.0 110.096 -171.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.483 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.4 m170 -154.5 88.49 1.21 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.21 0.944 . . . . 0.0 110.066 -176.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 7' ' ' VAL . 25.5 t -67.78 81.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 167.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.061 ' HG ' ' HG2' ' A' ' 17' ' ' GLU . 7.5 tt -80.38 108.92 14.39 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.356 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.358 HD23 ' O ' ' A' ' 161' ' ' SER . 7.3 mt -109.51 174.44 5.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 112.737 -2.029 . . . . 0.0 112.532 -173.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.895 HG22 HD12 ' A' ' 160' ' ' LEU . 94.9 m -159.91 95.11 1.16 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.078 -2.328 . . . . 0.0 108.447 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 1.022 HG22 HG12 ' A' ' 159' ' ' ILE . 19.8 p -84.53 161.2 20.31 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.997 1.436 . . . . 0.0 111.217 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 81.7 p -39.09 -43.59 1.05 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.419 -1.718 . . . . 0.0 110.861 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.774 ' HB2' HG12 ' A' ' 138' ' ' ILE . . . -52.84 -63.84 1.01 Allowed 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.42 1.075 . . . . 0.0 110.105 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.49 171.18 43.87 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.089 -177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.853 ' ND2' ' O ' ' A' ' 9' ' ' LEU . 2.1 t-20 -68.32 133.31 48.55 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.309 -1.445 . . . . 0.0 110.719 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.666 ' C ' ' HG3' ' A' ' 17' ' ' GLU . 16.5 pt -143.73 -179.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.922 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 1.061 ' HG2' ' HG ' ' A' ' 8' ' ' LEU . 35.9 mt-10 -161.62 110.89 1.55 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.799 -169.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.082 HD21 HD11 ' A' ' 105' ' ' ILE . 3.1 mm? -77.36 150.65 35.11 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 124.541 1.15 . . . . 0.0 110.106 165.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.795 ' HG3' ' HB3' ' A' ' 127' ' ' LYS . 12.6 pt-20 -122.84 121.49 36.37 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.909 174.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.018 HD13 ' HE2' ' A' ' 125' ' ' PHE . 61.3 mt -104.19 173.55 6.25 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.803 1.315 . . . . 0.0 112.66 -169.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 125' ' ' PHE . 73.2 m-20 -128.83 104.5 7.65 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.569 -178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -76.26 -39.54 54.11 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.831 1.332 . . . . 0.0 112.055 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.889 ' HG3' ' HD2' ' A' ' 24' ' ' LYS . 8.1 tp-100 -45.08 -66.85 0.34 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.211 0.945 . . . . 0.0 110.275 -171.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.889 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -83.55 19.48 1.59 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.817 1.323 . . . . 0.0 113.804 -175.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.012 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -160.59 64.97 2.21 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 123.904 0.752 . . . . 0.0 111.134 173.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 25' ' ' ALA . 50.8 Cg_exo -59.91 -58.72 0.51 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.517 2.811 . . . . 0.0 111.071 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.551 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 80.7 t -53.9 -69.86 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.157 -175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.436 ' OG ' ' HB1' ' A' ' 25' ' ' ALA . 75.2 p -48.05 -53.92 14.77 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.704 1.252 . . . . 0.0 111.023 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.012 HG23 ' O ' ' A' ' 25' ' ' ALA . 3.5 t -60.45 -41.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.318 1.012 . . . . 0.0 110.625 -173.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 1.31 ' O ' HG12 ' A' ' 33' ' ' VAL . 7.3 tm0? -49.87 -62.43 1.57 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.111 0.882 . . . . 0.0 108.923 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 1.039 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 11.1 m-80 -44.25 -52.48 7.45 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.585 1.178 . . . . 0.0 110.274 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.879 ' CD2' ' HA ' ' A' ' 29' ' ' VAL . 20.8 m-30 -41.51 -67.3 0.26 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.456 1.098 . . . . 0.0 109.806 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.31 HG12 ' O ' ' A' ' 30' ' ' GLN . 7.2 p -40.5 -40.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 124.782 1.301 . . . . 0.0 111.118 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 1.039 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 8.0 m-20 -44.96 -61.94 1.42 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.028 0.83 . . . . 0.0 109.445 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -55.53 -53.36 57.32 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.813 1.321 . . . . 0.0 109.317 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.629 HG11 HG13 ' A' ' 164' ' ' VAL . 76.3 t -45.15 -65.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 124.556 1.16 . . . . 0.0 109.464 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' SER . 22.1 m-20 -48.32 -48.63 36.01 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.803 1.314 . . . . 0.0 110.227 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 37' ' ' ASN . 54.5 m -52.98 -113.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.463 1.102 . . . . 0.0 110.913 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.1 78.05 0.08 OUTLIER Glycine 0 N--CA 1.473 1.141 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.513 ' CZ ' ' O ' ' A' ' 58' ' ' GLY . 74.4 t80 -116.22 -63.86 1.39 Allowed 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.196 1.174 . . . . 0.0 109.358 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.985 ' O ' HG23 ' A' ' 44' ' ' THR . 51.6 m-85 -59.73 -41.77 91.63 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.715 1.259 . . . . 0.0 111.605 -172.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.584 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 51.0 p30 -39.32 117.18 0.68 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.19 0.931 . . . . 0.0 111.333 -173.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 159' ' ' ILE . 23.7 t30 60.02 35.22 21.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.011 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.985 HG23 ' O ' ' A' ' 41' ' ' TYR . 69.9 p -79.2 -143.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.159 0.912 . . . . 0.0 108.848 165.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.944 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 55.3 p -163.21 -144.0 0.08 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.822 0.82 . . . . 0.0 112.725 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.944 ' CD1' ' O ' ' A' ' 45' ' ' THR . 8.2 m-30 -154.68 67.1 0.69 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.016 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.718 ' CG ' ' H ' ' A' ' 48' ' ' ARG . 6.3 p-80 -59.06 -65.04 0.73 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.855 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.894 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 25.3 tpt180 -69.29 119.02 12.92 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.583 1.177 . . . . 0.0 110.656 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.542 HG13 HG22 ' A' ' 55' ' ' ILE . 84.6 t -154.93 147.55 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 124.805 1.316 . . . . 0.0 110.834 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.594 ' CG2' ' CG ' ' A' ' 54' ' ' MET . 11.0 tt -157.95 125.58 2.74 Favored Pre-proline 0 N--CA 1.476 0.857 0 CA-C-N 113.777 -1.556 . . . . 0.0 108.955 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 53' ' ' PHE . 76.0 Cg_exo -34.22 161.78 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.67 2.913 . . . . 0.0 113.958 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -8.85 71.07 0.0 OUTLIER Glycine 0 N--CA 1.475 1.252 0 CA-C-N 114.049 -1.432 . . . . 0.0 113.548 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.112 ' HD1' ' HG2' ' A' ' 54' ' ' MET . 56.5 t80 -160.61 -58.97 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.856 0.974 . . . . 0.0 109.552 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.112 ' HG2' ' HD1' ' A' ' 53' ' ' PHE . 26.3 ptt? -169.22 159.64 9.08 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 124.299 0.999 . . . . 0.0 112.371 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 105' ' ' ILE . 41.7 pt -154.7 156.58 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 113.171 -1.831 . . . . 0.0 109.203 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.991 ' HG2' ' HB2' ' A' ' 104' ' ' PHE . 11.5 mt-30 -150.57 164.83 35.05 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.876 0.735 . . . . 0.0 112.142 -166.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.67 ' O ' ' CD1' ' A' ' 103' ' ' PHE . . . -162.11 155.98 27.43 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 124.06 0.85 . . . . 0.0 112.959 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.513 ' O ' ' CZ ' ' A' ' 40' ' ' PHE . . . 136.63 -57.29 0.67 Allowed Glycine 0 N--CA 1.475 1.271 0 CA-C-N 113.426 -1.387 . . . . 0.0 110.331 176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 58' ' ' GLY . . . -51.62 -125.16 0.01 OUTLIER Glycine 0 N--CA 1.471 1.033 0 O-C-N 124.593 0.819 . . . . 0.0 113.21 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -39.5 148.01 0.07 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.441 -172.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 62' ' ' GLU . 94.0 m -59.94 -92.47 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.463 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.678 ' HG3' ' O ' ' A' ' 62' ' ' GLU . 12.3 pt-20 -138.85 117.04 11.81 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 124.895 1.372 . . . . 0.0 108.882 -177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 1.291 ' O ' ' CG ' ' A' ' 64' ' ' MET . 67.2 tt0 76.91 -56.75 0.54 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.629 1.206 . . . . 0.0 108.8 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 1.291 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 49.4 mtt 155.82 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.046 1.403 . . . . 0.0 109.163 175.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.775 ' O ' ' O ' ' A' ' 66' ' ' GLN . 29.1 mm100 -142.87 82.21 1.76 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 110.908 -2.86 . . . . 0.0 104.965 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.825 ' C ' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -27.54 174.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -165.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HB3' ' H ' ' A' ' 68' ' ' LYS . 7.0 mtpm? -68.62 -146.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 111.0 -2.818 . . . . 0.0 113.617 -169.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 67' ' ' LYS . 28.0 tptp 179.11 73.75 0.14 Allowed Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 112.325 -2.216 . . . . 0.0 105.758 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.606 ' O ' ' OD1' ' A' ' 70' ' ' ASN . 62.5 Cg_endo -83.37 -165.02 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 123.351 2.701 . . . . 0.0 113.746 -162.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.998 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 8.6 m120 -163.34 169.89 8.06 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 113.126 -1.852 . . . . 0.0 110.029 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.998 ' HD2' ' HB3' ' A' ' 70' ' ' ASN . 35.1 Cg_endo -50.74 95.32 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.12 2.547 . . . . 0.0 109.818 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.997 ' HG3' HG22 ' A' ' 100' ' ' THR . 82.4 Cg_exo -51.86 -146.39 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.908 3.072 . . . . 0.0 113.46 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.558 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -160.05 152.83 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 124.296 0.997 . . . . 0.0 110.981 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 61.3 mttp -37.66 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.181 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.748 ' O ' ' HB3' ' A' ' 76' ' ' GLU . 56.0 p30 -64.02 -168.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.19 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.874 ' HB2' HD21 ' A' ' 79' ' ' ASN . 0.0 OUTLIER 160.43 141.17 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.383 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.004 ' HB1' ' CD2' ' A' ' 115' ' ' HIS . . . -157.6 -51.24 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.242 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -68.28 -49.43 60.55 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.473 1.108 . . . . 0.0 110.372 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.874 HD21 ' HB2' ' A' ' 76' ' ' GLU . 45.1 p30 -43.02 -43.38 4.23 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.22 0.95 . . . . 0.0 110.103 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.672 ' N ' ' OD1' ' A' ' 79' ' ' ASN . . . -42.85 -33.32 1.61 Allowed Glycine 0 N--CA 1.471 1.029 0 O-C-N 124.411 1.069 . . . . 0.0 112.131 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 66.1 mt 98.39 -131.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 1.018 ' O ' ' NE ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -169.0 110.12 0.49 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.977 0.798 . . . . 0.0 109.673 -179.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.734 ' HB2' HG21 ' A' ' 87' ' ' THR . 2.0 m-20 -132.74 -134.16 0.18 Allowed 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.963 1.414 . . . . 0.0 109.865 -176.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' OD1' ' A' ' 109' ' ' ASP . 10.2 m -169.6 163.77 10.21 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.822 0.82 . . . . 0.0 111.734 -167.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.937 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 58.2 ttt180 -18.67 103.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.199 165.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.946 ' O ' ' CG ' ' A' ' 127' ' ' LYS . . . 140.35 -23.19 2.7 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.256 -2.702 . . . . 0.0 110.581 -169.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.034 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 40.7 p -98.28 146.98 25.11 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.023 0.916 . . . . 0.0 112.94 -175.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -99.67 161.94 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.972 164.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.027 ' HB1' ' O ' ' A' ' 123' ' ' ALA . . . -159.78 156.66 27.95 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.558 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 1.217 ' CE ' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -74.4 123.74 25.23 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.752 -176.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.588 ' N ' ' SD ' ' A' ' 90' ' ' MET . . . -57.75 -151.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.089 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.824 ' NH1' ' O ' ' A' ' 93' ' ' THR . 68.0 ttp85 179.71 -104.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.743 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.824 ' O ' ' NH1' ' A' ' 92' ' ' ARG . 97.3 m 100.71 -98.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.638 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.475 ' N ' HG22 ' A' ' 93' ' ' THR . . . -61.95 -132.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.58 1.175 . . . . 0.0 110.93 -174.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 35.2 m-20 -58.24 172.12 0.49 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -56.16 -111.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.723 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.642 ' OD1' ' CG ' ' A' ' 75' ' ' ASN . 35.2 m-20 -52.4 103.57 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.776 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.836 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 68.4 m -165.76 -34.75 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.467 1.104 . . . . 0.0 111.619 -175.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 1.217 ' HB1' ' CE ' ' A' ' 90' ' ' MET . . . -33.58 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.846 0.716 . . . . 0.0 110.701 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.997 HG22 ' HG3' ' A' ' 72' ' ' PRO . 48.8 p -78.87 -60.4 2.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.182 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 78.7 p -171.57 97.57 0.18 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.251 0.97 . . . . 0.0 109.274 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.914 ' OE1' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER 171.23 134.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.727 1.267 . . . . 0.0 109.109 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.927 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -140.24 -171.29 3.16 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.458 -177.041 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.991 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 43.6 p90 -155.93 129.06 8.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.47 -172.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.082 HD11 HD21 ' A' ' 18' ' ' LEU . 57.8 mt -93.27 111.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.662 -2.063 . . . . 0.0 109.515 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.407 ' OD1' ' CE1' ' A' ' 104' ' ' PHE . 50.9 m-20 -65.38 155.26 35.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.398 1.061 . . . . 0.0 110.766 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 54' ' ' MET . 22.4 m -146.92 38.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.11 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 178.95 122.93 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.142 0.901 . . . . 0.0 110.067 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.937 ' OD1' ' HB3' ' A' ' 85' ' ' ARG . 34.0 m-20 -37.17 137.11 0.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.14 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -150.8 108.79 3.71 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.65 1.218 . . . . 0.0 110.097 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 113' ' ' LEU . . . -90.92 -49.96 6.14 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.893 170.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 1.251 ' O ' HD12 ' A' ' 113' ' ' LEU . 30.6 p90 -49.35 75.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.469 1.106 . . . . 0.0 109.235 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.251 HD12 ' O ' ' A' ' 112' ' ' PHE . 3.1 mp 179.28 -35.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.641 -2.072 . . . . 0.0 108.519 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.67 ' OD1' ' O ' ' A' ' 111' ' ' ALA . 6.6 m-20 -38.92 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.856 0.723 . . . . 0.0 110.657 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 1.054 ' CE1' ' O ' ' A' ' 122' ' ' TYR . 44.5 m-70 -46.92 122.27 4.23 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.901 1.375 . . . . 0.0 110.182 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.78 172.41 40.48 Favored Glycine 0 N--CA 1.478 1.455 0 O-C-N 124.524 1.14 . . . . 0.0 112.182 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 118' ' ' ARG . 3.0 mp0 53.25 -148.76 0.43 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.08 -1.06 . . . . 0.0 109.847 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.486 ' O ' ' O ' ' A' ' 117' ' ' GLN . 83.8 mtm180 -51.1 -115.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.726 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 120' ' ' PHE . 37.0 m-20 -60.28 126.68 28.41 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.625 1.203 . . . . 0.0 111.943 -175.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' A' ' 119' ' ' ASP . 24.3 m-85 -54.02 -140.82 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.446 173.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -170.11 -131.34 1.31 Allowed Glycine 0 N--CA 1.476 1.318 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.054 ' O ' ' CE1' ' A' ' 115' ' ' HIS . 89.9 m-85 -79.45 133.86 36.54 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.422 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.076 ' O ' HG23 ' A' ' 124' ' ' VAL . . . -69.55 -161.65 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.519 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.076 HG23 ' O ' ' A' ' 123' ' ' ALA . 54.9 t 178.8 144.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.753 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 1.018 ' HE2' HD13 ' A' ' 20' ' ' LEU . 30.3 p90 -168.74 26.16 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.749 ' HA3' HD23 ' A' ' 20' ' ' LEU . . . -167.17 -143.98 3.96 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 122.87 1.261 . . . . 0.0 113.906 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 1.034 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 40.4 ttmt 179.76 -139.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 111.51 -2.345 . . . . 0.0 109.656 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.988 ' H ' ' CG ' ' A' ' 127' ' ' LYS . 95.8 t -159.78 117.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.952 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.846 ' O ' ' HG3' ' A' ' 130' ' ' LYS . 35.2 m -73.75 -40.99 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.739 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.846 ' HG3' ' O ' ' A' ' 129' ' ' VAL . 8.4 mtpm? -166.19 -156.2 0.24 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.261 0.976 . . . . 0.0 111.379 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 134' ' ' VAL . . . 49.75 18.36 1.77 Allowed Glycine 0 N--CA 1.473 1.154 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.539 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 10.4 tpt -55.03 -48.04 73.95 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.72 ' O ' ' HB2' ' A' ' 136' ' ' ASP . 2.2 m-20 -43.29 -56.07 3.7 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.437 1.085 . . . . 0.0 110.018 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.627 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 55.1 t -39.7 -59.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.49 1.118 . . . . 0.0 109.671 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 132' ' ' MET . . . -45.5 -52.22 10.63 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.655 1.222 . . . . 0.0 109.529 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.929 ' C ' ' OE1' ' A' ' 140' ' ' GLN . 1.8 m-20 -50.51 -65.38 0.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.553 1.158 . . . . 0.0 109.042 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 14.5 mmmm -35.46 -55.02 0.67 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.498 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.157 ' O ' HG22 ' A' ' 141' ' ' VAL . 13.8 mt -56.95 -56.81 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.868 1.355 . . . . 0.0 109.169 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.0 p -64.23 3.25 0.46 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.929 ' OE1' ' C ' ' A' ' 136' ' ' ASP . 1.9 mp0 -97.24 -51.47 4.18 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.213 0.946 . . . . 0.0 108.717 172.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 1.157 HG22 ' O ' ' A' ' 138' ' ' ILE . 33.5 m -45.78 125.83 6.6 Favored Pre-proline 0 N--CA 1.473 0.689 0 O-C-N 124.436 1.085 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 141' ' ' VAL . 81.5 Cg_exo -44.6 177.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.332 -0.305 0 C-N-CA 123.637 2.891 . . . . 0.0 114.022 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.426 HG22 ' CA ' ' A' ' 153' ' ' PRO . 1.5 p -161.23 -140.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.127 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' ASP . 0.7 OUTLIER 179.65 164.49 1.06 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 110.485 -3.052 . . . . 0.0 111.017 169.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.816 ' HB3' ' OE1' ' A' ' 150' ' ' GLN . 34.7 m-20 -50.42 -143.91 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.652 168.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -161.68 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 168.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.55 -94.65 0.05 OUTLIER Glycine 0 N--CA 1.47 0.964 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 168.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.704 ' HG2' ' H ' ' A' ' 149' ' ' TYR . 97.5 Cg_endo -76.83 -65.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.917 3.078 . . . . 0.0 109.603 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.971 ' O ' HG23 ' A' ' 146' ' ' VAL . 39.3 m-85 -69.83 124.73 24.75 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.564 1.165 . . . . 0.0 111.695 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.816 ' OE1' ' HB3' ' A' ' 145' ' ' ASP . 49.5 mm-40 -75.75 -171.84 1.71 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.744 169.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 152' ' ' VAL . 20.6 m-20 44.89 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.615 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.824 ' HB ' HG22 ' A' ' 146' ' ' VAL . 83.7 t -159.16 128.74 3.26 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 113.164 -1.835 . . . . 0.0 107.726 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 1.426 ' CA ' HG22 ' A' ' 143' ' ' THR . 96.5 Cg_exo -39.25 -145.71 0.0 OUTLIER 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.308 2.672 . . . . 0.0 112.508 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 45.7 t -163.86 -8.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.373 1.046 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 1.107 ' HB3' ' HD3' ' A' ' 156' ' ' PRO . 87.8 tttt 178.91 -67.36 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.534 0.521 . . . . 0.0 111.667 175.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.164 ' O ' HG23 ' A' ' 157' ' ' VAL . 56.7 Cg_endo -75.04 76.84 3.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 123.524 2.816 . . . . 0.0 111.672 -168.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 1.164 HG23 ' O ' ' A' ' 156' ' ' PRO . 42.8 t -172.52 127.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.679 168.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 45' ' ' THR . 81.2 t -167.29 118.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 113.648 -1.615 . . . . 0.0 108.068 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.022 HG12 HG22 ' A' ' 11' ' ' THR . 34.2 mt -68.29 133.89 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.881 -176.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.895 HD12 HG22 ' A' ' 10' ' ' THR . 84.4 mt -87.23 -48.32 8.12 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.375 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 1.358 ' O ' HD23 ' A' ' 9' ' ' LEU . 32.4 t -167.89 162.68 13.68 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.395 1.059 . . . . 0.0 113.128 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.042 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -152.75 118.08 5.24 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.835 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 163' ' ' LYS . 19.7 ptpt -151.13 135.2 16.68 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.629 HG13 HG11 ' A' ' 36' ' ' VAL . 33.8 m -68.71 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.992 HD12 ' HD2' ' A' ' 166' ' ' PRO . 48.7 tp -62.12 121.5 66.34 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.795 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.992 ' HD2' HD12 ' A' ' 165' ' ' LEU . 86.1 Cg_exo . . . . . 0 C--O 1.251 1.155 0 C-N-CA 123.573 2.848 . . . . 0.0 112.074 177.607 . . . . . . . . 1 1 . 1 stop_ save_